PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shiau, CE; Lwigale, PY; Das, RM; Wilson, SA; Bronner-Fraser, M				Shiau, Celia E.; Lwigale, Peter Y.; Das, Raman M.; Wilson, Stuart A.; Bronner-Fraser, Marianne			Robo2-Slit1 dependent cell-cell interactions mediate assembly of the trigeminal ganglion	NATURE NEUROSCIENCE			English	Article							REPULSIVE AXON GUIDANCE; NEURAL CREST; EXPRESSION PATTERNS; ADHESION MOLECULES; GENE FAMILY; SLIT; MIGRATION; ROBO; RECEPTORS; MIDLINE	Vertebrate cranial sensory ganglia, responsible for sensation of touch, taste and pain in the face and viscera, are composed of both ectodermal placode and neural crest cells. The cellular and molecular interactions allowing generation of complex ganglia remain unknown. Here, we show that proper formation of the trigeminal ganglion, the largest of the cranial ganglia, relies on reciprocal interactions between placode and neural crest cells in chick, as removal of either population resulted in severe defects. We demonstrate that ingressing placode cells express the Robo2 receptor and early migrating cranial neural crest cells express its cognate ligand Slit1. Perturbation of this receptor-ligand interaction by blocking Robo2 function or depleting either Robo2 or Slit1 using RNA interference disrupted proper ganglion formation. The resultant disorganization mimics the effects of neural crest ablation. Thus, our data reveal a novel and essential role for Robo2-Slit1 signaling in mediating neural crest-placode interactions during trigeminal gangliogenesis.	[Shiau, Celia E.; Lwigale, Peter Y.; Bronner-Fraser, Marianne] CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA; [Das, Raman M.; Wilson, Stuart A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	California Institute of Technology; University of Sheffield	Bronner-Fraser, M (corresponding author), CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA.	mbronner@caltech.edu	Lwigale, Peter/AAV-2563-2020; Lwigale, Peter/A-3353-2011; Shiau, Celia/C-7679-2015	Lwigale, Peter/0000-0003-1799-4905; Shiau, Celia/0000-0002-9347-9158; Bronner, Marianne/0000-0003-4274-1862; Das, Raman/0000-0003-3375-619X; wilson, stuart/0000-0003-3073-258X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/13578] Funding Source: Medline; NIDCR NIH HHS [DE16459, DE016459-07] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07616] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; Anselmo MA, 2003, GENE EXPR PATTERNS, V3, P13, DOI 10.1016/S1567-133X(02)00095-9; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Begbie J, 2002, MOL CELL NEUROSCI, V21, P502, DOI 10.1006/mcne.2002.1197; Begbie J, 2001, SCIENCE, V294, P595, DOI 10.1126/science.1062028; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CHEDOTAL A, 2007, SLITS THEIR RECEPTOR; Chen HX, 2000, DISCRETE EVENT DYN S, V10, P233, DOI 10.1023/A:1008397810443; Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; DAMICOMARTEL A, 1980, J EMBRYOL EXP MORPH, V55, P167; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Fouquet C, 2007, J NEUROSCI, V27, P3037, DOI 10.1523/JNEUROSCI.0172-07.2007; GAMMILL LS, 2006, J NEUROBIOL, V67, P47, DOI DOI 10.1002/NEU.20326; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Kasemeier-Kulesa JC, 2006, DEVELOPMENT, V133, P4839, DOI 10.1242/dev.02662; Kee Y, 2001, MECH DEVELOP, V109, P331, DOI 10.1016/S0925-4773(01)00574-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Loes S, 2001, MECH DEVELOP, V107, P155, DOI 10.1016/S0925-4773(01)00454-3; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lwigale PY, 2001, DEV BIOL, V239, P323, DOI 10.1006/dbio.2001.0450; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; NORTHCUTT RG, 1995, J COMP NEUROL, V355, P427, DOI 10.1002/cne.903550309; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Parsons L, 2003, DEV BIOL, V264, P363, DOI 10.1016/j.ydbio.2003.08.020; Piotrowski T, 1996, BRAIN BEHAV EVOLUT, V47, P55, DOI 10.1159/000113229; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Santiago-Martinez E, 2006, P NATL ACAD SCI USA, V103, P12441, DOI 10.1073/pnas.0605284103; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; Vargesson N, 2001, MECH DEVELOP, V106, P175, DOI 10.1016/S0925-4773(01)00430-0; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zinn K, 1999, CELL, V97, P1, DOI 10.1016/S0092-8674(00)80707-2	47	61	64	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					269	276		10.1038/nn2051	http://dx.doi.org/10.1038/nn2051			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278043				2022-12-28	WOS:000253548300009
J	Ponce, CR; Lomber, SG; Born, RT				Ponce, Carlos R.; Lomber, Stephen G.; Born, Richard T.			Integrating motion and depth via parallel pathways	NATURE NEUROSCIENCE			English	Article							CORTICAL AREAS MT; MACAQUE VISUAL-CORTEX; HORIZONTAL DISPARITY; EYE-MOVEMENTS; DIRECTION SELECTIVITY; CHEMICAL LESIONS; STRIATE CORTEX; TEMPORAL AREA; ALERT MACAQUE; NEURONS	Processing of visual information is both parallel and hierarchical, with each visual area richly interconnected with other visual areas. An example of the parallel architecture of the primate visual system is the existence of two principal pathways providing input to the middle temporal visual area (MT): namely, a direct projection from striate cortex (V1), and a set of indirect projections that also originate in V1 but then relay through V2 and V3. Here we have reversibly inactivated the indirect pathways while recording from MT neurons and measuring eye movements in alert monkeys, a procedure that has enabled us to assess whether the two different input pathways are redundant or whether they carry different kinds of information. We find that this inactivation causes a disproportionate degradation of binocular disparity tuning relative to direction tuning in MT neurons, suggesting that the indirect pathways are important in the recovery of depth in three-dimensional scenes.	[Ponce, Carlos R.] Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Ponce, Carlos R.; Born, Richard T.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lomber, Stephen G.] Univ Western Ontario, Robarts Res Inst, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Lomber, Stephen G.] Univ Western Ontario, Robarts Res Inst, Dept Psychol, London, ON N6A 5K8, Canada	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Western University (University of Western Ontario); Western University (University of Western Ontario)	Ponce, CR (corresponding author), Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, 260 Longwood Ave, Boston, MA 02115 USA.	carlos_ponce@hms.harvard.edu	Born, Richard/M-6454-2019; Lomber, Stephen/B-6820-2015	Born, Richard/0000-0003-4360-427X; Lomber, Stephen/0000-0002-3001-7909; Ponce, Carlos/0000-0002-9887-3234	NEI NIH HHS [R01 EY11379, EY12196, P30 EY012196-109001, R01 EY011379-12, P30 EY012196, R01 EY011379] Funding Source: Medline; NINDS NIH HHS [F31NS052926, F31 NS052926] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011379, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS052926] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Anzai A, 2001, NAT NEUROSCI, V4, P513, DOI 10.1038/87462; Berzhanskaya J, 2007, SPATIAL VISION, V20, P337, DOI 10.1163/156856807780919000; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Broca P., 1863, B SOC ANTHR, V4, P200, DOI DOI 10.1515/9783110807783-002; Busettini C, 1996, NATURE, V380, P342, DOI 10.1038/380342a0; Busettini C, 1996, J NEUROPHYSIOL, V75, P1392, DOI 10.1152/jn.1996.75.4.1392; CHEN G, 2006, SOC NEUROSCI ABST; Churchland MM, 2005, J NEUROPHYSIOL, V93, P1235, DOI 10.1152/jn.00767.2004; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GIRARD P, 1992, J NEUROPHYSIOL, V67, P1437, DOI 10.1152/jn.1992.67.6.1437; Grossberg S, 2000, TRENDS COGN SCI, V4, P233, DOI 10.1016/S1364-6613(00)01464-9; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Inoue Y, 1998, EXP BRAIN RES, V121, P135, DOI 10.1007/s002210050445; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; Pack CC, 2006, J NEUROSCI, V26, P893, DOI 10.1523/JNEUROSCI.3226-05.2006; Pack CC, 2003, NEURON, V37, P525, DOI 10.1016/S0896-6273(02)01187-X; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Qian N, 1997, VISION RES, V37, P1683, DOI 10.1016/S0042-6989(96)00164-2; SANDELL JH, 1982, J NEUROPHYSIOL, V48, P38, DOI 10.1152/jn.1982.48.1.38; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; Sincich LC, 2003, J NEUROSCI, V23, P5684; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Takemura A, 2007, J NEUROSCI, V27, P529, DOI 10.1523/JNEUROSCI.3455-06.2007; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; ZAR JH, 1999, BIOSTAT ANAL, P380	48	84	85	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					216	223		10.1038/nn2039	http://dx.doi.org/10.1038/nn2039			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193039	Green Accepted, Green Submitted			2022-12-28	WOS:000252712100016
J	Aamodt, S				Aamodt, Sandra			Focus on glia and disease	NATURE NEUROSCIENCE			English	Editorial Material																			0	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1349	1349		10.1038/nn1107-1349	http://dx.doi.org/10.1038/nn1107-1349			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965653				2022-12-28	WOS:000250508400007
J	Lobo, MK; Cui, Y; Ostlund, SB; Balleine, BW; Yang, XW				Lobo, Mary Kay; Cui, Yijun; Ostlund, Sean B.; Balleine, Bernard W.; Yang, X. William			Genetic control of instrumental conditioning by striatopallidal neuron - specific S1P receptor Gpr6	NATURE NEUROSCIENCE			English	Article							DISEASE MODELS; BASAL GANGLIA; REWARD; ADDICTION; LIGAND; MOUSE	Instrumental conditioning allows animals to learn about the consequences of their own actions, but the underpinning molecular mechanisms remain elusive. Here we show that the sphingosine-1-phosphate (S1P) receptor Gpr6 is selectively expressed in the striatopallidal neurons in the striatum. Gpr6-deficient mice showed reduced striatal cyclic AMP production in vitro and selective alterations in instrumental conditioning in vivo. Thus, Gpr6 is the first striatopallidal neuron-specific genetic regulator of instrumental conditioning in a mammal.	Univ Calif Los Angeles, Ctr Neurobeh Genet, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yang, XW (corresponding author), Univ Calif Los Angeles, Ctr Neurobeh Genet, Jane & Terry Semel Inst Neurosci & Human Behav, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	balleine@psych.ucla.edu; xwyang@mednet.ucla.edu	Lobo, Mary Kay/K-7734-2015; Ostlund, Sean/D-6000-2017	Lobo, Mary Kay/0000-0002-9419-2079; Balleine, Bernard/0000-0001-8618-7950	NICHD NIH HHS [5T32HD007032] Funding Source: Medline; NIDA NIH HHS [P50 DA005010, P50DA05010] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4	14	68	70	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1395	1397		10.1038/nn1987	http://dx.doi.org/10.1038/nn1987			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934457				2022-12-28	WOS:000250508400014
J	Shen, W; Tian, X; Day, M; Ulrich, S; Tkatch, T; Nathanson, NM; Surmeier, DJ				Shen, Weixing; Tian, Xinyong; Day, Michelle; Ulrich, Sasha; Tkatch, Tatiana; Nathanson, Neil M.; Surmeier, D. James			Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; RECTIFYING POTASSIUM CHANNELS; RECTIFIER K+ CHANNEL; MUSCARINIC RECEPTORS; PARKINSONS-DISEASE; BASAL GANGLIA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRIATAL NEURONS; MESSENGER-RNAS; RAT STRIATUM	Dopamine-depleting lesions of the striatum that mimic Parkinson's disease induce a profound pruning of spines and glutamatergic synapses in striatopallidal medium spiny neurons, leaving striatonigral medium spiny neurons intact. The mechanisms that underlie this cell type-specific loss of connectivity are poorly understood. The Kir2 K+ channel is an important determinant of dendritic excitability in these cells. Here we show that opening of these channels is potently reduced by signaling through M1 muscarinic receptors in striatopallidal neurons, but not in striatonigral neurons. This asymmetry could be attributed to differences in the subunit composition of Kir2 channels. Dopamine depletion alters the subunit composition further, rendering Kir2 channels in striatopallidal neurons even more susceptible to modulation. Reduced opening of Kir2 channels enhances dendritic excitability and synaptic integration. This cell type-specific enhancement of dendritic excitability is an essential trigger for synaptic pruning after dopamine depletion, as pruning was prevented by genetic deletion of M1 muscarinic receptors.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu		Nathanson, Neil/0000-0002-9216-121X; Tkatch, Tatiana/0000-0001-6626-7435	NINDS NIH HHS [NS 34696] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, R01NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANDERSON JJ, 1994, J PHARMACOL EXP THER, V269, P1144; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; Chuang HH, 1997, CELL, V89, P1121, DOI 10.1016/S0092-8674(00)80299-8; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Figueroa A, 2002, SYNAPSE, V46, P215, DOI 10.1002/syn.10114; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HERSCH SM, 1994, J NEUROSCI, V14, P3351; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWE AR, 1995, J NEUROSCI, V15, P458; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Karschin C, 1996, J NEUROSCI, V16, P3559; KOCH C, 1993, J NEUROSCI, V13, P413; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; MANDEL RJ, 1994, BRAIN RES, V653, P57, DOI 10.1016/0006-8993(94)90372-7; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mermelstein PG, 1998, J NEUROSCI, V18, P6650; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Pruss H, 2003, MOL BRAIN RES, V110, P203, DOI 10.1016/S0169-328X(02)00649-6; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; ROBERTSON GS, 1992, EUR J PHARMACOL, V219, P323, DOI 10.1016/0014-2999(92)90313-S; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Topert C, 1998, J NEUROSCI, V18, P4096; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; WOOTEN G, 1990, NEUROBIOLOGY DIS; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2	50	181	185	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1458	1466		10.1038/nn1972	http://dx.doi.org/10.1038/nn1972			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906621				2022-12-28	WOS:000250508400024
J	George, L; Chaverra, M; Todd, V; Lansford, R; Lefcort, F				George, Lynn; Chaverra, Marta; Todd, Valerie; Lansford, Rusty; Lefcort, Frances			Nociceptive sensory neurons derive from contralaterally migrating, fate-restricted neural crest cells	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT-GANGLIA; CHICK-EMBRYO; NEUROTROPHIN RECEPTORS; REGULATES DEVELOPMENT; NERVOUS-SYSTEM; AVIAN EMBRYO; STEM-CELLS; IN-VIVO; EXPRESSION; LINEAGE	Neural crest cells (NCCs) are a transient population of multipotent progenitors that give rise to numerous cell types in the embryo. An unresolved issue is the degree to which the fate of NCCs is specified prior to their emigration from the neural tube. In chick embryos, we identified a subpopulation of NCCs that, upon delamination, crossed the dorsal midline to colonize spatially discrete regions of the contralateral dorsal root ganglia (DRG), where they later gave rise to nearly half of the nociceptor sensory neuron population. Our data indicate that before emigration, this NCC subset is phenotypically distinct, with an intrinsic lineage potential that differs from its temporally synchronized, but ipsilaterally migrating, cohort. These findings not only identify a major source of progenitor cells for the pain- and temperature-sensing afferents, but also reveal a previously unknown migratory pathway for sensory-fated NCCs that requires the capacity to cross the embryonic midline.	Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; CALTECH, Beckman Imaging Ctr, Pasadena, CA 91125 USA	Montana State University System; Montana State University Bozeman; California Institute of Technology	Lefcort, F (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Leon Johnson Hall,Rm 512, Bozeman, MT 59717 USA.	lefcort@montana.edu	Lansford, Rusty/C-6956-2014	George, Lynn/0000-0002-8125-2319; Lansford, Rusty/0000-0002-2159-3699	NINDS NIH HHS [F32 NS054529] Funding Source: Medline; PHS HHS [R01 35714, NRSA 7055571] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS054529, R15NS090384] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BHATTACHARYYA A, 1991, NEURON, V7, P831, DOI 10.1016/0896-6273(91)90285-8; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; CARR VM, 1978, J COMP NEUROL, V182, P741; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Couly G, 1996, DEVELOPMENT, V122, P3393; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FRANK E, 1991, DEVELOPMENT, V111, P895; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Henion PD, 1997, DEVELOPMENT, V124, P4351; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Nelson BR, 2002, MECH DEVELOP, V119, pS11, DOI 10.1016/S0925-4773(03)00084-4; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Pannese E, 1974, Adv Anat Embryol Cell Biol, V47, P7; Perez SE, 1999, DEVELOPMENT, V126, P1715; Raible DW, 2005, SEMIN CELL DEV BIOL, V16, P673, DOI 10.1016/j.semcdb.2005.06.008; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; SCHWEIZER G, 1983, CELL DIFFER DEV, V13, P191, DOI 10.1016/0045-6039(83)90089-1; SCOTT SA, 1992, NEURONS DEV DIVERSIT; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Teddy JM, 2005, BIOTECHNIQUES, V39, P703, DOI 10.2144/000112017; TEILLET M-A, 1971, Annales d'Embryologie et de Morphogenese, V4, P95; TOSNEY KW, 1978, DEV BIOL, V62, P317, DOI 10.1016/0012-1606(78)90219-1; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	49	34	38	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1287	1293		10.1038/nn1962	http://dx.doi.org/10.1038/nn1962			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828258				2022-12-28	WOS:000249720800015
J	Matsumoto, M; Matsumoto, K; Abe, H; Tanaka, K				Matsumoto, Madoka; Matsumoto, Kenji; Abe, Hiroshi; Tanaka, Keiji			Medial prefrontal cell activity signaling prediction errors of action values	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DOPAMINE NEURONS; REWARD PREDICTION; FRONTAL-CORTEX; MACAQUE MONKEY; NEURAL SYSTEM; BRAIN; REINFORCEMENT; PERFORMANCE; NEGATIVITY	To adapt behavior to a changing environment, one must monitor outcomes of executed actions and adjust subsequent actions accordingly. Involvement of the medial frontal cortex in performance monitoring has been suggested, but little is known about neural processes that link performance monitoring to performance adjustment. Here, we recorded from neurons in the medial prefrontal cortex of monkeys learning arbitrary action- outcome contingencies. Some cells preferentially responded to positive visual feedback stimuli and others to negative feedback stimuli. The magnitude of responses to positive feedback stimuli decreased over the course of behavioral adaptation, in correlation with decreases in the amount of prediction error of action values. Therefore, these responses in medial prefrontal cells may signal the direction and amount of error in prediction of values of executed actions to specify the adjustment in subsequent action selections.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; Kyoto Univ, Inst Primate Res, Dept Behav & Brain Sci, Inuyama, Aichi 4848506, Japan; Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan; Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	RIKEN; Kyoto University; Tokyo Institute of Technology; Saitama University	Matsumoto, K (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumot@riken.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Matsumoto, Kenji/0000-0003-0883-4280				Allport G. W., 1961, PATTERN GROWTH PERSO; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FANTINO E, 1969, J EXP ANAL BEHAV, V12, P723, DOI 10.1901/jeab.1969.12-723; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Maslow A.H., 1954, MOTIVATION PERSONALI; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Skinner BF., 1953, SCI HUMAN BEHAV; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WILLIAMS BA, 1994, BEHAV ANALYST, V17, P261, DOI 10.1007/BF03392675; WOODWORTH RS, 1958, DYNAMICS BEHAV; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	50	317	320	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					647	656		10.1038/nn1890	http://dx.doi.org/10.1038/nn1890			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160NB	17450137				2022-12-28	WOS:000245948000022
J	Grosmaitre, X; Santarelli, LC; Tan, J; Luo, MM; Ma, MH				Grosmaitre, Xavier; Santarelli, Lindsey C.; Tan, Jie; Luo, Minmin; Ma, Minghong			Dual functions of mammalian olfactory sensory neurons as odor detectors and mechanical sensors	NATURE NEUROSCIENCE			English	Article							BULB UNIT-ACTIVITY; EXTERNAL TUFTED CELLS; MOLECULAR-BASIS; RECEPTOR; RAT; INHIBITION; RESPONSES; PATTERNS; CHANNEL	Most sensory systems are primarily specialized to detect one sensory modality. Here we report that olfactory sensory neurons (OSNs) in the mammalian nose can detect two distinct modalities transmitted by chemical and mechanical stimuli. As revealed by patch-clamp recordings, many OSNs respond not only to odorants, but also to mechanical stimuli delivered by pressure ejections of odor-free Ringer solution. The mechanical responses correlate directly with the pressure intensity and show several properties similar to those induced by odorants, including onset latency, reversal potential and adaptation to repeated stimulation. Blocking adenylyl cyclase or knocking out the cyclic nucleotide-gated channel CNGA2 eliminates the odorant and the mechanical responses, suggesting that both are mediated by a shared cAMP cascade. We further show that this mechanosensitivity enhances the firing frequency of individual neurons when they are weakly stimulated by odorants and most likely drives the rhythmic activity (theta oscillation) in the olfactory bulb to synchronize with respiration.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Natl Inst Biol Sci, Beijing, Peoples R China	University of Pennsylvania; National Institute of Biological Sciences, Beijing	Ma, MH (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 215 Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	minghong@mail.med.upenn.edu		Grosmaitre, Xavier/0000-0001-8041-6919; Luo, Minmin/0000-0003-3535-6624; Ma, Minghong/0000-0002-5027-9623	NIDCD NIH HHS [R01 DC006213-01A2, R01 DC006213-02, R01 DC006213-03, R01 DC006213] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006213] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1951, J PHYSIOL-LONDON, V114, pP4; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fontanini A, 2003, J NEUROSCI, V23, P7993; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Hayar A, 2005, J NEUROSCI, V25, P8197, DOI 10.1523/JNEUROSCI.2374-05.2005; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Lai-Fook SJ, 2005, J APPL PHYSIOL, V98, P2204, DOI 10.1152/japplphysiol.00869.2004; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Ma MH, 1999, J NEUROSCI METH, V92, P31, DOI 10.1016/S0165-0270(99)00089-8; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Ma MH, 2003, J NEUROSCI, V23, P317; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; POTTER H, 1976, BRAIN RES, V116, P417, DOI 10.1016/0006-8993(76)90490-X; RAVEL N, 1987, EXP BRAIN RES, V65, P623; RAVEL N, 1990, NEUROSCI LETT, V115, P213, DOI 10.1016/0304-3940(90)90457-K; Rodolfo-Masera T., 1943, ARCH ITAL ANAT E EMBRIOL, V48, P157; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; UEKI S, 1961, J NEUROPHYSIOL, V24, P12, DOI 10.1152/jn.1961.24.1.12; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; ZUFALL F, 1991, P ROY SOC B-BIOL SCI, V246, P225, DOI 10.1098/rspb.1991.0148; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	39	213	215	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					348	354		10.1038/nn1856	http://dx.doi.org/10.1038/nn1856			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310245	Green Accepted			2022-12-28	WOS:000244480300017
J	Vijayraghavan, S; Wang, M; Birnbaum, SG; Williams, GV; Arnsten, AFT				Vijayraghavan, Susheel; Wang, Min; Birnbaum, Shari G.; Williams, Graham V.; Arnsten, Amy F. T.			Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; MODULATION; GENOTYPE; CORTEX; MECHANISMS; INTERNEURONS; PERFORMANCE; ACTIVATION; INHIBITION; EXCITABILITY	Dopamine (DA) D1 receptor (D1R) stimulation in prefrontal cortex (PFC) produces an 'inverted-U' dose-response, whereby either too little or too much D1R stimulation impairs spatial working memory. This response has been observed across species, including genetic linkages with human cognitive abilities, PFC activation states and DA synthesis. The cellular basis for the inverted U has long been sought, with in vitro intracellular recordings supporting a variety of potential mechanisms. The current study demonstrates that the D1R agonist inverted-U response can be observed in PFC neurons of behaving monkeys: low levels of D1R stimulation enhance spatial tuning by suppressing responses to nonpreferred directions, whereas high levels reduce delay-related firing for all directions, eroding tuning. These sculpting actions of D1R stimulation are mediated in monkeys and rats by cyclic AMP intracellular signaling. The evidence for an inverted U at the cellular level in behaving animals promises to bridge in vitro molecular analyses with human cognitive experience.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	Yale University; Yale University	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06520 USA.	amy.arnsten@yale.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER; NIMH NIH HHS [P50MH068789] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Chudasama Y, 2004, NEUROPSYCHOPHARMACOL, V29, P1628, DOI 10.1038/sj.npp.1300490; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Floresco SB, 2001, BEHAV NEUROSCI, V115, P934, DOI 10.1037/0735-7044.115.4.934; FRANKE P, 1994, PSYCHIAT RES, V54, P259, DOI 10.1016/0165-1781(94)90020-5; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Gibbs SEB, 2005, PSYCHOPHARMACOLOGY, V180, P644, DOI 10.1007/s00213-005-0077-5; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Lidow MS, 2003, SYNAPSE, V47, P101, DOI 10.1002/syn.10143; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mehta MA, 2000, J NEUROSCI, V20; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Minzenberg MJ, 2006, PSYCHIAT GENET, V16, P117, DOI 10.1097/01.ypg.0000199448.00163.e6; NUECHTERLEIN KH, 1992, SCHIZOPHRENIA BULL, V18, P387, DOI 10.1093/schbul/18.3.387; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; ROBBINS TW, 1979, NEUROPHARMACOLOGY, V18, P931, DOI 10.1016/0028-3908(79)90157-6; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHWARTZ ML, 1988, J NEUROSCI, V8, P1962; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Urban NN, 2002, J PHYSIOL-LONDON, V539, P707, DOI 10.1113/jphysiol.2001.015024; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Yan Z, 1997, NEURON, V19, P1115, DOI 10.1016/S0896-6273(00)80402-X; Yang CR, 1996, J NEUROSCI, V16, P1922; Yang CR, 1996, J NEUROSCI, V16, P1904; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016; Zhou FM, 1999, J NEUROPHYSIOL, V81, P967, DOI 10.1152/jn.1999.81.3.967	47	708	720	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					376	384		10.1038/nn1846	http://dx.doi.org/10.1038/nn1846			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17277774				2022-12-28	WOS:000244480300021
J	Biron, D; Shibuya, M; Gabel, C; Wasserman, SM; Clark, DA; Brown, A; Sengupta, P; Samuel, ADT				Biron, David; Shibuya, Mayumi; Gabel, Christopher; Wasserman, Sara M.; Clark, Damon A.; Brown, Adam; Sengupta, Piali; Samuel, Aravinthan D. T.			A diacylglycerol kinase modulates long-term thermotactic behavioral plasticity in C. elegans	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; GILL-WITHDRAWAL REFLEX; NUCLEOTIDE-GATED CHANNEL; EF-HAND MOTIFS; SYNAPTIC-TRANSMISSION; MORPHOLOGICAL BASIS; SENSORY NEURONS; NERVOUS-SYSTEM; AFD NEURON; HABITUATION	A memory of prior thermal experience governs Caenorhabditis elegans thermotactic behavior. On a spatial thermal gradient, C. elegans tracks isotherms near a remembered temperature we call the thermotactic set-point (T-S). The T-S corresponds to the previous cultivation temperature and can be reset by sustained exposure to a new temperature. The mechanisms underlying this behavioral plasticity are unknown, partly because sensory and experience-dependent components of thermotactic behavior have been difficult to separate. Using newly developed quantitative behavioral analyses, we demonstrate that the TS represents a weighted average of a worm's temperature history. We identify the DGK-3 diacylglycerol kinase as a thermal memory molecule that regulates the rate of TS resetting by modulating the temperature range of synaptic output, but not temperature sensitivity, of the AFD thermosensory neurons. These results provide the first mechanistic insight into the basis of experience-dependent plasticity in this complex behavior.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Brandeis University; Brandeis University; Harvard University	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, 415 S St, Waltham, MA 02454 USA.	sengupta@brandeis.edu; samuel@physics.harvard.edu		Wasserman, Sara/0000-0002-8720-1117; Clark, Damon/0000-0001-8487-700X; Gabel, Christopher/0000-0002-2763-3938	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NIMH NIH HHS [T32 MH019929] Funding Source: Medline; NINDS NIH HHS [NS44232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, J NEUROSCI, V8, P2452; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1978, SCIENCE, V202, P1306, DOI 10.1126/science.214854; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; COSSINS AR, 1994, PORTL PR P, P63; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HUTCHISON VH, 1979, AM ZOOL, V19, P367; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Maruyama H, 2001, NEUROSCIENCE, V104, P287, DOI 10.1016/S0306-4522(01)00097-5; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Ryu WS, 2002, J NEUROSCI, V22, P5727; SAKANE F, 1991, J BIOL CHEM, V266, P7096; SAKANE F, 1991, BIOCHEM BIOPH RES CO, V181, P1015, DOI 10.1016/0006-291X(91)92038-L; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamada K, 1997, BIOCHEM J, V321, P59, DOI 10.1042/bj3210059; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	50	68	72	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1499	1505		10.1038/nn1796	http://dx.doi.org/10.1038/nn1796			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17086178				2022-12-28	WOS:000242404000013
J	Katz, M				Katz, Michael			A genetics pioneer focused on child health challenges	NATURE NEUROSCIENCE			English	Editorial Material											Katz, M (corresponding author), 1275 Mamaroneck Ave, White Plains, NY 10605 USA.	mkatz@marchofdimes.com							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1211	1211		10.1038/nn1006-1211	http://dx.doi.org/10.1038/nn1006-1211			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	17001338	Bronze			2022-12-28	WOS:000241493900008
J	Kozorovitskiy, Y; Hughes, M; Lee, K; Gould, E				Kozorovitskiy, Yevgenia; Hughes, Maria; Lee, Kim; Gould, Elizabeth			Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							ACTIVATION; FOREBRAIN; PICTURES	Like human fathers, male marmosets help raise their young, yet the ways in which fatherhood influences the brain remain largely unknown. We show that first-time and experienced marmoset fathers have enhanced density of dendritic spines on pyramidal neurons in prefrontal cortex as compared to non-fathers. In parallel, the abundance of vasopressin V1a receptors and the proportion of V1a receptor - labeled dendritic spines increase.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Green Hall,Washington Rd, Princeton, NJ 08544 USA.	goulde@princeton.edu	Kozorovitskiy, Yevgenia/GOP-1185-2022; Rahmandar, Maria/I-7024-2015	Rahmandar, Maria/0000-0002-3226-9587; Kozorovitskiy, Yevgenia/0000-0002-3710-1484; Lee, Kim/0000-0002-5675-1896				Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; PEDEN JK, 1947, J COMP NEUROL, V86, P37, DOI 10.1002/cne.900860103; Radley JJ, 2005, EXP NEUROL, V196, P199, DOI 10.1016/j.expneurol.2005.07.008; Roky R, 1996, NEUROENDOCRINOLOGY, V63, P422, DOI 10.1159/000127067; Rylands AB, 1993, MARMOSETS TAMARINS S; Smeltzer MD, 2006, NEUROSCI LETT, V394, P146, DOI 10.1016/j.neulet.2005.10.019; Son MC, 2001, NEUROBIOL LEARN MEM, V76, P388, DOI 10.1006/nlme.2001.4020; Wang ZX, 1997, BRAIN RES, V768, P147, DOI 10.1016/S0006-8993(97)00636-7; Wynne-Edwards KE, 2001, HORM BEHAV, V40, P139, DOI 10.1006/hbeh.2001.1699	13	104	106	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1094	1095		10.1038/nn1753	http://dx.doi.org/10.1038/nn1753			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921371				2022-12-28	WOS:000240080800008
J	Lo, CC; Wang, XJ				Lo, Chung-Chuan; Wang, Xiao-Jing			Cortico-basal ganglia circuit mechanism for a decision threshold in reaction time tasks	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; MONKEY SUPERIOR COLLICULUS; NIGRA PARS RETICULATA; PERCEPTUAL DECISION; SENSORY STIMULI; CAUDATE NEURONS; REWARD; BRAIN; DOPAMINE; MODULATION	Growing evidence from primate neurophysiology and modeling indicates that in reaction time tasks, a perceptual choice is made when the firing rate of a selective cortical neural population reaches a threshold. This raises two questions: what is the neural substrate of the threshold and how can it be adaptively tuned according to behavioral demands? Using a biophysically based network model of spiking neurons, we show that local dynamics in the superior colliculus gives rise to an all-or-none burst response that signals threshold crossing in upstream cortical neurons. Furthermore, the threshold level depends only weakly on the efficacy of the cortico-collicular pathway. In contrast, the threshold and the rate of reward harvest are sensitive to, and hence can be optimally tuned by, the strength of cortico-striatal synapses, which are known to be modifiable by dopamine-dependent plasticity. Our model provides a framework to describe the main computational steps in a reaction time task and suggests that separate brain pathways are critical to the detection and adjustment of a decision threshold.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University	Wang, XJ (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.	xjwang@brandeis.edu	Lo, Chung-Chuan/C-3951-2008; Wang, Xiao-Jing/D-2722-2009	Lo, Chung-Chuan/0000-0001-7737-7250; 	NIMH NIH HHS [MH 062349] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Behan M, 2002, J COMP NEUROL, V452, P334, DOI 10.1002/cne.10378; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Gruber AJ, 2003, J NEUROPHYSIOL, V90, P1095, DOI 10.1152/jn.00618.2002; Hall WC, 2003, SUPERIOR COLLICULUS; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; HOUK JC, 1998, MODEL INFORMATION PR; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Luce R. D., 1986, RESPONSE TIMES; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pettit DL, 1999, J NEUROPHYSIOL, V81, P1424, DOI 10.1152/jn.1999.81.3.1424; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman JD, 2002, J NEUROSCI, V22, P9475; Saito Y, 2004, J NEUROPHYSIOL, V92, P3500, DOI 10.1152/jn.00033.2004; Saito Y, 2003, J NEUROSCI, V23, P5854; Saito Y, 1999, J NEUROPHYSIOL, V82, P754, DOI 10.1152/jn.1999.82.2.754; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WICKENS J, 1997, NETWORK COMP NEURAL, V8, P77; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	50	334	339	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					956	963		10.1038/nn1722	http://dx.doi.org/10.1038/nn1722			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16767089				2022-12-28	WOS:000238590800023
J	Majdan, M; Shatz, CJ				Majdan, M; Shatz, CJ			Effects of visual experience on activity-dependent gene regulation in cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; FACTOR MESSENGER-RNA; MONOCULAR DEPRIVATION; CRITICAL PERIOD; POSTNATAL-DEVELOPMENT; SYNAPTIC PLASTICITY; IMPULSE ACTIVITY; COLUMN FORMATION; NERVOUS-SYSTEM; EXPRESSION	There are critical periods in development when sensory experience directs the maturation of synapses and circuits within neocortex. We report that the critical period in mouse visual cortex has a specific molecular logic of gene regulation. Four days of visual deprivation regulated one set of genes during the critical period, and different sets before or after. Dark rearing perturbed the regulation of these age-specific gene sets. In addition, a 'common gene set', comprised of target genes belonging to a mitogen-activated protein (MAP) kinase signaling pathway, was regulated by vision at all ages but was impervious to prior history of sensory experience. Together, our results demonstrate that vision has dual effects on gene regulation in visual cortex and that sensory experience is needed for the sequential acquisition of age-specific, but not common, gene sets. Thus, a dynamic interplay between experience and gene expression drives activity-dependent circuit maturation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu			NEI NIH HHS [EY02858] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002858, R01EY002858] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CYNADER M, 1983, DEV BRAIN RES, V8, P155, DOI 10.1016/0165-3806(83)90002-0; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Deak F, 1997, J BIOL CHEM, V272, P9268; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Finkenstadt PM, 2002, J NEUROCHEM, V83, P202, DOI 10.1046/j.1471-4159.2002.01158.x; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lachance PED, 2004, J NEUROCHEM, V88, P1455, DOI 10.1046/j.1471-4159.2003.02274.x; Lein ES, 2000, J NEUROSCI, V20, P1470; MartinezRodriguez R, 1997, J BRAIN RES, V38, P61; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mize RR, 2000, BRAIN RES, V886, P15, DOI 10.1016/S0006-8993(00)02750-5; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mower GD, 2002, MOL BRAIN RES, V105, P157, DOI 10.1016/S0169-328X(02)00405-9; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Prasad SS, 2002, NEUROSCIENCE, V111, P35, DOI 10.1016/S0306-4522(01)00570-X; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sgambato V, 1998, J NEUROSCI, V18, P8814; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	50	124	124	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					650	659		10.1038/nn1674	http://dx.doi.org/10.1038/nn1674			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582906				2022-12-28	WOS:000237417200016
J	Keleman, K; Kruttner, S; Alenius, M; Dickson, BJ				Keleman, Krystyna; Kruettner, Sebastian; Alenius, Mattias; Dickson, Barry J.			Function of the Drosophila CPEB protein Orb2 in long-term courtship memory	NATURE NEUROSCIENCE			English	Article							CYTOPLASMIC POLYADENYLATION; CONSOLIDATED MEMORY; SYNAPTIC PLASTICITY; NEURONAL ISOFORM; NEURAL CIRCUITRY; MESSENGER-RNA; BEHAVIOR; GENE; SEX; LOCALIZATION	Both long-term behavioral memory and synaptic plasticity require protein synthesis, some of which may occur locally at specific synapses. Cytoplasmic polyadenylation element-binding (CPEB) proteins are thought to contribute to the local protein synthesis that underlies long-term changes in synaptic efficacy, but a role has not been established for them in the formation of long-term behavioral memory. We found that the Drosophila melanogaster CPEB protein Orb2 is acutely required for long-term conditioning of male courtship behavior. Deletion of the N-terminal glutamine-rich region of Orb2 resulted in flies that were impaired in their ability to form long-term, but not short-term, memory. Memory was restored by expressing Orb2 selectively in fruitless (fru)positive c neurons of the mushroom bodies and by providing Orb2 function in mushroom bodies only during and shortly after training. Our data thus demonstrate that a CPEB protein is important in long-term memory and map the molecular, spatial and temporal requirements for its function in memory formation.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Keleman, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keleman@imp.ac.at; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dukas R, 2005, ANIM BEHAV, V69, P1203, DOI 10.1016/j.anbehav.2004.08.012; Dukas R, 2006, ANIM BIOL, V56, P125, DOI 10.1163/157075606777304258; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1984, GENETICS, V106, P613; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1992, DEVELOPMENT, V115, P75; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Reif M, 2002, ANIM BEHAV, V63, P143, DOI 10.1006/anbe.2001.1876; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schlote, 1984, DROS INFORM SERV, V60, P210; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sitnik N A, 2003, Neurosci Behav Physiol, V33, P67, DOI 10.1023/A:1021131415653; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VANNATEERS WV, 2007, DROSOPHILA CURR BIOL, V17, P606; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	50	188	192	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1587	1593		10.1038/nn1996	http://dx.doi.org/10.1038/nn1996			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965711				2022-12-28	WOS:000251172900016
J	Ofen, N; Kao, YC; Sokol-Hessner, P; Kim, H; Whitfield-Gabrieli, S; Gabrieli, JDE				Ofen, Noa; Kao, Yun-Ching; Sokol-Hessner, Peter; Kim, Heesoo; Whitfield-Gabrieli, Susan; Gabrieli, John D. E.			Development of the declarative memory system in the human brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL FUNCTIONAL-ORGANIZATION; COMMON STEREOTACTIC SPACE; TEMPORAL-LOBE; CORTICAL DEVELOPMENT; STRUCTURAL MRI; FRONTAL-CORTEX; BOLD FMRI; CHILDREN; CHILDHOOD; ADULTS	Brain regions that are involved in memory formation, particularly medial temporal lobe ( MTL) structures and lateral prefrontal cortex ( PFC), have been identified in adults, but not in children. We investigated the development of brain regions involved in memory formation in 49 children and adults ( ages 8-24), who studied scenes during functional magnetic resonance imaging. Recognition memory for vividly recollected scenes improved with age. There was greater activation for subsequently remembered scenes than there was for forgotten scenes in MTL and PFC regions. These activations increased with age in specific PFC, but not in MTL, regions. PFC, but not MTL, activations correlated with developmental gains in memory for details of experiences. Voxel-based morphometry indicated that gray matter volume in PFC, but not in MTL, regions reduced with age. These results suggest that PFC regions that are important for the formation of detailed memories for experiences have a prolonged maturational trajectory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; NYU, Dept Psychol, New York, NY 10003 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Stanford University; Harvard University; New York University; University of California System; University of California Berkeley	Ofen, N (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall,Bldg 420, Stanford, CA 94305 USA.	noa@mit.edu	Gabrieli, John/AAJ-2869-2020	Ofen, Noa/0000-0003-3927-8408				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Billingsley RL, 2002, J EXP CHILD PSYCHOL, V82, P251, DOI 10.1016/S0022-0965(02)00007-3; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Chiu CYP, 2006, DEV NEUROPSYCHOL, V29, P321, DOI 10.1207/s15326942dn2902_3; Cycowicz YM, 2003, J COGNITIVE NEUROSCI, V15, P759, DOI 10.1162/jocn.2003.15.5.759; Cycowicz YM, 2001, NEUROPSYCHOLOGIA, V39, P255, DOI 10.1016/S0028-3932(00)00108-1; Czernochowski D, 2005, COGN AFFECT BEHAV NE, V5, P417, DOI 10.3758/CABN.5.4.417; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DIRKS J, 1977, J EXP CHILD PSYCHOL, V23, P315, DOI 10.1016/0022-0965(77)90108-4; Drummey AB, 2002, DEVELOPMENTAL SCI, V5, P502, DOI 10.1111/1467-7687.00243; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goswami U, 2006, NAT REV NEUROSCI, V7, P406, DOI 10.1038/nrn1907; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; MANDLER JM, 1978, J EXP CHILD PSYCHOL, V26, P122, DOI 10.1016/0022-0965(78)90114-5; Menon V, 2005, COGNITIVE BRAIN RES, V25, P379, DOI 10.1016/j.cogbrainres.2005.07.007; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wig GS, 2004, J COGNITIVE NEUROSCI, V16, P139, DOI 10.1162/089892904322755629; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; YONELINAS AP, 1995, PSYCHOL RES-PSYCH FO, V57, P156, DOI 10.1007/BF00431277	49	226	229	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1198	1205		10.1038/nn1950	http://dx.doi.org/10.1038/nn1950			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676059				2022-12-28	WOS:000249144000023
J	Choi, JT; Bastian, AJ				Choi, Julia T.; Bastian, Amy J.			Adaptation reveals independent control networks for human walking	NATURE NEUROSCIENCE			English	Article							CENTRAL PATTERN GENERATOR; LOW SPINAL CAT; INTERLIMB COORDINATION; SPINOCEREBELLAR TRACT; LOCOMOTOR ADAPTATIONS; FICTIVE LOCOMOTION; CORD; CEREBELLUM; NEURONS; DELETIONS	Human walking is remarkably adaptable on short and long timescales. We can immediately transition between directions and gait patterns, and we can adaptively learn accurate calibrations for different walking contexts. Here we studied the degree to which different motor patterns can adapt independently. We used a split-belt treadmill to adapt the right and left legs to different speeds and in different directions (forward versus backward). To our surprise, adults could easily walk with their legs moving in opposite directions. Analysis of aftereffects showed that walking adaptations are stored independently for each leg and do not transfer across directions. Thus, there are separate functional networks controlling forward and backward walking in humans, and the circuits controlling the right and left legs can be trained individually. Such training could provide a new therapeutic approach for correcting various walking asymmetries.	Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosurg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bastian, AJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	julia.choi@jhu.edu; bastian@kennedykrieger.org	Hoogkamer, Wouter/G-4498-2010	Choi, Julia/0000-0003-4963-9094	NCRR NIH HHS [C06RR15488] Funding Source: Medline; NICHD NIH HHS [R01HD048740] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015488] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Batschelet E., 1981, CIRCULAR STAT BIOL; BERKOWITZ A, 1994, J NEUROSCI, V14, P5105; Bosco G, 2006, EXP BRAIN RES, V175, P83, DOI 10.1007/s00221-006-0530-7; Bosco G, 2005, EXP BRAIN RES, V167, P394, DOI 10.1007/s00221-005-0033-y; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; DIETZ V, 1994, EXP BRAIN RES, V101, P513; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; Grasso R, 1998, J NEUROPHYSIOL, V80, P1868, DOI 10.1152/jn.1998.80.4.1868; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Hammar I, 2004, EUR J NEUROSCI, V19, P1305, DOI 10.1111/j.1460-9568.2004.03239.x; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; MORTIN LI, 1989, J NEUROSCI, V9, P2285; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; ORLOVSKY GN, 1972, BRAIN RES, V46, P85, DOI 10.1016/0006-8993(72)90007-8; ORLOVSKY GN, 1972, BRAIN RES, V40, P359, DOI 10.1016/0006-8993(72)90139-4; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Poppele RE, 2003, EXP BRAIN RES, V149, P361, DOI 10.1007/s00221-003-1378-8; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; REISMAN DS, 2007, BRAIN           0402, DOI DOI 10.1093/BRAIN/AWM035; Reynolds RF, 2004, J NEUROPHYSIOL, V91, P92, DOI 10.1152/jn.00495.2003; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292; Yang JF, 2005, J NEUROSCI, V25, P6869, DOI 10.1523/JNEUROSCI.1765-05.2005; Yang JF, 2004, CAN J PHYSIOL PHARM, V82, P662, DOI 10.1139/Y04-070; Zar JH., 1999, BIOSTAT ANAL, V663rd	38	236	243	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1055	1062		10.1038/nn1930	http://dx.doi.org/10.1038/nn1930			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603479				2022-12-28	WOS:000248357500020
J	Kuhl, BA; Dudukovic, NM; Kahn, I; Wagner, AD				Kuhl, Brice A.; Dudukovic, Nicole M.; Kahn, Itamar; Wagner, Anthony D.			Decreased demands on cognitive control reveal the neural processing benefits of forgetting	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL GYRUS; PREFRONTAL CORTEX; RECOGNITION MEMORY; CONFLICT; MECHANISMS; RETRIEVAL; ACTIVATION; INHIBITION; RECOLLECTION	Remembering often requires the selection of goal-relevant memories in the face of competition from irrelevant memories. Although there is a cost of selecting target memories over competing memories (increased forgetting of the competing memories), here we report neural evidence for the adaptive benefits of forgetting-namely, reduced demands on cognitive control during future acts of remembering. Functional magnetic resonance imaging during selective retrieval showed that repeated retrieval of target memories was accompanied by dynamic reductions in the engagement of functionally coupled cognitive control mechanisms that detect (anterior cingulate cortex) and resolve (dorsolateral and ventrolateral prefrontal cortex) mnemonic competition. Strikingly, regression analyses revealed that this prefrontal disengagement tracked the extent to which competing memories were forgotten; greater forgetting of competing memories was associated with a greater decline in demands on prefrontal cortex during target remembering. These findings indicate that, although forgetting can be frustrating, memory might be adaptive because forgetting confers neural processing benefits.	Stanford Univ, Dept Psychol, Neurosci Program, Stanford, CA 94305 USA	Stanford University	Kuhl, BA (corresponding author), Stanford Univ, Dept Psychol, Neurosci Program, Jordan Hall,Bldg 420,450 Serra Mall, Stanford, CA 94305 USA.	bkuhl@stanford.edu		Kahn, Itamar/0000-0002-1895-8677; Wagner, Anthony/0000-0003-0624-4543	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080309] Funding Source: NIH RePORTER; NIMH NIH HHS [1R01MH080309-01, R01 MH080309] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 2000, PSYCHON B REV, V7, P522, DOI 10.3758/BF03214366; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gates A. I., 1917, ARCH PSYCHOL, V40, P1; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; MENSINK GJ, 1988, PSYCHOL REV, V95, P434, DOI 10.1037/0033-295X.95.4.434; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Raye CL, 2002, NEUROIMAGE, V15, P447, DOI 10.1006/nimg.2001.0983; ROEDIGER HL, 1974, MEM COGNITION, V2, P261, DOI 10.3758/BF03208993; Roediger HL, 2000, CURR DIR PSYCHOL SCI, V9, P123, DOI 10.1111/1467-8721.00075; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Thompson-Schill SL, 2006, PSYCHON B REV, V13, P402, DOI 10.3758/BF03193860; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	50	191	195	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					908	914		10.1038/nn1918	http://dx.doi.org/10.1038/nn1918			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558403				2022-12-28	WOS:000247560200022
J	Dai, Y; Taru, H; Deken, SL; Grill, B; Ackley, B; Nonet, ML; Jin, YS				Dai, Ya; Taru, Hidenori; Deken, Scott L.; Grill, Brock; Ackley, Brian; Nonet, Michael L.; Jin, Yishi			SYD-2 Liprin-alpha organizes presynaptic active zone formation through ELKS	NATURE NEUROSCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; RIM-BINDING PROTEINS; CAENORHABDITIS-ELEGANS; C-ELEGANS; SYNAPSE FORMATION; RECEPTOR; FAMILY; FORMS; LOCALIZATION; CYTOMATRIX	A central event in synapse development is formation of the presynaptic active zone in response to positional cues. Three active zone proteins, RIM, ELKS (also known as ERC or CAST) and Liprin-alpha, bind each other and are implicated in linking active zone formation to synaptic vesicle release. Loss of function in Caenorhabditis elegans syd-2 Liprin-alpha alters the size of presynaptic specializations and disrupts synaptic vesicle accumulation. Here we report that a missense mutation in the coiled-coil domain of SYD-2 causes a gain of function. In HSN synapses, the syd-2(gf) mutation promotes synapse formation in the absence of syd-1, which is essential for HSN synapse formation. syd-2(gf) also partially suppresses the synaptogenesis defects in syg-1 and syg-2 mutants. The activity of syd-2(gf) requires elks-1, an ELKS homolog; but not unc-10, a RIM homolog. The mutant SYD-2 shows increased association with ELKS. These results establish a functional dependency for assembly of the presynaptic active zone in which SYD-2 plays a key role.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Washington University (WUSTL)	Jin, YS (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, 1156 High St, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu	Taru, Hidenori/B-7059-2009	Jin, Yishi/0000-0002-9371-9860; Grill, Brock/0000-0002-0379-3267; Ackley, Brian/0000-0002-1257-2407				Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BLOOM FE, 1972, STRUCTURE FUNCTION S, P101; BRENNER S, 1974, GENETICS, V77, P71; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; JIN Y, 2005, WORMBOOK; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Olsen O, 2006, CURR OPIN CELL BIOL, V18, P223, DOI 10.1016/j.ceb.2006.02.010; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	42	149	151	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1479	1487		10.1038/nn1808	http://dx.doi.org/10.1038/nn1808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115037				2022-12-28	WOS:000242404000011
J	Paz, R; Pelletier, JG; Bauer, EP; Pare, D				Paz, Rony; Pelletier, Joe Guillaume; Bauer, Elizabeth P.; Pare, Denis			Emotional enhancement of memory via amygdala-driven facilitation of rhinal interactions	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; PERIRHINAL CORTEX; BASOLATERAL AMYGDALA; ENTORHINAL CORTEX; GLUCOCORTICOID ENHANCEMENT; NORADRENERGIC ACTIVATION; NEOCORTICAL INPUTS; DECLARATIVE MEMORY; LONG-TERM; HIPPOCAMPAL	Emotions generally facilitate memory, an effect mediated by the basolateral amygdala (BLA). To study the underlying mechanisms, we recorded BLA, perirhinal and entorhinal neurons during an appetitive trace-conditioning task. We focused on the rhinal cortices because they constitute the interface between the hippocampus, a mediator of memory consolidation, and the neocortex, the storage site of declarative memories. We found that, after unexpected rewards, BLA activity increased impulse transmission from perirhinal to entorhinal neurons and that this effect decayed as the association between conditioned stimuli and rewards was learned. At this late phase of learning, the BLA effect occurred when the animals were anticipating the reward. By enhancing the processing of sensory cues, the BLA-mediated facilitation of rhinal interactions may explain how the amygdala promotes memory formation in emotional conditions.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	rony.paz@gmail.com; pare@axon.rutgers.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066856, R01MH073610] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-066856, R01 MH-073610] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Biella G, 2002, J NEUROSCI, V22, P9972; Brown MW, 2002, PHILOS T R SOC B, V357, P1083, DOI 10.1098/rstb.2002.1097; Buckley MJ, 1998, NEUROPSYCHOLOGIA, V36, P535, DOI 10.1016/S0028-3932(97)00120-6; BURWELL RD, 2002, PARAHIPPOCAMPAL REGI, P53; Bussey TJ, 2002, EUR J NEUROSCI, V15, P365, DOI 10.1046/j.0953-816x.2001.01851.x; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Christianson S. A., 1992, HDB EMOTION MEMORY C; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; DEDOUX JE, 2000, ANNU REV NEUROSCI, V23, P155; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Ferry B, 1999, BIOL PSYCHIAT, V46, P1140, DOI 10.1016/S0006-3223(99)00157-2; Ferry B, 1999, BEHAV NEUROSCI, V113, P118, DOI 10.1037/0735-7044.113.1.118; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Kajiwara R, 2003, J NEUROPHYSIOL, V89, P2176, DOI 10.1152/jn.01033.2002; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Luft T, 2004, NEUROBIOL LEARN MEM, V82, P52, DOI 10.1016/j.nlm.2004.03.002; MCGAUGH JL, 1990, NEUROSCI BIOBEHAV R, V14, P425, DOI 10.1016/S0149-7634(05)80065-X; Muir GM, 2003, HIPPOCAMPUS, V13, P93, DOI 10.1002/hipo.10052; Munera A, 2000, NEUROSCI LETT, V292, P33, DOI 10.1016/S0304-3940(00)01430-0; MURRAY EA, 1986, J NEUROSCI, V6, P1991; Murray EA, 2005, Q J EXP PSYCHOL-B, V58, P378, DOI 10.1080/02724990544000077; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Pelletier JG, 2005, J NEUROPHYSIOL, V94, P1837, DOI 10.1152/jn.00260.2005; Pelletier JG, 2005, LEARN MEMORY, V12, P96, DOI 10.1101/lm.88605; Pelletier JG, 2004, J NEUROPHYSIOL, V91, P2079, DOI 10.1152/jn.01197.2003; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pinto A, 2006, J COMP NEUROL, V495, P722, DOI 10.1002/cne.20905; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Ryou JW, 2001, NEUROBIOL LEARN MEM, V75, P121, DOI 10.1006/nlme.2000.3966; Seager MA, 1999, BEHAV BRAIN RES, V100, P143, DOI 10.1016/S0166-4328(98)00123-5; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Suzuki WA, 2000, ANN NY ACAD SCI, V911, P175; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; WITTER MP, 1986, J COMP NEUROL, V252, P1, DOI 10.1002/cne.902520102	50	129	130	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1321	1329		10.1038/nn1771	http://dx.doi.org/10.1038/nn1771			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	16964249				2022-12-28	WOS:000241493900026
J	Robles, E; Gomez, TM				Robles, Estuardo; Gomez, Timothy M.			Focal adhesion kinase signaling at sites of integrin-mediated adhesion controls axon pathfinding	NATURE NEUROSCIENCE			English	Article							SCANNING ELECTRON-MICROSCOPE; CENTRAL-NERVOUS-SYSTEM; GROWTH CONE FILOPODIA; SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; SPINAL-CORD; XENOPUS-LAEVIS; CELL-MIGRATION; BASAL LAMINA; GUIDANCE	Extracellular matrix (ECM) components regulate neurite outgrowth in tissue culture and in vivo. Live imaging of phosphotyrosine (PY) signals revealed that Xenopus laevis growth cones extending on permissive ECM substrata assemble adhesive point contacts containing enriched levels of tyrosine-phosphorylated proteins. Whereas focal adhesion kinase (FAK) signaling is dispensable for the assembly of focal adhesions in non-neuronal cells, FAK activity is required for the formation of growth cone point contacts. FAK-dependent point contacts promote rapid neurite outgrowth by stabilizing lamellipodial protrusions on permissive ECM substrata. Moreover, local FAK activity is required for ECM-dependent growth cone turning in vitro, suggesting that FAK may control axon pathfinding in vivo. Consistent with this possibility, proper growth and guidance of Rohon-Beard sensory neurons and spinal commissural interneurons requires FAK activity. These findings identify FAK as a key regulator of axon growth and guidance downstream of growth cone-ECM interactions.	Univ Wisconsin, Dept Anat, Bardeen Labs SMI 257, Madison, WI 53706 USA; Univ Wisconsin, Neurosci Training Program, Bardeen Labs SMI 257, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gomez, TM (corresponding author), Univ Wisconsin, Dept Anat, Bardeen Labs SMI 257, 1300 Univ Ave, Madison, WI 53706 USA.	tmgomez@wisc.edu		Gomez, Timothy/0000-0002-1515-8228; Robles, Estuardo/0000-0002-1202-2050	NINDS NIH HHS [NS41564, R01 NS041564-06, R01 NS041564] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS041564, R01NS041564] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON H, 1988, DEVELOPMENT, V104, P601; BERNHARDT RR, 1994, J COMP NEUROL, V350, P122, DOI 10.1002/cne.903500109; Bonner J, 2001, J NEUROSCI, V21, P9782, DOI 10.1523/JNEUROSCI.21-24-09782.2001; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; EASTER SS, 1984, J NEUROSCI, V4, P2173; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; Gomez TM, 2003, METHOD CELL BIOL, V71, P129, DOI 10.1016/S0091-679X(03)01008-2; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; HENS MD, 1995, DEV BIOL, V170, P274, DOI 10.1006/dbio.1995.1214; HIROSE G, 1979, DEV BIOL, V71, P191, DOI 10.1016/0012-1606(79)90163-5; Hoang B, 1998, J NEUROSCI, V18, P7847; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; JACOBSON M, 1981, J NEUROSCI, V1, P918; KLEITMAN N, 1989, CELL MOTIL CYTOSKEL, V13, P288, DOI 10.1002/cm.970130407; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KROTOSKI D, 1990, J EXP ZOOL, V253, P139, DOI 10.1002/jez.1402530204; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Matise MP, 1999, DEVELOPMENT, V126, P3649; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon MS, 2005, DEV BIOL, V288, P474, DOI 10.1016/j.ydbio.2005.09.049; Paulus JD, 2006, DEV DYNAM, V235, P213, DOI 10.1002/dvdy.20604; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; ROBERTS A, 1982, J EMBRYOL EXP MORPH, V69, P237; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Ruest PJ, 2000, CELL GROWTH DIFFER, V11, P41; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Somasekhar T, 1997, DEV BRAIN RES, V99, P208, DOI 10.1016/S0165-3806(97)00011-4; SOMASEKHAR T, 1995, DEV BRAIN RES, V88, P53, DOI 10.1016/0165-3806(95)00080-W; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; TAYLOR JSH, 1983, J EMBRYOL EXP MORPH, V75, P49; Volberg T, 2001, J CELL SCI, V114, P2279; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; Zacharias U, 2002, MOL CELL NEUROSCI, V21, P626, DOI 10.1006/mcne.2002.1203	49	162	164	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1274	1283		10.1038/nn1762	http://dx.doi.org/10.1038/nn1762			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964253				2022-12-28	WOS:000241493900021
J	Williams, DW; Kondo, S; Krzyzanowska, A; Hiromi, Y; Truman, JW				Williams, Darren W.; Kondo, Shu; Krzyzanowska, Agnieszka; Hiromi, Yasushi; Truman, James W.			Local caspase activity directs engulfment of dendrites during pruning	NATURE NEUROSCIENCE			English	Article							DROSOPHILA METAMORPHOSIS; SENSORY NEURONS; AXON; DEGENERATION; SYSTEM; CELLS	Pruning is important for sculpting neural circuits, as it removes excessive or inaccurate projections. Here we show that the removal of sensory neuron dendrites during pruning in Drosophila melanogaster is directed by local caspase activity. Suppressing caspase activity prevented dendrite removal, whereas a global activation of caspases within a neuron caused cell death. A new genetically encoded caspase probe revealed that caspase activity is confined to the degenerating dendrites of pruning neurons.	Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Natl Inst Genet, CREST, Japan Sci & Technol Agcy, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; Jikei Univ, Sch Med, Div Morphol & Organogenesis, Inst DNA Med, Tokyo 1058461, Japan	University of London; King's College London; University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Jikei University	Williams, DW (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England.	darren.williams@kcl.ac.uk	Williams, Darren/C-5356-2009; Kondo, Shu/AAH-8921-2020	Williams, Darren/0000-0001-5917-4935; Kondo, Shu/0000-0002-4625-8379; krzyzanowska, agnieszka/0000-0002-1288-7054	Medical Research Council [G9900989B] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029971] Funding Source: NIH RePORTER; Medical Research Council [G0600182] Funding Source: Medline; NINDS NIH HHS [NS-029971] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Grueber WB, 2002, DEVELOPMENT, V129, P2867; KONDO S, IN PRESS MOL CELL BI; KUMAR S, 2004, SCI STKE, pPE49; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928	15	247	250	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1234	1236		10.1038/nn1774	http://dx.doi.org/10.1038/nn1774			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980964				2022-12-28	WOS:000241493900014
J	Yao, JQ; Sasaki, Y; Wen, ZX; Bassell, GJ; Zheng, JQ				Yao, Jiaqi; Sasaki, Yukio; Wen, Zhexing; Bassell, Gary J.; Zheng, James Q.			An essential role for beta-actin mRNA localization and translation in Ca2+-dependent growth cone guidance	NATURE NEUROSCIENCE			English	Article							LOCAL PROTEIN-SYNTHESIS; NERVE GROWTH; AXON GUIDANCE; CHEMOTROPIC RESPONSES; INTRACELLULAR CALCIUM; BINDING-PROTEINS; CYTOSKELETAL; MOTILITY; FILOPODIA; TRANSPORT	Axon pathfinding requires directional responses of growth cones to extracellular cues, which have been shown to involve local synthesis of protein. The identity and functions of the locally produced proteins remain, however, unclear. Here we report that Ca2+-dependent bidirectional turning of Xenopus laevis growth cones requires localized distribution and translation of beta-actin messenger RNA. Both beta-actin mRNA and its zipcode-binding protein, ZBP1, are localized at the growth cone and become asymmetrically distributed upon local exposure to brain-derived neurotrophic factor ( BDNF). Inhibition of protein synthesis or antisense interference with beta-actin mRNA-ZBP1 binding abolishes both Ca2+-mediated attraction and repulsion. In addition, attraction involves a local increase in beta-actin, whereas repulsion is accompanied by a local decrease in beta-actin; thus, both produce a synthesis- and ZBP1 binding-dependent beta-actin asymmetry but with opposite polarities. Together with a similar asymmetry in Src activity during bidirectional responses, our findings indicate that Ca2+-dependent spatial regulation of b-actin synthesis through Src contributes to the directional motility of growth cones during guidance.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Emory University	Zheng, JQ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	zhengjq@umdnj.edu	Wen, Zhexing/B-9313-2014; Sasaki, Yukio/P-7662-2015; Wen, Zhexing/L-1228-2018	Sasaki, Yukio/0000-0001-6143-7001; Wen, Zhexing/0000-0002-1518-3845	NICHD NIH HHS [HD46368] Funding Source: Medline; NINDS NIH HHS [NS36241, R29 NS036241] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036241, R01NS036241] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2003, J NEUROSCI, V23, P2274; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 1997, J NEUROSCI, V17, P7860; Moccia R, 2003, J NEUROSCI, V23, P9409; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; SHUSTER CB, 1995, J CELL BIOL, V128, P837, DOI 10.1083/jcb.128.5.837; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140	47	285	287	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1265	1273		10.1038/nn1773	http://dx.doi.org/10.1038/nn1773			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980965				2022-12-28	WOS:000241493900020
J	Gil-Da-Costa, R; Martin, A; Lopes, MA; Munoz, M; Fritz, JB; Braun, AR				Gil-da-Costa, Ricardo; Martin, Alex; Lopes, Marco A.; Munoz, Monica; Fritz, Jonathan B.; Braun, Allen R.			Species-specific calls activate homologs of Broca's and Wernicke's areas in the macaque	NATURE NEUROSCIENCE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; AUDITORY-CORTEX; RHESUS-MONKEY; FUNCTIONAL NEUROANATOMY; ASSOCIATION CORTEX; COMPLEX SOUNDS; MOTOR SYSTEM; LANGUAGE; REPRESENTATION; PARIETAL	The origin of brain mechanisms that support human language - whether these originated de novo in humans or evolved from a neural substrate that existed in a common ancestor -remains a controversial issue. Although the answer is not provided by the fossil record, it is possible to make inferences by studying living species of nonhuman primates. Here we identified neural systems associated with perceiving species-specific vocalizations in rhesus macaques using H(2)(15)O positron emission tomography (PET). These vocalizations evoke distinct patterns of brain activity in homologs of the human perisylvian language areas. Rather than resulting from differences in elementary acoustic properties, this activity seems to reflect higher order auditory processing. Although parallel evolution within independent primate species is feasible, this finding suggests the possibility that the last common ancestor of macaques and humans, which lived 25-30 million years ago, possessed key neural mechanisms that were plausible candidates for exaptation during the evolution of language.	Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA; NIMH, NIH, Bethesda, MD 20892 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Gulbenkian Inst Sci, Program Biol & Med, P-2781 Oeiras, Portugal; UCL, Inst Child Hlth, London WC1N 3JH, England; Univ Maryland, Syst Res Inst, Ctr Auditory & Acoust Res, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; University of London; University College London; University System of Maryland; University of Maryland College Park	Braun, AR (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA.	brauna@nidcd.nih.gov	Munoz-Lopez, Monica/F-3154-2016; Munoz, Monica/C-9189-2009; Fritz, Jonathan/AAK-4863-2020; martin, alex/B-6176-2009	Munoz-Lopez, Monica/0000-0002-5530-2394; Fritz, Jonathan/0000-0002-0625-172X	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barsalou LW, 2005, TRENDS COGN SCI, V9, P309, DOI 10.1016/j.tics.2005.05.003; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Caplan D., 1987, NEUROLINGUISTICS LIN; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Damasio AR, 1984, ANNU REV NEUROSCI, V7, P127, DOI 10.1146/annurev.ne.07.030184.001015; Deacon T.W., 1989, Human Evolution, V4, P367, DOI 10.1007/BF02436435; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; GEMBA H, 1995, BRAIN RES, V697, P143, DOI 10.1016/0006-8993(95)00797-T; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Geyer S, 2000, ANAT EMBRYOL, V202, P443, DOI 10.1007/s004290000127; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Gifford GW, 2005, J COGNITIVE NEUROSCI, V17, P1471, DOI 10.1162/0898929054985464; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Gouzoules H, 2000, ANIM BEHAV, V59, P501, DOI 10.1006/anbe.1999.1318; HAST MH, 1974, BRAIN RES, V73, P229, DOI 10.1016/0006-8993(74)91046-4; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Papathanassiou D, 2000, NEUROIMAGE, V11, P347, DOI 10.1006/nimg.2000.0546; Passingham RE, 1998, COMP NEUROPSYCHOLOGY, P271; Paxinos G., 2000, RHESUS MONKEY BRAIN; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Poeppel D, 2004, NEUROPSYCHOLOGIA, V42, P183, DOI 10.1016/j.neuropsychologia.2003.07.010; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; PREUSS TM, 1991, J COMP NEUROL, V310, P475, DOI 10.1002/cne.903100403; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; SERENO MI, 1991, PROGRAM OF THE THIRTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P79; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Warren JD, 2003, J NEUROSCI, V23, P5799; WISE SP, IN PRESS EVOLUTION P, V4, pCH11	49	106	108	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1064	1070		10.1038/nn1741	http://dx.doi.org/10.1038/nn1741			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16862150				2022-12-28	WOS:000240080300020
J	Shintani, T; Ihara, M; Sakuta, H; Takahashi, H; Watakabe, I; Noda, M				Shintani, Takafumi; Ihara, Masaru; Sakuta, Hiraki; Takahashi, Hiroo; Watakabe, Ikuko; Noda, Masaharu			Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O	NATURE NEUROSCIENCE			English	Article							GANGLION-CELL AXONS; RETINOTECTAL PROJECTION; MULTIPLE MECHANISMS; REPULSIVE GUIDANCE; RETROVIRAL VECTORS; ZETA/RPTP-BETA; EXPRESSION; KINASE; LIGANDS; BINDING	Eph receptors are activated by the autophosphorylation of tyrosine residues upon the binding of their ligands, the ephrins; however, the protein tyrosine phosphatases (PTPs) responsible for the negative regulation of Eph receptors have not been elucidated. Here, we identified protein tyrosine phosphatase receptor type O (Ptpro) as a specific PTP that efficiently dephosphorylates both EphA and EphB receptors as substrates. Biochemical analyses revealed that Ptpro dephosphorylates a phosphotyrosine residue conserved in the juxtamembrane region, which is required for the activation and signal transmission of Eph receptors. Ptpro thus seems to moderate the amount of maximal activation of Eph receptors. Using the chick retinotectal projection system, we show that Ptpro controls the sensitivity of retinal axons to ephrins and thereby has a crucial role in the establishment of topographic projections. Our findings explain the molecular mechanism that determines the threshold of the response of Eph receptors to ephrins in vivo.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Shintani, Takafumi/0000-0002-6165-2307; Sakuta, Hiraki/0000-0003-2375-0528				Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Bell EJD, 1997, MOL BIOTECHNOL, V7, P289, DOI 10.1007/BF02740819; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Chen CMA, 1999, DEV BIOL, V214, P370, DOI 10.1006/dbio.1999.9432; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1997, CELL, V90, P403; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Ledig MM, 1999, J NEUROBIOL, V39, P81, DOI 10.1002/(SICI)1097-4695(199904)39:1<81::AID-NEU7>3.0.CO;2-K; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Shintani T, 2004, J NEUROBIOL, V59, P34, DOI 10.1002/neu.10338; Stepanek L, 2001, J CELL BIOL, V154, P867, DOI 10.1083/jcb.200105019; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	48	79	81	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					761	769		10.1038/nn1697	http://dx.doi.org/10.1038/nn1697			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680165				2022-12-28	WOS:000237895200016
J	Priebe, NJ; Ferster, D				Priebe, NJ; Ferster, D			Mechanisms underlying cross-orientation suppression in cat visual cortex	NATURE NEUROSCIENCE			English	Article							CORTICAL SIMPLE CELLS; STRIATE CORTEX; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; CONTRAST ADAPTATION; COMPLEX CELLS; INHIBITION; NEURONS; EXCITATION; INPUT	In simple cells of the cat primary visual cortex, null-oriented stimuli, which by themselves evoke no response, can completely suppress the spiking response to optimally oriented stimuli. This cross-orientation suppression has been interpreted as evidence for cross-orientation inhibition: synaptic inhibition among cortical cells with different preferred orientations. In intracellular recordings from simple cells, however, we found that cross-oriented stimuli suppressed, rather than enhanced, synaptic inhibition and, at the same time, suppressed synaptic excitation. Much of the suppression of excitation could be accounted for by the behavior of geniculate relay cells: contrast saturation and rectification in relay cell responses, when applied to a linear feed-forward model, predicted cross-orientation suppression of the modulation (F1) component of excitation evoked in simple cells. In addition, we found that the suppression of the spike output of simple cells was almost twice the suppression of their synaptic inputs. Thus, cross-orientation suppression, like orientation selectivity, is strongly amplified by threshold.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2145 N Sheridan Rd, Evanston, IL 60208 USA.	ferster@northwestern.edu			NEI NIH HHS [EY-04726, EY-014499] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY014499, R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REIG R, 2005, CEREB CORTEX    0817; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SMITH MA, 2006, IN PRESS J NEUROSCI; Sokal R.R., 2012, BIOMETRY; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351	50	127	129	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					552	561		10.1038/nn1660	http://dx.doi.org/10.1038/nn1660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520737				2022-12-28	WOS:000236310700023
J	Stranahan, AM; Khalil, D; Gould, E				Stranahan, AM; Khalil, D; Gould, E			Social isolation delays the positive effects of running on adult neurogenesis	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; DENTATE GYRUS; CELL-PROLIFERATION; VOLUNTARY EXERCISE; HIPPOCAMPAL NEUROGENESIS; INDUCED INCREASES; MESSENGER-RNA; STRESS; RATS; BEHAVIOR	Social isolation can exacerbate the negative consequences of stress and increase the risk of developing psychopathology. However, the influence of living alone on experiences generally considered to be beneficial to the brain, such as physical exercise, remains unknown. We report here that individual housing precludes the positive influence of short-term running on adult neurogenesis in the hippocampus of rats and, in the presence of additional stress, suppresses the generation of new neurons. Individual housing also influenced corticosterone levels-runners in both housing conditions had elevated corticosterone during the active phase, but individually housed runners had higher levels of this hormone in response to stress. Moreover, lowering corticosterone levels converted the influence of short-term running on neurogenesis in individually housed rats from negative to positive. These results suggest that, in the absence of social interaction, a normally beneficial experience can exert a potentially deleterious influence on the brain.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu	Stranahan, Alexis/AAF-3559-2020; Winwood, Peter/A-6363-2008		NIA NIH HHS [F31 AG024690, F31 AG024690-04, F31 AG024690-03, F31 AG024690-02, F31 AG024690-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F31AG024690] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Ambrogini P, 2002, NEUROENDOCRINOLOGY, V76, P366, DOI 10.1159/000067581; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cassano WJ, 2001, NEUROENDOCRINOLOGY, V74, P167, DOI 10.1159/000054683; CHALMERS DT, 1993, J NEUROSCI, V13, P914; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; GOULD E, 1992, J NEUROSCI, V12, P3642; HOFFMANN P, 1987, BEHAV NEURAL BIOL, V47, P346, DOI 10.1016/S0163-1047(87)90461-4; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; IVERSEN IH, 1993, J EXP ANAL BEHAV, V60, P219, DOI 10.1901/jeab.1993.60-219; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Perfilieva E, 2001, J CEREBR BLOOD F MET, V21, P211, DOI 10.1097/00004647-200103000-00004; Persson AI, 2004, EUR J NEUROSCI, V19, P1847, DOI 10.1111/j.1460-9568.2004.03268.x; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Roy MP, 1998, J PERS SOC PSYCHOL, V75, P1273, DOI 10.1037/0022-3514.75.5.1273; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schiller L, 2003, BRAIN RES, V980, P169, DOI 10.1016/S0006-8993(03)02832-4; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Selye Hans, 1976, STRESS LIFE; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; WEISS JM, 1971, J COMP PHYSIOL PSYCH, V77, P22, DOI 10.1037/h0031581; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6	47	351	358	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					526	533		10.1038/nn1668	http://dx.doi.org/10.1038/nn1668			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531997	Green Accepted			2022-12-28	WOS:000236310700020
J	Lobo, MK; Karsten, SL; Gray, M; Geschwind, DH; Yang, XW				Lobo, MK; Karsten, SL; Gray, M; Geschwind, DH; Yang, XW			FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains	NATURE NEUROSCIENCE			English	Article							ZINC-FINGER PROTEIN; GENE-EXPRESSION; D2 DOPAMINE; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; GANGLIA ANTIBODIES; RECEPTOR PROTEINS; TRANSGENIC MICE; TRANSCRIPTION; NEUROBIOLOGY	A major challenge in systems neuroscience is to perform precise molecular genetic analyses of a single neuronal population in the context of the complex mammalian brain. Existing technologies for profiling cell type-specific gene expression are largely limited to immature or morphologically identifiable neurons. In this study, we developed a simple method using fluorescent activated cell sorting (FACS) to purify genetically labeled neurons from juvenile and adult mouse brains for gene expression profiling. We identify and verify a new set of differentially expressed genes in the striatonigral and striatopallidal neurons, two functionally and clinically important projection neuron subtypes in the basal ganglia. We further demonstrate that Ebf1 is a lineage-specific transcription factor essential to the differentiation of striatonigral neurons. Our study provides a general approach for profiling cell type-specific gene expression in the mature mammalian brain and identifies a set of genes critical to the function and dysfunction of the striatal projection neuron circuit.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yang, XW (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	Lobo, Mary Kay/K-7734-2015; Karsten, Stan/AAI-4076-2021	Lobo, Mary Kay/0000-0002-9419-2079; Karsten, Stanislav/0000-0001-7387-4874	NICHD NIH HHS [5T32HD007032] Funding Source: Medline; NIDA NIH HHS [P50 DA005010, P50DA05010] Funding Source: Medline; NINDS NIH HHS [U24 NS43562, NS049501, NS047391, 5T32NS048004] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS043562, R01NS049501, T32NS048004, R21NS047391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Cao YX, 2001, CURR OPIN NEUROBIOL, V11, P615, DOI 10.1016/S0959-4388(00)00258-0; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Church AJ, 2002, NEUROLOGY, V59, P227, DOI 10.1212/WNL.59.2.227; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dougherty JD, 2005, NEURON, V45, P183, DOI 10.1016/j.neuron.2005.01.007; FISHELL G, 1991, J COMP NEUROL, V312, P33, DOI 10.1002/cne.903120104; Garel S, 1999, DEVELOPMENT, V126, P5285; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kamme F, 2003, J NEUROSCI, V23, P3607; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Martino D, 2004, CURR OPIN NEUROL, V17, P425, DOI 10.1097/01.wco.0000137532.76491.19; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rogers MA, 1998, BRAIN RES BULL, V47, P297, DOI 10.1016/S0361-9230(98)00126-9; Sabatti C, 2002, MATH BIOSCI, V176, P17, DOI 10.1016/S0025-5564(01)00102-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; TECOTT LH, 1989, DEV BRAIN RES, V49, P75, DOI 10.1016/0165-3806(89)90060-6; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wichmann T, 2003, ANN NY ACAD SCI, V991, P199, DOI 10.1111/j.1749-6632.2003.tb07477.x; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	50	315	322	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					443	452		10.1038/nn1654	http://dx.doi.org/10.1038/nn1654			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491081				2022-12-28	WOS:000235645600025
J	Brankatschk, M; Dickson, BJ				Brankatschk, M; Dickson, BJ			Netrins guide Drosophila commissural axons at short range	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE ATTRACTION; C-ELEGANS; HOMOLOGOUS RECOMBINATION; MORPHOGEN GRADIENT; COLORECTAL-CANCER; GENETIC-ANALYSIS; SONIC HEDGEHOG; MOTOR AXONS; CNS MIDLINE; GUIDANCE	Netrins are secreted axon guidance molecules required for commissure formation in a wide range of animal species, including Caenorhabditis elegans, Drosophila melanogaster and mice. They are generally thought to function as chemoattractants, acting at a distance to direct commissural axon growth toward the midline of the central nervous system. We show here, however, that D. melanogaster commissural axons still orient normally and reach the midline even in the complete absence of netrins, though some of them fail to cross the midline. Tethering endogenous netrin to the membrane selectively disrupts its long-range but not short- range activity, yet still allows normal commissure formation. We therefore propose that netrins act in commissural axon guidance as short-range cues that promote midline crossing, not as long-range chemoattractants.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Brankatschk, Marko/0000-0001-5274-4552				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Schmid A, 1999, DEVELOPMENT, V126, P4653; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Strigini M, 1997, DEVELOPMENT, V124, P4697; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	50	112	114	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					188	194		10.1038/nn1625	http://dx.doi.org/10.1038/nn1625			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429137				2022-12-28	WOS:000234990100013
J	Correia, SS; Bassani, S; Brown, TC; Lise, MF; Backos, DS; El-Husseini, A; Passafaro, M; Esteban, JA				Correia, Susana S.; Bassani, Silvia; Brown, Tyler C.; Lise, Marie-France; Backos, Donald S.; El-Husseini, Alaa; Passafaro, Maria; Esteban, Jose A.			Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation	NATURE NEUROSCIENCE			English	Article							MYOSIN-VA; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; RECYCLING ENDOSOMES; GRISCELLI-DISEASE; ACTIN-FILAMENTS; TRAFFICKING; PLASTICITY; SYNAPSES; NEURONS	The regulated trafficking of neurotransmitter receptors at synapses is critical for synaptic function and plasticity. However, the molecular machinery that controls active transport of receptors into synapses is largely unknown. We found that, in rat hippocampus, the insertion of AMPA receptors (AMPARs) into spines during synaptic plasticity requires a specific motor protein, which we identified as myosin Va. We found that myosin Va associates with AMPARs through its cargo binding domain. This interaction was enhanced by active, GTP-bound Rab11, which is also transported by the motor protein. Myosin Va mediated the CaMKII-triggered translocation of GluR1 receptors from the dendritic shaft into spines, but it was not required for constitutive GluR2 trafficking. Accordingly, myosin Va was specifically required for long-term potentiation, but not for basal synaptic transmission. In summary, we identified the specific motor protein and organelle acceptor that catalyze the directional transport of AMPARs into spines during activity-dependent synaptic plasticity.	[Correia, Susana S.; Brown, Tyler C.; Backos, Donald S.; Esteban, Jose A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bassani, Silvia; Passafaro, Maria] Univ Milan, Dept Pharmacol, Dulbecco Telethon Inst, Consiglio Nazl Ric Inst Neurosci, I-20129 Milan, Italy; [Brown, Tyler C.; Esteban, Jose A.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Lise, Marie-France; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Fac Med, Vancouver, BC V6T 1Z3, Canada	University of Michigan System; University of Michigan; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Milan; University of Michigan System; University of Michigan; University of British Columbia	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	estebanj@umich.edu	Esteban, Jose/L-4944-2014; Backos, Donald/Q-4791-2018; Bassani, Silvia/A-7241-2012; Backos, Donald/N-5265-2019	Esteban, Jose/0000-0002-3759-3300; Backos, Donald/0000-0001-6735-6210; Bassani, Silvia/0000-0003-0553-7168; Backos, Donald/0000-0001-6735-6210; Brown, Tyler/0000-0001-9543-8555	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH070205, R01MH070417] Funding Source: NIH RePORTER; NIMH NIH HHS [MH070417, F31-MH070205] Funding Source: Medline; Telethon [TCR07006] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon)		Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Brown JR, 2001, BIOL BULL, V201, P240, DOI 10.2307/1543343; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Gerges NZ, 2005, METHOD ENZYMOL, V403, P153, DOI 10.1016/S0076-6879(05)03013-2; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Piccini A, 2002, J NEUROSCI, V22, P5387; Rodriguez OC, 2002, J CELL SCI, V115, P991; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	50	192	196	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					457	466		10.1038/nn2063	http://dx.doi.org/10.1038/nn2063			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311135	Green Submitted			2022-12-28	WOS:000254359300018
J	Agosto, J; Choi, JC; Parisky, KM; Stilwell, G; Rosbash, M; Griffith, LC				Agosto, Jose; Choi, James C.; Parisky, Katherine M.; Stilwell, Geoffrey; Rosbash, Michael; Griffith, Leslie C.			Modulation of GABA(A) receptor desensitization uncouples sleep onset and maintenance in Drosophila	NATURE NEUROSCIENCE			English	Article							GABA(A) RECEPTORS; ANTIEPILEPTIC DRUGS; INSECTICIDE RESISTANCE; CYCLODIENE RESISTANCE; MUSHROOM BODIES; REDUCED SLEEP; A RECEPTOR; MELANOGASTER; CARBAMAZEPINE; MECHANISMS	Many lines of evidence indicate that GABA and GABA(A) receptors make important contributions to human sleep regulation. Pharmacological manipulation of these receptors has differential effects on sleep onset and sleep maintenance insomnia. Here we show that sleep is regulated by GABA in Drosophila and that a mutant GABAA receptor, Rdl(A302S), specifically decreases sleep latency. The drug carbamazepine (CBZ) has the opposite effect on sleep; it increases sleep latency as well as decreasing sleep. Behavioral and physiological experiments indicated that Rdl(A302S) mutant flies are resistant to the effects of CBZ on sleep latency and that mutant RDLA302S channels are resistant to the effects of CBZ on desensitization, respectively. These results suggest that this biophysical property of the channel, specifically channel desensitization, underlies the regulation of sleep latency in flies. These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest that the kinetics of GABA(A) receptor signaling dictate sleep latency.	[Choi, James C.; Parisky, Katherine M.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Agosto, Jose; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA; [Agosto, Jose; Choi, James C.; Parisky, Katherine M.; Rosbash, Michael; Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Stilwell, Geoffrey] Cambria Biosci, Woburn, MA 01801 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	griffith@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NIMH NIH HHS [R01 MH067284-06A1, R01 MH067284, MH 067284] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ambrosio AF, 2002, NEUROCHEM RES, V27, P121, DOI 10.1023/A:1014814924965; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; ARONSTEIN K, 1994, PESTIC BIOCHEM PHYS, V48, P229, DOI 10.1006/pest.1994.1024; Bazil CW, 2003, CNS DRUGS, V17, P719, DOI 10.2165/00023210-200317100-00003; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BREWSTER ME, 1991, J PHARM SCI, V80, P380, DOI 10.1002/jps.2600800420; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; GRANGER P, 1995, MOL PHARMACOL, V47, P1189; GREENLEAF AL, 1979, CELL, V18, P613, DOI 10.1016/0092-8674(79)90116-8; Greenspan RJ, 2004, HUM MOL GENET, V13, pR267, DOI 10.1093/hmg/ddh248; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lancel M, 1999, SLEEP, V22, P33, DOI 10.1093/sleep/22.1.33; Lee D, 2003, J NEUROSCI, V23, P4625; Masson M, 2005, CHEM PHARM BULL, V53, P958, DOI 10.1248/cpb.53.958; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Roth T, 2005, J CLIN PSYCHIAT, V66, P10; ROTH T, 2005, J CLIN PSYCHIAT S9, V9, P42; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Spina E, 2004, EPILEPTIC DISORD, V6, P57; STILWELL GE, 1995, J MOL BIOL, V253, P223, DOI 10.1006/jmbi.1995.0547; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; ZHANG HG, 1994, J PHYSIOL-LONDON, V479, P65, DOI 10.1113/jphysiol.1994.sp020278	39	134	135	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					354	359		10.1038/nn2046	http://dx.doi.org/10.1038/nn2046			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223647	Green Accepted			2022-12-28	WOS:000253548300019
J	Orger, MB; Kampff, AR; Severi, KE; Bollmann, JH; Engert, F				Orger, Michael B.; Kampff, Adam R.; Severi, Kristen E.; Bollmann, Johann H.; Engert, Florian			Control of visually guided behavior by distinct populations of spinal projection neurons	NATURE NEUROSCIENCE			English	Article							IDENTIFIED RETICULOSPINAL NEURONS; LARVAL ZEBRAFISH; MAUTHNER CELL; PREY CAPTURE; DECISION-MAKING; LASER-ABLATION; MOTOR CONTROL; HINDBRAIN; INTERNEURONS; ORGANIZATION	A basic question in the field of motor control is how different actions are represented by activity in spinal projection neurons. We used a new behavioral assay to identify visual stimuli that specifically drive basic motor patterns in zebrafish. These stimuli evoked consistent patterns of neural activity in the neurons projecting to the spinal cord, which we could map throughout the entire population using in vivo two-photon calcium imaging. We found that stimuli that drive distinct behaviors activated distinct subsets of projection neurons, consisting, in some cases, of just a few cells. This stands in contrast to the distributed activation seen for more complex behaviors. Furthermore, targeted cell by cell ablations of the neurons associated with evoked turns abolished the corresponding behavioral response. This description of the functional organization of the zebrafish motor system provides a framework for identifying the complete circuit underlying a vertebrate behavior.	[Orger, Michael B.; Kampff, Adam R.; Bollmann, Johann H.; Engert, Florian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Severi, Kristen E.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Harvard University; Northeastern University	Orger, MB (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	morger@mcb.harvard.edu	Severi, Kristen/AAB-8943-2019	Severi, Kristen/0000-0002-4568-1538; Kampff, Adam/0000-0003-3079-019X; Orger, Michael/0000-0002-9763-8902	NATIONAL EYE INSTITUTE [R01EY014429] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014429-01A2, R01 EY014429-05, R01 EY014429] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Bizzi E, 2002, NEUROSCIENTIST, V8, P437, DOI 10.1177/107385802236969; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Bosch TJ, 2001, J COMP NEUROL, V439, P306, DOI 10.1002/cne.1352; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Chong M, 2007, DEV NEUROBIOL, V67, P933, DOI 10.1002/dneu.20398; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 2002, BRAIN RES REV, V40, P166, DOI 10.1016/S0165-0173(02)00199-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gahtan E, 2004, J NEUROBIOL, V59, P147, DOI 10.1002/neu.20000; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gahtan E, 2001, J NEUROSCI METH, V108, P97, DOI 10.1016/S0165-0270(01)00382-X; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; LEE RKK, 1991, J COMP NEUROL, V304, P34; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orlovsky G., 1999, NEURONAL CONTROL LOC; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; WU J, 1994, SCIENCE, V263, P820, DOI 10.1126/science.8303300; Zelenin PV, 2007, J NEUROSCI, V27, P1024, DOI 10.1523/JNEUROSCI.4925-06.2007; Zelenin PV, 2005, EUR J NEUROSCI, V22, P2271, DOI 10.1111/j.1460-9568.2005.04395.x; Zottoli SJ, 1999, J COMP PHYSIOL A, V184, P207, DOI 10.1007/s003590050319	45	169	173	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					327	333		10.1038/nn2048	http://dx.doi.org/10.1038/nn2048			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18264094	Green Accepted, Green Published			2022-12-28	WOS:000253548300016
J	Kucenas, S; Takada, N; Park, HC; Woodruff, E; Broadie, K; Appel, B				Kucenas, Sarah; Takada, Norio; Park, Hae-Chul; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce			CNS-derived glia ensheath peripheral nerves and mediate motor root development	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST CELLS; TUBE VENT CELLS; NERVOUS-SYSTEM; FINE-STRUCTURE; DROSOPHILA-MELANOGASTER; SONIC-HEDGEHOG; SCHWANN-CELLS; FLOOR PLATE; ZEBRAFISH	Motor function requires that motor axons extend from the spinal cord at regular intervals and that they are myelinated by Schwann cells. Little attention has been given to another cellular structure, the perineurium, which ensheaths the motor nerve, forming a flexible, protective barrier. Consequently, the origin of perineurial cells and their roles in motor nerve formation are poorly understood. Using time-lapse imaging in zebrafish, we show that perineurial cells are born in the CNS, arising as ventral spinal-cord glia before migrating into the periphery. In embryos lacking perineurial glia, motor neurons inappropriately migrated outside of the spinal cord and had aberrant axonal projections, indicating that perineurial glia carry out barrier and guidance functions at motor axon exit points. Additionally, reciprocal signaling between perineurial glia and Schwann cells was necessary for motor nerve ensheathment by both cell types. These insights reveal a new class of CNS-born glia that critically contributes to motor nerve development.	[Kucenas, Sarah; Takada, Norio; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce] Vanderbilt Univ, Dept Biol Sci, Vanderbilt Kennedy Ctr Res Human Dev, Vanderbilt Program Dev Biol, Nashville, TN 37235 USA; [Kucenas, Sarah; Takada, Norio; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce] Vanderbilt Univ, Vanderbilt Ctr Mol Neurosci, Nashville, TN 37235 USA; [Park, Hae-Chul] Korea Univ, Sch Med, Ansan 425707, Gyeonggido, South Korea	Vanderbilt University; Vanderbilt University; Korea University; Korea University Medicine (KU Medicine)	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, Vanderbilt Kennedy Ctr Res Human Dev, Vanderbilt Program Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	b.appel@vanderbilt.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672; Kucenas, Sarah/0000-0002-1950-751X	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668] Funding Source: NIH RePORTER; NCRR NIH HHS [P40 RR012546] Funding Source: Medline; NIGMS NIH HHS [R01 GM054544] Funding Source: Medline; NIMH NIH HHS [T32 MH065215, MH65215-03] Funding Source: Medline; NINDS NIH HHS [R01 NS046668, R01 NS046668-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERT K, 1976, CELL TISSUE RES, V165, P281; ALLT G, 1969, J ANAT, V105, P283; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Boot MJ, 2003, ANAT EMBRYOL, V206, P327, DOI 10.1007/s00429-002-0302-5; Bourne GH, 1968, STRUCTURE FUNCTION N; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; BUNGE MB, 1989, SCIENCE, V243, P229, DOI 10.1126/science.2492115; BURKEL WE, 1967, ANAT RECORD, V158, P177, DOI 10.1002/ar.1091580207; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dickinson DP, 2004, J ANAT, V205, P79, DOI 10.1111/j.0021-8782.2004.00319.x; DuPlessis DG, 1996, J ANAT, V189, P631; Dutton KA, 2001, DEVELOPMENT, V128, P4113; ERLANDSON RA, 1991, ULTRASTRUCT PATHOL, V15, P335, DOI 10.3109/01913129109016243; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; GAMBLE HJ, 1964, J ANAT, V98, P655; GUYTON AC, 1972, STRUCTURE FUNCTION N; HALLER FR, 1971, AM J ANAT, V131, P1, DOI 10.1002/aja.1001310102; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jones DS, 1937, ANAT REC, V70, P45, DOI 10.1002/ar.1090700106; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; KRISTENSSON K, 1971, ACTA NEUROPATHOL, V17, P127, DOI 10.1007/BF00687488; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Macarenco RS, 2007, ARCH PATHOL LAB MED, V131, P625; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; NORDLANDER RH, 1981, J COMP NEUROL, V199, P535, DOI 10.1002/cne.901990407; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; OLSSON Y, 1990, CRIT REV NEUROBIOL, V5, P265; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Raven CP, 1937, J COMP NEUROL, V67, P221, DOI 10.1002/cne.900670205; Schafer M, 2007, DEV BIOL, V301, P117, DOI 10.1016/j.ydbio.2006.09.018; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Yaneza M, 2002, DEV DYNAM, V223, P163, DOI 10.1002/dvdy.1241; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071; ZUHORSTE GM, 2006, CURR OPIN NEUROL, V19, P464	50	166	169	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					143	151		10.1038/nn2025	http://dx.doi.org/10.1038/nn2025			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18176560	Green Accepted			2022-12-28	WOS:000252712100008
J	Ajami, B; Bennett, JL; Krieger, C; Tetzlaff, W; Rossi, FMV				Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; Tetzlaff, Wolfram; Rossi, Fabio M. V.			Local self-renewal can sustain CNS microglia maintenance and function throughout adult life	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEMATOPOIETIC STEM-CELLS; MOUSE MODEL; ORIGIN; TRANSPLANTATION; DEGENERATION; ENGRAFTMENT; ACTIVATION; PRECURSORS; PROGENITOR	Microgliosis is a common response to multiple types of damage in the CNS. However, the origin of the cells involved in this process is still controversial and the relative importance of local expansion versus recruitment of microglia progenitors from the bloodstream is unclear. Here, we investigated the origin of microglia using chimeric animals obtained by parabiosis. We found no evidence of microglia progenitor recruitment from the circulation in denervation or CNS neurodegenerative disease, suggesting that maintenance and local expansion of microglia are solely dependent on the self-renewal of CNS resident cells in these models.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Simon Fraser Univ, Dept Kinesiol, Burnaby, BC V5A 1S6, Canada; Vancouver Hosp & Hlth Sci Ctr, Dept Med, Div Neurol, Neuromuscular Dis Unit, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Zool, Dept Surg, Int Collaborat Repair Discoveries, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fabio@brc.ubc.ca	Tetzlaff, Wolfram/AAY-4430-2020; Rossi, Fabio MV/B-5587-2013; Ajami, Bahareh/AAA-7262-2019	Rossi, Fabio MV/0000-0002-0368-2620; 				Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; JENSEN MB, 1994, EXP BRAIN RES, V98, P245; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; KRALL WJ, 1994, BLOOD, V83, P2737; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Li SP, 2004, MOL BRAIN RES, V125, P156, DOI 10.1016/j.molbrainres.2004.02.025; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; McPhail LT, 2004, EXP NEUROL, V188, P331, DOI 10.1016/j.expneurol.2004.04.010; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	44	1084	1102	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1538	1543		10.1038/nn2014	http://dx.doi.org/10.1038/nn2014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026097				2022-12-28	WOS:000251172900010
J	Lobsiger, CS; Leveland, DW				Lobsiger, Christian S.; Cleveland, Don W.			Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SUPEROXIDE-DISMUTASE; ALS-LINKED SOD1; TRANSGENIC MICE; MOTOR-NEURONS; MOUSE MODEL; DOPAMINERGIC NEURODEGENERATION; PARKINSONS-DISEASE; HUNTINGTON-DISEASE; EXTEND SURVIVAL	A lesson from dominantly inherited forms of diverse neurodegenerative diseases, including amyotrophic lateral sclerosis, spinocerebellar ataxia and Huntington's disease, is that the selective dysfunction or death of the neuronal population most at risk in each disease is not mediated solely by damage from the mutant protein within the target neurons. The disease-causing toxic process, which in each case is caused by mutation in a gene that is widely or ubiquitously expressed, involves damage done by mutant proteins within the non-neuronal glial cells of the central nervous system, especially astrocytes and microglia. The disease mechanism is non-cell-autonomous, with toxicity derived from glia as a prominent contributor driving disease progression and in some instances even disease initiation.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Leveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Lobsiger, Christian S./AAA-5311-2019; Lobsiger, Christian/N-4369-2018; Cleveland, Don/AAN-9783-2021; Lobsiger, Christian S/B-2720-2017	Lobsiger, Christian S./0000-0002-4313-010X; Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS027036, R37 NS027036-22] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Liberatore GT, 1999, NAT MED, V5, P1403; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Son M, 2001, ANN NEUROL, V50, P273, DOI 10.1002/ana.1104; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; WU DC, 2000, P NATL ACAD SCI USA, V103, P12133; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Yvert G, 2001, HUM MOL GENET, V10, P1679, DOI 10.1093/hmg/10.16.1679; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	352	363	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1355	1360		10.1038/nn1988	http://dx.doi.org/10.1038/nn1988			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965655	Green Accepted			2022-12-28	WOS:000250508400009
J	Viswanathan, A; Freeman, RD				Viswanathan, Ahalya; Freeman, Ralph D.			Neurometabolic coupling in cerebral cortex reflects synaptic more than spiking activity	NATURE NEUROSCIENCE			English	Article							RAT CEREBELLAR CORTEX; MONKEY VISUAL-CORTEX; BLOOD-FLOW; SENSORY STIMULATION; HUMAN BRAIN; TISSUE OXYGENATION; FIELD POTENTIALS; NEURAL ACTIVITY; SIGNAL; SELECTIVITY	In noninvasive neuroimaging, neural activity is inferred from local fluctuations in deoxyhemoglobin. A fundamental question of functional magnetic resonance imaging (fMRI) is whether the inferred neural activity is driven primarily by synaptic or spiking activity. The answer is critical for the interpretation of the blood oxygen level-dependent (BOLD) signal in fMRI. Here, we have used well-established visual-system circuitry to create a stimulus that elicits synaptic activity without associated spike discharge. In colocalized recordings of neural and metabolic activity in cat primary visual cortex, we observed strong coupling between local field potentials (LFPs) and changes in tissue oxygen concentration in the absence of spikes. These results imply that the BOLD signal is more closely coupled to synaptic activity.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.	freeman@neurovision.berkeley.edu			NEI NIH HHS [EY01175, EY03716] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003716, R01EY001175] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Caesar K, 2003, P NATL ACAD SCI USA, V100, P16000, DOI 10.1073/pnas.2635195100; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Fatt I, 1976, POLAROGRAPHIC OXYGEN; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kim SG, 1997, J NEUROSCI METH, V74, P229, DOI 10.1016/S0165-0270(97)02252-8; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maex R, 1996, J NEUROPHYSIOL, V75, P1515, DOI 10.1152/jn.1996.75.4.1515; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Thompson JK, 2005, J NEUROSCI, V25, P9046, DOI 10.1523/JNEUROSCI.2127-05.2005; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	32	290	292	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1308	1312		10.1038/nn1977	http://dx.doi.org/10.1038/nn1977			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828254				2022-12-28	WOS:000249720800018
J	Martinowich, K; Manji, H; Lu, B				Martinowich, Keri; Manji, Husseini; Lu, Bai			New insights into BDNF function in depression and anxiety	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR TRANSCRIPTS; LONG-TERM DEPRESSION; BIPOLAR DISORDER; MESSENGER-RNA; KNOCKOUT MICE; BRAIN; EXPRESSION; RECEPTOR; STRESS; ACTIVATION	The 'neurotrophin hypothesis of depression' is based largely on correlations between stress or antidepressant treatment and down- or upregulation, respectively, of brain-derived neurotrophic factor ( BDNF). Genetic disruption of the signaling pathways involving BDNF and its receptor, the tyrosine kinase TrkB, does not seem to cause depressive behaviors, but does hamper the effect of antidepressant drugs. Thus, BDNF may be a target of antidepressants, but not the sole mediator of depression or anxiety. Advances in BDNF cell biology, including its transcription through multiple promoters, trafficking and secretion, may provide new insights into its role in mood disorders. Moreover, as the precursor proBDNF and the mature protein mBDNF can elicit opposite effects on cellular functions, the impact of proBDNF and its cleavage on mood should be considered. Opposing influences of mBDNF and proBDNF on long-term potentiation and long-term depression might contribute to the dichotomy of BDNF actions on behaviors mediated by the brain stress and reward systems.	NIMH, Mood & Anxiety Program, Bethesda, MD 20892 USA; NICHHD, Sect Neural Dev & Plastic, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Martinowich, K (corresponding author), NIMH, Mood & Anxiety Program, Bldg 35,Room 1C1004,35 Convent Dr,MSC 3714, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012; Martinowich, Keri/F-9841-2012; Yan, Shuo/B-8381-2009	Martinowich, Keri/0000-0002-5237-0789; Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHARNEY DS, 2004, SCI STKE; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Kohen R, 2005, PHARMACOGENOMICS J, V5, P278, DOI 10.1038/sj.tpj.6500322; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McEwen BS, 2000, PROG BRAIN RES, V122, P25; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pattabiraman PP, 2005, MOL CELL NEUROSCI, V28, P556, DOI 10.1016/j.mcn.2004.11.010; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Ren-Patterson RF, 2005, J NEUROSCI RES, V79, P756, DOI 10.1002/jnr.20410; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zorner B, 2003, BIOL PSYCHIAT, V54, P972, DOI 10.1016/S0006-3223(03)00418-9	50	841	885	3	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1089	1093		10.1038/nn1971	http://dx.doi.org/10.1038/nn1971			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726474				2022-12-28	WOS:000249144000006
J	Thierry, G; Martin, CD; Downing, P; Pegna, AJ				Thierry, Guillaume; Martin, Clara D.; Downing, Paul; Pegna, Alan J.			Controlling for interstimulus perceptual variance abolishes N170 face selectivity	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; EVENT-RELATED POTENTIALS; OBJECT; RECOGNITION; EXPERTISE; DYNAMICS; SPECIFICITY; ATTENTION; COMPONENT; STIMULI	Establishing when and how the human brain differentiates between object categories is key to understanding visual cognition. Event-related potential (ERP) investigations have led to the consensus that faces selectively elicit a negative wave peaking 170 ms after presentation, the 'N170'. In such experiments, however, faces are nearly always presented from a full front view, whereas other stimuli are more perceptually variable, leading to uncontrolled interstimulus perceptual variance (ISPV). Here, we compared ERPs elicited by faces, cars and butterflies while-for the first time-controlling ISPV (low or high). Surprisingly, the N170 was sensitive, not to object category, but to ISPV. In addition, we found category effects independent of ISPV 70 ms earlier than has been generally reported. These results demonstrate early ERP category effects in the visual domain, call into question the face selectivity of the N170 and establish ISPV as a critical factor to control in experiments relying on multitrial averaging.	Univ Wales, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; Univ Lyon, CNRS, Inst Sci Cognit, Lab Langage Cerveau & Cognit, F-69675 Bron, France; Univ Hosp Geneva, Neurol Clin, Neuropsychol Unit, Lab Expt Neuropsychol, CH-1211 Geneva, Switzerland	Bangor University; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Thierry, G (corresponding author), Univ Wales, Sch Psychol, Brigantia Bldg,Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales.	g.thierry@bangor.ac.uk	Martin, Clara/B-4563-2012; Pegna, A J/D-1297-2017; Thierry, Guillaume/C-2688-2008	Martin, Clara/0000-0003-2701-5045; Pegna, A J/0000-0001-9920-9290; Thierry, Guillaume/0000-0003-1325-2656; Downing, Paul/0000-0002-5046-2858				ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BENNETT TL, 1992, NEUROPSYCHOLOGY EPIL, P73; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boehm SG, 2006, NEUROIMAGE, V30, P1021, DOI 10.1016/j.neuroimage.2005.10.028; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Cauquil AS, 2000, NEUROREPORT, V11, P2167, DOI 10.1097/00001756-200007140-00021; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Herrmann MJ, 2005, BRAIN TOPOGR, V18, P77, DOI 10.1007/s10548-005-0277-7; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; HILLYARD SA, 1989, HDB PHYSL 1, P519; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Pegna AJ, 1997, HUM BRAIN MAPP, V5, P410, DOI 10.1002/(SICI)1097-0193(1997)5:6<410::AID-HBM2>3.0.CO;2-6; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2002, COGNITION, V85, P189, DOI 10.1016/S0010-0277(02)00101-4; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Seeck M, 2001, EPILEPSY BEHAV, V2, P545, DOI 10.1006/ebeh.2001.0266; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; *U LJUBJ FAC COMP, CVL FAC DAT; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Xu YD, 2005, NEUROPSYCHOLOGIA, V43, P588, DOI 10.1016/j.neuropsychologia.2004.07.016	43	166	168	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					505	511		10.1038/nn1864	http://dx.doi.org/10.1038/nn1864			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17334361				2022-12-28	WOS:000245228600022
J	Ohshiro, T; Weliky, M				Ohshiro, Tomokazu; Weliky, Michael			Simple fall-off pattern of correlated neural activity in the developing lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							FERRET VISUAL-CORTEX; RETINAL GANGLION-CELLS; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; NEURONAL-ACTIVITY; BINOCULAR INTERACTION; CONTRAST SENSITIVITY; SYNAPTIC PLASTICITY; RESPONSE PROPERTIES; SELF-ORGANIZATION	Activity-dependent models for cortical simple-cell receptive field development predict specific patterns of correlated neural activity within the visual pathway, such as a Mexican hat-shaped pattern of correlated activity in the lateral geniculate nucleus (LGN). However, such activity patterns have yet to be experimentally demonstrated. We performed multielectrode recordings in the LGN of immature awake ferrets and found simple fall-off-shaped, rather than Mexican hat-shaped, patterns of correlated activity. A weak surround in the LGN neuron's receptive field and the statistics of the input contributed to this pattern of correlated activity. Computer simulation of cortical receptive field development incorporating the experimentally observed activity patterns demonstrated that a simple-cell receptive field emerges when a newly devised 'split' constraint on synaptic growth is combined with Hebbian synaptic modification rules. Thus, given certain developmental constraints on synaptic plasticity, patterns of correlated activity within the LGN are compatible with Hebbian models of simple-cell receptive field development.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Ohshiro, T (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Meliora Hall, Rochester, NY 14627 USA.	toshiro@bcs.rochester.edu						Akerman CJ, 2004, J NEUROSCI, V24, P170, DOI 10.1523/JNEUROSCI.1002-03.2004; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 1996, J NEUROSCI, V16, P6443; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; DUBIN MW, 1977, J NEUROPHYSIOL, V40, P410, DOI 10.1152/jn.1977.40.2.410; Elliott T, 2002, NEURAL COMPUT, V14, P1311, DOI 10.1162/089976602753712954; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hebb Donald O., 1949, ORG BEHAV; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Lee AB, 2000, P NATL ACAD SCI USA, V97, P12875, DOI 10.1073/pnas.97.23.12875; LINSENMEIER RA, 1982, VISION RES, V22, P1173, DOI 10.1016/0042-6989(82)90082-7; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MILLER KD, 1994, J NEUROSCI, V14, P409; PRICE DJ, 1987, EXP BRAIN RES, V68, P28; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SO YT, 1981, J NEUROPHYSIOL, V45, P1107; TANAKA S, 1990, NEURAL NETWORKS, V3, P625, DOI 10.1016/0893-6080(90)90053-N; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; TOOTLE JS, 1986, J NEUROPHYSIOL, V56, P523, DOI 10.1152/jn.1986.56.2.523; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; von der Malsburg C, 1973, Kybernetik, V14, P85; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087	44	25	25	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1541	1548		10.1038/nn1799	http://dx.doi.org/10.1038/nn1799			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115045				2022-12-28	WOS:000242404000019
J	Wu, KY; Zippin, JH; Huron, DR; Kamenetsky, M; Hengst, U; Buck, J; Levin, LR; Jaffrey, SR				Wu, Karen Y.; Zippin, Jonathan H.; Huron, David R.; Kamenetsky, Margarita; Hengst, Ulrich; Buck, Jochen; Levin, Lonny R.; Jaffrey, Samie R.			Soluble adenylyl cyclase is required for netrin-1 signaling in nerve growth cones	NATURE NEUROSCIENCE			English	Article							ADENOSINE A2B RECEPTOR; AXON OUTGROWTH; SPINAL-CORD; GUIDANCE; DCC; CAMP; BICARBONATE; ATTRACTION; INHIBITION; SYSTEM	Growth cones at the tips of nascent and regenerating axons direct axon elongation. Netrin-1, a secreted molecule that promotes axon outgrowth and regulates axon pathfinding, elevates cyclic AMP (cAMP) levels in growth cones and regulates growth cone morphology and axonal outgrowth. These morphological effects depend on the intracellular levels of cAMP. However, the specific pathways that regulate cAMP levels in response to netrin-1 signaling are unclear. Here we show that 'soluble' adenylyl cyclase (sAC), an atypical calcium- regulated cAMP-generating enzyme previously implicated in sperm maturation, is expressed in developing rat axons and generates cAMP in response to netrin-1. Overexpression of sAC results in axonal outgrowth and growth cone elaboration, whereas inhibition of sAC blocks netrin-1-induced axon outgrowth and growth cone elaboration. Taken together, these results indicate that netrin-1 signals through sAC-generated cAMP, and identify a fundamental role for sAC in axonal development.	Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA	Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA.	srj2003@med.cornell.edu	Hengst, Ulrich/L-1413-2014	Hengst, Ulrich/0000-0002-8061-2861; Jaffrey, Samie/0000-0003-3615-6958; Levin, Lonny/0000-0002-5204-6356	NCI NIH HHS [T32 CA062948, 5T32CA062948] Funding Source: Medline; NICHD NIH HHS [R01 HD038722, HD38722, HD42060] Funding Source: Medline; NIDA NIH HHS [2T32 DA07274, T32 DA007274] Funding Source: Medline; NIGMS NIH HHS [R01 GM062328, GM07739, GM62328, T32 GM007739] Funding Source: Medline; NIMH NIH HHS [R01 MH066204-04, R01 MH066204, MH066204] Funding Source: Medline; NINDS NIH HHS [R01 NS055255-01A1, R01 NS055255] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038722] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328, T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007274] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BANKER G, 1998, CULTURING NERVE CELL; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; FORTE LR, 1983, MOL PHARMACOL, V24, P42; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Gille A, 2004, J BIOL CHEM, V279, P19955, DOI 10.1074/jbc.M312560200; Guirland C, 2003, J NEUROSCI, V23, P2274; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Jackman A, 2000, J COMP NEUROL, V418, P281; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Johnson RA, 1997, J BIOL CHEM, V272, P8962; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moore SW, 2006, J NEUROSCI, V26, P2419, DOI 10.1523/JNEUROSCI.5419-05.2006; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Seaman C, 2001, MECH DEVELOP, V103, P173, DOI 10.1016/S0925-4773(01)00350-1; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	47	82	85	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1257	1264		10.1038/nn1767	http://dx.doi.org/10.1038/nn1767			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964251	Green Accepted			2022-12-28	WOS:000241493900019
J	Yin, YQ; Henzl, MT; Lorber, B; Nakazawa, T; Thomas, TT; Jiang, F; Langer, R; Benowitz, LI				Yin, Yuqin; Henzl, Michael T.; Lorber, Barbara; Nakazawa, Toru; Thomas, Tommy T.; Jiang, Fan; Langer, Robert; Benowitz, Larry I.			Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							RAT OPTIC-NERVE; CILIARY NEUROTROPHIC FACTOR; DEATH IN-VIVO; CALCIUM-BINDING; SENSORY NEURONS; GROWTH-STATE; ADULT-RATS; SURVIVAL; INJURY; INHIBITION	The optic nerve, like most mature CNS pathways, does not regenerate after injury. Through unknown mechanisms, however, macrophage activation in the eye stimulates retinal ganglion cells (RGCs) to regenerate long axons beyond the site of optic nerve injury. Here we identify the calcium (Ca2+)-binding protein oncomodulin as a potent macrophage-derived growth factor for RGCs and other neurons. Oncomodulin binds to rat RGCs with high affinity in a cyclic AMP (cAMP)-dependent manner and stimulates more extensive outgrowth than other known trophic agents. Depletion of oncomodulin from macrophage-conditioned media (MCM) eliminates the axon-promoting activity of MCM. The effects of oncomodulin involve downstream signaling via Ca2+/calmodulin kinase and gene transcription. In vivo, oncomodulin released from microspheres promotes regeneration in the mature rat optic nerve. Oncomodulin also stimulates outgrowth from peripheral sensory neurons. Thus, oncomodulin is a new growth factor for neurons of the mature central and peripheral nervous systems.	Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; MIT, Dept Chem & Biomed Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Missouri System; University of Missouri Columbia; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Benowitz, LI (corresponding author), Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	larry.benowitz@childrens.harvard.edu		Benowitz, Larry/0000-0002-0277-7222; Lorber, Barbara/0000-0001-9986-4543	NEI NIH HHS [EY05690] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGUAYO AJ, 1991, PHILOS T R SOC B, V331, P337, DOI 10.1098/rstb.1991.0025; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; BUXSER S, 1990, J BIOL CHEM, V265, P12701; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cajal S.R.y., 1991, DEGENERATION REGENER; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chierzi S, 1999, J NEUROSCI, V19, P8367; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HAPAK RC, 1989, J BIOL CHEM, V264, P18751; Henzl MT, 2004, BIOCHEMISTRY-US, V43, P2747, DOI 10.1021/bi035890k; Henzl MT, 1997, HEARING RES, V106, P105, DOI 10.1016/S0378-5955(97)00005-1; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; Kermer P, 1998, J NEUROSCI, V18, P4656; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li YM, 2003, J NEUROSCI, V23, P7830; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lorber B, 2002, MOL CELL NEUROSCI, V21, P301, DOI 10.1006/mcne.2002.1175; LU X, 1991, J NEUROSCI, V11, P972; MACMANUS JP, 1982, ONCODEV BIOL MED, V3, P79; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Otori Y, 1998, INVEST OPHTH VIS SCI, V39, P972; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; PERNET V, 2006, BRAIN; Porter AC, 2002, BRAIN RES, V944, P82, DOI 10.1016/S0006-8993(02)02721-X; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; STREILEIN JW, 1992, CURR EYE RES, V11, P41, DOI 10.3109/02713689208999510; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X; Yin YQ, 2003, J NEUROSCI, V23, P2284; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	50	379	402	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					843	852		10.1038/nn1701	http://dx.doi.org/10.1038/nn1701			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699509				2022-12-28	WOS:000237895200025
J	Marmigere, F; Montelius, A; Wegner, M; Groner, Y; Reichardt, LF; Ernfors, P				Marmigere, F; Montelius, A; Wegner, M; Groner, Y; Reichardt, LF; Ernfors, P			The Runx1/AML1 transcription factor selectively regulates development and survival of TrkA nociceptive sensory neurons	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT-GANGLIA; CREST STEM-CELLS; NERVOUS-SYSTEM; OSTEOBLAST DIFFERENTIATION; RECEPTOR EXPRESSION; MOTOR-NEURONS; GENE; AML1; AFFERENTS; BRN-3.0	Neural crest cells ( NCCs) can adopt different neuronal fates. In NCCs, neurogenin-2 promotes sensory specification but does not specify different subclasses of sensory neurons. Understanding the gene cascades that direct Trk gene activation may reveal mechanisms generating sensory diversity, because different Trks are expressed in different sensory neuron subpopulations. Here we show in chick and mouse that the Runt transcription factor Runx1 promotes axonal growth, is selectively expressed in neural crest-derived TrkA(+) sensory neurons and mediates TrkA transactivation in migratory NCCs. Inhibition of Runt activity depletes TrkA expression and leads to neuronal death. Moreover, Runx1 overexpression is incompatible with multipotency in the migratory neural crest but does not induce expression of pan-neuronal genes. Instead, Runx1-induced neuronal differentiation depends on an existing neurogenin2 proneural gene program. Our data show that Runx1 directs, in a context-dependent manner, key aspects of the establishment of the TrkA(+) nociceptive subclass of neurons.	Karolinska Inst, Lab Mol Neurobiol, MBB, Stockholm, Sweden; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Karolinska Institutet; University of Erlangen Nuremberg; Weizmann Institute of Science; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ernfors, P (corresponding author), Karolinska Inst, Lab Mol Neurobiol, MBB, Scheeles Vag 1, Stockholm, Sweden.	Patrik.Ernfors@ki.se	Montelius, Andreas/B-3990-2009	MARMIGERE, FREDERIC/0000-0002-0515-7483; Ernfors, Patrik/0000-0002-1140-3986; Wegner, Michael/0000-0002-4586-3294	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, P50NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-22, NS 16033, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAE SC, 1994, MOL CELL BIOL, V14, P3242, DOI 10.1128/MCB.14.5.3242; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; CARR PA, 1993, BRAIN RES BULL, V30, P209, DOI 10.1016/0361-9230(93)90246-8; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eng SR, 2004, DEVELOPMENT, V131, P3859, DOI 10.1242/dev.01260; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Falk A, 2002, EXP CELL RES, V279, P34, DOI 10.1006/excr.2002.5569; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Kasemeier-Kulesa JC, 2005, DEVELOPMENT, V132, P235, DOI 10.1242/dev.01553; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Lefcort F, 1996, J NEUROSCI, V16, P3704; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Ma L, 2000, DEVELOPMENT, V127, P3777; Ma L, 2003, DEVELOPMENT, V130, P3525, DOI 10.1242/dev.00582; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; Nibu K, 2000, BIOCHEM BIOPH RES CO, V279, P172, DOI 10.1006/bbrc.2000.3899; Oakley RA, 1997, J NEUROSCI, V17, P4262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Perez SE, 1999, DEVELOPMENT, V126, P1715; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SHOLL DA, 1953, J ANAT, V87, P387; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TANAKA K, 1995, BIOCHEM BIOPH RES CO, V211, P1023, DOI 10.1006/bbrc.1995.1913; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Theriault FM, 2004, P NATL ACAD SCI USA, V101, P10343, DOI 10.1073/pnas.0400768101; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; vonBartheld CS, 1996, J NEUROSCI, V16, P2995; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	50	103	108	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					180	187		10.1038/nn1631	http://dx.doi.org/10.1038/nn1631			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429136	Green Accepted			2022-12-28	WOS:000234990100012
J	O'Keeffe, GW; Gutierrez, H; Pandolfi, PP; Riccardi, C; Davies, AM				O'Keeffe, Gerard W.; Gutierrez, Humberto; Pandolfi, Pier Paolo; Riccardi, Carlo; Davies, Alun M.			NGF-promoted axon growth and target innervation requires GITRL-GITR signaling	NATURE NEUROSCIENCE			English	Article							SYMPATHETIC NEURON DEVELOPMENT; KAPPA-B ACTIVATION; NEUROTROPHIC FACTOR; TNF RECEPTOR; T-CELLS; SURVIVAL; PATHWAY; DEATH; TRKA; CONTRIBUTES	Nerve growth factor (NGF) has an important role in regulating sympathetic neuron survival and target field innervation during development. Here we show that glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR), a member of the TNF superfamily, and its ligand (GITRL) are co-expressed in mouse sympathetic neurons when their axons are innervating their targets under the influence of target-derived NGF. In culture, GITRL enhanced NGF-promoted neurite growth from neonatal sympathetic neurons, and preventing GITR-GITRL interaction in these neurons or knocking down GITR inhibited NGF-promoted neurite growth without affecting neuronal survival. Tnfrsf18(-/-) (Gitr) neonates have reduced sympathetic innervation density in vivo compared with Gitr(+/+) littermates. GITR activation is required for the phosphorylation of extracellular signal-regulated kinases 1 and 2 by NGF that is necessary for neurite growth. Our results reveal a previously unknown signaling loop in developing sympathetic neurons that is crucial for NGF-dependent axon growth and target innervation.	[O'Keeffe, Gerard W.; Gutierrez, Humberto; Davies, Alun M.] Sch Biosci, Cardiff CF10 3US, Wales; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02115 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Riccardi, Carlo] Univ Perugia, Dept Clin & Expt Med, Pharmacol Sect, I-06100 Perugia, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Perugia	Davies, AM (corresponding author), Sch Biosci, Biomed Bldg,Museum Ave, Cardiff CF10 3US, Wales.	daviesalun@cf.ac.uk	Riccardi, Carlo/N-4610-2014; Davies, Alun M/A-4334-2010	Riccardi, Carlo/0000-0001-9257-3997; Davies, Alun M/0000-0001-5841-8176; O'Keeffe, Gerard/0000-0001-5149-0933; Gutierrez, Humberto/0000-0002-5021-8636	Wellcome Trust [071251] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; DAVIES AM, 1986, DEV BIOL, V115, P56, DOI 10.1016/0012-1606(86)90227-7; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Esparza EM, 2006, J BIOL CHEM, V281, P8559, DOI 10.1074/jbc.M512915200; Esparza EM, 2005, J IMMUNOL, V174, P7875, DOI 10.4049/jimmunol.174.12.7875; Forgie A, 2003, DEVELOPMENT, V130, P995, DOI 10.1242/dev.00329; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Krausz LT, 2007, THESCIENTIFICWORLDJO, V7, P533, DOI 10.1100/tsw.2007.106; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; SHOLL DA, 1953, J ANAT, V87, P387; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; Yang XM, 1998, J NEUROSCI, V18, P8369; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	30	50	52	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					135	142		10.1038/nn2034	http://dx.doi.org/10.1038/nn2034			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18176559	Green Accepted			2022-12-28	WOS:000252712100007
J	Friedman, MJ; Shah, AG; Fang, ZH; Ward, EG; Warren, ST; Li, SH; Li, XJ				Friedman, Meyer J.; Shah, Anjali G.; Fang, Zhi-Hui; Ward, Elizabeth G.; Warren, Stephen T.; Li, Shihua; Li, Xiao-Jiang			Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration	NATURE NEUROSCIENCE			English	Article							TATA-BINDING PROTEIN; DOMINANT CEREBELLAR-ATAXIA; NEURONS IN-VITRO; REPEAT EXPANSION; CELL-DEATH; HEAT-SHOCK-PROTEIN-27; TRANSCRIPTION; DISEASE; HUNTINGTIN; EXPRESSION	Expansion of the polyglutamine (polyQ) tract in human TATA-box binding protein (TBP) causes the neurodegenerative disease spinocerebellar ataxia 17 (SCA17). It remains unclear how the polyQ tract regulates normal protein function and induces selective neuropathology in SCA17. We generated transgenic mice expressing polyQ-expanded TBP. These mice showed weight loss, progressive neurological symptoms and neurodegeneration before early death. Expanded polyQ tracts reduced TBP dimerization but enhanced the interaction of TBP with the general transcription factor IIB (TFIIB). In SCA17 transgenic mice, the small heat shock protein HSPB1, a potent neuroprotective factor, was downregulated, and TFIIB occupancy of the Hspb1 promoter was decreased. Overexpression of HSPB1 or TFIIB alleviated mutant TBP-induced neuritic defects. These findings implicate the polyQ domain of TBP in transcriptional regulation and provide insight into the molecular pathogenesis of SCA17.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu	Warren, Stephen T/A-2498-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153, R01AG019206] Funding Source: NIH RePORTER; NIA NIH HHS [AG19206, R01 AG031153] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline; NINDS NIH HHS [R01 NS045016, R01 NS041669, NS045016, NS36232, NS41669] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Armstrong CL, 2001, J COMP NEUROL, V434, P262, DOI 10.1002/cne.1176; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Bondareva AA, 2003, MOL BIOL EVOL, V20, P1932, DOI 10.1093/molbev/msg205; Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Chang WH, 2005, BIOCHEM BIOPH RES CO, V336, P258, DOI 10.1016/j.bbrc.2005.08.065; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; GAESTEL M, 1993, GENE, V128, P279, DOI 10.1016/0378-1119(93)90575-N; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Lee M, 1997, MOL CELL BIOL, V17, P1336, DOI 10.1128/MCB.17.3.1336; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Michalik A, 2001, BIOTECHNIQUES, V31, P250, DOI 10.2144/01312bm02; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schmidt EE, 2003, J BIOL CHEM, V278, P6168, DOI 10.1074/jbc.M211205200; SEIPEL K, 1994, MOL REPROD DEV, V39, P215, DOI 10.1002/mrd.1080390215; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Taggart AKP, 1996, SCIENCE, V272, P1331, DOI 10.1126/science.272.5266.1331; Tansey WP, 1997, SCIENCE, V275, P829, DOI 10.1126/science.275.5301.829; Toyoshima Y, 2004, ANN NEUROL, V55, P281, DOI 10.1002/ana.10824; Tsai HF, 2005, BIOCHEM BIOPH RES CO, V334, P1279, DOI 10.1016/j.bbrc.2005.06.207; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	127	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1519	1528		10.1038/nn2011	http://dx.doi.org/10.1038/nn2011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994014				2022-12-28	WOS:000251172900008
J	Glasscock, E; Qian, J; Yoo, JW; Noebels, JL				Glasscock, Edward; Qian, Jing; Yoo, Jong W.; Noebels, Jeffrey L.			Masking epilepsy by combining two epilepsy genes	NATURE NEUROSCIENCE			English	Article							SIMPLE MENDELIAN DISORDERS; CHANNEL SUBUNIT KV1.1; COMPLEX TRAITS; MICE LACKING; MUTANT MOUSE; DEPENDENT MODULATION; ABSENCE EPILEPSY; EPISODIC ATAXIA; HYPEREXCITABILITY; TRANSMISSION	Inherited errors in ion channel genes comprise the largest subset of monogenic causes of idiopathic epilepsy, and pathogenic variants contribute to genetic risk in the complex inheritance of this common disorder. We generated a digenic mouse model of human idiopathic epilepsy by combining two epilepsy-associated ion channel mutations with mutually opposing excitability defects and overlapping subcellular localization. We found that increasing membrane excitability by removing Shaker-like K+ channels, which are encoded by the Kcna1 gene, masked the absence epilepsy caused by a P/Q-type Ca2+ channelopathy due to a missense mutation in the Cacna1a gene. Conversely, decreasing network excitability by impairing Cacna1a Ca2+-channel function attenuated limbic seizures and sudden death in Kcna1-null mice. We also identified intermediate excitability phenotypes at the network and axonal levels. Protective interactions between pathogenic ion channel variants may markedly alter the clinical expression of epilepsy, highlighting the need for comprehensive profiling of this candidate gene set to improve the accuracy of genetic risk assessment of this complex disease.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Noebels, JL (corresponding author), Baylor Coll Med, Dept Neurol, One Baylor Plaza, Houston, TX 77030 USA.	jnoebels@bcm.tmc.edu		Noebels, Jeffrey/0000-0002-2887-0839	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709, T32NS043124] Funding Source: NIH RePORTER; NINDS NIH HHS [NS43124, NS29709] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gourfinkel-An I, 2004, LANCET NEUROL, V3, P209, DOI 10.1016/S1474-4422(04)00706-9; Imbrici P, 2004, BRAIN, V127, P2682, DOI 10.1093/brain/awh301; Kearney JA, 2006, HUM MOL GENET, V15, P1043, DOI 10.1093/hmg/ddl019; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Liguori R, 2001, MUSCLE NERVE, V24, P630, DOI 10.1002/mus.1048; Lopantsev V, 2003, EPILEPSIA, V44, P1506, DOI 10.1111/j.0013-9580.2003.44602.x; Nadeau JH, 2006, NAT GENET, V38, P1095, DOI 10.1038/ng1006-1095; NOEBELS JL, 1990, BRAIN RES, V524, P225, DOI 10.1016/0006-8993(90)90695-8; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Pereira S, 2004, NEUROLOGY, V63, P191, DOI 10.1212/01.WNL.0000132844.20654.C1; Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000; Qian J, 1999, J PHYSIOL-LONDON, V519, P427, DOI 10.1111/j.1469-7793.1999.0427m.x; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WANG H, 1994, J NEUROSCI, V14, P4588; Zhang CL, 1999, J NEUROSCI, V19, P2852; Zhou YD, 2003, J PHYSIOL-LONDON, V547, P497, DOI 10.1113/jphysiol.2002.033415; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	25	100	102	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1554	1558		10.1038/nn1999	http://dx.doi.org/10.1038/nn1999			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982453				2022-12-28	WOS:000251172900012
J	Vilchez, D; Ros, S; Cifuentes, D; Pujadas, L; Valles, J; Garcia-Fojeda, B; Criado-Garcia, O; Fernandez-Sanchez, E; Medrano-Fernandez, I; Dominguez, J; Garcia-Rocha, M; Soriano, E; De Cordoba, SR; Guinovart, JJ				Vilchez, David; Ros, Susana; Cifuentes, Daniel; Pujadas, Lluis; Valles, Jordi; Garcia-Fojeda, Belen; Criado-Garcia, Olga; Fernandez-Sanchez, Elena; Medrano-Fernandez, Iria; Dominguez, Jorge; Garcia-Rocha, Mar; Soriano, Eduardo; De Cordoba, Santiago Rodriguez; Guinovart, Joan J.			Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy	NATURE NEUROSCIENCE			English	Article							LAFORA-DISEASE; PHOSPHORYLATION SITES; CORPORA-AMYLACEA; SYNTHASE; PROTEIN; PHOSPHATASE; GLUCOSE-6-PHOSPHATE; ACTIVATION; MUTATIONS; CELLS	Glycogen synthesis is normally absent in neurons. However, inclusion bodies resembling abnormal glycogen accumulate in several neurological diseases, particularly in progressive myoclonus epilepsy or Lafora disease. We show here that mouse neurons have the enzymatic machinery for synthesizing glycogen, but that it is suppressed by retention of muscle glycogen synthase (MGS) in the phosphorylated, inactive state. This suppression was further ensured by a complex of laforin and malin, which are the two proteins whose mutations cause Lafora disease. The laforin-malin complex caused proteasome-dependent degradation both of the adaptor protein targeting to glycogen, PTG, which brings protein phosphatase 1 to MGS for activation, and of MGS itself. Enforced expression of PTG led to glycogen deposition in neurons and caused apoptosis. Therefore, the malin-laforin complex ensures a blockade of neuronal glycogen synthesis even under intense glycogenic conditions. Here we explain the formation of polyglucosan inclusions in Lafora disease by demonstrating a crucial role for laforin and malin in glycogen synthesis.	Univ Barcelona, E-08028 Barcelona, Spain; Inst Res Biomed, E-08028 Barcelona, Spain; CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	De Cordoba, SR (corresponding author), Univ Barcelona, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.	SRdeCordoba@cib.csic.es	Ros, Susana/B-6350-2019; García-Fojeda, Belén/G-4214-2015; de Cordoba, Santiago Rodriguez/K-6727-2014; Medraño-Fernandez, Iria/AAN-4357-2020; Vilchez, David/A-8446-2008; Pujadas, Lluís/O-7442-2015; PUJADAS, LLUÍS/AAE-1595-2020; Soriano, Eduardo/AAB-3216-2019	García-Fojeda, Belén/0000-0002-9558-3020; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Medraño-Fernandez, Iria/0000-0002-7956-9915; Vilchez, David/0000-0002-0801-0743; Pujadas, Lluís/0000-0003-3890-8279; PUJADAS, LLUÍS/0000-0003-3890-8279; Soriano, Eduardo/0000-0002-3204-9285; Garcia-Rocha, Mar/0000-0003-2467-2090; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863; Ros, Susana/0000-0002-5451-1880; Criado, Olga/0000-0003-1200-6365; Cifuentes Buira, Daniel/0000-0001-5442-4843				ACHARYA JN, 1995, EPILEPSIA, V36, P429, DOI 10.1111/j.1528-1157.1995.tb00482.x; Allaman I, 2000, GLIA, V30, P382, DOI 10.1002/(SICI)1098-1136(200006)30:4<382::AID-GLIA70>3.3.CO;2-S; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BERKOVIC SF, 1993, EPILEPSIA, V34, pS19; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; KOBAYASHI K, 1990, EPILEPSIA, V31, P194, DOI 10.1111/j.1528-1167.1990.tb06306.x; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; LANG G, 1974, METHOD ENZYMAT AN, V6, P1238; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHLAMOWITZ M, 1951, J BIOL CHEM, V190, P519; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; VANHEYCOP TH, 1974, CLIN NEUROL, V15, P382; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200	46	254	255	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1407	1413		10.1038/nn1998	http://dx.doi.org/10.1038/nn1998			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952067	Green Submitted			2022-12-28	WOS:000250508400018
J	Anzai, A; Peng, XM; Van Essen, DC				Anzai, Akiyuki; Peng, Xinmiao; Van Essen, David C.			Neurons inmonkey visual area V2 encode combinations of orientations	NATURE NEUROSCIENCE			English	Article							OF-FIT TESTS; RECEPTIVE-FIELDS; STRIATE-CORTEX; FUNCTIONAL ARCHITECTURE; SIMPLE CELLS; MONKEY; STEREOPSIS; RESPONSES; CAT	Contours and textures are important attributes of object surfaces, and are often described by combinations of local orientations in visual images. To elucidate the neural mechanisms underlying contour and texture processing, we examined receptive field (RF) structures of neurons in visual area V2 of the macaque monkey for encoding combinations of orientations. By measuring orientation tuning at several locations within the classical RF, we found that a majority (70%) of V2 neurons have similar orientation tuning throughout the RF. However, many others have RFs containing subregions tuned to different orientations, most commonly about 90 degrees apart. By measuring interactions between two positions within the RF, we found that approximately one-third of neurons show inhibitory interactions that make them selective for combinations of orientations. These results indicate that V2 neurons could play an important role in analyzing contours and textures and could provide useful cues for surface segmentation.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Anzai, A (corresponding author), Univ Rochester, Ctr Visual Sci, Meliora Hall 248, Rochester, NY 14627 USA.	aanzai@cvs.rochester.edu	Van Essen, David/ABA-8888-2020		NATIONAL EYE INSTITUTE [R01EY002091] Funding Source: NIH RePORTER; NEI NIH HHS [EY 02091] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berry D.A., 1996, STAT BAYESIAN PERSPE; BROWN BM, 1994, J R STAT SOC B, V56, P275; Carandini M, 1997, J NEUROSCI, V17, P8621; DEANGELIS GC, 1995, PERCEPTION, V24, P3, DOI 10.1068/p240003; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEVALOIS RL, 1985, J OPT SOC AM A, V2, P1115, DOI 10.1364/JOSAA.2.001115; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fisher NI, 2001, BIOMETRIKA, V88, P499, DOI 10.1093/biomet/88.2.499; FSHER NI, 1993, STAT ANAL CIRCULAR D; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KUYPERS HGJ, 1965, EXP NEUROL, V11, P245, DOI 10.1016/0014-4886(65)90016-6; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Mahon LE, 2001, VISUAL NEUROSCI, V18, P973, DOI 10.1017/S0952523801186141; NAKAYAMA K, 1995, INVITATION COGNITIVE, V2, P1; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; PRESS WH, 1988, MODELING DATA NUMERI, P517; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; VANESSEN DC, 1986, J COMP NEUROL, V244, P541; Walker GA, 2002, J NEUROSCI, V22, P5659; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135	37	170	171	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1313	1321		10.1038/nn1975	http://dx.doi.org/10.1038/nn1975			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873872				2022-12-28	WOS:000249720800019
J	Armentano, M; Chou, SJ; Tomassy, GS; Leingaertner, A; O'Leary, DDM; Studer, M				Armentano, Maria; Chou, Shen-Ju; Tomassy, Giulio Srubek; Leingaertner, Axel; O'Leary, Dennis D. M.; Studer, Michele			COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas	NATURE NEUROSCIENCE			English	Article							THALAMOCORTICAL AXONS; CEREBRAL-CORTEX; DIFFERENTIAL EXPRESSION; DEVELOPING NEOCORTEX; EMX2; PAX6; REGIONALIZATION; SPECIFICATION; FOREBRAIN; NEURONS	We used cortex-specific deletion of the transcription factor gene COUP-TFI (also known as Nr2f1) in mice to demonstrate previously unknown fundamental roles for it in patterning mammalian neocortex into areas. The highest COUP-TFI expression is observed in the cortical progenitors and progeny in parietal and occipital cortex that form sensory areas, and the lowest expression was observed in frontal cortex that includes motor areas. Cortical deletion of COUP-TFI resulted in massive expansion of frontal areas, including motor, to occupy most of neocortex, paralleled by marked compression of sensory areas to caudal occipital cortex. These area patterning changes are preceded and paralleled by corresponding changes in molecular markers of area identity and altered axonal projections to maintain patterned area-specific input and output connections. We conclude that COUP-TFI is required for balancing patterning of neocortex into frontal/motor and sensory areas by acting in its expression domain to repress frontal/motor area identities and to specify sensory area identities.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; TIGEM, Dev Disorders Program, I-80131 Naples, Italy	Salk Institute; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu; studer@tigem.it	Studer, Michele/P-4580-2016	Studer, Michele/0000-0001-7105-2957	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS050646] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS31558, R01 NS50646] Funding Source: Medline; Telethon [TGM06S01, TGM06A04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Liu Q, 2000, J NEUROSCI, V20, P7682; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Stoykova A, 2000, J NEUROSCI, V20, P8042; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	33	164	166	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1277	1286		10.1038/nn1958	http://dx.doi.org/10.1038/nn1958			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828260				2022-12-28	WOS:000249720800014
J	Han, YK; Kover, H; Insanally, MN; Semerdjian, JH; Bao, SW				Han, Yoon K.; Koever, Hania; Insanally, Michele N.; Semerdjian, John H.; Bao, Shaowen			Early experience impairs perceptual discrimination	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; CORTICAL MAP REORGANIZATION; SOMATOSENSORY CORTEX; TEMPORAL PLASTICITY; PHONETIC PERCEPTION; MUSICAL INTERVALS; INFANTS SHOW; INFORMATION; SPEECH; REPRESENTATION	Sensory experience can reorganize cortical sensory representations in an epoch of early development. During this period, cortical sensory neurons may shift their response selectivity and become tuned to more frequently occurring stimuli. Although this enlarged cortical representation is believed to underlie improved sensory processing of the experienced stimuli, its precise perceptual consequences are still unknown. We show that rearing rats in a single-frequency tonal environment results in enlarged cortical representations of the frequencies near that of the experienced tone, but the animals are impaired in perceptual discrimination of the over-represented frequencies. By contrast, discrimination of the neighboring under-represented frequencies is substantially improved. Computational analysis indicated that the altered perceptual ability could be fully accounted for by the sound exposure-induced reorganization of cortical primary auditory representations. These results indicate that early experience shapes sensory perception. The same plasticity processes may be important in optimizing phonemic representations in humans.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bao, SW (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 210X Barker Hall, Berkeley, CA 94720 USA.	sbao@berkeley.edu		Insanally, Michele/0000-0002-1049-1697				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; BURNS EM, 1978, J ACOUST SOC AM, V63, P456, DOI 10.1121/1.381737; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chowdhury SA, 2000, J NEUROPHYSIOL, V83, P1856, DOI 10.1152/jn.2000.83.4.1856; Dayan P, 2001, COMPUTATIONAL NEUROS; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Godde B, 2000, J NEUROSCI, V20, P1597; Guenther FH, 1996, J ACOUST SOC AM, V100, P1111, DOI 10.1121/1.416296; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 2001, J NEUROPHYSIOL, V86, P326, DOI 10.1152/jn.2001.86.1.326; KNUDSEN EI, 1983, SCIENCE, V222, P939, DOI 10.1126/science.6635667; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; OHL FW, 1996, J NEUROSCI, V8, P1001; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; POWELL MJD, 1977, NUMERICAL ANAL; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1037; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; ZATORRE RJ, 1979, PERCEPT PSYCHOPHYS, V26, P384, DOI 10.3758/BF03204164; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	50	98	99	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1191	1197		10.1038/nn1941	http://dx.doi.org/10.1038/nn1941			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660815				2022-12-28	WOS:000249144000022
J	Iftinca, M; Hamid, J; Chen, L; Varela, D; Tadayonnejad, R; Altier, C; Turner, RW; Zamponi, GW				Iftinca, Mircea; Hamid, Jawed; Chen, Lina; Varela, Diego; Tadayonnejad, Reza; Altier, Christophe; Turner, Ray W.; Zamponi, Gerald W.			Regulation of T-type calcium channels by Rho-associated kinase	NATURE NEUROSCIENCE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; CELL-GROWTH; SERINE/THREONINE KINASE; LATERAL HABENULA; SENSORY NEURONS; BINDING; EXPRESSION; ISOFORMS; SUBUNITS; TARGET	We investigated the regulation of T-type channels by Rho-associated kinase ( ROCK). Activation of ROCK via the endogenous ligand lysophosphatidic acid (LPA) reversibly inhibited the peak current amplitudes of rat Cav3.1 and Cav3.3 channels without affecting the voltage dependence of activation or inactivation, whereas Cav3.2 currents showed depolarizing shifts in these parameters. LPA-induced inhibition of Cav3.1 was dependent on intracellular GTP, and was antagonized by treatment with ROCK and RhoA inhibitors, LPA receptor antagonists or GDP beta S. Site-directed mutagenesis of the Ca(v)3.1 alpha(1) subunit revealed that the ROCK-mediated effects involve two distinct phosphorylation consensus sites in the domain II-III linker. ROCK activation by LPA reduced native T-type currents in Y79 retinoblastoma and in lateral habenular neurons, and upregulated native Cav3.2 current in dorsal root ganglion neurons. Our data suggest that ROCK is an important regulator of T-type calcium channels, with potentially far-reaching implications for multiple cell functions modulated by LPA.	Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Anat & Cell Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Anat, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Varela, Diego/AAG-7489-2019	Varela, Diego/0000-0002-9352-414X; Zamponi, Gerald W./0000-0002-0644-9066				Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P509, DOI 10.1016/j.mcn.2004.11.002; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Cheng N, 2002, MOL CANCER RES, V1, P2; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dergham P, 2002, J NEUROSCI, V22, P6570; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Gu Y, 1999, PFLUG ARCH EUR J PHY, V438, P553, DOI 10.1007/s004240051075; Hirdes W, 2004, J PHYSIOL-LONDON, V559, P67, DOI 10.1113/jphysiol.2004.066944; Hirooka K, 2002, J NEUROPHYSIOL, V88, P196, DOI 10.1152/jn.2002.88.1.196; HUGUENARD JR, 1993, J NEUROPHYSIOL, V70, P158, DOI 10.1152/jn.1993.70.1.158; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Shimizu T, 2003, J BIOL CHEM, V278, P46046, DOI 10.1074/jbc.M306458200; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Todorovic SM, 2001, MOL PHARMACOL, V60, P603; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; WILCOX KS, 1988, J NEUROPHYSIOL, V59, P212, DOI 10.1152/jn.1988.59.1.212; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48	50	58	58	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					854	860		10.1038/nn1921	http://dx.doi.org/10.1038/nn1921			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558400				2022-12-28	WOS:000247560200015
J	Spiegel, I; Adamsky, K; Eshed, Y; Milo, R; Sabanay, H; Sarig-Nadir, O; Horresh, I; Scherer, SS; Rasband, MN; Peles, E				Spiegel, Ivo; Adamsky, Konstantin; Eshed, Yael; Milo, Ron; Sabanay, Helena; Sarig-Nadir, Offra; Horresh, Ido; Scherer, Steven S.; Rasband, Matthew N.; Peles, Elior			A central role for Necl4 ( SynCAM4) in Schwann cell- axon interaction and myelination	NATURE NEUROSCIENCE			English	Article							ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; N-CADHERIN; PROTEIN; NECTIN; GLYCOPROTEIN; EXPRESSION; CHANNELS; DOMAIN; NODES	Myelination in the peripheral nervous system requires close contact between Schwann cells and the axon, but the underlying molecular basis remains largely unknown. Here we show that cell adhesion molecules (CAMs) of the nectin-like (Necl, also known as SynCAM or Cadm) family mediate Schwann cell-axon interaction during myelination. Necl4 is the main Necl expressed by myelinating Schwann cells and is located along the internodes in direct apposition to Necl1, which is localized on axons. Necl4 serves as the glial binding partner for axonal Necl1, and the interaction between these two CAMs mediates Schwann cell adhesion. The disruption of the interaction between Necl1 and Necl4 by their soluble extracellular domains, or the expression of a dominant-negative Necl4 in Schwann cells, inhibits myelination. These results suggest that Necl proteins are important for mediating axon-glia contact during myelination in peripheral nerves.	Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Connecticut, Hlth Sci Ctr, Dept Neurosci, Farmington, CT 06032 USA	Weizmann Institute of Science; University of Pennsylvania; University of Connecticut	Peles, E (corresponding author), Weizmann Inst Sci, Dept Mol & Cell Biol, POB 26, IL-76100 Rehovot, Israel.	peles@weizmann.ac.il	Scherer, Steven S/F-7979-2011; Spiegel, Ivo/O-4025-2014	Peles, Elior/0000-0002-3325-0597; Milo, Ron/0000-0003-1641-2299; Rasband, Matthew/0000-0001-8184-2477; Spiegel, Ivo/0000-0003-0979-1358	NINDS NIH HHS [R01 NS044916, NS044916, R01 NS050220, R01 NS050220-03, NS50220, R37 NS044916] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044916, R01NS050220, R37NS044916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bartsch U, 2003, FRONT BIOSCI-LANDMRK, V8, pD477, DOI 10.2741/1028; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Fujita E, 2005, DEV BRAIN RES, V154, P199, DOI 10.1016/j.devbrainres.2004.10.015; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Gunn-Moore FJ, 2006, MOL CELL NEUROSCI, V33, P441, DOI 10.1016/j.mcn.2006.09.003; HALL SM, 1971, J CELL SCI, V9, P769; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Irie K, 2004, SEMIN CELL DEV BIOL, V15, P643, DOI 10.1016/j.semcdb.2004.09.002; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Ohno N, 2006, J NEUROSCI RES, V84, P568, DOI 10.1002/jnr.20949; Ohta Y, 2005, DEV BRAIN RES, V156, P23, DOI 10.1016/j.devbrainres.2005.01.001; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Spiegel I, 2002, MOL MEMBR BIOL, V19, P95, DOI 10.1080/09687680210130009; Spiegel I, 2006, NEURON GLIA BIOL, V2, P27, DOI 10.1017/S1740925X0600007X; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; THOMAS PK, 1984, PERIPHERAL NEUROPATH, V1, P97; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Wanner IB, 2006, GLIA, V54, P439, DOI 10.1002/glia.20390; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Yageta M, 2002, CANCER RES, V62, P5129; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	48	144	153	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					861	869		10.1038/nn1915	http://dx.doi.org/10.1038/nn1915			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558405	Green Accepted			2022-12-28	WOS:000247560200016
J	Kording, KP; Tenenbaum, JB; Shadmehr, R				Kording, Konrad P.; Tenenbaum, Joshua B.; Shadmehr, Reza			The dynamics of memory as a consequence of optimal adaptation to a changing body	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; CEREBELLAR CORTEX; SHORT-TERM; MONKEY; CONSOLIDATION; PLASTICITY; LESIONS; SHIFTS; TASK; SIZE	There are many causes for variation in the responses of the motor apparatus to neural commands. Fast-timescale disturbances occur when muscles fatigue. Slow-timescale disturbances occur when muscles are damaged or when limb dynamics change as a result of development. To maintain performance, motor commands need to adapt. Computing the best adaptation in response to any performance error results in a credit assignment problem: which timescale is responsible for this disturbance? Here we show that a Bayesian solution to this problem accounts for numerous behaviors of animals during both short- and long-term training. Our analysis focused on characteristics of the oculomotor system during learning, including the effects of time passage. However, we suggest that learning and memory in other paradigms, such as reach adaptation, adaptation of visual neurons and retrieval of declarative memories, largely follow similar rules.	Rehabil Inst Chicago, Chicago, IL 60611 USA; MIT, Cambridge, MA 02139 USA; Johns Hopkins Sch Med, Baltimore, MD 21205 USA	Shirley Ryan AbilityLab; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins Medicine	Kording, KP (corresponding author), Rehabil Inst Chicago, 446 E Ontario St,Rm 922, Chicago, IL 60611 USA.	kk@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057814] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NINDS NIH HHS [R01 NS057814, R01 NS057814-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson J. R., 1990, ADAPTIVE CHARACTER T; Bahcall DO, 1999, NATURE, V400, P864, DOI 10.1038/23693; BAHRICK HP, 1993, PSYCHOL SCI, V4, P316, DOI 10.1111/j.1467-9280.1993.tb00571.x; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BARTON JJS, 1995, NEUROLOGY, V45, P2065, DOI 10.1212/WNL.45.11.2065; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; Catz N, 2005, CURR BIOL, V15, P2179, DOI 10.1016/j.cub.2005.11.037; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Dempster Frank N., 1996, MEMORY, P317, DOI DOI 10.1016/B978-012102570-0/50011-2; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; EBBINGHAUS H, 1885, UBER GEDACHTNIS INTE; ERKELENS CJ, 1993, EXP BRAIN RES, V93, P157; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fitzgibbon E. J., 1986, ADAPTIVE PROCESSES V, P329; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gancarz G, 1999, VISION RES, V39, P3123, DOI 10.1016/S0042-6989(99)00049-8; GLENBERG AM, 1977, J EXP PSYCHOL-HUM L, V3, P282, DOI 10.1037/0278-7393.3.3.282; HAYKIN S, 2001, KALMAN FILTERIN NEUR; Hinton G.E., 1987, P 9 ANN C COGNITIVE, P177; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Jost A., 1897, Z PSYCHOL PHYSIOL SI, V16, P436; Kalman R.E., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; LEWIS RF, 1993, REV NEUROL, V149, P665; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Rescorla RA, 2004, LEARN BEHAV, V32, P401; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; WHITTEN WB, 1977, J VERB LEARN VERB BE, V16, P465, DOI 10.1016/S0022-5371(77)80040-6; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	42	259	261	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					779	786		10.1038/nn1901	http://dx.doi.org/10.1038/nn1901			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17496891	Green Accepted			2022-12-28	WOS:000246799800021
J	Samanez-Larkin, GR; Gibbs, SEB; Khanna, K; Nielsen, L; Carstensen, LL; Knutson, B				Samanez-Larkin, Gregory R.; Gibbs, Sasha E. B.; Khanna, Kabir; Nielsen, Lisbeth; Carstensen, Laura L.; Knutson, Brian			Anticipation of monetary gain but not loss in healthy older adults	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; AGE; VISUALIZATION; COGNITION; OUTCOMES; FMRI	Although global declines in structure have been documented in the aging human brain, little is known about the functional integrity of the striatum and prefrontal cortex in older adults during incentive processing. We used event-related functional magnetic resonance imaging to determine whether younger and older adults differed in both self-reported and neural responsiveness to anticipated monetary gains and losses. The present study provides evidence for intact striatal and insular activation during gain anticipation with age, but shows a relative reduction in activation during loss anticipation. These findings suggest that there is an asymmetry in the processing of gains and losses in older adults that may have implications for decision-making.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; NIA, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA; Stanford Ctr Longev, Stanford, CA 94305 USA; Stanford Univ, Inst Neurosci, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; Stanford University	Samanez-Larkin, GR (corresponding author), Stanford Univ, Dept Psychol, Bldg 420,Jordan Hall, Stanford, CA 94305 USA.	glarkin@stanford.edu	Samanez-Larkin, Gregory/A-1139-2007	Samanez-Larkin, Gregory/0000-0001-7846-3804; carstensen, laura/0000-0002-5011-3789; Knutson, Brian/0000-0002-7669-426X	NIA NIH HHS [P30 AG017253-09, R37 AG008816-17, AG017253, R01 AG008816, AG008816, AG024957, P30 AG017253, R37 AG008816, P30 AG024957-04, P30 AG024957] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG008816, P30AG024957, P30AG017253, R01AG008816] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Backman L, 2000, AM J PSYCHIAT, V157, P635; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Cabeza R., 2005, COGNITIVE NEUROSCIEN; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CARSTENSEN LL, 2005, HDB PSYCHOL AGING, P343; Cohen J, 2003, ANIM COGN, V6, P93, DOI 10.1007/s10071-003-0168-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Denburg NL, 2006, INT J PSYCHOPHYSIOL, V61, P19, DOI 10.1016/j.ijpsycho.2005.10.021; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Gazzaley A, 2005, COGNITIVE NEUROSCIEN, P107; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kennedy KM, 2005, J COGNITIVE NEUROSCI, P140; KISLEY MA, IN PRESS PSYCHOL SCI; Knight M., 2006, BIOL BASES PERSONALI, P159; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Marschner A, 2005, BRAIN RES BULL, V67, P382, DOI 10.1016/j.brainresbull.2005.06.010; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Neter J., 1996, APPL LINEAR STAT MOD; Park D.C., 2000, COGNITIVE AGING PRIM, V1st; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815	30	279	284	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					787	791		10.1038/nn1894	http://dx.doi.org/10.1038/nn1894			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	172JI	17468751	Green Accepted			2022-12-28	WOS:000246799800022
J	Cruikshank, SJ; Lewis, TJ; Connors, BW				Cruikshank, Scott J.; Lewis, Timothy J.; Connors, Barry W.			Synaptic basis for intense thalamocortical activation of feedforward inhibitory cells in neocortex	NATURE NEUROSCIENCE			English	Article							INTERNEURON DIVERSITY SERIES; SOMATOSENSORY BARREL CORTEX; CORTICAL RECEPTIVE-FIELDS; SPINY STELLATE NEURONS; PRIMARY VISUAL-CORTEX; LAYER-IV; RESPONSES; SYNAPSES; NETWORKS; GABA	The thalamus provides fundamental input to the neocortex. This input activates inhibitory interneurons more strongly than excitatory neurons, triggering powerful feedforward inhibition. We studied the mechanisms of this selective neuronal activation using a mouse somatosensory thalamocortical preparation. Notably, the greater responsiveness of inhibitory interneurons was not caused by their distinctive intrinsic properties but was instead produced by synaptic mechanisms. Axons from the thalamus made stronger and more frequent excitatory connections onto inhibitory interneurons than onto excitatory cells. Furthermore, circuit dynamics allowed feedforward inhibition to suppress responses in excitatory cells more effectively than in interneurons. Thalamocortical excitatory currents rose quickly in interneurons, allowing them to fire action potentials before significant feedforward inhibition emerged. In contrast, thalamocortical excitatory currents rose slowly in excitatory cells, overlapping with feedforward inhibitory currents that suppress action potentials. These results demonstrate the importance of selective synaptic targeting and precise timing in the initial stages of neocortical processing.	Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA	Brown University; University of California System; University of California Davis	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Div Biol & Med, Box G-LN, Providence, RI 02912 USA.	barry_connors@brown.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157				AGMON A, 1992, J NEUROSCI, V12, P319; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2002, J NEUROSCI, V22, P10966; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1996, J NEUROSCI, V16, P6567; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Inoue T, 2006, J NEUROPHYSIOL, V96, P1746, DOI 10.1152/jn.00301.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MCNAUGHTON BL, 1981, J NEUROPHYSIOL, V46, P952, DOI 10.1152/jn.1981.46.5.952; MILLER W, 1988, CABIOS, V4, P11; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MOUNTCASTLE VM, 1989, PERPETUAL NEUROSCIEN; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Walker HC, 2002, NEURON, V35, P161, DOI 10.1016/S0896-6273(02)00734-1; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Zhou FM, 1998, BRAIN RES, V780, P166, DOI 10.1016/S0006-8993(97)01311-5	41	391	397	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					462	468		10.1038/nn1861	http://dx.doi.org/10.1038/nn1861			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17334362	Green Published			2022-12-28	WOS:000245228600017
J	Fusi, S; Abbott, LF				Fusi, Stefano; Abbott, L. F.			Limits on the memory storage capacity of bounded synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY; TIMING-DEPENDENT PLASTICITY; FREQUENCY STIMULATION; INFORMATION-STORAGE; CORTICAL PLASTICITY; NEURAL NETWORKS; MODEL; HIPPOCAMPUS; LTP	Memories maintained in patterns of synaptic connectivity are rapidly overwritten and destroyed by ongoing plasticity related to the storage of new memories. Short memory lifetimes arise from the bounds that must be imposed on synaptic efficacy in any realistic model. We explored whether memory performance can be improved by allowing synapses to traverse a large number of states before reaching their bounds, or by changing the way these bounds are imposed. In the case of hard bounds, memory lifetimes grow proportional to the square of the number of synaptic states, but only if potentiation and depression are precisely balanced. Improved performance can be obtained without fine tuning by imposing soft bounds, but this improvement is only linear with respect to the number of synaptic states. We explored several other possibilities and conclude that improving memory performance requires a more radical modification of the standard model of memory storage.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kolb Res Annex, New York, NY 10032 USA	Columbia University	Abbott, LF (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kolb Res Annex, 1051 Riverside Dr, New York, NY 10032 USA.	lfa2103@columbia.edu	Fusi, Stefano/E-9109-2011	Fusi, Stefano/0000-0002-3035-6652	NIH HHS [5-DPI-OD114-02] Funding Source: Medline; PHS HHS [58754] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraham WC, 2002, J NEUROSCI, V22, P9626; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; AMIT DJ, 1992, NETWORK-COMP NEURAL, V3, P443, DOI 10.1088/0954-898X/3/4/008; AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLOCK HD, 1962, REV MOD PHYS, V34, P123, DOI 10.1103/RevModPhys.34.123; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Brunel N, 1998, NETWORK-COMP NEURAL, V9, P123, DOI 10.1088/0954-898X/9/1/007; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; FESTA R, 1978, PHYSICA A, V90, P229, DOI 10.1016/0378-4371(78)90111-5; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Fusi S, 2006, CHAOS, V16, DOI 10.1063/1.2213587; GROSSBERG S, 1982, PSYCHOL REV, V89, P529, DOI 10.1037/0033-295X.89.5.529; Gutig R, 2003, J NEUROSCI, V23, P3697; Hertz JA, 2018, INTRO THEORY NEURAL; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KAHN PE, 1995, NETWORK-COMP NEURAL, V6, P415, DOI 10.1088/0954-898X/6/3/007; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Minsky M., 1988, PERCEPTRONS; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; O'Dell T J, 1994, Learn Mem, V1, P129; PARISI G, 1986, J PHYS A-MATH GEN, V19, pL617, DOI 10.1088/0305-4470/19/10/011; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rubin JE, 2001, NETWORK-COMP NEURAL, V12, P131, DOI 10.1088/0954-898X/12/2/303; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P713, DOI 10.1142/S0217984990000891; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	48	130	133	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					485	493		10.1038/nn1859	http://dx.doi.org/10.1038/nn1859			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17351638				2022-12-28	WOS:000245228600020
J	Nicol, X; Voyatzis, S; Muzerelle, A; Narboux-Neme, N; Sudhof, TC; Miles, R; Gaspar, P				Nicol, Xavier; Voyatzis, Sylvie; Muzerelle, Aude; Narboux-Neme, Nicolas; Sudhof, Thomas C.; Miles, Richard; Gaspar, Patricia			cAMP oscillations and retinal activity are permissive for ephrin signaling during the establishment of the retinotopic map	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE; ELECTRICAL-ACTIVITY; CALCIUM TRANSIENTS; CYCLIC-AMP; IN-VIVO; RETINOCOLLICULAR AXONS; NEURITE OUTGROWTH; ADENYLYL-CYCLASE; RHO-GTPASES; CELL	Spontaneous activity generated in the retina is necessary to establish a precise retinotopic map, but the underlying mechanisms are poorly understood. We demonstrate here that neural activity controls ephrin-A-mediated responses. In the mouse retinotectal system, we show that spontaneous activity of the retinal ganglion cells (RGCs) is needed, independently of synaptic transmission, for the ordering of the retinotopic map and the elimination of exuberant retinal axons. Activity blockade suppressed the repellent action of ephrin-A on RGC growth cones by cyclic AMP (cAMP)-dependent pathways. Unexpectedly, the ephrin-A5-induced retraction required cAMP oscillations rather than sustained increases in intracellular cAMP concentrations. Periodic photoinduced release of caged cAMP in growth cones rescued the response to ephrin-A5 when activity was blocked. These results provide a direct molecular link between spontaneous neural activity and axon guidance mechanisms during the refinement of neural maps.	Hop La Pitie Salpetriere, INSERM, U616, F-75013 Paris, France; Univ Paris 06, Paris, France; Inst Fer Moulin, F-75005 Paris, France; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Neurosci, Dallas, TX 75390 USA; Univ Paris 06, Hop Salpetriere, U739, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gaspar, P (corresponding author), Hop La Pitie Salpetriere, INSERM, U616, 47 Blvd Hop, F-75013 Paris, France.	gaspar@chups.jussieu.fr	Nicol, Xavier/D-6087-2012; Gaspar, Patricia/G-8892-2011	Nicol, Xavier/0000-0002-0310-8047; Gaspar, Patricia/0000-0003-4217-5717; Narboux-Neme, Nicolas/0000-0002-3791-7459				Bansal A, 2000, J NEUROSCI, V20, P7672; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cline H, 2003, TRENDS NEUROSCI, V26, P655, DOI 10.1016/j.tins.2003.10.005; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Fagan KA, 2000, J BIOL CHEM, V275, P40187, DOI 10.1074/jbc.M006606200; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FIELDS RD, 1994, PROG BRAIN RES, V103, P127; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kolls BJ, 2002, J NEUROSCI, V22, P2626, DOI 10.1523/JNEUROSCI.22-07-02626.2002; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Ravary A, 2003, J NEUROSCI, V23, P2228; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spitzer NC, 2000, BIOESSAYS, V22, P811; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	50	131	133	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					340	347		10.1038/nn1842	http://dx.doi.org/10.1038/nn1842			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259982				2022-12-28	WOS:000244480300016
J	Ben Mamou, C; Gamache, K; Nader, K				Ben Mamou, Cyrinne; Gamache, Karine; Nader, Karim			NMDA receptors are critical for unleashing consolidated auditory fear memories	NATURE NEUROSCIENCE			English	Article							POTENTIATED STARTLE; AMYGDALA; RECONSOLIDATION; EXPRESSION; ACQUISITION; EXTINCTION; RETRIEVAL	Memories are dynamic and can change when recalled. The process that returns memories to a labile state during remembering is unclear. We found that the presence of NMDA, but not AMPA, receptor antagonists in the amygdala prior to recall prevented the consolidated fear memory from returning to a labile state. These findings suggest that NMDA receptors in the amygdala are critical for transforming a memory from a fixed to a labile state.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	McGill University	Nader, K (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.	karim.nader@mcgill.ca						Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KIM M, 1993, BEHAV NEURAL BIOL, V59, P5, DOI 10.1016/0163-1047(93)91075-X; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; SPEAR NE, 1973, PSYCHOL REV, V80, P163, DOI 10.1037/h0034326; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0	10	246	248	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1237	1239		10.1038/nn1778	http://dx.doi.org/10.1038/nn1778			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16998481				2022-12-28	WOS:000241493900015
J	Borrell, V; Marin, O				Borrell, Victor; Marin, Oscar			Meninges control tangential migration of hem-derived Cajal-Retzius cells via CXCL12/CXCR4 signaling	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; CHEMOKINE RECEPTOR CXCR4; STRUCTURAL ORGANIZATION; INTERNEURON MIGRATION; CORTICAL LAMINATION; NEURONAL MIGRATION; ONE CENTURY; LAYER-I; MOUSE; FOREBRAIN	Cajal-Retzius cells are critical in the development of the cerebral cortex, but little is known about the mechanisms controlling their development. Three focal sources of Cajal-Retzius cells have been identified in mice-the cortical hem, the ventral pallium and the septum-from where they migrate tangentially to populate the cortical surface. Using a variety of tissue culture assays and in vivo manipulations, we demonstrate that the tangential migration of cortical hem-derived Cajal-Retzius cells is controlled by the meninges. We show that the meningeal membranes are a necessary and sufficient substrate for the tangential migration of Cajal-Retzius cells. We also show that the chemokine CXCL12 secreted by the meninges enhances the dispersion of Cajal-Retzius cells along the cortical surface, while retaining them within the marginal zone in a CXCR4-dependent manner. Thus, the meningeal membranes are fundamental in the development of Cajal-Retzius cells and, hence, in the normal development of the cerebral cortex.	CSIC, Inst Neurociencias Alicante, Sant Joan Dalacant 03550, Spain; Univ Miguel Hernandez, Sant Joan Dalacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Marin, O (corresponding author), CSIC, Inst Neurociencias Alicante, Sant Joan Dalacant 03550, Spain.	o.marin@umh.es	Borrell, Victor/U-1802-2017; Marin, Oscar/F-3856-2012	Borrell, Victor/0000-0002-7833-3978; Marin, Oscar/0000-0001-6264-7027				Alcantara S, 1998, J NEUROSCI, V18, P7779; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bagri A, 2002, DEVELOPMENT, V129, P4249; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Fairen A, 2002, PROG BRAIN RES, V136, P281; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Halfter W, 2002, J NEUROSCI, V22, P6029; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; MARINPADILLA M, 1990, J COMP NEUROL, V299, P89, DOI 10.1002/cne.902990107; MARINPADILLA M, 1982, ANAT EMBRYOL, V164, P161, DOI 10.1007/BF00318504; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stumm RK, 2003, J NEUROSCI, V23, P5123; Super H, 1997, DEV BRAIN RES, V98, P9, DOI 10.1016/S0165-3806(96)00154-X; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Super H, 1997, DEV BRAIN RES, V98, P15, DOI 10.1016/S0165-3806(96)00155-1; TACHMINTZIS J, 1994, BIOCONTROL SCI TECHN, V4, P591, DOI 10.1080/09583159409355372; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhu Y, 2004, DEV BIOL, V267, P153, DOI 10.1016/j.ydbio.2003.10.037; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	195	204	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1284	1293		10.1038/nn1764	http://dx.doi.org/10.1038/nn1764			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964252				2022-12-28	WOS:000241493900022
J	Yazdanbakhsh, A; Livingstone, MS				Yazdanbakhsh, A; Livingstone, MS			End stopping in V1 is sensitive to contrast	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; RECEPTIVE-FIELD PROPERTIES; PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; COMPLEX CELLS; MACAQUE V1; 2-DIMENSIONAL SUBSTRUCTURE; HYPERCOMPLEX CELLS; LENGTH SUMMATION; OCCLUDED OBJECTS	Common situations that result in different perceptions of grouping and border ownership, such as shadows and occlusion, have distinct sign-of-contrast relationships at their edge-crossing junctions. Here we report a property of end stopping in V1 that distinguishes among different sign-of-contrast situations, thereby obviating the need for explicit junction detectors. We show that the inhibitory effect of the end zones in end-stopped cells is highly selective for the relative sign of contrast between the central activating stimulus and stimuli presented at the end zones. Conversely, the facilitatory effect of end zones in length-summing cells is not selective for the relative sign of contrast between the central activating stimulus and stimuli presented at the end zones. This finding indicates that end stopping belongs in the category of cortical computations that are selective for sign of contrast, such as direction selectivity and disparity selectivity, but length summation does not.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yazdanbakhsh, A (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, WAB 232,220 Longwood Ave, Boston, MA 02115 USA.	arash_yazdanbakhsh@hms.harvard.edu		Livingstone, Margaret/0000-0002-1950-0123	NEI NIH HHS [R01 EY013135, EY13135, R01 EY013135-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013135] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BECK J, 1984, PERCEPT PSYCHOPHYS, V35, P407, DOI 10.3758/BF03203917; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; CLELAND BG, 1983, J NEUROSCI, V3, P108; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOBBINS A, 1989, VISION RES, V29, P1371, DOI 10.1016/0042-6989(89)90193-4; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRIEVE KL, 1991, EXP BRAIN RES, V84, P319; Grossberg S, 2005, VISION RES, V45, P1725, DOI 10.1016/j.visres.2005.01.006; HAMMOND P, 1990, EXP BRAIN RES, V80, P135; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HOWE PD, 2005, CEREB CORTEX; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; Livingstone MS, 2003, J NEUROPHYSIOL, V89, P2743, DOI 10.1152/jn.00822.2002; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nakayama K, 1995, VISUAL COGNITION INV, P1; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P833, DOI 10.1152/jn.1979.42.3.833; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2003, NEURON, V37, P525, DOI 10.1016/S0896-6273(02)01187-X; Rensink RA, 1998, VISION RES, V38, P2489, DOI 10.1016/S0042-6989(98)00051-0; ROSE D, 1979, VISION RES, V19, P533, DOI 10.1016/0042-6989(79)90138-X; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SILLITO AM, 1993, EXP BRAIN RES, V93, P6; SILLITO AM, 1977, J PHYSIOL-LONDON, V273, P775, DOI 10.1113/jphysiol.1977.sp012123; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; TANAKA K, 1987, EXP BRAIN RES, V65, P549; WATANABE T, 1992, PERCEPTION, V21, P133, DOI 10.1068/p210133; WATANABE T, 1993, VISION RES, V33, P2339, DOI 10.1016/0042-6989(93)90111-9; WATANABE T, 1993, SPATIAL VISION, V7, P95, DOI 10.1163/156856893X00306; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	47	31	31	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					697	702		10.1038/nn1693	http://dx.doi.org/10.1038/nn1693			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16633342	Green Accepted			2022-12-28	WOS:000237417200022
J	Williams, ZM; Eskandar, EN				Williams, ZM; Eskandar, EN			Selective enhancement of associative learning by microstimulation of the anterior caudate	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; NEURONAL-ACTIVITY; PRIMATE STRIATUM; MONKEY STRIATUM; DOPAMINE; REPRESENTATIONS; ORGANIZATION; STIMULATION; EXPECTATION; SIGNAL	Primates have the remarkable ability to rapidly adjust or modify associations between visual cues and specific motor responses. Whereas little is known as to how such adjustments in behavioral policy are implemented, recent learning models suggest that the anterior striatum is optimally positioned to have a role in this process. We recorded from single units and delivered microstimulation in the striatum of rhesus monkeys performing an associative learning task. Caudate activity during reinforcement was closely correlated with the rate of learning and peaked during the steepest portion of the learning curve when new associations were being acquired. Moreover, delivering microstimulation in the caudate during the reinforcement period significantly increased the rate of learning without altering the monkeys' ultimate performance. These findings suggest that the caudate is responsible for implementing selective adjustments to the 'associative weights' between sensory cues and motor responses during learning, thus enhancing the likelihood of selecting profitable actions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Eskandar, EN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	eeskandar@partners.org						ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; ALEXANDER GE, 1994, J CLIN NEUROPHYSIOL, V11, P420, DOI 10.1097/00004691-199407000-00004; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; Cragg SJ, 2000, J NEUROSCI, V20, P8209; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; Hadj-Bouziane F, 2003, EXP BRAIN RES, V153, P190, DOI 10.1007/s00221-003-1592-4; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; HOUK J, 1995, MODELS INFORMATION P; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Press WH., 2002, NUMERICAL RECIPES C, V2; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schraudolph NN, 2002, NEURAL COMPUT, V14, P1723, DOI 10.1162/08997660260028683; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	29	184	184	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					562	568		10.1038/nn1662	http://dx.doi.org/10.1038/nn1662			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501567				2022-12-28	WOS:000236310700024
J	Gutig, R; Sompolinsky, H				Gutig, R; Sompolinsky, H			The tempotron: a neuron that learns spike timing-based decisions	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; RETINAL GANGLION-CELLS; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; DEPENDENT PLASTICITY; TEMPORAL INFORMATION; DEPRESSION; NETWORKS; MEMORY	The timing of action potentials in sensory neurons contains substantial information about the eliciting stimuli. Although the computational advantages of spike timing-based neuronal codes have long been recognized, it is unclear whether, and if so how, neurons can learn to read out such representations. We propose a new, biologically plausible supervised synaptic learning rule that enables neurons to efficiently learn a broad range of decision rules, even when information is embedded in the spatiotemporal structure of spike patterns rather than in mean firing rates. The number of categorizations of random spatiotemporal patterns that a neuron can implement is several times larger than the number of its synapses. The underlying nonlinear temporal computation allows neurons to access information beyond single-neuron statistics and to discriminate between inputs on the basis of multineuronal spike statistics. Our work demonstrates the high capacity of neural systems to learn to decode information embedded in distributed patterns of spike synchrony.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; Charite Med Fac Berlin, Neurosci Res Ctr, D-10117 Berlin, Germany; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University	Gutig, R (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	guetig@cc.huji.ac.il; haim@fiz.huji.ac.il	Sompolinsky, Haim/ABB-8398-2021					ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BRESSLOFF PC, 1992, J PHYS A-MATH GEN, V25, P4373, DOI 10.1088/0305-4470/25/16/014; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Foehring RC, 1999, CAN J EXP PSYCHOL, V53, P45, DOI 10.1037/h0087299; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P257, DOI 10.1088/0305-4470/21/1/030; Gutig R, 2003, J NEUROSCI, V23, P3697; Guyonneau R, 2005, NEURAL COMPUT, V17, P859, DOI 10.1162/0899766053429390; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kuhn A, 2003, NEURAL COMPUT, V15, P67, DOI 10.1162/089976603321043702; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Minsky M., 1969, PERCEPTRONS; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	476	486	1	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					420	428		10.1038/nn1643	http://dx.doi.org/10.1038/nn1643			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474393				2022-12-28	WOS:000235645600022
J	Miller, RH; Mi, S				Miller, Robert H.; Mi, Sha			Dissecting demyelination	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PRECURSOR CELLS; CHEMOKINE RECEPTOR CXCR2; DEVELOPING SPINAL-CORD; MULTIPLE-SCLEROSIS; PROGENITOR-CELL; REMYELINATION; GENERATION; EXPRESSION; LESIONS	The loss of central nervous system myelin and the failure of remyelination by oligodendrocytes contribute to the functional impairment that characterizes diseases such as multiple sclerosis. Why myelin repair fails in multiple sclerosis is currently unclear; however, new understanding of the generation of oligodendrocytes and myelination during development, as well as an increasing understanding of the bases of successful remyelination, are providing new insights and therapeutic targets. We propose that successful myelin repair of the adult CNS recapitulates a sequence of stages that generally correlate with those seen during development, whereas unsuccessful myelin repair results from the perturbation of a critical process in any one of several sequential events. Defining the rate-limiting steps and most vulnerable aspects at each stage of myelin repair will provide logical targets for therapeutic intervention in demyelinating diseases such as multiple sclerosis.	Case Western Reserve Univ, Ctr Translat Neurosci, Dept Neurosci, Cleveland, OH 44106 USA; Biogen Idec, Dept Discovery Biol, Cambridge Ctr 14, Cambridge, MA 02142 USA	Case Western Reserve University; Biogen	Miller, RH (corresponding author), Case Western Reserve Univ, Ctr Translat Neurosci, Dept Neurosci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	rhm3@case.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036674, R15NS031800, R01NS036674] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36674, NS31800] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Camara J, 2007, J NEUROL, V254, P15, DOI 10.1007/s00415-007-1004-y; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Enzmann GU, 2005, EXP NEUROL, V195, P293, DOI 10.1016/j.expneurol.2005.04.021; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Jarjour AA, 2003, J NEUROSCI, V23, P3735; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Keyoung HM, 2007, NEUROSURG CLIN N AM, V18, P93, DOI 10.1016/j.nec.2006.10.009; Kiernan BW, 1996, MOL CELL NEUROSCI, V7, P322, DOI 10.1006/mcne.1996.0024; Lachapelle F, 2005, BRAIN PATHOL, V15, P198; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Padovani-Claudio DA, 2006, GLIA, V54, P471, DOI 10.1002/glia.20383; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Penderis J, 2003, BRAIN, V126, P1382, DOI 10.1093/brain/awg126; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Waubant E, 2006, DIS MARKERS, V22, P235, DOI 10.1155/2006/709869; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Woodhoo A, 2007, BRAIN, V130, P2175, DOI 10.1093/brain/awm125; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	50	87	90	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1351	1354		10.1038/nn1995	http://dx.doi.org/10.1038/nn1995			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965654				2022-12-28	WOS:000250508400008
J	Gaillard, A; Prestoz, L; Dumartin, B; Cantereau, A; Morel, F; Roger, M; Jaber, M				Gaillard, Afsaneh; Prestoz, Laetitia; Dumartin, Brigitte; Cantereau, Anne; Morel, Franck; Roger, Michel; Jaber, Mohamed			Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; PURKINJE NEURONS; BRAIN INFARCTS; RATS; TRANSPLANTS; MICE; NEOCORTEX; TISSUE; CELLS; CONNECTIONS	Damage to the adult motor cortex leads to severe and frequently irreversible deficits in motor function. Transplantation of embryonic cortical neurons into the damaged adult motor cortex was previously shown to induce partial recovery, but reports on graft efferents have varied from no efferent projections to sparse innervation. Here, we grafted embryonic cortical tissue from transgenic mice overexpressing a green fluorescent protein into the damaged motor cortex of adult mice. Grafted neurons developed efferent projections to appropriate cortical and subcortical host targets, including the thalamus and spinal cord. These projections were not a result of cell fusion between the transplant and the host neurons. Host and transplanted neurons formed synaptic contacts and numerous graft efferents were myelinated. These findings demonstrate that there is substantial anatomical reestablishment of cortical circuitry following embryonic cortex grafting into the adult brain. They suggest that there is an unsuspected potential for neural cell transplantation to promote reconstruction after brain injury.	Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France; Univ Bordeaux 2, Lab Mouvement Adaptat Cognit, CNRS, F-33077 Bordeaux, France; Univ Poitiers, Lab Cytokines & Inflammat, EA 3806, F-86022 Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite de Poitiers	Gaillard, A (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Afsaneh.Gaillard@univ-poitiers.fr	Morel, Franck/AAI-4274-2021	Morel, Franck/0000-0003-3812-9304; Jaber, Mohamed/0000-0003-2536-1913; prestoz, Laetitia/0000-0002-2407-195X				Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BRAGIN AG, 1988, NEUROSCIENCE, V25, P751, DOI 10.1016/0306-4522(88)90034-6; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen KA, 2006, EXP NEUROL, V198, P129, DOI 10.1016/j.expneurol.2005.11.016; DAS GD, 1972, BRAIN RES, V38, P233, DOI 10.1016/0006-8993(72)90710-X; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; DUNNETT SB, 1987, BEHAV NEUROSCI, V101, P489, DOI 10.1037/0735-7044.101.4.489; EBRAHIMIGAILLAR.A, 1994, BRAIN RES DEV BRAIN, V18, P271; EBRAHIMIGAILLARD A, 1995, NEUROSCIENCE, V64, P49, DOI 10.1016/0306-4522(94)00396-M; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Gaillard A, 2000, CEREB CORTEX, V10, P443, DOI 10.1093/cercor/10.5.443; Gaillard A, 1998, ADV ANAT EMBRYOL CEL, V148, P1; Gaillard F, 2004, NEUROSCIENCE, V126, P631, DOI 10.1016/j.neuroscience.2004.04.011; Gates M A, 2000, Prog Brain Res, V127, P115; GONZALEZ MF, 1988, EXP NEUROL, V99, P154, DOI 10.1016/0014-4886(88)90135-5; GRABOWSKI M, 1993, ANN NEUROL, V34, P362, DOI 10.1002/ana.410340310; GUITET J, 1994, NEUROSCI LETT, V180, P265, DOI 10.1016/0304-3940(94)90535-5; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; ISACSON O, 1988, PROG BRAIN RES, V78, P13; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pinaudeau C, 2000, EUR J NEUROSCI, V12, P2486, DOI 10.1046/j.1460-9568.2000.00148.x; PLUMET J, 1993, RESTOR NEUROL NEUROS, V6, P9, DOI 10.3233/RNN-1993-6102; Riolobos AS, 2001, NEUROBIOL LEARN MEM, V75, P274, DOI 10.1006/nlme.2000.3979; Roger M, 1994, Rev Neurosci, V5, P11; Sorensen JC, 1996, EXP NEUROL, V138, P227, DOI 10.1006/exnr.1996.0061; STEIN DG, 1987, ANN NY ACAD SCI, V495, P444, DOI 10.1111/j.1749-6632.1987.tb23693.x; Uematsu J, 1996, BRAIN DEV-JPN, V18, P29, DOI 10.1016/0387-7604(95)00102-6; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Zhou WB, 1998, BRAIN RES, V792, P97, DOI 10.1016/S0006-8993(98)00125-5	36	127	130	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1294	1299		10.1038/nn1970	http://dx.doi.org/10.1038/nn1970			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828256				2022-12-28	WOS:000249720800016
J	Lockhart, DB; Ting, LH				Lockhart, Daniel B.; Ting, Lena H.			Optimal sensorimotor transformations for balance	NATURE NEUROSCIENCE			English	Article							AUTOMATIC POSTURAL RESPONSES; MUSCLE SYNERGIES; MOTOR CONTROL; STANCE; FORCE; PERTURBATIONS; INFORMATION; MOVEMENT; MODEL; CAT	Here we have identified a sensorimotor transformation that is used by a mammalian nervous system to produce a multijoint motor behavior. Using a simple biomechanical model, a delayed-feedback rule based on an optimal tradeoff between postural error and neural effort explained patterns of muscle activation in response to a sudden loss of balance in cats. Following the loss of large sensory afferents, changes in these muscle-activation patterns reflected an optimal reweighting of sensory feedback gains to minimize postural instability. Specifically, a loss of center-of-mass-acceleration information, which allowed for a rapid initial rise in the muscle activity in intact animals, was absent after large-fiber sensory neuropathy. Our results demonstrate that a simple and flexible neural feedback control strategy coordinates multiple muscles over time via a small set of extrinsic, task-level variables during complex multijoint natural movements.	Emory Univ, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Ting, LH (corresponding author), Emory Univ, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	lting@emory.edu	Ting, Lena H/I-9311-2014		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046922] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD046922] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexandrov AV, 2001, BIOL CYBERN, V84, P425, DOI 10.1007/PL00007986; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; BOYD IA, 1954, J PHYSIOL-LONDON, V124, P476, DOI 10.1113/jphysiol.1954.sp005122; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Chhabra M, 2006, NEURAL COMPUT, V18, P2320, DOI 10.1162/neco.2006.18.10.2320; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 2007, PHYSIOL BEHAV, V92, P148, DOI 10.1016/j.physbeh.2007.05.023; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GOLLHOFER A, 1989, NEUROSCI LETT, V105, P73, DOI 10.1016/0304-3940(89)90014-1; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; HE JP, 1991, P 28 IEEE C DEC CONT, V1, P518; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; INGLIS JT, 1995, J NEUROPHYSIOL, V73, P1181, DOI 10.1152/jn.1995.73.3.1181; Jeka J, 2004, J NEUROPHYSIOL, V92, P2368, DOI 10.1152/jn.00983.2003; Jo S, 2004, BIOL CYBERN, V91, P188, DOI 10.1007/s00422-004-0497-z; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P181, DOI 10.1007/BF00229015; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Lin DC, 2000, J NEUROPHYSIOL, V83, P652, DOI 10.1152/jn.2000.83.2.652; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Macpherson JM, 2007, J NEUROPHYSIOL, V97, P4357, DOI 10.1152/jn.01338.2006; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; MACPHERSON JM, 1994, EXP BRAIN RES, V101, P397; Macpherson JM, 1999, J NEUROPHYSIOL, V82, P3066, DOI 10.1152/jn.1999.82.6.3066; NASHNER LM, 1977, EXP BRAIN RES, V30, P13; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Poppele R, 2003, TRENDS NEUROSCI, V26, P269, DOI 10.1016/S0166-2236(03)00073-0; Risher DW, 1997, J BIOMECH ENG-T ASME, V119, P417, DOI 10.1115/1.2798288; Runge CF, 1998, EXP BRAIN RES, V122, P403, DOI 10.1007/s002210050528; SCHAFER SS, 1967, EXPERIENTIA, V23, P1026, DOI 10.1007/BF02136428; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; Stapley PJ, 2002, J NEUROSCI, V22, P5803; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Ting LH, 2004, J NEUROPHYSIOL, V92, P808, DOI 10.1152/jn.00773.2003; Todorov E, 2005, J ROBOTIC SYST, V22, P691, DOI 10.1002/rob.20093; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; van Antwerp KW, 2007, J BIOMECH, V40, P3570, DOI 10.1016/j.jbiomech.2007.06.001; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527	50	151	157	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1329	1336		10.1038/nn1986	http://dx.doi.org/10.1038/nn1986			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873869				2022-12-28	WOS:000249720800021
J	Foldy, C; Lee, SY; Szabadics, J; Neu, A; Soltesz, I				Foeldy, Csaba; Lee, Soo Yeun; Szabadics, Janos; Neu, Axel; Soltesz, Ivan			Cell type - specific gating of perisomatic inhibition by cholecystokinin	NATURE NEUROSCIENCE			English	Review							GABA RELEASE; MODULATION; RATS	Parvalbumin- and cholecystokinin ( CCK)-expressing basket cells provide two parallel, functionally distinct sources of perisomatic inhibition to postsynaptic cells. We show that exogenously applied CCK enhances the output from rat parvalbumin-expressing basket cells, while concurrently suppressing GABA release from CCK-expressing neurons through retrograde endocannabinoid action. These results indicate that CCK may act as a molecular switch that determines the source of perisomatic inhibition for hippocampal principal cells.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Foldy, C (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	cfoldy@uci.edu		Szabadics, Janos/0000-0002-4968-2562; Neu, Axel/0000-0001-7045-7194; Foldy, Csaba/0000-0001-8709-8490	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038580] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38580] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Deng PY, 2006, J PHYSIOL-LONDON, V572, P425, DOI 10.1113/jphysiol.2005.104463; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gallopin T, 2006, CEREB CORTEX, V16, P1440, DOI 10.1093/cercor/bhj081; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Miller KK, 1997, J NEUROSCI, V17, P4994; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; RAVARD S, 1990, TRENDS PHARMACOL SCI, V11, P271, DOI 10.1016/0165-6147(90)90004-R; VALLEBUONA F, 1993, J NEUROCHEM, V61, P490; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; [No title captured]	15	98	98	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1128	1130		10.1038/nn1952	http://dx.doi.org/10.1038/nn1952			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676058				2022-12-28	WOS:000249144000012
J	Burr, D; Tozzi, A; Morrone, MC				Burr, David; Tozzi, Arianna; Morrone, M. Concetta			Neural mechanisms for timing visual events are spatially selective in real-world coordinates	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; PARIETAL CORTEX; TIME; NEURONS; REPRESENTATION; ADAPTATION; MACAQUE; SPACE	It is generally assumed that perceptual events are timed by a centralized supramodal clock. This study challenges this notion in humans by providing clear evidence that visual events of subsecond duration are timed by visual neural mechanisms with spatially circumscribed receptive fields, localized in real-world, rather than retinal, coordinates.	Univ Florence, Dept Psychol, Florence, Italy; Univ Western Australia, Nedlands, WA 6009, Australia; CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Vita & Salute San Rafaele, Fac Psicol, Milan, Italy	University of Florence; University of Western Australia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Vita-Salute San Raffaele University	Burr, D (corresponding author), Univ Florence, Dept Psychol, Via S Nicolo 89, Florence, Italy.	dave@in.cnr.it	Morrone, Maria Concetta/C-6756-2014	Morrone, Maria Concetta/0000-0002-1025-0316; Burr, David/0000-0003-1541-8832				BUETI D, 2006, J COGN NEUROSCI F, V58, P335; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; MORGAN MJ, 2006, J VIS, V6, P1012; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; THOMPSON P, 1981, VISION RES, V21, P337, DOI 10.1016/0042-6989(81)90161-9	15	177	180	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					423	425		10.1038/nn1874	http://dx.doi.org/10.1038/nn1874			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369824				2022-12-28	WOS:000245228600012
J	Hyngstrom, AS; Johnson, MD; Miller, JF; Heckman, CJ				Hyngstrom, Allison S.; Johnson, Michael D.; Miller, Jack F.; Heckman, C. J.			Intrinsic electrical properties of spinal motoneurons vary with joint angle	NATURE NEUROSCIENCE			English	Article							EFFECTIVE SYNAPTIC CURRENTS; TRICEPS SURAE MOTONEURONS; IN-VIVO; RECIPROCAL INHIBITION; SYSTEMATIC VARIATIONS; MEDIAL GASTROCNEMIUS; HINDLIMB MOTONEURONS; FICTIVE LOCOMOTION; DECEREBRATE CATS; INPUT	The dendrites of spinal motoneurons amplify synaptic inputs to a marked degree through persistent inward currents (PICs). Dendritic amplification is subject to neuromodulatory control from the brainstem by axons releasing the monoamines serotonin and norepinephrine; however, the monoaminergic projection to the cord is diffusely organized and does not allow independent adjustment of amplification in different motor pools. Using in vivo voltage-clamp techniques, here we show that dendritic PICs in ankle extensor motoneurons in the cat are reduced about 50% by small rotations (+/- 10 degrees) of the ankle joint. This reduction is primarily due to reciprocal inhibition, a tightly focused input shared only among strict muscle antagonists. These results demonstrate how a specific change in limb position can regulate intrinsic cellular properties set by a background of diffuse descending neuromodulation.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Heckman, CJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	c-heckman@northwestern.edu	Johnson, Mark/B-6921-2009	Heckman, CJ/0000-0002-1324-7278	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS048757] Funding Source: NIH RePORTER; NINDS NIH HHS [NS034282, 5F31NS048757-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alaburda A, 2002, ADV EXP MED BIOL, V508, P219; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2023, DOI 10.1152/jn.1998.80.4.2023; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2038, DOI 10.1152/jn.1998.80.4.2038; Binder MD, 1998, J NEUROPHYSIOL, V80, P241, DOI 10.1152/jn.1998.80.1.241; BINDER MD, 1981, SPINAL SUPRASPINAL M, V8, P72; Bjorklund AS, 1982, BRAIN STEM CONTROL S, P55; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BROWNSTONE RM, 1994, EXP BRAIN RES, V102, P34; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; Chen XY, 2006, J NEUROPHYSIOL, V96, P2144, DOI 10.1152/jn.00253.2006; Chen Y, 2005, J NEUROSCI, V25, P6898, DOI 10.1523/JNEUROSCI.1684-05.2005; CLELAND CL, 1990, J NEUROPHYSIOL, V64, P1303, DOI 10.1152/jn.1990.64.4.1303; CRONE C, 1987, J PHYSIOL-LONDON, V389, P163, DOI 10.1113/jphysiol.1987.sp016652; CULLHEIM S, 1987, J COMP NEUROL, V255, P82, DOI 10.1002/cne.902550107; Curtis DR, 1998, EXP BRAIN RES, V121, P319, DOI 10.1007/s002210050465; Cushing S, 2005, J NEUROPHYSIOL, V94, P3465, DOI 10.1152/jn.00439.2005; Fedirchuk B, 2004, J PHYSIOL-LONDON, V557, P355, DOI 10.1113/jphysiol.2004.064022; Fyffe REW, 2001, METH NE FRO NEUROSCI, P21; Hammar I, 2003, J NEUROSCI, V23, P332; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; HECKMAN CJ, 1988, J NEUROPHYSIOL, V60, P1946, DOI 10.1152/jn.1988.60.6.1946; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; HOUNSGAARD J, 1993, J PHYSIOL-LONDON, V468, P245, DOI 10.1113/jphysiol.1993.sp019769; Hultborn H, 2004, PROG BRAIN RES, V143, P77, DOI 10.1016/S0079-6123(03)43008-2; Hultborn H, 2003, J PHYSIOL-LONDON, V552, P945, DOI 10.1113/jphysiol.2003.050971; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Krawitz S, 2001, J PHYSIOL-LONDON, V532, P271, DOI 10.1111/j.1469-7793.2001.0271g.x; Kuo JJ, 2003, J NEUROPHYSIOL, V90, P3617, DOI 10.1152/jn.00521.2003; LABELLA LA, 1990, J NEUROPHYSIOL, V64, P403, DOI 10.1152/jn.1990.64.2.403; Lee RH, 2003, J NEUROPHYSIOL, V89, P27, DOI 10.1152/jn.00137.2002; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1996, J NEUROPHYSIOL, V76, P2107, DOI 10.1152/jn.1996.76.3.2107; Lee RH, 2000, J NEUROSCI, V20, P6734, DOI 10.1523/JNEUROSCI.20-17-06734.2000; Machacek DW, 2001, J PHYSIOL-LONDON, V537, P201, DOI 10.1111/j.1469-7793.2001.0201k.x; Matthews P. B. C., 1972, MONOGR PHYSL SOC, V23, P1; Nichols T. Richard, 1999, P255; NIELSEN J, 1995, EXP BRAIN RES, V104, P99; POWERS RK, 1993, J NEUROPHYSIOL, V70, P1460, DOI 10.1152/jn.1993.70.4.1460; Powers RK, 2001, REV PHYSIOL BIOCH P, V143, P137, DOI 10.1007/BFb0115594; ROSE PK, 1985, J COMP NEUROL, V239, P89, DOI 10.1002/cne.902390108; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V54, P1101, DOI 10.1152/jn.1985.54.5.1101; STEPHENS JA, 1975, J NEUROPHYSIOL, V38, P1217, DOI 10.1152/jn.1975.38.5.1217; Svirskis G, 1997, J NEUROPHYSIOL, V78, P1740, DOI 10.1152/jn.1997.78.3.1740; Svirskis G, 1998, J NEUROPHYSIOL, V79, P45, DOI 10.1152/jn.1998.79.1.45; Wargon I, 2006, EXP BRAIN RES, V168, P203, DOI 10.1007/s00221-005-0088-9	50	92	92	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					363	369		10.1038/nn1852	http://dx.doi.org/10.1038/nn1852			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293858				2022-12-28	WOS:000244480300019
J	Russell, IJ; Legan, PK; Lukashkina, VA; Lukashkin, AN; Goodyear, RJ; Richardson, GP				Russell, Ian J.; Legan, P. Kevin; Lukashkina, Victoria A.; Lukashkin, Andrei N.; Goodyear, Richard J.; Richardson, Guy P.			Sharpened cochlear tuning in a mouse with a genetically modified tectorial membrane	NATURE NEUROSCIENCE			English	Article							INNER-EAR; DISTORTION-PRODUCT; FREQUENCY MAP; HAIR-CELLS; RESPONSES; ORGAN; CORTI; STIMULATION; BEHAVIOR; DEAFNESS	Frequency tuning in the cochlea is determined by the passive mechanical properties of the basilar membrane and active feedback from the outer hair cells, sensory- effector cells that detect and amplify sound- induced basilar membrane motions. The sensory hair bundles of the outer hair cells are imbedded in the tectorial membrane, a sheet of extracellular matrix that overlies the cochlea's sensory epithelium. The tectorial membrane contains radially organized collagen fibrils that are imbedded in an unusual striated- sheet matrix formed by two glycoproteins, alpha-tectorin ( Tecta) and beta-tectorin ( Tectb). In Tectb(-/-) mice the structure of the striated- sheet matrix is disrupted. Although these mice have a low- frequency hearing loss, basilar- membrane and neural tuning are both significantly enhanced in the high-frequency regions of the cochlea, with little loss in sensitivity. These findings can be attributed to a reduction in the acting mass of the tectorial membrane and reveal a new function for this structure in controlling interactions along the cochlea.	Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Russell, IJ (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	I.J.Russell@sussex.ac.uk; G.P.Richardson@sussex.ac.uk	Lukashkin, Andrei N/N-1447-2017	Lukashkin, Andrei N/0000-0003-4577-8716; Lukashkina, Victoria/0000-0002-9154-8746; Legan, P. Kevin/0000-0002-7403-6415; Russell, Ian/0000-0002-4915-2772	MRC [G0301057] Funding Source: UKRI; Medical Research Council [G0301057, G0801693] Funding Source: Medline; Wellcome Trust [071394] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALLEN JB, 1993, J ACOUST SOC AM, V94, P809, DOI 10.1121/1.408182; ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; BONFILS P, 1986, HEARING RES, V24, P277, DOI 10.1016/0378-5955(86)90026-2; BROWN AM, 1992, P ROY SOC B-BIOL SCI, V250, P29, DOI 10.1098/rspb.1992.0126; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; CRANE HD, 1982, J ACOUST SOC AM, V72, P93, DOI 10.1121/1.388029; Dallos P, 2003, JARO-J ASSOC RES OTO, V4, P416, DOI 10.1007/s10162-002-3049-z; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Dallos P., 1996, COCHLEA, P1; EHRET G, 1984, HEARING RES, V14, P45, DOI 10.1016/0378-5955(84)90068-6; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; Freeman DM, 2003, HEARING RES, V180, P1, DOI 10.1016/S0378-5955(03)00073-X; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; GASKILL SA, 1990, J ACOUST SOC AM, V88, P821, DOI 10.1121/1.399732; Geisler C. D., 1998, SOUND SYNAPSE; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOSSL M, 1995, P NATL ACAD SCI USA, V92, P276, DOI 10.1073/pnas.92.1.276; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lukashkin AN, 2005, J NEUROSCI METH, V148, P122, DOI 10.1016/j.jneumeth.2005.04.014; LUKASHKIN AN, IN PRESS J ACOUST SO; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; Nowotny M, 2006, P NATL ACAD SCI USA, V103, P2120, DOI 10.1073/pnas.0511125103; Rau A, 1999, J COMP NEUROL, V405, P271; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rueda J, 1996, ANAT EMBRYOL, V194, P501; Russell IJ, 1999, J NEUROPHYSIOL, V82, P676, DOI 10.1152/jn.1999.82.2.676; SELLICK PM, 1980, HEARING RES, V2, P439, DOI 10.1016/0378-5955(80)90080-5; Shera CA, 2004, EAR HEARING, V25, P86, DOI 10.1097/01.AUD.0000121200.90211.83; Shera CA, 2003, J ACOUST SOC AM, V114, P244, DOI 10.1121/1.1575750; Shoelson B, 2004, BIOPHYS J, V87, P2768, DOI 10.1529/biophysj.104.040774; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Steele CR, 2005, INT J SOLIDS STRUCT, V42, P5887, DOI 10.1016/j.ijsolstr.2005.03.056; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; vonBekesy G., 1960, EXPT HEARING; ZWISLOCKI J, 2002, AUDITORY SOUND TRANS; ZWISLOCKI JJ, 1980, HEARING RES, V2, P171, DOI 10.1016/0378-5955(80)90055-6; ZWISLOCKI JJ, 1986, HEARING RES, V22, P155, DOI 10.1016/0378-5955(86)90091-2; ZWISLOCKI JJ, 1989, HEARING RES, V42, P211, DOI 10.1016/0378-5955(89)90146-9	49	139	143	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					215	223		10.1038/nn1828	http://dx.doi.org/10.1038/nn1828			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220887	Green Accepted			2022-12-28	WOS:000244175200016
J	Darrow, KN; Maison, SF; Liberman, MC				Darrow, Keith N.; Maison, Stephane F.; Liberman, M. Charles			Cochlear efferent feedback balances interaural sensitivity	NATURE NEUROSCIENCE			English	Article							BRAIN-STEM; OLIVOCOCHLEAR; PATHWAYS; SYSTEM; CAT	Neurons in the lateral superior olive (LSO) compute sound location based on differences in interaural intensity, coded in ascending signals from the two cochleas. Unilateral destruction of the neuronal feedback from the LSO to the cochlea, the lateral olivocochlear efferents, disrupted the normal interaural correlation in response amplitudes to sounds of equal intensity. Thus, lateral olivocochlear feedback maintains the binaural balance in neural excitability required for accurate localization of sounds in space.	Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; Harvard & MIT, Program Speech & Hearing Biosci & Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard University; Harvard Medical School	Liberman, MC (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	Charles_Liberman@meei.harvard.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000038, P30DC005209, R01DC000188] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC000188, P30 DC005209, T32 DC000038, P30 DC5209, R01 DC0188, T32 DC0038] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; CHEN QC, 1995, J EXP BIOL, V198, P2007; EHRET G, 1984, J EXP BIOL, V109, P163; Groff JA, 2003, J NEUROPHYSIOL, V90, P3178, DOI 10.1152/jn.00537.2003; GUINAN JJ, 1996, SPRINGER VERLAG HDB, V8; Le Prell CG, 2003, JARO-J ASSOC RES OTO, V4, P276, DOI 10.1007/s10162-002-3018-6; LU SM, 1987, HEARING RES, V31, P137, DOI 10.1016/0378-5955(87)90119-5; May BJ, 2004, ARCH OTOLARYNGOL, V130, P660, DOI 10.1001/archotol.130.5.660; Melcher JR, 1996, HEARING RES, V93, P1, DOI 10.1016/0378-5955(95)00178-6; Mills DM, 2003, J ACOUST SOC AM, V113, P914, DOI 10.1121/1.1535942; SCHARF B, 1994, HEARING RES, V75, P11, DOI 10.1016/0378-5955(94)90051-5; SCHOFIELD BR, 1994, J COMP NEUROL, V344, P83, DOI 10.1002/cne.903440107; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Warr WB, 1997, HEARING RES, V108, P89, DOI 10.1016/S0378-5955(97)00044-0	14	105	105	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1474	1476		10.1038/nn1807	http://dx.doi.org/10.1038/nn1807			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115038	Green Accepted			2022-12-28	WOS:000242404000009
J	Ma, WJ; Beck, JM; Latham, PE; Pouget, A				Ma, Wei Ji; Beck, Jeffrey M.; Latham, Peter E.; Pouget, Alexandre			Bayesian inference with probabilistic population codes	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; INTEGRATION; NEURONS; INFORMATION; RESPONSES; CORTEX; REPRESENTATION; COMPUTATION; DECISION; NOISE	Recent psychophysical experiments indicate that humans perform near-optimal Bayesian inference in a wide variety of tasks, ranging from cue integration to decision making to motor control. This implies that neurons both represent probability distributions and combine those distributions according to a close approximation to Bayes' rule. At first sight, it would seem that the high variability in the responses of cortical neurons would make it difficult to implement such optimal statistical inference in cortical circuits. We argue that, in fact, this variability implies that populations of neurons automatically represent probability distributions over the stimulus, a type of code we call probabilistic population codes. Moreover, we demonstrate that the Poisson-like variability observed in cortex reduces a broad class of Bayesian inference to simple linear combinations of populations of neural activity. These results hold for arbitrary probability distributions over the stimulus, for tuning curves of arbitrary shape and for realistic neuronal variability.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of Rochester; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365; Ma, Wei Ji/0000-0002-9835-9083	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447, T32MH019942] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; ANDERSON CH, 1994, COMPUTATIONAL INTELL, P213; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Clark J.J., 1990, DATA FUSION SENSORY; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; DENEVE S, 2005, NEURAL INFORM PROCES; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hinton GE, 1999, IEE CONF PUBL, P1, DOI 10.1049/cp:19991075; HOYER PO, 2003, NEURAL INFORM PROCES, P277; HUYS Q, IN PRESS NEURAL COMP; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; Knill DC, 1996, PERCEPTION BAYESIAN; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Sahani M, 2003, NEURAL COMPUT, V15, P2255, DOI 10.1162/089976603322362356; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Weiss Y, 2002, NEU INF PRO, P77; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	48	856	860	3	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1432	1438		10.1038/nn1790	http://dx.doi.org/10.1038/nn1790			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057707				2022-12-28	WOS:000242403800022
J	Rust, NC; Mante, V; Simoncelli, EP; Movshon, JA				Rust, Nicole C.; Mante, Valerio; Simoncelli, Eero P.; Movshon, J. Anthony			How MT cells analyze the motion of visual patterns	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; MACAQUE V1 NEURONS; RECEPTIVE-FIELD STRUCTURE; AREA MT; COMPLEX CELLS; FUNCTIONAL ARCHITECTURE; RESPONSE PROPERTIES; SPATIAL SUMMATION; CORTICAL-NEURONS; MONKEY	Neurons in area MT ( V5) are selective for the direction of visual motion. In addition, many are selective for the motion of complex patterns independent of the orientation of their components, a behavior not seen in earlier visual areas. We show that the responses of MT cells can be captured by a linear-nonlinear model that operates not on the visual stimulus, but on the afferent responses of a population of nonlinear V1 cells. We fit this cascade model to responses of individual MT neurons and show that it robustly predicts the separately measured responses to gratings and plaids. The model captures the full range of pattern motion selectivity found in MT. Cells that signal pattern motion are distinguished by having convergent excitatory input from V1 cells with a wide range of preferred directions, strong motion opponent suppression and a tuned normalization that may reflect suppressive input from the surround of V1 cells.	NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Federal Inst Technol, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; New York University; New York University; University of Zurich	Rust, NC (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rust@mit.edu		Simoncelli, Eero/0000-0002-1206-527X	NATIONAL EYE INSTITUTE [R01EY004440, R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY004440, EY02017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; Britten KH, 1999, J NEUROSCI, V19, P5074; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Collins CE, 2003, J NEUROSCI, V23, P2251; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; EFRON B, 1993, INTRO BOOTHSTRAP; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1212, DOI 10.1152/jn.1987.58.6.1212; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Lennie P, 2005, J OPT SOC AM A, V22, P2013, DOI 10.1364/JOSAA.22.002013; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; MANTTE V, 2000, THESIS U ZURICH; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Movshon Adelson, 1985, PATTERN RECOGNITION, V54, P117, DOI 10.1098/rstb.1998.0333; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 1996, J NEUROSCI, V16, P7733; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; ROCKLAND KS, 1989, VISUAL NEUROSCI, V3, P155, DOI 10.1017/S0952523800004466; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; RODMAN HR, 1989, J NEUROSCI, V9, P2033; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tinsley CJ, 2003, J NEUROPHYSIOL, V90, P930, DOI 10.1152/jn.00708.2002; VANDENBERG AV, 1993, EXP BRAIN RES, V96, P519, DOI 10.1007/BF00234120; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	50	354	357	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1421	1431		10.1038/nn1786	http://dx.doi.org/10.1038/nn1786			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041595				2022-12-28	WOS:000242403800021
J	Shaban, H; Humeau, Y; Herry, C; Cassasus, G; Shigemoto, R; Ciocchi, S; Barbieri, S; van der Putten, H; Kaupmann, K; Bettler, B; Luthi, A				Shaban, Hamdy; Humeau, Yann; Herry, Cyril; Cassasus, Guillaume; Shigemoto, Ryuichi; Ciocchi, Stephane; Barbieri, Samuel; van der Putten, Herman; Kaupmann, Klemens; Bettler, Bernhard; Luethi, Andreas			Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT LATERAL AMYGDALA; GABA(B) RECEPTORS; BASOLATERAL AMYGDALA; STIMULUS-GENERALIZATION; AUDITORY-CORTEX; IN-VITRO; NEURONS; INDUCTION; LOCALIZATION	Pavlovian fear conditioning, a simple form of associative learning, is thought to involve the induction of associative, NMDA receptor dependent long-term potentiation (LTP) in the lateral amygdala. Using a combined genetic and electrophysiological approach, we show here that lack of a specific GABA(B) receptor subtype, GABA(B(1a, 2)), unmasks a nonassociative, NMDA receptor-independent form of presynaptic LTP at cortico-amygdala afferents. Moreover, the level of presynaptic GABA(B(1a, 2)) receptor activation, and hence the balance between associative and nonassociative forms of LTP, can be dynamically modulated by local inhibitory activity. At the behavioral level, genetic loss of GABA(B(1a)) results in a generalization of conditioned fear to nonconditioned stimuli. Our findings indicate that presynaptic inhibition through GABA(B(1a, 2)) receptors serves as an activity-dependent constraint on the induction of homosynaptic plasticity, which may be important to prevent the generalization of conditioned fear.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; CNRS, UMR 7168, F-67084 Strasbourg, France; Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Univ Basel, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); University of Basel; Novartis	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	shaban, Hamdy/C-1939-2014; Shaban, Hamdy/ABD-5617-2021; Shigemoto, Ryuichi/E-3628-2013; Herry, Cyril/AAP-9902-2020; bettler, bernhard/AAO-8018-2020	shaban, Hamdy/0000-0003-3760-6113; Shaban, Hamdy/0000-0003-3760-6113; Shigemoto, Ryuichi/0000-0001-8761-9444; Herry, Cyril/0000-0003-2973-0843; Ciocchi, Stephane/0000-0002-5701-9250; Bettler, Bernhard/0000-0003-0842-8207; Kaupmann, Klemens/0000-0001-8903-2508				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; ASPRODINI EK, 1992, J PHARMACOL EXP THER, V262, P1011; Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dittman JS, 1997, J NEUROSCI, V17, P9048; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lang EJ, 1997, J NEUROPHYSIOL, V77, P353, DOI 10.1152/jn.1997.77.1.353; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McDonald AJ, 2004, BRAIN RES, V1018, P147, DOI 10.1016/j.brainres.2004.05.053; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; SUGITA S, 1993, BRAIN RES, V612, P151, DOI 10.1016/0006-8993(93)91655-C; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Szinyei C, 2000, J NEUROSCI, V20, P8909; THOMPSON RF, 1962, J COMP PHYSIOL PSYCH, V55, P279, DOI 10.1037/h0047856; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4; Zhu PJ, 2005, J NEUROSCI, V25, P6199, DOI 10.1523/JNEUROSCI.1148-05.2005	48	153	156	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1028	1035		10.1038/nn1732	http://dx.doi.org/10.1038/nn1732			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819521				2022-12-28	WOS:000240080300015
J	Mevorach, C; Humphreys, GW; Shalev, L				Mevorach, C; Humphreys, GW; Shalev, L			Opposite biases in salience-based selection for the left and right posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							VISUAL-ATTENTION; BRAIN; LATERALIZATION; SEARCH; FOREST; TREES	Visual selection is determined in part by the saliency of stimuli. We assessed the brain mechanisms determining attentional responses to saliency. Repetitive transcranial magnetic stimulation (rTMS) was applied to the left and right posterior parietal cortices (PPC) immediately before participants were asked to identify a compound letter. rTMS to the right PPC disrupted the guidance of attention toward salient stimuli, whereas rTMS to the left PPC affected the ability to bias selection away from salient stimuli. We conclude that right and left PPC have opposite roles in biasing selection to and from salient stimuli in the environment.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England; Open Univ Israel, Dept Educ & Psychol, Raanana, Israel	University of Birmingham; Open University Israel	Mevorach, C (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England.	c.mevorach@bham.ac.uk	Shalev, Lilach/ABA-8783-2021; Mevorach, Carmel/AAT-9229-2021	Mevorach, Carmel/0000-0003-1596-1026	BBSRC [BB/E000134/1] Funding Source: UKRI; MRC [G9806428] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000134/1] Funding Source: Medline; Medical Research Council [G9806428] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Evans MA, 2000, NEUROPSYCHOLOGIA, V38, P225, DOI 10.1016/S0028-3932(99)00080-9; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HUMPHREYS GW, 1994, NATURE, V372, P357, DOI 10.1038/372357a0; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; LAMB MR, 1988, PERCEPT PSYCHOPHYS, V44, P172, DOI 10.3758/BF03208710; Mevorach C, 2006, NEUROPSYCHOLOGIA, V44, P307, DOI 10.1016/j.neuropsychologia.2005.04.015; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; POSNER MI, 1984, J NEUROSCI, V4, P25; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492	15	141	144	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					740	742		10.1038/nn1709	http://dx.doi.org/10.1038/nn1709			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699505				2022-12-28	WOS:000237895200013
J	Yanai, A; Huang, K; Kang, RJ; Singaraja, RR; Arstikaitis, P; Gan, L; Orban, PC; Mullard, A; Cowan, CM; Raymond, LA; Drisdel, RC; Green, WN; Ravikumar, B; Rubinsztein, DC; El-Husseini, A; Hayden, MR				Yanai, Anat; Huang, Kun; Kang, Rujun; Singaraja, Roshni R.; Arstikaitis, Pamela; Gan, Lu; Orban, Paul C.; Mullard, Asher; Cowan, Catherine M.; Raymond, Lynn A.; Drisdel, Renaldo C.; Green, William N.; Ravikumar, Brinda; Rubinsztein, David C.; El-Husseini, Alaa; Hayden, Michael R.			Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function	NATURE NEUROSCIENCE			English	Article							YAC128 MOUSE MODEL; MUTANT HUNTINGTIN; PROTEIN PALMITOYLATION; NUCLEAR-LOCALIZATION; INCLUSION-BODIES; PLASMA-MEMBRANE; NEURONAL DEATH; IN-VIVO; DISEASE; PHOSPHORYLATION	Post-translational modification by the lipid palmitate is crucial for the correct targeting and function of many proteins. Here we show that huntingtin (htt) is normally palmitoylated at cysteine 214, which is essential for its trafficking and function. The palmitoylation and distribution of htt are regulated by the palmitoyl transferase huntingtin interacting protein 14 (HIP14). Expansion of the polyglutamine tract of htt, which causes Huntington disease, results in reduced interaction between mutant htt and HIP14 and consequently in a marked reduction in palmitoylation. Mutation of the palmitoylation site of htt, making it palmitoylation resistant, accelerates inclusion formation and increases neuronal toxicity. Downregulation of HIP14 in mouse neurons expressing wild-type and mutant htt increases inclusion formation, whereas overexpression of HIP14 substantially reduces inclusions. These results suggest that the expansion of the polyglutamine tract in htt results in decreased palmitoylation, which contributes to the formation of inclusion bodies and enhanced neuronal toxicity.	Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; British Columbia Childrens Hosp, Childrens & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; University of Chicago; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; BC Childrens Hospital; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	alaa@interchange.ubc.ca; mrh@cmmt.ubc.ca	Raymond, Lynn A./R-6707-2016; Rubinsztein, David C/C-3472-2011; Raymond, Lynn A/A-6664-2010; Cowan, Catherine/F-4181-2010; Hayden, Michael R/D-8581-2011	Raymond, Lynn A./0000-0002-8610-1042; Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867; Yanai, Anat/0000-0002-0792-6901	NINDS NIH HHS [R01 NS043782-04, R01 NS043782-02, R01 NS043782-01A2, R01 NS043782-05, R01 NS043782-03, R01 NS043782] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Rakhilin S, 1999, J CELL BIOL, V146, P203; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	36	217	224	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					824	831		10.1038/nn1702	http://dx.doi.org/10.1038/nn1702			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699508	Green Accepted			2022-12-28	WOS:000237895200023
J	Jazayeri, M; Movshon, JA				Jazayeri, M; Movshon, JA			Optimal representation of sensory information by neural populations	NATURE NEUROSCIENCE			English	Article							VISUAL AREA MT; PERCEPTUAL DECISION; PSYCHOPHYSICAL PERFORMANCE; MOTION DIRECTION; PARIETAL CORTEX; MACAQUE MT; NEURONS; MICROSTIMULATION; DISCRIMINATION; RESPONSES	Sensory information is encoded by populations of neurons. The responses of individual neurons are inherently noisy, so the brain must interpret this information as reliably as possible. In most situations, the optimal strategy for decoding the population signal is to compute the likelihoods of the stimuli that are consistent with an observed neural response. But it has not been clear how the brain can directly compute likelihoods. Here we present a simple and biologically plausible model that can realize the likelihood function by computing a weighted sum of sensory neuron responses. The model provides the basis for an optimal decoding of sensory information. It explains a variety of psychophysical observations on detection, discrimination and identification, and it also directly predicts the relative contributions that different sensory neurons make to perceptual judgments.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Movshon, JA (corresponding author), NYU, Ctr Neural Sci, 4 Wasington Pl,Room 809, New York, NY 10003 USA.	movshon@nyu.edu			NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [EY2017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Groh JM, 1997, J NEUROSCI, V17, P4312; Hill Robert E., 1992, Current Opinion in Cell Biology, V4, P967, DOI 10.1016/0955-0674(92)90126-W; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Roitman JD, 2002, J NEUROSCI, V22, P9475; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SEKULER R, 1977, SCIENCE, V198, P60, DOI 10.1126/science.897682; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	41	350	350	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					690	696		10.1038/nn1691	http://dx.doi.org/10.1038/nn1691			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617339				2022-12-28	WOS:000237417200021
J	Dong, Y; Green, T; Saal, D; Marie, H; Neve, R; Nestler, EJ; Malenka, RC				Dong, Y; Green, T; Saal, D; Marie, H; Neve, R; Nestler, EJ; Malenka, RC			CREB modulates excitability of nucleus accumbens neurons	NATURE NEUROSCIENCE			English	Article							COCAINE; ADDICTION	Drugs of abuse cause activation of the cyclic AMP response element binding protein (CREB) in the nucleus accumbens (NAc). Expression of active CREB in rat NAc medium spiny neurons (MSNs) increased their excitability, whereas dominant-negative CREB had the opposite effect. Decreasing excitability of NAc MSNs in vivo by overexpression of potassium channels enhanced locomotor responses to cocaine, suggesting that the increased NAc MSN excitability caused by CREB helped to limit behavioral sensitivity to cocaine.	Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Dept Genet, Cambridge, MA 02478 USA; Harvard Univ, McClean Hosp, Cambridge, MA 02478 USA	Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University	Malenka, RC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Marie, Hélène/F-1404-2011; Dong, Yan/A-4154-2016	Marie, Hélène/0000-0003-2310-6097; Dong, Yan/0000-0003-0016-9028				Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Johns DC, 1999, J NEUROSCI, V19, P1691; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119; Zhang XF, 1998, J NEUROSCI, V18, P488	13	244	248	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					475	477		10.1038/nn1661	http://dx.doi.org/10.1038/nn1661			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520736				2022-12-28	WOS:000236310700010
J	Awh, E; Vogel, EK				Awh, Edward; Vogel, Edward K.			The bouncer in the brain	NATURE NEUROSCIENCE			English	Editorial Material							WORKING-MEMORY CAPACITY; SHORT-TERM-MEMORY; BASAL GANGLIA; INDIVIDUAL-DIFFERENCES; ATTENTION; INHIBITION; MECHANISMS; CORTEX	Efficiency variations in the filtering of relevant from irrelevant information could contribute to individual differences in working memory. A new functional imaging study suggests that the basal ganglia act as this filter because activity in this region before stimulus presentation was inversely correlated with unnecessary storage.	[Awh, Edward; Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Awh, E (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	awh@uoregon.edu; vogel@uoregon.edu	Vogel, Edward K/AAW-9466-2021	Awh, Edward/0000-0002-5211-5278				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Hayes AE, 1998, J COGNITIVE NEUROSCI, V10, P178, DOI 10.1162/089892998562645; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	15	91	95	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					5	6		10.1038/nn0108-5	http://dx.doi.org/10.1038/nn0108-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160954				2022-12-28	WOS:000252117900002
J	Levine, JD				Levine, Joel D.			Glia and romance	NATURE NEUROSCIENCE			English	Editorial Material							DROSOPHILA; BEHAVIOR; BRAIN; GENE	Drosophila courtship is a complex behavior. A new study shows that glia modulate neurotransmission to influence male preference, but the authors should have resisted the temptation to describe their results in tabloid language.	Univ Toronto, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Levine, JD (corresponding author), Univ Toronto, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	jlevine@utm.utoronto.ca						Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; BURR C, 1997, ATLANTIC MONTHLY JUN, V279; EWER J, 1992, J NEUROSCI, V12, P3321; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; LACROIX A, 2007, PHILOSOPHIE MAGZ MAR, V8; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SOLAIRE F, 2007, AGORA VOX       0411; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Vosshall LB, 2007, NATURE, V450, P193, DOI 10.1038/nature06335	14	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					8	10		10.1038/nn0108-8	http://dx.doi.org/10.1038/nn0108-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160956				2022-12-28	WOS:000252117900004
J	Toni, N; Teng, EM; Bushong, EA; Aimone, JB; Zhao, CM; Consiglio, A; van Praag, H; Martone, ME; Ellisman, MH; Gage, FH				Toni, Nicolas; Teng, E. Matthew; Bushong, Eric A.; Aimone, James B.; Zhao, Chunmei; Consiglio, Antonella; van Praag, Henriette; Martone, Maryann E.; Ellisman, Mark H.; Gage, Fred H.			Synapse formation on neurons born in the adult hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; DENTATE GYRUS; IN-VIVO; 3-DIMENSIONAL STRUCTURE; STRUCTURAL PLASTICITY; GRANULE CELLS; NEUROGENESIS; FILOPODIA	Although new and functional neurons are produced in the adult brain, little is known about how they integrate into mature networks. Here we explored the mechanisms of synaptogenesis on neurons born in the adult mouse hippocampus using confocal microscopy, electron microscopy and live imaging. We report that new neurons, similar to mature granule neurons, were contacted by axosomatic, axodendritic and axospinous synapses. Consistent with their putative role in synaptogenesis, dendritic filopodia were more abundant during the early stages of maturation and, when analyzed in three dimensions, the tips of all filopodia were found within 200 nm of preexisting boutons that already synapsed on other neurons. Furthermore, dendritic spines primarily synapsed on multiple-synapse boutons, suggesting that initial contacts were preferentially made with preexisting boutons already involved in a synapse. The connectivity of new neurons continued to change until at least 2 months, long after the formation of the first dendritic protrusions.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	van Praag, Henriette/F-3939-2015; Aimone, James B/C-7821-2011; consiglio, antonella/AAA-5864-2019; consiglio, antonella/G-1815-2016; Toni, Nicolas/M-2057-2014; Aimone, James Bradley/H-4694-2016	van Praag, Henriette/0000-0002-5727-434X; consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Toni, Nicolas/0000-0001-5585-268X; Aimone, James Bradley/0000-0002-7361-253X; Martone, Maryann/0000-0002-8406-3871	NINDS NIH HHS [NS050217-02] Funding Source: Medline; PHS HHS [RRP41-04050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000328, Z01AG000328] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	418	440	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					727	734		10.1038/nn1908	http://dx.doi.org/10.1038/nn1908			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486101				2022-12-28	WOS:000246799800015
J	Christensen, MS; Lundbye-Jensen, J; Geertsen, SS; Petersen, TH; Paulson, OB; Nielsen, JB				Christensen, Mark Schram; Lundbye-Jensen, Jesper; Geertsen, Svend Sparre; Petersen, Tue Hvass; Paulson, Olaf B.; Nielsen, Jens Bo			Premotor cortex modulates somatosensory cortex during voluntary movements without proprioceptive feedback	NATURE NEUROSCIENCE			English	Article							PATHWAYS; SENSE	Movement perception relies on sensory feedback, but the involvement of efference copies remains unclear. We investigated movements without proprioceptive feedback using ischemic nerve block during fMRI in healthy humans, and found preserved activation of the primary somatosensory cortex. This activation was associated with increased interaction with premotor cortex during voluntary movements, which demonstrates that perception of movements relies in part on predictions of sensory consequences of voluntary movements that are mediated by the premotor cortex.	Univ Copenhagen, Panum Inst, Dept Exercise & Sport Sci, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Neurobiol Res Unit,Dept Neurol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Christensen, MS (corresponding author), Univ Copenhagen, Panum Inst, Dept Exercise & Sport Sci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	markc@drcmr.dk	Geertsen, Svend/L-8526-2014; Geertsen, Svend/ABG-6254-2020; Nielsen, Jens Bo/C-7632-2015; Paulson, Olaf B./N-6924-2016; Lundbye-Jensen, Jesper/ABH-4025-2020	Geertsen, Svend/0000-0003-4497-3616; Geertsen, Svend/0000-0003-4497-3616; Nielsen, Jens Bo/0000-0001-5568-2916; Paulson, Olaf B./0000-0001-7712-8596; Lundbye-Jensen, Jesper/0000-0003-3144-861X				Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; COLE JD, 1991, ELECTROEN CLIN NEURO, V80, P103, DOI 10.1016/0168-5597(91)90147-P; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; FORGET R, 1987, HUM NEUROBIOL, V6, P27; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; LASZLO JI, 1966, Q J EXP PSYCHOL, V18, P1, DOI 10.1080/14640746608400001; SINCLAIR DC, 1948, J NEUROPHYSIOL, V11, P75, DOI 10.1152/jn.1948.11.2.75; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; TAUB E, 1966, SCIENCE, V151, P593, DOI 10.1126/science.151.3710.593; VANHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464	14	134	137	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					417	419		10.1038/nn1873	http://dx.doi.org/10.1038/nn1873			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369825				2022-12-28	WOS:000245228600010
J	Daw, MI; Ashby, MC; Isaac, JTR				Daw, Michael I.; Ashby, Michael C.; Isaac, John T. R.			Coordinated developmental recruitment of latent fast spiking interneurons in layer IV barrel cortex	NATURE NEUROSCIENCE			English	Article							RAT SOMATOSENSORY CORTEX; THALAMOCORTICAL FEEDFORWARD INHIBITION; CRITICAL PERIOD; SYNAPTIC PLASTICITY; EXCITATORY ACTIONS; TRANSGENIC MICE; SILENT SYNAPSES; NEURONS; NEOCORTEX; GABA	Feedforward inhibitory GABAergic transmission is critical for mature cortical circuit function; in the neonate, however, GABA is depolarizing and believed to have a different role. Here we show that the GABA(A) receptor-mediated conductance is depolarizing in excitatory (stellate) cells in neonatal (postnatal day [P]3-5) layer IV barrel cortex, but GABAergic transmission at this age is not engaged by thalamocortical input in the feedforward circuit and has no detectable circuit function. However, recruitment occurs at P6-7 as a result of coordinated increases in thalamic drive to fast-spiking interneurons, fast-spiking interneuron-stellate cell connectivity and hyperpolarization of the GABA(A) receptor-mediated response. Thus, GABAergic circuits are not engaged by thalamocortical input in the neonate, but are poised for a remarkably coordinated development of feedforward inhibition at the end of the first postnatal week, which has profound effects on circuit function at this critical time in development.	Univ Bristol, Dept Anat, MRC, Ctr Synap Plast, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synap Plast, Bristol BS8 1TD, Avon, England.	isaacj@ninds.nih.gov		Daw, Michael/0000-0002-8374-5977; Ashby, Michael/0000-0002-8593-8473	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, Z01NS003011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AKEMAN CJ, 2006, J NEUROSCI, V26, P5117; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Bannister NJ, 2005, J NEUROSCI, V25, P5259, DOI 10.1523/JNEUROSCI.0827-05.2005; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Beierlein M, 2002, J NEUROSCI, V22, P9885; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; KIM HG, 1995, CEREB CORTEX, V5, P148, DOI 10.1093/cercor/5.2.148; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wells JE, 2000, J NEUROSCI, V20, P8822; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	47	134	135	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					453	461		10.1038/nn1866	http://dx.doi.org/10.1038/nn1866			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351636				2022-12-28	WOS:000245228600016
J	Jordan, BA; Fernholz, BD; Khatri, L; Ziff, EB				Jordan, Bryen A.; Fernholz, Brian D.; Khatri, Latika; Ziff, Edward B.			Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEOMIC ANALYSIS; LATE-PHASE; SYNAPTIC PLASTICITY; NMDA RECEPTORS; MESSENGER-RNA; DENTATE GYRUS; TRANSCRIPTION; ISOFORM; BINDING	Neuronal development, plasticity and survival require activity-dependent synapse-to-nucleus signaling. Most studies implicate an activity-dependent regulation of gene expression in this phenomenon. However, little is known about other nuclear functions that are regulated by synaptic activity. Here we show that a newly identified component of rat postsynaptic densities (PSDs), AIDA-1d, can regulate global protein synthesis by altering nucleolar numbers. AIDA-1d binds to the first two postsynaptic density-95/Discs large/zona occludens-1 (PDZ) domains of the scaffolding protein PSD-95 via its C-terminal three amino acids. Stimulation of NMDA receptors (NMDARs), which are also bound to PSD-95, results in a Ca2+-independent translocation of AIDA-1d to the nucleus, where it couples to Cajal bodies and induces Cajal body-nucleolar association. Long-term neuronal stimulation results in an AIDA-1-dependent increase in nucleolar numbers and protein synthesis. We propose that AIDA-1d mediates a link between synaptic activity and control of protein biosynthetic capacity by regulating nucleolar assembly.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA	New York University; New York University	Jordan, BA (corresponding author), NYU, Sch Med, Dept Biochem, 550 1St Ave, New York, NY 10016 USA.	jordab01@med.nyu.edu		Ziff, Edward/0000-0001-7389-8649; Jordan, Bryen/0000-0002-4967-444X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229, K01MH073759] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH073759-02, R01 MH67229] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cajal S. R., 1903, TRAB LAB INVEST BIOL, V2, P129, DOI DOI 10.1037/H0069505; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DUFFY C, 1981, SCIENCE, V212, P1148, DOI 10.1126/science.7233208; FAZELI MS, 1993, J NEUROSCI, V13, P1346; FREY S, 1991, BIOMED BIOCHIM ACTA, V50, P1231; Fu XY, 1999, ONCOGENE, V18, P4920, DOI 10.1038/sj.onc.1202874; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; HYSON RL, 1995, BRAIN RES, V672, P196, DOI 10.1016/0006-8993(94)01390-4; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jordan B.A., 2006, FRON NEUROS; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LAFARGA M, 1995, ANAT EMBRYOL, V191, P359, DOI 10.1007/BF00534689; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Solovei I, 2004, CYTOGENET GENOME RES, V105, P302, DOI 10.1159/000078202; STEWARD O, 1986, J NEUROSCI, V6, P412; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Xu HZ, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-23; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Zatsepina O, 2003, DEV BIOL, V253, P66, DOI 10.1006/dbio.2002.0865	50	89	91	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					427	435		10.1038/nn1867	http://dx.doi.org/10.1038/nn1867			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17334360				2022-12-28	WOS:000245228600013
J	Soltesz, I; Staley, K				Soltesz, Ivan; Staley, Kevin			High times for memory: cannabis disrupts temporal coordination among hippocampal neurons	NATURE NEUROSCIENCE			English	Editorial Material							OSCILLATIONS; INHIBITION; REVEAL		Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital	Soltesz, I (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	kstaley@partners.org						Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Hampson RE, 2000, J NEUROSCI, V20, P8932; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049	12	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1461	1463		10.1038/nn1206-1461	http://dx.doi.org/10.1038/nn1206-1461			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17128279				2022-12-28	WOS:000242404000002
J	Farrow, K; Haag, J; Borst, A				Farrow, Karl; Haag, Juergen; Borst, Alexander			Nonlinear, binocular interactions underlying flow field selectivity of a motion-sensitive neuron	NATURE NEUROSCIENCE			English	Article							INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; PLATE TANGENTIAL CELLS; VISUAL RESPONSE PROPERTIES; NATURALISTIC OPTIC FLOW; LOBULA PLATE; HORIZONTAL CELLS; NETWORK INTERACTIONS; MEMBRANE-PROPERTIES; INPUT ORGANIZATION; OPTOMOTOR SYSTEM	Neurons in many species have large receptive fields that are selective for specific optic flow fields. Here, we studied the neural mechanisms underlying flow field selectivity in lobula plate tangential cells (LPTCs) of the blowfly. Among these cells, the H2 cell responds preferentially to visual stimuli approximating rotational optic flow. Through double recordings from H2 and many other LPTCs, we characterized a bidirectional commissural pathway that allows visual information to be shared between the hemispheres. This pathway is mediated by axo-axonal electrical coupling of H2 and the horizontal system equatorial (HSE) cell located in the opposite hemisphere. Using single-cell ablations, we found that this pathway is sufficient to allow H2 to amplify and attenuate dendritic input during binocular visual stimuli. This is accomplished through a modulation of H2's membrane potential by input from the contralateral HSE cell, which scales the firing rate of H2 during visual stimulation but is not sufficient to induce action potentials.	Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Farrow, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, 50 Blossom St,Thier 429, Boston, MA 02114 USA.	kfarrow@partners.org	Farrow, Karl/C-6215-2008	Farrow, Karl/0000-0003-1409-096X				Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; DAVIES MNO, 1990, NATURWISSENSCHAFTEN, V77, P142, DOI 10.1007/BF01134481; ECKERT H, 1983, J INSECT PHYSIOL, V29, P547, DOI 10.1016/0022-1910(83)90020-3; EGELHAAF M, 1993, J NEUROPHYSIOL, V69, P340, DOI 10.1152/jn.1993.69.2.340; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Farrow K, 2003, J NEUROSCI, V23, P9805; FARROW K, 2005, THESIS LUDWIG MAXIMI; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gauck V, 1997, J COMP NEUROL, V381, P489; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; HATEREN JH, 1999, J EXP BIOL, V202, P1491; Hausen K., 1981, Verhandlungen der Deutschen Zoologischen Gesellschaft, V74, P49; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1980, CELL TISSUE RES, V208, P371; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Horstmann W, 2000, EUR J NEUROSCI, V12, P2157, DOI 10.1046/j.1460-9568.2000.00094.x; Karmeier K, 2006, J NEUROPHYSIOL, V96, P1602, DOI 10.1152/jn.00023.2006; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LAND MF, 1973, NATURE, V243, P299, DOI 10.1038/243299a0; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; Mizutani A, 2003, NATURE, V423, P604, DOI 10.1038/423604a; Nadim F, 2006, J NEUROPHYSIOL, V95, P3831, DOI 10.1152/jn.00033.2006; Schilstra C, 1999, J EXP BIOL, V202, P1481; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; SIMPSON JI, 1988, J NEUROPHYSIOL, V60, P2055, DOI 10.1152/jn.1988.60.6.2055; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SOODAK RE, 1988, J NEUROPHYSIOL, V60, P2037, DOI 10.1152/jn.1988.60.6.2037; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; STRAUSFELD NJ, 1985, CELL TISSUE RES, V242, P531; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; van Hateren JH, 2005, J NEUROSCI, V25, P4343, DOI 10.1523/JNEUROSCI.0616-05.2005; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329; WYLIE DR, 1990, VISUAL NEUROSCI, V5, P489, DOI 10.1017/S0952523800000614; WYLIE DR, 1993, J NEUROPHYSIOL, V70, P2632, DOI 10.1152/jn.1993.70.6.2632	50	41	41	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1312	1320		10.1038/nn1769	http://dx.doi.org/10.1038/nn1769			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964250				2022-12-28	WOS:000241493900025
J	Grill-Spector, K; Sayres, R; Ress, D				Grill-Spector, Kalanit; Sayres, Rory; Ress, David			High-resolution imaging reveals highly selective nonface clusters in the fusiform face area	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; LATERAL OCCIPITAL COMPLEX; HUMAN OBJECT AREAS; MACAQUE; FMRI; ORGANIZATION; PERCEPTION; REPRESENTATIONS; EXPERTISE; GYRUS	A region in ventral human cortex (fusiform face area, FFA) thought to be important for face perception responds strongly to faces and less strongly to nonface objects. This pattern of response may reflect a uniform face-selective neural population or activity averaged across populations with heterogeneous selectivity. Using high-resolution functional magnetic resonance imaging (MRI), we found that the FFA has a reliable heterogeneous structure: localized subregions within the FFA highly selective to faces are spatially interdigitated with localized subregions highly selective to different object categories. We found a preponderance of face-selective responses in the FFA, but no difference in selectivity to faces compared to nonfaces. Thus, standard fMRI of the FFA reflects averaging of heterogeneous highly selective neural populations of differing sizes, rather than higher selectivity to faces. These results suggest that visual processing in this region is not exclusive to faces. Overall, our approach provides a framework for understanding the fine-scale structure of neural representations in the human brain.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Stanford University; Stanford University; Brown University	Grill-Spector, K (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	kalanit@psych.stanford.edu		Grill-Spector, Kalanit/0000-0002-5404-9606	NATIONAL EYE INSTITUTE [F31EY015937, R21EY016199] Funding Source: NIH RePORTER; NEI NIH HHS [1 R21EY016199-0, 5 F31 EY015937] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Duda R. O., 2001, PATTERN CLASSIFICATI; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	39	149	150	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1177	1185		10.1038/nn1745	http://dx.doi.org/10.1038/nn1745			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892057				2022-12-28	WOS:000240080800020
J	Bystron, I; Rakic, P; Molnar, Z; Blakemore, C				Bystron, Irina; Rakic, Pasko; Molnar, Zoltan; Blakemore, Colin			The first neurons of the human cerebral cortex	NATURE NEUROSCIENCE			English	Article							CAJAL-RETZIUS CELLS; MAMMALIAN TELENCEPHALON; PROGENITOR CELLS; BASAL FOREBRAIN; MIGRATION; EXPRESSION; NUCLEOKINESIS; POPULATION; PREPLATE; ORIGINS	We describe a distinctive, widespread population of neurons situated beneath the pial surface of the human embryonic forebrain even before complete closure of the neural tube. These 'predecessor' cells include the first neurons seen in the primordium of the cerebral cortex, before the onset of local neurogenesis. Morphological analysis, combined with the study of centrosome location, regional transcription factors and patterns of mitosis and neurogenesis, indicates that predecessor cells invade the cortical primordium by tangential migration from the subpallium. These neurons, described here for the first time, precede all other known cell types of the developing cortex.	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; Inst Expt Med, Dept Morphol, St Petersburg, Russia; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	University of Oxford; Institute of Experimental Medicine; Yale University; Yale University	Bystron, I (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	irina.bystron@physiol.ox.ac.uk	Molnar, Zoltan/J-7281-2012	Molnar, Zoltan/0000-0002-6852-6004; Blakemore, Colin/0000-0003-2659-7899	MRC [G0300200] Funding Source: UKRI; Medical Research Council [G0300200, G0700377] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Ang ESBC, 2003, J NEUROSCI, V23, P5805; [Anonymous], 1970, Anat Rec, V166, P257; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Bystron I, 2005, J NEUROSCI, V25, P2781, DOI 10.1523/JNEUROSCI.4770-04.2005; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CARNEY RSE, 2004, FENS FORUM ABSTR, V2, P145; *COMM REV GUID RES, 1989, REV GUID RES US FET; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jimenez D, 2002, DEV BIOL, V244, P155, DOI 10.1006/dbio.2002.0586; KENNEDY H, 1993, CEREB CORTEX, V3, P171, DOI 10.1093/cercor/3.3.171; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Meyer G, 2000, J NEUROSCI, V20, P1858; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Meyer G, 1998, J COMP NEUROL, V397, P493; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Muller F, 2004, CELLS TISSUES ORGANS, V178, P93, DOI 10.1159/000081720; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; O'Rahilly Ronan, 1999, EMBRYONIC HUMAN BRAI; RAKIC P, 1968, J NEUROPATH EXP NEUR, V27, P246; Rakic S, 2003, CEREB CORTEX, V13, P1072, DOI 10.1093/cercor/13.10.1072; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; VALVERDE F, 1995, CEREB CORTEX, V5, P483, DOI 10.1093/cercor/5.6.483; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Whitlock KE, 2004, BRAIN BEHAV EVOLUT, V64, P126, DOI 10.1159/000079742; Whitlock KE, 1998, J NEUROSCI, V18, P8919; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	46	116	123	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					880	886		10.1038/nn1726	http://dx.doi.org/10.1038/nn1726			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783367				2022-12-28	WOS:000238590800013
J	Morfini, G; Pigino, G; Szebenyi, G; You, YM; Pollema, S; Brady, ST				Morfini, Gerardo; Pigino, Gustavo; Szebenyi, Gyorgyi; You, Yimei; Pollema, Sarah; Brady, Scott T.			JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport	NATURE NEUROSCIENCE			English	Article							BULBAR MUSCULAR-ATROPHY; N-TERMINAL KINASE; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; KINESIN HEAVY-CHAIN; REPEAT EXPANSION; PROTEIN-KINASES; LIGHT-CHAINS; DISEASE; STRESS	Expansion of the polyglutamine ( polyQ) stretch in the androgen receptor ( AR) protein leads to spinal and bulbar muscular atrophy ( SBMA), a neurodegenerative disease characterized by lower motor neuron degeneration. The pathogenic mechanisms underlying SBMA remain unknown, but recent experiments show that inhibition of fast axonal transport ( FAT) by polyQ-expanded proteins, including polyQ-AR, represents a new cytoplasmic pathogenic lesion. Using pharmacological, biochemical and cell biological experiments, we found a new pathogenic pathway that is affected in SBMA and results in compromised FAT. PolyQ-AR inhibits FAT in a human cell line and in squid axoplasm through a pathway that involves activation of cJun N-terminal kinase ( JNK) activity. Active JNK phosphorylated kinesin-1 heavy chains and inhibited kinesin-1 microtubule-binding activity. JNK inhibitors prevented polyQ-AR-mediated inhibition of FAT and reversed suppression of neurite formation by polyQ-AR. We propose that JNK represents a promising target for therapeutic interventions in SBMA.	Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Texas, SW Med Ctr, Basic Neurosci Ctr, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brady, ST (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	stbrady@uic.edu	Morfini, Gerardo/AAP-8070-2021; Pigino, Gustavo/L-7002-2019	Morfini, Gerardo/0000-0001-6059-5518; 	NINDS NIH HHS [NS23868, R01 NS023868, NS41170, NS43408, NS23320] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R01NS023320, R01NS041170, R01NS043408] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Avila DM, 2003, EXP BIOL MED, V228, P982, DOI 10.1177/153537020322800815; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Cowan KJ, 2003, HUM MOL GENET, V12, P1377, DOI 10.1093/hmg/ddg151; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; GOEMAEREVANNESTE J, 1988, J NEUROCHEM, V51, P1746, DOI 10.1111/j.1471-4159.1988.tb01154.x; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hirokawa N, 2003, TRENDS BIOCHEM SCI, V28, P558, DOI 10.1016/j.tibs.2003.08.006; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Ishihara H, 2001, J NEUROL, V248, P856, DOI 10.1007/s004150170069; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1496, DOI 10.1210/me.15.9.1496; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KUIPER GGJM, 1993, BIOCHEM J, V296, P161, DOI 10.1042/bj2960161; Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mandelkow E, 2002, TRENDS CELL BIOL, V12, P585, DOI 10.1016/S0962-8924(02)02400-5; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; MCQUARRIE IG, 1989, NEUROBIOL AGING, V10, P359, DOI 10.1016/0197-4580(89)90049-3; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Morfini G, 2001, DEV NEUROSCI-BASEL, V23, P364, DOI 10.1159/000048720; Morfini G., 2000, KINESIN PROTOCOLS, P147; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Pigino G, 2003, J NEUROSCI, V23, P4499; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; TRAISH AM, 1986, ENDOCRINOLOGY, V118, P1327, DOI 10.1210/endo-118-4-1327; Wilson CM, 1996, MOL CELL ENDOCRINOL, V120, P51, DOI 10.1016/0303-7207(96)03819-1; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	145	149	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					907	916		10.1038/nn1717	http://dx.doi.org/10.1038/nn1717			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16751763				2022-12-28	WOS:000238590800017
J	Mizuguchi, R; Kriks, S; Cordes, R; Gossler, A; Ma, QF; Goulding, M				Mizuguchi, Rumiko; Kriks, Sonja; Cordes, Ralf; Gossler, Achim; Ma, Qiufu; Goulding, Martyn			Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal sensory interneurons	NATURE NEUROSCIENCE			English	Article							NEURONAL DIFFERENTIATION; CORD; SPECIFICATION; GENE; LBX1; NEUROGENESIS; EXPRESSION; PATHWAY; MASH1; PRESENILIN-1	Sensory information from the periphery is integrated and transduced by excitatory and inhibitory interneurons in the dorsal spinal cord. Recent studies have identified a number of postmitotic factors that control the generation of these sensory interneurons. We show that Gsh1/2 and Ascl1 (Mash1), which are expressed in sensory interneuron progenitors, control the choice between excitatory and inhibitory cell fates in the developing mouse spinal cord. During the early phase of neurogenesis, Gsh1/2 and Ascl1 coordinately regulate the expression of Tlx3, which is a critical postmitotic determinant for dorsal glutamatergic sensory interneurons. However, at later developmental times, Ascl1 controls the expression of Ptf1a in dIL(A) progenitors to promote inhibitory neuron differentiation while at the same time upregulating Notch signaling to ensure the proper generation of dIL(B) excitatory neurons. We propose that this switch in Ascl1 function enables the cogeneration of inhibitory and excitatory sensory interneurons from a common pool of dorsal progenitors.	Scripps Res Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Hannover Med Sch, Inst Mol Biol, Hannover, Germany	Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Hannover Medical School	Goulding, M (corresponding author), Scripps Res Inst, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu						ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Casarosa S, 1999, DEVELOPMENT, V126, P525; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dottori M, 2001, DEVELOPMENT, V128, P4127; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Handler M, 2000, DEVELOPMENT, V127, P2593; Helms AW, 2005, DEVELOPMENT, V132, P2709, DOI 10.1242/dev.01859; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; JASONI CL, 1994, DEVELOPMENT, V120, P769; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Koizumi K, 2001, DEVELOPMENT, V128, P1391; Kriks S, 2005, DEVELOPMENT, V132, P2991, DOI 10.1242/dev.01878; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Li H, 1996, EMBO J, V15, P714, DOI 10.1002/j.1460-2075.1996.tb00407.x; Li SG, 2005, P NATL ACAD SCI USA, V102, P10688, DOI 10.1073/pnas.0504799102; Matise M, 2002, NEURON, V34, P491, DOI 10.1016/S0896-6273(02)00710-9; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; SZENTAGOTHAI J, 1964, J COMP NEUROL, V122, P219, DOI 10.1002/cne.901220207; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Willis Jr W. D., 1991, SENSORY MECH SPINAL; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0	38	134	134	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					770	778		10.1038/nn1706	http://dx.doi.org/10.1038/nn1706			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715081				2022-12-28	WOS:000237895200017
J	Kraves, S; Weitz, CJ				Kraves, S; Weitz, CJ			A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity	NATURE NEUROSCIENCE			English	Article							LEUKEMIA INHIBITORY FACTOR; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; EFFERENT PROJECTIONS; TARGETED DISRUPTION; SIGNAL TRANSDUCER; FACTOR-RECEPTOR; GOLDEN-HAMSTER; CNTF RECEPTOR; CLOCK NEURONS	The suprachiasmatic nucleus ( SCN) drives circadian rhythms of locomotor behavior by releasing factors that act on receptor sites near the third ventricle. Here we show that cardiotrophin-like cytokine ( CLC) satisfies multiple criteria for a circadian regulator of locomotor activity. In the mouse, CLC is expressed in a subpopulation of SCN vasopressin neurons with a circadian rhythm that peaks during the daily period of locomotor quiescence. CLC receptors flank the third ventricle, and acute infusion of CLC into the third ventricle produced a transient blockade of locomotor activity without affecting the circadian clock. The hypothalamic infusion of neutralizing antibodies to the CLC receptor produced extra daily locomotor activity at the time when CLC is maximally expressed. These results suggest that CLC is probably an SCN output signal important for shaping daily rhythms of behavior; moreover, they indicate an unexpected role for a cytokine in adult brain function.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X				Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Auernhammer CJ, 1999, ENDOCRINOLOGY, V140, P1559, DOI 10.1210/en.140.4.1559; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chesnokova V, 2002, ENDOCRINOLOGY, V143, P1571, DOI 10.1210/en.143.5.1571; DAVIS FC, 1980, AM J PHYSIOL, V239, pR149, DOI 10.1152/ajpregu.1980.239.1.R149; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Fukada T, 1999, GROWTH FACTORS, V17, P81, DOI 10.3109/08977199909103518; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kramer A, 2005, METHOD ENZYMOL, V393, P645, DOI 10.1016/S0076-6879(05)93034-6; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; LeSauter J, 1997, J BIOL RHYTHM, V12, P327, DOI 10.1177/074873049701200405; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; Wang ZY, 1996, ENDOCRINOLOGY, V137, P2947, DOI 10.1210/en.137.7.2947; WARE CB, 1995, DEVELOPMENT, V121, P1283; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	46	117	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					212	219		10.1038/nn1633	http://dx.doi.org/10.1038/nn1633			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429135				2022-12-28	WOS:000234990100016
J	Reynolds, SM; Berridge, KC				Reynolds, Sheila M.; Berridge, Kent C.			Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens	NATURE NEUROSCIENCE			English	Article							DEFENSIVE BEHAVIOR; INCENTIVE SALIENCE; FEEDING-BEHAVIOR; SHELL; GABA; ADDICTION; GRADIENTS; SYSTEMS; REWARD	The nucleus accumbens mediates both appetitive motivation for rewards and fearful motivation toward threats, which are generated in part by glutamate-related circuits organized in a keyboard fashion. At rostral sites of the medial shell, localized glutamate disruptions typically generate intense appetitive behaviors in rats, but the disruption incrementally generates fearful behaviors as microinjection sites move more caudally. We found that exposure to stressful environments caused caudal fear-generating zones to expand rostrally, filling similar to 90% of the shell. Conversely, a preferred home environment caused fear-generating zones to shrink and appetitive-generating zones to expand caudally, filling similar to 90% of the shell. Thus, the emotional environments retuned the generation of motivation in corticolimbic circuits.	[Reynolds, Sheila M.; Berridge, Kent C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Berridge, KC (corresponding author), Univ Michigan, Dept Psychol, 525 E Univ Ave, Ann Arbor, MI 48109 USA.	sheilar@umich.edu; berridge@umich.edu	Berridge, Kent C/C-1525-2009	Berridge, Kent C/0000-0002-6031-2626	NIDA NIH HHS [F31 DA014679, R01 DA015188, DA015188, R01 DA015188-06A1, DA14679, R01 DA015188-05] Funding Source: Medline; NIMH NIH HHS [MH63649, R01 MH063649-06A1, R01 MH063649-07, R01 MH063649] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA014679, R01DA015188] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Stratford TR, 1997, J NEUROSCI, V17, P4434; VALENSTEIN ES, 1969, SCIENCE, V163, P1084, DOI 10.1126/science.163.3871.1084; WILKIE DM, 1979, J EXP ANAL BEHAV, V31, P299, DOI 10.1901/jeab.1979.31-299	14	170	172	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					423	425		10.1038/nn2061	http://dx.doi.org/10.1038/nn2061			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344996	Green Accepted			2022-12-28	WOS:000254359300013
J	Nienborg, H; Cumming, BG				Nienborg, Hendrikje; Cumming, Bruce G.			Psychophysically measured task strategy for disparity discrimination is reflected in V2 neurons	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; MACAQUE VISUAL-CORTEX; AREA MT; DEPTH DISCRIMINATION; REVERSE-CORRELATION; APPARENT MOTION; CHOICE; MONKEY; PERCEPTION; RESPONSES	In perceptual tasks, subjects attempt to rely on their most informative cues. Such strategic choices should be reflected in the types of sensory neurons that are used. We investigated this in a binocular-disparity discrimination task. Using psychophysical reverse-correlation, also known as image classification, we identified the perceptual strategies of two macaques (Macaca mulatta). Correlations between reported disparity signs and disparity noise samples for each trial yielded detection 'filters'. Filter amplitude was greater at near disparities than at far disparities, indicating that the subjects relied more on near disparities. Recordings from both macaques' disparity-selective V2 neurons showed a correlation between neuronal responses and perceptual judgment in near-preferring, but not far-preferring, units, mirroring the psychophysically measured strategy. After one monkey learned to weight near and far disparities equally, activity in its far-preferring neurons correlated with choice. Thus, the pattern of correlations between neuronal activity and perceptual reports indicates how subjects use their neuronal signals.	Natl Inst Hlth, NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nienborg, H (corresponding author), Natl Inst Hlth, NEI, Sensorimotor Res Lab, 49-2A50 Convent Dr, Bethesda, MD 20892 USA.	hn@lsr.nei.nih.gov			NATIONAL EYE INSTITUTE [Z01EY000404] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 EY000404-06, Z01 EY000404-07] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AHUMADA AJ, 1996, PERCEPTION, V26, P18; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Broadbent D.E., 1958, PERCEPTION COMMUNICA; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Davison AC, 1997, BOOTSTRAP METHODS TH; DeAngelis GC, 2004, PLOS BIOL, V2, P394, DOI 10.1371/journal.pbio.0020077; DEUTSCH JA, 1963, PSYCHOL REV, V70, P80, DOI 10.1037/h0039515; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Neri P, 2006, VISION RES, V46, P2465, DOI 10.1016/j.visres.2006.02.002; Nienborg H, 2005, J NEUROSCI, V25, P10207, DOI 10.1523/JNEUROSCI.2342-05.2005; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; NORCIA AM, 1984, VISION RES, V24, P395, DOI 10.1016/0042-6989(84)90037-3; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	35	38	39	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1608	1614		10.1038/nn1991	http://dx.doi.org/10.1038/nn1991			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965712	Green Accepted			2022-12-28	WOS:000251172900019
J	Qiu, FTT; Sugihara, T; von der Heydt, R				Qiu, Fangtu T.; Sugihara, Tadashi; von der Heydt, Ruediger			Figure-ground mechanisms provide structure for selective attention	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CORTICAL AREAS V1; NEURAL MECHANISMS; V4; V2; SEGMENTATION; MONKEY; ORGANIZATION; OBJECTS	Attention depends on figure- ground organization: figures draw attention, whereas shapes of the ground tend to be ignored. Recent research has revealed mechanisms for figure- ground organization in the visual cortex, but how these mechanisms relate to the attention process remains unclear. Here we show that the influences of figure- ground organization and volitional ( top- down) attention converge in single neurons of area V2 in Macaca mulatta. Although we found assignment of border ownership for attended and for ignored figures, attentional modulation was stronger when the attended figure was located on the neuron's preferred side of border ownership. When the border between two overlapping figures was placed in the receptive field, responses depended on the side of attention, and enhancement was generally found on the neuron's preferred side of border ownership. This correlation suggests that the neural network that creates figure- ground organization also provides the interface for the top- down selection process.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Qiu, FTT (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY002966, R01EY016281] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002966, EY16281, R01 EY016281, R01 EY002966-29A1, EY02966] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Conner CE, 1997, J NEUROSCI, V17, P3201; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Koffka K, 1935, PRINCIPLES GESTALT P; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MACK A, 1992, COGNITIVE PSYCHOL, V24, P475, DOI 10.1016/0010-0285(92)90016-U; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Qiu FTT, 2007, NAT NEUROSCI, V10, P283, DOI 10.1038/nn1853; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rubin E., 1921, VISUELL WAHRGENOMMEN; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; SCHUETZE H, 2003, J VIS, V3, P114; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	29	156	159	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1492	1499		10.1038/nn1989	http://dx.doi.org/10.1038/nn1989			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	225HT	17922006	Green Accepted			2022-12-28	WOS:000250508400028
J	Wang, WY; Takimoto, JK; Louie, GV; Baiga, TJ; Noel, JP; Lee, KF; Slesinger, PA; Wang, L				Wang, Wenyuan; Takimoto, Jeffrey K.; Louie, Gordon V.; Baiga, Thomas J.; Noel, Joseph P.; Lee, Kuo-Fen; Slesinger, Paul A.; Wang, Lei			Genetically encoding unnatural amino acids for cellular and neuronal studies	NATURE NEUROSCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; GREEN FLUORESCENT PROTEINS; POLYMERASE-III; K+ CHANNEL; POTASSIUM CHANNELS; INACTIVATION GATE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; BINDING-SITE; CODE	Proteins participate in various biological processes and can be harnessed to probe and control biological events selectively and reproducibly, but the genetic code limits the building block to 20 common amino acids for protein manipulation in living cells. The genetic encoding of unnatural amino acids will remove this restriction and enable new chemical and physical properties to be precisely introduced into proteins. Here we present new strategies for generating orthogonal tRNA-synthetase pairs, which made possible the genetic encoding of diverse unnatural amino acids in different mammalian cells and primary neurons. Using this new methodology, we incorporated unnatural amino acids with extended side chains into the K(+) channel Kv1.4, and found that the bulkiness of residues in the inactivation peptide is essential for fast channel inactivation, a finding that had not been possible using conventional mutagenesis. This technique will stimulate and facilitate new molecular studies using tailored unnatural amino acids for cell biology and neurobiology.	Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu; lwang@salk.edu	Noel, Joseph P/A-9459-2009; wang, wenyuan/F-7218-2011; Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060833] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD034534-10A2, R01 HD034534, R01 HD034534-11] Funding Source: Medline; NINDS NIH HHS [R01 NS060833, R01 NS060833-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CORNISH VW, 1995, ANGEW CHEM INT EDIT, V34, P621, DOI 10.1002/anie.199506211; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DOCTOR BP, 1963, J BIOL CHEM, V238, P3677; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Summerer D, 2006, P NATL ACAD SCI USA, V103, P9785, DOI 10.1073/pnas.0603965103; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; YUAN Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P33, DOI 10.1016/0167-4781(91)90081-V; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	38	122	129	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1063	1072		10.1038/nn1932	http://dx.doi.org/10.1038/nn1932			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603477	Green Accepted			2022-12-28	WOS:000248357500021
J	Rasin, MR; Gazula, VR; Breunig, JJ; Kwan, KY; Johnson, MB; Liu-Chen, S; Li, HS; Jan, LY; Jan, YN; Rakic, P; Sestan, N				Rasin, Mladen-Roko; Gazula, Valeswara-Rao; Breunig, Joshua J.; Kwan, Kenneth Y.; Johnson, Matthew B.; Liu-Chen, Susan; Li, Hua-Shun; Jan, Lily Yeh; Jan, Yuh-Nung; Rakic, Pasko; Sestan, Nenad			Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors	NATURE NEUROSCIENCE			English	Article							ASYMMETRIC CELL-DIVISION; FATE DETERMINANT NUMB; RADIAL GLIA; NEUROEPITHELIAL CELLS; CEREBRAL-CORTEX; CORTICAL NEUROGENESIS; ADHERENS JUNCTIONS; ENDOCYTIC PROTEIN; STEM-CELLS; BRAIN	The polarity and adhesion of radial glial cells (RGCs), which function as progenitors and migrational guides for neurons, are critical for morphogenesis of the cerebral cortex. These characteristics largely depend on cadherin-based adherens junctions, which anchor apical end-feet of adjacent RGCs to each other at the ventricular surface. Here, we show that mouse numb and numb-like are required for maintaining radial glial adherens junctions. Numb accumulates in the apical end-feet, where it localizes to adherens junction-associated vesicles and interacts with cadherins. Numb and Numbl inactivation in RGCs decreases proper basolateral insertion of cadherins and disrupts adherens junctions and polarity, leading to progenitor dispersion and disorganized cortical lamination. Conversely, overexpression of Numb prolongs RGC polarization, in a cadherin-dependent manner, beyond the normal neurogenic period. Thus, by regulating RGC adhesion and polarity, Numb and Numbl are required for the tissue architecture of neurogenic niches and the cerebral cortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Coll Med, Inst Mol Med & Genet, Dev Neurobiol Program, Augusta, GA 30912 USA	Yale University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Breunig, Joshua/F-8490-2012; Kwan, Kenneth/AAI-2841-2021; Kwan, Kenneth Y/F-8489-2011	Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Breunig, Joshua/0000-0002-3735-3390	NIA NIH HHS [AG019394] Funding Source: Medline; NICHD NIH HHS [HD045481] Funding Source: Medline; NINDS NIH HHS [NS047200] Funding Source: Medline; Autism Speaks [AS1672] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019394] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; CHENN, 1998, MOL CELL NEUOSCI, V11, P183; Doe CQ, 1998, J NEUROBIOL, V36, P111, DOI 10.1002/(SICI)1097-4695(199808)36:2<111::AID-NEU2>3.0.CO;2-4; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LANGFORD LA, 1986, ACTA NEUROPATHOL, V71, P136, DOI 10.1007/BF00687975; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Mashayekhi F, 2002, BRAIN, V125, P1859, DOI 10.1093/brain/awf182; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Osanai Makoto, 2004, Medical Electron Microscopy, V37, P193; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	50	251	268	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					819	827		10.1038/nn1924	http://dx.doi.org/10.1038/nn1924			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589506				2022-12-28	WOS:000247560200011
J	Amedi, A; Stern, WM; Camprodon, JA; Bermpohl, F; Merabet, L; Rotman, S; Hemond, C; Meijer, P; Pascual-Leone, A				Amedi, Amir; Stern, William M.; Camprodon, Joan A.; Bermpohl, Felix; Merabet, Lotfi; Rotman, Stephen; Hemond, Christopher; Meijer, Peter; Pascual-Leone, Alvaro			Shape conveyed by visual-to-auditory sensory substitution activates the lateral occipital complex	NATURE NEUROSCIENCE			English	Article							CORTEX; PERCEPTION; PATHWAY; VISION	The lateral-occipital tactile-visual area (LOtv) is activated when objects are recognized by vision or touch. We report here that the LOtv is also activated in sighted and blind humans who recognize objects by extracting shape information from visual-to-auditory sensory substitution soundscapes. Recognizing objects by their typical sounds or learning to associate specific soundscapes with specific objects do not activate this region. This suggests that LOtv is driven by the presence of shape information.	Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Hebrew Univ Jerusalem, Dept Physiol, IL-91220 Jerusalem, Israel; Hebrew Univ Jerusalem, Program Cognit Sci, IL-91220 Jerusalem, Israel; Charite Univ Med Berlin, Dept Psychiat, D-10117 Berlin, Germany; NXP Semicond, NL-5656 AE Eindhoven, Netherlands	Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; NXP Semiconductors	Amedi, A (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, 330 Brookline Ave, Boston, MA 02115 USA.	aamedi@bidmc.harvard.edu; apleone@bidmc.harvard.edu	Merabet, Lotfi B./V-2735-2017; Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Hemond, Christopher/AAJ-7568-2020; merabet, lotfi/AAU-8259-2020; Camprodon, Joan Albert/M-9093-2017	Merabet, Lotfi B./0000-0002-8094-9536; Pascual-Leone, Alvaro/0000-0001-8975-0382; Hemond, Christopher/0000-0002-2408-4638; merabet, lotfi/0000-0002-8094-9536; Camprodon, Joan Albert/0000-0003-1282-9257; Amedi, Amir/0000-0001-5042-2533; Bermpohl, Felix/0000-0002-3260-6328	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER; NCRR NIH HHS [K24-RR018875] Funding Source: Medline; NEI NIH HHS [R01-EY12091, R21-EY0116168] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Hull J.M., 1992, TOUCHING ROCK EXPERI; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 2001, VISION NEURONS COGNI, pCH27; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Renier L, 2005, NEUROIMAGE, V26, P573, DOI 10.1016/j.neuroimage.2005.01.047; RICCIARDI E, 2007, CEREB, DOI DOI 10.1098/CERC3R/BH7018; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	15	270	272	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					687	689		10.1038/nn1912	http://dx.doi.org/10.1038/nn1912			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515898				2022-12-28	WOS:000246799800010
J	Kindt, KS; Viswanath, V; Macpherson, L; Quast, K; Hu, HZ; Patapoutian, A; Schafer, WR				Kindt, Katie S.; Viswanath, Veena; Macpherson, Lindsey; Quast, Kathleen; Hu, Hongzhen; Patapoutian, Ardem; Schafer, William R.			Caenorhabditis elegans TRPA-1 functions in mechanosensation	NATURE NEUROSCIENCE			English	Article							ION-CHANNEL TRPA1; SENSORY NEURONS; CANDIDATE; ACTIVATION; PROTEIN	Members of the transient receptor potential ( TRP) ion channel family mediate diverse sensory transduction processes in both vertebrates and invertebrates. In particular, members of the TRPA subfamily have distinct thermosensory roles in Drosophila, and mammalian TRPA1 is postulated to have a function in noxious cold sensation and mechanosensation. Here we show that mutations in trpa-1, the C. elegans ortholog of mouse Trpa1, confer specific defects in mechanosensory behaviors related to nosetouch responses and foraging. trpa-1 is expressed and functions in sensory neurons required for these mechanosensory behaviors, and contributes to neural responses of these cells to touch, particularly after repeated mechanical stimulation. Furthermore, mechanical pressure can activate C. elegans TRPA- 1 heterologously expressed in mammalian cells. Collectively, these data demonstrate that trpa-1 encodes an ion channel that can be activated in response to mechanical pressure and is required for mechanosensory neuron function, suggesting a possible role in mechanosensory transduction or modulation.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; MRC Laboratory Molecular Biology; University of California System; University of California San Diego; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Hopkins Rd, San Diego, CA 92121 USA.	apatapou@gnf.org; wschafer@mrc-lmb.cam.ac.uk	Kindt, Katie/AAS-3275-2020	Macpherson, Lindsey/0000-0002-1089-3733; Hu, Hongzhen/0000-0002-8967-7522; Schafer, William/0000-0002-6676-8034; Kindt, Katie/0000-0002-1065-8215	MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01DA018341, R01DA016445] Funding Source: Medline; NIDCR NIH HHS [R01DE016927] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341, R01DA016445] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Chakfe Y, 2006, AM J PHYSIOL-REG I, V290, pR1183, DOI 10.1152/ajpregu.00716.2005; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie M, 1997, BIOL BULL, V192, P125, DOI 10.2307/1542584; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Colbert HA, 1997, J NEUROSCI, V17, P8259; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman Miriam B, 2006, WormBook, P1; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hilliard MA, 2005, EMBO J, V24, P1489, DOI 10.1038/sj.emboj.7600639; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Kanzaki M, 1999, SCIENCE, V285, P1493; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McBride D W Jr, 1999, Methods Enzymol, V294, P482; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SACHS F, 1990, J PHYSIOL-LONDON, V431, P103; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	157	169	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					568	577		10.1038/nn1886	http://dx.doi.org/10.1038/nn1886			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450139				2022-12-28	WOS:000245948000013
J	Wang, XL; Zhang, MS; Cohen, IS; Goldberg, ME				Wang, Xiaolan; Zhang, Mingsha; Cohen, Ian S.; Goldberg, Michael E.			The proprioceptive representation of eye position in monkey primary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SUPERIOR COLLICULUS; COROLLARY DISCHARGE; MUSCLE PROPRIOCEPTION; VISUAL SPACE; AREA 3A; NEURONS; INFORMATION; MOVEMENTS; LOCALIZATION	The cerebral cortex must have access to an eye position signal, as humans can report passive changes in eye position in total darkness, and visual responses in many cortical areas are modulated by eye position. The source of this signal is unknown. Here we demonstrate a representation of eye position in monkey primary somatosensory cortex, in the representation of the trigeminal nerve, near cells with a tactile representation of the contralateral brow. The neurons have eye position signals that increase monotonically with increasing orbital eccentricity from near the center of gaze, with directionally selectivity tuned in a Gaussian manner. All directions of eye position are represented in a single hemisphere. The signal is proprioceptive, because it can be obliterated by anesthetizing the contralateral orbit. It is not related to foveal or peripheral visual stimulation, and it represents the position of the eye in the head and not the angle of gaze in space.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Zhang, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	mz2132@columbia.edu			NATIONAL EYE INSTITUTE [R24EY015634, R01EY014978, R21EY017938, R01EY017039] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017039, 1 R24 EY015634-01, R24 EY015634, R01 EY014978, 1 R01 EY014978-01, R21 EY017938] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Buttner-Ennever JA, 2002, CURR OPIN NEUROL, V15, P35, DOI 10.1097/00019052-200202000-00007; Campos M, 2006, J NEUROPHYSIOL, V95, P505, DOI 10.1152/jn.00639.2005; Dengis CA, 1998, EXP BRAIN RES, V119, P475, DOI 10.1007/s002210050363; Donaldson IML, 2000, PHILOS T R SOC B, V355, P1685, DOI 10.1098/rstb.2000.0732; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Eberhorn AC, 2005, ANN NY ACAD SCI, V1039, P1, DOI 10.1196/annals.1325.001; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hays AV, 1982, WESCON C P, V2, P1; HENN V, 1984, BRAIN, V107, P619, DOI 10.1093/brain/107.2.619; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Klier EM, 2003, J NEUROPHYSIOL, V89, P2839, DOI 10.1152/jn.00763.2002; Krubitzer L, 2004, J COMP NEUROL, V471, P97, DOI 10.1002/cne.20025; LAL R, 1990, J NEUROPHYSIOL, V63, P502, DOI 10.1152/jn.1990.63.3.502; LEWIS RF, 1994, J NEUROPHYSIOL, V72, P1028, DOI 10.1152/jn.1994.72.2.1028; Lewis RF, 1998, J NEUROPHYSIOL, V80, P1605, DOI 10.1152/jn.1998.80.3.1605; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PORTER JD, 1983, J COMP NEUROL, V218, P208, DOI 10.1002/cne.902180208; Pouget A, 1999, Prog Brain Res, V121, P81; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; Rose D, 1999, PERCEPTION, V28, P675, DOI 10.1068/p2881; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; SALINAS E, 1995, J NEUROSCI, V15, P6461; SKAVENSKI AA, 1972, VISION RES, V12, P221, DOI 10.1016/0042-6989(72)90113-7; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STEINBACH MJ, 1986, ACTA PSYCHOL, V63, P297, DOI 10.1016/0001-6918(86)90049-1; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; Taylor A, 2006, J PHYSIOL-LONDON, V571, P711, DOI 10.1113/jphysiol.2005.101634; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Widener GL, 1997, J NEUROPHYSIOL, V77, P2446, DOI 10.1152/jn.1997.77.5.2446; WISE SP, 1981, J NEUROPHYSIOL, V45, P482, DOI 10.1152/jn.1981.45.3.482; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P727, DOI 10.1152/jn.1969.32.5.727; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	41	164	165	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					640	646		10.1038/nn1878	http://dx.doi.org/10.1038/nn1878			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396123				2022-12-28	WOS:000245948000021
J	Winocur, G; Moscovitch, M; Sekeres, M				Winocur, Gordon; Moscovitch, Morris; Sekeres, Melanie			Memory consolidation or transformation: context manipulation and hippocampal representations of memory	NATURE NEUROSCIENCE			English	Article							RETROGRADE-AMNESIA; DORSAL HIPPOCAMPAL; SPATIAL MEMORY; LESIONS; FEAR; NEUROANATOMY; ANTEROGRADE; MONKEYS; COMPLEX; DAMAGE	The traditional view is that the hippocampus is necessary for retaining memories until they are consolidated in their original form in the neocortex. An alternative view is that the original memory, which is hippocampus- and context- dependent, becomes transformed with time to one that is more schematic and independent of the hippocampus. By manipulating context in two protocols that are widely used to investigate hippocampal- neocortical interactions in memory, we find evidence for the transformation view.	Rotman Res Inst, Baycrest Ctr, Toronto, ON M6A 2E1, Canada; Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Baycrest; Trent University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Winocur, G (corresponding author), Rotman Res Inst, Baycrest Ctr, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	gwinocur@rotman-baycrest.on.ca		Sekeres, Melanie/0000-0002-7952-3175				ALVAREZ P, 1995, J NEUROSCI, V15, P3796; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GISQUETVERRIER P, 1986, ANIM LEARN BEHAV, V14, P349, DOI 10.3758/BF03200078; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4	15	165	165	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					555	557		10.1038/nn1880	http://dx.doi.org/10.1038/nn1880			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396121				2022-12-28	WOS:000245948000011
J	Endo, K; Aoki, T; Yoda, Y; Kimura, KI; Hama, C				Endo, Keita; Aoki, Tomoko; Yoda, Yuka; Kimura, Ken-ichi; Hama, Chihiro			Notch signal organizes the Drosophila olfactory circuitry by diversifying the sensory neuronal lineages	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; MOLECULAR-BASIS; ANTENNAL LOBE; AXON GUIDANCE; CELL FATES; FLY BRAIN; MAP; MELANOGASTER; EXPRESSION	An essential feature of the organization and function of the vertebrate and insect olfactory systems is the generation of a variety of olfactory receptor neurons ( ORNs) that have different specificities in regard to both odorant receptor expression and axonal targeting. Yet the underlying mechanisms that generate this neuronal diversity remain elusive. Here we demonstrate that the Notch signal is involved in the diversification of ORNs in Drosophila melanogaster. A systematic clonal analysis showed that a cluster of ORNs housed in each sensillum were differentiated into two classes, depending on the level of Notch activity in their sibling precursors. Notably, ORNs of different classes segregated their axonal projections into distinct domains in the antennal lobes. In addition, both the odorant receptor expression and the axonal targeting of ORNs were specified according to their Notch-mediated identities. Thus, Notch signaling contributes to the diversification of ORNs, thereby regulating multiple developmental events that establish the olfactory map in Drosophila.	RIKEN, Ctr Dev Biol, Lab Neural Network Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Chiyoda Ku, Tokyo 1028666, Japan; Hokkaido Univ, Iwarnizawa, Hokkaido 0688642, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Hokkaido University	Hama, C (corresponding author), RIKEN, Ctr Dev Biol, Lab Neural Network Dev, Chuo Ku, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	hama@cdb.riken.jp						Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Giraldez AJ, 2002, MECH DEVELOP, V115, P101, DOI 10.1016/S0925-4773(02)00124-7; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Schuldt AJ, 1999, DEV BIOL, V205, P287, DOI 10.1006/dbio.1998.9014; Sen A, 2003, DEV BIOL, V254, P79, DOI 10.1016/S0012-1606(02)00021-0; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Yoshikawa S, 2004, CURR OPIN NEUROBIOL, V14, P45, DOI 10.1016/j.conb.2004.01.005	43	85	88	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					153	160		10.1038/nn1832	http://dx.doi.org/10.1038/nn1832			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220884				2022-12-28	WOS:000244175200009
J	Belmonte, MK; Bourgeron, T				Belmonte, Matthew K.; Bourgeron, Thomas			Fragile X syndrome and autism at the intersection of genetic and neural networks	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; SEROTONIN TRANSPORTER; NEURODEVELOPMENTAL DISORDERS; SOCIAL-INTERACTION; NEUROLIGIN GENES; MUTATIONS; BRAIN; SUSCEPTIBILITY; INDIVIDUALS; EXPRESSION	Autism, an entirely behavioral diagnosis with no largely understood etiologies and no population-wide biomarkers, contrasts with fragile X syndrome (FXS), a single-gene disorder with definite alterations of gene expression and neuronal morphology. Nevertheless, the behavioral overlap between autism and FXS suggests some overlapping mechanisms. Understanding how the single-gene alteration in FXS plays out within complex genetic and neural network processes may suggest targets for autism research and illustrate strategies for relating autism to more singular genetic syndromes.	Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA; Inst Pasteur, Lab Genet Humaine & Fonct Cognit, F-75015 Paris 15, France; Univ Paris 07, F-75251 Paris 05, France	Cornell University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Belmonte, MK (corresponding author), Cornell Univ, Dept Human Dev, Martha Van Rensselaer Hall, Ithaca, NY 14853 USA.	belmonte@mit.edu	; Belmonte, Matthew/G-1170-2015	Bourgeron, Thomas/0000-0001-8164-9220; Belmonte, Matthew/0000-0002-4633-9400				BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beckel-Mitchener A, 2004, MENT RETARD DEV D R, V10, P53, DOI 10.1002/mrdd.20009; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Blasi F, 2006, AM J MED GENET B, V141B, P220, DOI 10.1002/ajmg.b.30287; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; CLIFFORD S, IN PRESS J AUTISM DE; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; Delorme R, 2005, MOL PSYCHIATR, V10, P1059, DOI 10.1038/sj.mp.4001728; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Eliez S, 2001, BRAIN, V124, P1610, DOI 10.1093/brain/124.8.1610; Feinstein C, 1998, J AUTISM DEV DISORD, V28, P393, DOI 10.1023/A:1026000404855; FILIPEK PA, 2005, HDB AUTISM PERVASIVE, P534; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gauthier J, 2005, AM J MED GENET B, V132B, P74, DOI 10.1002/ajmg.b.30066; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Hollander E, 2003, PSYCHIAT RES, V117, P11, DOI 10.1016/S0165-1781(02)00304-9; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson MH, 2002, DEV PSYCHOPATHOL, V14, P521, DOI 10.1017/S0954579402003073; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Kogan CS, 2004, NEUROLOGY, V63, P1634, DOI 10.1212/01.WNL.0000142987.44035.3B; Kogan CS, 2004, BRAIN, V127, P591, DOI 10.1093/brain/awh069; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISCHMANN T, 1995, S AFR J GEOL, V1, P1; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Vincent JB, 2004, AM J MED GENET B, V129B, P82, DOI 10.1002/ajmg.b.30069; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	224	268	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1221	1225		10.1038/nn1765	http://dx.doi.org/10.1038/nn1765			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001341				2022-12-28	WOS:000241493900011
J	Cano, M; Bezdudnaya, T; Swadlow, HA; Alonso, JM				Cano, Monica; Bezdudnaya, Tatiana; Swadlow, Harvey A.; Alonso, Jose-Manuel			Brain state and contrast sensitivity in the awake visual thalamus	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; NEURONS; GAIN; MODULATION; ATTENTION; CELLS; FIELD; BURST; V4	Neuronal responses to visual stimuli depend on both the nature of the stimulus and brain state. Here we examined the contrast sensitivity of visual thalamic neurons as awake rabbits shifted between alert and nonalert states. We found that despite a large increase in response gain with alertness, contrast sensitivity remained nearly constant. This accurate scaling might be achieved through a balanced increase in excitation and inhibition with alertness.	SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, 33 W 42nd St, New York, NY 10036 USA.	jalonso@sunyopt.edu	cano, monica/F-5833-2010		NATIONAL EYE INSTITUTE [R03EY013788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER; NEI NIH HHS [EY13788] Funding Source: Medline; NIMH NIH HHS [MH-64024] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Li B, 1999, J PHYSIOL-LONDON, V514, P857, DOI 10.1111/j.1469-7793.1999.857ad.x; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Murphy BK, 2003, J NEUROSCI, V23, P10040; Przybyszewski AW, 2000, VISUAL NEUROSCI, V17, P485, DOI 10.1017/S0952523800174012; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P168, DOI 10.1152/jn.1985.54.1.168; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	15	40	40	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1240	1242		10.1038/nn1760	http://dx.doi.org/10.1038/nn1760			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964255				2022-12-28	WOS:000241493900016
J	Volynski, KE; Rusakov, DA; Kullmann, DM				Volynski, Kirill E.; Rusakov, Dmitri A.; Kullmann, Dimitri M.			Presynaptic fluctuations and release-independent depression	NATURE NEUROSCIENCE			English	Article							MEMBRANE-FUSION; VESICLE FUSION; PLASTICITY; PROBABILITY; MODULATION; SYNAPSES; CALCIUM	Although vesicle depletion contributes to short-term depression, several studies have reported that the release probability can be transiently depressed even if an action potential fails to evoke release. Here we argue that stochastic fluctuation in the release machinery can give rise to apparent release-independent depression as a result of sampling bias. The relationship between this apparent depression and the interstimulus interval provides a window on the kinetics of state transitions of the release apparatus.	UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Volynski, KE (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	k.volynski@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Volynski, Kirill/0000-0001-8208-1905	Medical Research Council [G0400627(76527), G0802216, G0900613, G116/147, G0400627(71256), G0600089, G0400627, G0600368(77987), G0600368] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline; MRC [G0400627, G0600089, G116/147] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Brody DL, 2000, J NEUROSCI, V20, P2480; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Finley MFA, 2002, J NEUROSCI, V22, P1266, DOI 10.1523/JNEUROSCI.22-04-01266.2002; Hanse E, 2001, J PHYSIOL-LONDON, V531, P481, DOI 10.1111/j.1469-7793.2001.0481i.x; Hanse E, 2001, J NEUROSCI, V21, P8362, DOI 10.1523/JNEUROSCI.21-21-08362.2001; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thomson AM, 1999, J PHYSIOL-LONDON, V519, P57, DOI 10.1111/j.1469-7793.1999.0057o.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	13	9	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1091	1093		10.1038/nn1746	http://dx.doi.org/10.1038/nn1746			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16878129	Green Accepted			2022-12-28	WOS:000240080800007
J	Womelsdorf, T; Anton-Erxleben, K; Pieper, F; Treue, S				Womelsdorf, Thilo; Anton-Erxleben, Katharina; Pieper, Florian; Treue, Stefan			Dynamic shifts of visual receptive fields in cortical area MT by spatial attention	NATURE NEUROSCIENCE			English	Article							FOCUSED ATTENTION; PARIETAL CORTEX; EYE-MOVEMENTS; V4; RESOLUTION; NEURONS; SPACE; LOCALIZATION; MECHANISMS; RESPONSES	Voluntary attention is the top-down selection process that focuses cortical processing resources on the most relevant sensory information. Spatial attention - that is, selection based on stimulus position - alters neuronal responsiveness throughout primate visual cortex. It has been hypothesized that it also changes receptive field profiles by shifting their centers toward attended locations and by shrinking them around attended stimuli. Here we examined, at high resolution, receptive fields in cortical area MT of rhesus macaque monkeys when their attention was directed to different locations within and outside these receptive fields. We found a shift of receptive fields, even far from the current location of attention, accompanied by a small amount of shrinkage. Thus, already in early extrastriate cortex, receptive fields are not static entities but are highly modifiable, enabling the dynamic allocation of processing resources to attended locations and supporting enhanced perception within the focus of attention by effectively increasing the local cortical magnification.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands; German Primate Ctr, Cognit Neurosci Lab, D-37077 Gottingen, Germany	Radboud University Nijmegen; Deutsches Primatenzentrum (DPZ)	Womelsdorf, T (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Kapittelweg 29, NL-6525 EN Nijmegen, Netherlands.	t.womelsdorf@fcdonders.ru.nl	Womelsdorf, Thilo/C-3096-2015	Womelsdorf, Thilo/0000-0001-6921-4187				Britten KH, 1999, J NEUROSCI, V19, P5074; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Conner CE, 1997, J NEUROSCI, V17, P3201; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P103; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Tsal Y, 1999, PSYCHON B REV, V6, P292, DOI 10.3758/BF03212332; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	30	218	220	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1156	1160		10.1038/nn1748	http://dx.doi.org/10.1038/nn1748			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16906153				2022-12-28	WOS:000240080800017
J	Yu, FH; Mantegazza, M; Westenbroek, RE; Robbins, CA; Kalume, F; Burton, KA; Spain, WJ; McKnight, GS; Scheuer, T; Catterall, WA				Yu, Frank H.; Mantegazza, Massimo; Westenbroek, Ruth E.; Robbins, Carol A.; Kalume, Franck; Burton, Kimberly A.; Spain, William J.; McKnight, G. Stanley; Scheuer, Todd; Catterall, William A.			Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; SCN1A MUTATIONS; CHANNEL SUBTYPES; NERVOUS-SYSTEM; GENE SCN1A; SUBUNIT; SUSCEPTIBILITY; SEIZURES; MICE; EXPRESSION	Voltage-gated sodium channels (Na-V) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a(-/-) mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a(+/-) mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a(+/-) and Scn1a(-/-) mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a(+/-) heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Inst Neurol Besta, Dept Neurophysiol, I-20126 Milan, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; IRCCS Istituto Neurologico Besta	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu	Ritter, Stefanie L/D-9312-2012; Mantegazza, Massimo/J-8802-2016	Mantegazza, Massimo/0000-0002-1070-7929; Yu, Frank/0000-0001-9306-1731				BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; BRANDON EP, 1995, RECENT PROG HORM RES, V50, P403; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Ceulemans B, 2004, J CHILD NEUROL, V19, P516, DOI 10.1177/08830738040190070701; Claes L, 2003, HUM MUTAT, V21, P615, DOI 10.1002/humu.10217; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Coppola G, 2002, EPILEPSY RES, V49, P45, DOI 10.1016/S0920-1211(02)00010-4; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Dravet Charlotte, 1992, P75; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; FERRARO TN, 1995, EPILEPSIA, V36, P301, DOI 10.1111/j.1528-1157.1995.tb00999.x; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Fukuma G, 2004, EPILEPSIA, V45, P140, DOI 10.1111/j.0013-9580.2004.15103.x; Gong B, 1999, J COMP NEUROL, V412, P342; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Guerrini R, 1998, EPILEPSIA, V39, P508, DOI 10.1111/j.1528-1157.1998.tb01413.x; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Krzemien DM, 2000, J COMP NEUROL, V420, P70; LOTHMAN EW, 1992, EPILEPSY RES, P301; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oguni H, 2001, BRAIN DEV-JPN, V23, P736, DOI 10.1016/S0387-7604(01)00276-5; Ohmori I, 2002, BIOCHEM BIOPH RES CO, V295, P17, DOI 10.1016/S0006-291X(02)00617-4; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHWARTZKROIN PA, 1994, HIPPOCAMPUS, V4, P239, DOI 10.1002/hipo.450040302; Singh R, 2001, EPILEPSIA, V42, P837, DOI 10.1046/j.1528-1157.2001.042007837.x; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Walls A. F., 2001, Clinical and Experimental Allergy Reviews, V1, P68, DOI 10.1046/j.1472-9725.2001.00009.x; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2003, J NEUROSCI, V23, P7577; YU FH, 2004, SCI STKE; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	50	735	802	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1142	1149		10.1038/nn1754	http://dx.doi.org/10.1038/nn1754			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921370				2022-12-28	WOS:000240080800015
J	Gopfert, MC; Albert, JT; Nadrowski, B; Kamikouchi, A				Goepfert, Martin C.; Albert, Joerg T.; Nadrowski, B.; Kamikouchi, A.			Specification of auditory sensitivity by Drosophila TRP channels	NATURE NEUROSCIENCE			English	Article							HAIR-CELLS; TRANSDUCTION CHANNEL; HEARING; MECHANISMS; CANDIDATE	Ears achieve their exquisite sensitivity by means of mechanical feedback: motile mechanosensory cells through their active motion boost the mechanical input from the ear. Examination of the auditory mechanics in Drosophila melanogaster mutants shows that the transient receptor potential (TRP) channel NompC is required to promote this feedback, whereas the TRP vanilloid (TRPV) channels Nan and Iav serve to control the feedback gain. The combined function of these channels specifies the sensitivity of the fly auditory organ.	Univ Cologne, Inst Zool, Volkswagen Fdn Res Grp, D-50923 Cologne, Germany	University of Cologne; Volkswagen; Volkswagen Germany	Gopfert, MC (corresponding author), Univ Cologne, Inst Zool, Volkswagen Fdn Res Grp, Weyertal 119, D-50923 Cologne, Germany.	m.gopfert@uni-koeln.de	Nadrowski, Björn/D-4979-2012	Kamikouchi, Azusa/0000-0003-1552-6892; Gopfert, Martin/0000-0001-8201-5334				Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Frolenkov GI, 2003, CELL CALCIUM, V33, P185, DOI 10.1016/S0143-4160(02)00228-2; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zheng JF, 2003, J NEUROPHYSIOL, V90, P444, DOI 10.1152/jn.00919.2002	15	114	117	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					999	1000		10.1038/nn1735	http://dx.doi.org/10.1038/nn1735			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819519				2022-12-28	WOS:000240080300009
J	Somerville, LH; Heatherton, TF; Kelley, WM				Somerville, Leah H.; Heatherton, Todd F.; Kelley, William M.			Anterior cingulate cortex responds differentially to expectancy violation and social rejection	NATURE NEUROSCIENCE			English	Article								This study investigated human anterior cingulate cortex (ACC) involvement during a task that dissociated expectancy violation from social rejection. Across two studies, participants underwent functional magnetic resonance imaging while making social judgments and receiving fictitious feedback that was either positive or negative and consistent or inconsistent with their expectations. The results demonstrate that the dorsal ACC is sensitive to expectancy violations, whereas the ventral ACC is differentially responsive to social feedback.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Kelley, WM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	william.kelley@dartmouth.edu	Heatherton, Todd F/H-5478-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059282, R21MH066720] Funding Source: NIH RePORTER; NIMH NIH HHS [R21 MH066720, MH59282, MH66720] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CONDON JW, 1988, J PERS SOC PSYCHOL, V54, P789, DOI 10.1037/0022-3514.54.5.789; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Newcomb T.M, 1961, ACQUAINTANCE PROCESS; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0	7	303	310	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1007	1008		10.1038/nn1728	http://dx.doi.org/10.1038/nn1728			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819523				2022-12-28	WOS:000240080300012
J	Plant, K; Pelkey, KA; Bortolotto, ZA; Morita, D; Terashima, A; McBain, CJ; Collingridge, GL; Isaac, JTR				Plant, K; Pelkey, KA; Bortolotto, ZA; Morita, D; Terashima, A; McBain, CJ; Collingridge, GL; Isaac, JTR			Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation	NATURE NEUROSCIENCE			English	Article							CALCIUM-PERMEABLE AMPA; SUBUNIT COMPOSITION; PYRAMIDAL NEURONS; RECTIFICATION; SWITCH; TRAFFICKING; SYNAPSES; SUBTYPE; BLOCK; LTP	Postnatal glutamatergic principal neuron synapses are typically presumed to express only calcium-impermeable (CI), GluR2-containing AMPARs under physiological conditions. Here, however, we demonstrate that long-term potentiation (LTP) in CA1 hippocampal pyramidal neurons causes rapid incorporation of GluR2-lackingcalcium-permeable (CP)AMPARs: CP-AMPARs are present transiently, being replaced by GluR2-containing AMPARs similar to 25 min after LTP induction. Thus, CP-AMPARs are physiologically expressed at CA1 pyramidal cell synapses during LTP, and may be required for LTP consolidation.	Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; NINDS, Dev Synapt Plast Unit, NIH, Bethesda, MD 20892 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	isaacj@ninds.nih.gov	Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Collingridge, Graham L/0000-0002-9572-5359; 	MRC [G9532377] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003011, ZIANS003011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9532377] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000	15	392	406	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					602	604		10.1038/nn1678	http://dx.doi.org/10.1038/nn1678			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582904				2022-12-28	WOS:000237417200008
J	Nielsen, KJ; Callaway, EM				Nielsen, Kristina J.; Callaway, Edward M.			More than a feeling: sensation from cortical stimulation	NATURE NEUROSCIENCE			English	Editorial Material							EYE-MOVEMENTS; MICROSTIMULATION	Changes in neuronal firing underlie sensation, but how many neurons are needed to perceive these activity shifts? Two new studies in Nature suggest that the experimental modulation of only a few neurons can influence perception.	[Nielsen, Kristina J.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Nielsen, KJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Nielsen, Kristina/M-2298-2016; Callaway, Edward/D-4336-2011	Nielsen, Kristina/0000-0002-9155-2972; Callaway, Edward/0000-0002-6366-5267	NEI NIH HHS [R01 EY010742-16, R01 EY010742] Funding Source: Medline; NIMH NIH HHS [R01 MH063912-08, R01 MH063912] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; HOUWELING AR, 2007, NATURE ADV ONLINE PU; HUBER D, 2007, NATURE ADV ONLINE PU; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	15	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					10	12		10.1038/nn0108-10	http://dx.doi.org/10.1038/nn0108-10			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160957	Green Accepted			2022-12-28	WOS:000252117900005
J	Sdrulla, AD; Linden, DJ				Sdrulla, Andrei D.; Linden, David J.			Double dissociation between long-term depression and dendritic spine morphology in cerebellar Purkinje cells	NATURE NEUROSCIENCE			English	Article							POTENTIATION; PLASTICITY	Experiments in hippocampal area CA1 suggest that long-term potentiation could be associated with spine addition and enlargement, and long-term depression ( LTD) with spine shrinkage and loss. Is this a general principle of synaptic plasticity? We used two-photon microscopy to measure dendritic spines in rat cerebellar Purkinje cells. Neither local synaptic induction of LTD nor global chemical induction of LTD changed spine number or size. Conversely, a manipulation that evoked persistent dendritic spine retraction did not alter parallel fiber - evoked excitatory postsynaptic currents.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,916 Hunterian Bldg, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Sdrulla, Andrei/AAU-7664-2021		NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	8	48	48	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					546	548		10.1038/nn1889	http://dx.doi.org/10.1038/nn1889			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435753				2022-12-28	WOS:000245948000008
J	Ziskin, JL; Nishiyama, A; Rubio, M; Fukaya, M; Bergles, DE				Ziskin, Jennifer L.; Nishiyama, Akiko; Rubio, Maria; Fukaya, Masahiro; Bergles, Dwight E.			Vesicular release of glutamate from unmyelinated axons in white matter	NATURE NEUROSCIENCE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; GLIAL PROGENITOR CELLS; NG2 PROTEOGLYCAN; CORPUS-CALLOSUM; SYNAPTIC-TRANSMISSION; ALPHA-LATROTOXIN; NMDA RECEPTORS; RHESUS-MONKEY; RAT CNS; ADULT	Directed fusion of transmitter-laden vesicles enables rapid intercellular signaling in the central nervous system and occurs at synapses within gray matter. Here we show that action potentials also induce the release of glutamate from axons in the corpus callosum, a white matter region responsible for interhemispheric communication. Callosal axons release glutamate by vesicular fusion, which induces quantal AMPA receptor-mediated currents in NG2(+) glial progenitors at anatomically distinct axo-glial synaptic junctions. Glutamate release from axons was facilitated by repetitive stimulation and could be inhibited through activation of metabotropic autoreceptors. Although NG2(+) cells form associations with nodes of Ranvier in white matter, measurements of conduction velocity indicated that unmyelinated fibers are responsible for glutamatergic signaling with NG2(+) glia. This activity-dependent secretion of glutamate was prevalent in the developing and mature mouse corpus callosum, indicating that axons within white matter both conduct action potentials and engage in rapid neuron-glia communication.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Connecticut, Dept Neurobiol & Physiol, Storrs, CT 06269 USA; Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Johns Hopkins University; University of Connecticut; Hokkaido University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,WBSB 813, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051509, R01NS049267] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049267, R01 NS051509, NS049267, R01 NS051509-01A1, NS051509] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAM JA, 1988, J NEUROSCI METH, V23, P211, DOI 10.1016/0165-0270(88)90005-2; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clancy B, 2001, J COMP NEUROL, V434, P233, DOI 10.1002/cne.1174; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukaya M, 2000, J COMP NEUROL, V426, P572; FULTON BP, 1992, J NEUROSCI, V12, P4816; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; Hassel B, 2003, J NEUROCHEM, V87, P230, DOI 10.1046/j.1471-4159.2003.01984.x; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Lin SC, 2002, J NEUROCYTOL, V31, P537, DOI 10.1023/A:1025799816285; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; MALGAROLI A, 1989, NEUROSCIENCE, V32, P393, DOI 10.1016/0306-4522(89)90088-2; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Morgenstern DA, 2003, MOL CELL NEUROSCI, V24, P787, DOI 10.1016/S1044-7431(03)00245-8; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Tillet E, 1997, J BIOL CHEM, V272, P10769; Ughrin YM, 2003, J NEUROSCI, V23, P175; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WESTRUM LE, 1962, J COMP NEUROL, V119, P281, DOI 10.1002/cne.901190303; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	357	360	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					321	330		10.1038/nn1854	http://dx.doi.org/10.1038/nn1854			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293857	Green Accepted			2022-12-28	WOS:000244480300014
J	Nevian, T; Larkum, ME; Polsky, A; Schiller, J				Nevian, Thomas; Larkum, Matthew E.; Polsky, Alon; Schiller, Jackie			Properties of basal dendrites of layer 5 pyramidal neurons: a direct patch-clamp recording study	NATURE NEUROSCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; ACTION-POTENTIAL INITIATION; DISTAL APICAL DENDRITES; SYNAPTIC PLASTICITY; OBLIQUE DENDRITES; CALCIUM SPIKES; VISUAL-CORTEX; NMDA SPIKES; EVOKED CA2+; IN-VIVO	Basal dendrites receive the majority of synapses that contact neocortical pyramidal neurons, yet our knowledge of synaptic processing in these dendrites has been hampered by their inaccessibility for electrical recordings. A new approach to patch-clamp recordings enabled us to characterize the integrative properties of these cells. Despite the short physical length of rat basal dendrites, synaptic inputs were electrotonically remote from the soma ( > 30- fold excitatory postsynaptic potential ( EPSP) attenuation) and back- propagating action potentials were significantly attenuated. Unitary EPSPs were location dependent, reaching large amplitudes distally ( > 8 mV), yet their somatic contribution was relatively location independent. Basal dendrites support sodium and NMDA spikes, but not calcium spikes, for 75% of their length. This suggests that basal dendrites, despite their proximity to the site of action potential initiation, do not form a single basal- somatic region but rather should be considered as a separate integrative compartment favoring two integration modes: subthreshold, location- independent summation versus local amplification of incoming spatiotemporally clustered information.	Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel; Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Technion Israel Institute of Technology; University of Bern; Max Planck Society	Schiller, J (corresponding author), Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel.	jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129; Nevian, Thomas/0000-0001-9804-608X; Larkum, Matthew/0000-0001-9799-2656				Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ariav G, 2003, J NEUROSCI, V23, P7750; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Colbert CM, 1997, J NEUROSCI, V17, P6512; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; LARKMAN AU, 1992, J COMP NEUROL, V323, P137, DOI 10.1002/cne.903230202; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Milojkovic BA, 2004, J PHYSIOL-LONDON, V558, P193, DOI 10.1113/jphysiol.2004.061416; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rhodes P, 2006, J NEUROSCI, V26, P6704, DOI 10.1523/JNEUROSCI.3791-05.2006; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	50	280	286	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					206	214		10.1038/nn1826	http://dx.doi.org/10.1038/nn1826			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17206140				2022-12-28	WOS:000244175200015
J	Watari-Goshima, N; Ogura, KI; Wolf, FW; Goshima, Y; Garriga, G				Watari-Goshima, Natsuko; Ogura, Ken-ichi; Wolf, Fred W.; Goshima, Yoshio; Garriga, Gian			C-elegans VAB-8 and UNC-73 regulate the SAX-3 receptor to direct cell and growth-cone migrations	NATURE NEUROSCIENCE			English	Article							ANTERIOR-POSTERIOR GUIDANCE; AXON GUIDANCE; CAENORHABDITIS-ELEGANS; NETRIN RECEPTOR; COMMISSURAL AXONS; ROUNDABOUT RECEPTOR; COLORECTAL-CANCER; KINASE UNC-51; IN-VIVO; PROTEIN	During nervous system development, a small number of conserved guidance cues and receptors regulate many axon trajectories. How could a limited number of cues and receptors regulate such complex projection patterns? One way is to modulate receptor function. Here we show that the Caenorhabditis elegans kinesin-related protein VAB-8L, which is necessary and sufficient for posterior cell and growth-cone migrations, directs these migrations by regulating the levels of the guidance receptor SAX-3 ( also known as robo). Genetic experiments indicate that VAB-8L and the Rac guanine nucleotide exchange factor activity of UNC-73 ( trio) increase the ability of the SLT-1 ( slit) and UNC-6 ( netrin) guidance pathways to promote posterior guidance. The observations of higher SAX-3 receptor abundance in animals with increasing amounts of VAB-8L, and of physical interactions between UNC-73 and both VAB-8L and the intracellular domain of the SAX- 3, support a model whereby VAB-8L directs cell and growth- cone migrations by promoting localization of guidance receptors to the cell surface.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Yokohama City University; Japan Science & Technology Agency (JST)	Garriga, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	garriga@berkeley.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32057] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fleming TC, 2005, DEVELOPMENT, V132, P4857, DOI 10.1242/dev.02020; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Lai T, 2004, DEVELOPMENT, V131, P5991, DOI 10.1242/dev.01457; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; Merz DC, 2001, GENETICS, V158, P1071; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ogura K, 2006, DEVELOPMENT, V133, P3441, DOI 10.1242/dev.02503; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Spencer AG, 2001, P NATL ACAD SCI USA, V98, P13132, DOI 10.1073/pnas.241504098; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Su MW, 2000, DEVELOPMENT, V127, P585; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wightman B, 1996, DEVELOPMENT, V122, P671; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	50	71	86	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					169	176		10.1038/nn1834	http://dx.doi.org/10.1038/nn1834			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237778				2022-12-28	WOS:000244175200011
J	Ji, DY; Wilson, MA				Ji, Daoyun; Wilson, Matthew A.			Coordinated memory replay in the visual cortex and hippocampus during sleep	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL NEURONS; PHASE-LOCKING; SPATIAL MAP; REACTIVATION; OSCILLATION; SEQUENCES; NETWORK; STATE; EXPERIENCE; PATTERNS	Sleep replay of awake experience in the cortex and hippocampus has been proposed to be involved in memory consolidation. However, whether temporally structured replay occurs in the cortex and whether the replay events in the two areas are related are unknown. Here we studied multicell spiking patterns in both the visual cortex and hippocampus during slow-wave sleep in rats. We found that spiking patterns not only in the cortex but also in the hippocampus were organized into frames, defined as periods of stepwise increase in neuronal population activity. The multicell firing sequences evoked by awake experience were replayed during these frames in both regions. Furthermore, replay events in the sensory cortex and hippocampus were coordinated to reflect the same experience. These results imply simultaneous reactivation of coherent memory traces in the cortex and hippocampus during sleep that may contribute to or reflect the result of the memory consolidation process.	MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Wilson, MA (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Bldg 46,Room 5233,43 Vassar St, Cambridge, MA 02139 USA.	dji@mit.edu; mwilson@mit.edu						Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 1998, NEUROSCIENCE, V82, P671; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Robert C, 1999, J NEUROSCI METH, V88, P111, DOI 10.1016/S0165-0270(99)00027-8; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 1998, J SLEEP RES, V7, P30, DOI 10.1046/j.1365-2869.7.s1.4.x; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Suzuki WA, 2006, NEURON, V50, P19, DOI 10.1016/j.neuron.2006.03.029; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	50	1016	1041	1	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					100	107		10.1038/nn1825	http://dx.doi.org/10.1038/nn1825			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173043				2022-12-28	WOS:000243096100021
J	Ahissar, M; Lubin, Y; Putter-Katz, H; Banai, K				Ahissar, Merav; Lubin, Yedida; Putter-Katz, Hanna; Banai, Karen			Dyslexia and the failure to form a perceptual anchor	NATURE NEUROSCIENCE			English	Article							AUDITORY FREQUENCY DISCRIMINATION; DEVELOPMENTAL DYSLEXIA; PROCESSING DEFICITS; MISMATCH; CHILDREN; MEMORY; BRAIN; PITCH; INTELLIGENCE; REPETITION	In a large subgroup of dyslexic individuals (D-LDs), reading difficulties are part of a broader learning and language disability. Recent studies indicate that D-LDs perform poorly in many psychoacoustic tasks compared with individuals with normal reading ability. We found that D-LDs perform as well as normal readers in speech perception in noise and in a difficult tone comparison task. However, their performance did not improve when these same tasks were performed with a smaller stimulus set. In contrast to normal readers, they did not benefit from stimulus-specific repetitions, suggesting that they have difficulties forming perceptual anchors. These findings are inconsistent with previously suggested static models of dyslexia. Instead, we propose that D-LDs' core deficit is a general difficulty in dynamically constructing stimulus-specific predictions, deriving from deficient stimulus-specific adaptation mechanisms. This hypothesis provides a direct link between D-LDs' high-level difficulties and mechanisms at the level of specific neuronal circuits.	Hebrew Univ Jerusalem, Dept Psychol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Cognit Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Northwestern Univ, Dept Commun Sci, Evanston, IL 60208 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Northwestern University	Ahissar, M (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91904 Jerusalem, Israel.	msmerava@mscc.huji.ac.il	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470; Ahissar, Merav/0000-0001-7694-8111				Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; Baldeweg T, 1999, ANN NEUROL, V45, P495, DOI 10.1002/1531-8249(199904)45:4<495::AID-ANA11>3.0.CO;2-M; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Ben-Yehudah G, 2004, NEUROREPORT, V15, P627, DOI 10.1097/00001756-200403220-00011; Ben-Yehudah G, 2004, VISION RES, V44, P1047, DOI 10.1016/j.visres.2003.12.001; Ben-Yehudah G, 2001, BRAIN, V124, P1381, DOI 10.1093/brain/124.7.1381; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Clement S, 1999, J ACOUST SOC AM, V106, P2805, DOI 10.1121/1.428106; Deary LJ, 2004, AM J PSYCHOL, V117, P1, DOI 10.2307/1423593; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Dreschler WA, 2001, AUDIOLOGY, V40, P148; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Halliday LF, 2005, J SPEECH LANG HEAR R, V48, P1187, DOI 10.1044/1092-4388(2005/083); Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; HARRIS JD, 1948, AM J PSYCHOL, V61, P309, DOI 10.2307/1417151; Hartley DEH, 2002, J ACOUST SOC AM, V112, P2962, DOI 10.1121/1.1512701; Heath SM, 1999, J CHILD PSYCHOL PSYC, V40, P637, DOI 10.1111/1469-7610.00480; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hulslander J, 2004, J EXP CHILD PSYCHOL, V88, P274, DOI 10.1016/j.jecp.2004.03.006; KONIG E, 1957, J ACOUST SOC AM, V29, P606; Kujala T, 2006, CLIN NEUROPHYSIOL, V117, P885, DOI 10.1016/j.clinph.2006.01.002; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; McArthur GM, 2004, J SPEECH LANG HEAR R, V47, P527, DOI 10.1044/1092-4388(2004/041); Mengler ED, 2005, DYSLEXIA, V11, P155, DOI 10.1002/dys.302; MORI S, 1992, J ACOUST SOC AM, V91, P246, DOI 10.1121/1.402768; Naatanen R., 2018, ATTENTION BRAIN FUNC; Putter-Katz H, 2005, PLASTICITY AND SIGNAL REPRESENTATION IN THE AUDITORY SYSTEM, P251, DOI 10.1007/0-387-23181-1_23; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; RAZ N, 1987, PERS INDIV DIFFER, V8, P201, DOI 10.1016/0191-8869(87)90175-9; Renvall H, 2003, ANN NEUROL, V53, P551, DOI 10.1002/ana.10504; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Shovman MM, 2006, VISION RES, V46, P3514, DOI 10.1016/j.visres.2006.05.011; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; SWANSON HL, 1993, J EXP CHILD PSYCHOL, V56, P87, DOI 10.1006/jecp.1993.1027; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; Wright BA, 2004, P NATL ACAD SCI USA, V101, P9942, DOI 10.1073/pnas.0401825101	50	161	167	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1558	1564		10.1038/nn1800	http://dx.doi.org/10.1038/nn1800			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TP	17115044				2022-12-28	WOS:000242404000021
J	Kampa, BM; Letzkus, JJ; Stuart, GJ				Kampa, Bjorn M.; Letzkus, Johannes J.; Stuart, Greg J.			Cortical feed-forward networks for binding different streams of sensory information	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; HORIZONTAL CONNECTIONS; PYRAMIDAL NEURONS; SYNAPSE LOCATION; STRIATE CORTEX; ORGANIZATION; PROJECTIONS; INHIBITION; PLASTICITY; EXCITATION	Different streams of sensory information are transmitted to the cortex where they are merged into a percept in a process often termed 'binding.' Using recordings from triplets of rat cortical layer 2/3 and layer 5 pyramidal neurons, we show that specific subnetworks within layer 5 receive input from different layer 2/3 subnetworks. This cortical microarchitecture may represent a mechanism that enables the main output of the cortex (layer 5) to bind different features of a sensory stimulus.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Kampa, BM (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Mills Rd, Canberra, ACT 0200, Australia.	kampa@hifo.inizh.ch	Kampa, Bjoern/GWC-5714-2022; stuart, greg j/F-7328-2011; Kampa, Bjoern M/D-6213-2015; Kampa, Bjoern/A-1612-2008	Kampa, Bjoern/0000-0002-4343-2634; Kampa, Bjoern M/0000-0002-4343-2634; Letzkus, Johannes/0000-0001-5678-3030; stuart, greg/0000-0001-9395-2219				BERMAN N, 1982, J NEUROPHYSIOL, V48, P1362, DOI 10.1152/jn.1982.48.6.1362; Bosking WH, 1997, J NEUROSCI, V17, P2112; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	15	97	99	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1472	1473		10.1038/nn1798	http://dx.doi.org/10.1038/nn1798			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099707				2022-12-28	WOS:000242404000008
J	Hahn, TTG; Sakmann, B; Mehta, MR				Hahn, Thomas T. G.; Sakmann, Bert; Mehta, Mayank R.			Phase-locking of hippocampal interneurons' membrane potential to neocortical up-down states	NATURE NEUROSCIENCE			English	Article							SLEEP	During quiet wakefulness and sleep, and under anesthesia, the membrane potentials of neocortical pyramidal neurons show synchronous, slow oscillations, so-called up-down states ( UDS), that can be detected in the local field potential ( LFP). The influence of this synchronized, spontaneous neocortical activity on the hippocampus is largely unknown. We performed the first in vivo whole-cell recordings from hippocampal dorsal CA1 interneurons and found that their membrane potentials were phase-locked to neocortical up- down states with a small delay. These results provide strong evidence for cortico-hippocampal interaction and suggest that neocortical activity drives hippocampal interneurons during UDS.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Max Planck Society; Brown University	Hahn, TTG (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	thahn@mpimf-heidelberg.mpg.de; Mayank@brown.edu		Mehta, Mayank/0000-0003-2005-2468				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Miller R., 1991, CORTICO HIPPOCAMPAL; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	15	106	107	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1359	1361		10.1038/nn1788	http://dx.doi.org/10.1038/nn1788			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041594				2022-12-28	WOS:000242403800009
J	Galaburda, AM; LoTurco, J; Ramus, F; Fitch, RH; Rosen, GD				Galaburda, Albert M.; LoTurco, Joseph; Ramus, Franck; Fitch, R. Holly; Rosen, Glenn D.			From genes to behavior in developmental dyslexia	NATURE NEUROSCIENCE			English	Article							DOUBLECORTIN-LIKE-KINASE; NEURONAL MIGRATION; READING-DISABILITY; LANGUAGE IMPAIRMENT; INDUCED MICROGYRIA; SEX-DIFFERENCES; CANDIDATE GENE; AXON GUIDANCE; RATS; BRAIN	All four genes thus far linked to developmental dyslexia participate in brain development, and abnormalities in brain development are increasingly reported in dyslexia. Comparable abnormalities induced in young rodent brains cause auditory and cognitive deficits, underscoring the potential relevance of these brain changes to dyslexia. Our perspective on dyslexia is that some of the brain changes cause phonological processing abnormalities as well as auditory processing abnormalities; the latter, we speculate, resolve in a proportion of individuals during development, but contribute early on to the phonological disorder in dyslexia. Thus, we propose a tentative pathway between a genetic effect, developmental brain changes, and perceptual and cognitive deficits associated with dyslexia.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Behav Neurol, Boston, MA 02215 USA; Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; Ecole Normale Super, Lab Sci Cognit & Psycholinguist, F-75230 Paris 05, France; Univ Connecticut, Dept Psychol Behav Neurosci, Storrs, CT 06269 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Connecticut; University of Connecticut	Galaburda, AM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Behav Neurol, 330 Brookline Ave, Boston, MA 02215 USA.	agalabur@bidmc.harvard.edu	Fitch, Roslyn Holly/A-2562-2014; Ramus, Franck/A-1755-2009	Ramus, Franck/0000-0002-1122-5913; Rosen, Glenn/0000-0001-8281-5446	NICHD NIH HHS [P01 HD020806, HD20806, P01 HD057853] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057853] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD020806] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allen KM, 1998, GENOMICS, V52, P214, DOI 10.1006/geno.1998.5424; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Chang BS, 2005, NEUROLOGY, V64, P799, DOI 10.1212/01.WNL.0000152874.57180.AF; Chapman NH, 2004, AM J MED GENET B, V131B, P67, DOI 10.1002/ajmg.b.30018; Clark MG, 2000, BRAIN RES, V871, P94, DOI 10.1016/S0006-8993(00)02447-1; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; DENENBERG VH, 1991, BRAIN RES, V562, P98, DOI 10.1016/0006-8993(91)91192-4; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; DRAKE WE, 1968, J LEARN DISABIL-US, V1, P486, DOI 10.1177/002221946800100901; Eckert M, 2004, NEUROSCIENTIST, V10, P362, DOI 10.1177/1073858404263596; Erskine L, 2000, J NEUROSCI, V20, P4975; FISHER SE, IN PRESS TRENDS COGN; FITCH RH, 1994, CEREB CORTEX, V4, P260, DOI 10.1093/cercor/4.3.260; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; GALABURDA AM, 1994, P NATL ACAD SCI USA, V91, P8010, DOI 10.1073/pnas.91.17.8010; Hage SRD, 2006, ARQ NEURO-PSIQUIAT, V64, P173, DOI 10.1590/S0004-282X2006000200001; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Hinshelwood J., 1917, CONGENITAL WORD BLIN; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Leonard CM, 2002, J COMMUN DISORD, V35, P501, DOI 10.1016/S0021-9924(02)00120-X; LoTurco JJ, 2006, EXTRAORDINARY BRAIN, P119; Marino C, 2005, EUR J HUM GENET, V13, P491, DOI 10.1038/sj.ejhg.5201356; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Peiffer AM, 2004, DEV BRAIN RES, V152, P93, DOI 10.1016/j.devbrainres.2004.06.003; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Rosen GD, 2000, J COMP NEUROL, V418, P423; ROSEN GD, 1995, BRAIN RES, V681, P177, DOI 10.1016/0006-8993(95)00312-E; Rosen GD, 1999, CEREB CORTEX, V9, P27, DOI 10.1093/cercor/9.1.27; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Snowling M., 2000, DYSLEXIA; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; WANG Y, 2003, ANN DYSLEXIA, V53, P1; White S, 2006, COGN NEUROPSYCHOL, V23, P748, DOI 10.1080/02643290500438607; Wigg KG, 2004, MOL PSYCHIATR, V9, P1111, DOI 10.1038/sj.mp.4001543; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	48	243	248	6	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1213	1217		10.1038/nn1772	http://dx.doi.org/10.1038/nn1772			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001339				2022-12-28	WOS:000241493900009
J	Stuphorn, V; Schall, JD				Stuphorn, Veit; Schall, Jeffrey D.			Executive control of countermanding saccades by the supplementary eye field	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ELECTRICAL-STIMULATION; INTRACORTICAL MICROSTIMULATION; COGNITIVE CONTROL; GUIDED SACCADES; MACAQUE MONKEY; MOVEMENTS; CONNECTIONS; PROJECTIONS; INITIATION	The supplementary eye field registers the occurrence of conflict, errors and reward in macaque monkeys performing a saccade-countermanding task. Using intracortical microstimulation, we determined whether the supplementary eye field only monitors or can actually influence performance. Weak microstimulation of many sites in the supplementary eye field improved monkeys' performance on a 'stop signal' task by delaying saccade initiation. This effect depended on the context of the task because simple visually guided saccades were not delayed by the same stimulation. These results demonstrate that the supplementary eye field can exert contextual executive control over saccade generation.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37203 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	Vanderbilt University; Johns Hopkins University; Johns Hopkins University	Stuphorn, V (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Dept Psychol, Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.	veit@jhu.edu			NEI NIH HHS [P30-EY08126] Funding Source: Medline; NICHD NIH HHS [P30-HD015052] Funding Source: Medline; NIMH NIH HHS [R01-MH55806] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055806] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavina-Pratesi C, 2001, J EXP PSYCHOL HUMAN, V27, P932, DOI 10.1037//0096-1523.27.4.932; Dobson A.J., 2002, INTRO GEN LINEAR MOD; Efron B., 1993, INTRO BOOTSTRAP, P436, DOI [10.1007/978-1-4899-4541-9, DOI 10.1007/978-1-4899-4541-9]; FALKENSTEIN M, 1995, PERSPECTIVES EVENT S, V44, P287; FRIED I, 1991, J NEUROSCI, V11, P3656; Fujii N, 1995, NEUROREPORT, V6, P2565, DOI 10.1097/00001756-199512150-00028; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; Isoda M, 2005, J NEUROPHYSIOL, V93, P3016, DOI 10.1152/jn.01176.2004; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; KEATING EG, 1983, BRAIN RES, V269, P145, DOI 10.1016/0006-8993(83)90971-X; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LIM SH, 1994, ELECTROEN CLIN NEURO, V91, P179, DOI 10.1016/0013-4694(94)90068-X; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luppino G, 2003, EUR J NEUROSCI, V17, P559, DOI 10.1046/j.1460-9568.2003.02476.x; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Martinez-Trujillo JC, 2004, NEURON, V44, P1057, DOI 10.1016/j.neuron.2004.12.004; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Russo GS, 2000, J NEUROPHYSIOL, V84, P2605, DOI 10.1152/jn.2000.84.5.2605; Schacht J, 2006, AUDIOL NEURO-OTOL, V11, P1, DOI 10.1159/000088850; SCHALL JD, 1993, VISUAL NEUROSCI, V10, P385, DOI 10.1017/S0952523800003771; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; SCHILLER PH, 1980, J NEUROPHYSIOL, V44, P1175, DOI 10.1152/jn.1980.44.6.1175; SCHILLER PH, 1977, BRAIN RES, V122, P154, DOI 10.1016/0006-8993(77)90672-2; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Tehovnik EJ, 2003, EUR J NEUROSCI, V17, P870, DOI 10.1046/j.1460-9568.2003.02489.x; WAGMAN IH, 1958, J COMP NEUROL, V109, P169, DOI 10.1002/cne.901090203; WALKER EA, 1940, J NEUROPHYSIOL, V3, P369	41	175	177	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					925	931		10.1038/nn1714	http://dx.doi.org/10.1038/nn1714			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732274				2022-12-28	WOS:000238590800019
J	Shen, Q; Wang, Y; Dimos, JT; Fasano, CA; Phoenix, TN; Lemischka, IR; Ivanova, NB; Stifani, S; Morrisey, EE; Temple, S				Shen, Qin; Wang, Yue; Dimos, John T.; Fasano, Christopher A.; Phoenix, Timothy N.; Lemischka, Ihor R.; Ivanova, Natalia B.; Stifani, Stefano; Morrisey, Edward E.; Temple, Sally			The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; STEM-CELLS; CAENORHABDITIS-ELEGANS; NEURAL PROGENITORS; NEURONS ARISE; FERRET CORTEX; SELF-RENEWAL; ZONE CELLS; FATE; SPECIFICATION	In the developing cerebral cortex, neurons are born on a predictable schedule. Here we show in mice that the essential timing mechanism is programmed within individual progenitor cells, and its expression depends solely on cell-intrinsic and environmental factors generated within the clonal lineage. Multipotent progenitor cells undergo repeated asymmetric divisions, sequentially generating neurons in their normal in vivo order: first preplate cells, including Cajal-Retzius neurons, then deep and finally superficial cortical plate neurons. As each cortical layer arises, stem cells and neuroblasts become restricted from generating earlier-born neuron types. Growth as neurospheres or in co-culture with younger cells did not restore their plasticity. Using short-hairpin RNA (shRNA) to reduce Foxg1 expression reset the timing of mid- but not late-gestation progenitors, allowing them to remake preplate neurons and then cortical-plate neurons. Our data demonstrate that neural stem cells change neuropotency during development and have a window of plasticity when restrictions can be reversed.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Mol Cardiol Res Ctr, Philadelphia, PA 19104 USA	Albany Medical College; Princeton University; McGill University; University of Pennsylvania; University of Pennsylvania	Shen, Q (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	shenq@mail.amc.edu		Stifani, Stefano/0000-0002-2376-7701	NINDS NIH HHS [R37NS033529] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bayer S.A., 1991, NEOCORTICAL DEV; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Desai AR, 2000, DEVELOPMENT, V127, P2863; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Isshiki T, 2004, CELL CYCLE, V3, P296; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Morrow T, 2001, DEVELOPMENT, V128, P3585; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Polleux F, 1997, J COMP NEUROL, V385, P95; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133	46	436	450	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					743	751		10.1038/nn1694	http://dx.doi.org/10.1038/nn1694			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680166				2022-12-28	WOS:000237895200014
J	Hartman, KN; Pal, SK; Burrone, J; Murthy, VN				Hartman, KN; Pal, SK; Burrone, J; Murthy, VN			Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons	NATURE NEUROSCIENCE			English	Article							VESICULAR GABA TRANSPORTER; VISUAL-CORTEX; CRITICAL PERIOD; RECEPTOR TRAFFICKING; GABAERGIC SYNAPSES; SLICE CULTURES; MESSENGER-RNA; PLASTICITY; BRAIN; BDNF	Neural activity regulates the number and properties of GABAergic synapses in the brain, but the mechanisms underlying these changes are unclear. We found that blocking spike activity globally in developing hippocampal neurons from rats reduced the density of GABAergic terminals as well as the frequency and amplitude of miniature inhibitory postsynaptic currents (mIPSCs). Chronic inactivity later in development led to a reduction in the mIPSC amplitude, without any change in GABAergic synapse density. By contrast, hyperpolarizing or abolishing spike activity in single neurons did not alter GABAergic synaptic inputs. Suppressing activity in individual presynaptic GABAergic neurons also failed to decrease synaptic output. Our results indicate that GABAergic synapses are regulated by the level of activity in surrounding neurons. Notably, we found that the expression of GABAergic plasticity involves changes in the amount of neurotransmitter in individual vesicles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu	Burrone, Juan/C-5654-2009	Burrone, Juan/0000-0003-1233-668X; Murthy, Venkatesh/0000-0003-2443-4252	Medical Research Council [G9900989B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; Barberis A, 2005, MOL PHARMACOL, V67, P1221, DOI 10.1124/mol.104.006437; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENSON DL, 1989, MOL BRAIN RES, V5, P279, DOI 10.1016/0169-328X(89)90062-4; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Genoud C, 2004, J NEUROSCI, V24, P2394, DOI 10.1523/JNEUROSCI.4040-03.2004; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jones MV, 2001, BIOPHYS J, V81, P2660, DOI 10.1016/S0006-3495(01)75909-7; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangan PS, 2005, MOL PHARMACOL, V67, P775, DOI 10.1124/mol.104.007385; Marty S, 2000, J NEUROSCI, V20, P8087; Marty S, 2004, EUR J NEUROSCI, V20, P427, DOI 10.1111/j.1460-9568.2004.03491.x; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Morales B, 2002, J NEUROSCI, V22, P8084; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Owens DF, 1996, J NEUROSCI, V16, P6414; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Rosato-Siri M, 2002, EUR J NEUROSCI, V16, P2123, DOI 10.1046/j.1460-9568.2002.02291.x; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; SEIL FJ, 1994, J COMP NEUROL, V342, P366, DOI 10.1002/cne.903420305; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Xu XR, 2005, J NEUROSCI RES, V79, P428, DOI 10.1002/jnr.20378	48	155	159	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					642	649		10.1038/nn1677	http://dx.doi.org/10.1038/nn1677			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582905				2022-12-28	WOS:000237417200015
J	Li, W; DeVries, SH				Li, W; DeVries, SH			Bipolar cell pathways for color and luminance vision in a dichromatic mammalian retina	NATURE NEUROSCIENCE			English	Article							GROUND-SQUIRREL RETINA; PRIMATE RETINA; GANGLION-CELLS; CONE PHOTORECEPTORS; MACAQUE RETINA; S-CONE; CALLITHRIX-JACCHUS; KAINATE RECEPTORS; MIDGET PATHWAY; MONKEY RETINA	The mammalian retina is fundamentally dichromatic, with trichromacy only recently emerging in some primates. In dichromats, an array of short wavelength-sensitive (S, blue) and middle wavelength-sensitive ( M, green) cones is sampled by approximately ten bipolar cell types, and the sampling pattern determines how retinal ganglion cells and ultimately higher visual centers encode color and luminance. By recording from cone-bipolar cell pairs in the retina of the ground squirrel, we show that the bipolar cell types sample cone signals in three ways: one type receives input exclusively from S-cones, two types receive mixed S/M-cone input and the remaining types receive an almost pure M-cone signal. Bipolar cells that carry S- or M-cone signals can have a role in color discrimination and may contact color-opponent ganglion cells. Bipolar cells that sum signals from S- and M-cones may signal to ganglion cells that encode luminance.	Northwestern Univ, Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Li, W (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, 303 E Chicago Ave,Tarry 5-715, Chicago, IL 60611 USA.	w-li2@northwestern.edu		Li, Wei/0000-0002-2897-649X	NEI NIH HHS [EY12141] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Calkins D.J., 1999, COLOR VISION GENES P, P163; Calkins DJ, 2001, PROG RETIN EYE RES, V20, P255, DOI 10.1016/S1350-9462(00)00026-4; Calkins DJ, 1996, VISION RES, V36, P3373, DOI 10.1016/0042-6989(95)00333-9; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Chan TL, 2001, J COMP NEUROL, V437, P219, DOI 10.1002/cne.1280; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1992, VISUAL NEUROSCI, V9, P279, DOI 10.1017/S0952523800010695; Dacey DM, 1999, COLOR VISION GENES P, P181; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Herr S, 2003, J COMP NEUROL, V457, P185, DOI 10.1002/cne.10553; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; JACOBS GH, 1981, J NEUROPHYSIOL, V45, P891, DOI 10.1152/jn.1981.45.5.891; JACOBS GH, 1981, J NEUROPHYSIOL, V45, P903, DOI 10.1152/jn.1981.45.5.903; JACOBS GH, 2002, HDB PSYCHOL, V3, P47; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; Klug K, 2003, J NEUROSCI, V23, P9881; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; KRAFT TW, 1988, J PHYSIOL-LONDON, V404, P199, DOI 10.1113/jphysiol.1988.sp017286; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Lee SCS, 2005, EUR J NEUROSCI, V22, P437, DOI 10.1111/j.1460-9568.2005.04231.x; Lee SCS, 2004, J COMP NEUROL, V474, P353, DOI 10.1002/cne.20139; Li W, 2004, NAT NEUROSCI, V7, P751, DOI 10.1038/nn1275; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; Martin PR, 1998, J PHYSIOL-LONDON, V513, P631, DOI 10.1111/j.1469-7793.1998.631ba.x; Reid RC, 2002, J NEUROSCI, V22, P6158; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; Snellman J, 2004, J NEUROSCI, V24, P6621, DOI 10.1523/JNEUROSCI.1474-04.2004; Sun H, 2006, J NEUROPHYSIOL, V95, P837, DOI 10.1152/jn.00714.2005; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WEST RW, 1976, J COMP NEUROL, V168, P355, DOI 10.1002/cne.901680304; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656; Yamada ES, 2005, VISUAL NEUROSCI, V22, P383, DOI 10.1017/S095252380522401X; Zhang J, 2005, VISUAL NEUROSCI, V22, P535, DOI 10.1017/S0952523805224148	50	78	78	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					669	675		10.1038/nn1686	http://dx.doi.org/10.1038/nn1686			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617341				2022-12-28	WOS:000237417200018
J	Maccarrone, M; Rossi, S; Bari, M; De Chiara, V; Fezza, F; Musella, A; Gasperi, V; Prosperetti, C; Bernardi, G; Finazzi-Agro, A; Cravatt, BF; Centonze, D				Maccarrone, Mauro; Rossi, Silvia; Bari, Monica; De Chiara, Valentina; Fezza, Filomena; Musella, Alessandra; Gasperi, Valeria; Prosperetti, Chiara; Bernardi, Giorgio; Finazzi-Agro, Alessandro; Cravatt, Benjamin F.; Centonze, Diego			Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; PHOSPHOLIPASE-D; ENDOCANNABINOID RELEASE; RECEPTOR; ACTIVATION; STIMULATION; MODULATION; 2-ARACHIDONOYL-GLYCEROL	Of the endocannabinoids (eCBs), anandamide (AEA) and 2-arachidonoylglycerol (2-AG) have received the most study. A functional interaction between these molecules has never been described. Using mouse brain slices, we found that stimulation of metabotropic glutamate 5 receptors by 3,5-dihydroxyphenylglycine (DHPG) depressed inhibitory transmission in the striatum through selective involvement of 2-AG metabolism and stimulation of presynaptic CB1 receptors. Elevation of AEA concentrations by pharmacological or genetic inhibition of AEA degradation reduced the levels, metabolism and physiological effects of 2-AG. Exogenous AEA and the stable AEA analog methanandamide inhibited basal and DHPG-stimulated 2-AG production, confirming that AEA is responsible for the downregulation of the other eCB. AEA is an endovanilloid substance, and the stimulation of transient receptor potential vanilloid 1 (TRPV1) channels mimicked the effects of endogenous AEA on 2-AG metabolism through a previously unknown glutathione-dependent pathway. Consistently, the interaction between AEA and 2-AG was lost after pharmacological and genetic inactivation of TRPV1 channels.	[Maccarrone, Mauro; Gasperi, Valeria] Univ Teramo, Dipartimento Sci Biomed, I-64100 Teramo, Italy; [Maccarrone, Mauro; Rossi, Silvia; De Chiara, Valentina; Fezza, Filomena; Musella, Alessandra; Prosperetti, Chiara; Bernardi, Giorgio; Centonze, Diego] CERC, Fdn Santa Lucia, I-00143 Rome, Italy; [Rossi, Silvia; De Chiara, Valentina; Musella, Alessandra; Prosperetti, Chiara; Bernardi, Giorgio; Cravatt, Benjamin F.; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Neurosci, Neurol Clin, I-00133 Rome, Italy; [Bari, Monica; Fezza, Filomena; Finazzi-Agro, Alessandro] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy; [Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Teramo; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; Scripps Research Institute; Scripps Research Institute	Maccarrone, M (corresponding author), Univ Teramo, Dipartimento Sci Biomed, Piazza Aldo Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it; centonze@uniroma2.it	gasperi, valeria/AGO-4500-2022; Gasperi, Valeria/AAN-9210-2021; musella, alessandra/K-6372-2016; Maccarrone, Mauro/K-5398-2012; Centonze, Diego/J-7767-2016	gasperi, valeria/0000-0003-3200-8093; musella, alessandra/0000-0001-7889-9253; Maccarrone, Mauro/0000-0002-3990-2963; Centonze, Diego/0000-0002-8390-8545; Rossi, Silvia/0000-0003-3257-8248; Prosperetti, Chiara/0000-0001-8069-2163				Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Barinaga M, 2001, SCIENCE, V291, P2530, DOI 10.1126/science.291.5513.2530; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Cartoni A, 2004, TETRAHEDRON LETT, V45, P2723, DOI 10.1016/j.tetlet.2004.02.045; Centonze D, 2005, BIOL PSYCHIAT, V57, P1583, DOI 10.1016/j.biopsych.2005.03.008; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; de Lago E, 2005, BIOCHEM PHARMACOL, V70, P446, DOI 10.1016/j.bcp.2005.05.011; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Evans RM, 2004, BRIT J PHARMACOL, V141, P1223, DOI 10.1038/sj.bjp.0705723; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gubellini P, 2002, J NEUROSCI, V22, P6900; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Hermann A, 2006, AAPS J, V8, pE409, DOI 10.1007/BF02854913; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; PELLMAR TC, 1992, BRAIN RES, V583, P194, DOI 10.1016/S0006-8993(10)80024-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani A, 2001, NEUROPHARMACOLOGY, V40, P460, DOI 10.1016/S0028-3908(00)00184-2; Rouach N, 2003, EUR J NEUROSCI, V18, P1017, DOI 10.1046/j.1460-9568.2003.02823.x; Sagara Y, 1998, J NEUROSCI, V18, P6662; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; SUGIURA T, 2002, FATTY ACIDS, V66, P173; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Wang Y, 2001, ANAL BIOCHEM, V294, P73, DOI 10.1006/abio.2001.5015; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	50	242	244	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					152	159		10.1038/nn2042	http://dx.doi.org/10.1038/nn2042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204441				2022-12-28	WOS:000252712100009
J	Korman, M; Doyon, J; Doljansky, J; Carrier, J; Dagan, Y; Karni, A				Korman, Maria; Doyon, Julien; Doljansky, Julia; Carrier, Julie; Dagan, Yaron; Karni, Avi			Daytime sleep condenses the time course of motor memory consolidation	NATURE NEUROSCIENCE			English	Article							SKILL; ACQUISITION; PLASTICITY; PERFORMANCE; ADAPTATION; SEQUENCE; PERFECT; SYSTEMS; CORTEX	Two behavioral phenomena characterize human motor memory consolidation: diminishing susceptibility to interference by a subsequent experience and the emergence of delayed, offline gains in performance. A recent model proposes that the sleep-independent reduction in interference is followed by the sleep-dependent expression of offline gains. Here, using the finger-opposition sequence-learning task, we show that an interference experienced at 2 h, but not 8 h, following the initial training prevented the expression of delayed gains at 24 h post-training. However, a 90-min nap, immediately post-training, markedly reduced the susceptibility to interference, with robust delayed gains expressed overnight, despite interference at 2 h post-training. With no interference, a nap resulted in much earlier expression of delayed gains, within 8 h post-training. These results suggest that the evolution of robustness to interference and the evolution of delayed gains can coincide immediately post-training and that both effects reflect sleep-sensitive processes.	Univ Haifa, Brain Behav Res Ctr, IL-31905 Haifa, Israel; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Sheba Med Ctr, Chronobiol & Sleep Lab, IL-52662 Tel Aviv, Israel	University of Haifa; Universite de Montreal; Chaim Sheba Medical Center	Korman, M (corresponding author), Univ Haifa, Brain Behav Res Ctr, IL-31905 Haifa, Israel.	mariakorman@yahoo.com	Korman, Maria/GWQ-3314-2022; Korman, Maria/N-6515-2019	Korman, Maria/0000-0003-1895-0189; Korman, Maria/0000-0003-1895-0189; Carrier, Julie/0000-0001-5311-2370				ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Korman M, 2005, BEHAV BRAIN SCI, V28, P74, DOI 10.1017/S0140525X05320024; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rechtschaffen A, 1968, MANUAL STANDARIZED T; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Walker M. P., 2005, BEHAV BRAIN SCI, V28, P64, DOI [DOI 10.1017/S0140525X05000026, 10.1017/s0140525x05000026]; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, CLIN SPORT MED, V24, P301, DOI 10.1016/j.csm.2004.11.002; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	51	279	280	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1206	1213		10.1038/nn1959	http://dx.doi.org/10.1038/nn1959			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694051				2022-12-28	WOS:000249144000024
J	Ressler, KJ; Mayberg, HS				Ressler, Kerry J.; Mayberg, Helen S.			Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic	NATURE NEUROSCIENCE			English	Review							TRANSCRANIAL MAGNETIC STIMULATION; DEEP-BRAIN-STIMULATION; VAGUS NERVE-STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; TREATMENT-RESISTANT DEPRESSION; CONDITIONED FEAR EXTINCTION; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; CEREBRAL-BLOOD-FLOW	Recent decades have witnessed tremendous advances in the neuroscience of emotion, learning and memory, and in animal models for understanding depression and anxiety. This review focuses on new rationally designed psychiatric treatments derived from preclinical human and animal studies. Nonpharmacological treatments that affect disrupted emotion circuits include vagal nerve stimulation, rapid transcranial magnetic stimulation and deep brain stimulation, all borrowed from neurological interventions that attempt to target known pathological foci. Other approaches include drugs that are given in relation to specific learning events to enhance or disrupt endogenous emotional learning processes. Imaging data suggest that common regions of brain activation are targeted with pharmacological and somatic treatments as well as with the emotional learning in psychotherapy. Although many of these approaches are experimental, the rapidly developing understanding of emotional circuit regulation is likely to provide exciting and powerful future treatments for debilitating mood and anxiety disorders.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30329 USA	Emory University; Emory University; Emory University	Ressler, KJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 954 Gatewood Dr, Atlanta, GA 30329 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018; Bullmore, Ed/C-1706-2012; Jovicich, Jorge/D-2293-2010	Ressler, Kerry J/0000-0002-5158-1103; Bullmore, Ed/0000-0002-8955-8283; 	NIDA NIH HHS [R01 DA019624-01A2, DA-019624, R01 DA019624, R01 DA019624-02] Funding Source: Medline; NIMH NIH HHS [1R01MH073719, K01 MH069884, MH071537, P50 MH058922, R01 MH073719, P50 MH077083, P50 MH58922, MH069884, R01 MH071537, R56 MH071537] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073719, R01MH071537, P50MH058922, R56MH071537, P50MH077083, K01MH069884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682; BARKER AT, 1985, LANCET, V1, P1106; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; BENMENACHEM E, 1995, EPILEPSY RES, V20, P221, DOI 10.1016/0920-1211(94)00083-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bohning DE, 1997, NEUROREPORT, V8, P2535, DOI 10.1097/00001756-199707280-00023; Bohning DE, 2001, INVEST RADIOL, V36, P470, DOI 10.1097/00004424-200108000-00006; BORNSTEIN SR, 1966, MOL PSYCHIATR, V11, P892; BORRELL J, 1983, BEHAV NEURAL BIOL, V39, P241, DOI 10.1016/S0163-1047(83)90910-X; Botreau F, 2006, BEHAV BRAIN RES, V172, P173, DOI 10.1016/j.bbr.2006.05.012; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Cai WH, 2006, J NEUROSCI, V26, P9560, DOI 10.1523/JNEUROSCI.2397-06.2006; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Carpenter LL, 2006, J PSYCHOPHARMACOL, V20, P35, DOI 10.1177/1359786806064327; Couturier JL, 2005, J PSYCHIATR NEUROSCI, V30, P83; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davis KD, 1997, NAT MED, V3, P671, DOI 10.1038/nm0697-671; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; EPSTEIN CM, 1990, NEUROLOGY, V40, P666, DOI 10.1212/WNL.40.4.666; Ferry B, 1999, J NEUROSCI, V19, P5119; Furmark T, 2002, ARCH GEN PSYCHIAT, V59, P425, DOI 10.1001/archpsyc.59.5.425; George Mark S, 2007, Expert Rev Neurother, V7, P63, DOI 10.1586/14737175.7.1.63; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647; Guastella AJ, 2007, BEHAV RES THER, V45, P663, DOI 10.1016/j.brat.2006.07.005; Guastella AJ, 2007, J PSYCHIATR RES, V41, P466, DOI 10.1016/j.jpsychires.2006.05.006; Harbishettar V, 2005, PARKINSONISM RELAT D, V11, P85, DOI 10.1016/j.parkreldis.2004.07.006; Henry TR, 1998, EPILEPSIA, V39, P983, DOI 10.1111/j.1528-1157.1998.tb01448.x; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Hermann LL, 2006, J CLIN PSYCHIAT, V67, P1870, DOI 10.4088/JCP.v67n1206; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim EJ, 2006, NEUROSCI LETT, V405, P79, DOI 10.1016/j.neulet.2006.06.023; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P1603, DOI 10.1016/S0006-3223(99)00195-X; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Kosel M, 2003, NEUROPSYCHOPHARMACOL, V28, P2045, DOI 10.1038/sj.npp.1300293; Krahl SE, 2000, EPILEPSY RES, V38, P171, DOI 10.1016/S0920-1211(99)00089-3; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lisanby SH, 2003, CNS SPECTR, V8, P529, DOI 10.1017/S1092852900019003; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; Malow BA, 2001, NEUROLOGY, V57, P879, DOI 10.1212/WNL.57.5.879; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; MONAHAN JB, 1989, PHARMACOL BIOCHEM BE, V34, P649, DOI 10.1016/0091-3057(89)90571-6; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nahas Z, 2007, NEUROPSYCHOPHARMACOL, V32, P1649, DOI 10.1038/sj.npp.1301288; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nobler MS, 2000, DEPRESS ANXIETY, V12, P144; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Otto MW, 2002, BIOL PSYCHIAT, V52, P917, DOI 10.1016/S0006-3223(02)01719-5; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Paus T, 2004, J PSYCHIATR NEUROSCI, V29, P268; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; SACKEIM HA, 1986, ANN NY ACAD SCI, V462, P326, DOI 10.1111/j.1749-6632.1986.tb51267.x; Sackeim HA, 2007, INT J NEUROPSYCHOPH, V10, P817, DOI 10.1017/S1461145706007425; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Walker BR, 1999, EPILEPSIA, V40, P1051, DOI 10.1111/j.1528-1157.1999.tb00818.x; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Yang YL, 2005, NEUROSCIENCE, V134, P247, DOI 10.1016/j.neuroscience.2005.04.003; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; Zobel A, 2005, PSYCHIAT RES-NEUROIM, V139, P165, DOI 10.1016/j.pscychresns.2005.02.010	100	686	710	6	208	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1116	1124		10.1038/nn1944	http://dx.doi.org/10.1038/nn1944			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726478	Green Accepted			2022-12-28	WOS:000249144000010
J	Kee, N; Teixeira, CM; Wang, AH; Frankland, PW				Kee, Nohjin; Teixeira, Catia M.; Wang, Afra H.; Frankland, Paul W.			Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; RETROGRADE-AMNESIA; NEURONS; INTEGRATION; EXPRESSION; MATURATION; BRAIN; YOUNG; BORN; TIME	Throughout adulthood, new neurons are continuously added to the dentate gyrus, a hippocampal subregion that is important in spatial learning. Whether these adult-generated granule cells become functionally integrated into memory networks is not known. We used immunohistochemical approaches to visualize the recruitment of new neurons into circuits supporting water maze memory in intact mice. We show that as new granule cells mature, they are increasingly likely to be incorporated into circuits supporting spatial memory. By the time the cells are 4 or more weeks of age, they are more likely than existing granule cells to be recruited into circuits supporting spatial memory. This preferential recruitment supports the idea that new neurons make a unique contribution to memory processing in the dentate gyrus.	Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Porto, Grad Program Areas Basic & Appl Biol, P-4050465 Oporto, Portugal	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Universidade do Porto	Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	paul.frankland@sickkids.ca		Teixeira, Catia/0000-0002-6577-0730				Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song HJ, 2005, J NEUROSCI, V25, P10366, DOI 10.1523/JNEUROSCI.3452-05.2005; Takehara K, 2003, J NEUROSCI, V23, P9897; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhang WP, 2005, LEARN MEMORY, V12, P239, DOI 10.1101/lm.90005; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	50	677	697	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					355	362		10.1038/nn1847	http://dx.doi.org/10.1038/nn1847			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17277773				2022-12-28	WOS:000244480300018
J	Zurborg, S; Yurgionas, B; Jira, JA; Caspani, O; Heppenstall, PA				Zurborg, Sandra; Yurgionas, Brian; Jira, Julia A.; Caspani, Ombretta; Heppenstall, Paul A.			Direct activation of the ion channel TRPA1 by Ca2+	NATURE NEUROSCIENCE			English	Article							CATION CHANNEL; CA2+-BINDING PROTEINS; COLD; SENSITIVITY; ANKTM1; TRPM5	TRPA1 is an ion channel expressed by nociceptors and activated by irritant compounds such as mustard oil. The endogenous function of TRPA1 has remained unclear, a fact highlighted by ongoing debate over its potential role as a sensor of noxious cold. Here we show that intracellular Ca2+ activates human TRPA1 via an EF-hand domain and that cold sensitivity occurs indirectly ( and nonphysiologically) through increased [Ca2+](i) during cooling in heterologous systems.	Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heppenstall, PA (corresponding author), Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	paul.heppenstall@charite.de	Yurgionas, Brian/AAD-3551-2019	Caspani, Ombretta/0000-0002-9700-3149				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	15	369	383	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					277	279		10.1038/nn1843	http://dx.doi.org/10.1038/nn1843			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259981				2022-12-28	WOS:000244480300007
J	Glykys, J; Peng, ZC; Chandra, D; Homanics, GE; Houser, CR; Mody, I				Glykys, Joseph; Peng, Zechun; Chandra, Dev; Homanics, Gregg E.; Houser, Carolyn R.; Mody, Istvan			A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; DELTA-SUBUNIT; TONIC INHIBITION; DENTATE GYRUS; GRANULE CELLS; A RECEPTORS; ALPHA-1 SUBUNIT; DEFICIENT MICE; KNOCKOUT MICE; RAT-BRAIN	According to the rules of GABA(A) receptor (GABA(A)R) subunit assembly, alpha 4 and alpha 6 subunits are considered to be the natural partners of delta subunits. These GABA(A)Rs are a preferred target of low, sobriety-impairing concentrations of ethanol. Here we demonstrate a new naturally occurring GABAAR subunit partnership: d subunits of hippocampal interneurons are coexpressed and colocalized with alpha 1 subunits, but not with alpha 4, alpha 6 or any other alpha subunits. Ethanol potentiates the tonic inhibition mediated by such native alpha 1/delta GABA(A)Rs in wild-type and in alpha 4 subunit-deficient (Gabra4(-/-)) mice, but not in delta subunit - deficient (Gabrd(-/-)) mice. We also ruled out any compensatory upregulation of alpha 6 subunits that might have accounted for the ethanol effect in Gabra4(-/-) mice. Thus, alpha 1/delta subunit assemblies represent a new neuronal GABA(A)R subunit partnership present in hippocampal interneurons, mediate tonic inhibitory currents and are highly sensitive to low concentrations of ethanol.	Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; VA Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA.	mody@ucla.edu		Glykys, Joseph/0000-0002-1499-9172; Homanics, Gregg/0000-0003-3641-8153	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549, R01NS051311, R56NS051311] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000404] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA14003] Funding Source: Medline; NINDS NIH HHS [NS051311, NS30549, NS35958] Funding Source: Medline; BLRD VA [I01 BX000404] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BLRD VA		Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Esclapez M, 1996, HIPPOCAMPUS, V6, P225; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; GAO B, 1994, EUR J NEUROSCI, V6, P837, DOI 10.1111/j.1460-9568.1994.tb00994.x; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; Hanchar HJ, 2004, LIFE SCI, V76, P1, DOI 10.1016/j.lfs.2004.05.035; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones A, 1997, J NEUROSCI, V17, P1350; Korpi ER, 2002, NEUROSCIENCE, V109, P733, DOI 10.1016/S0306-4522(01)00527-9; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; Wafford KA, 2004, BIOCHEM SOC T, V32, P553, DOI 10.1042/BST0320553; Wall MJ, 2002, NEUROPHARMACOLOGY, V43, P737, DOI 10.1016/S0028-3908(02)00085-0; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wei WZ, 2003, J NEUROSCI, V23, P10650; Weiner JL, 1997, J NEUROPHYSIOL, V77, P1306, DOI 10.1152/jn.1997.77.3.1306; Weiner JL, 1997, J NEUROCHEM, V68, P1949; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002	52	200	202	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					40	48		10.1038/nn1813	http://dx.doi.org/10.1038/nn1813			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159992				2022-12-28	WOS:000243096100014
J	Haynes, SE; Hollopeter, G; Yang, G; Kurpius, D; Dailey, ME; Gan, WB; Julius, D				Haynes, Sharon E.; Hollopeter, Gunther; Yang, Guang; Kurpius, Dana; Dailey, Michael E.; Gan, Wen-Biao; Julius, David			The P2Y(12) receptor regulates microglial activation by extracellular nucleotides	NATURE NEUROSCIENCE			English	Article							ANTITHROMBOTIC DRUGS; IN-VIVO; ADP; ATP; INJURY; BRAIN; CELLS; IDENTIFICATION; RELEASE; CHEMOTAXIS	Microglia are primary immune sentinels of the CNS. Following injury, these cells migrate or extend processes toward sites of tissue damage. CNS injury is accompanied by release of nucleotides, serving as signals for microglial activation or chemotaxis. Microglia express several purinoceptors, including a G(i)-coupled subtype that has been implicated in ATP- and ADP-mediated migration in vitro. Here we show that microglia from mice lacking G(i)-coupled P2Y(12) receptors exhibit normal baseline motility but are unable to polarize, migrate or extend processes toward nucleotides in vitro or in vivo. Microglia in P2ry(12)(-/-) mice show significantly diminished directional branch extension toward sites of cortical damage in the living mouse. Moreover, P2Y(12) expression is robust in the 'resting' state, but dramatically reduced after microglial activation. These results imply that P2Y(12) is a primary site at which nucleotides act to induce microglial chemotaxis at early stages of the response to local CNS injury.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; NYU, Sch Med, Skirball Inst, Program Mol Neurobiol,Dept Physiol & Neurosci, New York, NY 10016 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University; University of Iowa	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, 600 16th St, San Francisco, CA 94158 USA.	julius@cmp.ucsf.edu		Yang, Guang/0000-0002-5739-9126	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043468] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR017941] Funding Source: Medline; NINDS NIH HHS [R01 NS043468, NS434468] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Brass S, 2001, NATURE, V409, P145, DOI 10.1038/35051688; Burnstock G, 1996, CIBA F SYMP, V198, P1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chakfe Y, 2002, J NEUROSCI, V22, P3061, DOI 10.1523/JNEUROSCI.22-08-03061.2002; CHAO CC, 1992, J IMMUNOL, V149, P2736; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hanisch Uwe-Karsten, 2002, P79; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Moller T, 2000, BRAIN RES, V853, P49, DOI 10.1016/S0006-8993(99)02244-1; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Salimi K, 2002, BRAIN RES, V946, P283, DOI 10.1016/S0006-8993(02)02896-2; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Streit Wolfgang J., 2002, P1; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	34	931	957	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1512	1519		10.1038/nn1805	http://dx.doi.org/10.1038/nn1805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115040	Green Published			2022-12-28	WOS:000242404000015
J	Andermann, ML; Moore, CI				Andermann, ML; Moore, CI			A somatotopic map of vibrissa motion direction within a barrel column	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS; RECEPTIVE-FIELDS; STRIATE CORTEX; IN-VIVO; RAT; PLASTICITY; PREFERENCE; NEURONS	Most mammals possess high-resolution visual perception, with primary visual cortices containing fine-scale, inter-related feature representations (for example, orientation and ocular dominance). Rats lack precise vision, but their vibrissa sensory system provides a precise tactile modality, including vibrissa-related 'barrel' columns in primary somatosensory cortex. Here, we examined the subcolumnar organization of direction preference and somatotopy using a new omni-directional, multi-vibrissa stimulator. We discovered a direction map that was systematically linked to somatotopy, such that neurons were tuned for motion toward their preferred surround vibrissa. This sub-barrel column direction map demonstrated an emergent refinement from layer IV to layer II/III. These data suggest that joint processing of multiple sensory features is a common property of high-resolution sensory systems.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Program Biophys, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 46 2171, Cambridge, MA 02139 USA.	cim@mit.edu	Moore, Christopher/C-5588-2009	Moore, Christopher/0000-0003-4534-1602				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bender KJ, 2003, J NEUROSCI, V23, P8759; BENISON AM, 2006, J NEUROPHYSIOL  0104; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; Bruno RM, 2003, J NEUROSCI, V23, P9565; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carreira-Perpinan MA, 2004, J NEUROPHYSIOL, V92, P2947, DOI 10.1152/jn.00281.2004; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Head H., 1920, STUDIES NEUROLOGY; Huang W, 1998, J NEUROPHYSIOL, V80, P3261, DOI 10.1152/jn.1998.80.6.3261; Hubel D H, 1976, Cold Spring Harb Symp Quant Biol, V40, P581; Hubener M, 1997, J NEUROSCI, V17, P9270; Land PW, 2005, J COMP NEUROL, V490, P414, DOI 10.1002/cne.20677; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; MERZENICH MM, 1980, PROGR PSYCHOBIOL PHY, V9, P1; MOORE CI, SOMATOSENSORY PLASTI, P21; Neimark MA, 2003, J NEUROSCI, V23, P6499; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Timofeeva E, 2003, J NEUROSCI, V23, P10717; WAITE PME, 1992, J COMP NEUROL, V322, P233, DOI 10.1002/cne.903220209; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; WINESKI LE, 1985, J MORPHOL, V183, P199, DOI 10.1002/jmor.1051830208; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011; Zar J. H., 1996, BIOSTATISTICAL ANAL	50	102	102	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					543	551		10.1038/nn1671	http://dx.doi.org/10.1038/nn1671			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547511				2022-12-28	WOS:000236310700022
J	Otten, LJ; Quayle, AH; Akram, S; Ditewig, TA; Rugg, MD				Otten, LJ; Quayle, AH; Akram, S; Ditewig, TA; Rugg, MD			Brain activity before an event predicts later recollection	NATURE NEUROSCIENCE			English	Article							MEMORY; ATTENTION; STATE	Neural activity elicited by an event can predict whether the event is successfully encoded into memory. Here we assessed whether memory encoding relies not only on neural activity that follows an event, but also on activity that precedes it. In two experiments we found that human brain activity elicited by a cue presented just before a word could predict whether the word would be recollected in a later memory test.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of London; University College London; University of London; University College London; University of California System; University of California Irvine; University of California System; University of California Irvine	Otten, LJ (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	l.otten@ucl.ac.uk	Otten, Leun/C-6036-2008		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074528] Funding Source: NIH RePORTER; NIMH NIH HHS [1R01MH074528] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Driver J, 2000, NAT REV NEUROSCI, V1, P147, DOI 10.1038/35039083; Duzel E, 2005, NEUROIMAGE, V25, P690, DOI 10.1016/j.neuroimage.2004.11.038; MANGUN GR, 1995, OX PSYCH S, P40; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Uhl F, 1990, J Cogn Neurosci, V2, P373, DOI 10.1162/jocn.1990.2.4.373; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	15	122	123	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					489	491		10.1038/nn1663	http://dx.doi.org/10.1038/nn1663			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501566				2022-12-28	WOS:000236310700015
J	Le Bras, B; Barallobre, MJ; Homman-Lidiye, J; Ny, A; Wyns, S; Tammela, T; Haiko, P; Karkkainen, MJ; Yuan, L; Muriel, MP; Chatzopoulou, E; Breant, A; Zalc, B; Carmeliet, P; Alitalo, K; Eichmann, A; Thomas, JL				Le Bras, B; Barallobre, MJ; Homman-Lidiye, J; Ny, A; Wyns, S; Tammela, T; Haiko, P; Karkkainen, MJ; Yuan, L; Muriel, MP; Chatzopoulou, E; Breant, A; Zalc, B; Carmeliet, P; Alitalo, K; Eichmann, A; Thomas, JL			VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain	NATURE NEUROSCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT OPTIC-NERVE; STIMULATES AXONAL OUTGROWTH; IN-VITRO; LYMPHATIC VESSELS; PRECURSOR CELLS; SPINAL-CORD; STEM-CELLS; NEUROGENESIS; DIFFERENTIATION	Vascular endothelial growth factor C (VEGF-C) was first identified as a regulator of the vascular system, where it is required for the development of lymphatic vessels. Here we report actions of VEGF-C in the central nervous system. We detected the expression of the VEGF-C receptor VEGFR-3 in neural progenitor cells in Xenopus laevis and mouse embryos. In Xenopus tadpole VEGF-C knockdowns and in mice lacking Vegfc, the proliferation of neural progenitors expressing VEGFR-3 was severely reduced, in the absence of intracerebral blood vessel defects. In addition, Vegfc-deficient mouse embryos showed a selective loss of oligodendrocyte precursor cells (OPCs) in the embryonic optic nerve. In vitro, VEGF-C stimulated the proliferation of OPCs expressing VEGFR-3 and nestin-positive ventricular neural cells. VEGF-C thus has a new, evolutionary conserved function as a growth factor selectively required by neural progenitor cells expressing its receptor VEGFR-3.	INSERM, U711, F-75013 Paris, France; Univ Paris 06, Fac Med Pitie Salpetriere, IFR 70, F-75005 Paris, France; Catholic Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Univ Helsinki, Haartman Inst & Biomed, FIN-00014 Helsinki, Finland; Univ Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; INSERM, U679, F-75651 Paris, France; Coll France, F-75005 Paris, France; INSERM, U36x, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thomas, JL (corresponding author), INSERM, U711, F-75013 Paris, France.	jlthomas@ccr.jussieu.fr	Thomas, Jean-Leon/F-1151-2016; Carmeliet, Peter/AAQ-5140-2020; Alitalo, Kari K/J-5013-2014; Messier, Claude/A-2322-2008; Ny, Annelii/R-7712-2018; Barallobre, Maria Jose/L-9928-2014	Carmeliet, Peter/0000-0001-7961-1821; Alitalo, Kari K/0000-0002-7331-0902; Messier, Claude/0000-0002-4791-1763; Ny, Annelii/0000-0002-3678-5941; Barallobre, Maria Jose/0000-0002-0101-7803; Homman-Ludiye, Jihane/0000-0001-6689-1457; /0000-0003-3675-6961	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075183-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avantaggiato V, 1998, MECH DEVELOP, V73, P221, DOI 10.1016/S0925-4773(98)00049-5; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BREIER G, 1992, DEVELOPMENT, V114, P521; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Joukov V, 1996, EMBO J, V15, P1751; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Jussila L, 2002, PHYSIOL REV, V82, P673, DOI 10.1152/physrev.00005.2002; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mi HY, 1999, J NEUROSCI, V19, P1049; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi JY, 1998, J NEUROSCI, V18, P4627; Shibata T, 1997, J NEUROSCI, V17, P9212; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Spassky N, 2002, J NEUROSCI, V22, P5992; Spassky N, 1998, J NEUROSCI, V18, P8331; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun T, 2003, J NEUROSCI, V23, P9547; YANG K, 1996, J NEUROSCI, V16, P6089; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000	49	146	148	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					340	348		10.1038/nn1646	http://dx.doi.org/10.1038/nn1646			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462734				2022-12-28	WOS:000235645600013
J	Paton, JFR; Abdala, APL; Koizumi, H; Smith, JC; St John, WM				Paton, JFR; Abdala, APL; Koizumi, H; Smith, JC; St John, WM			Respiratory rhythm generation during gasping depends on persistent sodium current	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; PATTERNS; MODELS; EUPNEA	In severe hypoxia, homeostatic mechanisms maintain function of the brainstem respiratory network. We hypothesized that hypoxia involves a transition from neuronal mechanisms of normal breathing (eupnea) to a rudimentary pattern of inspiratory movements (gasping). We provide evidence for hypoxia-driven transformation within the central respiratory oscillator, in which gasping relies on persistent sodium current, whereas eupnea does not depend on this cellular mechanism.	Univ Bristol, Sch Med Sci, Bristol Heart Inst, Dept Physiol, Bristol BS8 1TH, Avon, England; NINDS, Cellular & Syst Neurobiol Sect, NIH, Bethesda, MD 20892 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, Lebanon, NH 03756 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Dartmouth College	Paton, JFR (corresponding author), Univ Bristol, Sch Med Sci, Bristol Heart Inst, Dept Physiol, Bristol BS8 1TH, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Paton, Julian/AAM-2121-2020; Sheikh, Ana Paula Abdala/G-9104-2014; Abdala, Ana Paula/G-9104-2014	Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Abdala, Ana Paula/0000-0001-6051-2591; Paton, Julian/0000-0001-7410-2913	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Hammarstrom AKM, 2000, J PHYSIOL-LONDON, V529, P107, DOI 10.1111/j.1469-7793.2000.00107.x; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Pena F, 2004, NEURON, V43, P105, DOI 10.1016/j.neuron.2004.06.023; Ramirez JM, 2005, RESP PHYSIOL NEUROBI, V147, P145, DOI 10.1016/j.resp.2005.05.003; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Rybak IA, 2003, EUR J NEUROSCI, V18, P239, DOI 10.1046/j.1460-9568.2003.02739.x; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; St-John WM, 2003, RESP PHYSIOL NEUROBI, V139, P97, DOI 10.1016/S1569-9048(03)00193-9; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8	15	170	170	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					311	313		10.1038/nn1650	http://dx.doi.org/10.1038/nn1650			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474390				2022-12-28	WOS:000235645600009
J	Averbeck, BB; Sohn, JW; Lee, D				Averbeck, BB; Sohn, JW; Lee, D			Activity in prefrontal cortex during dynamic selection of action sequences	NATURE NEUROSCIENCE			English	Article							COPYING GEOMETRICAL SHAPES; SUPPLEMENTARY EYE FIELD; NEURONAL-ACTIVITY; NEURAL ACTIVITY; TEMPORAL ORGANIZATION; CAUDATE-NUCLEUS; FRONTAL-LOBE; MOTOR; ACQUISITION; MONKEY	Completing everyday tasks often requires the execution of action sequences matched to a particular problem. To study the neural processes underlying these behaviors, we trained monkeys to produce a series of eye movements according to a sequence that changed unpredictably from one block of trials to the next. We then applied a decoding algorithm to estimate which sequence was being represented by the ensemble activity in prefrontal cortex. We found that the sequence predicted by this analysis changed gradually from the sequence that had been correct in the previous block to the sequence that was correct in the current block, closely following the fraction of executed movements that were consistent with the corresponding sequence. Thus, the neural activity dynamically tracked the monkeys' uncertainty about the correct sequence of actions. These results are consistent with prefrontal involvement in representing subjective knowledge of the correct action sequence.	Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Averbeck, BB (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	baverbeck@cvs.rochester.edu	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X	NEI NIH HHS [P30-EY01319] Funding Source: Medline; NIMH NIH HHS [T32-MH19942, R01-MH59216] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019942, R01MH059216] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Averbeck BB, 2003, EXP BRAIN RES, V150, P142, DOI 10.1007/s00221-003-1417-5; Averbeck BB, 2003, EXP BRAIN RES, V150, P127, DOI 10.1007/s00221-003-1416-6; BARONE P, 1989, EXP BRAIN RES, V78, P447; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Chen LL, 1997, J NEUROPHYSIOL, V78, P1166, DOI 10.1152/jn.1997.78.2.1166; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; Isoda M, 2003, J NEUROPHYSIOL, V90, P3054, DOI 10.1152/jn.00367.2003; Jaynes E.T., 2003, PROBABILITY THEORY L; KERMADI I, 1993, EXP BRAIN RES, V94, P352; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Lee D, 1998, J NEUROSCI, V18, P1161; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MITZ AR, 1991, J NEUROSCI, V11, P1855; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631	31	107	108	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					276	282		10.1038/nn1634	http://dx.doi.org/10.1038/nn1634			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429134				2022-12-28	WOS:000234990100024
J	Petkov, CI; Kayser, C; Steudel, T; Whittingstall, K; Augath, M; Logothetis, NK				Petkov, Christopher I.; Kayser, Christoph; Steudel, Thomas; Whittingstall, Kevin; Augath, Mark; Logothetis, Nikos K.			A voice region in the monkey brain	NATURE NEUROSCIENCE			English	Article							HUMAN AUDITORY-CORTEX; RHESUS-MONKEY; TEMPORAL-LOBE; INFEROTEMPORAL CORTEX; MACACA-MULATTA; MACAQUE; FACE; VOCALIZATIONS; ADAPTATION; PRIMATES	For vocal animals, recognizing species-specific vocalizations is important for survival and social interactions. In humans, a voice region has been identified that is sensitive to human voices and vocalizations. As this region also strongly responds to speech, it is unclear whether it is tightly associated with linguistic processing and is thus unique to humans. Using functional magnetic resonance imaging of macaque monkeys (Old World primates, Macaca mulatta) we discovered a high-level auditory region that prefers species-specific vocalizations over other vocalizations and sounds. This region not only showed sensitivity to the 'voice' of the species, but also to the vocal identify of conspecific individuals. The monkey voice region is located on the superior-temporal plane and belongs to an anterior auditory 'what' pathway. These results establish functional relationships with the human voice region and support the notion that, for different primate species, the anterior temporal regions of the brain are adapted for recognizing communication signals from conspecifics.	[Petkov, Christopher I.; Kayser, Christoph; Steudel, Thomas; Whittingstall, Kevin; Augath, Mark; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Imaging Sci & Biomed Engn, Manchester N13 9PT, Lancs, England	Max Planck Society; University of Manchester	Petkov, CI (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Logothetis, Nikos/U-9282-2019; Petkov, Christopher/O-5318-2015; Kayser, Christoph/A-3203-2012	Petkov, Christopher/0000-0002-4932-7907; Kayser, Christoph/0000-0001-7362-5704				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Fullerton BC, 2007, J COMP NEUROL, V504, P470, DOI 10.1002/cne.21432; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Ghazanfar AA, 2006, CURR BIOL, V16, pR879, DOI 10.1016/j.cub.2006.09.026; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Gil-Da-Costa R, 2006, NAT NEUROSCI, V9, P1064, DOI 10.1038/nn1741; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Van Lancker D R, 1982, Brain Cogn, V1, P185, DOI 10.1016/0278-2626(82)90016-1; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WINTER P, 1973, EXP BRAIN RES, V18, P489	50	252	258	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					367	374		10.1038/nn2043	http://dx.doi.org/10.1038/nn2043			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18264095				2022-12-28	WOS:000253548300021
J	Lazarus, M; Yoshida, K; Coppari, R; Bass, CE; Mochizuki, T; Lowell, BB; Saper, CB				Lazarus, Michael; Yoshida, Kyoko; Coppari, Roberto; Bass, Caroline E.; Mochizuki, Takatoshi; Lowell, Bradford B.; Saper, Clifford B.			EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses	NATURE NEUROSCIENCE			English	Review							BROWN ADIPOSE-TISSUE; FEBRILE RESPONSE; MICE; LIPOPOLYSACCHARIDE; THERMOGENESIS; TEMPERATURE; RAPHE	Fever is a result of the action of prostaglandin E2 ( PGE2) on the brain and appears to require EP3 prostaglandin receptors ( EP3Rs), but the specific neurons on which PGE2 acts to produce fever have not been definitively established. Here we report that selective genetic deletion of the EP3Rs in the median preoptic nucleus of mice resulted in abrogation of the fever response. These observations demonstrate that the EP3R-bearing neurons in the median preoptic nucleus are required for fever responses.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Wake Forest University; Wake Forest University School of Medicine	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02215 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019; Mochizuki, Takatoshi/AAB-2522-2020; Coppari, Roberto/B-4799-2014; Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474; COPPARI, Roberto/0000-0003-1288-6948; Yoshida-Court, Kyoko/0000-0002-7558-9943; Bass, Caroline/0000-0002-5856-6387; Mochizuki, Takatoshi/0000-0001-6976-7240; Lazarus, Michael/0000-0003-4700-7894	NHLBI NIH HHS [HL60292] Funding Source: Medline; NIDA NIH HHS [F32 DA017543] Funding Source: Medline; NINDS NIH HHS [NS33987] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA017543] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Oka T, 2003, BRAIN RES, V968, P256, DOI 10.1016/S0006-8993(03)02268-6; Romanovsky AA, 2003, AM J PHYSIOL-REG I, V285, pR420, DOI 10.1152/ajpregu.00757.2002; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Tanaka M, 2005, AM J PHYSIOL-REG I, V289, pR1592, DOI 10.1152/ajpregu.00141.2005; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	15	230	238	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1131	1133		10.1038/nn1949	http://dx.doi.org/10.1038/nn1949			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676060				2022-12-28	WOS:000249144000013
J	Stalnaker, TA; Roesch, MR; Franz, TM; Calu, DJ; Singh, T; Schoenbaum, G				Stalnaker, Thomas A.; Roesch, Matthew R.; Franz, Theresa M.; Calu, Donna J.; Singh, Teghpal; Schoenbaum, Geoffrey			Cocaine-induced decisionmaking deficits are mediated by miscoding in basolateral amygdala	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; SEEKING BEHAVIOR; LESIONS; RATS; ACQUISITION; IMPAIRMENTS; EXTINCTION; NEURONS; MONKEYS	Addicts and drug-experienced animals have decision-making deficits in reversal-learning tasks and more complex 'gambling' variants. Here we show evidence that these deficits are mediated by persistent encoding of outdated associative information in the basolateral amygdala. Cue-selective neurons in the basolateral amygdala, recorded in cocaine-treated rats, failed to change cue preference during reversal learning. Further, the presence of these neurons was critical to the expression of the reversal-learning deficit in the cocaine-treated rats.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Stalnaker, TA (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St,HSF-2 S251, Baltimore, MD 21201 USA.	tstal002@umaryland.edu		Calu, Donna/0000-0003-2377-9494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA015718-05, R01 DA015718, DA015718] Funding Source: Medline; NIDCD NIH HHS [T32 DC000054, T32-DC00054] Funding Source: Medline; NINDS NIH HHS [T32 NS007375, T32-NS07375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Calu DJ, 2007, LEARN MEMORY, V14, P325, DOI 10.1101/lm.534807; Carelli RM, 2003, J NEUROSCI, V23, P8204; Fuchs RA, 2006, EUR J NEUROSCI, V23, P2809, DOI 10.1111/j.1460-9568.2006.04806.x; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Jentsch JD, 2002, NEUROPSYCHOPHARMACOL, V26, P183, DOI 10.1016/S0893-133X(01)00355-4; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; See RE, 2003, NEUROSCIENCE, V117, P477, DOI 10.1016/S0306-4522(02)00665-6; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014	15	49	49	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					949	951		10.1038/nn1931	http://dx.doi.org/10.1038/nn1931			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603478	Green Accepted			2022-12-28	WOS:000248357500008
J	Wulff, P; Goetz, T; Leppa, E; Linden, AM; Renzi, M; Swinny, JD; Vekovischeva, OY; Sieghart, W; Somogyi, P; Korpi, ER; Farrant, M; Wisden, W				Wulff, Peer; Goetz, Thomas; Leppa, Elli; Linden, Anni-Maija; Renzi, Massimiliano; Swinny, Jerome D.; Vekovischeva, Olga Y.; Sieghart, Werner; Somogyi, Peter; Korpi, Esa R.; Farrant, Mark; Wisden, William			From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; AMINOBUTYRIC ACID(A) RECEPTOR; ZOLPIDEM BINDING-SITES; SUBUNIT MESSENGER-RNAS; POINT MUTATION; RAT-BRAIN; IN-VIVO; REVERSIBLE INACTIVATION; BENZODIAZEPINE SITE; NEURAL CIRCUITRY	In mammals, identifying the contribution of specific neurons or networks to behavior is a key challenge. Here we describe an approach that facilitates this process by enabling the rapid modulation of synaptic inhibition in defined cell populations. Binding of zolpidem, a systemically active allosteric modulator that enhances the function of the GABAA receptor, requires a phenylalanine residue (Phe77) in the gamma 2 subunit. Mice in which this residue is changed to isoleucine are insensitive to zolpidem. By Cre recombinase-induced swapping of the gamma 2 subunit (that is, exchanging Ile77 for Phe77), zolpidem sensitivity can be restored to GABAA receptors in chosen cell types. We demonstrate the power of this method in the cerebellum, where zolpidem rapidly induces significant motor deficits when Purkinje cells are made uniquely sensitive to its action. This combined molecular and pharmacological technique has demonstrable advantages over targeted cell ablation and will be invaluable for investigating many neuronal circuits.	Univ Heidelberg, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; Univ Helsinki, Inst Biomed, Biomed Helsinki, FIN-00014 Helsinki, Finland; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Oxford, MRC Anatom Neuropharmacol Unit, Oxford OX1 3TH, England; Med Univ Vienna, Ctr Brain Res, Sect Biochem & Mol Biol Nervous Syst, A-1090 Vienna, Austria; Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	Ruprecht Karls University Heidelberg; University of Helsinki; University of London; University College London; University of Oxford; Medical University of Vienna; University of Aberdeen	Wulff, P (corresponding author), Univ Heidelberg, Dept Clin Neurobiol, Im Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	p.wulff@abdn.ac.uk	Wisden, William/A-4071-2011; Sieghart, Werner/A-4877-2013	Wisden, William/0000-0003-4743-0334; Sieghart, Werner/0000-0002-0443-0302; Linden, Anni-Maija/0000-0003-1573-8051; RENZI, MASSIMILIANO/0000-0001-6973-3569; Wulff, Peer/0000-0002-0282-7832; Farrant, Mark/0000-0002-9918-0376; Korpi, Esa R./0000-0003-0683-4009; Swinny, Jerome/0000-0002-8194-5481	Medical Research Council [G0501584, MC_U138135973, G0601498(79979), G0601498] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0601498, MC_U138135973, G0501584] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; BENAVIDES J, 1988, J PHARMACOL EXP THER, V245, P1033; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Cope DW, 2005, EUR J NEUROSCI, V21, P3002, DOI 10.1111/j.1460-9568.2005.04127.x; Cope DW, 2004, NEUROPHARMACOLOGY, V47, P17, DOI 10.1016/j.neuropharm.2004.03.007; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; Crestani F, 2000, NAT NEUROSCI, V3, P1059, DOI 10.1038/80553; Crick F, 1999, PHILOS T ROY SOC B, V354, P2021, DOI 10.1098/rstb.1999.0541; De Vasconcelos AP, 2006, NEUROSCIENCE, V141, P1649, DOI 10.1016/j.neuroscience.2006.05.023; DUNCAN GE, 1995, NEUROSCIENCE, V64, P1113, DOI 10.1016/0306-4522(94)00433-6; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leppa E, 2005, NEUROPHARMACOLOGY, V48, P469, DOI 10.1016/j.neuropharm.2004.11.007; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McCartney MR, 2007, MOL PHARMACOL, V71, P539, DOI 10.1124/mol.106.028597; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; NIDDAM R, 1987, J NEUROCHEM, V49, P890, DOI 10.1111/j.1471-4159.1987.tb00977.x; OERTEL WH, 1981, NEUROSCIENCE, V6, P2715, DOI 10.1016/0306-4522(81)90115-9; Ogris W, 2004, BIOCHEM PHARMACOL, V68, P1621, DOI 10.1016/j.bcp.2004.07.020; Perrais D, 1999, J NEUROSCI, V19, P578; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Thomson AM, 2000, EUR J NEUROSCI, V12, P425, DOI 10.1046/j.1460-9568.2000.00915.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Whiting PJ, 2006, CURR OPIN PHARMACOL, V6, P24, DOI 10.1016/j.coph.2005.08.005; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wulff P, 2005, TRENDS NEUROSCI, V28, P44, DOI 10.1016/j.tins.2004.11.004; Yamamoto M, 2003, J NEUROSCI, V23, P6759; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	90	90	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					923	929		10.1038/nn1927	http://dx.doi.org/10.1038/nn1927			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17572671	Green Accepted			2022-12-28	WOS:000247560200024
J	Kiyonaka, S; Wakamori, M; Miki, T; Uriu, Y; Nonaka, M; Bito, H; Beedle, AM; Mori, E; Hara, Y; De Waard, M; Kanagawa, M; Itakura, M; Takahashi, M; Campbell, KP; Mori, Y				Kiyonaka, Shigeki; Wakamori, Minoru; Miki, Takafumi; Uriu, Yoshitsugu; Nonaka, Mio; Bito, Haruhiko; Beedle, Aaron M.; Mori, Emiko; Hara, Yuji; De Waard, Michel; Kanagawa, Motoi; Itakura, Makoto; Takahashi, Masami; Campbell, Kevin P.; Mori, Yasuo			RIM1 confers sustained activity and neurotransmitter vesicle anchring to presynaptic Ca+2 channels	NATURE NEUROSCIENCE			English	Article							VOLTAGE-DEPENDENT INACTIVATION; NEURONAL CALCIUM-CHANNELS; I-II-LOOP; CA2+ CHANNELS; BETA-SUBUNIT; N-TYPE; SYNAPTIC-TRANSMISSION; RAB3 EFFECTOR; PROTEIN; RELEASE	The molecular organization of presynaptic active zones is important for the neurotransmitter release that is triggered by depolarization-induced Ca2+ influx. Here, we demonstrate a previously unknown interaction between two components of the presynaptic active zone, RIM1 and voltage-dependent Ca2+ channels (VDCCs), that controls neurotransmitter release in mammalian neurons. RIM1 associated with VDCC beta-subunits via its C terminus to markedly suppress voltage-dependent inactivation among different neuronal VDCCs. Consistently, in pheochromocytoma neuroendocrine PC12 cells, acetylcholine release was significantly potentiated by the full-length and C-terminal RIM1 constructs, but membrane docking of vesicles was enhanced only by the full-length RIM1. The beta construct beta-AID dominant negative, which disrupts the RIM1-beta association, accelerated the inactivation of native VDCC currents, suppressed vesicle docking and acetylcholine release in PC12 cells, and inhibited glutamate release in cultured cerebellar neurons. Thus, RIM1 association with b in the presynaptic active zone supports release via two distinct mechanisms: sustaining Ca2+ influx through inhibition of channel inactivation, and anchoring neurotransmitter-containing vesicles in the vicinity of VDCCs.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; INSERM, U607, Lab Canaux Calc Fonct & Pathol, F-38054 Grenoble 09, France; Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2288555, Japan	Kyoto University; University of Tokyo; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); Kitasato University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura Campus,Nishikyo Ku, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Beedle, Aaron M/K-1902-2015; Bito, Haruhiko/A-8635-2008; Kiyonaka, Shigeki/AAM-7303-2021; Beedle, Aaron/AAI-7014-2020; Wakamori, Minoru/AAE-2661-2019; De Waard, Michel/G-7406-2014	Beedle, Aaron M/0000-0002-1019-3235; De Waard, Michel/0000-0002-2782-9615; Kanagawa, Motoi/0000-0003-0984-6398; Wakamori, Minoru/0000-0001-8574-3310; Campbell, Kevin/0000-0003-2066-5889; Bito, Haruhiko/0000-0001-6315-9594				Atwood HL, 2006, SCIENCE, V312, P1008, DOI 10.1126/science.1128445; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Liu HY, 1996, J NEUROSCI, V16, P7557; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nonaka M, 2006, J NEUROSCI, V26, P763, DOI 10.1523/JNEUROSCI.2489-05.2006; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; WANG L, 2000, CHEM J INTERNET, V2, P44; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	50	164	170	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					691	701		10.1038/nn1904	http://dx.doi.org/10.1038/nn1904			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17496890	Green Submitted, Green Accepted			2022-12-28	WOS:000246799800011
J	Rouw, R; Scholte, HS				Rouw, Romke; Scholte, H. Steven			Increased structural connectivity in grapheme-color synesthesia	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; INDIVIDUAL-DIFFERENCES; VISUAL-PERCEPTION; SYNAESTHESIA; CORTEX; FMRI; ACTIVATION; MECHANISMS; CONSCIOUSNESS; IMAGES	Diffusion tensor imaging allowed us to validate for the first time the hypothesis that hyperconnectivity causes the added sensations in synesthesia. Grapheme- color synesthetes (n = 18), who experience specific colors with particular letters or numbers (for example, 'R is sky blue'), showed greater anisotropic diffusion compared with matched controls. Greater anisotropic diffusion indicates more coherent white matter. Anisotropy furthermore differentiated subtypes of grapheme-color synesthesia. Greater connectivity in the inferior temporal cortex was particularly strong for synesthetes who see synesthetic color in the outside world ('projectors') as compared with synesthetes who see the color in their 'mind's eye' only ('associators'). In contrast, greater connectivity (as compared with non-synesthetes) in the superior parietal or frontal cortex did not differentiate between subtypes of synesthesia. In conclusion, we found evidence that increased structural connectivity is associated with the presence of grapheme-color synesthesia, and has a role in the subjective nature of synesthetic color experience.	Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam	Rouw, R (corresponding author), Univ Amsterdam, Dept Psychol, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	R.Rouw@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788				BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; DAY S, 2005, SYNESTHESIA PERSPECT, P11; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2005, NEURON, V45, P821, DOI 10.1016/j.neuron.2005.03.007; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Esterman M, 2006, J COGNITIVE NEUROSCI, V18, P1570, DOI 10.1162/jocn.2006.18.9.1570; Evans A. C., 1992, Society for Neuroscience Abstracts, V18, P408; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mondloch CJ, 2004, COGN AFFECT BEHAV NE, V4, P133, DOI 10.3758/CABN.4.2.133; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sperling JM, 2006, CORTEX, V42, P295, DOI 10.1016/S0010-9452(08)70355-1; WARD J, 2006, CORTEX, V42; Weiss PH, 2005, NEUROIMAGE, V28, P859, DOI 10.1016/j.neuroimage.2005.06.052; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	45	277	282	9	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					792	797		10.1038/nn1906	http://dx.doi.org/10.1038/nn1906			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515901				2022-12-28	WOS:000246799800023
J	Eisenman, LN; Shu, HJ; Akk, G; Wang, C; Manion, BD; Kress, GJ; Evers, AS; Steinbach, JH; Covey, DF; Zorumski, CF; Mennerick, S				Eisenman, Lawrence N.; Shu, Hong-Jin; Akk, Gustav; Wang, Cunde; Manion, Brad D.; Kress, Geraldine J.; Evers, Alex S.; Steinbach, Joe Henry; Covey, Douglas F.; Zorumski, Charles F.; Mennerick, Steven			Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light	NATURE NEUROSCIENCE			English	Article							GABA-A; NEUROACTIVE STEROIDS; MODULATION; RECEPTORS; CURRENTS; BRAIN	Most photoactivatable compounds suffer from the limitations of the ultraviolet wavelengths that are required for activation. We synthesized a neuroactive steroid analog with a fluorescent (7-nitro-2,1,3-benzoxadiazol-4-yl) amino (NBD) group in the beta configuration at the C2 position of (3 alpha, 5 alpha)-3-hydroxypregnan-20-one (allopregnanolone, 3 alpha 5 alpha P). Light wavelengths (480 nm) that excite compound fluorescence strongly potentiate GABA(A) receptor function. Potentiation is limited by photodepletion of the receptor-active species. Photopotentiation is long-lived and stereoselective and shows single-channel hallmarks similar to steroid potentiation. Other NBD-conjugated compounds also generate photopotentiation, albeit with lower potency. Thus, photopotentiation does not require a known ligand for neurosteroid potentiating sites on the GABA(A) receptor. Photoactivation of a membrane-impermeant, fluorescent steroid analog demonstrates that membrane localization is critical for activity. The photoactivatable steroid silences pathological spiking in cultured rat hippocampal neurons and anesthetizes tadpoles. Fluorescent steroids photoactivated by visible light may be useful for modulating GABA(A) receptor function in a spatiotemporally defined manner.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave, St Louis, MO 63110 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017; Akk, Gustav/CAG-1703-2022	Mennerick, Steven/0000-0003-0868-0664; Kress, Geraldine/0000-0001-9442-8734; Evers, Alex/0000-0002-0342-0575	NIAAA NIH HHS [AA12951, AA12952, AA14707] Funding Source: Medline; NIGMS NIH HHS [P01 GM047969, GM 47969] Funding Source: Medline; NIMH NIH HHS [MH78823] Funding Source: Medline; NINDS NIH HHS [NS54174, NS44041] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS044041, R01NS054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA014707, R01AA012951, R01AA012952] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Akk G, 2004, J PHYSIOL-LONDON, V558, P59, DOI 10.1113/jphysiol.2004.066571; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Chang YH, 2001, J PHYSIOL-LONDON, V536, P471, DOI 10.1111/j.1469-7793.2001.0471c.xd; Covey DF, 2001, BRAIN RES REV, V37, P91, DOI 10.1016/S0165-0173(01)00126-6; DODT HU, 2002, SCI STKE, pPL2; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eisenman LN, 2003, J PHYSIOL-LONDON, V550, P679, DOI 10.1113/jphysiol.2003.043810; Gasior M, 1999, TRENDS PHARMACOL SCI, V20, P107, DOI 10.1016/S0165-6147(99)01318-8; HARRISON NL, 1987, J NEUROSCI, V7, P604; Hess GP, 2003, BIOPHYS CHEM, V100, P493, DOI 10.1016/S0301-4622(02)00301-0; Leszkiewicz DN, 2003, EUR J NEUROSCI, V17, P2077, DOI 10.1046/j.1460-9568.2003.02656.x; MAJEWSKA MD, 1988, NEUROSCI LETT, V90, P279, DOI 10.1016/0304-3940(88)90202-9; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Morrell M, 2006, CURR OPIN NEUROL, V19, P164, DOI 10.1097/01.wco.0000218233.60217.84; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; PHILLIPPS GH, 1975, J STEROID BIOCHEM, V6, P607, DOI 10.1016/0022-4731(75)90041-2; Shembekar VR, 2005, BIOCHEMISTRY-US, V44, P7107, DOI 10.1021/bi047665o; Shu HJ, 2007, BRIT J PHARMACOL, V150, P164, DOI 10.1038/sj.bjp.0706973; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; Wang MD, 2002, J NEUROSCI, V22, P3366; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wittmer LL, 1996, MOL PHARMACOL, V50, P1581; WOODWARD RM, 1992, MOL PHARMACOL, V41, P89; Zorumski C F, 2000, Curr Opin Investig Drugs, V1, P360	26	17	19	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					523	530		10.1038/nn1862	http://dx.doi.org/10.1038/nn1862			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322875				2022-12-28	WOS:000245228600024
J	Shen, H; Gong, QH; Aoki, C; Yuan, ML; Ruderman, Y; Dattilo, M; Williams, K; Smith, SS				Shen, Hui; Gong, Qi Hua; Aoki, Chiye; Yuan, Maoli; Ruderman, Yevgeniy; Dattilo, Michael; Williams, Keith; Smith, Sheryl S.			Reversal of neurosteroid effects at alpha 4 beta 2 delta GABA(A) receptors triggers anxiety at puberty	NATURE NEUROSCIENCE			English	Article							TONIC INHIBITION; ALLOPREGNANOLONE LEVELS; NEURONS; BRAIN; STEROIDS; CHANNEL; METABOLITES; MODULATION; WITHDRAWAL; NUCLEUS	Puberty is characterized by mood swings and anxiety, which are often produced by stress. Here we show that THP ( allopregnanolone), a steroid that is released as a result of stress, increases anxiety in pubertal female mice, in contrast to its anxiety-reducing effect in adults. Anxiety is regulated by GABAergic inhibition in limbic circuits. Although this inhibition is increased by THP administration before puberty and in adults, during puberty THP reduces the tonic inhibition of pyramidal cells in hippocampal region CA1, leading to increased excitability. This paradoxical effect of THP results from inhibition of alpha 4 beta delta GABA(A) receptors. These receptors are normally expressed at very low levels, but at puberty, their expression is increased in hippocampal area CA1, where they generate outward currents. THP also decreases the outward current at recombinant alpha 4 beta 2 delta receptors, and this effect depends on arginine 353 in the alpha 4 subunit, a putative site for modulation by Cl-. Therefore, inhibition of alpha 4 beta 2 delta GABA(A) receptors by THP provides a mechanism for the generation of anxiety at puberty.	Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Smith, SS (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	sheryl.smith@downstate.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Smith, Sheryl/0000-0003-4308-3267	NEI NIH HHS [R01 EY008055-09, P30 EY013079-079003, R01 EY013145, P30 EY013079, R01 EY013145-04] Funding Source: Medline; NIAAA NIH HHS [R01 AA012958] Funding Source: Medline; NIDA NIH HHS [R01 DA009618] Funding Source: Medline; NINDS NIH HHS [R25 NS080686, R01 NS041091, R01 NS041091-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY013079, R01EY008055, R01EY013145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Andreen L, 2005, PSYCHONEUROENDOCRINO, V30, P212, DOI 10.1016/j.psyneuen.2004.07.003; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Bitran D, 1999, BRAIN RES, V850, P217, DOI 10.1016/S0006-8993(99)02150-2; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Corpechot C, 1997, BRAIN RES, V766, P276, DOI 10.1016/S0006-8993(97)00749-X; Fadalti M, 1999, PEDIATR RES, V46, P323, DOI 10.1203/00006450-199909000-00013; Freeman EW, 2002, J CLIN PSYCHOPHARM, V22, P516, DOI 10.1097/00004714-200210000-00013; FREEMAN EW, 1993, NEUROENDOCRINOLOGY, V58, P478, DOI 10.1159/000126579; Girdler SS, 2006, PSYCHOPHYSIOLOGY, V43, P331, DOI 10.1111/j.1469-8986.2006.00410.x; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; Lundgren P, 2003, BRAIN RES, V982, P45, DOI 10.1016/S0006-8993(03)02939-1; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; McEwen BS, 2005, J PSYCHIATR NEUROSCI, V30, P315; Mele P, 2004, J NEUROCHEM, V89, P1471, DOI 10.1111/j.1471-4159.2004.02444.x; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MODESTI PA, 1994, ANGIOLOGY, V45, P443, DOI 10.1177/000331979404500605; OLSEN RW, 1982, J NEUROSCI, V2, P1812; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Romeo RD, 2005, VITAM HORM, V71, P1, DOI 10.1016/S0083-6729(05)71001-3; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; Smith SS, 2006, PSYCHOPHARMACOLOGY, V186, P323, DOI 10.1007/s00213-005-0168-3; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Ulrich D, 1997, J NEUROSCI, V17, P2348; Wei WZ, 2003, J NEUROSCI, V23, P10650; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wu YM, 2001, J NEUROSCI, V21, P2630, DOI 10.1523/JNEUROSCI.21-08-02630.2001	50	187	191	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					469	477		10.1038/nn1868	http://dx.doi.org/10.1038/nn1868			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351635	Green Accepted			2022-12-28	WOS:000245228600018
J	Russo, SJ; Bolanos, CA; Theobald, DE; DeCarolis, NA; Renthal, W; Kumar, A; Winstanley, CA; Renthal, NE; Wiley, MD; Self, DW; Russell, DS; Neve, RL; Eisch, AJ; Nestler, EJ				Russo, Scott J.; Bolanos, Carlos A.; Theobald, David E.; DeCarolis, Nathan A.; Renthal, William; Kumar, Arvind; Winstanley, Catharine A.; Renthal, Nora E.; Wiley, Matthew D.; Self, David W.; Russell, David S.; Neve, Rachael L.; Eisch, Amelia J.; Nestler, Eric J.			IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; PHOSPHOLIPASE-C-GAMMA; NEUROTROPHIC FACTOR; CHRONIC MORPHINE; DRUG-ADDICTION; NUCLEUS-ACCUMBENS; COCAINE; WITHDRAWAL; REWARD; RATS	Chronic morphine administration ( via subcutaneous pellet) decreases the size of dopamine neurons in the ventral tegmental area (VTA), a key reward region in the brain, yet the molecular basis and functional consequences of this effect are unknown. In this study, we used viral-mediated gene transfer in rat to show that chronic morphine-induced downregulation of the insulin receptor substrate 2 (IRS2)-thymoma viral proto-oncogene (Akt) signaling pathway in the VTA mediates the decrease in dopamine cell size seen after morphine exposure and that this downregulation diminishes morphine reward, as measured by conditioned place preference. We further show that the reduction in size of VTA dopamine neurons persists up to 2 weeks after morphine withdrawal, which parallels the tolerance to morphine's rewarding effects caused by previous chronic morphine exposure. These findings directly implicate the IRS2-Akt signaling pathway as a critical regulator of dopamine cell morphology and opiate reward.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Neurosci Program, Tallahassee, FL 32306 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Yale University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kumar, Arvind/B-6094-2009; Russo, Scott/R-7107-2019; Winstanley, Catharine/K-5003-2015	Russo, Scott/0000-0002-6470-1805; Winstanley, Catharine/0000-0001-7032-4471; Kumar, Arvind/0000-0003-2879-3826; Eisch, Amelia/0000-0001-6476-5385; Renthal, William/0000-0003-0206-2101	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA019727, K08DA000302] Funding Source: NIH RePORTER; NIDA NIH HHS [K08 DA000302-05, F32 DA019727] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Aston-Jones G, 2004, NEUROPHARMACOLOGY, V47, P167, DOI 10.1016/j.neuropharm.2004.06.020; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BECHARA A, 1992, BEHAV NEUROSCI, V106, P364, DOI 10.1037/0735-7044.106.2.364; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Bolanos CA, 2003, J NEUROSCI, V23, P7569; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Georges F, 2006, J NEUROSCI, V26, P5720, DOI 10.1523/JNEUROSCI.5032-05.2006; Glass MJ, 2004, SYNAPSE, V53, P191, DOI 10.1002/syn.20049; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P292, DOI 10.1038/sj.npp.1300037; Horger BA, 1999, J NEUROSCI, V19, P4110; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Paladini CA, 2004, J NEUROSCI, V24, P5209, DOI 10.1523/JNEUROSCI.1079-04.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276; Russo SJ, 2003, NEUROSCIENCE, V120, P523, DOI 10.1016/S0306-4522(03)00317-8; SELF DW, 1995, SYNAPSE, V21, P312, DOI 10.1002/syn.890210405; SHIPPENBERG TS, 1988, PSYCHOPHARMACOLOGY, V96, P110, DOI 10.1007/BF02431542; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spiga S, 2003, EUR J NEUROSCI, V17, P605, DOI 10.1046/j.1460-9568.2003.02435.x; Walker JR, 2003, PHARMACOL BIOCHEM BE, V75, P349, DOI 10.1016/S0091-3057(03)00094-7; WISE RA, 1989, NEUROSCI BIOBEHAV R, V13, P129, DOI 10.1016/S0149-7634(89)80021-1; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Ziolkowska B, 2006, BRAIN RES, V1069, P1, DOI 10.1016/j.brainres.2005.11.042	40	168	172	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					93	99		10.1038/nn1812	http://dx.doi.org/10.1038/nn1812			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17143271				2022-12-28	WOS:000243096100020
J	Hafed, ZM; Krauzlis, RJ				Hafed, Ziad M.; Krauzlis, Richard J.			Ongoing eye movements constrain visual perception	NATURE NEUROSCIENCE			English	Article							BRAIN-STEM TELLS; PSYCHOMETRIC FUNCTION; PERCEIVED DIRECTION; SUPERIOR COLLICULUS; MOTION PERCEPTION; FORM CONSTRAINTS; FRONTAL-CORTEX; PURSUIT; SACCADES; SIGNALS	Eye movements markedly change the pattern of retinal stimulation. To maintain stable vision, the brain possesses a variety of mechanisms that compensate for the retinal consequences of eye movements. However, eye movements may also be important for resolving the ambiguities often posed by visual inputs, because motor commands contain additional spatial information that is necessarily absent from retinal signals. To test this possibility, we used a perceptually ambiguous stimulus composed of four line segments, consistent with a shape whose vertices were occluded. In a passive condition, subjects fixated a spot while the shape translated along a certain trajectory. In several active conditions, the spot, occluder and shape translated such that when subjects tracked the spot, they experienced the same retinal stimulus as during fixation. We found that eye movements significantly promoted perceptual coherence compared to fixation. These results indicate that eye movement information constrains the perceptual interpretation of visual inputs.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rich@salk.edu		Richard, Krauzlis/0000-0002-1826-0447	NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER; NEI NIH HHS [EY12212] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; Bedell HE, 2004, VISION RES, V44, P895, DOI 10.1016/j.visres.2003.11.006; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Burr D, 2004, CURR BIOL, V14, pR195, DOI 10.1016/j.cub.2004.02.020; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Castet E, 2000, NAT NEUROSCI, V3, P177, DOI 10.1038/72124; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; FERRERA VP, 1990, VISION RES, V30, P273, DOI 10.1016/0042-6989(90)90043-K; GRIMES J, 1996, PERCEPTION VANCOUVER, V5, P89; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; HEELEY DW, 1992, VISION RES, V32, P97, DOI 10.1016/0042-6989(92)90117-2; Henderson JM, 2003, PSYCHOL SCI, V14, P493, DOI 10.1111/1467-9280.02459; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; Irwin DE, 2004, PSYCHOL SCI, V15, P467, DOI 10.1111/j.0956-7976.2004.00703.x; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Krauzlis RJ, 1999, TRENDS NEUROSCI, V22, P544, DOI 10.1016/S0166-2236(99)01464-2; Krukowski AE, 2005, NEURON, V45, P315, DOI 10.1016/j.neuron.2005.01.005; Li HCO, 2002, VISION RES, V42, P2569, DOI 10.1016/S0042-6989(02)00295-X; Lorenceau J, 2001, NAT NEUROSCI, V4, P745, DOI 10.1038/89543; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; Lorenceau J, 1998, VISION RES, V38, P1605, DOI 10.1016/S0042-6989(97)00295-2; McConkie GW, 1996, J EXP PSYCHOL HUMAN, V22, P563, DOI 10.1037/0096-1523.22.3.563; McDermott J, 2004, J VISION, V4, P944, DOI 10.1167/4.10.9; McDermott J, 2001, PERCEPTION, V30, P905, DOI 10.1068/p3219; MINGOLLA E, 1992, VISION RES, V32, P1015, DOI 10.1016/0042-6989(92)90003-2; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RUBIN N, 1993, VISION RES, V33, P1385, DOI 10.1016/0042-6989(93)90045-X; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Souman JL, 2005, EXP BRAIN RES, V164, P376, DOI 10.1007/s00221-005-2261-6; Souman JL, 2005, VISION RES, V45, P845, DOI 10.1016/j.visres.2004.10.010; STEINBACH MJ, 1976, VISION RES, V16, P1371, DOI 10.1016/0042-6989(76)90154-1; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Thier P, 2001, NEUROIMAGE, V14, pS33, DOI 10.1006/nimg.2001.0840; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	48	27	27	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1449	1457		10.1038/nn1782	http://dx.doi.org/10.1038/nn1782			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TN	17028586				2022-12-28	WOS:000242403800025
J	Marcus, G; Rabagliati, H				Marcus, Gary; Rabagliati, Hugh			What developmental disorders can tell us about the nature and origins of language	NATURE NEUROSCIENCE			English	Article							FRAGILE-X; WILLIAMS-SYNDROME; GENERALIST GENES; SPEECH; IMPAIRMENT; EVOLUTION; FACULTY; EXPRESSION; COGNITION; DEFICITS	Few areas in the cognitive sciences evoke more controversy than language evolution, due in part to the difficulty in gathering relevant empirical data. The study of developmental disorders is well placed to provide important new clues, but has been hampered by a lack of consensus on the aims and interpretation of the research project. We suggest that the application of the Darwinian principle of 'descent with modification' can help to reconcile much apparently inconsistent data. We close by illustrating how systematic analyses within and between disorders, suitably informed by evolutionary theory -and ideally facilitated by the creation of an open-access database-could provide new insights into language evolution.	NYU, Dept Psychol, New York, NY 10003 USA	New York University	Marcus, G (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	gary.marcus@nyu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037059] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37059] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abbeduto L, 2003, AM J MENT RETARD, V108, P149, DOI 10.1352/0895-8017(2003)108<0149:RLSOAA>2.0.CO;2; Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; BaronCohen S, 1997, CHILD DEV, V68, P48; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BELLUGI U, 1990, AM J MED GENET, P115; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Cornish K, 2004, MENT RETARD DEV D R, V10, P11, DOI 10.1002/mrdd.20003; Cornish KM, 1999, CORTEX, V35, P263, DOI 10.1016/S0010-9452(08)70799-8; Cosmides L., 1994, MAPPING MIND DOMAIN, P85; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fitch WT, 2005, COGNITION, V97, P179, DOI 10.1016/j.cognition.2005.02.005; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; GOLINKOFF RM, 1994, J CHILD LANG, V21, P125, DOI 10.1017/S0305000900008692; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; Hagerman R J, 1999, NEURODEVELOPMENTAL D, P61; Halberda J, 2003, COGNITION, V87, pB23, DOI 10.1016/S0010-0277(02)00186-5; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Jarrold C, 1998, J CHILD PSYCHOL PSYC, V39, P511; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Laws G, 2004, INT J LANG COMM DIS, V39, P423, DOI 10.1080/13682820410001681207; Levy Y, 2006, J CHILD LANG, V33, P125, DOI 10.1017/S030500090500718X; LIEBEN A, 1901, MONATSH CHEM, V22, P289; Marcus G., 2004, BIRTH MIND TINY NUMB; Marcus GF, 2006, TRENDS COGN SCI, V10, P397, DOI 10.1016/j.tics.2006.07.003; Marcus GF, 2006, COGNITION, V101, P443, DOI 10.1016/j.cognition.2006.04.009; Marcus GF, 2006, NATURE, V440, P1117, DOI 10.1038/4401117a; Margulies EH, 2001, GENOME RES, V11, P1686, DOI 10.1101/gr.192601; Mervis CB, 1999, DEV COGN NEUROSCI, P65; Nadel L, 1999, DEV COGN NEUROSCI, P197; Pepperberg IM, 2000, J COMP PSYCHOL, V114, P219, DOI 10.1037//0735-7036.114.3.219; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Preissler MA, 2005, COGNITION, V97, pB13, DOI 10.1016/j.cognition.2005.01.008; Rice ML, 2005, APPL PSYCHOLINGUIST, V26, P7, DOI 10.1017/S0142716405050034; RICE ML, 1995, J SPEECH HEAR RES, V38, P850, DOI 10.1044/jshr.3804.850; RONDAL J, 1995, EXCEPTIONAL LANGAUGE; Rosin M.M., 1988, COMMUN DIS Q, V12, P49, DOI [10.1177/152574018801200105, DOI 10.1177/152574018801200105]; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; THOMAS M, 2002, BEHAV BRAIN SCI, V25, P750; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van der Lely HKJ, 1998, CURR BIOL, V8, P1253, DOI 10.1016/S0960-9822(07)00534-9; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930	50	17	17	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1226	1229		10.1038/nn1766	http://dx.doi.org/10.1038/nn1766			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001342				2022-12-28	WOS:000241493900012
J	Wang, W; Jones, HE; Andolina, IM; Salt, TE; Sillito, AM				Wang, Wei; Jones, Helen E.; Andolina, Ian M.; Salt, Thomas E.; Sillito, Adam M.			Functional alignment of feedback effects from visual cortex to thalamus	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; CORTICOFUGAL FEEDBACK; RELAY CELLS; PRIMATE V1; LAYER-VI; CAT; BURST; NEURONS; ORIENTATION; CONNECTIONS	Following from the classical work of Hubel and Wiesel, it has been recognized that the orientation and the on- and off-zones of receptive fields of layer 4 simple cells in the visual cortex are linked to the spatial alignment and properties of the cells in the visual thalamus that relay the retinal input. Here we present evidence showing that the orientation and the on- and off-zones of receptive fields of layer 6 simple cells in cat visual cortex that provide feedback to the thalamus are similarly linked to the alignment and properties of the receptive fields of the thalamic cells they contact. However, the pattern of influence linked to on- and off-zones is phase-reversed. This has important functional implications.	UCL, Inst Ophthalmol, London EC1V 9EL, England	University of London; University College London	Sillito, AM (corresponding author), UCL, Inst Ophthalmol, Bath St, London EC1V 9EL, England.	a.sillito@ucl.ac.uk	Salt, Thomas E/A-6405-2009; Andolina, Ian Max/S-7179-2019	Andolina, Ian Max/0000-0001-9985-3414				Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; BRUGGER F, 1993, EUR J PHARMACOL, V235, P153, DOI 10.1016/0014-2999(93)90836-7; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Cudeiro J, 1996, J PHYSIOL-LONDON, V490, P481, DOI 10.1113/jphysiol.1996.sp021159; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Erwin E, 1998, J NEUROSCI, V18, P9870; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Gerstein GL, 2001, NEURAL NETWORKS, V14, P589, DOI 10.1016/S0893-6080(01)00042-9; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; GRIEVE KL, 1995, EXP BRAIN RES, V104, P12; GRIEVE KL, 1995, J NEUROSCI, V15, P4868; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; HARVEY AR, 1980, J PHYSIOL-LONDON, V302, P507; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kara P, 2003, J NEUROSCI, V23, P8547; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; Ramcharan EJ, 2000, J NEUROPHYSIOL, V84, P1982, DOI 10.1152/jn.2000.84.4.1982; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rivadulla C, 2003, J PHYSIOL-LONDON, V553, P601, DOI 10.1113/jphysiol.2003.048561; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SILLITO AM, 1997, THALAMUS, V2, P1; SO YT, 1981, J NEUROPHYSIOL, V45, P107, DOI 10.1152/jn.1981.45.1.107; TSUMOTO T, 1978, EXP BRAIN RES, V32, P345; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107	39	93	94	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1330	1336		10.1038/nn1768	http://dx.doi.org/10.1038/nn1768			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980966				2022-12-28	WOS:000241493900027
J	Meredith, AL; Wiler, SW; Miller, BH; Takahashi, JS; Fodor, AA; Ruby, NF; Aldrich, RW				Meredith, Andrea L.; Wiler, Steven W.; Miller, Brooke H.; Takahashi, Joseph S.; Fodor, Anthony A.; Ruby, Norman F.; Aldrich, Richard W.			BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output	NATURE NEUROSCIENCE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CA2+-ACTIVATED K+ CHANNEL; VPAC(2) RECEPTOR; EXPLANTS INVITRO; CLOCK MUTATION; SCN NEURONS; FIRING RATE; IN-VITRO; PERIOD; MOUSE	Spontaneous action potentials in the suprachiasmatic nucleus (SCN) are necessary for normal circadian timing of behavior in mammals. The SCN exhibits a daily oscillation in spontaneous firing rate (SFR), but the ionic conductances controlling SFR and the relationship of SFR to subsequent circadian behavioral rhythms are not understood. We show that daily expression of the large conductance Ca2+ activated K+ channel (BK) in the SCN is controlled by the intrinsic circadian clock. BK channel-null mice (Kcnma1(-/-)) have increased SFRs in SCN neurons selectively at night and weak circadian amplitudes in multiple behaviors timed by the SCN. Kcnma1(-/-) mice show normal expression of clock genes such as Arnt1 (Bmal1), indicating a role for BK channels in SCN pacemaker output, rather than in intrinsic time- keeping. Our findings implicate BK channels as important regulators of the SFR and suggest that the SCN pacemaker governs the expression of circadian behavioral rhythms through SFR modulation.	Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Northwestern University; Howard Hughes Medical Institute; Northwestern University; Stanford University	Meredith, AL (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	ameredith@som.umaryland.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Meredith, Andrea/0000-0003-1061-2302	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL102758-01, R01 HL102758] Funding Source: Medline; NIMH NIH HHS [MH-60385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060385] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2005, DEV BRAIN RES, V157, P8, DOI 10.1016/j.devbrainres.2005.02.017; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; EARNEST DJ, 1991, BRAIN RES BULL, V26, P677, DOI 10.1016/0361-9230(91)90160-L; EARNEST DJ, 1986, BRAIN RES, V382, P129, DOI 10.1016/0006-8993(86)90119-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lundkvist GB, 2005, METHOD ENZYMOL, V393, P623, DOI 10.1016/S0076-6879(05)93033-4; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RATTRAY M, 1998, IN SITU HYBRIDISATIO, P23; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	50	178	179	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1041	1049		10.1038/nn1740	http://dx.doi.org/10.1038/nn1740			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845385	Green Accepted			2022-12-28	WOS:000240080300017
J	Aimone, JB; Wiles, J; Gage, FH				Aimone, James B.; Wiles, Janet; Gage, Fred H.			Potential role for adult neurogenesis in the encoding of time in new memories	NATURE NEUROSCIENCE			English	Article							GENERATED GRANULE CELLS; HIPPOCAMPAL FUNCTION; DENTATE GYRUS; AUTOBIOGRAPHICAL MEMORY; RAT HIPPOCAMPUS; CA3; EVENTS; PROLIFERATION; PLASTICITY; RETRIEVAL		Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld 4072, Australia	Salk Institute; University of Queensland	Aimone, JB (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Aimone, James B/C-7821-2011; Aimone, James Bradley/H-4694-2016; Wiles, Janet/C-1989-2008	Aimone, James Bradley/0000-0002-7361-253X; Wiles, Janet/0000-0002-4051-4116	NIA NIH HHS [AG-020938] Funding Source: Medline; NINDS NIH HHS [NS-05052842, NS-05050217] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG020938] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BARNES J, 1984, COMPLETE WORK ARTIST, P714; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Brown NR, 1998, APPL COGNITIVE PSYCH, V12, P305, DOI 10.1002/(SICI)1099-0720(199808)12:4<305::AID-ACP569>3.0.CO;2-5; Burt CDB, 2003, MEM COGNITION, V31, P317, DOI 10.3758/BF03194390; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; FRIEDMAN WJ, 1993, PSYCHOL BULL, V113, P44, DOI 10.1037/0033-2909.113.1.44; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LOFTUS EF, 1983, MEM COGNITION, V11, P114, DOI 10.3758/BF03213465; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McMahon DBT, 2002, J NEUROPHYSIOL, V88, P528, DOI 10.1152/jn.2002.88.1.528; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Schinder AF, 2004, PHYSIOLOGY, V19, P253, DOI 10.1152/physiol.00012.2004; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shum MS, 1998, PSYCHOL BULL, V124, P423, DOI 10.1037/0033-2909.124.3.423; Song HJ, 2005, J NEUROSCI, V25, P10366, DOI 10.1523/JNEUROSCI.3452-05.2005; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	50	513	539	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					723	727		10.1038/nn1707	http://dx.doi.org/10.1038/nn1707			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16732202				2022-12-28	WOS:000237895200008
J	Pu, L; Liu, QS; Poo, MM				Pu, L; Liu, QS; Poo, MM			BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; VENTRAL TEGMENTAL AREA; NEUROTROPHIC FACTOR; BRAIN; ADDICTION; EXPOSURE; HIPPOCAMPUS; PLASTICITY; REWARD; LTP	The neural mechanism underlying the relapse to drug use after drug withdrawal is largely unknown. We found that after withdrawal from repeated cocaine exposure, excitatory synapses onto dopamine neurons in the ventral tegmental area (VTA) of the rat midbrain became highly susceptible to potentiation by weak presynaptic stimuli, an effect requiring endogenous brain-derived neurotrophic factor-tyrosine kinase B (BDNF-TrkB) signaling. The elevated BDNF expression in the VTA after cocaine withdrawal may prime these synapses for potentiation by cue-associated activity, triggering drug craving and relapse.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@berkeley.edu		Pu, Lu/0000-0001-5370-2557				BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Grimm JW, 2003, J NEUROSCI, V23, P742; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7	15	109	109	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					605	607		10.1038/nn1687	http://dx.doi.org/10.1038/nn1687			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16633344				2022-12-28	WOS:000237417200009
J	Diano, S; Farr, SA; Benoit, SC; McNay, EC; da Silva, I; Horvath, B; Gaskin, FS; Nonaka, N; Jaeger, LB; Banks, WA; Morley, JE; Pinto, S; Sherwin, RS; Xu, L; Yamada, KA; Sleeman, MW; Tschop, MH; Horvath, TL				Diano, S; Farr, SA; Benoit, SC; McNay, EC; da Silva, I; Horvath, B; Gaskin, FS; Nonaka, N; Jaeger, LB; Banks, WA; Morley, JE; Pinto, S; Sherwin, RS; Xu, L; Yamada, KA; Sleeman, MW; Tschop, MH; Horvath, TL			Ghrelin controls hippocampal spine synapse density and memory performance	NATURE NEUROSCIENCE			English	Article							SPONTANEOUS-ALTERNATION; GLUCOSE-CONCENTRATION; INTRASEPTAL MORPHINE; GROWTH-HORMONE; ACETYLCHOLINE OUTPUT; SPATIAL MEMORY; MEDIAL SEPTUM; BRAIN; ATTENUATION; INFUSIONS	The gut hormone and neuropeptide ghrelin affects energy balance and growth hormone release through hypothalamic action that involves synaptic plasticity in the melanocortin system. Ghrelin binding is also present in other brain areas, including the telencephalon, where its function remains elusive. Here we report that circulating ghrelin enters the hippocampus and binds to neurons of the hippocampal formation, where it promotes dendritic spine synapse formation and generation of long-term potentiation. These ghrelin-induced synaptic changes are paralleled by enhanced spatial learning and memory. Targeted disruption of the gene that encodes ghrelin resulted in decreased numbers of spine synapses in the CA1 region and impaired performance of mice in behavioral memory testing, both of which were rapidly reversed by ghrelin administration. Our observations reveal an endogenous function of ghrelin that links metabolic control with higher brain functions and suggest novel therapeutic strategies to enhance learning and memory processes.	Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT 06520 USA; VA Med Ctr, GRECC, St Louis, MO 63106 USA; St Louis Univ, Sch Med, Div Geriatr Med, Dept Internal Med, St Louis, MO 63103 USA; Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Rockefeller Univ, Howard Hughes Med Inst, Dept Mol Genet, New York, NY 10021 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA	Yale University; Geriatric Research Education & Clinical Center; Saint Louis University; University System of Ohio; University of Cincinnati; Yale University; Howard Hughes Medical Institute; Rockefeller University; Regeneron; Washington University (WUSTL); Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	morley, john e/F-9177-2011; Morley, John Edward/K-1570-2019; Silva, Ivaldo/E-4143-2012; Banks, William A/K-1330-2017; Horvath, Balazs/GQH-5692-2022; Tschoep, Matthias H/I-5443-2014; Xu, Lin/C-4662-2011	morley, john e/0000-0001-6444-2965; Silva, Ivaldo/0000-0002-2370-943X; Banks, William A/0000-0002-0496-3619; Horvath, Balazs/0000-0002-1566-6564; Tschoep, Matthias/0000-0002-4744-371X; Farr, Susan/0000-0002-0481-2570	NIAAA NIH HHS [AA12743] Funding Source: Medline; NIA NIH HHS [AG22880] Funding Source: Medline; NIDDK NIH HHS [DK61619, DK60711, DK70039, DK7386] Funding Source: Medline; NINDS NIH HHS [NS41725, NS40525] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007386, R01DK070039, R01DK061619, R01DK060711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040525, R01NS041725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012743] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; BOSTOCK E, 1988, BEHAV NEUROSCI, V102, P643, DOI 10.1037/0735-7044.102.5.643; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Grove KL, 2005, J CLIN INVEST, V115, P3393, DOI 10.1172/JCI27211; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Horvath TL, 2003, CURR PHARM DESIGN, V9, P1383, DOI 10.2174/1381612033454748; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; McNay EC, 1998, J NEUROSCI, V18, P3853; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Morley JE, 2000, PEPTIDES, V21, P1761, DOI 10.1016/S0196-9781(00)00342-9; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; RAGOZZINO ME, 1994, BRAIN RES, V655, P77, DOI 10.1016/0006-8993(94)91599-7; Ragozzino ME, 1995, BEHAV NEUROSCI, V109, P1074; RAGOZZINO ME, 1992, BRAIN RES, V597, P241, DOI 10.1016/0006-8993(92)91480-3; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Rigamonti AE, 2002, J ENDOCRINOL, V175, pR1, DOI 10.1677/joe.0.175R001; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Seyler DE, 2000, DRUG DEVELOP RES, V49, P260, DOI 10.1002/1098-2299(200004)49:4<260::AID-DDR5>3.0.CO;2-6; Talley CP, 1999, NEUROBIOL LEARN MEM, V71, P62, DOI 10.1006/nlme.1998.3861; Thio LL, 2000, NEUROLOGY, V54, P325, DOI 10.1212/WNL.54.2.325; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; WAN RQ, 1995, NEUROBIOL LEARN MEM, V63, P74, DOI 10.1006/nlme.1995.1007; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	42	645	675	0	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					381	388		10.1038/nn1656	http://dx.doi.org/10.1038/nn1656			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491079				2022-12-28	WOS:000235645600018
J	Nitschke, JB; Dixon, GE; Sarinopoulos, I; Short, SJ; Cohen, JD; Smith, EE; Kosslyn, SM; Rose, RM; Davidson, RJ				Nitschke, JB; Dixon, GE; Sarinopoulos, I; Short, SJ; Cohen, JD; Smith, EE; Kosslyn, SM; Rose, RM; Davidson, RJ			Altering expectancy dampens neural response to aversive taste in primary taste cortex	NATURE NEUROSCIENCE			English	Article; Proceedings Paper	34th Annual Meeting of the Society-for-Neuroscience	OCT 23-27, 2004	San Diego, CA	Soc Neurosci			FUNCTIONAL NEUROANATOMY; GUSTATORY CORTEX; INSULAR CORTEX; MACAQUE MONKEY; CONFIDENCE-INTERVALS; PLACEBO; PAIN; ACTIVATION; HUMANS; REPRESENTATION	The primary taste cortex consists of the insula and operculum. Previous work has indicated that neurons in the primary taste cortex respond solely to sensory input from taste receptors and lingual somatosensory receptors. Using functional magnetic resonance imaging, we show here that expectancy modulates these neural responses in humans. When subjects were led to believe that a highly aversive bitter taste would be less distasteful than it actually was, they reported it to be less aversive than when they had accurate information about the taste and, moreover, the primary taste cortex was less strongly activated. In addition, the activation of the right insula and operculum tracked online ratings of the aversiveness for each taste. Such expectancy-driven modulation of primary sensory cortex may affect perceptions of external events.	Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychiat, Madison, WI 53705 USA; Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychol, Madison, WI 53705 USA; Princeton Univ, Dept Psychol, Ctr Study Brain, Princeton, NJ 08544 USA; Columbia Univ, Dept Psychol, New York, NY 10027 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Texas, Med Branch, Mind Brain Body & Hlth Initiat, Galveston, TX 77555 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; Columbia University; Harvard University; University of Texas System; University of Texas Medical Branch Galveston	Nitschke, JB (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychiat, 1500 Highland Ave, Madison, WI 53705 USA.	jnitschke@wisc.edu; rjdavids@wisc.edu	sarinopoulos, isidoros/B-5453-2010	Sarinopoulos, Issidoros/0000-0001-9879-5515; Short, Sarah/0000-0003-0985-999X; Davidson, Richard/0000-0002-8506-4964	NICHD NIH HHS [P30 HD03352] Funding Source: Medline; NIMH NIH HHS [T32-MH18931, K05-MH00875, K08-MH63984, MH43454, MH40747, P50-MH52354] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040747, K05MH000875, P50MH052354, K08MH063984, R37MH043454, R01MH043454, T32MH018931] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2000, J NEUROSCI, V20, P2683; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benedetti F, 1999, J NEUROSCI, V19, P3639; Bornstein W S, 1940, Yale J Biol Med, V12, P719; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Damasio A.R., 2003, LOOKING SPINOZA JOY; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mai JK, 2004, ATLAS HUMAN BRAIN; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Montgomery G, 1996, PSYCHOL SCI, V7, P174, DOI 10.1111/j.1467-9280.1996.tb00352.x; MOTTA G, 1959, Bull Sci Med (Bologna), V131, P480; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OGAWA H, 1994, NEUROSCI RES, V20, P1, DOI 10.1016/0168-0102(94)90017-5; Ostrowsky K, 2000, EPILEPSIA, V41, P681, DOI 10.1111/j.1528-1157.2000.tb00228.x; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Penfield W, 1954, EPILEPSY FUNCTIONAL; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; PFAFFMANN C, 1971, HDB SENSORY PHYSL, P75; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; ROLLS ET, 1988, J PHYSIOL-LONDON, V397, P1, DOI 10.1113/jphysiol.1988.sp016984; ROLLS ET, 1999, BRAIN EMOTION; SCOTT TR, 1986, J NEUROPHYSIOL, V56, P876, DOI 10.1152/jn.1986.56.3.876; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; SUDAKOV K, 1971, BRAIN RES, V28, P19, DOI 10.1016/0006-8993(71)90521-X; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanriover N, 2004, J NEUROSURG, V100, P891, DOI 10.3171/jns.2004.100.5.0891; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; YAXLEY S, 1988, PHYSIOL BEHAV, V42, P223, DOI 10.1016/0031-9384(88)90074-1; YAXLEY S, 1990, J NEUROPHYSIOL, V63, P689, DOI 10.1152/jn.1990.63.4.689; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	50	145	149	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					435	442		10.1038/nn1645	http://dx.doi.org/10.1038/nn1645			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	016UI	16462735				2022-12-28	WOS:000235645600024
J	Matsumoto, T; Rauskolb, S; Polack, M; Klose, J; Kolbeck, R; Korte, M; Barde, YA				Matsumoto, Tomoya; Rauskolb, Stefanie; Polack, Martin; Klose, Johannes; Kolbeck, Roland; Korte, Martin; Barde, Yves-Alain			Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; NEUROTROPHIC FACTOR; BRAIN; P75(NTR); ACTIVATION; GENE; MICE	Pro- and mature BDNF activate very different receptors and intracellular pathways, potentially leading to either neuronal death or survival. Here we examined the biochemistry of endogenous BDNF in mouse neurons using sensitive reagents and found that pro-BDNF is rapidly converted intracellularly to mature BDNF, the latter being stored and released by excitatory input.	[Matsumoto, Tomoya; Rauskolb, Stefanie; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Polack, Martin; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; [Klose, Johannes; Kolbeck, Roland; Barde, Yves-Alain] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Kolbeck, Roland] Medimmune Inc, Gaithersburg, MD 20878 USA	University of Basel; Braunschweig University of Technology; Max Planck Society; AstraZeneca; Medimmune	Barde, YA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X; Rauskolb, Stefanie/0000-0002-8936-5414				BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	15	263	272	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					131	133		10.1038/nn2038	http://dx.doi.org/10.1038/nn2038			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204444				2022-12-28	WOS:000252712100006
J	Grosjean, Y; Grillet, M; Augustin, H; Ferveur, JF; Featherstone, DE				Grosjean, Yael; Grillet, Micheline; Augustin, Hrvoje; Ferveur, Jean-Francois; Featherstone, David E.			A glial amino-acid transporter controls synapse strength and courtship in Drosophila	NATURE NEUROSCIENCE			English	Article							VESICULAR GLUTAMATE TRANSPORTER; MALE SEXUAL-BEHAVIOR; NUCLEUS-ACCUMBENS; EXPRESSION; GENE; WHITE; RECEPTORS; DOPAMINE; MUTATION; CENTERS	Mate choice is an evolutionarily critical decision that requires the detection of multiple sex-specific signals followed by central integration of these signals to direct appropriate behavior. The mechanisms controlling mate choice remain poorly understood. Here, we show that the glial amino-acid transporter genderblind controls whether Drosophila melanogaster males will attempt to mate with other males. Genderblind (gb) mutant males showed no alteration in heterosexual courtship or copulation, but were attracted to normally unappealing male species-specific chemosensory cues. As a result, genderblind mutant males courted and attempted to copulate with other Drosophila males. This homosexual behavior could be induced within hours using inducible RNAi, suggesting that genderblind controls nervous system function rather than its development. Consistent with this, and indicating that glial genderblind regulates ambient extracellular glutamate to suppress glutamatergic synapse strength in vivo, homosexual behavior could be turned on and off by altering glutamatergic transmission pharmacologically and/or genetically.	[Grillet, Micheline; Ferveur, Jean-Francois] Univ Bourgogne, CNRS 5548, UMR 5548, F-21000 Dijon, France; [Grosjean, Yael; Augustin, Hrvoje; Featherstone, David E.] Univ Illinois, Chicago, IL USA	Universite de Bourgogne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Featherstone, DE (corresponding author), Univ Lausanne, Inst Integrat Genom, Genopode Bldg,Room 3033, CH-1015 Lausanne, Switzerland.	def@uic.edu	Grosjean, Yael/E-2634-2017; AUGUSTIN, Hrvoje/AAK-9188-2020	Grosjean, Yael/0000-0003-0689-8344; Augustin, H/0000-0002-2041-3844; Grillet, Micheline/0000-0001-8992-3255	NINDS NIH HHS [R01 NS045628-03, R01 NS045628-04, R01 NS045628, R01 NS 045628] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045628] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adachi A, 2002, GLIA, V39, P268, DOI 10.1002/glia.10109; An X, 2000, J NEUROGENET, V14, P227, DOI 10.3109/01677060009084500; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Baker DA, 2002, J NEUROSCI, V22, P9134; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; BAKER DA, 2007, PSYCHOPHARMACOLOGY, DOI DOI 10.1038/SJ.NPP.1301532; Balakireva M, 1998, J NEUROSCI, V18, P4335; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; Burdo J, 2006, J HISTOCHEM CYTOCHEM, V54, P549, DOI 10.1369/jhc.5A6840.2006; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grosjean Y, 2001, GENET RES, V77, P239; Hing ALY, 1996, J NEUROBIOL, V30, P454; HORZ HP, 2004, MJ RES APPL NOTE, V3, P1; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; JUHASZ G, 1991, EUR J PHARMACOL, V209, P131, DOI 10.1016/0014-2999(91)90024-K; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee Y, 2007, PSYCHOPHARMACOLOGY, V191, P55, DOI 10.1007/s00213-006-0652-4; Lena I, 2005, J NEUROSCI RES, V81, P891, DOI 10.1002/jnr.20602; Lim J, 2005, INVEST OPHTH VIS SCI, V46, P2869, DOI 10.1167/iovs.05-0156; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; PIYANKARAGE SC, 2008, IN PRESS ANAL CHEM; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schuster Christoph M., 1993, Experientia Supplementum (Basel), V63, P234; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shirangi TR, 2007, DEV BIOL, V306, P10, DOI 10.1016/j.ydbio.2007.03.022; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; WOODARD C, 1989, GENETICS, V123, P315; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	49	80	85	0	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					54	61		10.1038/nn2019	http://dx.doi.org/10.1038/nn2019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066061	Green Accepted, Green Submitted			2022-12-28	WOS:000252117900012
J	Padoa-Schioppa, C; Assad, JA				Padoa-Schioppa, Camillo; Assad, John A.			The representation of economic value in the orbitofrontal cortex is invariant for changes of menu	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; REWARD VALUE; FRONTOTEMPORAL DEMENTIA; DECISION-MAKING; PARIETAL CORTEX; CHOICE; TRANSITIVITY; PREFERENCE; MONKEYS	Economic choice entails assigning values to the available options and is impaired by lesions to the orbitofrontal cortex (OFC). Recent results show that some neurons in the OFC encode the values that monkeys (Macaca mulatta) assign to different goods when they choose between them. A broad and fundamental question is how this neuronal representation of value depends on the behavioral context. Here we show that neuronal responses in the OFC are typically invariant for changes of menu. In other words, the activity of a neuron in response to one particular good usually does not depend on what other goods are available at the same time. Neurons in the OFC encode economic value, not relative preference. The fact that their responses are menu invariant suggests that transitivity, a fundamental trait of economic choice, may be rooted in the activity of individual neurons.	[Padoa-Schioppa, Camillo; Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Padoa-Schioppa, C (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	camillo@alum.mit.edu		Padoa-Schioppa, Camillo/0000-0002-7519-8790	NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH080852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041000] Funding Source: NIH RePORTER; NIMH NIH HHS [K99 MH080852-01, K99 MH080852, K99 MH 080852] Funding Source: Medline; NINDS NIH HHS [R01 NS041000, R01 NS041000-05, R01 NS 41000] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLINGHAM M, 2002, CHOICE THEORY VERY S, V125; Arana FS, 2003, J NEUROSCI, V23, P9632; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; CAMPIONE JC, 1969, J EXP CHILD PSYCHOL, V7, P387, DOI 10.1016/0022-0965(69)90001-0; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CHOI S, IN PRESS AM EC REV; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; GRACE RC, 1993, J EXP ANAL BEHAV, V60, P185, DOI 10.1901/jeab.1993.60-185; Hodges JR, 2001, NEUROLOGY, V56, pS6, DOI 10.1212/WNL.56.suppl_4.S6; Hosokawa T, 2007, NEUROSCI RES, V57, P434, DOI 10.1016/j.neures.2006.12.003; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; KREPS DM, 1990, COURSE MICROECONOMIC, V850; LOGAN FA, 1965, J COMP PHYSIOL PSYCH, V59, P1, DOI 10.1037/h0021633; Luce R, 1959, INDIVIDUAL CHOICE BE; MAZUR JE, 1987, J EXP ANAL BEHAV, V47, P287, DOI 10.1901/jeab.1987.47-287; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; NAVARICK DJ, 1972, J EXP ANAL BEHAV, V18, P389, DOI 10.1901/jeab.1972.18-389; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; PADOASCHIOPPA C, 2007, ANN NY ACAD SCI, DOI DOI 10.1196/ANNALS.1404.011; Pasquier F, 1997, EUR NEUROL, V38, P1, DOI 10.1159/000112894; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Pritchard TC, 2005, J NEUROSCI, V25, P6047, DOI 10.1523/JNEUROSCI.0430-05.2005; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; SHAFIR S, 1994, ANIM BEHAV, V48, P55, DOI 10.1006/anbe.1994.1211; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x	47	259	263	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					95	102		10.1038/nn2020	http://dx.doi.org/10.1038/nn2020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066060	Green Accepted			2022-12-28	WOS:000252117900017
J	Wu, CL; Xia, S; Fu, TF; Wang, H; Chen, YH; Leong, D; Chiang, AS; Tully, T				Wu, Chia-Lin; Xia, Shouzhen; Fu, Tsai-Feng; Wang, Huaien; Chen, Ying-Hsiu; Leong, Daniel; Chiang, Ann-Shyn; Tully, Tim			Specific requirement of NMDA receptors for long-term memory consolidation in Drosophila ellipsoid body	NATURE NEUROSCIENCE			English	Article							DOUBLE-STRANDED-RNA; MUSHROOM BODIES; CENTRAL COMPLEX; NEURONS; GENE; MELANOGASTER; BRAIN; ORGANIZATION; INTERFERENCE; EXPRESSION	In humans and many other animals, memory consolidation occurs through multiple temporal phases and usually involves more than one neuroanatomical brain system. Genetic dissection of Pavlovian olfactory learning in Drosophila melanogaster has revealed multiple memory phases, but the predominant view holds that all memory phases occur in mushroom body neurons. Here, we demonstrate an acute requirement for NMDA receptors (NMDARs) outside of the mushroom body during long-term memory (LTM) consolidation. Targeted dsRNA-mediated silencing of Nmdar1 and Nmdar2 (also known as dNR1 or dNR2, respectively) in cholinergic R4m-subtype large-field neurons of the ellipsoid body specifically disrupted LTM consolidation, but not retrieval. Similar silencing of functional NMDARs in the mushroom body disrupted an earlier memory phase, leaving LTM intact. Our results clearly establish an anatomical site outside of the mushroom body involved with LTM consolidation, thus revealing both a distributed brain system subserving olfactory memory formation and the existence of a system-level memory consolidation in Drosophila.	Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Univ Syst Taiwan, Brain Res Ctr, Hsinchu 30013, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Natl Chi Nan Univ, Dept Appl Chem, Nantou 545, Taiwan	National Tsing Hua University; National Tsing Hua University; Cold Spring Harbor Laboratory; National Chi Nan University	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Sect 2,Kuang-Fu Rd, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw; tully@cshl.edu		Fu, Tsai-Feng/0000-0002-0343-3018; Chiang, Ann-Shyn/0000-0001-9668-7115; Wu, Chia-Lin/0000-0002-7906-2364	NIMH NIH HHS [R01 MH066910-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066910] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; ALLWEIS C, 1991, NEURAL BEHAV PLASTIC, P370; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Dash PK, 2004, BRAIN RES REV, V45, P30, DOI 10.1016/j.brainresrev.2004.02.001; Davis J, 2002, OXFORD REV EDUC, V28, P275, DOI 10.1080/03054980220143423; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; EICHENBAUM H, 2001, CONDITIONING CONSCIO, P583; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Renn SCP, 1999, J NEUROBIOL, V41, P189; Roberts AC, 2003, TRENDS NEUROSCI, V26, P662, DOI 10.1016/j.tins.2003.09.014; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037	48	129	137	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1578	1586		10.1038/nn2005	http://dx.doi.org/10.1038/nn2005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982450	Green Accepted			2022-12-28	WOS:000251172900015
J	Hanisch, UK; Kettenmann, H				Hanisch, Uwe-Karsten; Kettenmann, Helmut			Microglia: active sensor and versatile effector cells in the normal and pathologic brain	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; SCAVENGER-RECEPTOR-AI/II; MYELIN PHAGOCYTOSIS; INTERFERON-GAMMA; IFN-GAMMA; DOWN-REGULATION; IMMUNE-SYSTEM; MACROPHAGES; ACTIVATION; EXPRESSION	Microglial cells constitute the resident macrophage population of the CNS. Recent in vivo studies have shown that microglia carry out active tissue scanning, which challenges the traditional notion of 'resting' microglia in the normal brain. Transformation of microglia to reactive states in response to pathology has been known for decades as microglial activation, but seems to be more diverse and dynamic than ever anticipated-in both transcriptional and nontranscriptional features and functional consequences. This may help to explain why engagement of microglia can be either neuroprotective or neurotoxic, resulting in containment or aggravation of disease progression. Moreover, little is known about the heterogeneity of microglial responses in different pathologic contexts that results from regional adaptations or from the progression of a disease. In this review, we focus on several key observations that illustrate the multi-faceted activities of microglia in the normal and pathologic brain.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	kettenmann@mdc-berlin.de	Kettenmann, Helmut/AAJ-5142-2021; Calabrese, Massimiliano/I-6195-2012	Kettenmann, Helmut/0000-0001-8208-0291				Bartnik BL, 2000, MULT SCLER, V6, P37, DOI 10.1191/135245800678827400; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Butovsky O, 2007, MOL CELL NEUROSCI, V35, P490, DOI 10.1016/j.mcn.2007.04.009; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DENES A, 2007, J CEREB BLOOD F 0418; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Elkabes S, 1996, J NEUROSCI, V16, P2508; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Glanzer JG, 2007, J NEUROCHEM, V102, P627, DOI 10.1111/j.1471-4159.2007.04568.x; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hanisch UK, 2001, EUR J IMMUNOL, V31, P2104, DOI 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Kitamura Y, 2000, J NEUROIMMUNOL, V106, P95, DOI 10.1016/S0165-5728(00)00239-3; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuwabara Y, 2003, J NEUROSCI RES, V73, P22, DOI 10.1002/jnr.10637; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369; Liu Y, 2006, J NEUROSCI, V26, P12904, DOI 10.1523/JNEUROSCI.2531-06.2006; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Magnus T, 2001, J IMMUNOL, V167, P5004, DOI 10.4049/jimmunol.167.9.5004; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Makranz C, 2004, NEUROBIOL DIS, V15, P279, DOI 10.1016/j.nbd.2003.11.007; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; POCOCK JM, IN PRESS TRENDS NEUR; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Qian L, 2006, J NEURAL TRANSM-SUPP, P367; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Reichert F, 2003, NEUROBIOL DIS, V12, P65, DOI 10.1016/S0969-9961(02)00008-6; Ren LQ, 1999, MOL BRAIN RES, V65, P198, DOI 10.1016/S0169-328X(99)00016-9; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Stadelmann C, 2002, BRAIN, V125, P75, DOI 10.1093/brain/awf015; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Synowitz M, 2006, CANCER RES, V66, P8550, DOI 10.1158/0008-5472.CAN-06-0365; Takata K, 2007, FEBS LETT, V581, P475, DOI 10.1016/j.febslet.2007.01.009; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wirenfeldt M, 2005, J NEUROSCI RES, V82, P507, DOI 10.1002/jnr.20659; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	100	2566	2626	10	387	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1387	1394		10.1038/nn1997	http://dx.doi.org/10.1038/nn1997			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965659				2022-12-28	WOS:000250508400013
J	Jacob, J; Ferri, AL; Milton, C; Prin, F; Pla, P; Lin, W; Gavalas, A; Ang, SL; Briscoe, J				Jacob, John; Ferri, Anna L.; Milton, Christopher; Prin, Fabrice; Pla, Patrick; Lin, Wei; Gavalas, Anthony; Ang, Siew-Lan; Briscoe, James			Transcriptional repression coordinates the temporal switch from motor to serotonergic neurogenesis	NATURE NEUROSCIENCE			English	Article							HOMEOBOX GENE PHOX2B; FLOOR PLATE; OLIGODENDROCYTE DIFFERENTIATION; SEROTONINERGIC NEURONS; NEURAL-TUBE; SPECIFICATION; IDENTITY; HEDGEHOG; EXPRESSION; NKX2.2	In many regions of the developing CNS, distinct cell types are born at different times. The means by which discrete and stereotyped temporal switches in cellular identities are acquired remains poorly understood. To address this, we have examined how visceral motor neurons (VMNs) and serotonergic neurons, two neuronal subtypes, are sequentially generated from a common progenitor pool in the vertebrate hindbrain. We found that the forkhead transcription factor Foxa2, acting in progenitors, is essential for the transition from VMN to serotonergic neurogenesis. Loss-of-function and gain-of-function experiments indicated that Foxa2 activates the switch through a temporal cross-repressive interaction with paired-like homeobox 2b (Phox2b), the VMN progenitor determinant. This mechanism bears a marked resemblance to the cross-repression between neighboring domains of transcription factors that establish discrete progenitor identities along the spatial axes. Moreover, the subsequent differentiation of central serotonergic neurons required both the suppression of VMN neurogenesis and the induction of downstream intrinsic determinants of serotonergic identity by Foxa2.	Natl Inst Med Res, Ridgeway, London NW7 1AA, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Ecole Normale Super, CNRS, UMR8542, Dept Biol, F-75005 Paris, France; Acad Athens, Biomed Res Fdn, Dev Biol Lab, Athens 11527, Greece	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Academy of Athens	Briscoe, J (corresponding author), Natl Inst Med Res, Ridgeway, Mill Hill, London NW7 1AA, England.	sang@nimr.mrc.ac.uk; jbrisco@nimr.mrc.ac.uk	Ferri, Luca Angelo/AAC-5890-2022; Gavalas, Anthony/F-5817-2015	Ferri, Luca Angelo/0000-0001-9031-6284; Briscoe, James/0000-0002-1020-5240; Pla, Patrick/0000-0002-5957-2340; Gavalas, Anthony/0000-0003-4897-0359	Medical Research Council [G108/527, MC_U117570533, MC_U117560541] Funding Source: Medline; MRC [MC_U117560541, G108/527] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTABA ARI, 1995, MOL CELL NEUROSCI, V6, P106, DOI 10.1006/mcne.1995.1011; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cheng LP, 2003, J NEUROSCI, V23, P9961; Cordes SP, 2001, NAT REV NEUROSCI, V2, P611, DOI 10.1038/35090039; COVELL DA, 1989, J COMP NEUROL, V286, P488, DOI 10.1002/cne.902860407; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Hallonet M, 2002, DEV BIOL, V243, P20, DOI 10.1006/dbio.2001.0536; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2000, MOL CELL NEUROSCI, V16, P14, DOI 10.1006/mcne.2000.0855; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jeong Y, 2003, DEVELOPMENT, V130, P3891, DOI 10.1242/dev.00590; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pierce E T, 1973, Prog Brain Res, V40, P53; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Qi YC, 2001, DEVELOPMENT, V128, P2723; Rand CM, 2007, PEDIATR RES, V62, P180, DOI 10.1203/PDR.0b013e3180a725a0; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; SAKO H, 1986, J COMP NEUROL, V253, P61, DOI 10.1002/cne.902530106; Samad OA, 2004, DEVELOPMENT, V131, P4071, DOI 10.1242/dev.01282; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Tiveron MC, 2003, DEV BIOL, V260, P46, DOI 10.1016/S0012-1606(03)00213-6; VALLET V, 1995, MOL CELL BIOL, V15, P5453; van Doorninck J H, 1999, J Neurosci, V19, pRC12; WALLACE JA, 1985, J COMP NEUROL, V236, P443, DOI 10.1002/cne.902360403; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	50	66	66	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1433	1439		10.1038/nn1985	http://dx.doi.org/10.1038/nn1985			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17922007				2022-12-28	WOS:000250508400021
J	Canli, T; Lesch, KP				Canli, Turhan; Lesch, Klaus-Peter			Long story short: the serotonin transporter in emotion regulation and social cognition	NATURE NEUROSCIENCE			English	Review							ANXIETY-RELATED TRAITS; STRESSFUL LIFE EVENTS; PROMOTER POLYMORPHISM; MAJOR DEPRESSION; GENETIC-VARIATION; HIPPOCAMPAL VOLUME; PERSONALITY-TRAITS; HUMAN AMYGDALA; FUNCTIONAL POLYMORPHISM; PSYCHIATRIC-DISORDERS	The gene encoding the serotonin transporter ( 5-HTT) contains a regulatory variation that has been associated with anxiety-related traits and susceptibility for depression. Here we highlight recent discoveries related to allelic variation of 5-HTT function with respect to emotion regulation and social behavior, drawing from an interdisciplinary perspective of behavioral genetics and cognitive neuroscience. Following a reductionistic path that leads from gene-behavior association studies to neuroimaging and epigenetic studies, we compare two models of 5-HTT-dependent modulation of brain activity and discuss the role of life stress experience in modifying 5-HTT function in the brain. Integration of these findings suggests that the impact of the 5-HTT gene on behavior is much broader than is commonly appreciated and may have a role in social cognition.	SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; Univ Wurzburg, Dept Psychiat & Psychotherapy, D-97080 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Canli, T (corresponding author), SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA.	turhan.canli@sunysb.edu; kplesch@mail.uni-wuerzburg.de	Canli, Turhan/F-9274-2019; Lesch, Klaus-Peter/J-4906-2013	Canli, Turhan/0000-0003-3646-239X; Lesch, Klaus-Peter/0000-0001-8348-153X	NCRR NIH HHS [5-M01-RR10710] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Amat J, 2004, NEUROSCIENCE, V129, P509, DOI 10.1016/j.neuroscience.2004.07.052; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Ball D, 1997, NEUROREPORT, V8, P1301, DOI 10.1097/00001756-199703240-00048; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Barr CS, 2003, ALCOHOL CLIN EXP RES, V27, P812, DOI 10.1097/01.ALC.0000067976.62827.ED; BAUMEISTER RF, 1990, J SOC CLIN PSYCHOL, V9, P165, DOI 10.1521/jscp.1990.9.2.165; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; de Geus EJC, 2001, BEHAV GENET, V31, P489, DOI 10.1023/A:1013360909048; Deary IJ, 1999, PSYCHOL MED, V29, P735, DOI 10.1017/S0033291798007557; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455; Fisher PM, 2006, NAT NEUROSCI, V9, P1362, DOI 10.1038/nn1780; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Forster GL, 2006, NEUROSCIENCE, V141, P1047, DOI 10.1016/j.neuroscience.2006.04.006; Frodl T, 2004, ARCH GEN PSYCHIAT, V61, P177, DOI 10.1001/archpsyc.61.2.177; Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GOTTESMAN II, 1973, BRIT J PSYCHIAT, V122, P15, DOI 10.1192/bjp.122.1.15; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamer D, 2002, SCIENCE, V298, P71, DOI 10.1126/science.1077582; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; HEINZ A, 2004, BIOL PSYCHIAT, V161, P1957; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; HIGLEY JD, 1991, PSYCHOPHARMACOLOGY, V103, P551, DOI 10.1007/BF02244258; Jorm AF, 1998, MOL PSYCHIATR, V3, P449, DOI 10.1038/sj.mp.4000424; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LOANNIDIS JP, 2006, JNCI-J NATL CANCER I, V98, P1350; Mazzanti CM, 1998, ARCH GEN PSYCHIAT, V55, P936, DOI 10.1001/archpsyc.55.10.936; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Moerk KC, 2000, J AFFECT DISORDERS, V58, P117, DOI 10.1016/S0165-0327(99)00102-0; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Munafo MR, 2005, MOL PSYCHIATR, V10, P895, DOI 10.1038/sj.mp.4001706; Munafo MR, 2005, MOL PSYCHIATR, V10, P415, DOI 10.1038/sj.mp.4001627; Nakamura T, 1997, AM J MED GENET, V74, P544, DOI 10.1002/(SICI)1096-8628(19970919)74:5<544::AID-AJMG18>3.0.CO;2-C; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Praschak-Rieder N, 2007, BIOL PSYCHIAT, V62, P327, DOI 10.1016/j.biopsych.2006.09.022; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Reif A, 2003, BEHAV BRAIN RES, V139, P1, DOI 10.1016/S0166-4328(02)00267-X; Reimold M, 2007, J NEURAL TRANSM, V114, P635, DOI 10.1007/s00702-006-0609-0; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rusch BD, 2001, BIOL PSYCHIAT, V50, P960, DOI 10.1016/S0006-3223(01)01248-3; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shioe K, 2003, SYNAPSE, V48, P184, DOI 10.1002/syn.10204; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sirota LA, 1999, PSYCHIATR GENET, V9, P35, DOI 10.1097/00041444-199903000-00006; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Thapar A, 1997, J CHILD PSYCHOL PSYC, V38, P651, DOI 10.1111/j.1469-7610.1997.tb01692.x; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; Thierry Bernard, 2000, P106; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Wendland JR, 2006, BEHAV GENET, V36, P163, DOI 10.1007/s10519-005-9017-8; Wessel J, 2007, GENOMICS, V90, P132, DOI 10.1016/j.ygeno.2007.03.003; Willis-Owen SAG, 2005, BIOL PSYCHIAT, V58, P451, DOI 10.1016/j.biopsych.2005.04.050; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103	92	680	691	4	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1103	1109		10.1038/nn1964	http://dx.doi.org/10.1038/nn1964			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726476				2022-12-28	WOS:000249144000008
J	Remedios, R; Huilgol, D; Saha, B; Hari, P; Bhatnagar, L; Kowalczyk, T; Hevner, RF; Suda, Y; Aizawa, S; Ohshima, T; Stoykova, A; Tole, S				Remedios, Ryan; Huilgol, Dhananjay; Saha, Bhaskar; Hari, Padmanabhan; Bhatnagar, Lahar; Kowalczyk, Thomas; Hevner, Robert F.; Suda, Yoko; Aizawa, Shinichi; Ohshima, Toshio; Stoykova, Anastassia; Tole, Shubha			A stream of cells migrating from the caudal telencephalon reveals a link between the amygdala and neocortex	NATURE NEUROSCIENCE			English	Article							EMBRYONIC CEREBRAL-CORTEX; GANGLIONIC EMINENCE; MOUSE TELENCEPHALON; NEURONAL MIGRATION; SIGNALING PATHWAY; EVOLUTION; EXPRESSION; REELIN; GENES; ORGANIZATION	The amygdaloid complex consists of diverse nuclei that belong to distinct functional systems, yet many issues about its development are poorly understood. Here, we identify a stream of migrating cells that form specific amygdaloid nuclei in mice. In utero electroporation showed that this caudal amygdaloid stream ( CAS) originated in a unique domain at the caudal telencephalic pole that is contiguous with the dorsal pallium, which was previously thought to generate only neocortical cells. The CAS and the neocortex share mechanisms for specification ( transcription factors Tbr1, Lhx2 and Emx1/ 2) and migration ( reelin and Cdk5). Reelin, a critical cue for migration in the neocortex, and Cdk5, which is specifically required for migration along radial glia in the neocortex, were both selectively required for the normal migration of the CAS, but not for that of other amygdaloid nuclei. This is first evidence of a dorsal pallial contribution to the amygdala, demonstrating a developmental and mechanistic link between the amygdala and the neocortex.	Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chou Ku, Kobe, Hyogo 6500047, Japan; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama 3510198, Japan; Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1698555, Japan; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Tata Institute of Fundamental Research (TIFR); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; RIKEN; RIKEN; Waseda University; Max Planck Society	Tole, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd,B-304, Bombay 400005, Maharashtra, India.	stole@tifr.res.in	Remedios, Ryan/AAA-2389-2020; Huilgol, Dhananjay/AAM-7793-2020	Huilgol, Dhananjay/0000-0003-4393-7242; Padmanabhan, Hari/0000-0002-2289-0249; Remedios, Ryan/0000-0001-6004-808X	Wellcome Trust [056684/Z/99/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aboitiz F, 2002, BRAIN RES REV, V39, P141, DOI 10.1016/S0165-0173(02)00180-7; Aboitiz F, 1999, CEREB CORTEX, V9, P655, DOI 10.1093/cercor/9.7.655; ALHEID GF, 1995, RAT NERVOUS SYSTEM, V2, P495; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bar I, 2000, TRENDS NEUROSCI, V23, P633, DOI 10.1016/S0166-2236(00)01675-1; Barton RA, 2003, P ROY SOC B-BIOL SCI, V270, P539, DOI 10.1098/rspb.2002.2276; Beffert U, 2004, J NEUROSCI, V24, P1897, DOI 10.1523/JNEUROSCI.4084-03.2004; Broccoli Vania, 1999, Bioessays, V21, P974, DOI 10.1002/(SICI)1521-1878(199911)21:11<974::AID-BIES10>3.0.CO;2-8; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Caviness V S Jr, 1982, Brain Res, V256, P293; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; Martinez-Garcia F, 2002, BRAIN RES BULL, V57, P463, DOI 10.1016/S0361-9230(01)00665-7; MARTINEZGARCIA F, 1991, J COMP NEUROL, V305, P337, DOI 10.1002/cne.903050214; MCCONNELL J, 1983, BRAIN RES, V272, P150, DOI 10.1016/0006-8993(83)90372-4; McDonald AJ, 2003, ANN NY ACAD SCI, V985, P1; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Molnar Z, 2002, BIOESSAYS, V24, P530, DOI 10.1002/bies.10100; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Porter FD, 1997, DEVELOPMENT, V124, P2935; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Remedios R, 2004, J NEUROSCI, V24, P6986, DOI 10.1523/JNEUROSCI.0001-04.2004; Rice DS, 1998, DEVELOPMENT, V125, P3719; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Santiago AC, 2004, J COMP NEUROL, V471, P314, DOI 10.1002/cne.20028; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Tissir F, 2002, BRAZ J MED BIOL RES, V35, P1473, DOI 10.1590/S0100-879X2002001200007; Tole S, 2005, J NEUROSCI, V25, P2753, DOI 10.1523/JNEUROSCI.3014-04.2005; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Vyas A, 2003, J COMP NEUROL, V466, P545, DOI 10.1002/cne.10900; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yamamoto K, 2005, BRAIN RES BULL, V66, P341, DOI 10.1016/j.brainresbull.2005.02.016; Yun K, 2001, DEVELOPMENT, V128, P193	50	72	76	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1141	1150		10.1038/nn1955	http://dx.doi.org/10.1038/nn1955			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694053	Green Published			2022-12-28	WOS:000249144000016
J	Aguirre, A; Dupree, JL; Mangin, JM; Gallo, V				Aguirre, Adan; Dupree, Jeff L.; Mangin, J. M.; Gallo, Vittorio			A functional role for EGFR signaling in myelination and remyelination	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; OLIGODENDROCYTE LINEAGE; MULTIPLE-SCLEROSIS; NEURAL PROGENITORS; TYROSINE KINASE; ADULT FOREBRAIN; NERVOUS-SYSTEM; WHITE-MATTER	Cellular strategies for oligodendrocyte regeneration and remyelination involve characterizing endogenous neural progenitors that are capable of generating oligodendrocytes during normal development and after demyelination, and identifying the molecular signals that enhance oligodendrogenesis from these progenitors. Using both gain- and loss-of-function approaches, we explored the role of epidermal growth factor receptor (EGFR) signaling in adult myelin repair and in oligodendrogenesis. We show that 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase (CNP) promoter-driven overexpression of human EGFR (hEGFR) accelerated remyelination and functional recovery following focal demyelination of mouse corpus callosum. Lesion repopulation by Cspg(4+) (also known as NG2) Ascl1(+) (also known as Mash1) Olig2(+) progenitors and functional remyelination were accelerated in CNP-hEGFR mice compared with wild-type mice. EGFR overexpression in subventricular zone (SVZ) and corpus callosum during early postnatal development also expanded this NG2(+)Mash1(+)Olig2(+) progenitor population and promoted SVZ-to-lesion migration, enhancing oligodendrocyte generation and axonal myelination. Analysis of hypomorphic EGFR-mutant mice confirmed that EGFR signaling regulates oligodendrogenesis and remyelination by NG2(+)Mash1(+)Olig2(+) progenitors. EGFR targeting holds promise for enhancing oligodendrocyte regeneration and myelin repair.	Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Children's National Health System; Virginia Commonwealth University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, 111 Michigan Ave,NW, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Mangin, Jean-Marie/0000-0002-7804-0251	NICHD NIH HHS [P30HD40677] Funding Source: Medline; NINDS NIH HHS [5P30NS047463, R01NS045702, R21NS050463] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045702, P30NS047463, R21NS050463] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ferrer I, 1996, PROG NEUROBIOL, V49, P99; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Goddard DR, 2001, MOL CELL NEUROSCI, V18, P557, DOI 10.1006/mcne.2001.1025; Hidalgo A, 2002, TRENDS NEUROSCI, V25, P365, DOI 10.1016/S0166-2236(02)02186-0; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; Jin KL, 2002, J NEUROSCI, V22, P5365; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Knapp PE, 2004, EXP CELL RES, V296, P135, DOI 10.1016/j.yexcr.2004.02.007; Kornblum HI, 2000, DEV NEUROSCI-BASEL, V22, P16, DOI 10.1159/000017423; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Lisovoski F, 1997, J NEUROPATH EXP NEUR, V56, P459, DOI 10.1097/00005072-199705000-00001; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mason JL, 2003, J NEUROSCI, V23, P7710; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; MATTHIEU JM, 1992, J NEUROIMMUNOL, V40, P231, DOI 10.1016/0165-5728(92)90138-B; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; NIETOSAMPEDRO M, 1988, NEUROSCI LETT, V91, P276, DOI 10.1016/0304-3940(88)90693-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Stangel M, 2002, PROG NEUROBIOL, V68, P361, DOI 10.1016/S0301-0082(02)00105-3; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368	50	267	272	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					990	1002		10.1038/nn1938	http://dx.doi.org/10.1038/nn1938			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618276				2022-12-28	WOS:000248357500013
J	Mak, GK; Enwere, EK; Gregg, C; Pakarainen, T; Poutanen, M; Huhtaniemi, I; Weiss, S				Mak, Gloria K.; Enwere, Emeka K.; Gregg, Christopher; Pakarainen, Tomi; Poutanen, Matti; Huhtaniemi, Ilpo; Weiss, Samuel			Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior	NATURE NEUROSCIENCE			English	Article							MAIN OLFACTORY EPITHELIUM; NEWLY GENERATED NEURONS; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; LUTEINIZING-HORMONE; MAMMALIAN BRAIN; ENRICHED ENVIRONMENT; PROLACTIN PRL; MICE; RECEPTOR	The regulation of female reproductive behaviors may involve memories of male pheromone signatures, formed in part by neural circuitry involving the olfactory bulb and hippocampus. These neural structures are the principal sites of adult neurogenesis; however, previous studies point to their independent regulation by sensory and physiological stimuli. Here we report that the pheromones of dominant (but not subordinate) males stimulate neuronal production in both the olfactory bulb and hippocampus of female mice, which are independently mediated by prolactin and luteinizing hormone, respectively. Neurogenesis induced by dominant-male pheromones correlates with a female preference for dominant males over subordinate males, whereas blocking neurogenesis with the mitotic inhibitor cytosine arabinoside eliminated this preference. These results suggest that male pheromones are involved in regulating neurogenesis in both the olfactory bulb and hippocampus, which may be important for female reproductive success.	Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland; Univ London Imperial Coll Sci & Technol, Inst Reprod & Dev Biol, London W12 0NN, England; Childrens Hosp Eastern Ontario, Res Inst 2, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Calgary; University of Turku; Imperial College London; University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Howard Hughes Medical Institute	Weiss, S (corresponding author), Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	weiss@ucalgary.ca	Oka, Yoshitaka/C-9670-2010; Poutanen, Matti/I-1700-2018	Oka, Yoshitaka/0000-0002-3482-3051; Poutanen, Matti/0000-0002-8953-1734				Bakker J, 2003, J NEUROENDOCRINOL, V15, P615, DOI 10.1046/j.1365-2826.2003.01036.x; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Brennan PA, 2004, HORM BEHAV, V46, P231, DOI 10.1016/j.yhbeh.2004.01.010; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Foster D L., 1994, PHYSL REPROD, V2; Ganem G, 2005, BIOL J LINN SOC, V84, P461, DOI 10.1111/j.1095-8312.2005.00447.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Huhtaniemi I, 2002, MOL CELL ENDOCRINOL, V187, P49, DOI 10.1016/S0303-7207(01)00698-0; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mossman CA, 1996, J COMP PSYCHOL, V110, P131, DOI 10.1037/0735-7036.110.2.131; Mucignat-Caretta C, 1999, BEHAVIOUR, V136, P331, DOI 10.1163/156853999501351; Rao CV, 2002, MOL CELL ENDOCRINOL, V187, P57, DOI 10.1016/S0303-7207(01)00694-3; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	50	246	252	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1003	1011		10.1038/nn1928	http://dx.doi.org/10.1038/nn1928			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603480				2022-12-28	WOS:000248357500014
J	Williams, MA; Dang, S; Kanwisher, NG				Williams, Mark A.; Dang, Sabin; Kanwisher, Nancy G.			Only some spatial patterns of fMRI response are read out in task performance	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; MICROSTIMULATION; REPRESENTATIONS; RECOGNITION	Classification methods show that the spatial pattern of a functional magnetic resonance imaging response across the cortex contains category information, but whether such patterns are used, or 'read out', in behavioral performance remains untested. We show that although the spatial pattern in both the retinotopic and lateral occipital cortex (LOC) in humans contains category information, only in the LOC is the pattern stronger for correct than for incorrect trials. Thus, some, but not all, spatial patterns are read out during task performance.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Macquarie University; Harvard University; Massachusetts General Hospital	Williams, MA (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	markaw@mit.edu		Williams, Mark/0000-0002-3897-5167	NEI NIH HHS [R01 EY013455, R01 EY013455-05A1] Funding Source: Medline; PHS HHS [13455] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Chambers CD, 2005, TRENDS COGN SCI, V9, P542, DOI 10.1016/j.tics.2005.09.010; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006	14	146	146	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					685	686		10.1038/nn1900	http://dx.doi.org/10.1038/nn1900			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486103	Green Accepted			2022-12-28	WOS:000246799800009
J	Petreanu, L; Huber, D; Sobczyk, A; Svoboda, K				Petreanu, Leopoldo; Huber, Daniel; Sobczyk, Aleksander; Svoboda, Karel			Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections	NATURE NEUROSCIENCE			English	Article							SYNAPTIC CONNECTIONS; CORPUS-CALLOSUM; OPTICAL CONTROL; NEURONS; RAT; ORGANIZATION; SYNAPSES; PHOTOSTIMULATION; INTERNEURONS; RESPONSES	The functions of cortical areas depend on their inputs and outputs, but the detailed circuits made by long- range projections are unknown. We show that the light- gated channel channelrhodopsin- 2 ( ChR2) is delivered to axons in pyramidal neurons in vivo. In brain slices from ChR2- expressing mice, photostimulation of ChR2- positive axons can be transduced reliably into single action potentials. Combining photostimulation with whole- cell recordings of synaptic currents makes it possible to map circuits between presynaptic neurons, defined by ChR2 expression, and postsynaptic neurons, defined by targeted patching. We applied this technique, ChR2- assisted circuit mapping ( CRACM), to map long- range callosal projections from layer ( L) 2/3 of the somatosensory cortex. L2/3 axons connect with neurons in L5, L2/3 and L6, but not L4, in both ipsilateral and contralateral cortex. In both hemispheres the L2/3- to- L5 projection is stronger than the L2/3- to- L2/3 projection. Our results suggest that laminar specificity may be identical for local and longrange cortical projections.	Howard Hughes Med Inst, Ashburn, VA 20147 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679				Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CZEIGER D, 1993, J COMP NEUROL, V330, P502, DOI 10.1002/cne.903300406; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Dantzker JL, 1998, J NEUROSCI, V18, P4145; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; IVY GO, 1979, BRAIN RES, V173, P532, DOI 10.1016/0006-8993(79)90247-6; Karayannis T, 2007, CEREB CORTEX, V17, P1213, DOI 10.1093/cercor/bhl035; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; WHITE EL, 1991, J COMP NEUROL, V303, P233, DOI 10.1002/cne.903030206; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	45	625	635	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					663	668		10.1038/nn1891	http://dx.doi.org/10.1038/nn1891			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435752				2022-12-28	WOS:000245948000024
J	Zhong, J; Li, XY; McNamee, C; Chen, AP; Baccarini, M; Snider, WD				Zhong, Jian; Li, Xiaoyan; McNamee, Cara; Chen, Adele P.; Baccarini, Manuela; Snider, William D.			Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo	NATURE NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; B-RAF; A-RAF; MUTATIONS; ERK; CELLS; BRAF; NEUROTROPHIN; EXPRESSION; INSIGHTS	To define the role of the Raf serine/ threonine kinases in nervous system development, we conditionally targeted B-Raf and C-Raf, two of the three known mammalian Raf homologs, using a mouse line expressing Cre recombinase driven by a nestin promoter. Targeting of B-Raf, but not C-Raf, markedly attenuated baseline phosphorylation of Erk in neural tissues and led to growth retardation. Conditional elimination of B-Raf in dorsal root ganglion (DRG) neurons did not interfere with survival, but instead caused marked eduction in expression of the glial cell line - derived neurotrophic factor receptor Ret at postnatal stages, associated with a profound reduction in levels of transcription factor CBF-beta. Elimination of both alleles of Braf, which encodes B-Raf, and one allele of Raf1, which encodes C-Raf, affected DRG neuron maturation as well as proprioceptive axon projection toward the ventral horn in the spinal cord. Finally, conditional elimination of all Braf and Raf1 alleles strongly reduced neurotrophin-dependent axon growth in vitro as well as cutaneous axon terminal arborization in vivo. We conclude that Raf function is crucial for several aspects of DRG neuron development, including differentiation and axon growth.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Vienna Bioctr, A-1030 Vienna, Austria	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vienna Biocenter (VBC)	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu	Baccarini, Manuela/B-6481-2014	Baccarini, Manuela/0000-0002-3033-391X	Austrian Science Fund FWF [P 18712] Funding Source: Medline; NINDS NIH HHS [NS45892] Funding Source: Medline; PHS HHS [R01N0S31768] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Althini S, 2004, MOL CELL NEUROSCI, V25, P345, DOI 10.1016/j.mcn.2003.10.015; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Klinz FJ, 1996, J NEUROSCI RES, V46, P720, DOI 10.1002/(SICI)1097-4547(19961215)46:6<720::AID-JNR8>3.0.CO;2-H; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LU XY, 1994, EMBO J, V13, P2592, DOI 10.1002/j.1460-2075.1994.tb06549.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Marek L, 2004, J CELL PHYSIOL, V201, P459, DOI 10.1002/jcp.20087; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; MELNICK MB, 1993, DEVELOPMENT, V118, P127; Mercer K, 2002, ONCOGENE, V21, P347, DOI 10.1038/sj.onc.1205101; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; MURAKAMI MS, 2001, SCI STKE, pPE30; Nekrasova T, 2005, J IMMUNOL, V175, P2374, DOI 10.4049/jimmunol.175.4.2374; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Pierchala BA, 2007, J NEUROCHEM, V100, P1169, DOI 10.1111/j.1471-4159.2006.04292.x; RODRIGUEZVICIAN.P, 2006, SCIENCE; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	50	73	78	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					598	607		10.1038/nn1898	http://dx.doi.org/10.1038/nn1898			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396120				2022-12-28	WOS:000245948000016
J	Doyere, V; Debiec, J; Monfils, MH; Schafe, GE; LeDoux, JE				Doyere, Valerie; Debiec, Jacek; Monfils, Marie-H; Schafe, Glenn E.; LeDoux, Joseph E.			Synapse-specific reconsolidation of distinct fear memories in the lateral amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RETRIEVAL	When reactivated, memories enter a labile, protein synthesis dependent state, a process referred to as reconsolidation. Here, we show in rats that fear memory retrieval produces a synaptic potentiation in the lateral amygdala that is selective to the reactivated memory, and that disruption of reconsolidation is correlated with a reduction of synaptic potentiation in the lateral amygdala. Thus, both retrieval and reconsolidation alter memories via synaptic plasticity at selectively targeted synapses.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA; Univ Paris 11, CNRS, UMR8620, NAMC, F-91405 Orsay, France; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	New York University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Yale University	LeDoux, JE (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, 4 Washington Pl, New York, NY 10003 USA.	ledoux@cns.nyu.edu	Monfils, Marie/F-1282-2013; Debiec, Jacek/B-6820-2008	Debiec, Jacek/0000-0002-8473-1534; Doyere, Valerie/0000-0002-3851-669X; Monfils, Marie-H./0000-0001-8971-6651	NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH067048, R37MH038774, R01MH046516, P50MH058911] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH38774, K05 MH067048, P50 MH58911, R01 MH46516] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindquist DH, 2004, J NEUROSCI, V24, P3610, DOI 10.1523/JNEUROSCI.4839-03.2004; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022	13	141	144	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					414	416		10.1038/nn1871	http://dx.doi.org/10.1038/nn1871			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351634				2022-12-28	WOS:000245228600009
J	Segura, I; Essmann, CL; Weinges, S; Acker-Palmer, A				Segura, Inmaculada; Essmann, Clara L.; Weinges, Stefan; Acker-Palmer, Amparo			Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; EPH RECEPTOR; KINASE; ACTIVATION; PLASTICITY; SRC; PROTEIN; HIPPOCAMPUS; COMPLEXES; MOTILITY	Dendritic spines are small protrusions emerging from dendrites that receive excitatory input. The process of spine morphogenesis occurs both in the developing brain and during synaptic plasticity. Molecules regulating the cytoskeleton are involved in spine formation and maintenance. Here we show that reverse signaling by the transmembrane ligands for Eph receptors, ephrinBs, is required for correct spine morphogenesis. The molecular mechanism underlying this function of ephrinBs involves the SH2 and SH3 domain-containing adaptor protein Grb4 and the G protein-coupled receptor kinase-interacting protein (GIT) 1. Grb4 binds by its SH2 domain to Tyr392 in the synaptic localization domain of GIT1. Phosphorylation of Tyr392 and the recruitment of GIT1 to synapses are regulated by ephrinB activation. Disruption of this pathway in cultured rat hippocampal neurons impairs spine morphogenesis and synapse formation. We thus show an important role for ephrinB reverse signaling in spine formation and have mapped the downstream pathway involved in this process.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Acker-Palmer, A (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	palmer@neuro.mpg.de	Segura, Inmaculada/D-2878-2013; Segura, Inmaculada/AAA-7958-2020	Segura, Inmaculada/0000-0003-1849-5569				Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; Bauer A, 2003, EUR J BIOCHEM, V270, P570, DOI 10.1046/j.1432-1033.2003.03428.x; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	33	111	115	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					301	310		10.1038/nn1858	http://dx.doi.org/10.1038/nn1858			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310244				2022-12-28	WOS:000244480300012
J	Huber, R; Ghilardi, MF; Massimini, M; Ferrarelli, F; Riedner, BA; Peterson, MJ; Tononi, G				Huber, Reto; Ghilardi, M. Felice; Massimini, Marcello; Ferrarelli, Fabio; Riedner, Brady A.; Peterson, Michael J.; Tononi, Giulio			Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; EEG; STIMULATION; MEMORY; OSCILLATIONS; EXCITABILITY; MECHANISM; RAT	Sleep slow wave activity (SWA) is thought to reflect sleep need, increasing after wakefulness and decreasing after sleep. We showed recently that a learning task involving a circumscribed brain region produces a local increase in sleep SWA. We hypothesized that increases in cortical SWA reflect synaptic potentiation triggered by learning. To further investigate the link between synaptic plasticity and sleep, we asked whether a procedure leading to synaptic depression would cause instead a decrease in sleep SWA. We show here that if a subject's arm is immobilized during the day, motor performance deteriorates and both somatosensory and motor evoked potentials decrease over contralateral sensorimotor cortex, indicative of local synaptic depression. Notably, during subsequent sleep, SWA over the same cortical area is markedly reduced. Thus, cortical plasticity is linked to local sleep regulation without learning in the classical sense. Moreover, when synaptic strength is reduced, local sleep need is also reduced.	CUNY City Coll, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA; Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53719 USA	City University of New York (CUNY) System; City College of New York (CUNY); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), CUNY City Coll, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA.	mg79@columbia.edu; gtononi@wisc.edu	ferrarelli, fabio/C-2945-2011; Ferrarelli, Fabio/D-3219-2019; Tononi, Giulio/B-8387-2009; Peterson, Michael J./A-8834-2009; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Peterson, Michael J./0000-0001-9181-1009; Massimini, Marcello/0000-0003-2271-957X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055185] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01 NS 055 185-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; Candia V, 2003, P NATL ACAD SCI USA, V100, P7942, DOI 10.1073/pnas.1231193100; Cirelli C, 2005, J NEUROSCI, V25, P4503, DOI 10.1523/JNEUROSCI.4845-04.2005; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Facchini S, 2002, CLIN NEUROPHYSIOL, V113, P367, DOI 10.1016/S1388-2457(02)00009-3; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huber R, 2000, NEUROREPORT, V11, P3321, DOI 10.1097/00001756-200010200-00012; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KRYGER MH, 2006, PRINCIPLES PRACTICE; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Mauguiere F, 1999, EEG CL N SU, P255; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WALKER MP, 2005, ANN REV PSYCHOL; Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Ziemann U, 2004, REV NEUROSCIENCE, V15, P253; Ziemann U, 2002, J NEUROSCI, V22, P5563	49	397	406	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1169	1176		10.1038/nn1758	http://dx.doi.org/10.1038/nn1758			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16936722				2022-12-28	WOS:000240080800019
J	Wienisch, M; Klingauf, J				Wienisch, Martin; Klingauf, Jurgen			Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE ENDOCYTOSIS; CULTURED HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; TRANSMITTER RELEASE; MEMBRANE-PROTEINS; CLATHRIN; SYNAPSES; KINETICS; DYNAMIN	Upon exocytosis, synaptic vesicle proteins are released into the plasma membrane and have to be retrieved by compensatory endocytosis. When green fluorescent protein-labeled versions of the vesicle proteins synaptobrevin-2 and synaptotagmin-1 are overexpressed in rat hippocampal neurons, up to 30% are found on axonal membranes under resting conditions. To test whether and to what extent these plasma membrane-stranded proteins participate in exo-endocytic cycling, a new proteolytic approach was used to visualize the fate of newly exocytosed proteins separately from that of the plasma membrane-stranded ones. We found that both pools were mixed and that endocytosed vesicles were largely composed of previously stranded molecules. The degree of nonidentity of vesicular proteins exo-and endocytosed depended on stimulus duration. By using an antibody to the external domain of synaptotagmin-1, we estimated that under physiological conditions a few percent of vesicular proteins were located near the active zone, from where they were preferentially recycled upon stimulation.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.	J.Klingauf@mpi-bpc.mpg.de						Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Estes PS, 1996, J NEUROSCI, V16, P5443; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Loerke D, 2005, TRAFFIC, V6, P918, DOI 10.1111/j.1600-0854.2005.00329.x; Martin TFJ, 2000, NAT CELL BIOL, V2, pE9, DOI 10.1038/71392; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 1997, J NEUROSCI, V17, P5858; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	49	171	175	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1019	1027		10.1038/nn1739	http://dx.doi.org/10.1038/nn1739			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845386	Green Published			2022-12-28	WOS:000240080300014
J	Nakamura, K; Morrison, SF				Nakamura, Kazuhiro; Morrison, Shaun F.			A thermosensory pathway that controls body temperature	NATURE NEUROSCIENCE			English	Article							PROSTAGLANDIN EP3 RECEPTOR; BROWN ADIPOSE-TISSUE; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; SYMPATHETIC PREMOTOR NEURONS; PARABRACHIAL NUCLEUS; DORSOMEDIAL HYPOTHALAMUS; EFFERENT PROJECTIONS; PREOPTIC AREA; THERMOREGULATORY FUNCTIONS; EVOKED THERMOGENESIS	Defending body temperature against environmental thermal challenges is one of the most fundamental homeostatic functions that are governed by the nervous system. Here we describe a somatosensory pathway that essentially constitutes the afferent arm of the thermoregulatory reflex that is triggered by cutaneous sensation of environmental temperature changes. Using in vivo electrophysiological and anatomical approaches in the rat, we found that lateral parabrachial neurons are pivotal in this pathway by glutamatergically transmitting cutaneous thermosensory signals received from spinal somatosensory neurons directly to the thermoregulatory command center, the preoptic area. This feedforward pathway mediates not only sympathetic and shivering thermogenic responses but also metabolic and cardiac responses to skin cooling challenges. Notably, this 'thermoregulatory afferent' pathway exists in parallel with the spinothalamocortical somatosensory pathway that mediates temperature perception. These findings make an important contribution to our understanding of both the somatosensory system and thermal homeostasis-two mechanisms that are fundamental to the nervous system and to our survival.	[Nakamura, Kazuhiro; Morrison, Shaun F.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA	Oregon Health & Science University	Nakamura, K (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	nakamura@ohsu.edu	Morrison, Shaun F./T-5869-2017; Nakamura, Kazuhiro/A-5431-2008	Morrison, Shaun F./0000-0002-8813-8359; Nakamura, Kazuhiro/0000-0002-6095-8996	NCRR NIH HHS [S10 RR016858-01, RR 016858] Funding Source: Medline; NIDDK NIH HHS [R01 DK057838-07, R01 DK057838, DK 57838] Funding Source: Medline; NINDS NIH HHS [NS 40987, R01 NS040987-07, R01 NS040987] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040987] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; Blomqvist A, 1996, EXP BRAIN RES, V108, P33; BOULANT JA, 1977, BRAIN RES, V120, P367, DOI 10.1016/0006-8993(77)90916-7; BOULANT JA, 1974, J PHYSIOL-LONDON, V240, P639, DOI 10.1113/jphysiol.1974.sp010627; Bratincsak A, 2005, NEUROSCIENCE, V135, P525, DOI 10.1016/j.neuroscience.2005.06.028; BROMAN J, 1992, J NEUROSCI, V12, P204; CECHETTO DF, 1985, J COMP NEUROL, V240, P153, DOI 10.1002/cne.902400205; Chen XM, 1998, J PHYSIOL-LONDON, V512, P883, DOI 10.1111/j.1469-7793.1998.883bd.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; Craig AD, 2001, J NEUROPHYSIOL, V86, P856, DOI 10.1152/jn.2001.86.2.856; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; HAMMEL HT, 1968, ANNU REV PHYSIOL, V30, P641, DOI 10.1146/annurev.ph.30.030168.003233; HELLON RF, 1975, J PHYSIOL-LONDON, V248, P349, DOI 10.1113/jphysiol.1975.sp010978; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HORI T, 1988, BRAIN RES BULL, V20, P879, DOI 10.1016/0361-9230(88)90105-0; HUCKABA C E, 1971, International Journal of Biometeorology, V15, P141, DOI 10.1007/BF01803888; HYLDEN JLK, 1989, NEUROSCIENCE, V28, P27, DOI 10.1016/0306-4522(89)90229-7; Johnston GAR, 1996, PHARMACOL THERAPEUT, V69, P173, DOI 10.1016/0163-7258(95)02043-8; Kobayashi A, 2003, PFLUG ARCH EUR J PHY, V446, P760, DOI 10.1007/s00424-003-1119-7; KRUKOFF TL, 1993, BRAIN RES BULL, V30, P163, DOI 10.1016/0361-9230(93)90054-F; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Madden CJ, 2003, NEUROSCIENCE, V122, P5, DOI 10.1016/S0306-4522(03)00527-X; Morrison SF, 2000, AM J PHYSIOL-REG I, V279, pR1763, DOI 10.1152/ajpregu.2000.279.5.R1763; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nakamura K, 2005, NEUROSCI RES, V51, P1, DOI 10.1016/j.neures.2004.09.007; Nakamura K, 2004, J THERM BIOL, V29, P339, DOI 10.1016/j.jtherbio.2004.08.001; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura K, 2001, NEUROSCIENCE, V103, P763, DOI 10.1016/S0306-4522(01)00027-6; Nakamura K, 1999, NEUROSCI LETT, V260, P117, DOI 10.1016/S0304-3940(98)00962-8; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; Savage MV, 1996, J APPL PHYSIOL, V80, P1249, DOI 10.1152/jappl.1996.80.4.1249; Zaretskaia MV, 2003, NEUROSCI LETT, V340, P1, DOI 10.1016/S0304-3940(03)00047-8; Zhang XJ, 2006, J NEUROSCI, V26, P5215, DOI 10.1523/JNEUROSCI.0701-06.2006	50	282	292	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					62	71		10.1038/nn2027	http://dx.doi.org/10.1038/nn2027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084288	Green Accepted			2022-12-28	WOS:000252117900013
J	Xu, JH; McNeil, B; Wu, W; Nees, D; Bai, L; Wu, LG				Xu, Jianhua; McNeil, Benjamin; wu, Wei; Nees, David; Bai, Li; Wu, Ling-Gang			GTP-independent rapid and slow endocytosis at a central synapse	NATURE NEUROSCIENCE			English	Article							RETINAL BIPOLAR CELLS; SHORT-TERM DEPRESSION; VESICLE ENDOCYTOSIS; MEMBRANE RETRIEVAL; CHROMAFFIN CELLS; MEDIAL NUCLEUS; TRAPEZOID BODY; 2 MODES; DYNAMIN; CALYX	Vesicle endocytosis is essential for maintaining synaptic transmission. Its key step, membrane scission, is thought to be mediated by the GTPase dynamin in all forms of endocytosis at synapses. Our findings indicate that GTP-independent and probably dynamin-independent endocytosis co-exist with GTP- and dynamin-dependent endocytosis at the same synaptic nerve terminal, the calyx of Held, in rats. This previously undescribed form of endocytosis could be slow (tens of seconds) and/or rapid (a few seconds), similar to GTP- and dynamin-dependent endocytosis. It was activated during intense stimulation, whereas GTP- and dynamin-dependent endocytosis dominated during mild stimulation. These results establish a new model, in which vesicles are divided into two pools depending on their requirement for GTP and dynamin for retrieval. The GTP- and dynamin-dependent pool has higher priority for release and retrieval, but limited capacity, saturation of which leads to release and thus retrieval of GTP- and dynamin-independent vesicles.	[Xu, Jianhua; McNeil, Benjamin; wu, Wei; Nees, David; Bai, Li; Wu, Ling-Gang] NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Rm 2B-1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov	Gimenez, Luis E Diaz/D-9291-2011	McNeil, Benjamin/0000-0001-7545-3598; Xu, Jianhua/0000-0003-0084-8856	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Dautry-Varsat A, 2001, ENDOCYTOSIS, P26; De Camilli P, 2001, SYNAPSES, P217; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, TRENDS CELL BIOL, V16, P413, DOI 10.1016/j.tcb.2006.06.007; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Satzler K, 2002, J NEUROSCI, V22, P10567; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sun JY, 2004, J NEUROSCI METH, V134, P121, DOI 10.1016/j.jneumeth.2003.11.018; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8	48	65	66	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					45	53		10.1038/nn2021	http://dx.doi.org/10.1038/nn2021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066059				2022-12-28	WOS:000252117900011
J	Huntwork, S; Littleton, JT				Huntwork, Sarah; Littleton, J. Troy			A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth	NATURE NEUROSCIENCE			English	Article							VESICLE EXOCYTOSIS; PROTEINS; EVENTS	Neuronal signaling occurs through both action potential triggered synaptic vesicle fusion and spontaneous release, although the fusion clamp machinery that prevents premature exocytosis of synaptic vesicles in the absence of calcium is unknown. Here we demonstrate that spontaneous release at synapses is regulated by complexin, a SNARE complex-binding protein. Analysis of Drosophila melanogaster complexin null mutants showed a marked increase in spontaneous fusion and a profound overgrowth of synapses, suggesting that complexin functions as the fusion clamp in vivo and may modulate structural remodeling of neuronal connections by controlling the rate of spontaneous release.	MIT, Dept Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Littleton, JT (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, Bldg 46,Room 3243, Cambridge, MA 02139 USA.	troy@mit.edu		Littleton, J. Troy/0000-0001-5576-2887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS040296, R01 NS040296-07] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sawada K, 2005, ARCH GEN PSYCHIAT, V62, P263, DOI 10.1001/archpsyc.62.3.263; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541	15	191	192	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1235	1237		10.1038/nn1980	http://dx.doi.org/10.1038/nn1980			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873870				2022-12-28	WOS:000249720800006
J	Van Buskirk, C; Sternberg, PW				Van Buskirk, Cheryl; Sternberg, Paul W.			Epidermal growth factor signaling induces behavioral quiescence in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; VULVAR INDUCTION; TYROSINE KINASE; FACTOR RECEPTOR; NERVOUS-SYSTEM; LET-23; GENE; EXPRESSION; NEUREGULIN; SYNAPSES	The epidermal growth factor receptor (EGFR)/ErbB receptor tyrosine kinases regulate several aspects of development, including the development of the mammalian nervous system. ErbB signaling also has physiological effects on neuronal function, with influences on synaptic plasticity and daily cycles of activity. However, little is known about the effectors of EGFR activation in neurons. Here we show that EGF signaling has a nondevelopmental effect on behavior in Caenorhabditis elegans. Ectopic expression of the EGF-like ligand LIN-3 at any stage induces a reversible cessation of feeding and locomotion. These effects are mediated by neuronal EGFR ( also called LET-23) and phospholipase C-gamma (PLC-gamma), diacylglycerol-binding proteins, and regulators of synaptic vesicle release. Activation of EGFR within a single neuron, ALA, is sufficient to induce a quiescent state. This pathway modulates the cessation of pharyngeal pumping and locomotion that normally occurs during the lethargus period that precedes larval molting. Our results reveal an evolutionarily conserved role for EGF signaling in the regulation of behavioral quiescence.	CALTECH, Div Biol 156 29, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Div Biol 156 29, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pws@caltech.edu		Sternberg, Paul/0000-0002-7699-0173; Van Buskirk, Cheryl/0000-0003-1929-5948	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER; NIDA NIH HHS [DA018341] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery Leon, 1993, Genetics, V134, P455; BRENNER S, 1974, GENETICS, V77, P71; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang C, 1999, CURR BIOL, V9, P237, DOI 10.1016/S0960-9822(99)80112-2; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Dutt A, 2004, PLOS BIOL, V2, P1799, DOI 10.1371/journal.pbio.0020334; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Keane J, 2003, GENETICS, V164, P153; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Lesa GM, 1997, MOL BIOL CELL, V8, P779, DOI 10.1091/mbc.8.5.779; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Nonet ML, 1998, J NEUROSCI, V18, P70; OKKEMA PG, 1993, GENETICS, V135, P385; Popovici C, 2002, NEUROSCI LETT, V329, P116, DOI 10.1016/S0304-3940(02)00595-5; Pujol N, 2000, DEVELOPMENT, V127, P3361; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Snodgrass-Belt P, 2005, BRAIN RES, V1038, P171, DOI 10.1016/j.brainres.2005.01.030; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yin XY, 2004, MOL BIOL CELL, V15, P3938, DOI 10.1091/mbc.E04-03-0198	49	149	186	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1300	1307		10.1038/nn1981	http://dx.doi.org/10.1038/nn1981			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17891142				2022-12-28	WOS:000249720800017
J	de Quervain, DJF; Kolassa, IT; Ertl, V; Onyut, PL; Neuner, F; Elbert, T; Papassotiropoulos, A				de Quervain, Dominique J-F; Kolassa, Iris-Tatjana; Ertl, Verena; Onyut, P. Lamaro; Neuner, Frank; Elbert, Thomas; Papassotiropoulos, Andreas			A deletion variant of the alpha 2b-adrenoceptor is related to emotional memory in Europeans and Africans	NATURE NEUROSCIENCE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; DECLARATIVE MEMORY	Emotionally arousing events are recalled better than neutral events. This phenomenon, which helps us to remember important and potentially vital information, depends on the activation of noradrenergic transmission in the brain. Here we show that a deletion variant of ADRA2B, the gene encoding the alpha 2b-adrenergic receptor, is related to enhanced emotional memory in healthy Swiss subjects and in survivors of the Rwandan civil war who experienced highly aversive emotional situations.	Univ Zurich, Div Psychiat Res, CH-8032 Zurich, Switzerland; Univ Konstanz, Dept Psychol, D-78457 Constance, Germany; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Mbarara Univ Sci & Technol, Fac Sci & Educ, Mbarara, Uganda; Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland; Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland	University of Zurich; University of Konstanz; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Mbarara University of Science & Technology; University of Basel; University of Basel	de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8032 Zurich, Switzerland.	quervain@bli.unizh.ch; andreas.papas@unibas.ch	Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; Papassotiropoulos, Andreas/0000-0002-2210-9651; Neuner, Frank/0000-0001-5427-3432; de Quervain, Dominique/0000-0001-7131-2464				Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; LANG PJ, 1999, A4 CTR RES PSYCH U F; Maheu FS, 2004, BEHAV NEUROSCI, V118, P420, DOI 10.1037/0735-7044.118.2.420; McGaugh J. L., 2003, MEMORY EMOTION MAKIN; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Wechsler D., 2008, WECHSLER ADULT INTEL, P257	14	145	145	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1137	1139		10.1038/nn1945	http://dx.doi.org/10.1038/nn1945			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660814	Green Submitted			2022-12-28	WOS:000249144000015
J	Lee, SH; Blake, R; Heeger, DJ				Lee, Sang-Hun; Blake, Randolph; Heeger, David J.			Hierarchy of cortical responses underlying binocular rivalry	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; NEURONAL-ACTIVITY; TRAVELING-WAVES; PERCEPTION; INTEGRATION; HUMANS; BRAIN; CONSCIOUSNESS; CONNECTIONS	During binocular rivalry, physical stimulation is dissociated from conscious visual awareness. Human brain imaging reveals a tight linkage between the neural events in human primary visual cortex (V1) and the dynamics of perceptual waves during transitions in dominance during binocular rivalry. Here, we report results from experiments in which observers' attention was diverted from the rival stimuli, implying that: competition between two rival stimuli involves neural circuits in V1, and attention is crucial for the consequences of this neural competition to advance to higher visual areas and promote perceptual waves.	Seoul Natl Univ, Dept Psychol, Seoul 151746, South Korea; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; NYU, Ctr Neural Sci, Dept Psychol, New York, NY 10003 USA	Seoul National University (SNU); Vanderbilt University; New York University	Lee, SH (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul 151746, South Korea.	visionsl@snu.ac.kr	Lee, Sang-Hun/B-9898-2008		NEI NIH HHS [R01-EY16752, R01-EY13356, R01 EY016752-02, R01-EY12741, R03-EY14437, R01 EY012741-12, R03 EY014437, R01 EY016752] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016752, R01EY012741, R03EY014437] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angelucci A, 2002, J NEUROSCI, V22, P8633; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; EFRON B, 1985, BIOMETRIKA, V72, P45, DOI 10.1093/biomet/72.1.45; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2005, P NATL ACAD SCI USA, V102, P14925, DOI 10.1073/pnas.0501684102; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Nguyen VA, 2001, PERCEPT PSYCHOPHYS, V63, P348, DOI 10.3758/BF03194475; Nishida S, 2003, J NEUROPHYSIOL, V90, P3242, DOI 10.1152/jn.00693.2003; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tse PU, 2005, P NATL ACAD SCI USA, V102, P17178, DOI 10.1073/pnas.0508010102; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	46	111	111	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1048	1054		10.1038/nn1939	http://dx.doi.org/10.1038/nn1939			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632508	Green Accepted			2022-12-28	WOS:000248357500019
J	Szapiro, G; Barbour, B				Szapiro, German; Barbour, Boris			Multiple climbing fibers signal to molecular layer interneurons exclusively via glutamate spillover	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; AMPA RECEPTORS; SYNAPTIC-TRANSMISSION; PRESYNAPTIC INHIBITION; NMDA RECEPTORS; GABA RELEASE; ACTIVATION; SYNAPSES; TRANSPORTERS; RAT	Spillover of glutamate under physiological conditions has only been established as an adjunct to conventional synaptic transmission. Here we describe a pure spillover connection between the climbing fiber and molecular layer interneurons in the rat cerebellar cortex. We show that, instead of acting via conventional synapses, multiple climbing fibers activate AMPA- and NMDA-type glutamate receptors on interneurons exclusively via spillover. Spillover from the climbing fiber represents a form of glutamatergic volume transmission that could be triggered in a regionalized manner by experimentally observed synchronous climbing fiber activity. Climbing fibers are known to direct parallel fiber synaptic plasticity in interneurons, so one function of this spillover is likely to involve controlling synaptic plasticity.	Ecole Normale Super, CNRS, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Barbour, B (corresponding author), Ecole Normale Super, CNRS, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	barbour@ens.fr		Barbour, Boris/0000-0002-1911-0539				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Atluri PP, 1998, J NEUROSCI, V18, P8214; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cox DR, 1966, STAT ANAL SERIES EVE; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Glitsch M, 1999, J NEUROSCI, V19, P511; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Lang EJ, 1999, J NEUROSCI, V19, P2728; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Marcaggi P, 2005, NEUROPHARMACOLOGY, V49, P843, DOI 10.1016/j.neuropharm.2005.07.011; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Palay S.L., 1974, CEREBELLAR CORTEX; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Satake S, 2006, J NEUROSCI, V26, P2278, DOI 10.1523/JNEUROSCI.4894-05.2006; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Satake S, 2004, EUR J NEUROSCI, V19, P2464, DOI 10.1111/j.0953-816X.2004.03347.x; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Sugihara I, 1999, J COMP NEUROL, V414, P131; Takayasu Y, 2006, J NEUROSCI, V26, P6563, DOI 10.1523/JNEUROSCI.5342-05.2006; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	47	170	171	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					735	742		10.1038/nn1907	http://dx.doi.org/10.1038/nn1907			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515900	Green Submitted			2022-12-28	WOS:000246799800016
J	Verhagen, JV; Wesson, DW; Netoff, TI; White, JA; Wachowiak, M				Verhagen, Justus V.; Wesson, Daniel W.; Netoff, Theoden I.; White, John A.; Wachowiak, Matt			Sniffing controls an adaptive filter of sensory input to the olfactory bulb	NATURE NEUROSCIENCE			English	Article							RECEPTOR NEURON INPUT; MUCOSAL ACTIVITY PATTERNS; RESPONSE PROPERTIES; GLOMERULAR LAYER; UNIT-ACTIVITY; MITRAL CELLS; ODOR; RATS; REPRESENTATIONS; CORTEX	Most sensory stimuli are actively sampled, yet the role of sampling behavior in shaping sensory codes is poorly understood. Mammals sample odors by sniffing, a complex behavior that controls odorant access to receptor neurons. Whether sniffing shapes the neural code for odors remains unclear. We addressed this question by imaging receptor input to the olfactory bulb of awake rats performing odor discriminations that elicited different sniffing behaviors. High- frequency sniffing of an odorant attenuated inputs encoding that odorant, whereas lower sniff frequencies caused little attenuation. Odorants encountered later in a sniff bout were encoded as the combination of that odorant and the background odorant during low- frequency sniffing, but were encoded as the difference between the two odorants during high- frequency sniffing. Thus, sniffing controls an adaptive filter for detecting changes in the odor landscape. These data suggest an unexpected functional role for sniffing and show that sensory codes can be transformed by sampling behavior alone.	Boston Univ, Dept Biol, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Wachowiak, M (corresponding author), Boston Univ, Dept Biol, 24 Cummington St, Boston, MA 02215 USA.	dmattw@bu.edu	Wesson, Daniel/AAJ-6719-2020	Wesson, Daniel/0000-0002-3192-3866; Netoff, Theoden/0000-0002-0115-1930; White, John/0000-0003-1073-2638	NIDCD NIH HHS [R03 DC008197] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008197] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1951, J PHYSIOL-LONDON, V114, pP4; ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kent PF, 1996, J NEUROSCI, V16, P345; KENT PF, 1992, J NEUROPHYSIOL, V68, P1804, DOI 10.1152/jn.1992.68.5.1804; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1975, BEHAV BIOL, V14, P295, DOI 10.1016/S0091-6773(75)90419-8; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; SCHMITT BC, 1979, SCIENCE, V205, P204, DOI 10.1126/science.205.4402.204; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Sobel N, 2000, CHEM SENSES, V25, P1, DOI 10.1093/chemse/25.1.1; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERWOLF CH, 1987, PHARMACOL BIOCHEM BE, V26, P299, DOI 10.1016/0091-3057(87)90122-5; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Walker JKL, 1997, RESP PHYSIOL, V107, P241, DOI 10.1016/S0034-5687(96)02520-0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008	46	245	246	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					631	639		10.1038/nn1892	http://dx.doi.org/10.1038/nn1892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450136				2022-12-28	WOS:000245948000020
J	Vrontou, E; Nilsen, SP; Demir, E; Kravitz, EA; Dickson, BJ				Vrontou, Eleftheria; Nilsen, Steven P.; Demir, Ebru; Kravitz, Edward A.; Dickson, Barry J.			fruitless regulates aggression and dominance in Drosophila	NATURE NEUROSCIENCE			English	Article							MALE SEXUAL-BEHAVIOR; MELANOGASTER; GENE; ORIENTATION; PATHWAY	When competing for resources, two Drosophila melanogaster flies of the same sex fight each other. Males and females fight with distinctly different styles, and males but not females establish dominance relationships. Here we show that sex-specific splicing of the fruitless gene plays a critical role in determining who and how a fly fights, and whether a dominance relationship forms.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Harvard University; Harvard Medical School	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072411, R01GM067645] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM072411, GM067645] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259	13	129	130	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1469	1471		10.1038/nn1809	http://dx.doi.org/10.1038/nn1809			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115036				2022-12-28	WOS:000242404000007
J	Cappello, S; Attardo, A; Wu, XW; Iwasato, T; Itohara, S; Wilsch-Brauninger, M; Eilken, HM; Rieger, MA; Schroeder, TT; Huttner, WB; Brakebusch, C; Gotz, M				Cappello, Silvia; Attardo, Alessio; Wu, Xunwei; Iwasato, Takuji; Itohara, Shigeyoshi; Wilsch-Braeuninger, Michaela; Eilken, Hanna M.; Rieger, Michael A.; Schroeder, Timm T.; Huttner, Wieland B.; Brakebusch, Cord; Goetz, Magdalena			The Rho-GTPase cdc42 regulates neural progenitor fate at the apical surface	NATURE NEUROSCIENCE			English	Article							CELL-CYCLE; NEUROEPITHELIAL CELLS; SUBVENTRICULAR ZONE; RADIAL GLIA; ASYMMETRIC DISTRIBUTION; ADHERENS JUNCTIONS; BRAIN-DEVELOPMENT; LAYER NEURONS; BETA-CATENIN; MOUSE-BRAIN	Stem cell persistence into adulthood requires self-renewal from early developmental stages. In the developing mouse brain, only apical progenitors located at the ventricle are self-renewing, whereas basal progenitors gradually deplete. However, nothing is known about the mechanisms regulating the fundamental difference between these progenitors. Here we show that the conditional deletion of the small Rho-GTPase cdc42 at different stages of neurogenesis in mouse telencephalon results in an immediate increase in basal mitoses. Whereas cdc42-deficient progenitors have normal cell cycle length, orientation of cell division and basement membrane contact, the apical location of the Par complex and adherens junctions are gradually lost, leading to an increasing failure of apically directed interkinetic nuclear migration. These cells then undergo mitoses at basal positions and acquire the fate of basal progenitors. Thus, cdc42 has a crucial role at the apical pole of progenitors, thereby regulating the position of mitoses and cell fate.	GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Munich, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Copenhagen, Inst Mol Pathol, Fac Hlth Sci, DK-2100 Copenhagen, Denmark; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; Univ Munich, Inst Physiol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; University of Copenhagen; RIKEN; University of Munich	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Munich, Germany.	magdalena.goetz@gsf.de	Wu, Xunwei/J-9014-2018; Huttner, Wieland B./P-4080-2018; Rieger, Michael A/L-8324-2017; Schroeder, Timm/F-8448-2010; Itohara, Shigeyoshi/I-8769-2012; Cappello, Silvia/AAQ-4590-2021	Wu, Xunwei/0000-0002-0822-1700; Rieger, Michael A/0000-0002-4158-5872; Schroeder, Timm/0000-0001-9320-0252; Itohara, Shigeyoshi/0000-0002-2410-9989; Cappello, Silvia/0000-0003-1553-6775; Attardo, Alessio/0000-0003-0665-6011; Brakebusch, Cord/0000-0002-9342-1634				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; ETO K, 1995, DEV GROWTH DIFFER, V37, P123, DOI 10.1046/j.1440-169X.1995.t01-1-00001.x; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1976, J ANAT, V121, P71; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	50	305	314	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1099	1107		10.1038/nn1744	http://dx.doi.org/10.1038/nn1744			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892058				2022-12-28	WOS:000240080800010
J	Rudebeck, PH; Walton, ME; Smyth, AN; Bannerman, DM; Rushworth, MFS				Rudebeck, Peter H.; Walton, Mark E.; Smyth, Angharad N.; Bannerman, David M.; Rushworth, Matthew F. S.			Separate neural pathways process different decision costs	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; NEURONAL SIGNALS; VENTRAL STRIATUM; RAT; LESIONS; SENSITIVITY	Behavioral ecologists and economists emphasize that potential costs, as well as rewards, influence decision making. Although neuroscientists assume that frontal areas are central to decision making, the evidence is contradictory and the critical region remains unclear. Here it is shown that frontal lobe contributions to cost-benefit decision making can be understood by positing the existence of two independent systems that make decisions about delay and effort costs. Anterior cingulate cortex lesions affected how much effort rats decided to invest for rewards. Orbitofrontal cortical lesions affected how long rats decided to wait for rewards. The pattern of disruption suggested the deficit could be related to impaired associative learning. Impairments of the two systems may underlie apathetic and impulsive choice patterns in neurological and psychiatric illnesses. Although the existence of two systems is not predicted by economic accounts of decision making, our results suggest that delay and effort may exert distinct influences on decision making.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Rudebeck, PH (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	peter.rudebeck@psy.ox.ac.uk	de Cates, Angharad/N-6550-2013; Rudebeck, Peter/G-7931-2012	de Cates, Angharad/0000-0001-7848-1295; Bannerman, David/0000-0002-3024-7595; Rudebeck, Peter/0000-0002-1411-7555; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0300665] Funding Source: UKRI; Medical Research Council [G0300665] Funding Source: Medline; Wellcome Trust [087736] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aoki N, 2006, BEHAV BRAIN RES, V168, P1, DOI 10.1016/j.bbr.2005.10.002; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Barbelivien A, 2001, CEREB CORTEX, V11, P1056, DOI 10.1093/cercor/11.11.1056; Bautista LM, 2001, P NATL ACAD SCI USA, V98, P1089, DOI 10.1073/pnas.98.3.1089; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; BURNS SM, 1985, BRAIN RES, V340, P71, DOI 10.1016/0006-8993(85)90774-7; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; CARDINAL RN, IN PRESS NEURAL NETW; Chudasama Y, 2003, J NEUROSCI, V23, P8771; COUSINS MS, 1994, PHARMACOL BIOCHEM BE, V49, P85, DOI 10.1016/0091-3057(94)90460-X; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Kacelnik A, 2003, TIME DECISION EC PSY, P115; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kheramin S, 2003, BEHAV PROCESS, V64, P239, DOI 10.1016/S0376-6357(03)00142-6; KOLB B, 1974, BEHAV BIOL, V10, P329, DOI 10.1016/S0091-6773(74)91924-5; Long A, 2005, CURR BIOL, V15, pR874, DOI 10.1016/j.cub.2005.10.024; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; NIV Y, 2005, ADV NEURAL INFORMATI, P1019; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; ROESCH M, IN PRESS NEURON; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schweimer J, 2005, LEARN MEMORY, V12, P334, DOI 10.1101/lm.90605; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Stevens JR, 2005, CURR BIOL, V15, P1855, DOI 10.1016/j.cub.2005.09.016; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; THIEBOT MH, 1985, PSYCHOPHARMACOLOGY, V86, P147, DOI 10.1007/BF00431700; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; WALTON ME, IN PRESS NEURAL NETW; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	50	419	427	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1161	1168		10.1038/nn1756	http://dx.doi.org/10.1038/nn1756			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921368				2022-12-28	WOS:000240080800018
J	Miyazaki, M; Yamamoto, S; Uchida, S; Kitazawa, S				Miyazaki, Makoto; Yamamoto, Shinya; Uchida, Sunao; Kitazawa, Shigeru			Bayesian calibration of simultaneity in tactile temporal order judgment	NATURE NEUROSCIENCE			English	Article							PERCEPTION; INTEGRATION; STIMULI	Human judgment of the temporal order of two sensory signals is liable to change depending on our prior experiences. Previous studies have reported that signals presented at short intervals but in the same order as the most frequently repeated signal are perceived as occurring simultaneously. Here we report opposite perceptual changes that conform to a Bayesian integration theory in judging the order of two stimuli delivered one to each hand.	Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; Waseda Univ, Adv Res Ctr Human Sci, Fac Human Sci, Tokorozawa, Saitama 3591192, Japan; Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3058575, Japan; Juntendo Univ, Dept Neurophysiol, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Waseda University; Waseda University; Japan Science & Technology Agency (JST); Juntendo University	Kitazawa, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	kitazawa@med.juntendo.ac.jp	Yamamoto, Shinya/S-3134-2016	Yamamoto, Shinya/0000-0002-0505-8848				BENNETT RG, 1985, VISION RES, V25, P565, DOI 10.1016/0042-6989(85)90161-0; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Guo K, 2004, VISION RES, V44, P2349, DOI 10.1016/j.visres.2004.04.014; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kording KP, 2004, J NEUROPHYSIOL, V92, P3161, DOI 10.1152/jn.00275.2004; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Okada M, 2003, NEUROREPORT, V14, P261, DOI 10.1097/00001756-200302100-00021; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	12	91	93	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					875	877		10.1038/nn1712	http://dx.doi.org/10.1038/nn1712			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732276				2022-12-28	WOS:000238590800011
J	Jordan, H; Fallah, M; Stoner, GR				Jordan, H; Fallah, M; Stoner, GR			Adaptation of gender derived from biological motion	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL SYSTEM; NEURONS; PERCEPTION	Human observers adapted to complex biological motions that distinguish males from females: viewing the gait of one gender biased judgments of subsequent gaits toward the opposite gender. This adaptation was not simply due to local features of the stimuli but instead relied upon the global motion of the figures. These results suggest the existence of neurons selective for gender and demonstrate that gender-from-motion judgments are not fixed but depend upon recent viewing history.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Jordan, H (corresponding author), York Univ, Ctr Vis Res, 4500 Keele St, N York, ON M3J 1P3, Canada.	Jordan@cvr.yorku.ca	Fallah, Mazyar/ABH-9906-2020	Fallah, Mazyar/0000-0001-5979-3955	NATIONAL EYE INSTITUTE [R01EY012872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; NEI NIH HHS [2R01EY12872-05] Funding Source: Medline; NIMH NIH HHS [5T32MH020002-05] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARCLAY CD, 1978, PERCEPT PSYCHOPHYS, V23, P145, DOI 10.3758/BF03208295; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420	15	41	41	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					738	739		10.1038/nn1710	http://dx.doi.org/10.1038/nn1710			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715080				2022-12-28	WOS:000237895200012
J	Wang, XH; Lou, NH; Xu, QW; Tian, GF; Peng, WG; Han, XN; Kang, J; Takano, T; Nedergaard, M				Wang, Xiaohai; Lou, Nanhong; Xu, Qiwu; Tian, Guo-Feng; Peng, Wei Guo; Han, Xiaoning; Kang, Jian; Takano, Takahiro; Nedergaard, Maiken			Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; RAT BARREL CORTEX; NEURONAL-ACTIVITY; CALCIUM WAVES; SYNAPTIC-TRANSMISSION; GLUTAMATE; RECEPTORS; BRAIN; SITU; OSCILLATIONS	Although astrocytes are the most abundant cell type in the brain, evidence for their activation during physiological sensory activity is lacking. Here we show that whisker stimulation evokes increases in astrocytic cytosolic calcium (Ca2+) within the barrel cortex of adult mice. Increases in astrocytic Ca2+ were a function of the frequency of stimulation, occurred within several seconds and were inhibited by metabotropic glutamate receptor antagonists. To distinguish between synaptic input and output, local synaptic activity in cortical layer 2 was silenced by iontophoresis of AMPA and NMDA receptor antagonists. The antagonists did not reduce astrocytic Ca2+ responses despite a marked reduction in excitatory postsynaptic currents in response to whisker stimulation. These findings indicate that astrocytes respond to synaptic input, by means of spillover or ectopic release of glutamate, and that increases in astrocytic Ca2+ occur independently of postsynaptic excitatory activity.	Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	University of Rochester; New York Medical College	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Nedergaard@URMC.Rochester.edu		Takano, Takahiro/0000-0002-6235-6673; Wang, Xiaohai/0000-0001-5814-4072	NINDS NIH HHS [NS38073, NS30007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030007, R01NS038073, R01NS030007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1998, J NEUROSCI, V18, P6822; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Brickley SG, 2001, NEUROPHARMACOLOGY, V41, P730, DOI 10.1016/S0028-3908(01)00135-6; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina M., 2005, NEUROGLIA, P229; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DUFFY S, 1995, J NEUROSCI, V15, P5535; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kettenmann H, 1999, Adv Neurol, V79, P565; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; NILSSON M, 1991, DEV BRAIN RES, V63, P33, DOI 10.1016/0165-3806(91)90064-P; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; PORTER T, 1995, IEEE MULTIMEDIA, V2, P101; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Schuchmann S, 2002, NEUROBIOL DIS, V11, P96, DOI 10.1006/nbdi.2002.0533; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Venance L, 1997, J NEUROSCI, V17, P1981; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	50	487	501	4	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					816	823		10.1038/nn1703	http://dx.doi.org/10.1038/nn1703			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699507				2022-12-28	WOS:000237895200022
J	Lai, SL; Lee, T				Lai, SL; Lee, T			Genetic mosaic with dual binary transcriptional systems in Drosophila	NATURE NEUROSCIENCE			English	Article							REPRESSIBLE CELL MARKER; MUSHROOM BODIES; ANTENNAL LOBE; NERVOUS-SYSTEM; MELANOGASTER; EXPRESSION; BRAIN; NEUROBLAST; ACTIVATOR; PATTERNS	MARCM (mosaic analysis with a repressible cell marker) involves specific labeling of GAL80-minus and GAL4-positive homozygous cells in otherwise heterozygous tissues. Here we demonstrate how the concurrent use of two independent binary transcriptional systems may facilitate complex MARCM studies in the Drosophila nervous system. By fusing LexA with the VP16 acidic activation domain (VP16) or the GAL4 activation domain (GAD), we obtained both GAL80-insensitive and GAL80-suppressible transcriptional factors. LexA:: VP16 can mediate MARCM-independent binary transgene induction in mosaic organisms. The incorporation of LexA:: GAD into MARCM, which we call dual-expression-control MARCM, permits the induction of distinct transgenes in different patterns among GAL80-minus cells in mosaic tissues. Lineage analysis with dual-expression-control MARCM suggested the presence of neuroglioblasts in the developing optic lobes but did not indicate the production of glia by postembryonic mushroom body neuronal precursors. In addition, dualexpression-control MARCM with a ubiquitous LexA:: GAD driver revealed many unidentified cells in the GAL4-GH146-positive projection neuron lineages.	Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Massachusetts System; University of Massachusetts Worcester	Lee, T (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.	Tzumin.Lee@umassmed.edu		Lai, Sen-Lin/0000-0002-7531-283X				BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dearborn R, 2004, DEVELOPMENT, V131, P2291, DOI 10.1242/dev.01111; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Szuts D, 2000, P NATL ACAD SCI USA, V97, P5351, DOI 10.1073/pnas.97.10.5351; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; XIONG WC, 1995, NEURON, V14, P581, DOI 10.1016/0896-6273(95)90314-3; XU T, 1993, DEVELOPMENT, V117, P1223; YANG MY, 1995, NEURON, V15, P45; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zugates CT, 2004, CURR OPIN NEUROBIOL, V14, P647, DOI 10.1016/j.conb.2004.08.005	39	306	309	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					703	709		10.1038/nn1681	http://dx.doi.org/10.1038/nn1681			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582903				2022-12-28	WOS:000237417200023
J	Tropea, D; Kreiman, G; Lyckman, A; Mukherjee, S; Yu, HB; Horng, S; Sur, M				Tropea, D; Kreiman, G; Lyckman, A; Mukherjee, S; Yu, HB; Horng, S; Sur, M			Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; OCULAR DOMINANCE PLASTICITY; BINDING PROTEIN-5 IGFBP-5; CORTICAL PLASTICITY; CRITICAL PERIOD; MONOCULAR DEPRIVATION; STRIATE CORTEX; NEUROTROPHIC FACTOR; BRAIN-DEVELOPMENT; CEREBRAL-CORTEX	Two key models for examining activity-dependent development of primary visual cortex (V1) involve either reduction of activity in both eyes via dark-rearing (DR) or imbalance of activity between the two eyes via monocular deprivation (MD). Combining DNA microarray analysis with computational approaches, RT-PCR, immunohistochemistry and physiological imaging, we find that DR leads to (i) upregulation of genes subserving synaptic transmission and electrical activity, consistent with a coordinated response of cortical neurons to reduction of visual drive, and (ii) downregulation of parvalbumin expression, implicating parvalbumin-expressing interneurons as underlying the delay in cortical maturation after DR. MD partially activates homeostatic mechanisms but differentially upregulates molecular pathways related to growth factors and neuronal degeneration, consistent with reorganization of connections after MD. Expression of a binding protein of insulin-like growth factor-1 (IGF1) is highly upregulated after MD, and exogenous application of IGF1 prevents the physiological effects of MD on ocular dominance plasticity examined in vivo.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Duke Univ, Inst Genome Sci & Policy, CIEMAS, Durham, NC 27708 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Duke University	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu	Tropea, Daniela/AAX-8147-2020	Tropea, Daniela/0000-0001-9730-6636; Kreiman, Gabriel/0000-0003-3505-8475; Mukherjee, Sayan/0000-0002-6715-3920				Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BEAR MF, 1990, J NEUROSCI, V10, P909; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Bondy CA, 2002, INT REV NEUROBIOL, V51, P189, DOI 10.1016/S0074-7742(02)51006-0; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Iwadate H, 2003, LIFE SCI, V73, P3149, DOI 10.1016/j.lfs.2003.06.010; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lodovichi C, 2000, J NEUROSCI, V20, P2155; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Morales B, 2002, J NEUROSCI, V22, P8084; Murray KD, 2003, NEUROSCIENCE, V122, P407, DOI 10.1016/j.neuroscience.2003.07.015; NEVE RL, 1989, P NATL ACAD SCI USA, V86, P4781, DOI 10.1073/pnas.86.12.4781; Obata S, 1999, CEREB CORTEX, V9, P238, DOI 10.1093/cercor/9.3.238; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prasad SS, 2002, NEUROSCIENCE, V111, P35, DOI 10.1016/S0306-4522(01)00570-X; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tonner E, 2000, ADV EXP MED BIOL, V480, P45; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Xue J, 2001, MOL BRAIN RES, V93, P95, DOI 10.1016/S0169-328X(01)00168-1; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	50	166	168	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					660	668		10.1038/nn1689	http://dx.doi.org/10.1038/nn1689			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16633343				2022-12-28	WOS:000237417200017
J	Kerr, MA; Belluscio, L				Kerr, MA; Belluscio, L			Olfactory experience accelerates glomerular refinement in the mammalian olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT RECEPTORS; CREB	Primary olfactory sensory neurons (OSNs) impart both molecular and functional organization to the olfactory bulb. Because OSNs can be selectively activated by odorants in vivo, we sought to determine whether odorant experience alters the cellular dynamics of specific OSNs or their axonal projections. Using mice, we found that odorant stimulation associated with behavioral conditioning influenced OSN wiring by accelerating glomerular refinement independent of OSN number; furthermore, this wiring was strongly associated with olfactory learning.	NINDS, Dev Neural Plast Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Belluscio, L (corresponding author), NINDS, Dev Neural Plast Unit, NIH, Bethesda, MD 20892 USA.	belluscl@ninds.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003002, ZIANS003002] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; COOPERSMITH R, 1986, DEV BRAIN RES, V27, P191, DOI 10.1016/0165-3806(86)90245-2; COOPERSMITH R, 1986, DEV BRAIN RES, V24, P271, DOI 10.1016/0165-3806(86)90195-1; GUENTHER E, 1948, ESSENTIAL OILS, V3; JOHNSON BA, 1995, BRAIN RES, V699, P192, DOI 10.1016/0006-8993(95)00896-X; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Yuan Q, 2000, LEARN MEMORY, V7, P413, DOI 10.1101/lm.35900; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	15	66	67	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					484	486		10.1038/nn1673	http://dx.doi.org/10.1038/nn1673			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547509				2022-12-28	WOS:000236310700013
J	Wang, Y; Markram, H; Goodman, PH; Berger, TK; Ma, JY; Goldman-Rakic, PS				Wang, Y; Markram, H; Goodman, PH; Berger, TK; Ma, JY; Goldman-Rakic, PS			Heterogeneity in the pyramidal network of the medial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SHORT-TERM PLASTICITY; IN-VITRO; PERSISTENT ACTIVITY; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; WORKING-MEMORY; VISUAL-CORTEX; RAT NEOCORTEX; PAIRED-PULSE; FRONTAL-LOBE	The prefrontal cortex is specially adapted to generate persistent activity that outlasts stimuli and is resistant to distractors, presumed to be the basis of working memory. The pyramidal network that supports this activity is unknown. Multineuron patch-clamp recordings in the ferret medial prefrontal cortex showed a heterogeneity of synapses interconnecting distinct subnetworks of different pyramidal cells. One subnetwork was similar to the pyramidal network commonly found in primary sensory areas, consisting of accommodating pyramidal cells interconnected with depressing synapses. The other subnetwork contained complex pyramidal cells with dual apical dendrites displaying nonaccommodating discharge patterns; these cells were hyper-reciprocally connected with facilitating synapses displaying pronounced synaptic augmentation and post-tetanic potentiation. These cellular, synaptic and network properties could amplify recurrent interactions between pyramidal neurons and support persistent activity in the prefrontal cortex.	Tufts Univ, Caritas St Elizabeths Med Ctr, Div Neurol Res, Boston, MA 02135 USA; Ecole Polytech Fed Lausanne, Brain & Mind Inst, CH-1015 Lausanne, Switzerland; Univ Nevada, Dept Internal Med, Reno, NV 89557 USA; Univ Nevada, Biomed Engn Program, Reno, NV 89557 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	St. Elizabeth's Medical Center; Tufts University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University	Wang, Y (corresponding author), Tufts Univ, Caritas St Elizabeths Med Ctr, Div Neurol Res, Boston, MA 02135 USA.	yun.wang@tufts.edu						Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Douglas RJ, 1996, J NEUROCYTOL, V25, P893, DOI 10.1007/BF02284849; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; McCormick DA, 2001, NAT NEUROSCI, V4, P113, DOI 10.1038/83917; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WEST DC, CEREB CORTEX, V16, P200; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	307	308	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					534	542		10.1038/nn1670	http://dx.doi.org/10.1038/nn1670			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547512				2022-12-28	WOS:000236310700021
J	Darcy, KJ; Staras, K; Collinson, LM; Goda, Y				Darcy, KJ; Staras, K; Collinson, LM; Goda, Y			Constitutive sharing of recycling synaptic vesicles between presynaptic boutons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; RELEASE; PLASTICITY; TRANSPORT; VISUALIZATION; TRANSMITTER; ENDOCYTOSIS; GLUTAMATE; MEMBRANE; TURNOVER	The synaptic vesicle cycle is vital for sustained neurotransmitter release. It has been assumed that functional synaptic vesicles are replenished autonomously at individual presynaptic terminals. Here we tested this assumption by using FM dyes in combination with fluorescence recovery after photobleaching and correlative light and electron microscopy in cultured rat hippocampal neurons. After photobleaching, synapses acquired recently recycled FM dye-labeled vesicles originating from nonphotobleached synapses by a process requiring dynamic actin turnover. The imported vesicles entered the functional pool at their host synapses, as revealed by the exocytic release of the dye upon stimulation. FM1-43 photoconversion and ultrastructural analysis confirmed the incorporation of imported vesicles into the presynaptic terminal, where they mixed with the native vesicle pools. Our results demonstrate that synaptic vesicle recycling is not confined to individual presynaptic terminals as is widely believed; rather, a substantial proportion of recycling vesicles are shared constitutively between boutons.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, Electron Microscopy Facil, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; Dept Pharmacol, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Goda, Y (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	y.goda@ucl.ac.uk	Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Collinson, Lucy/0000-0003-0260-613X; Staras, Kevin/0000-0003-4141-339X	Medical Research Council [MC_U122669937] Funding Source: Medline; MRC [MC_U122669937] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hiruma H, 2003, J NEUROSCI, V23, P8967; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shtrahman M, 2005, BIOPHYS J, V89, P3615, DOI 10.1529/biophysj.105.059295; STINCHCOMBE JC, 1995, J CELL BIOL, V131, P1387, DOI 10.1083/jcb.131.6.1387; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	42	158	161	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					315	321		10.1038/nn1640	http://dx.doi.org/10.1038/nn1640			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462738				2022-12-28	WOS:000235645600010
J	Kable, JW; Glimcher, PW				Kable, Joseph W.; Glimcher, Paul W.			The neural correlates of subjective value during intertemporal choice	NATURE NEUROSCIENCE			English	Article							POSTERIOR CINGULATE CORTEX; DECISION-MAKING; PARIETAL CORTEX; ORBITOFRONTAL CORTEX; PRIMATE STRIATUM; MONETARY REWARDS; VENTRAL STRIATUM; PREFERENCE; RESPONSES; RISK	Neuroimaging studies of decision-making have generally related neural activity to objective measures (such as reward magnitude, probability or delay), despite choice preferences being subjective. However, economic theories posit that decision-makers behave as though different options have different subjective values. Here we use functional magnetic resonance imaging to show that neural activity in several brain regions-particularly the ventral striatum, medial prefrontal cortex and posterior cingulate cortex-tracks the revealed subjective value of delayed monetary rewards. This similarity provides unambiguous evidence that the subjective value of potential rewards is explicitly represented in the human brain.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Kable, JW (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Room 809, New York, NY 10003 USA.	kable@cns.nyu.edu; glimcher@cns.nyu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH075544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER; NIMH NIH HHS [F32-MH75544, F32 MH075544] Funding Source: Medline; NINDS NIH HHS [R01 NS054775-02, R01-NS054775, R01 NS054775] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; BENHABIB J, 2006, PESENT BIAS QUASI HY; BERNOULLI D, 1982, WORKS; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Coller M., 1999, Experimental Economics, V2, P107, DOI 10.1007/BF01673482; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; GUI F, 2005, CASE MINDLESS EC; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Johnson KO, 2002, NEUROSCIENTIST, V8, P111, DOI 10.1177/107385840200800207; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; SAMUELSON P. A., 1947, FDN EC ANAL; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SMITH VL, 1993, ECON INQ, V31, P245, DOI 10.1111/j.1465-7295.1993.tb00881.x; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; TELLER DY, 1983, LINKING PROPOSITIONS, P577; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Weber E. H., 1834, PULSU RESORPTIONE AU; WERNERM GERHARD, 1968, P112; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	49	1195	1221	8	195	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1625	1633		10.1038/nn2007	http://dx.doi.org/10.1038/nn2007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982449	Green Accepted			2022-12-28	WOS:000251172900021
J	Rossi, DJ; Brady, JD; Mohr, C				Rossi, David J.; Brady, James D.; Mohr, Claudia			Astrocyte metabolism and signaling during brain ischemia	NATURE NEUROSCIENCE			English	Review							GLUTAMATE TRANSPORTER GLT-1; GAP-JUNCTION HEMICHANNELS; FOCAL CEREBRAL-ISCHEMIA; CULTURED RAT ASTROCYTES; EXCITATORY AMINO-ACIDS; CELL-DEATH; VESICULAR GLUTAMATE; IN-VIVO; SYNAPTIC-TRANSMISSION; SIMULATED ISCHEMIA	Brain ischemia results from cardiac arrest, stroke or head trauma. These conditions can cause severe brain damage and are a leading cause of death and long-term disability. Neurons are far more susceptible to ischemic damage than neighboring astrocytes, but astrocytes have diverse and important functions in many aspects of ischemic brain damage. Here we review three main roles of astrocytes in ischemic brain damage. First, we consider astrocyte glycogen stores, which can defend the brain against hypoglycemic brain damage but may aggravate brain damage during ischemia due to enhanced lactic acidosis. Second, we review recent breakthroughs in understanding astrocytic mechanisms of transmitter release, particularly for those transmitters with known roles in ischemic brain damage: glutamate, D-serine, ATP and adenosine. Third, we discuss the role of gap-junctionally connected networks of astrocytes in mediating the spread of damaging molecules to healthy 'bystanders' during infarct expansion in stroke.	Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97232 USA	Oregon Health & Science University	Rossi, DJ (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97232 USA.	rossid@ohsu.edu			NINDS NIH HHS [R01 NS051561, 5R01NS051561] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051561] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOI DW, 1987, J NEUROSCI, V7, P357; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Cusato K, 2003, J NEUROSCI, V23, P6413; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dawson DA, 2001, BRAIN RES, V892, P344, DOI 10.1016/S0006-8993(00)03269-8; Devuyst G, 2001, J NEUROL, V248, P735, DOI 10.1007/s004150170087; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Duffy S, 1996, J NEUROSCI, V16, P71; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Figiel M, 2007, MOL CELL NEUROSCI, V35, P130, DOI 10.1016/j.mcn.2007.02.009; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; Gebhardt C, 2002, J CEREBR BLOOD F MET, V22, P569, DOI 10.1097/00004647-200205000-00008; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; Hamann M, 2002, EUR J NEUROSCI, V15, P308, DOI 10.1046/j.0953-816x.2001.01861.x; HANSEN AJ, 1988, NEUROCHEM PATHOL, V9, P195; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Higuchi T, 2002, J CEREBR BLOOD F MET, V22, P71, DOI 10.1097/00004647-200201000-00009; Hoshi A, 2006, J NEUROSCI RES, V84, P130, DOI 10.1002/jnr.20869; Hua X, 2004, J NEUROSCI RES, V76, P86, DOI 10.1002/jnr.20061; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; KATCHMAN AN, 1993, J NEUROPHYSIOL, V70, P1; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Li PA, 1996, STROKE, V27, P1592, DOI 10.1161/01.STR.27.9.1592; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; LI PA, 1995, NEUROBIOL DIS, V2, P97, DOI 10.1006/nbdi.1995.0010; Lin JHC, 2003, J NEUROSCI, V23, P430, DOI 10.1523/JNEUROSCI.23-02-00430.2003; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lindsberg PJ, 2004, STROKE, V35, P363, DOI 10.1161/01.STR.0000115297.92132.84; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; LOWRY OH, 1964, J BIOL CHEM, V239, P18; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NICHOLLS DG, 2007, J NEUROSCI RES  0423, DOI DOI 10.1002/JNR.2190; Ottersen OP, 1996, J CHEM NEUROANAT, V12, P1, DOI 10.1016/S0891-0618(96)00178-0; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Parkinson FE, 2004, J NEUROCHEM, V88, P1305, DOI 10.1046/j.1471-4159.2003.02266.x; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Phillis JW, 1996, NEUROCHEM INT, V29, P115, DOI 10.1016/0197-0186(95)00154-9; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Queiroz G, 1999, NEUROSCIENCE, V91, P1171, DOI 10.1016/S0306-4522(98)00644-7; Ranat S, 2007, NEUROSCI LETT, V415, P45, DOI 10.1016/j.neulet.2006.12.043; Ransom BR, 1997, GLIA, V21, P134; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Schubert P, 1994, J Neural Transm Suppl, V44, P73; Schurr A, 2002, CRIT CARE, V6, P330; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; Shaked I, 2002, J NEUROCHEM, V83, P574, DOI 10.1046/j.1471-4159.2002.01168.x; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; SILVER IA, 1994, J NEUROSCI, V14, P5068; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Takahashi M, 1997, J EXP BIOL, V200, P401; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Uyttenboogaart M, 2007, BRAIN, V130, P1626, DOI 10.1093/brain/awm087; WOLOSKER H, 2006, SCI STKE, pE41; Wygoda MR, 1997, CANCER RES, V57, P1699; XIE M, 2007, J CEREB BLOOD F 0822, DOI DOI 10.1038/5J.JCBFM.9600545; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1352, DOI 10.1038/sj.jcbfm.9600441	100	419	445	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1377	1386		10.1038/nn2004	http://dx.doi.org/10.1038/nn2004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965658	Green Accepted			2022-12-28	WOS:000250508400012
J	Diba, K; Buzsaki, G				Diba, Kamran; Buzsaki, Gyoergy			Forward and reverse hippocampal place-cell sequences during ripples	NATURE NEUROSCIENCE			English	Article							MEMORY; EXPERIENCE; SLEEP; ENSEMBLE; REPLAY; MODEL; RAT	We report that temporal spike sequences from hippocampal place neurons of rats on an elevated track recurred in reverse order at the end of a run, but in forward order in anticipation of the run, coinciding with sharp waves. Vector distances between the place fields were reflected in the temporal structure of these sequences. This bidirectional re-enactment of temporal sequences may contribute to the establishment of higher-order associations in episodic memory.	Rutgers State Univ, Ctr Mol & Behav Neurobiol, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Diba, K (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurobiol, 197 Univ Ave, Newark, NJ 07102 USA.	diba@andromeda.rutgers.edu; buzsaki@axon.rutgers.edu		Diba, Kamran/0000-0001-5128-4478; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [R01 MH054671, R01 MH054671-04, R01 MH054671-08, MH54671, R01 MH054671-07, R01 MH054671-05, R01 MH054671-09, R01 MH054671-06, R01 MH054671-03] Funding Source: Medline; NINDS NIH HHS [R01 NS034994-07, R01 NS034994-06, NS34994, R01 NS034994-11, R01 NS034994, R01 NS034994-04, R01 NS034994-09, R01 NS034994-07S1, R01 NS034994-08, R01 NS034994-05, R01 NS034994-05S1, R01 NS034994-10] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Drosopoulos S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000376; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	15	619	626	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1241	1242		10.1038/nn1961	http://dx.doi.org/10.1038/nn1961			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828259	Green Accepted			2022-12-28	WOS:000249720800008
J	Lunn, ML; Nassirpour, R; Arrabit, C; Tan, J; Mcleod, I; Arias, CM; Sawchenko, PE; Yates, JR; Slesinger, PA				Lunn, Marie-Louise; Nassirpour, Rounak; Arrabit, Christine; Tan, Joshua; Mcleod, Ian; Arias, Carlos M.; Sawchenko, Paul E.; Yates, John R., III; Slesinger, Paul A.			A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; MESSENGER-RNAS; PROTEINS; BINDING; RECEPTORS; MODULATION; ACTIVATE; SUBUNITS; HOMOLOG; NEURONS	G protein-gated potassium (Kir3) channels are important for controlling neuronal excitability in the brain. Using a proteomics approach, we have identified a unique rodent intracellular protein, sorting nexin 27 (SNX27), which regulates the trafficking of Kir3 channels. Like most sorting nexins, SNX27 possesses a functional PX domain that selectively binds the membrane phospholipid phosphatidylinositol-3-phosphate (P13P) and is important for trafficking to the early endosome. SNX27, however, is the only sorting nexin to contain a PDZ domain. This PDZ domain discriminates between channels with similar class I PDZ-binding motifs, associating with the C-terminal end of Kir3.3 and Kir3.2c (-ESKV), but not with that of Kir2.1 (-ESEI) or Kv1.4 (-ETDV). SNX27 promotes the endosomal movement of Kir3 channels, leading to reduced surface expression, increased degradation and smaller Kir3 potassium currents. The regulation of endosomal trafficking via sorting nexins reveals a previously unknown mechanism for controlling potassium channel surface expression.	Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Salk Institute	Slesinger, PA (corresponding author), Salk Inst Biol Studies, Peptide Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu			NINDS NIH HHS [R01 NS37682] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037682] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DiMagno L, 1996, PFLUG ARCH EUR J PHY, V431, P335, DOI 10.1007/BF02207270; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Karschin C, 1996, J NEUROSCI, V16, P3559; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Sun QQ, 2001, J PHYSIOL-LONDON, V531, P67, DOI 10.1111/j.1469-7793.2001.0067j.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	46	121	128	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1249	1259		10.1038/nn1953	http://dx.doi.org/10.1038/nn1953			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828261				2022-12-28	WOS:000249720800011
J	Graham, DL; Edwards, S; Bachtell, RK; DiLeone, RJ; Rios, M; Self, DW				Graham, Danielle L.; Edwards, Scott; Bachtell, Ryan K.; DiLeone, Ralph J.; Rios, Maribel; Self, David W.			Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse	NATURE NEUROSCIENCE			English	Article							D-3 RECEPTOR EXPRESSION; FACTOR PROTEIN-LEVELS; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; SEROTONIN METABOLISM; RETROGRADE TRANSPORT; DENDRITIC SPINES; MOUSE-BRAIN; DELTA-FOSB; IN-VIVO	A single exposure to cocaine rapidly induces the brief activation of several immediate early genes, but the role of such short-term regulation in the enduring consequences of cocaine use is poorly understood. We found that 4 h of intravenous cocaine self-administration in rats induced a transient increase in brain-derived neurotrophic factor (BDNF) and activation of TrkB-mediated signaling in the nucleus accumbens (NAc). Augmenting this dynamic regulation with five daily NAc BDNF infusions caused enduring increases in cocaine self-administration, and facilitated relapse to cocaine seeking in withdrawal. In contrast, neutralizing endogenous BDNF regulation with intra-NAc infusions of antibody to BDNF subsequently reduced cocaine self-administration and attenuated relapse. Using localized inducible BDNF knockout in mice, we found that BDNF originating from NAc neurons was necessary for maintaining increased cocaine self-administration. These findings suggest that dynamic induction and release of BDNF from NAc neurons during cocaine use promotes the development and persistence of addictive behavior.	Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA; Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat, New Haven, CT 06508 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Tufts University	Self, DW (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA.	david.self@utsouthwestern.edu	Bachtell, Ryan/H-7436-2013; Graham, Danielle L/K-8459-2014	Bachtell, Ryan/0000-0001-5268-5927; DiLeone, Ralph/0000-0002-4770-2590	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016857, R01DA010460, R29DA010460, R01DA018743, P01DA008227] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 18743, DA 10460, DA 08227, DA 016857] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Altar C A, 1998, Adv Pharmacol, V42, P915; ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; Colby CR, 2003, J NEUROSCI, V23, P2488; Conner JM, 1997, J NEUROSCI, V17, P2295; DSM-IV-TR, 2000, DIAGN STAT MAN MENT, V4th; Elmer E, 1998, NEUROSCIENCE, V83, P351, DOI 10.1016/S0306-4522(97)00387-4; Filip M, 2006, BRAIN RES, V1071, P218, DOI 10.1016/j.brainres.2005.11.099; GALL CM, 1992, TRENDS PHARMACOL SCI, V13, P401, DOI 10.1016/0165-6147(92)90123-N; Grimm JW, 2003, J NEUROSCI, V23, P742; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Horger BA, 1999, J NEUROSCI, V19, P4110; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kuppers E, 2001, NEUROREPORT, V12, P1175; Le Foll B, 2005, NEUROREPORT, V16, P175, DOI 10.1097/00001756-200502080-00022; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; MARTINIVERSON MT, 1994, J NEUROSCI, V14, P1262, DOI 10.1523/JNEUROSCI.14-03-01262.1994; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mufson EJ, 1996, NEUROSCIENCE, V71, P179, DOI 10.1016/0306-4522(95)00431-9; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; Narita M, 2003, NEUROSCIENCE, V119, P767, DOI 10.1016/S0306-4522(03)00099-X; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pu L, 2006, NAT NEUROSCI, V9, P605, DOI 10.1038/nn1687; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249	47	302	309	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1029	1037		10.1038/nn1929	http://dx.doi.org/10.1038/nn1929			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618281				2022-12-28	WOS:000248357500017
J	Maness, PF; Schachner, M				Maness, Patricia F.; Schachner, Melitta			Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration	NATURE NEUROSCIENCE			English	Review							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CLOSE HOMOLOG; MICE DEFICIENT; CYTOPLASMIC DOMAIN; POLYSIALIC ACID; LIPID RAFTS; HOMOPHILIC BINDING; ANKYRIN BINDING; FGF RECEPTOR	Recognition molecules of the immunoglobulin superfamily have important roles in neuronal interactions during ontogeny, including migration, survival, axon guidance and synaptic targeting. Their downstream signal transduction events specify whether a cell changes its place of residence or projects axons and dendrites to targets in the brain, allowing the construction of a dynamic neural network. A wealth of recent discoveries shows that cell adhesion molecules interact with attractant and repellent guidance receptors to control growth cone and cell motility in a coordinate fashion. We focus on the best-studied subclasses, the neural cell adhesion molecule NCAM and the L1 family of adhesion molecules, which share important structural and functional features. We have chosen these paradigmatic molecules and their interactions with other recognition molecules as instructive for elucidating the mechanisms by which other recognition molecules may guide cell interactions during development or modify their function as a result of injury, learning and memory.	Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Neurosci Res Ctr, Chapel Hill, NC 27599 USA; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; Dalian Med Univ, Sino German Ctr Neurosci, Dalian 116011, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Dalian Medical University	Maness, PF (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	srclab@med.unc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049109] Funding Source: NIH RePORTER; NIMH NIH HHS [MH064056] Funding Source: Medline; NINDS NIH HHS [NS049109] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AA, 2005, J NEUROCHEM, V95, P570, DOI 10.1111/j.1471-4159.2005.03417.x; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; DahlinHuppe K, 1997, MOL CELL NEUROSCI, V9, P144, DOI 10.1006/mcne.1997.0608; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Gil OD, 2003, J CELL BIOL, V162, P719, DOI 10.1083/jcb.200211011; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Hubschmann MV, 2005, J NEUROSCI RES, V80, P826, DOI 10.1002/jnr.20530; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kolkova K, 2000, J NEUROSCI, V20, P2238; Krushel LA, 1999, J BIOL CHEM, V274, P2432, DOI 10.1074/jbc.274.4.2432; Kurumaji A, 2001, AM J MED GENET, V105, P99; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Petridis AK, 2004, DEV DYNAM, V230, P675, DOI 10.1002/dvdy.20094; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; RAO Y, 1994, J BIOL CHEM, V269, P27540; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rolf B, 2002, J NEUROSCI, V22, P8357; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; SCHAGEN P, 1974, ADV IMAGE PICKUP DIS, V1, P1; Schmid RS, 2000, J NEUROSCI, V20, P4177; Schmid RS, 2004, NEUROREPORT, V15, P2791; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017	100	643	658	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					19	26		10.1038/nn1827	http://dx.doi.org/10.1038/nn1827			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17189949				2022-12-28	WOS:000243096100010
J	Norena, AJ; Gourevitch, B; Aizawa, N; Eggermont, JJ				Norena, Arnaud J.; Gourevitch, Boris; Aizawa, Naotaka; Eggermont, Jos J.			Spectrally enhanced acoustic environment disrupts frequency representation in cat auditory cortex	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PLASTICITY; CEREBRAL-CORTEX; CRITICAL PERIOD; STRIATE CORTEX; TUNING CURVES; NOISE TRAUMA; HEARING-LOSS; MAP CHANGES; BRAIN-STEM; MECHANISMS	Sensory environments are known to shape nervous system organization. Here we show that passive long-term exposure to a spectrally enhanced acoustic environment ( EAE) causes reorganization of the tonotopic map in juvenile cat auditory cortex without inducing any hearing loss. The EAE consisted of tone pips of 32 different frequencies ( 5 - 20 kHz), presented in random order at an average rate of 96 Hz. The EAE caused a strong reduction of the representation of EAE frequencies and an over-representation of frequencies neighboring those of the EAE. This is in sharp contrast with earlier developmental studies showing an enlargement of the cortical representation of EAEs consisting of a narrow frequency band. We observed fewer than normal appropriately tuned short-latency responses to EAE frequencies, together with more common long-latency responses tuned to EAE-neighboring frequencies.	Univ Lyon 1, CNRS, UMR 5020, Neurosci & Sensory Syst Lab, F-69365 Lyon, France; Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Calgary; University of Calgary	Eggermont, JJ (corresponding author), Univ Lyon 1, CNRS, UMR 5020, Neurosci & Sensory Syst Lab, F-69365 Lyon, France.	eggermon@ucalgary.ca		Gourevitch, Boris/0000-0001-6742-8739				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2003, J NEUROSCI, V23, P10765; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Bonham BH, 2004, J NEUROPHYSIOL, V91, P841, DOI 10.1152/jn.00017.2003; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CRAGG BG, 1975, J COMP NEUROL, V160, P147, DOI 10.1002/cne.901600202; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2121, DOI 10.1097/00001756-199511000-00006; Eggermont JJ, 1999, J NEUROSCI, V19, P2780; Eggermont JJ, 1996, AUDIT NEUROSCI, V2, P309; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Eggermont JJ, 1996, EXP BRAIN RES, V110, P379; EGGERMONT JJ, 1992, J NEUROPHYSIOL, V68, P1216, DOI 10.1152/jn.1992.68.4.1216; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Kadia SC, 2003, J NEUROPHYSIOL, V89, P1603, DOI 10.1152/jn.00271.2001; Kamke MR, 2005, NEURON, V48, P675, DOI 10.1016/j.neuron.2005.09.014; Kanwal JS, 1999, DESIGN OF ANIMAL COMMUNICATION, P133; Kilgard MP, 2002, BIOL CYBERN, V87, P333, DOI 10.1007/s00422-002-0352-z; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Nakahara H, 2004, P NATL ACAD SCI USA, V101, P7170, DOI 10.1073/pnas.0401196101; Ngan EM, 2001, HEARING RES, V156, P44, DOI 10.1016/S0378-5955(01)00264-7; Norena A, 2002, HEARING RES, V166, P202, DOI 10.1016/S0378-5955(02)00329-5; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; SANES DH, 1985, J NEUROSCI, V5, P1152; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Stanton SG, 1996, AUDIT NEUROSCI, V2, P97; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; TSUMOTO T, 1982, EXP BRAIN RES, V45, P433, DOI 10.1007/BF01208604; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; WINFIELD DA, 1983, DEV BRAIN RES, V9, P155, DOI 10.1016/0165-3806(83)90048-2; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	50	111	111	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					932	939		10.1038/nn1720	http://dx.doi.org/10.1038/nn1720			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783369				2022-12-28	WOS:000238590800020
J	Bandell, M; Dubin, AE; Petrus, MJ; Orth, A; Mathur, J; Hwang, SW; Patapoutian, A				Bandell, M; Dubin, AE; Petrus, MJ; Orth, A; Mathur, J; Hwang, SW; Patapoutian, A			High-throughput random mutagenesis screen reveals TRPM8 residues specifically required for activation by menthol	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNELS; ION-CHANNEL; MOLECULAR MECHANISM; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; CRYSTAL-STRUCTURE; HCN CHANNELS; K+ CHANNEL; COLD; TRPA1	Menthol is a cooling compound derived from mint leaves and is extensively used as a flavoring chemical. Menthol activates transient receptor potential melastatin 8 (TRPM8), an ion channel also activated by cold, voltage and phosphatidylinositol-4,5-bisphosphate (PIP2). Here we investigated the mechanism by which menthol activates mouse TRPM8. Using a new high-throughput approach, we screened a random mutant library consisting of similar to 14,000 individual TRPM8 mutants for clones that are affected in their response to menthol while retaining channel function. We identified determinants of menthol sensitivity in two regions: putative transmembrane segment 2 (S2) and the C-terminal TRP domain. Analysis of these mutants indicated that activation by menthol involves a gating mechanism distinct and separable from gating by cold, voltage or PIP2. Notably, TRP domain mutations mainly attenuated menthol efficacy, suggesting that this domain influences events downstream of initial binding. In contrast, S2 mutations strongly shifted the concentration dependence of menthol activation, raising the possibility that S2 influences menthol binding.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480	PHS HHS [MS046303] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, NEURON, V42, P193, DOI 10.1016/S0896-6273(04)00199-0; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Taylor J. R., 1982, INTRO ERROR ANAL STU; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; YU FH, 2004, SCI STKE; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012	39	195	200	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					493	500		10.1038/nn1665	http://dx.doi.org/10.1038/nn1665			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520735				2022-12-28	WOS:000236310700016
J	Carvalho, RF; Beutler, M; Marler, KJM; Knoll, B; Becker-Barroso, E; Heintzmann, R; Ng, T; Drescher, U				Carvalho, RF; Beutler, M; Marler, KJM; Knoll, B; Becker-Barroso, E; Heintzmann, R; Ng, T; Drescher, U			Silencing of EphA3 through a cis interaction with ephrinA5	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASES; GANGLION-CELL AXONS; LIPID RAFTS; MOLECULAR GRADIENTS; VISUAL-SYSTEM; A LIGANDS; GUIDANCE; ADHESION; GROWTH; MAP	EphAs and ephrinAs are expressed in multiple areas of the developing brain in overlapping countergradients, notably in the retina and tectum. Here they are involved in targeting retinal axons to their correct topographic position in the tectum. We have used truncated versions of EphA3, single-amino acid point mutants of ephrinA5 and fluorescence resonance energy transfer technology to uncover a cis interaction between EphA3 and ephrinA5 that is independent of the established ligand-binding domain of EphA3. This cis interaction abolishes the induction of tyrosine phosphorylation of EphA3 and results in a loss of sensitivity of retinal axons to ephrinAs in trans. Our data suggest that formation of this complex transforms the uniform expression of EphAs in the nasal part of the retina into a gradient of functional EphAs and has a key role in controlling retinotectal mapping.	Univ London Kings Coll, Ctr Dev Neurobiol, Med Res Council, London SE1 1UL, England; Univ London Kings Coll, Randall Div Cell & Mol Biophys, London SE1 1UL, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London	Drescher, U (corresponding author), Univ London Kings Coll, Ctr Dev Neurobiol, Med Res Council, New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	uwe.drescher@kcl.ac.uk	Heintzmann, Rainer/AAY-4849-2020; Heintzmann, Rainer/I-5667-2012; Drescher, Uwe/C-5438-2009	Heintzmann, Rainer/0000-0002-4950-1936; Ng, Tony/0000-0003-3894-5619; Drescher, Uwe/0000-0001-9725-7643	Medical Research Council [G0100152] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G9900989B] Funding Source: researchfish; MRC [G0100152] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Bohme B, 1996, J BIOL CHEM, V271, P24747, DOI 10.1074/jbc.271.40.24747; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; CIOSSEK T, 1995, ONCOGENE, V11, P2085; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Erskine L, 2000, J NEUROSCI, V20, P4975; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Goodhill GJ, 2004, NEURAL COMPUT, V16, P2221, DOI 10.1162/0899766041941934; Gu CK, 2005, ONCOGENE, V24, P4243, DOI 10.1038/sj.onc.1208584; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Niclou SP, 2000, J NEUROSCI, V20, P4962; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Ringstedt T, 2000, J NEUROSCI, V20, P4983; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sobieszczuk DF, 1999, CURR BIOL, V9, pR469, DOI 10.1016/S0960-9822(99)80296-6; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	50	142	146	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					322	330		10.1038/nn1655	http://dx.doi.org/10.1038/nn1655			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491080				2022-12-28	WOS:000235645600011
J	Jensen, P; Farago, AF; Awatramani, RB; Scott, MM; Deneris, ES; Dymecki, SM				Jensen, Patricia; Farago, Anna F.; Awatramani, Rajeshwar B.; Scott, Michael M.; Deneris, Evan S.; Dymecki, Susan M.			Redefining the serotonergic system by genetic lineage	NATURE NEUROSCIENCE			English	Article							NEURON DEVELOPMENT; HINDBRAIN; BRAIN; BOUNDARIES; FATE; RAT	Central serotonin-producing neurons are heterogeneous differing in location, morphology, neurotoxin sensitivity and associated clinical disorders - but the underpinnings of this heterogeneity are largely unknown, as are the markers that distinguish physiological subtypes of serotonergic neurons. Here we redefined serotonergic subtypes on the basis of genetic programs that are differentially enacted in progenitor cells. We uncovered a molecular framework for the serotonergic system that, having genetic lineages as its basis, is likely to have physiological relevance and will permit access to genetically defined subtypes for manipulation.	[Jensen, Patricia; Farago, Anna F.; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; [Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; [Jensen, Patricia; Farago, Anna F.; Awatramani, Rajeshwar B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Case Western Reserve University	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu	Jensen, Patricia/Z-1523-2018	Jensen, Patricia/0000-0001-6459-7289	NICHD NIH HHS [P01 HD036379-120007, P01 HD036379-130007, P01 HD036379] Funding Source: Medline; NIDA NIH HHS [R21 DA023643-01, R21 DA023643, R21 DA023643-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK067826, R01 DK 067826, R01 DK067826-04] Funding Source: Medline; NIMH NIH HHS [R01 MH062723, R01 MH62723] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Kimmel RA, 2000, GENE DEV, V14, P1377; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Riikonen RS, 2005, BIOL PSYCHIAT, V57, P1565, DOI 10.1016/j.biopsych.2005.01.029; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; WALLACE JA, 1982, BRAIN RES BULL, V9, P117, DOI 10.1016/0361-9230(82)90127-7; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	15	182	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					417	419		10.1038/nn2050	http://dx.doi.org/10.1038/nn2050			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344997	Green Accepted			2022-12-28	WOS:000254359300011
J	Gras, C; Amilhon, B; Lepicard, EM; Poirel, O; Vinatier, J; Herbin, M; Dumas, S; Tzavara, ET; Wade, MR; Nomikos, GG; Hanoun, N; Saurini, F; Kemel, ML; Gasnier, B; Giros, B; El Mestikawy, S				Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Herbin, Marc; Dumas, Sylvie; Tzavara, Eleni T.; Wade, Mark R.; Nomikos, George G.; Hanoun, Naima; Saurini, Francoise; Kemel, Marie-Louise; Gasnier, Bruno; Giros, Bruno; El Mestikawy, Salah			The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone	NATURE NEUROSCIENCE			English	Article							CHOLINERGIC CELL ABLATION; SYNAPTIC VESICLES; MOLECULAR-CLONING; BASAL GANGLIA; DOPAMINE; RELEASE; NEURONS; MOUSE; IDENTIFICATION; LOCALIZATION	Three subtypes of vesicular transporters accumulate glutamate into synaptic vesicles to promote its vesicular release. One of the subtypes, VGLUT3, is expressed in neurons, including cholinergic striatal interneurons, that are known to release other classical transmitters. Here we showed that disruption of the Slc17a8 gene (also known as Vglut3) caused an unexpected hypocholinergic striatal phenotype. Vglut3(-/-) mice were more responsive to cocaine and less prone to haloperidol-induced catalepsy than wild-type littermates, and acetylcholine release was decreased in striatum slices lacking VGLUT3. These phenotypes were associated with a colocalization of VGLUT3 and the vesicular acetylcholine transporter (VAChT) in striatal synaptic vesicles and the loss of a synergistic effect of glutamate on vesicular acetylcholine uptake. We propose that this vesicular synergy between two transmitters is the result of the unbalanced bioenergetics of VAChT, which requires anion co-entry for continuing vesicular filling. Our study reveals a previously unknown effect of glutamate on cholinergic synapses with potential functional and pharmacological implications.	[Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Tzavara, Eleni T.; Giros, Bruno; El Mestikawy, Salah] Univ Paris 06, INSERM, U513, F-75005 Paris, France; [Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Tzavara, Eleni T.; Giros, Bruno; El Mestikawy, Salah] Univ Paris 06, F-75005 Paris, France; [Herbin, Marc] MNHN, CNRS, UMR 7179, USM 301, F-75005 Paris, France; [Dumas, Sylvie] Helios Biosci, Fac Med, F-94010 Creteil, France; [Wade, Mark R.; Nomikos, George G.] Amgen Cambridge Res Ctr, Cambridge, MA 02139 USA; [Wade, Mark R.; Nomikos, George G.] Univ Paris 06, Fac Med, INSERM, UMR 677, Paris 13, France; [Kemel, Marie-Louise] Coll France, INSERM, U 667, F-75231 Paris, France; [Gasnier, Bruno] Univ Paris 07, CNRS, Inst Biol Physico Chim, UPR 1929, F-75005 Paris, France; [Giros, Bruno; El Mestikawy, Salah] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Quebec City, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; McGill University	El Mestikawy, S (corresponding author), Univ Paris 06, INSERM, U513, 9 Quai St Bernard, F-75005 Paris, France.	salah.elmestikawy@snv.jussieu.fr	Kemel, Marie-Louise/M-4967-2018; hanoun, naima NH/M-6408-2014; Gasnier, Bruno/AAD-9124-2022; Amilhon, Bénédicte/AAZ-3182-2021; GIROS, Bruno/ABD-5790-2021	Gasnier, Bruno/0000-0003-4458-6296; GIROS, Bruno/0000-0001-5876-9822; el mestikawy, salah/0000-0002-6253-0002				Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; BESSON MJ, 1969, P NATL ACAD SCI USA, V62, P741, DOI 10.1073/pnas.62.3.741; Blanchet F, 1998, NEUROSCIENCE, V85, P1025, DOI 10.1016/S0306-4522(97)00610-6; Bonsi P, 2007, AMINO ACIDS, V32, P189, DOI 10.1007/s00726-006-0320-3; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Consolo S, 1996, EUR J NEUROSCI, V8, P2702, DOI 10.1111/j.1460-9568.1996.tb01565.x; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Duplus E, 2008, J NEUROCHEM, V104, P1321, DOI 10.1111/j.1471-4159.2007.05074.x; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fujiyama F, 2004, EUR J NEUROSCI, V20, P3322, DOI 10.1111/j.1460-9568.2004.03807.x; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Gras C, 2002, J NEUROSCI, V22, P5442; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMON M, 1988, J PHARMACOL EXP THER, V246, P745; Herbin M, 2004, J COMP PHYSIOL A, V190, P895, DOI 10.1007/s00359-004-0545-0; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hikida T, 2003, P NATL ACAD SCI USA, V100, P6169, DOI 10.1073/pnas.0631749100; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; HITZEMANN R, 1993, J PHARMACOL EXP THER, V266, P431; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; KAWAGUCHI Y, 1992, J NEUROPHYSIOL, V67, P1669, DOI 10.1152/jn.1992.67.6.1669; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KEMEL ML, 1989, P NATL ACAD SCI USA, V86, P9006, DOI 10.1073/pnas.86.22.9006; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; Nguyen ML, 1998, BIOCHEMISTRY-US, V37, P13400, DOI 10.1021/bi9802263; Poulin AN, 2006, J COMP NEUROL, V498, P690, DOI 10.1002/cne.21081; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roseth S, 1998, BIOCHEM PHARMACOL, V56, P1243, DOI 10.1016/S0006-2952(98)00200-7; SCATTON B, 1982, NATURE, V297, P422, DOI 10.1038/297422a0; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; SCHERMAN D, 1980, BIOCHIM BIOPHYS ACTA, V601, P664, DOI 10.1016/0005-2736(80)90567-2; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Tzavara ET, 2006, MOL PSYCHIATR, V11, P187, DOI 10.1038/sj.mp.4001763; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	47	154	160	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					292	300		10.1038/nn2052	http://dx.doi.org/10.1038/nn2052			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278042				2022-12-28	WOS:000253548300012
J	Labouebe, G; Lomazzi, M; Cruz, HG; Creton, C; Lujan, R; Li, M; Yanagawa, Y; Obata, K; Watanabe, M; Wickman, K; Boyer, SB; Slesinger, PA; Luscher, C				Labouebe, Gwenael; Lomazzi, Marta; Cruz, Hans G.; Creton, Cyril; Lujan, Rafael; Li, Meng; Yanagawa, Yuchio; Obata, Kunihiko; Watanabe, Masahiko; Wickman, Kevin; Boyer, Stephanie B.; Slesinger, Paul A.; Luescher, Christian			RGS2 modulates coupling between GABA(B) receptors and GIRK channels in dopamine neurons of the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							GAMMA-HYDROXYBUTYRIC ACID; K+-CHANNEL; INWARD RECTIFIER; PROTEIN; EXPRESSION; REGULATORS; SUBUNITS; AGONISTS; CLONING; INHIBITION	Agonists of GABA(B) receptors exert a bi-directional effect on the activity of dopamine (DA) neurons of the ventral tegmental area, which can be explained by the fact that coupling between GABA(B) receptors and G protein-gated inwardly rectifying potassium (GIRK) channels is significantly weaker in DA neurons than in GABA neurons. Thus, low concentrations of agonists preferentially inhibit GABA neurons and thereby disinhibit DA neurons. This disinhibition might confer reinforcing properties on addictive GABA(B) receptor agonists such as gamma-hydroxybutyrate (GHB) and its derivatives. Here we show that, in DA neurons of mice, the low coupling efficiency reflects the selective expression of heteromeric GIRK2/3 channels and is dynamically modulated by a member of the regulator of G protein signaling (RGS) protein family. Moreover, repetitive exposure to GHB increases the GABA(B) receptor-GIRK channel coupling efficiency through downregulation of RGS2. Finally, oral self-administration of GHB at a concentration that is normally rewarding becomes aversive after chronic exposure. On the basis of these results, we propose a mechanism that might underlie tolerance to GHB.	Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; Univ Castilla La Mancha, Fac Med CRIB, Dept Med Sci, Albacete 02006, Spain; Imperial Coll London, London W12 0NN, England; Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Hokkaido Univ, Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; Imperial College London; Gunma University; RIKEN; Hokkaido University; University of Minnesota System; University of Minnesota Twin Cities; Salk Institute; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Michel-Servet 1, CH-1211 Geneva 4, Switzerland.	Christian.Luscher@medecine.unige.ch	Li, Meng/I-6941-2013; Lujan, Rafael/G-2555-2015; Watanabe, Masahiko/S-3614-2019; Lüscher, Christian/A-2496-2011; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; Lüscher, Christian/0000-0001-7917-4596; WATANABE, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545; Wickman, Kevin/0000-0002-5179-9540	MRC [MC_U120085817] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806] Funding Source: NIH RePORTER; Medical Research Council [MC_U120085817] Funding Source: Medline; NIDA NIH HHS [P50 DA011806, DA011806] Funding Source: Medline; NIMH NIH HHS [R01 MH061933, MH61933] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Brebner K, 2002, ALCOHOL ALCOHOLISM, V37, P478, DOI 10.1093/alcalc/37.5.478; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; COLOMBO G, 1995, EUR J PHARMACOL, V285, P103, DOI 10.1016/0014-2999(95)00493-5; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Crunelli V, 2006, CURR OPIN PHARMACOL, V6, P44, DOI 10.1016/j.coph.2005.10.001; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J NEUROSCI, V17, P8024; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jaen C, 2006, J BIOL CHEM, V281, P34549, DOI 10.1074/jbc.M603177200; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Martellotta MC, 1997, PSYCHOPHARMACOLOGY, V132, P1, DOI 10.1007/s002130050312; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Schoots O, 1999, CELL SIGNAL, V11, P871, DOI 10.1016/S0898-6568(99)00059-5; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Snead OC, 2005, NEW ENGL J MED, V352, P2721, DOI 10.1056/NEJMra044047; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	49	161	166	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1559	1568		10.1038/nn2006	http://dx.doi.org/10.1038/nn2006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965710				2022-12-28	WOS:000251172900013
J	Narayan, R; Best, V; Ozmeral, E; McClaine, E; Dent, M; Shinn-Cunningham, B; Sen, K				Narayan, Rajiv; Best, Virginia; Ozmeral, Erol; McClaine, Elizabeth; Dent, Micheal; Shinn-Cunningham, Barbara; Sen, Kamal			Cortical interference effects in the cocktail party problem	NATURE NEUROSCIENCE			English	Article							MASKING LEVEL DIFFERENCES; PRIMARY AUDITORY-CORTEX; INFERIOR COLLICULUS; RECEPTIVE-FIELDS; NATURAL SOUNDS; NEURONS; DISCRIMINATION; RESPONSES; STIMULI; COMPLEX	Humans and animals must often discriminate between complex natural sounds in the presence of competing sounds (maskers). Although the auditory cortex is thought to be important in this task, the impact of maskers on cortical discrimination remains poorly understood. We examined neural responses in zebra finch (Taeniopygia guttata) field L (homologous to primary auditory cortex) to target birdsongs that were embedded in three different maskers (broadband noise, modulated noise and birdsong chorus). We found two distinct forms of interference in the neural responses: the addition of spurious spikes occurring primarily during the silent gaps between song syllables and the suppression of informative spikes occurring primarily during the syllables. Both effects systematically degraded neural discrimination as the target intensity decreased relative to that of the masker. The behavioral performance of songbirds degraded in a parallel manner. Our results identify neural interference that could explain the perceptual interference at the heart of the cocktail party problem.	Boston Univ, Hearing Res Ctr, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA	Boston University; Boston University; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sen, K (corresponding author), Boston Univ, Hearing Res Ctr, 44 Cummington St, Boston, MA 02215 USA.	kamalsen@bu.edu	Best, Virginia/AAE-4279-2020	Shinn-Cunningham, Barbara/0000-0002-5096-5914; Ozmeral, Erol/0000-0001-9529-001X	NIDCD NIH HHS [1 R01 DC-007610-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007610] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Appeltants D, 2005, BEHAV PROCESS, V69, P331, DOI 10.1016/j.beproc.2005.01.010; Asari H, 2006, J NEUROSCI, V26, P7477, DOI 10.1523/JNEUROSCI.1563-06.2006; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Best V, 2005, J ACOUST SOC AM, V118, P3766, DOI 10.1121/1.2130949; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRONKHORST AW, 1992, J ACOUST SOC AM, V92, P3132, DOI 10.1121/1.404209; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Endepols H, 2003, BEHAV BRAIN RES, V145, P63, DOI 10.1016/S0166-4328(03)00098-6; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Haykin S, 2005, NEURAL COMPUT, V17, P1875, DOI 10.1162/0899766054322964; Hofer SB, 2003, J NEUROSCI, V23, P5732; Hulse SH, 1997, J COMP PSYCHOL, V111, P3, DOI 10.1037/0735-7036.111.1.3; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Kidd G, 1998, J ACOUST SOC AM, V104, P422, DOI 10.1121/1.423246; Lane CC, 2005, J NEUROPHYSIOL, V94, P1180, DOI 10.1152/jn.01112.2004; LANGNER G, 1981, EXP BRAIN RES, V43, P11; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Lin WY, 2001, J COMP PHYSIOL A, V187, P699, DOI 10.1007/s00359-001-0241-2; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; McAlpine D, 1996, J ACOUST SOC AM, V100, P490, DOI 10.1121/1.415862; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Neuert V, 2004, J NEUROSCI, V24, P5789, DOI 10.1523/JNEUROSCI.0450-04.2004; Nieder A, 2001, EUR J NEUROSCI, V13, P1033, DOI 10.1046/j.0953-816x.2001.01465.x; Palmer AR, 1999, J NEUROPHYSIOL, V81, P722, DOI 10.1152/jn.1999.81.2.722; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Pressnitzer D, 2001, J NEUROSCI, V21, P6377, DOI 10.1523/JNEUROSCI.21-16-06377.2001; Ramachandran R, 2000, JARO-J ASSOC RES OTO, V1, P144, DOI 10.1007/s101620010029; Ratnam R, 1998, J NEUROPHYSIOL, V80, P2848, DOI 10.1152/jn.1998.80.6.2848; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; SCHEICH H, 1979, J COMP PHYSIOL, V132, P257, DOI 10.1007/BF00614497; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Theunissen FE, 2000, J NEUROSCI, V20, P2315; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Verhey JL, 2003, EXP BRAIN RES, V153, P405, DOI 10.1007/s00221-003-1607-1; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	50	57	59	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1601	1607		10.1038/nn2009	http://dx.doi.org/10.1038/nn2009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994016				2022-12-28	WOS:000251172900018
J	Compe, E; Malerba, M; Soler, L; Marescaux, J; Borrelli, E; Egly, JM				Compe, Emmanuel; Malerba, Monica; Soler, Luc; Marescaux, Jacques; Borrelli, Emiliana; Egly, Jean-Marc			Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH	NATURE NEUROSCIENCE			English	Article							THYROID-HORMONE RECEPTORS; REPAIR SYNDROME TRICHOTHIODYSTROPHY; PROLIFERATOR-ACTIVATED RECEPTOR; MOLECULAR-BASIS; RAR-ALPHA; MICROCEPHALIC CEREBRUM; NUCLEAR RECEPTORS; BRAIN-DEVELOPMENT; RESPONSIVE GENES; XPD MUTATIONS	Mutations in the XPD subunit of the DNA repair/transcription factor TFIIH yield the rare genetic disorder trichothiodystrophy (TTD). Although this syndrome was initially associated with a DNA repair defect, individuals with TTD develop neurological features, such as microcephaly and hypomyelination that could be connected to transcriptional defects. Here we show that an XPD mutation in TTD mice results in a spatial and selective deregulation of thyroid hormone target genes in the brain. Molecular analyses performed on the mice brain tissue demonstrate that TFIIH is required for the stabilization of thyroid hormone receptors (TR) to their DNA-responsive elements. The limiting amounts of TFIIH found in individuals with TTD thus contribute to the deregulation of TR-responsive genes. The discovery of an unexpected stabilizing function for TFIIH deepens our understanding of the pathogenesis and neurological manifestations observed in TTD individuals.	Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Inst Rech Canc Appareil Digestif, F-67091 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Borrelli, E (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France.	borrelli@uci.edu; egly@titus.u-strasbg.fr	Borrelli, Emiliana/M-8994-2018; Compe, Emmanuel/N-8718-2016; Compe, Emmanuel/U-1071-2019	Compe, Emmanuel/0000-0002-9189-7444				Anderson GW, 2001, FRONT NEUROENDOCRIN, V22, P1, DOI 10.1006/frne.2000.0208; Barradas PC, 2001, J NEUROSCI RES, V66, P254, DOI 10.1002/jnr.1218; Battistella PA, 1996, CHILD NERV SYST, V12, P110, DOI 10.1007/BF00819509; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Billon N, 2004, DEVELOPMENT, V131, P1211, DOI 10.1242/dev.01035; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; Botta E, 2002, HUM MOL GENET, V11, P2919, DOI 10.1093/hmg/11.23.2919; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Bour G, 2005, P NATL ACAD SCI USA, V102, P16608, DOI 10.1073/pnas.0505556102; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; CHEN E, 1994, J INVEST DERMATOL, V103, pS154, DOI 10.1111/1523-1747.ep12399493; Cheng SW, 2000, COMB OPT (SER), V6, P137; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; Drane P, 2004, MOL CELL, V16, P187, DOI 10.1016/j.molcel.2004.10.007; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Guan JZ, 2005, BIOCHEM J, V392, P389, DOI 10.1042/BJ20042102; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; INOUE T, 1990, J BIOL CHEM, V265, P19065; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; LEHMANN AR, 1988, CANCER RES, V48, P6090; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; LIU HC, 1994, MOL ENDOCRINOL, V8, P1021, DOI 10.1210/me.8.8.1021; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NOGUCHI T, 1991, COMP BIOCHEM PHYS C, V98, P239; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Potter GB, 2001, J NEUROSCI, V21, P4373, DOI 10.1523/JNEUROSCI.21-12-04373.2001; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; SUGISAKI T, 1992, INT J DEV NEUROSCI, V10, P453, DOI 10.1016/0736-5748(92)90036-Y; Thompson CC, 1996, J NEUROSCI, V16, P7832; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; Weeda G, 1997, AM J HUM GENET, V60, P320; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	50	69	69	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1414	1422		10.1038/nn1990	http://dx.doi.org/10.1038/nn1990			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952069				2022-12-28	WOS:000250508400019
J	Roberts, M; Delicato, LS; Herrero, J; Gieselmann, MA; Thiele, A				Roberts, Mark; Delicato, Louise S.; Herrero, Jose; Gieselmann, Mark A.; Thiele, Alexander			Attention alters spatial integration in macaque V1 in an eccentricity-dependent manner	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CONTRAST RESPONSE FUNCTIONS; ORIENTATION SELECTIVITY; CONTEXTUAL INFLUENCES; RECEPTIVE-FIELD; SINGLE NEURONS; SIMPLE CELLS; MECHANISMS; V4; NORMALIZATION	Attention can selectively enhance neuronal responses and exclude external noise, but the neuronal computations that underlie these effects remain unknown. At the neuronal level, noise exclusion might result in altered spatial integration properties. We tested this proposal by recording neuronal activity and length tuning in neurons of the primary visual cortex of the macaque when attention was directed toward or away from stimuli presented in each neuron's classical receptive field. For cells with central-parafoveal receptive fields, attention reduced spatial integration, as demonstrated by a reduction in preferred stimulus length and in the size of the spatial summation area. Conversely, in cells that represented more peripheral locations, attention increased spatial integration by increasing the cell's summation area. This previously unknown dichotomy between central and peripheral vision could support accurate analysis of attended foveal objects and target selection for impending eye movements to peripheral objects.	Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Thiele, A (corresponding author), Newcastle Univ, Inst Neurosci, Henry Wellcome Bldg,Famlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	Delicato, Louise/AAT-1921-2020; Roberts, Mark/C-7011-2018	Delicato, Louise/0000-0001-8271-2324; Thiele, Alexander/0000-0003-4894-0213; Roberts, Mark/0000-0001-7513-1281	Biotechnology and Biological Sciences Research Council [BBS/B/09325] Funding Source: Medline; Wellcome Trust [070380, 070380/Z/03/Z] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Angelucci A, 2002, PROG BRAIN RES, V136, P373; Angelucci A, 2002, J NEUROSCI, V22, P8633; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; Carandini M, 1997, J NEUROSCI, V17, P8621; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lu ZL, 2002, J VISION, V2, DOI 10.1167/2.4.4; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Ringach D, 2004, COGNITIVE SCI, V28, P147, DOI 10.1016/j.cogsci.2003.11.003; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Thiele A, 2004, P NATL ACAD SCI USA, V101, P9810, DOI 10.1073/pnas.0307754101; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zenger B, 2000, VISION RES, V40, P3717, DOI 10.1016/S0042-6989(00)00218-2	40	99	101	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1483	1491		10.1038/nn1967	http://dx.doi.org/10.1038/nn1967			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906622	Green Accepted			2022-12-28	WOS:000250508400027
J	Chen, Z; Kujawa, SG; Sewell, WF				Chen, Zhiqiang; Kujawa, Sharon G.; Sewell, William F.			Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; TRAFFICKING; SYNAPSES; NEURONS; INTERNALIZATION; COCHLEA; NERVE	We report a robust regulation of surface AMPA receptors in mouse auditory neurons, both with application of glutamate receptor agonists in cultured neurons and in response to acoustic stimulation in vivo. The reversible reduction of surface AMPA receptors following acoustic stimulation correlated with changes in acoustic sensitivity. Thus we show that AMPA receptor cycling is important for optimizing synaptic transfer at one of the most exacting synapses in the body.	Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Dept Otolaryngol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Dept Audiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Sewell, WF (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, 243 Charles St, Boston, MA 02114 USA.	wfs@epl.meei.harvard.edu						Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; dAldin CG, 1997, INT J DEV NEUROSCI, V15, P619, DOI 10.1016/S0736-5748(96)00116-5; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Kiang NYS, 1965, DISCHARGE PATTERNS S; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Parks TN, 2000, HEARING RES, V147, P77, DOI 10.1016/S0378-5955(00)00122-2; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6	15	42	42	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1238	1240		10.1038/nn1974	http://dx.doi.org/10.1038/nn1974			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828255				2022-12-28	WOS:000249720800007
J	Sananbenesi, F; Fischer, A; Wang, XY; Schrick, C; Neve, R; Radulovic, J; Tsai, LH				Sananbenesi, Farahnaz; Fischer, Andre; Wang, Xinyu; Schrick, Christina; Neve, Rachael; Radulovic, Jelena; Tsai, Li-Huei			A hippocampal Cdk5 pathway regulates extinction of contextual fear	NATURE NEUROSCIENCE			English	Article							CYCLIN-DEPENDENT KINASE-5; DENDRITIC SPINE; MEMORY CONSOLIDATION; PREFRONTAL CORTEX; PROTEIN-SYNTHESIS; ADENYLYL-CYCLASE; P35/CDK5 KINASE; TRANSGENIC MICE; LIM-KINASE; IN-VIVO	Treatment of emotional disorders involves the promotion of extinction processes, which are defined as the learned reduction of fear. The molecular mechanisms underlying extinction have only begun to be elucidated. By employing genetic and pharmacological approaches in mice, we show here that extinction requires downregulation of Rac-1 and cyclin-dependent kinase 5 (Cdk5), and upregulation of p21 activated kinase-1 (PAK-1) activity. This is physiologically achieved by a Rac-1-dependent relocation of the Cdk5 activator p35 from the membrane to the cytosol and dissociation of p35 from PAK-1. Moreover, our data suggest that Cdk5/p35 activity prevents extinction in part by inhibition of PAK-1 activity in a Rac-1-dependent manner. We propose that extinction of contextual fear is regulated by counteracting components of a molecular pathway involving Rac-1, Cdk5 and PAK-1. Our data suggest that this pathway could provide a suitable target for therapeutic treatment of emotional disorders.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Gottingen, Sch Med, European Neurosci Inst, Max Planck Soc, D-37077 Gottingen, Germany; Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; McLean Hosp, Belmont, MA 02478 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Max Planck Society; University of Gottingen; Northwestern University; Feinberg School of Medicine; Harvard University; McLean Hospital	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	andre.fischer@mpi-mail.mpg.de; j-radulovic@northwestern.edu; lhtsai@mit.edu	Fischer, Andre/AAU-7487-2021	Radulovic, Jelena/0000-0002-0268-2426; Fischer, Andre/0000-0001-8546-1161	NIMH NIH HHS [R01 MH073669, MH073669, R01 MH073669-02, R01 MH073669-01A2] Funding Source: Medline; NINDS NIH HHS [R01 NS051874, NS051874] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874, R37NS051874] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; Delamater AR, 2004, Q J EXP PSYCHOL-B, V57, P97, DOI 10.1080/02724990344000097; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; FALLS WA, 1992, J NEUROSCI, V12, P854; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2007, NEUROBIOL LEARN MEM, V87, P149, DOI 10.1016/j.nlm.2006.08.003; Fischer A, 2003, CNS NEUROL DISORD-DR, V2, P375, DOI 10.2174/1568007033482706; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; HAWASLI AH, 2007, NAT NEUROSCI    0527; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Howell D, 2002, STAT METHODS PSYCHOL; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; KITAGAWA M, 1993, ONCOGENE, V8, P2425; Lattal KM, 2006, BIOL PSYCHIAT, V60, P344, DOI 10.1016/j.biopsych.2006.05.038; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lin CH, 2003, J NEUROSCI, V23, P1574; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Vianna MR, 2004, CURR NEUROVASC RES, V1, P55, DOI 10.2174/1567202043480170; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x	49	117	131	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1012	1019		10.1038/nn1943	http://dx.doi.org/10.1038/nn1943			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632506	Green Accepted, Green Submitted			2022-12-28	WOS:000248357500015
J	Banissy, MJ; Ward, J				Banissy, Michael J.; Ward, Jamie			Mirror-touch synesthesia is linked with empathy	NATURE NEUROSCIENCE			English	Editorial Material							AUTISM SPECTRUM DISORDERS; SIMULATION; QUOTIENT; SYSTEM; FMRI; MIND	Watching another person being touched activates a similar neural circuit to actual touch and, for some people with 'mirror-touch' synesthesia, can produce a felt tactile sensation on their own body. In this study, we provide evidence for the existence of this type of synesthesia and show that it correlates with heightened empathic ability. This is consistent with the notion that we empathize with others through a process of simulation.	UCL, Dept Psychol, Bedford WC1H OAP, England	University of London; University College London	Banissy, MJ (corresponding author), UCL, Dept Psychol, 26 Bedford Way, Bedford WC1H OAP, England.	m.banissy@ucl.ac.uk	Ward, Jamie/F-3609-2011	Ward, Jamie/0000-0001-7007-1902				Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	14	154	158	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					815	816		10.1038/nn1926	http://dx.doi.org/10.1038/nn1926			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17572672				2022-12-28	WOS:000247560200009
J	Yao, HS; Shi, L; Han, F; Gao, HF; Dan, Y				Yao, Haishan; Shi, Lei; Han, Feng; Gao, Hongfeng; Dan, Yang			Rapid learning in cortical coding of visual scenes	NATURE NEUROSCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; TIMING-DEPENDENT PLASTICITY; IN-VIVO; SYNAPTIC MODIFICATION; CORTEX; NEURONS; SLEEP; REPLAY; EXPERIENCE; SEQUENCES	Experience-dependent plasticity in adult visual cortex is believed to have important roles in visual coding and perceptual learning. Here we show that repeated stimulation with movies of natural scenes induces a rapid improvement in response reliability in cat visual cortex, whereas stimulation with white noise or flashed bar stimuli does not. The improved reliability can be accounted for by a selective increase in spiking evoked by preferred stimuli, and the magnitude of improvement depends on the sparseness of the response. The increase in reliability persists for at least several minutes in the absence of further movie stimulation. During this period, spontaneous spiking activity shows detectable reverberation of the movie-evoked responses. Thus, repeated exposure to natural stimuli not only induces a rapid improvement in cortical response reliability, but also leaves a 'memory trace' in subsequent spontaneous activity.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NEI NIH HHS [EY 015180] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015180] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; Fahle M, 2002, PERCEPTUAL LEARNING; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; HEBBB DO, 1949, ORG BEHAV; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; RAO RPN, 2000, PREDICTIV SEAQUENCE; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Touryan J, 2002, J NEUROSCI, V22, P10811; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3	50	89	91	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					772	778		10.1038/nn1895	http://dx.doi.org/10.1038/nn1895			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468750	Green Submitted			2022-12-28	WOS:000246799800020
J	DeBruyne, JP; Weaver, DR; Reppert, SM				DeBruyne, Jason P.; Weaver, David R.; Reppert, Steven M.			CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock	NATURE NEUROSCIENCE			English	Article							EXPRESSION; MAMMALS; MICE	Heterodimers of CLOCK and BMAL1, bHLH-PAS transcription factors, are believed to be the major transcriptional regulators of the circadian clock mechanism in mammals. However, a recent study shows that CLOCK-deficient mice continue to exhibit robust behavioral and molecular rhythms. Here we report that the transcription factor NPAS2 ( MOP4) is able to functionally substitute for CLOCK in the master brain clock in mice to regulate circadian rhythmicity.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; DeBruyne, Jason/0000-0001-9803-9568; Weaver, David/0000-0001-7941-6719	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141, R01NS056125] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM074277, F32 GM074277-02] Funding Source: Medline; NINDS NIH HHS [R01 NS056125, R01 NS056125-01, R01 NS047141, R01 NS056125-02, R01 NS047141-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Green CB, 2003, SCIENCE, V301, P319, DOI 10.1126/science.1087824; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	13	336	352	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					543	545		10.1038/nn1884	http://dx.doi.org/10.1038/nn1884			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417633	Green Published, Green Accepted			2022-12-28	WOS:000245948000007
J	Schenk, T				Schenk, Thomas			An allocentric rather than perceptual deficit in patient DF	NATURE NEUROSCIENCE			English	Article							VISUAL FORM AGNOSIA; OPTIC ATAXIA; ILLUSIONS	The perception/action model states that vision for perception and vision for action are processed in separate pathways. This model was inspired by observations in patient D. F. who seemed unable to use vision for perceptual tasks while retaining 'normal' visuomotor capacity. I found that D.F.'s performance is preserved in perceptual and visuomotor tasks when the required spatial information is hand-centered and impaired when the information is object-centered.	Univ Durham, Wolfson Res Inst, Cognit Neurosci Res Unit, Stockton On Tees TS17 6BH, England	Durham University	Schenk, T (corresponding author), Univ Durham, Wolfson Res Inst, Cognit Neurosci Res Unit, Queens Campus, Stockton On Tees TS17 6BH, England.	thomas.schenk@dur.ac.uk	S, T/GXF-0648-2022; S, T/GRY-0013-2022		MRC [G0401090] Funding Source: UKRI; Medical Research Council [G0401090] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Carey DP, 1996, NEUROPSYCHOLOGIA, V34, P329, DOI 10.1016/0028-3932(95)00169-7; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Franz VH, 2001, J EXP PSYCHOL HUMAN, V27, P1124, DOI 10.1037//0096-1523.27.5.1124; Glover S, 2002, TRENDS COGN SCI, V6, P288, DOI 10.1016/S1364-6613(02)01920-4; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; JACOB P, 2003, WAYS SEEING SCOPE LI; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Milner A. D., 1995, VISUAL BRAIN ACTION; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549	15	120	120	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1369	1370		10.1038/nn1784	http://dx.doi.org/10.1038/nn1784			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028584	Green Accepted			2022-12-28	WOS:000242403800013
J	Sereno, MI; Huang, RS				Sereno, Martin I.; Huang, Ruey-Song			A human parietal face area contains aligned head-centered visual and tactile maps	NATURE NEUROSCIENCE			English	Article							VENTRAL INTRAPARIETAL AREA; FUNCTIONAL-ORGANIZATION; RESPONSE PROPERTIES; POSTERIOR PARIETAL; MACAQUE MONKEY; CORTEX; SPACE; FMRI; CONNECTIONS; ACTIVATION	Visually guided eating, biting and kissing, and avoiding objects moving toward the face and toward which the face moves require prompt, coordinated processing of spatial visual and somatosensory information in order to protect the face and the brain. Single-cell recordings in parietal cortex have identified multisensory neurons with spatially restricted, aligned visual and somatosensory receptive fields, but so far, there has been no evidence for a topographic map in this area. Here we mapped the organization of a multisensory parietal face area in humans by acquiring functional magnetic resonance images while varying the polar angle of facial air puffs and close-up visual stimuli. We found aligned maps of tactile and near-face visual stimuli at the highest level of human association cortex-namely, in the superior part of the postcentral sulcus. We show that this area may code the location of visual stimuli with respect to the face, not with respect to the retina.	Univ Calif San Diego, Dept Cognit Sci, Inst Neural Computat, La Jolla, CA 92093 USA; Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sereno, MI (corresponding author), Univ Calif San Diego, Dept Cognit Sci, Inst Neural Computat, La Jolla, CA 92093 USA.	sereno@cogsci.ucsd.edu	Huang, Ruey-Song/GZL-0985-2022; Sereno, Martin I/F-7657-2012	Sereno, Martin I/0000-0002-7598-7829; Huang, Ruey-Song/0000-0003-0385-9358	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041925, R01NS036722] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD041581] Funding Source: Medline; NINDS NIH HHS [R01 NS36722, R01 NS41925] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Astafiev SV, 2003, J NEUROSCI, V23, P4689; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bremmer F, 2005, J PHYSIOL-LONDON, V566, P29, DOI 10.1113/jphysiol.2005.082552; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Calvert G., 2004, HDB MULTISENSORY PRO; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Cooke DF, 2004, NEURON, V43, P585, DOI 10.1016/j.neuron.2004.07.029; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; HAGLER DJ, IN PRESS NEURIMAGE; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; HUANG RS, IN PRESS NEURIMAGE; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Monteiro GA, 2003, NEUROREPORT, V14, P2139, DOI 10.1097/00001756-200312020-00002; MORI A, 1991, NEUROSCI RES, V11, P198, DOI 10.1016/0168-0102(91)90043-X; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Spence C., 2004, CROSSMODAL SPACE CRO; THOMAS HC, 1987, BRAIN RES, V417, P214, DOI 10.1016/0006-8993(87)90445-8; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9	39	232	235	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1337	1343		10.1038/nn1777	http://dx.doi.org/10.1038/nn1777			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16998482				2022-12-28	WOS:000241493900028
J	Perez-Otano, I; Lujan, R; Tavalin, SJ; Plomann, M; Modregger, J; Liu, XB; Jones, EG; Heinemann, SF; Lo, DC; Ehlers, MD				Perez-Otano, I; Lujan, R; Tavalin, SJ; Plomann, M; Modregger, J; Liu, XB; Jones, EG; Heinemann, SF; Lo, DC; Ehlers, MD			Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD; SUBUNIT; TRAFFICKING; PROTEIN; LOCALIZATION; DENSITY; INTERNALIZATION; EXPRESSION; MEMBRANE; SYNAPSES	A key step in glutamatergic synapse maturation is the replacement of developmentally expressed N-methyl-D-aspartate receptors (NMDARs) with mature forms that differ in subunit composition, electrophysiological properties and propensity to elicit synaptic plasticity. However, the mechanisms underlying the removal and replacement of synaptic NMDARs are poorly understood. Here we demonstrate that NMDARs containing the developmentally regulated NR3A subunit undergo rapid endocytosis from the dendritic plasma membrane in cultured rat hippocampal neurons. This endocytic removal is regulated by PACSIN1/syndapin1, which directly and selectively binds the carboxy-terminal domain of NR3A through its NPF motifs and assembles a complex of proteins including dynamin and clathrin. Endocytosis of NR3A by PACSIN1 is activity dependent, and disruption of PACSIN1 function causes NR3A accumulation at synaptic sites. Our results reveal a new activity-dependent mechanism involved in the regulation of NMDAR expression at synapses during development, and identify a brain-specific endocytic adaptor that confers spatiotemporal and subunit specificity to NMDAR endocytosis.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Navarra, CIMA, Dept Neurosci, Cellular Neurobiol Lab, Pamplona 31008, Spain; Univ Castilla La Mancha, Fac Med, CRIB, Dept Ciencias Med, Albacete 02006, Spain; Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; University of Navarra; Universidad de Castilla-La Mancha; University of Tennessee System; University of Tennessee Health Science Center; University of Cologne; University of Cologne; University of California System; University of California Davis; Salk Institute; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Perez-Otano, Isabel/S-9613-2017; Lujan, Rafael/G-2555-2015	Perez-Otano, Isabel/0000-0002-7222-8202; Modregger, Jan/0000-0001-6209-5891; Lujan Miras, Rafael/0000-0003-2001-9545	NIMH NIH HHS [MH64748, R01 MH064748] Funding Source: Medline; NINDS NIH HHS [R01 NS047574, NS46661, NS39402, NS32742, R01 NS028709, R01 NS28709, R01 NS046661, R01 NS039402] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032742, R01NS047574, R01NS046661, R01NS039402, R01NS028709, R01NS032742] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BURGARD EC, 1994, DEV BRAIN RES, V80, P275, DOI 10.1016/0165-3806(94)90113-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; da Costa SR, 2003, MOL BIOL CELL, V14, P4397, DOI 10.1091/mbc.E03-05-0315; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; KATO N, 1993, P NATL ACAD SCI USA, V90, P7114, DOI 10.1073/pnas.90.15.7114; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; LEVITTGILMOUR TA, 1986, J NEUROSCI, V6, P1606; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Racca C, 2000, J NEUROSCI, V20, P2512; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao A, 1998, J NEUROSCI, V18, P1217; ROBERTS A, 1987, J FAM VIOLENCE, V2, P81, DOI DOI 10.1007/BF00976372; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tovar KR, 2002, NEURON, V34, P253; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314	50	150	158	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					611	621		10.1038/nn1680	http://dx.doi.org/10.1038/nn1680			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617342	Green Accepted			2022-12-28	WOS:000237417200011
J	Wang, R; King, T; Ossipov, MH; Rossomando, AJ; Vanderah, TW; Harvey, P; Cariani, P; Frank, E; Sah, DWY; Porreca, F				Wang, Ruizhong; King, Tamara; Ossipov, Michael H.; Rossomando, Anthony J.; Vanderah, Todd W.; Harvey, Pamela; Cariani, Peter; Frank, Eric; Sah, Dinah W. Y.; Porreca, Frank			Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury	NATURE NEUROSCIENCE			English	Article							ADULT SPINAL-CORD; NEUROTROPHIC FACTOR; NERVE INJURY; RECEPTOR COMPONENTS; AXONAL REGENERATION; NEUROPATHIC PAIN; SCHWANN-CELLS; SCIATIC-NERVE; GDNF FAMILY; C-FOS	Dorsal root injury results in substantial and often irreversible loss of sensory functions as a result of the limited regenerative capacity of sensory axons and the inhibitory barriers that prevent both axonal entry into and regeneration in the spinal cord. Here, we describe previously unknown effects of the growth factor artemin after crush injury of the dorsal spinal nerve roots in rats. Artemin not only promoted re-entry of multiple classes of sensory fibers into the spinal cord and re-establishment of synaptic function and simple behavior, but it also, surprisingly, promoted the recovery of complex behavior. These effects occurred after a 2-week schedule of intermittent, systemic administration of artemin and persisted for at least 6 months following treatment, suggesting a substantial translational advantage. Systemic artemin administration produced essentially complete and persistent restoration of nociceptive and sensorimotor functions, and could represent a promising therapy that may effectively promote sensory neuronal regeneration and functional recovery after injury.	[Wang, Ruizhong; King, Tamara; Ossipov, Michael H.; Vanderah, Todd W.; Porreca, Frank] Univ Arizona, Dept Pharmacol, Coll Med, Tucson, AZ 85724 USA; [Rossomando, Anthony J.; Sah, Dinah W. Y.] Biogen Idec, Cambridge, MA 02142 USA; [Harvey, Pamela; Cariani, Peter; Frank, Eric] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	University of Arizona; Biogen; Tufts University	Porreca, F (corresponding author), Univ Arizona, Dept Pharmacol, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	frankp@u.arizona.edu		HARVEY, PAMELA/0000-0001-9102-8823	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064494] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS064494] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBADIE C, 1992, BRAIN RES, V578, P17, DOI 10.1016/0006-8993(92)90224-W; Al-Qattan MM, 2003, ANN PLAS SURG, V51, P257, DOI 10.1097/01.SAP.0000063750.16982.E4; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BALOH RH, 1997, RET NEURON, V18, P793; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; CARLSTEDT T, 1985, BRAIN RES, V347, P188, DOI 10.1016/0006-8993(85)90911-4; Fraher JP, 2000, J ANAT, V196, P137; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Gardell LR, 2003, NAT MED, V9, P1383, DOI 10.1038/nm944; Hammarberg H, 1996, NEUROREPORT, V7, P857, DOI 10.1097/00001756-199603220-00004; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Honore P, 1999, J NEUROSCI, V19, P7670, DOI 10.1523/JNEUROSCI.19-17-07670.1999; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Neumann S, 2005, P NATL ACAD SCI USA, V102, P16848, DOI 10.1073/pnas.0508538102; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OBLINGER MM, 1984, J NEUROSCI, V4, P1736; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176; PRESLEY RW, 1990, J NEUROSCI, V10, P323; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Ramer MS, 2002, MOL CELL NEUROSCI, V19, P239, DOI 10.1006/mcne.2001.1067; Ramer MS, 2001, J NEUROCHEM, V77, P864, DOI 10.1046/j.1471-4159.2001.00288.x; ROBERTSON B, 1985, NEUROSCIENCE, V14, P895, DOI 10.1016/0306-4522(85)90152-6; Sah DWY, 2005, CURR TOP MED CHEM, V5, P577, DOI 10.2174/1568026054367593; Sah DWY, 2003, NAT REV DRUG DISCOV, V2, P460, DOI 10.1038/nrd1107; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Wang R, 2003, NEUROSCIENCE, V121, P815, DOI 10.1016/S0306-4522(03)00491-3; Wong LF, 2006, NAT NEUROSCI, V9, P243, DOI 10.1038/nn1622; Woolf CJ, 2002, SCIENCE, V297, P1132, DOI 10.1126/science.1076247; WUJEK JR, 1983, J NEUROSCI, V3, P243; Yan H, 2003, DEV DYNAM, V227, P395, DOI 10.1002/dvdy.10294	46	74	85	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					488	496		10.1038/nn2069	http://dx.doi.org/10.1038/nn2069			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344995	Green Accepted			2022-12-28	WOS:000254359300021
J	Lin, MT; Lujan, R; Watanabe, M; Adelman, JP; Maylie, J				Lin, Mike T.; Lujan, Rafael; Watanabe, Masahiko; Adelman, John P.; Maylie, James			SK2 channel plasticity contributes to LTP at Schaffer collateral-CA1 synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA2+-ACTIVATED POTASSIUM CHANNEL; SYNAPTIC PLASTICITY; SMALL-CONDUCTANCE; AMPA RECEPTORS; DENDRITIC SPINES; CALCIUM-CHANNELS; PROTEIN-KINASE; LATE-PHASE; I-H	Long-term potentiation (LTP) of synaptic strength at Schaffer collateral synapses has largely been attributed to changes in the number and biophysical properties of AMPA receptors (AMPARs). Small-conductance Ca2(+)-activated K+ channels (SK2 channels) are functionally coupled with NMDA receptors (NMDARs) in CA1 spines such that their activity modulates the shape of excitatory postsynaptic potentials (EPSPs) and increases the threshold for induction of LTP. Here we show that LTP induction in mouse hippocampus abolishes SK2 channel activity in the potentiated synapses. This effect is due to SK2 channel internalization from the postsynaptic density (PSD) into the spine. Blocking PKA or cell dialysis with a peptide representing the C-terminal domain of SK2 that contains three known PKA phosphorylation sites blocks the internalization of SK2 channels after LTP induction. Thus the increase in AMPARs and the decrease in SK2 channels combine to produce the increased EPSP underlying LTP.	[Lin, Mike T.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, Albacete 02006, Spain; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Universidad de Castilla-La Mancha; Hokkaido University; Oregon Health & Science University	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	adelman@ohsu.edu; mayliej@ohsu.edu	WATANABE, Masahiko/A-4055-2012; Lujan, Rafael/G-2555-2015; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076752, F32MH080480, R01MH081860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH076752-03, F32 MH080480, R01 MH081860, R01 MH076752, R01 MH081860-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS038880-08, R01 NS038880] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown GP, 2000, J NEUROSCI, V20, P7880; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stackman RW, 2002, J NEUROSCI, V22, P10163; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112	48	169	172	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					170	177		10.1038/nn2041	http://dx.doi.org/10.1038/nn2041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204442	Green Accepted			2022-12-28	WOS:000252712100011
J	Di Cristo, G; Chattopadhyaya, B; Kuhlman, SJ; Fu, Y; Belanger, MC; Wu, CZ; Rutishauser, U; Maffei, L; Huang, ZJ				Di Cristo, Graziella; Chattopadhyaya, Bidisha; Kuhlman, Sandra J.; Fu, Yu; Belanger, Marie-Claude; Wu, Cai Zhi; Rutishauser, Urs; Maffei, Lamberto; Huang, Z. Josh			Activity-dependent PSA expression regulates inhibitory maturation and onset of critical period plasticity	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION MOLECULE; PRIMARY VISUAL-CORTEX; GAMMA-AMINOBUTYRIC-ACID; POLYSIALIC ACID; GABAERGIC INNERVATION; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; ADULT; AXONS; NCAM	Functional maturation of GABAergic innervation in the developing visual cortex is regulated by neural activity and sensory inputs and in turn influences the critical period of ocular dominance plasticity. Here we show that polysialic acid (PSA), presented by the neural cell adhesion molecule, has a role in the maturation of GABAergic innervation and ocular dominance plasticity. Concentrations of PSA significantly decline shortly after eye opening in the adolescent mouse visual cortex; this decline is hindered by visual deprivation. The developmental and activity-dependent regulation of PSA expression is inversely correlated with the maturation of GABAergic innervation. Premature removal of PSA in visual cortex results in precocious maturation of perisomatic innervation by basket interneurons, enhanced inhibitory synaptic transmission, and earlier onset of ocular dominance plasticity. The developmental and activity-dependent decline of PSA expression therefore regulates the timing of the maturation of GABAergic inhibition and the onset of ocular dominance plasticity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11734 USA; SUNY Stony Brook, Neurosci Program, Stony Brook, NY 11790 USA; Univ Montreal, CHU St Justine, Montreal, PQ H3T 1C5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Inst Neuro Fisiol Ctr Nazl Ricerca, I-56124 Pisa, Italy	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Memorial Sloan Kettering Cancer Center	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11734 USA.	huangj@cshl.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282; Huang, Z. Josh/0000-0003-0592-028X	NEI NIH HHS [R01 EY 13564-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bouzioukh F, 2001, J NEUROSCI, V21, P4721, DOI 10.1523/JNEUROSCI.21-13-04721.2001; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dupuy ST, 1996, J NEUROSCI, V16, P6919; Echevarria D, 2000, DEV BRAIN RES, V123, P151, DOI 10.1016/S0165-3806(00)00089-4; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; El Maarouf A, 2003, J COMP NEUROL, V460, P203, DOI 10.1002/cne.10635; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Morales B, 2002, J NEUROSCI, V22, P8084; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Seki T, 1998, J NEUROSCI, V18, P3757; Soares S, 2000, J NEUROSCI, V20, P2551; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Toki S, 2007, EUR J NEUROSCI, V25, P815, DOI 10.1111/j.1460-9568.2007.05288.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamamoto N, 2000, J NEUROSCI, V20, P9145; YIN XH, 1995, DEVELOPMENT, V121, P3439	50	150	150	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1569	1577		10.1038/nn2008	http://dx.doi.org/10.1038/nn2008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026099				2022-12-28	WOS:000251172900014
J	Mildner, A; Schmidt, H; Nitsche, M; Merkler, D; Hanisch, UK; Mack, M; Heikenwalder, M; Bruck, W; Priller, J; Prinz, M				Mildner, Alexander; Schmidt, Hauke; Nitsche, Mirko; Merkler, Doron; Hanisch, Uwe-Karsten; Mack, Matthias; Heikenwalder, Mathias; Brueck, Wolfgang; Priller, Josef; Prinz, Marco			Microglia in the adult brain arise from Ly-6C(hi)CCR2(+) monocytes only under defined host conditions	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GREEN FLUORESCENT PROTEIN; MARROW-DERIVED MICROGLIA; BETA-AMYLOID DEPOSITION; NF-KAPPA-B; BONE-MARROW; HEMATOPOIETIC-CELLS; STEM-CELLS; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS	Microglia are crucially important myeloid cells in the CNS and constitute the first immunological barrier against pathogens and environmental insults. The factors controlling microglia recruitment from the blood remain elusive and the direct circulating microglia precursor has not yet been identified in vivo. Using a panel of bone marrow chimeric and adoptive transfer experiments, we found that circulating Ly-6C(hi)CCR2(+) monocytes were preferentially recruited to the lesioned brain and differentiated into microglia. Notably, microglia engraftment in CNS pathologies, which are not associated with overt blood-brain barrier disruption, required previous conditioning of brain (for example, by direct tissue irradiation). Our results identify Ly-6C(hi)CCR2(+) monocytes as direct precursors of microglia in the adult brain and establish the importance of local factors in the adult CNS for microglia engraftment.	Univ Gottingen, Inst Neuropathol, D-3400 Gottingen, Germany; Univ Gottingen, Dept Radiat Oncol, D-3400 Gottingen, Germany; Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany; Univ Zurich Spital, Inst Neuropathol, Zurich, Switzerland; Univ Gottingen, Inst Multiple Sclerosis Res, D-3400 Gottingen, Germany; Charite Univ Med Berlin, Mol Psychiat Lab, Berlin, Germany	University of Gottingen; University of Gottingen; University of Regensburg; University of Zurich; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Prinz, M (corresponding author), Univ Gottingen, Inst Neuropathol, D-3400 Gottingen, Germany.	mprinz@med.uni-goettingen.de	Nitsche, Mirko/K-8851-2019; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AAF-9451-2022; mildner, alexander/GQA-3761-2022; mildner, alexander/AFK-2161-2022; Merkler, Doron/N-9157-2016; Priller, Josef/ABW-3835-2022; Heikenwalder, Mathias/AAA-2269-2020	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Merkler, Doron/0000-0002-0247-2007; Priller, Josef/0000-0001-7596-0979				Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; BAKKER DA, 1987, J NEUROL SCI, V78, P125, DOI 10.1016/0022-510X(87)90055-4; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Furuya T, 2003, NEUROREPORT, V14, P629, DOI 10.1097/00001756-200303240-00021; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; KONDO A, 1987, BRAIN RES, V425, P186, DOI 10.1016/0006-8993(87)90499-9; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vallieres L, 2003, J NEUROSCI, V23, P5197; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; Wehner T, 2003, J NEUROSCI, V23, P5004; WILLIAMS AE, 1994, NEUROPATH APPL NEURO, V20, P47, DOI 10.1111/j.1365-2990.1994.tb00956.x; WSIRSKI FK, 2007, J CLIN INVEST, V117, P195; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4	50	789	806	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1544	1553		10.1038/nn2015	http://dx.doi.org/10.1038/nn2015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026096				2022-12-28	WOS:000251172900011
J	Uemura, M; Nakao, S; Suzuki, ST; Takeichi, M; Hirano, S				Uemura, Masato; Nakao, Shinsuke; Suzuki, Shintaro T.; Takeichi, Masatoshi; Hirano, Shinji			OL-protocadherin is essential for growth of striatal axons and thalamocortical projections	NATURE NEUROSCIENCE			English	Article							GANGLIONIC EMINENCE; GAMMA-PROTOCADHERINS; INTERMEDIATE TARGET; MOUSE-BRAIN; CORTEX; MICE; CONNECTIVITY; EXPRESSION; NEURONS; SYSTEM	The ventral telencephalon in the embryonic brain is thought to provide guidance cues for navigation of thalamocortical axons, but the mechanisms involved remain largely elusive. OL-protocadherin ( OL-pc), a member of the cadherin superfamily, is highly expressed by striatal neurons in the developing ventral telencephalon. Here we show that OL-pc-deficient ( Pcdh10(-/-)) mice have defects in axon pathways through the ventral telencephalon; for example, thalamocortical and corticothalamic projections cannot cross the ventral telencephalon. In the ventral telencephalon, striatal axons fail to grow out, and, concomitantly, the caudal portion of the globus pallidus and the associated 'corridor' thought to be important for thalamocortical fiber navigation do not form. The inability of the striatum to extend axons is also observed in vitro. These results show that OL-pc is essential for both elongation of striatal axons and patterning of the putative guidance cues for thalamocortical projections.	Ctr Dev Biol, RIKEN, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	RIKEN; Kyoto University; Kwansei Gakuin University; Japan Science & Technology Agency (JST)	Takeichi, M (corresponding author), Ctr Dev Biol, RIKEN, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp; s-hirano@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378				Aoki E, 2003, NEUROSCIENCE, V117, P593, DOI 10.1016/S0306-4522(02)00944-2; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Hanashima C, 2006, CELL, V125, P24, DOI 10.1016/j.cell.2006.03.021; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Hirano S, 1999, J NEUROSCI, V19, P995; Hogan B, 1994, MANIPULATING MOUSE E; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jones L, 2002, DEVELOPMENT, V129, P5041; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Luckner R, 2001, CELL TISSUE RES, V303, P159, DOI 10.1007/s004410000292; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Muller K, 2004, J COMP NEUROL, V470, P240, DOI 10.1002/cne.11044; Nakao S, 2005, MOL BRAIN RES, V134, P294, DOI 10.1016/j.molbrainres.2004.11.017; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Phillips GR, 2003, J NEUROSCI, V23, P5096; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	42	120	120	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1151	1159		10.1038/nn1960	http://dx.doi.org/10.1038/nn1960			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17721516				2022-12-28	WOS:000249144000017
J	Bendor, D; Wang, XQ				Bendor, Daniel; Wang, Xiaoqin			Differential neural coding of acoustic flutter within primate auditory cortex	NATURE NEUROSCIENCE			English	Article							AMPLITUDE-MODULATED SOUNDS; PERCEPTUAL DISCRIMINATION; FREQUENCY DISCRIMINATION; SOMATOSENSORY CORTEX; TEMPORAL MODULATIONS; SINGLE NEURONS; MACAQUE MONKEY; VISUAL-CORTEX; STIMULI; REPRESENTATIONS	A sequence of acoustic events is perceived either as one continuous sound or as a stream of temporally discrete sounds (acoustic flutter), depending on the rate at which the acoustic events repeat. Acoustic flutter is perceived at repetition rates near or below the lower limit for perceiving pitch, and is akin to the discrete percepts of visual flicker and tactile flutter caused by the slow repetition of sensory stimulation. It has been shown that slowly repeating acoustic events are represented explicitly by stimulus-synchronized neuronal firing patterns in primary auditory cortex (AI). Here we show that a second neural code for acoustic flutter exists in the auditory cortex of marmoset monkeys (Callithrix jacchus), in which the firing rate of a neuron is a monotonic function of an acoustic event's repetition rate. Whereas many neurons in AI encode acoustic flutter using a dual temporal/rate representation, we find that neurons in cortical fields rostral to AI predominantly use a monotonic rate code and lack stimulus-synchronized discharges. These findings indicate that the neural representation of acoustic flutter is transformed along the caudal-to-rostral axis of auditory cortex.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University	Bendor, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,Traylor Bldg 412, Baltimore, MD 21205 USA.	dbendor@jhu.edu; xiaoqin.wang@jhu.edu		Bendor, Daniel/0000-0001-6621-793X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180, F31DC006528] Funding Source: NIH RePORTER; NIDCD NIH HHS [F31 DC006528, F31 DC 006528, DC 03180, R01 DC003180] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; BESSER GM, 1967, NATURE, V214, P17, DOI 10.1038/214017a0; Bieser A, 1996, EXP BRAIN RES, V108, P273; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; DiMattina C, 2006, J NEUROPHYSIOL, V95, P1244, DOI 10.1152/jn.00818.2005; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Fishman YI, 2000, J ACOUST SOC AM, V108, P235, DOI 10.1121/1.429460; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6485, DOI 10.1523/JNEUROSCI.5061-05.2006; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; HARTMANN E, 1979, VISION RES, V19, P1019, DOI 10.1016/0042-6989(79)90227-X; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lu T, 2004, J NEUROPHYSIOL, V91, P301, DOI 10.1152/jn.00022.2003; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mardia KV, 2000, DIRECTIONAL STAT; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MILLER GA, 1948, J ACOUST SOC AM, V20, P171, DOI 10.1121/1.1906360; MOODY DB, 1994, J ACOUST SOC AM, V95, P3499, DOI 10.1121/1.409967; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Pistorio AL, 2006, J ACOUST SOC AM, V120, P1655, DOI 10.1121/1.2225899; POLLACK I, 1968, J ACOUST SOC AM, V43, P1107, DOI 10.1121/1.1910945; POLLACK I, 1969, J ACOUST SOC AM, V46, P422, DOI 10.1121/1.1911706; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Salinas E, 2006, PLOS BIOL, V4, P2383, DOI 10.1371/journal.pbio.0040387; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004	50	107	109	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					763	771		10.1038/nn1888	http://dx.doi.org/10.1038/nn1888			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468752				2022-12-28	WOS:000246799800019
J	Bonnin, A; Torii, M; Wang, L; Rakic, P; Levitt, P				Bonnin, Alexandre; Torii, Masaaki; Wang, Lilly; Rakic, Pasko; Levitt, Pat			Serotonin modulates the response of embryonic thalamocortical axons to netrin-1	NATURE NEUROSCIENCE			English	Article							THALAMIC NEURONS; CORTICAL DEVELOPMENT; EXPRESSION PATTERNS; PROTEIN-KINASE; MUTANT MICE; GROWTH; PROJECTIONS; RECEPTOR; RAT; ACTIVATION	Modifying serotonin ( 5- HT) abundance in the embryonic mouse brain disrupts the precision of sensory maps formed by thalamocortical axons ( TCAs), suggesting that 5- HT influences their growth. We investigated the mechanism by which 5- HT influences TCAs during development. 5- HT1B and 5- HT1D receptor expression in the fetal forebrain overlaps with that of the axon guidance receptors DCC and Unc5c. In coculture assays, axons originating from anterior and posterior halves of the embryonic day 14.5 dorsal thalamus responded differently to netrin- 1, reflecting the patterns of DCC and Unc5c expression. 5- HT converts the attraction exerted by netrin- 1 on posterior TCAs to repulsion. Pharmacological manipulation of 5- HT1B/1D receptors and intracellular cAMP showed the signaling cascade through which this modulation occurs. An in vivo correlate of altered TCA pathfinding was obtained by transient manipulation of 5- HT1B/1D receptor expression abundance in the dorsal thalamus by in utero electroporation. These data demonstrate that serotonergic signaling has a previously unrecognized role in the modulation of axonal responsiveness to a classic guidance cue.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Yale University; Yale University; Vanderbilt University	Levitt, P (corresponding author), Vanderbilt Univ, Dept Pharmacol, 465 21st Ave S, Nashville, TN 37232 USA.	pat.levitt@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NICHD NIH HHS [P30HD15052] Funding Source: Medline; NIMH NIH HHS [MH65299] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADHAM N, 1992, MOL PHARMACOL, V41, P1; AITKEN AR, 1988, J COMP NEUROL, V274, P32, DOI 10.1002/cne.902740105; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Geerts IS, 1999, BRIT J PHARMACOL, V127, P1327, DOI 10.1038/sj.bjp.0702684; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lotto B, 1999, NEUROSCI LETT, V269, P87, DOI 10.1016/S0304-3940(99)00422-X; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Persico AM, 2006, BRAIN RES, V1095, P17, DOI 10.1016/j.brainres.2006.04.006; Price GW, 1997, N-S ARCH PHARMACOL, V356, P312, DOI 10.1007/PL00005056; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Rehn AE, 2005, CLIN EXP PHARMACOL P, V32, P687, DOI 10.1111/j.1440-1681.2005.04257.x; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110	49	191	194	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					588	597		10.1038/nn1896	http://dx.doi.org/10.1038/nn1896			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450135				2022-12-28	WOS:000245948000015
J	Schlief, ML; Wilson, RI				Schlief, Michelle L.; Wilson, Rachel I.			Olfactory processing and behavior downstream from highly selective receptor neurons	NATURE NEUROSCIENCE			English	Article							DROSOPHILA ANTENNAL LOBE; PHEROMONE-SENSITIVE NEURONS; COURTSHIP BEHAVIOR; HOST-ODOR; BRAIN; MELANOGASTER; SYSTEM; COMBINATORIAL; INFORMATION; FLY	In both the vertebrate nose and the insect antenna, most olfactory receptor neurons ( ORNs) respond to multiple odors. However, some ORNs respond to just a single odor, or at most to a few highly related odors. It has been hypothesized that narrowly tuned ORNs project to narrowly tuned neurons in the brain, and that these dedicated circuits mediate innate behavioral responses to a particular ligand. Here we have investigated neural activity and behavior downstream from two narrowly tuned ORN types in Drosophila melanogaster. We found that genetically ablating either of these ORN types impairs innate behavioral attraction to their cognate ligand. Neurons in the antennal lobe postsynaptic to one of these ORN types are, like their presynaptic ORNs, narrowly tuned to a pheromone. However, neurons postsynaptic to the second ORN type are broadly tuned. These results demonstrate that some narrowly tuned ORNs project to dedicated central circuits, ensuring a tight connection between stimulus and behavior, whereas others project to central neurons that participate in the ensemble representations of many odors.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC008174-02, R01 1R01DC008174-01, R01 DC008174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANTON S, 1994, J COMP NEUROL, V350, P199, DOI 10.1002/cne.903500205; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Baxi KN, 2006, TRENDS NEUROSCI, V29, P1, DOI 10.1016/j.tins.2005.10.002; BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028; BOECKH J, 1979, J COMP PHYSIOL, V132, P235, DOI 10.1007/BF00614495; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; CHRISTENSEN TA, 1991, J COMP PHYSIOL A, V169, P259; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DERBY CD, 1984, J NEUROPHYSIOL, V51, P906, DOI 10.1152/jn.1984.51.5.906; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Guerenstein PG, 2004, J COMP PHYSIOL A, V190, P707, DOI 10.1007/s00359-004-0529-0; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Laissue PP, 1999, J COMP NEUROL, V405, P543; Light DM, 1999, J CHEM ECOL, V25, P2757, DOI 10.1023/A:1020855625244; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schneider D., 1968, Symposia of the Zoological Society of London, VNo. 23, P279; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	49	108	108	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					623	630		10.1038/nn1881	http://dx.doi.org/10.1038/nn1881			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417635	Green Accepted			2022-12-28	WOS:000245948000019
J	Aksay, E; Olasagasti, I; Mensh, BD; Baker, R; Goldman, MS; Tank, DW				Aksay, Emre; Olasagasti, Itsaso; Mensh, Brett D.; Baker, Robert; Goldman, Mark S.; Tank, David W.			Functional dissection of circuitry in a neural integrator	NATURE NEUROSCIENCE			English	Article							NUCLEUS-PREPOSITUS-HYPOGLOSSI; PERSISTENT ACTIVITY; PERCEPTUAL DECISION; WORKING-MEMORY; EYE-POSITION; TEMPORAL INTEGRATION; SYNAPTIC PLASTICITY; RECURRENT NETWORK; OCULOMOTOR SYSTEM; NEURONAL-ACTIVITY	In neural integrators, transient inputs are accumulated into persistent firing rates that are a neural correlate of short-term memory. Integrators often contain two opposing cell populations that increase and decrease sustained firing as a stored parameter value rises. A leading hypothesis for the mechanism of persistence is positive feedback through mutual inhibition between these opposing populations. We tested predictions of this hypothesis in the goldfish oculomotor velocity-to-position integrator by measuring the eye position and firing rates of one population, while pharmacologically silencing the opposing one. In complementary experiments, we measured responses in a partially silenced single population. Contrary to predictions, induced drifts in neural firing were limited to half of the oculomotor range. We built network models with synaptic-input thresholds to demonstrate a new hypothesis suggested by these data: mutual inhibition between the populations does not provide positive feedback in support of integration, but rather coordinates persistent activity intrinsic to each population.	Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Wellesley Coll, Dept Phys, Wellesley, MA 02481 USA; Wellesley Coll, Program Neurosci, Wellesley, MA 02481 USA; Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02139 USA; NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA	Cornell University; Princeton University; Princeton University; Wellesley College; Wellesley College; Harvard University; Harvard Medical School; New York University	Goldman, MS (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave,Box 75, New York, NY 10021 USA.	mgoldma2@wellesley.edu		Aksay, Emre/0000-0002-4561-4175; Baker, Robert/0000-0001-7920-1769; Olasagasti, Itsaso/0000-0002-5172-5373	NIMH NIH HHS [R01 MH069726, R01 MH069726-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069726] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2003, J NEUROSCI, V23, P10852; Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; Arnold DB, 1999, VISION RES, V39, P4286, DOI 10.1016/S0042-6989(99)00142-X; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; CHERON G, 1986, J PHYSIOL-LONDON, V372, P75, DOI 10.1113/jphysiol.1986.sp015998; CRAWFORD JD, 1993, EXP BRAIN RES, V96, P443; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; Fall CP, 2006, J COMPUT NEUROSCI, V20, P97, DOI 10.1007/s10827-006-4791-8; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Idoux E, 2006, J NEUROPHYSIOL, V96, P175, DOI 10.1152/jn.01355.2005; Kaneko CRS, 1997, J NEUROPHYSIOL, V78, P1753, DOI 10.1152/jn.1997.78.4.1753; Kiehn O, 1998, CURR OPIN NEUROBIOL, V8, P746, DOI 10.1016/S0959-4388(98)80117-7; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2004, P NATL ACAD SCI USA, V101, P7745, DOI 10.1073/pnas.0401992101; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McCrea RA, 2006, PROG BRAIN RES, V151, P205, DOI 10.1016/S0079-6123(05)51007-0; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; METTENS P, 1994, J NEUROPHYSIOL, V72, P785, DOI 10.1152/jn.1994.72.2.785; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Navarro-Lopez JD, 2004, J NEUROSCI, V24, P5109, DOI 10.1523/JNEUROSCI.0235-04.2004; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS., 2003, HDB BRAIN THEORY NEU, V2, P94; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Sklavos SG, 2002, BIOL CYBERN, V86, P97, DOI 10.1007/S004220100281; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	50	83	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					494	504		10.1038/nn1877	http://dx.doi.org/10.1038/nn1877			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369822	Green Accepted			2022-12-28	WOS:000245228600021
J	Waxman, SG				Waxman, Stephen G.			Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype	NATURE NEUROSCIENCE			English	Article							SEVERE MYOCLONIC EPILEPSY; OF-FUNCTION MUTATION; ALPHA-SUBUNIT; ELECTROPHYSIOLOGICAL PROPERTIES; SENSORY NEURONS; MOLECULAR-BASIS; UP-REGULATION; NA(V)1.7 PN1; GENE SCN2A; EXPRESSION	What is the relationship between sodium channel function, neuronal function and clinical status in channelopathies of the nervous system? Given the central role of sodium channels in the generation of neuronal activity, channelopathies involving sodium channels might be expected to cause either enhanced sodium channel function and neuronal hyperexcitability associated with positive clinical manifestations such as seizures, or attenuated channel function and neuronal hypoexcitability associated with negative clinical manifestations such as paralysis. In this article, I review observations showing that changes in neuronal function and clinical status associated with channelopathies are not necessarily predictable solely from the altered physiological properties of the mutated channel itself. I discuss evidence showing that cell background acts as a filter that can strongly influence the effects of ion channel mutations.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; Vet Affairs Connecticut Healthcare Ctr, Neuro Rehabil Res Ctr, West Haven, CT 06516 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Waxman, SG (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.	stephen.waxman@yale.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177				ADRIAN ED, 1965, NOBEL PRIZE LECT PHY; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Bergren SK, 2005, MAMM GENOME, V16, P683, DOI 10.1007/s00335-005-0049-4; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Black JA, 2000, P NATL ACAD SCI USA, V97, P11598, DOI 10.1073/pnas.97.21.11598; Blair NT, 2002, J NEUROSCI, V22, P10277; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 1997, J NEUROSCI, V17, P3503; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Damarjian TG, 2004, NEUROSCI LETT, V369, P186, DOI 10.1016/j.neulet.2004.07.023; Davis MDP, 2003, ARCH DERMATOL, V139, P1337, DOI 10.1001/archderm.139.10.1337; DeSimone R, 1996, NEUROPATH APPL NEURO, V22, P54; Dib-Hajj SD, 1998, J NEUROPHYSIOL, V79, P2668, DOI 10.1152/jn.1998.79.5.2668; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Djouhri L, 2003, J PHYSIOL-LONDON, V546, P565, DOI 10.1113/jphysiol.2002.026559; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; George Alfred L Jr, 2004, Epilepsy Curr, V4, P65, DOI 10.1111/j.1535-7597.2004.42010.x; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JACKSON JH, 1931, SELECTED WRITINGS; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2003, J NEUROSCI, V23, P11289; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mork C, 2002, J INVEST DERMATOL, V118, P699, DOI 10.1046/j.1523-1747.2002.01726.x; Mulley JC, 2006, NEUROLOGY, V67, P1094, DOI 10.1212/01.wnl.0000237322.04338.2b; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Renganathan M, 2003, BRAIN RES, V959, P235, DOI 10.1016/S0006-8993(02)03750-2; Renganathan M, 2000, J NEUROPHYSIOL, V84, P710, DOI 10.1152/jn.2000.84.2.710; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Saab CY, 2004, EXP BRAIN RES, V158, P1, DOI 10.1007/s00221-004-1867-4; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; STYS PK, 1992, J NEUROSCI, V12, P430; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Waxman SG, 2005, TRENDS MOL MED, V11, P555, DOI 10.1016/j.molmed.2005.10.004; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	50	67	71	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					405	409		10.1038/nn1857	http://dx.doi.org/10.1038/nn1857			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17387329				2022-12-28	WOS:000245228600007
J	Levy-Strumpf, N; Culotti, JG				Levy-Strumpf, Naomi; Culotti, Joseph G.			VAB-8, UNC-73 and MIG-2 regulate axon polarity and cell migration functions of UNC-40 in C-elegans	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; COLORECTAL-CANCER; NETRIN CUES; LIPID RAFTS; RAC GTPASE; GUIDANCE; RECEPTOR; DCC; ACTIVATION; OUTGROWTH	One of the most intriguing features of axons is their ability to pioneer precise paths to their targets. How guidance-cue information is interpreted and integrated to form intricate neuronal networks has not been fully deciphered. Using Caenorhabditis elegans, we show that highly conserved receptors that guide pioneer axons along the dorsoventral axis, such as UNC-40 and SAX-3 ( receptors for UNC-6 and SLT-1 guidance cues, respectively), can be co-opted to affect axon and cell migrations along the anterior-posterior axis. We further identify the kinesin-related VAB-8 protein as an upstream regulator of UNC-40, illuminating VAB-8' s mechanism of action in determining the polarity of cell and axon migration. Finally, we show that UNC-73 and its target MIG-2 function with VAB-8 as upstream regulators of UNC-40 and that MIG-2 activity specifies UNC-40 subcellular localization. These data are indicative of previously unidentified regulatory roles for VAB-8 and small GTPases, which act together to regulate guidance receptor functions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Culotti, JG (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	culotti@mshri.on.ca	Culotti, Joseph/G-6467-2013	Levy-Strumpf, Naomi/0000-0002-5454-8800; Culotti, Joseph/0000-0001-6325-4612	NINDS NIH HHS [R01NS41397] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041397] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Buck KB, 2002, J NEUROSCI, V22, P9358; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Dalpe G, 2004, DEVELOPMENT, V131, P2073, DOI 10.1242/dev.01063; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Honigberg L, 2000, DEVELOPMENT, V127, P4655; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Kubiseski TJ, 2003, MOL CELL BIOL, V23, P6823, DOI 10.1128/MCB.23.19.6823-6835.2003; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Su MW, 2000, DEVELOPMENT, V127, P585; Sulston J.E., 1998, METHODS NEMATODE CAE; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vignal E, 2001, MOL CELL BIOL, V21, P8022, DOI 10.1128/MCB.21.23.8022-8034.2001; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Wightman B, 1996, DEVELOPMENT, V122, P671; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0; Zou YM, 2006, NEURON, V49, P787, DOI 10.1016/j.neuron.2006.03.004	45	65	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					161	168		10.1038/nn1835	http://dx.doi.org/10.1038/nn1835			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237777				2022-12-28	WOS:000244175200010
J	Porter, J; Craven, B; Khan, RM; Chang, SJ; Kang, I; Judkewitz, B; Volpe, J; Settles, G; Sobel, N				Porter, Jess; Craven, Brent; Khan, Rehan M.; Chang, Shao-Ju; Kang, Irene; Judkewitz, Benjamin; Volpe, Jason; Settles, Gary; Sobel, Noam			Mechanisms of scent-tracking in humans	NATURE NEUROSCIENCE			English	Article							INFORMATION; OLFACTION; BEHAVIOR; PRIMATES; PLUME; SMELL	Whether mammalian scent-tracking is aided by inter-nostril comparisons is unknown. We assessed this in humans and found that (i) humans can scent-track, (ii) they improve with practice, (iii) the human nostrils sample spatially distinct regions separated by similar to 3.5 cm and, critically, (iv) scent-tracking is aided by inter-nostril comparisons. These findings reveal fundamental mechanisms of scent-tracking and suggest that the poor reputation of human olfaction may reflect, in part, behavioral demands rather than ultimate abilities.	Univ Calif Berkeley, Program Biophys, 299 Life Sci Addict,MC 3200, Berkeley, CA 94720 USA; Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Bioengn Program, Berkeley, CA 94720 USA; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Weizmann Institute of Science	Porter, J (corresponding author), Univ Calif Berkeley, Program Biophys, 299 Life Sci Addict,MC 3200, Berkeley, CA 94720 USA.	jessiep@berkeley.edu; noam.sobel@weizmann.ac.il	Settles, Gary S/D-5260-2009; Khan, Rehan/AAR-4803-2020; Judkewitz, Benjamin/C-3645-2014	Khan, Rehan/0000-0001-8724-5788; Judkewitz, Benjamin/0000-0002-8570-3869; Sobel, Noam/0000-0002-3232-9391; Kang, Irene/0000-0002-9472-3853	NIDCD NIH HHS [DC005958, DC006915] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005958, R01DC006915] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; Gibbons B., 1986, NATL GEOGRAPHIC, V170, P324; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; MOULTON DG, 1967, AM ZOOL, V7, P421; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Settles GS, 2005, J FLUID ENG-T ASME, V127, P189, DOI 10.1115/1.1891146; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; THESEN A, 1993, J EXP BIOL, V180, P247; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8	15	208	210	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					27	29		10.1038/nn1819	http://dx.doi.org/10.1038/nn1819			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173046				2022-12-28	WOS:000243096100011
J	Urgesi, C; Candidi, M; Ionta, S; Aglioti, SM				Urgesi, Cosimo; Candidi, Matteo; Ionta, Silvio; Aglioti, Salvatore M.			Representation of body identity and body actions in extrastriate body area and ventral premotor cortex	NATURE NEUROSCIENCE			English	Article							PERSPECTIVE	Although inherently linked, body form and body action may be represented in separate neural substrates. Using repetitive transcranial magnetic stimulation in healthy individuals, we show that interference with the extrastriate body area impairs the discrimination of bodily forms, and interference with the ventral premotor cortex impairs the discrimination of bodily actions. This double dissociation suggests that whereas extrastriate body area mainly processes actors' body identity, premotor cortex is crucial for visual discriminations of actions.	Univ Roma La Sapienza, Dipartimento Piscol, I-00185 Rome, Italy; Ist Ricovero & Cura Carattere Sci E Medea, I-33078 San Vito Al Tagliamento, Pordenone, Italy; Ist Ricovero & Cura Carattere Sci Fdn St Lucia, I-00179 Rome, Italy	Sapienza University Rome; IRCCS Eugenio Medea; IRCCS Santa Lucia	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Piscol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	urgesi@sv.lnf.it; salvatoremaria.aglioti@uniroma1.it	ionta, silvio/AGB-3634-2022; Urgesi, Cosimo/K-4688-2016; Candidi, Matteo/K-9245-2016; Aglioti, Salvatore M/E-9829-2012	ionta, silvio/0000-0003-2078-4861; Urgesi, Cosimo/0000-0003-0572-1328; CANDIDI, MATTEO/0000-0001-8201-7954; Aglioti, Salvatore Maria/0000-0001-8175-7563				Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	15	212	216	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					30	31		10.1038/nn1815	http://dx.doi.org/10.1038/nn1815			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159990	Green Published			2022-12-28	WOS:000243096100012
J	Pasalar, S; Roitman, AV; Durfee, WK; Ebner, TJ				Pasalar, S.; Roitman, A. V.; Durfee, W. K.; Ebner, T. J.			Force field effects on cerebellar Purkinje cell discharge with implications for internal models	NATURE NEUROSCIENCE			English	Article							CIRCULAR MANUAL TRACKING; SIMPLE SPIKE DISCHARGE; PRIMARY MOTOR CORTEX; NEURONAL-ACTIVITY; REACHING MOVEMENTS; VENTRAL PARAFLOCCULUS; VOLUNTARY MOVEMENT; ARM MOVEMENTS; MONKEY; DYNAMICS	The cerebellum has been hypothesized to provide internal models for limb movement control. If the cerebellum is the site of an inverse dynamics model, then cerebellar neural activity should signal limb dynamics and be coupled to arm muscle activity. To address this, we recorded from 166 task-related Purkinje cells in two monkeys performing circular manual tracking under varying viscous and elastic loads. Hand forces and arm muscle activity increased with the load, and their spatial tuning differed markedly between the viscous and elastic fields. In contrast, the simple spike firing of 91.0% of the Purkinje cells was not significantly modulated by the force nor was their spatial tuning affected. For the 15 cells with a significant force effect, changes were small and isolated. These results do not support the hypothesis that Purkinje cells represent the output of an inverse dynamics model of the arm. Instead these neurons provide a kinematic representation of arm movements.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ebner, TJ (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	ebner001@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018338] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS-18338] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Batschelet E., 1981, CIRCULAR STAT BIOL; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Coltz JD, 1999, J NEUROSCI, V19, P1782; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; FRYSINGER RC, 1984, J NEUROPHYSIOL, V51, P32, DOI 10.1152/jn.1984.51.1.32; Fu QG, 1997, J NEUROPHYSIOL, V78, P478, DOI 10.1152/jn.1997.78.1.478; Gomi H, 1998, J NEUROPHYSIOL, V80, P818, DOI 10.1152/jn.1998.80.2.818; Goodkin HP, 2003, J NEUROPHYSIOL, V89, P896, DOI 10.1152/jn.00115.2002; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Liu XG, 2003, J NEUROPHYSIOL, V89, P1223, DOI 10.1152/jn.00817.2002; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Mason CR, 2006, J NEUROPHYSIOL, V95, P144, DOI 10.1152/jn.00492.2005; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Monzee J, 2004, J NEUROPHYSIOL, V91, P1230, DOI 10.1152/jn.01120.2002; Norris SA, 2004, J NEUROPHYSIOL, V92, P1867, DOI 10.1152/jn.01251.2003; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Richter S, 2004, J MOTOR BEHAV, V36, P28, DOI 10.3200/JMBR.36.1.28-38; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; SCHIEBER MH, 1985, J NEUROPHYSIOL, V54, P1228, DOI 10.1152/jn.1985.54.5.1228; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; SMITH AM, 1981, J NEUROPHYSIOL, V45, P286, DOI 10.1152/jn.1981.45.2.286; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Timmann D, 1996, BEHAV BRAIN RES, V81, P99, DOI 10.1016/S0166-4328(96)89075-9; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2	47	136	136	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1404	1411		10.1038/nn1783	http://dx.doi.org/10.1038/nn1783			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028585				2022-12-28	WOS:000242403800018
J	Veruki, ML; Morkve, SH; Hartveit, E				Veruki, Margaret Lin; Morkve, Svein Harald; Hartveit, Espen			Activation of a presynaptic glutamate transporter regulates synaptic transmission through electrical signaling	NATURE NEUROSCIENCE			English	Article							AMINO-ACID TRANSPORTER; ROD BIPOLAR CELLS; MAMMALIAN RIBBON SYNAPSE; RAT RETINA; AMACRINE CELLS; EXTRASYNAPTIC GLUTAMATE; TRANSMITTER CLEARANCE; TIGER SALAMANDER; CURRENTS; LOCALIZATION	Whereas glutamate transporters in glial cells and postsynaptic neurons contribute significantly to re-uptake of synaptically released transmitter, the functional role of presynaptic glutamate transporters is poorly understood. Here, we used electrophysiological recording to examine the functional properties of a presynaptic glutamate transporter in rat retinal rod bipolar cells and its role in regulating glutamatergic synaptic transmission between rod bipolar cells and amacrine cells. Release of glutamate activated the presynaptic transporter with a time course that suggested a perisynaptic localization. The transporter was also activated by spillover of glutamate from neighboring rod bipolar cells. By recording from pairs of rod bipolar cells and All amacrine cells, we demonstrate that activation of the transporter-associated anion current hyperpolarizes the presynaptic terminal and thereby inhibits synaptic transmission by suppressing transmitter release. Given the evidence for presynaptic glutamate transporters, similar mechanisms could be of general importance for transmission in the nervous system.	Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Hartveit, E (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	espen.hartveit@biomed.uib.no		Hartveit, Espen/0000-0003-1798-1901; Veruki, Margaret/0000-0002-0532-144X				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ELIASOF S, 1993, J NEUROSCI, V13, P402; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hasegawa J, 2006, NEURON, V50, P63, DOI 10.1016/j.neuron.2006.02.022; He Y, 2000, J COMP NEUROL, V418, P255; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Otis TS, 1998, J NEUROSCI, V18, P7099; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Protti DA, 1998, J NEUROSCI, V18, P3715; Rauen T, 1998, CELL TISSUE RES, V291, P19; RAUEN T, 1994, NEUROSCI LETT, V169, P137, DOI 10.1016/0304-3940(94)90375-1; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SARANTIS M, 1988, NATURE, V332, P451, DOI 10.1038/332451a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; TACHIBANA M, 1988, P NATL ACAD SCI USA, V85, P5315, DOI 10.1073/pnas.85.14.5315; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; YAMASHITA M, 1991, VISUAL NEUROSCI, V6, P399, DOI 10.1017/S0952523800006635; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	49	136	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1388	1396		10.1038/nn1793	http://dx.doi.org/10.1038/nn1793			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041592				2022-12-28	WOS:000242403800016
J	Witten, IB; Bergan, JF; Knudsen, EI				Witten, Ilana B.; Bergan, Joseph F.; Knudsen, Eric I.			Dynamic shifts in the owl's auditory space map predict moving sound location	NATURE NEUROSCIENCE			English	Article							INFERIOR COLLICULUS NEURONS; INTERAURAL PHASE DISPARITY; BINAURAL RESPONSE PROPERTIES; BARN OWL; OPTIC TECTUM; RECEPTIVE-FIELDS; TYTO-ALBA; NEURAL MAPS; TIME; LOCALIZATION	The optic tectum of the barn owl contains a map of auditory space. We found that, in response to moving sounds, the locations of receptive fields that make up the map shifted toward the approaching sound. The magnitude of the receptive field shifts increased systematically with increasing stimulus velocity and, therefore, was appropriate to compensate for sensory and motor delays inherent to auditory orienting behavior. Thus, the auditory space map is not static, but shifts adaptively and dynamically in response to stimulus motion. We provide a computational model to account for these results. Because the model derives predictive responses from processes that are known to occur commonly in neural networks, we hypothesize that analogous predictive responses will be found to exist widely in the central nervous system. This hypothesis is consistent with perceptions of stimulus motion in humans for many sensory parameters.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	eknudsen@stanford.edu			NIDCD NIH HHS [F31 DC007813] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alais D, 2003, CURR BIOL, V13, P59, DOI 10.1016/S0960-9822(02)01402-1; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Borisyuk A, 2002, J NEUROPHYSIOL, V88, P2134, DOI 10.1152/jn.2002.88.4.2134; Brainard MS, 1998, J NEUROSCI, V18, P3929; Cai HM, 1998, J ACOUST SOC AM, V103, P494, DOI 10.1121/1.421130; DeBello WM, 2004, J NEUROSCI, V24, P6853, DOI 10.1523/JNEUROSCI.0480-04.2004; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Gold JI, 2001, J NEUROPHYSIOL, V85, P1575, DOI 10.1152/jn.2001.85.4.1575; Gutfreund Y, 2006, J NEUROPHYSIOL, V96, P813, DOI 10.1152/jn.01144.2005; Ingham NJ, 2001, J NEUROPHYSIOL, V85, P23, DOI 10.1152/jn.2001.85.1.23; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V202, P778, DOI 10.1126/science.715444; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; McAlpine D, 2000, J NEUROPHYSIOL, V83, P1356, DOI 10.1152/jn.2000.83.3.1356; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; OLSEN JF, 1989, J NEUROSCI, V9, P2591; PAYNE RS, 1971, J EXP BIOL, V54, P535; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; Sheth BR, 2000, NAT NEUROSCI, V3, P489, DOI 10.1038/74865; Spitzer MW, 1998, J NEUROPHYSIOL, V80, P3062, DOI 10.1152/jn.1998.80.6.3062; SPITZER MW, 1993, J NEUROPHYSIOL, V69, P1245, DOI 10.1152/jn.1993.69.4.1245; WAGNER H, 1990, EUR J NEUROSCI, V2, P949, DOI 10.1111/j.1460-9568.1990.tb00007.x; Wilson WW, 1998, J NEUROPHYSIOL, V79, P2040, DOI 10.1152/jn.1998.79.4.2040	30	25	25	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1439	1445		10.1038/nn1781	http://dx.doi.org/10.1038/nn1781			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013379				2022-12-28	WOS:000242403800023
J	Glickfeld, LL; Scanziani, M				Glickfeld, Lindsey L.; Scanziani, Massimo			Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells	NATURE NEUROSCIENCE			English	Article							DUAL INTRACELLULAR-RECORDINGS; HIPPOCAMPAL PYRAMIDAL CELLS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; NETWORK OSCILLATIONS; FEEDFORWARD INHIBITION; DENDRITIC INHIBITION; GAMMA OSCILLATIONS; GABA RELEASE; IN-VITRO	Cannabinoids are powerful modulators of inhibition, yet the precise spike timing of cannabinoid receptor (CB1R)-expressing inhibitory neurons in relation to other neurons in the circuit is poorly understood. Here we found that the spike timing of CB1R-expressing basket cells, a major target for cannabinoids in the rat hippocampus, was distinct from the other main group of basket cells, the CB1R-negative. Despite receiving the same afferent inputs, the synaptic and biophysical properties of the two cell types were tuned to detect different features of activity. CB1R-negative basket cells responded reliably and immediately to subtle and repetitive excitation. In contrast, CB1R-positive basket cells responded later and did not follow repetitive activity, but were better suited to integrate the consecutive excitation of independent afferents. This temporal separation in the activity of the two basket cell types generated distinct epochs of somatic inhibition that were differentially affected by endocannabinoids.	Univ Calif San Diego, Div Biol, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Div Biol, Grad Program Neurosci, La Jolla, CA 92093 USA.	massimo@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401, R01MH070058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007315] Funding Source: NIH RePORTER; NIDA NIH HHS [T32 DA007315, 5T32DA007315] Funding Source: Medline; NIMH NIH HHS [MH71401, R01 MH070058, MH70058, R01 MH071401] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; ANDERSEN P, 1973, EXP BRAIN RES, V17, P152; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/S0306-4522(96)00251-5; DINGLEDINE R, 1980, BRAIN RES, V185, P277, DOI 10.1016/0006-8993(80)91068-9; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fukuda T, 1996, NEUROSCI RES, V26, P181, DOI 10.1016/S0168-0102(96)01102-9; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Katona I, 1999, J NEUROSCI, V19, P4544; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Matyas F, 2004, EUR J NEUROSCI, V19, P1243, DOI 10.1111/j.1460-9568.2004.03225.x; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Morales M, 2002, HIPPOCAMPUS, V12, P756, DOI 10.1002/hipo.10025; Nicoll RA, 2004, SCI AM, V291, P68, DOI 10.1038/scientificamerican1204-68; PITLER TA, 1994, NEURON, V13, P1447; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; SIK A, 1995, J NEUROSCI, V15, P6651; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Wierenga CJ, 2003, NEUROSCIENCE, V118, P1129, DOI 10.1016/S0306-4522(03)00060-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	42	166	167	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					807	815		10.1038/nn1688	http://dx.doi.org/10.1038/nn1688			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648849	Green Accepted			2022-12-28	WOS:000237895200021
J	Lien, CC; Mu, YL; Vargas-Caballero, M; Poo, MM				Lien, CC; Mu, YL; Vargas-Caballero, M; Poo, MM			Visual stimuli-induced LTD of GABAergic synapses mediated by presynaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DEVELOPING RETINOTECTAL SYNAPSES; XENOPUS-LAEVIS; GABA RELEASE; SYNAPTIC MODIFICATION; TRANSMITTER RELEASE; CORRELATED ACTIVITY; RAT HIPPOCAMPUS; PLASTICITY; NEURONS	Local GABA (c-aminobutyric acid) circuits contribute to sensory experience-dependent refinement of neuronal connections in the developing nervous system, but whether GABAergic synapses themselves can be rapidly modified by sensory stimuli is largely unknown. Here we report that repetitive light stimuli or theta burst stimulation (TBS) of the optic nerve in the developing Xenopus retinotectal system induces long-term potentiation (LTP) of glutamatergic inputs but long-term depression (LTD) of GABAergic inputs to the same tectal neuron. The LTD is due to a reduction in presynaptic GABA release and requires activation of presynaptic NMDA (N-methyl-D-aspartate) receptors (NMDARs) and coincident high-level GABAergic activity. Thus, the presynaptic NMDAR may function as a coincidence detector for adjacent glutamatergic and GABAergic activities, leading to coordinated synaptic modification by sensory experience.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Lien, Cheng-Chang/AAO-6249-2020	Lien, Cheng-Chang/0000-0002-6692-9942; Vargas-Caballero, Mariana/0000-0003-2326-4001	NEI NIH HHS [EY014949] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Brody DL, 2000, J NEUROSCI, V20, P2480; Caillard O, 1999, J NEUROSCI, V19, P7568, DOI 10.1523/JNEUROSCI.19-17-07568.1999; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cottone E, 2003, J COMP NEUROL, V464, P487, DOI 10.1002/cne.10808; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Ferster D, 2004, SCIENCE, V303, P1619, DOI 10.1126/science.1096224; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glaum SR, 1996, J NEUROPHYSIOL, V76, P30, DOI 10.1152/jn.1996.76.1.30; Glitsch M, 1999, J NEUROSCI, V19, P511; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Paquet M, 2000, J COMP NEUROL, V423, P330, DOI 10.1002/1096-9861(20000724)423:2<330::AID-CNE10>3.0.CO;2-9; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; RYBICKA KK, 1994, EUR J NEUROSCI, V6, P1567, DOI 10.1111/j.1460-9568.1994.tb00547.x; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Tzingounis AV, 2004, NAT NEUROSCI, V7, P419, DOI 10.1038/nn0504-419; Udin SB, 1999, PROG NEUROBIOL, V59, P81, DOI 10.1016/S0301-0082(98)00096-3; Unni VK, 2004, J NEUROSCI, V24, P9612, DOI 10.1523/JNEUROSCI.5583-03.2004; Vargas-Caballero M, 2004, J NEUROSCI, V24, P6171, DOI 10.1523/JNEUROSCI.1380-04.2004; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	50	79	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					372	380		10.1038/nn1649	http://dx.doi.org/10.1038/nn1649			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474391				2022-12-28	WOS:000235645600017
J	Renaud, J; Kerjan, G; Sumita, I; Zagar, Y; Georget, V; Kim, D; Fouquet, C; Suda, K; Sanbo, M; Suto, F; Ackerman, SL; Mitchell, KJ; Fujisawa, H; Chedotal, A				Renaud, Julie; Kerjan, Geraldine; Sumita, Itsuko; Zagar, Yvrick; Georget, Virginie; Kim, Doyeun; Fouquet, Coralie; Suda, Kazunori; Sanbo, Makoto; Suto, Fumikazu; Ackerman, Susan L.; Mitchell, Kevin J.; Fujisawa, Hajime; Chedotal, Alain			Plexin-A2 and its ligand, Sema6A, control nucleus-centrosome coupling in migrating granule cells	NATURE NEUROSCIENCE			English	Article							NEURONAL MIGRATION; ACTIVATING PROTEIN; GROWTH CONE; RECEPTOR; LIS1; TRANSMEMBRANE; ORGANIZATION; SEMAPHORINS; MOVEMENT; DYNEIN	During their migration, cerebellar granule cells switch from a tangential to a radial mode of migration. We have previously demonstrated that this involves the transmembrane semaphorin Sema6A. We show here that plexin-A2 is the receptor that controls Sema6A function in migrating granule cells. In plexin-A2-deficient (Plxna2(-/-)) mice, which were generated by homologous recombination, many granule cells remained in the molecular layer, as we saw in Sema6a mutants. A similar phenotype was observed in mutant mice that were generated by mutagenesis with N-ethyl-N-nitrosourea and had a single amino-acid substitution in the semaphorin domain of plexin-A2. We found that this mutation abolished the ability of Sema6A to bind to plexin-A2. Mouse chimera studies further suggested that plexin-A2 acts in a cell-autonomous manner. We also provide genetic evidence for a ligand-receptor relationship between Sema6A and plexin-A2 in this system. Using time-lapse video microscopy, we found that centrosome-nucleus coupling and coordinated motility were strongly perturbed in Sema6a(-/-) and Plxna2(-/-) granule cells. This suggests that semaphorin-plexin signaling modulates cell migration by controlling centrosome positioning.	[Renaud, Julie; Kerjan, Geraldine; Zagar, Yvrick; Georget, Virginie; Fouquet, Coralie; Chedotal, Alain] Univ Paris 06, UMR 7102, F-75005 Paris, France; [Sumita, Itsuko; Suda, Kazunori; Fujisawa, Hajime] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4688602, Japan; [Georget, Virginie] Inst Fed Biol Integrat, F-75005 Paris, France; [Kim, Doyeun; Ackerman, Susan L.] Jackson Lab, Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Sanbo, Makoto] Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 4448585, Japan; [Suto, Fumikazu] Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; [Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Chedotal, Alain] Grp Hosp Pitie Salpetriere, AP HP, F-75013 Paris, France; CNRS, UMR 7102, F-75005 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Nagoya University; Howard Hughes Medical Institute; Jackson Laboratory; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Trinity College Dublin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Chedotal, A (corresponding author), INSERM, Inst Vis, UMR S592, 17 Rue Moreau, F-75012 Paris, France.	chedotal@infobiogen.fr	Georget, Virginie/AAQ-1843-2020; Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794; Mitchell, Kevin/0000-0002-3433-4530; Suda, Kazunori/0000-0002-5350-5227	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035900, U01NS041215] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [NS35900, NS041215] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Ding S, 2007, BIOCHEM BIOPH RES CO, V356, P857, DOI 10.1016/j.bbrc.2007.03.073; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; FATEMI SH, 2007, CEREBELLUM, P1, DOI DOI 10.1080/14734220701392969; FUJII T, 2007, BIOL PSYCHIAT, V31, P873, DOI DOI 10.1016/J.PNPBP.2007.01.027; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Higginbotham H, 2006, MOL CELL NEUROSCI, V32, P118, DOI 10.1016/j.mcn.2006.03.003; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Mah S, 2006, MOL PSYCHIATR, V11, P471, DOI 10.1038/sj.mp.4001785; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Sakagami H, 1999, EUR J NEUROSCI, V11, P2531, DOI 10.1046/j.1460-9568.1999.00675.x; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takeshita M, 2008, SCHIZOPHR RES, V99, P359, DOI 10.1016/j.schres.2007.11.002; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wray NR, 2007, ARCH GEN PSYCHIAT, V64, P318, DOI 10.1001/archpsyc.64.3.318; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Zmuda JF, 2000, J NEUROBIOL, V43, P313, DOI 10.1002/1097-4695(20000615)43:4<313::AID-NEU1>3.0.CO;2-2	50	114	115	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					440	449		10.1038/nn2064	http://dx.doi.org/10.1038/nn2064			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18327254				2022-12-28	WOS:000254359300016
J	Rilling, JK; Glasser, MF; Preuss, TM; Ma, XY; Zhao, TJ; Hu, XP; Behrens, TEJ				Rilling, James K.; Glasser, Matthew F.; Preuss, Todd M.; Ma, Xiangyang; Zhao, Tiejun; Hu, Xiaoping; Behrens, Timothy E. J.			The evolution of the arcuate fasciculus revealed with comparative DTI	NATURE NEUROSCIENCE			English	Article							PROBABILISTIC DIFFUSION TRACTOGRAPHY; LANGUAGE; BRAIN; TOOL	The arcuate fasciculus is a white-matter fiber tract that is involved in human language. Here we compared cortical connectivity in humans, chimpanzees and macaques (Macaca mulatta) and found a prominent temporal lobe projection of the human arcuate fasciculus that is much smaller or absent in nonhuman primates. This human specialization may be relevant to the evolution of language.	[Rilling, James K.; Glasser, Matthew F.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Rilling, James K.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Rilling, James K.; Preuss, Todd M.] Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30302 USA; [Rilling, James K.] Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA 30329 USA; [Preuss, Todd M.] Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Emory Univ Hosp, Pathol & Lab Med, Atlanta, GA 30322 USA; [Ma, Xiangyang; Zhao, Tiejun; Hu, Xiaoping] Emory Univ, Biomed Imaging Technol Ctr, Atlanta, GA 30322 USA; [Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; [Behrens, Timothy E. J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Emory University; Emory University; Emory University; Emory University; Emory University; University of Oxford; University of Oxford	Rilling, JK (corresponding author), Emory Univ, Dept Anthropol, 207 Anthropol Bldg,1557 Dickey Dr, Atlanta, GA 30322 USA.	jrillin@emory.edu	Preuss, Todd/GSI-6571-2022; Kennedy, Kristen M/B-4699-2008; Glasser, Matthew Frederick/AAE-7291-2019	Kennedy, Kristen M/0000-0001-5373-9026; Hu, Xiaoping/0000-0001-7014-5983; Behrens, Timothy/0000-0003-0048-1177	Medical Research Council [G0501316] Funding Source: Medline; NCRR NIH HHS [RR-00165] Funding Source: Medline; NIBIB NIH HHS [R01EB002009] Funding Source: Medline; MRC [G0501316] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002009] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Deacon T., 1997, SYMBOLIC SPECIES; Dejerine J., 1895, ANATOMIE CENTRES NER; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; GLASSER MF, 2008, CEREB CORTEX, P14, DOI DOI 10.1093/CERC0R/BHN011; GOULD SJ, 1991, J SOC ISSUES, V47, P43, DOI 10.1111/j.1540-4560.1991.tb01822.x; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Preuss T.M., 2004, COGNITIVE NEUROSCIEN, V3rd, P5; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Rilling JK, 2002, J HUM EVOL, V42, P505, DOI 10.1006/jhev.2001.0537; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394	15	548	554	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					426	428		10.1038/nn2072	http://dx.doi.org/10.1038/nn2072			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344993				2022-12-28	WOS:000254359300014
J	Han, YG; Spassky, N; Romaguera-Ros, M; Garcia-Verdugo, JM; Aguilar, A; Schneider-Maunoury, S; Alvarez-Buylla, A				Han, Young-Goo; Spassky, Nathalie; Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel; Aguilar, Andrea; Schneider-Maunoury, Sylvie; Alvarez-Buylla, Arturo			Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells	NATURE NEUROSCIENCE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; DENTATE GYRUS; SONIC HEDGEHOG; KINESIN-II; REPRESSOR FUNCTIONS; KIDNEY-DISEASE; IN-VIVO; MOUSE; MOTOR; MICE	Neural stem cells that continue to produce neurons are retained in the adult hippocampal dentate gyrus. The mechanisms by which embryonic neural progenitors expand and transform into postnatal neural stem cells, an essential process for the continual production of neurons throughout life, remain unknown. We found that radial astrocytes, the postnatal progenitors in the dentate gyrus, failed to develop after embryonic ablation of ciliary genes or Smoothened (Smo), an essential component for Sonic hedgehog (Shh) signaling. Postnatal dentate neurogenesis failed in these mutant mice, and the dentate gyrus became severely hypotrophic. In contrast, expression of a constitutively active Smo (SmoM2-YFP) resulted in a marked expansion of the dentate gyrus. Double-mutant analyses suggested that both wild-type Smo and SmoM2-YFP function through the primary cilia. We conclude that Shh signaling, acting through the primary cilia, has a critical role in the expansion and establishment of postnatal hippocampal progenitors.	[Han, Young-Goo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA; [Spassky, Nathalie; Aguilar, Andrea] Univ Paris 06, INSERM, Hop Piete Salpetriere, U711,IFR Neurosci, F-75013 Paris, France; [Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel] Univ Valencia, Lab Morfol Celuar, Unidad Asociada, E-46100 Valencia, Spain; [Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel] Ctr Invest Principle Felipe, E-46100 Valencia, Spain; [Schneider-Maunoury, Sylvie] Univ Paris 06, CNRS, UMR 7622, F-75005 Paris, France	University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Valencia; Prince Felipe Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Han, Young-Goo/N-2664-2018; Schneider-Maunoury, Sylvie/K-6795-2017; García-Verdugo, José Manuel/L-8421-2017; Spassky, Nathalie/E-3932-2016	Han, Young-Goo/0000-0002-4008-294X; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; García-Verdugo, José Manuel/0000-0001-9872-6499; spassky, nathalie/0000-0003-4722-6464; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Aguilar, Andrea/0000-0002-6115-0040	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R01NS028478, R37NS028478] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32116] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bagri A, 2002, DEVELOPMENT, V129, P4249; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Doetsch F, 1997, J NEUROSCI, V17, P5046; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Long FX, 2001, DEVELOPMENT, V128, P5099; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Matsuura K, 2002, CELL MOTIL CYTOSKEL, V52, P195, DOI 10.1002/cm.10051; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Muresan V, 1999, J NEUROSCI, V19, P1027; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	46	361	377	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					277	284		10.1038/nn2059	http://dx.doi.org/10.1038/nn2059			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297065				2022-12-28	WOS:000253548300010
J	Koenigs, M; Huey, ED; Raymont, V; Cheon, B; Solomon, J; Wassermann, EM; Grafman, J				Koenigs, Michael; Huey, Edward D.; Raymont, Vanessa; Cheon, Bobby; Solomon, Jeffrey; Wassermann, Eric M.; Grafman, Jordan			Focal brain damage protects against post-traumatic stress disorder in combat veterans	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; DOUBLE-BLIND; AMYGDALA; VIETNAM; ACTIVATION; PTSD	Post-traumatic stress disorder ( PTSD) is an often debilitating mental illness that is characterized by recurrent distressing memories of traumatic events. PTSD is associated with hypoactivity in the ventromedial prefrontal cortex ( vmPFC), hyperactivity in the amygdala and reduced volume in the hippocampus, but it is unknown whether these neuroimaging findings reflect the underlying cause or a secondary effect of the disorder. To investigate the causal contribution of specific brain areas to PTSD symptoms, we studied a unique sample of Vietnam War veterans who suffered brain injury and emotionally traumatic events. We found a substantially reduced occurrence of PTSD among those individuals with damage to one of two regions of the brain: the vmPFC and an anterior temporal area that included the amygdala. These results suggest that the vmPFC and amygdala are critically involved in the pathogenesis of PTSD.	[Koenigs, Michael; Huey, Edward D.; Raymont, Vanessa; Wassermann, Eric M.; Grafman, Jordan] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Raymont, Vanessa; Cheon, Bobby] Natl Naval Med Ctr, Henry M Jackson Fdn, Vietnam Head Injury Study, Bethesda, MD 20889 USA; [Solomon, Jeffrey] Med Numer, Germantown, MD 20876 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed National Military Medical Center	Grafman, J (corresponding author), Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, US Natl Inst Hlth, 10 Ctr Dr,MSC 1440, Bethesda, MD 20892 USA.	grafmanj@ninds.nih.gov	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Koenigs, Michael/0000-0002-5799-4881; Cheon, Bobby/0000-0001-6815-619X; Grafman, Jordan H./0000-0001-8645-4457	Intramural NIH HHS [Z01 NS003024-01, Z01 NS002792-19] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002977, ZIANS003024, ZIANS002792] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ayuso-Mateos JL., 2002, GLOBAL BURDEN POST T; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; First MB, 2002, STRUCTURED CLIN INTE; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Talairach J., 1988, COPLANAR STEREOTAXIC; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	38	175	183	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					232	237		10.1038/nn2032	http://dx.doi.org/10.1038/nn2032			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18157125	Green Accepted, Green Published			2022-12-28	WOS:000252712100018
J	Arganda, S; Guantes, R; De Polavieja, GG				Arganda, Sara; Guantes, Raul; De Polavieja, Gonzalo G.			Sodium pumps adapt spike bursting to stimulus statistics	NATURE NEUROSCIENCE			English	Article							T-SENSORY NEURONS; NEOCORTICAL PYRAMIDAL NEURONS; ACTIVITY-DEPENDENT INCREASE; CENTRAL-NERVOUS-SYSTEM; INFORMATION-TRANSMISSION; VARIANCE ADAPTATION; CONTRAST ADAPTATION; NEURAL INFORMATION; ELECTROGENIC PUMP; CONDUCTION BLOCK	Pump activity is a homeostatic mechanism that maintains ionic gradients. Here we examined whether the slow reduction in excitability induced by sodium-pump activity that has been seen in many neuronal types is also involved in neuronal coding. We took intracellular recordings from a spike-bursting sensory neuron in the leech Hirudo medicinalis in response to naturalistic tactile stimuli with different statistical distributions. We show that regulation of excitability by sodium pumps is necessary for the neuron to make different responses depending on the statistical context of the stimuli. In particular, sodium-pump activity allowed spike-burst sizes and rates to code not for stimulus values per se, but for their ratio with the standard deviation of the stimulus distribution. Modeling further showed that sodium pumps can be a general mechanism of adaptation to statistics on the time scale of 1 min. These results implicate the ubiquitous pump activity in the adaptation of neural codes to statistics.	Univ Autonoma Madrid, Fac Ciencias, Inst Nicolas Cabrera Fis Mat, Neural Processing Lab, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Ciencias, Dept Condensed Matter Phys, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Ciencias, Dept Theoret Phys, E-28049 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid	De Polavieja, GG (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Inst Nicolas Cabrera Fis Mat, Neural Processing Lab, C-16, E-28049 Madrid, Spain.	gonzalo.polavieja@uam.es	Carreras, Sara Arganda/B-2200-2017; Guantes, Raul/B-7271-2014	Carreras, Sara Arganda/0000-0002-9875-2379; Guantes, Raul/0000-0003-1916-944X; de Polavieja, Gonzalo/0000-0001-5359-3426				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barlow H, 1982, THE SENSES; BAYLOR DA, 1969, J PHYSIOL-LONDON, V203, P571, DOI 10.1113/jphysiol.1969.sp008880; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Cataldo E, 2005, J COMPUT NEUROSCI, V18, P5, DOI 10.1007/s10827-005-5477-3; CATARSI S, 1990, J COMP PHYSIOL A, V167, P469, DOI 10.1007/BF00190817; CATARSI S, 1991, J EXP BIOL, V155, P261; Chubbuck JG, 1966, APL TECH DIGEST, V5, P18; Darbon P, 2003, J NEUROPHYSIOL, V90, P3119, DOI 10.1152/jn.00579.2003; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; FAIRHALL A, 2002, HDB BRAIN THEORY NEU, P90; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FRENCH AS, 1989, J NEUROPHYSIOL, V62, P768, DOI 10.1152/jn.1989.62.3.768; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; GUSTAFSSON B, 1983, BRAIN RES, V275, P159, DOI 10.1016/0006-8993(83)90429-8; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; JANSEN JKS, 1973, J PHYSIOL-LONDON, V229, P635, DOI 10.1113/jphysiol.1973.sp010158; Kepecs A, 2002, J NEUROSCI, V22, P9053; Kiernan MC, 2004, J PHYSIOL-LONDON, V558, P341, DOI 10.1113/jphysiol.2004.063966; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kobayashi J, 1997, NEUROSCI LETT, V236, P171, DOI 10.1016/S0304-3940(97)00790-8; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; Mar A, 1996, J NEUROSCI, V16, P4335; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Mozzachiodi R, 2001, NEUROSCIENCE, V107, P519, DOI 10.1016/S0306-4522(01)00365-7; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHLUE WR, 1991, J NEUROPHYSIOL, V65, P736, DOI 10.1152/jn.1991.65.3.736; Scuri R, 2005, J NEUROPHYSIOL, V94, P1066, DOI 10.1152/jn.00075.2005; Scuri R, 2002, J NEUROPHYSIOL, V88, P2490, DOI 10.1152/jn.01027.2001; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shen KZ, 1998, J PHYSIOL-LONDON, V512, P449, DOI 10.1111/j.1469-7793.1998.449be.x; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; VANESSEN DC, 1973, J PHYSIOL-LONDON, V230, P509, DOI 10.1113/jphysiol.1973.sp010201; Walraven J, 1990, VISUAL PERCEPTION NE, P53; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549	50	32	33	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1467	1473		10.1038/nn1982	http://dx.doi.org/10.1038/nn1982			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906619				2022-12-28	WOS:000250508400025
J	Kawai, H; Lazar, R; Metherate, R				Kawai, Hideki; Lazar, Ronit; Metherate, Raju			Nicotinic control of axon excitability regulates thalamocortical transmission	NATURE NEUROSCIENCE			English	Article							AUDITORY-CORTEX; ACETYLCHOLINE-RECEPTORS; VISUAL-CORTEX; IN-VITRO; SYNAPTIC-TRANSMISSION; SPECTRAL INTEGRATION; EVOKED-POTENTIALS; TOBACCO SMOKING; RAT NEOCORTEX; SYNAPSES	The thalamocortical pathway, a bundle of myelinated axons that arises from thalamic relay neurons, carries sensory information to the neocortex. Because axon excitation is an obligatory step in the relay of information from the thalamus to the cortex, it represents a potential point of control. We now show that, in adult mice, the activation of nicotinic acetylcholine receptors ( nAChRs) in the initial portion of the auditory thalamocortical pathway modulates thalamocortical transmission of information by regulating axon excitability. Exogenous nicotine enhanced the probability and synchrony of evoked action potential discharges along thalamocortical axons in vitro, but had little effect on synaptic release mechanisms. In vivo, the blockade of nAChRs in the thalamocortical pathway reduced sound-evoked cortical responses, especially those evoked by sounds near the acoustic threshold. These data indicate that endogenous acetylcholine activates nAChRs in the thalamocortical pathway to lower the threshold for thalamocortical transmission and to increase the magnitude of sensory-evoked cortical responses. Our results show that a neurotransmitter can modulate sensory processing by regulating conduction along myelinated thalamocortical axons.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Metherate, R (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, 2205 McGaugh Hall, Irvine, CA 92697 USA.	rmethera@uci.edu		Kawai, Hideki/0000-0003-2113-6866	NIDA NIH HHS [DA12929] Funding Source: Medline; NIDCD NIH HHS [DC02967, DC08204] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002967, R29DC002967, R03DC008204, R55DC002967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012929] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARMETT CJ, 1961, J PHYSIOL-LONDON, V155, P372, DOI 10.1113/jphysiol.1961.sp006634; Ashley WH, 2001, HEARING RES, V160, P89; BROWN DA, 1984, J PHYSIOL-LONDON, V353, P101, DOI 10.1113/jphysiol.1984.sp015325; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chu ZG, 2000, BRAIN RES, V887, P399, DOI 10.1016/S0006-8993(00)03076-6; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Ding YS, 2004, SYNAPSE, V53, P184, DOI 10.1002/syn.20051; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Domino EF, 2003, BRAIN COGNITION, V53, P66, DOI 10.1016/S0278-2626(03)00204-5; DOSSI RC, 1991, J NEUROPHYSIOL, V65, P393, DOI 10.1152/jn.1991.65.3.393; Edeline JM, 2003, EXP BRAIN RES, V153, P554, DOI 10.1007/s00221-003-1608-0; FRIEDMAN J, 1974, NATURE, V248, P455, DOI 10.1038/248455a0; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; HASHIKAWA T, 1995, J COMP NEUROL, V362, P195, DOI 10.1002/cne.903620204; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; KNOTT VJ, 1985, NEUROPSYCHOBIOLOGY, V13, P74, DOI 10.1159/000118166; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Lan CT, 1996, ANAT EMBRYOL, V194, P177; Lang PM, 2003, J NEUROPHYSIOL, V90, P3295, DOI 10.1152/jn.00512.2003; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Liang K, 2006, EUR J NEUROSCI, V24, P857, DOI 10.1111/j.1460-9568.2006.04945.x; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; MULLERPREUSS P, 1984, HEARING RES, V16, P133, DOI 10.1016/0378-5955(84)90003-0; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAWLINS FA, 1978, J CELL BIOL, V77, P371, DOI 10.1083/jcb.77.2.371; Roerig B, 1997, J NEUROSCI, V17, P8353; Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004; Sarter M, 2000, NEUROSCIENCE, V95, P933; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; VOLGUSHEV M, 1995, EUR J NEUROSCI, V7, P1751, DOI 10.1111/j.1460-9568.1995.tb00695.x; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Wessler I, 1997, N-S ARCH PHARMACOL, V356, P694, DOI 10.1007/PL00005107; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Zhang CL, 2004, J NEUROPHYSIOL, V91, P1025, DOI 10.1152/jn.00769.2003	49	114	117	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1168	1175		10.1038/nn1956	http://dx.doi.org/10.1038/nn1956			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17704774				2022-12-28	WOS:000249144000019
J	Douglas, KM; Bilkey, DK				Douglas, Katie M.; Bilkey, David K.			Amusia is associated with deficits in spatial processing	NATURE NEUROSCIENCE			English	Article							CONGENITAL AMUSIA; MENTAL ROTATION; TONE-DEAFNESS; SEX DIFFERENCE; DIGIT RATIO; MUSIC; PERFORMANCE; TASK; TESTOSTERONE; DISORDERS	Amusia (commonly referred to as tone-deafness) is a difficulty in discriminating pitch changes in melodies that affects around 4% of the human population. Amusia cannot be explained as a simple sensory impairment. Here we show that amusia is strongly related to a deficit in spatial processing in adults. Compared to two matched control groups (musicians and non-musicians), participants in the amusic group were significantly impaired on a visually presented mental rotation task. Amusic subjects were also less prone to interference in a spatial stimulus-response incompatibility task and performed significantly faster than controls in an interference task in which they were required to make simple pitch discriminations while concurrently performing a mental rotation task. This indicates that the processing of pitch in music normally depends on the cognitive mechanisms that are used to process spatial representations in other modalities.	Univ Otago, Dept Psychol, Dunedin 9054, New Zealand	University of Otago	Bilkey, DK (corresponding author), Univ Otago, Dept Psychol, 95 Union St,PO Box 56, Dunedin 9054, New Zealand.	dbilkey@psy.otago.ac.nz	Douglas, Katie/AAB-5554-2020	Douglas, Katie/0000-0002-5344-2959				Allen G, 1878, MIND, V3, P157, DOI [DOI 10.1093/MIND/OS-3.10.157, 10.1093/mind/os-3.10.157]; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Berenbaum SA, 2001, ENDOCRIN METAB CLIN, V30, P173, DOI 10.1016/S0889-8529(08)70025-2; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; HASSLER M, 1992, INT J NEUROSCI, V65, P45, DOI 10.3109/00207459209003277; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Kopiez R, 2006, NEUROPSYCHOLOGIA, V44, P1079, DOI 10.1016/j.neuropsychologia.2005.10.023; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Pratt CC, 1930, J EXP PSYCHOL, V13, P278, DOI 10.1037/h0072651; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Rauscher FH, 1997, NEUROL RES, V19, P2; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Schellenberg EG, 2005, CURR DIR PSYCHOL SCI, V14, P317, DOI 10.1111/j.0963-7214.2005.00389.x; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sloboda JA, 2005, ANN NY ACAD SCI, V1060, P255, DOI 10.1196/annals.1360.018; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015	31	93	94	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					915	921		10.1038/nn1925	http://dx.doi.org/10.1038/nn1925			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589505				2022-12-28	WOS:000247560200023
J	Barry, C; Hayman, R; Burgess, N; Jeffery, KJ				Barry, Caswell; Hayman, Robin; Burgess, Neil; Jeffery, Kathryn J.			Experience-dependent rescaling of entorhinal grids	NATURE NEUROSCIENCE			English	Article							PATH-INTEGRATION; PLACE FIELDS; CORTEX; HIPPOCAMPUS; REPRESENTATION; CELLS; MODEL; MAP	The firing pattern of entorhinal 'grid cells' is thought to provide an intrinsic metric for space. We report a strong experience-dependent environmental influence: the spatial scales of the grids (which are aligned and have fixed relative sizes within each animal) vary parametrically with changes to a familiar environment's size and shape. Thus grid scale reflects an interaction between intrinsic, path-integrative calculation of location and learned associations to the external environment.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Anat, London WC1E 6BT, England; UCL, Dept Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of London; University College London	Barry, C (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.		Jeffery, Kathryn J/C-2409-2008; Burgess, Neil/B-2420-2009	Jeffery, Kathryn J/0000-0002-9495-0378; Burgess, Neil/0000-0003-0646-6584; Hayman, Robin/0000-0003-1075-0430	Medical Research Council [G0501672] Funding Source: Medline; MRC [G0501672] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barry C, 2006, REV NEUROSCIENCE, V17, P71; BROOKINGS T, 2006, PREPINT; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gorchetchnikov A, 2007, NEURAL NETWORKS, V20, P182, DOI 10.1016/j.neunet.2006.11.007; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Kloosterman F, 2004, HIPPOCAMPUS, V14, P1026, DOI 10.1002/hipo.20022; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572	15	336	341	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					682	684		10.1038/nn1905	http://dx.doi.org/10.1038/nn1905			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486102				2022-12-28	WOS:000246799800008
J	Nagai, M; Re, DB; Nagata, T; Chalazonitis, A; Jessell, TM; Wichterle, H; Przedborski, S				Nagai, Makiko; Re, Diane B.; Nagata, Tetsuya; Chalazonitis, Alcmene; Jessell, Thomas M.; Wichterle, Hynek; Przedborski, Serge			Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; EMBRYONIC STEM-CELLS; SPINAL-CORD; EXTEND SURVIVAL; IN-VITRO; DISEASE; MICE; DEGENERATION	Mutations in superoxide dismutase-1 ( SOD1) cause a form of the fatal paralytic disorder amyotrophic lateral sclerosis ( ALS), presumably by a combination of cell-autonomous and non - cell- autonomous processes. Here, we show that expression of mutated human SOD1 in primary mouse spinal motor neurons does not provoke motor neuron degeneration. Conversely, rodent astrocytes expressing mutated SOD1 kill spinal primary and embryonic mouse stem cell - derived motor neurons. This is triggered by soluble toxic factor( s) through a Bax- dependent mechanism. However, mutant astrocytes do not cause the death of spinal GABAergic or dorsal root ganglion neurons or of embryonic stem cell - derived interneurons. In contrast to astrocytes, fibroblasts, microglia, cortical neurons and myocytes expressing mutated SOD1 do not cause overt neurotoxicity. These findings indicate that astrocytes may play a role in the specific degeneration of spinal motor neurons in ALS. Identification of the astrocyte- derived soluble factor( s) may have far- reaching implications for ALS from both a pathogenic and therapeutic standpoint.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.	SP30@Columbia.edu		Nagata, Tetsuya/0000-0003-4111-2693; Re, Diane/0000-0002-6842-6759; Wichterle, Hynek/0000-0002-7817-0080	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS038370, P50NS011766, R01NS042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER; NIA NIH HHS [AG 21617, R01 AG021617] Funding Source: Medline; NIDDK NIH HHS [R01 DK058056, DK58056] Funding Source: Medline; NIEHS NIH HHS [ES013177, R21 ES013177] Funding Source: Medline; NINDS NIH HHS [P01 NS011766, NS42269, P50 NS038370, NS38370, R01 NS042269, NS11766] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CHALAZONITIS A, 1988, BRAIN RES, V458, P231, DOI 10.1016/0006-8993(88)90466-0; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; DAS S, 1995, NEURON, V14, P447, DOI 10.1016/0896-6273(95)90300-3; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; KAJI K, 1979, EXP CELL RES, V119, P231, DOI 10.1016/0014-4827(79)90351-3; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lukas TJ, 2006, MOL CELL PROTEOMICS, V5, P1233, DOI 10.1074/mcp.M500431-MCP200; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Przedborski S, 1996, J NEUROCHEM, V67, P1383; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Ricart K, 2006, J NEUROCHEM, V97, P222, DOI 10.1111/j.1471-4159.2006.03739.x; Rideout HJ, 2004, J BIOL CHEM, V279, P46915, DOI 10.1074/jbc.M405146200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Silva GA, 1998, J NEUROSCI METH, V80, P75, DOI 10.1016/S0165-0270(97)00198-2; Suurmeijer AJH, 1999, LAB INVEST, V79, P619; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zona C, 2006, J NEUROPHYSIOL, V96, P3314, DOI 10.1152/jn.00566.2006	38	890	922	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					615	622		10.1038/nn1876	http://dx.doi.org/10.1038/nn1876			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435755	Green Accepted			2022-12-28	WOS:000245948000018
J	Fernandez, F; Morishita, W; Zuniga, E; Nguyen, J; Blank, M; Malenka, RC; Garner, CC				Fernandez, Fabian; Morishita, Wade; Zuniga, Elizabeth; Nguyen, James; Blank, Martina; Malenka, Robert C.; Garner, Craig C.			Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; TS65DN MOUSE; ABNORMALITIES; STORAGE; MICE; LTP	Ts65Dn mice, a model for Down syndrome, have excessive inhibition in the dentate gyrus, a condition that could compromise synaptic plasticity and mnemonic processing. We show that chronic systemic treatment of these mice with GABA(A) antagonists at non-epileptic doses causes a persistent post-drug recovery of cognition and long-term potentiation. These results suggest that over-inhibition contributes to intellectual disabilities associated with Down syndrome and that GABA(A) antagonists may be useful therapeutic agents for this disorder.	Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA	Stanford University	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA.	cgarner@stanford.edu		Fernandez, Fabian-Xose/0000-0002-4288-5383; Garner, Craig/0000-0003-1970-5417				Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; HANSON JE, IN PRESS J PHYSL LON; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Ivic L, 2003, J BIOL CHEM, V278, P49279, DOI 10.1074/jbc.M304034200; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; LEVY S, 1953, JAMA-J AM MED ASSOC, V153, P1260, DOI 10.1001/jama.1953.02940310028007; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Seregaza Z, 2006, BEHAV GENET, V36, P387, DOI 10.1007/s10519-006-9056-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	15	376	394	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					411	413		10.1038/nn1860	http://dx.doi.org/10.1038/nn1860			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322876				2022-12-28	WOS:000245228600008
J	Kukley, M; Capetillo-Zarate, E; Dietrich, D				Kukley, Maria; Capetillo-Zarate, Estibaliz; Dietrich, Dirk			Vesicular glutamate release from axons in white matter	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; CORPUS-CALLOSUM; GLIAL-CELLS; MOLECULAR-MECHANISMS; PRESYNAPTIC CALCIUM; ELECTRICAL-ACTIVITY; HIPPOCAMPAL SLICES; TERM DEPRESSION	Vesicular release of neurotransmitter is the universal output signal of neurons in the brain. It is generally believed that fast transmitter release is restricted to nerve terminals that contact postsynaptic cells in the gray matter. Here we show in the rat brain that the neurotransmitter glutamate is also released at discrete sites along axons in white matter in the absence of neurons and nerve terminals. The propagation of single action potentials along axons leads to rapid vesicular release of glutamate, which is detected by ionotropic glutamate receptors on local oligodendrocyte precursor cells. Axonal release of glutamate is reliable, involves highly localized calcium microdomain signaling and is strongly calcium cooperative, similar to vesicle fusion at synapses. This axonal transmitter release represents a widespread mechanism for high-fidelity, activity-dependent signaling at the axon-glia interface in white matter.	Univ Clin Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Clin Bonn, Dept Neuropathol, D-53105 Bonn, Germany	University of Bonn; University of Bonn	Kukley, M (corresponding author), Univ Clin Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	maria.kukley@gmx.de; dirk.dietrich@ukb.uni-bonn.de	Kukley, Maria/I-4064-2017; Capetillo-Zarate, Estibaliz/Z-5772-2019; Messier, Claude/A-2322-2008	Kukley, Maria/0000-0002-4567-1241; Capetillo-Zarate, Estibaliz/0000-0002-8416-0495; Messier, Claude/0000-0002-4791-1763				Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BERGER T, 1991, J NEUROSCI, V11, P3008; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hille B., 1992, IONIC CHANNELS EXCIT; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; Li S, 1999, J Neurosci, V19, pRC16; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Riederer BM, 2004, EUR J NEUROSCI, V19, P2039, DOI 10.1111/j.1460-9568.2004.03305.x; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Stanton PK, 2003, J NEUROSCI, V23, P5936; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Stricker C, 2003, J NEUROSCI METH, V130, P159, DOI 10.1016/j.jneumeth.2003.09.021; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Zhen M, 2004, CURR OPIN NEUROBIOL, V14, P280, DOI 10.1016/j.conb.2004.05.013	50	343	349	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					311	320		10.1038/nn1850	http://dx.doi.org/10.1038/nn1850			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293860				2022-12-28	WOS:000244480300013
J	d'Avossa, G; Tosetti, M; Crespi, S; Biagi, L; Burr, DC; Morrone, MC				d'Avossa, Giovanni; Tosetti, Michela; Crespi, Sofia; Biagi, Laura; Burr, David C.; Morrone, Maria Concetta			Spatiotopic selectivity of BOLD responses to visual motion in human area MT	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL; CORTICAL AREA; OPTIC FLOW; CORTEX; REPRESENTATION; INTEGRATION; LOCATIONS; SHAPE; FORM	Many neurons in the monkey visual extrastriate cortex have receptive fields that are affected by gaze direction. In humans, psychophysical studies suggest that motion signals may be encoded in a spatiotopic fashion. Here we use functional magnetic resonance imaging to study spatial selectivity in the human middle temporal cortex ( area MT or V5), an area that is clearly implicated in motion perception. The results show that the response of MT is modulated by gaze direction, generating a spatial selectivity based on screen rather than retinal coordinates. This area could be the neurophysiological substrate of the spatiotopic representation of motion signals.	Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy; Washington Univ, Sch Med, St Louis, MO 63110 USA; Fdn Stella Maris, I-56018 Pisa, Italy; Univ Milan, Dept Psychol, I-20126 Milan, Italy; Univ Florence, Dept Psychol, Florence, Italy; Univ Western Australia, Dept Psychol, Nedlands, WA 6009, Australia	Vita-Salute San Raffaele University; Washington University (WUSTL); IRCCS Fondazione Stella Maris; University of Milan; University of Milano-Bicocca; University of Florence; University of Western Australia	Morrone, MC (corresponding author), Univ Vita Salute San Raffaele, Fac Psicol, Via Olgettina 58, I-20132 Milan, Italy.	concetta.morrone@hsr.it	Biagi, Laura/K-5692-2016; Tosetti, Michela/K-5749-2016; Morrone, Maria Concetta/C-6756-2014	Biagi, Laura/0000-0003-2159-439X; Tosetti, Michela/0000-0002-2515-7560; Morrone, Maria Concetta/0000-0002-1025-0316; CRESPI, Sofia Allegra/0000-0001-7429-0440; Burr, David/0000-0003-1541-8832				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; d'Avossa G, 2003, J NEUROPHYSIOL, V90, P360, DOI 10.1152/jn.01040.2002; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; Huk AC, 2002, J NEUROSCI, V22, P7195; MCKYTON A, 2006, CEREB CORTEX, DOI DOI 10.1093/CERCORBH1027; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nieman DR, 2005, VISION RES, V45, P2885, DOI 10.1016/j.visres.2005.06.029; Nishida S, 2003, VISION RES, V43, P639, DOI 10.1016/S0042-6989(03)00007-5; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Talairach J., 1988, STEREOTACTIC COPLANA; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005; ZEKI S, 1991, J NEUROSCI, V11, P641; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	40	126	125	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					249	255		10.1038/nn1824	http://dx.doi.org/10.1038/nn1824			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17195842				2022-12-28	WOS:000244175200020
J	Isoda, M; Hikosaka, O				Isoda, Masaki; Hikosaka, Okihide			Switching from automatic to controlled action by monkey medial frontal cortex	NATURE NEUROSCIENCE			English	Article							PRESUPPLEMENTARY MOTOR AREA; SUPPLEMENTARY EYE FIELD; MEMORY-GUIDED SACCADES; NEURONAL-ACTIVITY; ELECTRICAL-STIMULATION; MACAQUE MONKEY; SUBTHALAMIC NUCLEUS; RESPONSE-CONFLICT; BASAL GANGLIA; PRE-SMA	Human behavior is mostly composed of habitual actions that require little conscious control. Such actions may become invalid if the environment changes, at which point individuals need to switch behavior by overcoming habitual actions that are otherwise triggered automatically. It is unknown how the brain controls this type of behavioral switching. Here we show that the presupplementary motor area ( pre- SMA) in the medial frontal cortex has a function in switching from automatic to volitionally controlled action in rhesus macaque monkeys. We found that a group of pre- SMA neurons was selectively activated when subjects successfully switched to a controlled alternative action. Electrical stimulation in the pre- SMA replaced automatic incorrect responses with slower correct responses. A further test suggested that the pre- SMA enabled switching by first suppressing an automatic unwanted action and then boosting a controlled desired action. Our data suggest that the pre- SMA resolves response conflict so that the desired action can be selected.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Isoda, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	isodam@nei.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; DOVE E, 2000, BRAIN RES COGN BRAIN, V9, P103; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Isoda M, 2005, J NEUROPHYSIOL, V93, P3016, DOI 10.1152/jn.01176.2004; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2261, DOI 10.1152/jn.00085.2004; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LOGAN GD, 1980, COGNITIVE PSYCHOL, V12, P523, DOI 10.1016/0010-0285(80)90019-5; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; LUPPINO G, 1991, J COMP NEUROL, V311, P466; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; PARENT A, 1984, BRAIN RES, V303, P385, DOI 10.1016/0006-8993(84)91224-1; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Wang Y, 2005, NEUROSCI RES, V53, P1, DOI 10.1016/j.neures.2005.05.005; Yamamoto J, 2004, BRAIN, V127, P873, DOI 10.1093/brain/awh110; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; [No title captured]	49	335	340	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					240	248		10.1038/nn1830	http://dx.doi.org/10.1038/nn1830			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237780				2022-12-28	WOS:000244175200019
J	Wang, XN; Shaw, R; Tsang, HTH; Reid, E; O'Kane, CJ				Wang, Xinnan; Shaw, Robert; Tsang, Hilda T. H.; Reid, Evan; O'Kane, Cahir J.			Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; II RECEPTOR; PROTEIN; GENE; STABILITY; SPASTIN; FORM; MUTATIONS; PROLIFERATION; LOCALIZATION	To understand the functions of NIPA1, mutated in the neurodegenerative disease hereditary spastic paraplegia, and of ichthyin, mutated in autosomal recessive congenital ichthyosis, we have studied their Drosophila melanogaster ortholog, spichthyin ( Spict). Spict is found on early endosomes. Loss of Spict leads to upregulation of bone morphogenetic protein ( BMP) signaling and expansion of the neuromuscular junction. BMP signaling is also necessary for a normal microtubule cytoskeleton and axonal transport; analysis of loss- and gain- of- function phenotypes indicate that Spict may antagonize this function of BMP signaling. Spict interacts with BMP receptors and promotes their internalization from the plasma membrane, implying that it inhibits BMP signaling by regulating BMP receptor traffic. This is the first demonstration of a role for a hereditary spastic paraplegia protein or ichthyin family member in a specific signaling pathway, and implies disease mechanisms for hereditary spastic paraplegia that involve dependence of the microtubule cytoskeleton on BMP signaling.	Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Cambridge, Dept Med Genet, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge; University of Cambridge; University of Cambridge	O'Kane, CJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	c.okane@gen.cam.ac.uk	O'Kane, Cahir J/C-4413-2011; O'Kane, Cahir/Q-6681-2019; Wang, Xinnan/B-2393-2013; Reid, Evan/F-3250-2010	O'Kane, Cahir/0000-0002-3488-2078; Reid, Evan/0000-0003-1623-7304	Wellcome Trust [073483] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Casso D, 2000, MECH DEVELOP, V91, P449; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Chen SH, 2005, AGENT BASED SOC SYST, V1, P135, DOI 10.1007/4-431-26925-8_13; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; DiGiovanna JJ, 2003, AM J CLIN DERMATOL, V4, P81, DOI 10.2165/00128071-200304020-00002; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Goold RG, 1999, J CELL SCI, V112, P3373; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kaneko S, 2006, MOVEMENT DISORD, V21, P1531, DOI 10.1002/mds.21005; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Reed JA, 2005, NEUROGENETICS, V6, P79, DOI 10.1007/s10048-004-0209-9; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	50	136	138	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					177	185		10.1038/nn1841	http://dx.doi.org/10.1038/nn1841			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220882	Green Accepted			2022-12-28	WOS:000244175200012
J	Munoz, DP				Munoz, Douglas P.			Stabilizing the visual world	NATURE NEUROSCIENCE			English	Editorial Material							FRONTAL EYE FIELD; BRAIN-STEM TELLS; SUPERIOR COLLICULUS; CORTEX; REPRESENTATION		Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Munoz, DP (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	doug_munoz@biomed.queensu.ca						DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; SOMMER MA, IN PRESS NATURE; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; VONHELMHOLTZ H, 2000, HELMHOLTZS TREATISE; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988	14	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1467	1468		10.1038/nn1206-1467	http://dx.doi.org/10.1038/nn1206-1467			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17128283				2022-12-28	WOS:000242404000006
J	Crochet, S; Petersen, CCH				Crochet, S; Petersen, CCH			Correlating whisker behavior with membrane potential in barrel cortex of awake mice	NATURE NEUROSCIENCE			English	Article							THALAMOCORTICAL SYNAPSES; SENSORY RESPONSES; IN-VIVO; SYSTEM; INHIBITION; DEPRESSION; NEURONS	To investigate synaptic events underlying sensory perception, we made whole-cell membrane potential recordings of barrel cortex neurons in awake mice while recording whisker-related behavior. During quiet periods, we recorded slow, large-amplitude membrane potential changes, which switched during whisking to small, fast fluctuations that were correlated with whisker position. Robust subthreshold responses were evoked by passive whisker stimulation during quiet behavior and by active whisker contact with an object.	Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, SV BML LSENS AAB 105, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, SV BML LSENS AAB 105, Stn 15, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Crochet, Sylvain/0000-0002-2965-8899				Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; HENTSCHKE H, 2005, CEREB; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545	15	379	381	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					608	610		10.1038/nn1690	http://dx.doi.org/10.1038/nn1690			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617340				2022-12-28	WOS:000237417200010
J	Tsankova, NM; Berton, O; Renthal, W; Kumar, A; Neve, RL; Nestler, EJ				Tsankova, NM; Berton, O; Renthal, W; Kumar, A; Neve, RL; Nestler, EJ			Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC-FACTOR; HISTONE ACETYLATION; SOCIAL STRESS; LONG-TERM; RAT HIPPOCAMPUS; GENE-EXPRESSION; MESSENGER-RNA; BRAIN; BDNF; MEMORY	To better understand the molecular mechanisms of depression and antidepressant action, we administered chronic social defeat stress followed by chronic imipramine (a tricyclic antidepressant) to mice and studied adaptations at the levels of gene expression and chromatin remodeling of five brain-derived neurotrophic factor (Bdnf) splice variant mRNAs (I-V) and their unique promoters in the hippocampus. Defeat stress induced lasting downregulation of Bdnf transcripts III and IV and robustly increased repressive histone methylation at their corresponding promoters. Chronic imipramine reversed this downregulation and increased histone acetylation at these promoters. This hyperacetylation by chronic imipramine was associated with a selective downregulation of histone deacetylase (Hdac) 5. Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior. These experiments underscore an important role for histone remodeling in the pathophysiology and treatment of depression and highlight the therapeutic potential for histone methylation and deacetylation inhibitors in depression.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Belmont, MA 02178 USA; McLean Hosp 202 MRC, Dept Psychiat, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kumar, Arvind/B-6094-2009; Yan, Shuo/B-8381-2009; Winwood, Peter/A-6363-2008	Kumar, Arvind/0000-0003-2879-3826; Renthal, William/0000-0003-0206-2101				Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Dennis KE, 2005, MOL BRAIN RES, V140, P1, DOI 10.1016/j.molbrainres.2005.06.014; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoshino M, 2003, J NEUROCHEM, V87, P257, DOI 10.1046/j.1471-4159.2003.01991.x; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Huang YF, 2002, J NEUROSCI, V22, P8422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koolhaas JM, 1997, ACTA PHYSIOL SCAND, V161, P69; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; Miczek KA, 2004, NEUROSCI BIOBEHAV R, V27, P787, DOI 10.1016/j.neubiorev.2003.11.005; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Newton SS, 2003, J NEUROSCI, V23, P10841; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Russo-Neustadt A, 1999, NEUROPSYCHOPHARMACOL, V21, P679, DOI 10.1016/S0893-133X(99)00059-7; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286	50	1296	1369	0	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					519	525		10.1038/nn1659	http://dx.doi.org/10.1038/nn1659			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501568				2022-12-28	WOS:000236310700019
J	Northoff, G; Walter, M; Schulte, RF; Beck, J; Dydak, U; Henning, A; Boeker, H; Grimm, S; Boesiger, P				Northoff, Georg; Walter, Martin; Schulte, Rolf F.; Beck, Johannes; Dydak, Ulrike; Henning, Anke; Boeker, Heinz; Grimm, Simone; Boesiger, Peter			GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; FUNCTIONAL MRI; RESTING-STATE; MODULATION; BRAIN; ATTENUATION; ANXIETY; SIGNAL	The human anterior cingulate cortex (ACC) is part of the default-mode network that shows predominant negative blood oxygen level-dependent (BOLD) responses in functional magnetic resonance imaging (fMRI). We combined fMRI during emotional processing and resting-state magnetic resonance spectroscopy measurements and observed that the concentration of GABA in the ACC specifically correlated with the amount of negative BOLD responses in the very same region. Our findings show that default-mode network negative BOLD responses during emotions are mediated by GABA.	Univ Magdeburg, Dept Psychiat, D-39120 Magdeburg, Germany; Univ Zurich, ETH Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; Univ Zurich, Dept Psychiat, CH-8029 Zurich, Switzerland	Otto von Guericke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Northoff, G (corresponding author), Univ Magdeburg, Dept Psychiat, Leipziger Str 44, D-39120 Magdeburg, Germany.	georg.northoff@medizin.uni-magdeburg.de		Henning, Anke/0000-0002-2267-4861; Walter, Martin/0000-0001-7857-4483				Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Northoff G, 2004, HUM BRAIN MAPP, V21, P202, DOI 10.1002/hbm.20002; Northoff G, 2002, J COGNITIVE NEUROSCI, V14, P348, DOI 10.1162/089892902317361895; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Schulte RF, 2006, NMR BIOMED, V19, P255, DOI 10.1002/nbm.1026; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193	15	277	281	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1515	1517		10.1038/nn2001	http://dx.doi.org/10.1038/nn2001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982452				2022-12-28	WOS:000251172900007
J	Quinn, JJ; Hitchcott, PK; Umeda, EA; Arnold, AP; Taylor, JR				Quinn, Jennifer J.; Hitchcott, Paul K.; Umeda, Elizabeth A.; Arnold, Arthur P.; Taylor, Jane R.			Sex chromosome coemplement regulates habit formation	NATURE NEUROSCIENCE			English	Article							GENE	Sex differences in brain function and behavior are regularly attributed to gonadal hormones. Some brain sexual dimorphisms, however, are direct actions of sex chromosome genes that are not mediated by gonadal hormones. We used mice in which sex chromosome complement (XX versus XY) and gonadal sex ( ovaries versus testes) were independent, and found that XX mice showed faster food-reinforced instrumental habit formation than XY mice, regardless of gonadal phenotype.	Yale Univ, Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, Div Mol Psychiat, New Haven, CT 06508 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA	Yale University; University of California System; University of California Los Angeles	Taylor, JR (corresponding author), Yale Univ, Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, Div Mol Psychiat, 34 Pk St, New Haven, CT 06508 USA.	jane.taylor@yale.edu		Arnold, Arthur/0000-0002-9908-9767	NIDA NIH HHS [DA16556, DA11717] Funding Source: Medline; NINDS NIH HHS [NS045966] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA016556, R01DA011717] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; HITCHCOTT PK, 2007, CEREB CORTEX    0224, DOI DOI 10.1093/CERCOR/BH7010; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Lynch WJ, 2002, PSYCHOPHARMACOLOGY, V164, P121, DOI 10.1007/s00213-002-1183-2; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	14	114	115	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1398	1400		10.1038/nn1994	http://dx.doi.org/10.1038/nn1994			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952068				2022-12-28	WOS:000250508400015
J	Foltenyi, K; Greenspan, RJ; Newport, JW				Foltenyi, Krisztina; Greenspan, Ralph J.; Newport, John W.			Activation of EGFR and ERK by rhomboid signaling regulates the consolidation and maintenance of sleep in Drosophila	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; CIRCADIAN-RHYTHMS; CORPUS CARDIACUM; PROTEIN-KINASES; MUSHROOM BODIES; DOWN-REGULATION; PATHWAY; MELANOGASTER; COMPONENTS; BRAIN	Epidermal growth factor receptor ( EGFR) signaling in the mammalian hypothalamus is important in the circadian regulation of activity. We have examined the role of this pathway in the regulation of sleep in Drosophila melanogaster. Our results demonstrate that rhomboid ( Rho)- and Star-mediated activation of EGFR and ERK signaling increases sleep in a dose-dependent manner, and that blockade of rhomboid ( rho) expression in the nervous system decreases sleep. The requirement of rho for sleep localized to the pars intercerebralis, a part of the fly brain that is developmentally and functionally analogous to the hypothalamus in vertebrates. These results suggest that sleep and its regulation by EGFR signaling may be ancestral to insects and mammals.	Inst Neurosci, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Greenspan, RJ (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	greenspan@nsi.edu						Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Basyuk E, 2000, Nucleic Acids Res, V28, pE46, DOI 10.1093/nar/28.10.e46; Botella JA, 2003, MOL BIOL CELL, V14, P241, DOI 10.1091/mbc.E02-05-0297; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; De Velasco B, 2004, DEV BIOL, V274, P280, DOI 10.1016/j.ydbio.2004.07.015; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Guichard A, 2002, P NATL ACAD SCI USA, V99, P3752, DOI 10.1073/pnas.052028699; Guichard A, 1999, DEVELOPMENT, V126, P2663; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kushikata T, 1998, AM J PHYSIOL-REG I, V275, pR509, DOI 10.1152/ajpregu.1998.275.2.R509; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SCHEJTER ED, 1986, CELL, V46, P1091, DOI 10.1016/0092-8674(86)90709-9; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sokal R.R., 2012, BIOMETRY; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; SUZUKI T, 1995, NEUROSCI RES, V22, P277, DOI 10.1016/0168-0102(95)00902-6; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	50	181	182	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1160	1167		10.1038/nn1957	http://dx.doi.org/10.1038/nn1957			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694052				2022-12-28	WOS:000249144000018
J	Olsson, A; Phelps, EA				Olsson, Andreas; Phelps, Elizabeth A.			Social learning of fear	NATURE NEUROSCIENCE			English	Review							FACIAL EXPRESSIONS; RELEVANT STIMULI; CONDITIONED FEAR; NEURAL SYSTEMS; ELECTRODERMAL RESPONSES; POTENTIATED STARTLE; PERSPECTIVE-TAKING; AVOIDANCE-BEHAVIOR; PREFRONTAL CORTEX; LATERAL AMYGDALA	Research across species highlights the critical role of the amygdala in fear conditioning. However, fear conditioning, involving direct aversive experience, is only one means by which fears can be acquired. Exploiting aversive experiences of other individuals through social fear learning is less risky. Behavioral research provides important insights into the workings of social fear learning, and the neural mechanisms are beginning to be understood. We review research suggesting that an amygdala-centered model of fear conditioning can help to explain social learning of fear through observation and instruction. We also describe how observational and instructed fear is distinguished by involvement of additional neural systems implicated in social-emotional behavior, language and explicit memory, and propose a modified conditioning model to account for social fear learning. A better understanding of social fear learning promotes integration of biological principles of learning with cultural evolution.	Columbia Univ, Dept Psychol, New York, NY 10027 USA; NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Columbia University; New York University; New York University	Olsson, A (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	aolsson@psych.columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER; NIMH NIH HHS [MH62104] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral D.G., 1986, Advances in Experimental Medicine and Biology, V203, P3; Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; BANDURA A, 1968, J PERS SOC PSYCHOL, V8, P99, DOI 10.1037/h0025260; Bandura A., 1977, SOCIAL LEARNING THEO, V1; Barton RA, 2003, P ROY SOC B-BIOL SCI, V270, P539, DOI 10.1098/rspb.2002.2276; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; BENNET G, 1993, ANN LEARN BEHAV, V21, P214; BERGER SM, 1962, PSYCHOL REV, V69, P450, DOI 10.1037/h0046466; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; COOK EW, 1986, J ABNORM PSYCHOL, V95, P195, DOI 10.1037/0021-843X.95.3.195; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Curio E., 1988, P75; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Ekman P., 1982, EMOTION HUMAN FACE; EVERITT B J, 1992, P401; Field AP, 2001, BEHAV RES THER, V39, P1259, DOI 10.1016/S0005-7967(00)00080-2; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gazzaniga M, 1978, THE INTEGRATED MIND; Gerull FC, 2002, BEHAV RES THER, V40, P279, DOI 10.1016/S0005-7967(01)00013-4; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hauser, 1996, EVOL COMMUN; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; HEYES CM, 1993, BEHAV BRAIN SCI, V16, P524, DOI 10.1017/S0140525X00031393; Hooker CI, 2006, J NEUROSCI, V26, P8915, DOI 10.1523/JNEUROSCI.3048-05.2006; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; HUGDAHL K, 1977, J EXP PSYCHOL-HUM L, V3, P608, DOI 10.1037/0278-7393.3.5.608; HYGGE S, 1978, J PERS SOC PSYCHOL, V36, P271, DOI 10.1037/0022-3514.36.3.271; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; JOHN ER, 1968, SCIENCE, V159, P1489, DOI 10.1126/science.159.3822.1489; Kavaliers M, 2001, BEHAV NEUROSCI, V115, P661, DOI 10.1037/0735-7044.115.3.661; Keller M, 2004, EUR J NEUROSCI, V20, P3433, DOI 10.1111/j.1460-9568.2004.03812.x; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; King NJ, 1998, BEHAV RES THER, V36, P297, DOI 10.1016/S0005-7967(98)00015-1; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; LANZETTA JT, 1980, J PERS SOC PSYCHOL, V39, P1081, DOI 10.1037/h0077713; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; MASSERMAN JH, 1964, AM J PSYCHIAT, V121, P584, DOI 10.1176/ajp.121.6.584; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; MINEKA S, 1993, J EXP PSYCHOL GEN, V122, P23, DOI 10.1037/0096-3445.122.1.23; MINEKA S, 1984, J ABNORM PSYCHOL, V93, P355, DOI 10.1037/0021-843X.93.4.355; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Munksgaard L, 2001, APPL ANIM BEHAV SCI, V73, P15, DOI 10.1016/S0168-1591(01)00119-8; MYERS RE, 1973, BRAIN RES, V64, P257, DOI 10.1016/0006-8993(73)90182-0; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Pavlov I.P., 1927, CONDITIONED REFLEXES; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PLOTKIN HC, 1981, BEHAV BRAIN SCI, V4, P225, DOI 10.1017/S0140525X00008566; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; PRICE JL, 1981, J NEUROSCI, V1, P1242; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; RACHMAN S, 1976, BEHAV RES THER, V14, P437, DOI 10.1016/0005-7967(76)90090-5; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; ROLLS ET, 1994, EXP BRAIN RES, V101, P473; ROLLS ET, 1999, BRAIN EMOTION; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schneider M, 2005, NEUROPSYCHOPHARMACOL, V30, P944, DOI 10.1038/sj.npp.1300634; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; SIMON H, 1979, BRAIN RES, V178, P17, DOI 10.1016/0006-8993(79)90085-4; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Squires AS, 2006, NEUROBIOL LEARN MEM, V85, P95, DOI 10.1016/j.nlm.2005.08.012; Thorpe W. H, 1963, LEARNING INSTINCT AN; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; VAUGHAN KB, 1980, J PERS SOC PSYCHOL, V38, P909, DOI 10.1037/0022-3514.38.6.909; Whalen PJ, 1998, J NEUROSCI, V18, P411; White DJ, 1998, ANIM LEARN BEHAV, V26, P433, DOI 10.3758/BF03199236; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Young M P, 1994, Rev Neurosci, V5, P227; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	100	387	392	3	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1095	1102		10.1038/nn1968	http://dx.doi.org/10.1038/nn1968			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	205VZ	17726475				2022-12-28	WOS:000249144000007
J	Hawasli, AH; Benavides, DR; Nguyen, C; Kansy, JW; Hayashi, K; Chambon, P; Greengard, P; Powell, CM; Cooper, DC; Bibb, JA				Hawasli, Ammar H.; Benavides, David R.; Nguyen, Chan; Kansy, Janice W.; Hayashi, Kanehiro; Chambon, Pierre; Greengard, Paul; Powell, Craig M.; Cooper, Donald C.; Bibb, James A.			Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation	NATURE NEUROSCIENCE			English	Article							LONG-TERM-POTENTIATION; NR2B SUBUNIT; CDK5 ACTIVITY; RECEPTOR; MEMORY; ROLES; MICE; P25; EXPRESSION; CLEAVAGE	Learning is accompanied by modulation of postsynaptic signal transduction pathways in neurons. Although the neuronal protein kinase cyclin-dependent kinase 5 (Cdk5) has been implicated in cognitive disorders, its role in learning has been obscured by the perinatal lethality of constitutive knockout mice. Here we report that conditional knockout of Cdk5 in the adult mouse brain improved performance in spatial learning tasks and enhanced hippocampal long-term potentiation and NMDA receptor ( NMDAR)mediated excitatory postsynaptic currents. Enhanced synaptic plasticity in Cdk5 knockout mice was attributed to reduced NR2B degradation, which caused elevations in total, surface and synaptic NR2B subunit levels and current through NR2B-containing NMDARs. Cdk5 facilitated the degradation of NR2B by directly interacting with both it and its protease, calpain. These findings reveal a previously unknown mechanism by which Cdk5 facilitates calpain-mediated proteolysis of NR2B and may control synaptic plasticity and learning.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Ctr Univ Strasbourg, Inst Genet & Biol Mol & Cellular, F-67404 Strasbourg, France; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rockefeller University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bibb, JA (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu	Hayashi, Kanehiro/L-2777-2013	Powell, Craig/0000-0001-5451-2165; Greengard, Paul/0000-0002-4437-0893	NIDA NIH HHS [F31 DA020199, K01 DA017750] Funding Source: Medline; NIMH NIH HHS [K08 MH065975-04, K08 MH065975-05, K08 MH065975] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA017750] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; BERNASCONIGUASTALLA S, 1994, HIPPOCAMPUS, V4, P53, DOI 10.1002/hipo.450040107; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gold SJ, 1997, J NEUROSCI, V17, P8024; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Itoh K, 2005, MOL CELL NEUROSCI, V29, P245, DOI 10.1016/j.mcn.2005.02.014; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Picconi B, 2006, STROKE, V37, P1895, DOI 10.1161/01.STR.0000226981.57777.b0; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sweatt JD, 2003, MECH MEMORY; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	43	236	257	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					880	886		10.1038/nn1914	http://dx.doi.org/10.1038/nn1914			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529984	Green Accepted			2022-12-28	WOS:000247560200018
J	Melcher, D				Melcher, David			Predictive remapping of visual features precedes saccadic eye movements	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; ORIENTATION; TIME; REPRESENTATION; INTEGRATION; ADAPTATION; PERCEPTION; NEURONS; MOTION; FIELD	The frequent occurrence of saccadic eye movements raises the question of how information is combined across separate glances into a stable, continuous percept. Here I show that visual form processing is altered at both the current fixation position and the location of the saccadic target before the saccade. When human observers prepared to follow a displacement of the stimulus with the eyes, visual form adaptation was transferred from current fixation to the future gaze position. This transfer of adaptation also influenced the perception of test stimuli shown at an intermediate position between fixation and saccadic target. Additionally, I found a presaccadic transfer of adaptation when observers prepared to move their eyes toward a stationary adapting stimulus in peripheral vision. The remapping of visual processing, demonstrated here with form adaptation, may help to explain our impression of a smooth transition, with no temporal delay, of visual perception across glances.	Univ Trent, Ctr Mind Brain Studies, Dept Cognit Sci, I-38068 Rovereto, Italy; Oxford Brookes Univ, Dept Psychol, Oxford OX3 0BP, England	University of Trento; Oxford Brookes University	Melcher, D (corresponding author), Univ Trent, Ctr Mind Brain Studies, Dept Cognit Sci, Corso Bettini 31, I-38068 Rovereto, Italy.	david.melcher@form.unitn.it	Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X				BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Carpenter RHS, 1988, MOVEMENTS EYES; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Georgeson M, 2004, CURR BIOL, V14, pR751, DOI 10.1016/j.cub.2004.09.011; GEORGESON MA, 1976, PERCEPTION, V5, P99, DOI 10.1068/p050099; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; PARKER DM, 1972, Q J EXP PSYCHOL, V24, P1, DOI 10.1080/14640747208400260; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373	25	165	166	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					903	907		10.1038/nn1917	http://dx.doi.org/10.1038/nn1917			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589507				2022-12-28	WOS:000247560200021
J	Mizrahi, A				Mizrahi, Adi			Dendritic development and plasticity of adult-born neurons in the mouse olfactory bulb	NATURE NEUROSCIENCE			English	Article							NEOCORTEX IN-VIVO; HIPPOCAMPAL DENDRITES; SYNAPTIC PLASTICITY; INDIVIDUAL NEURONS; LENTIVIRAL VECTORS; SPINE STABILITY; NEUROGENESIS; CORTEX; DYNAMICS; RECEPTOR	The mammalian brain maintains few developmental niches where neurogenesis persists into adulthood. One niche is located in the olfactory system where the olfactory bulb continuously receives functional interneurons. In vivo two-photon microscopy of lentivirus-labeled newborn neurons was used to directly image their development and maintenance in the olfactory bulb. Time-lapse imaging of newborn neurons over several days showed that dendritic formation is highly dynamic with distinct differences between spiny neurons and non-spiny neurons. Once incorporated into the network, adult-born neurons maintain significant levels of structural dynamics. This structural plasticity is local, cumulative and sustained in neurons several months after their integration. Thus, I provide a new experimental system for directly studying the pool of regenerating neurons in the intact mammalian brain and suggest that regenerating neurons form a cellular substrate for continuous wiring plasticity in the olfactory bulb.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il						Ailles LE, 2002, CURR TOP MICROBIOL, V261, P31; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Dailey ME, 1996, J NEUROSCI, V16, P2983; Davenne M, 2005, CHEM SENSES, V30, pI115, DOI 10.1093/chemse/bjh141; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kasthuri N, 2004, CURR OPIN NEUROBIOL, V14, P105, DOI 10.1016/j.conb.2004.01.013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizrahi A, 2006, P NATL ACAD SCI USA, V103, P1912, DOI 10.1073/pnas.0506297103; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Petreanu L, 2002, J NEUROSCI, V22, P6106; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; PURVES D, 1986, J NEUROSCI, V6, P1051; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shepherd GM, 2004, OLFACTORY BULB SYNAP, P165; SHOLL DA, 1953, J ANAT, V87, P387; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wu GY, 1999, J NEUROSCI, V19, P4472; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	50	97	98	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					444	452		10.1038/nn1875	http://dx.doi.org/10.1038/nn1875			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369823				2022-12-28	WOS:000245228600015
J	Hu, XY; Hicks, CW; He, WX; Wong, P; Macklin, WB; Trapp, BD; Yan, RQ				Hu, Xiangyou; Hicks, Caitlin W.; He, Wanxia; Wong, Philip; Macklin, Wendy B.; Trapp, Bruce D.; Yan, Riqiang			Bace1 modulates myelination in the central and peripheral nervous system	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; ASPARTYL PROTEASE; CLEAVING ENZYME; CELL-ADHESION; A-BETA; CLEAVAGE; DISEASE; NEUREGULIN-1; BRAIN	Bace1 is an endopeptidase that cleaves the amyloid precursor protein at the beta-secretase site. Apart from this cleavage, the functional importance of Bace1 in other physiological events is unknown. We show here that Bace1 regulates the process of myelination and myelin sheath thickness in the central and peripheral nerves. In Bace1-null mice, the process of myelination was delayed and myelin thickness was markedly reduced, indicating that genetic deletion of Bace1 causes hypomyelination. Bace1-null mice also showed altered neurological behaviors such as elevated pain sensitivity and reduced grip strength. Further mechanistic studies showed an altered neuregulin-Akt signaling pathway in Bace1-null mice. Full-length neuregulin-1 was increased and its cleavage product was decreased in the CNS of Bace1-null mice. Furthermore, phosphorylated Akt was also reduced. Based upon these and previous studies, we postulate that neuronally enriched Bace1 cleaves neuregulin-1 and that processed neuregulin-1 regulates myelination by means of phosphorylation of Akt in myelin-forming cells.	Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Cleveland Clinic Foundation; Johns Hopkins University	Yan, RQ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617; Hicks, Caitlin/0000-0001-7638-1936				Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lemke Greg, 2006, Sci STKE, V2006, ppe11, DOI 10.1126/stke.3252006pe11; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sussman CR, 2005, J NEUROSCI, V25, P5757, DOI 10.1523/JNEUROSCI.4748-04.2005; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174	39	474	491	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1520	1525		10.1038/nn1797	http://dx.doi.org/10.1038/nn1797			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099708				2022-12-28	WOS:000242404000016
J	Robbe, D; Montgomery, SM; Thome, A; Rueda-Orozco, PE; McNaughton, BL; Buzsaki, G				Robbe, David; Montgomery, Sean M.; Thome, Alexander; Rueda-Orozco, Pavel E.; McNaughton, Bruce L.; Buzsaki, Gyoergy			Cannabinoids reveal importance of spike timing coordination in hippocampal function	NATURE NEUROSCIENCE			English	Article							IMPAIRS SPATIAL MEMORY; NETWORK OSCILLATIONS; THETA-OSCILLATIONS; ENDOCANNABINOID SYSTEM; ACETYLCHOLINE-RELEASE; WORKING-MEMORY; PHASE-LOCKING; BEHAVING RAT; IN-VITRO; EEG	Cannabinoids impair hippocampus-dependent memory in both humans and animals, but the network mechanisms responsible for this effect are unknown. Here we show that the cannabinoids Delta(9)-tetrahydrocannabinol and CP55940 decreased the power of theta, gamma and ripple oscillations in the hippocampus of head-restrained and freely moving rats. These effects were blocked by a CB1 antagonist. The decrease in theta power correlated with memory impairment in a hippocampus-dependent task. By simultaneously recording from large populations of single units, we found that CP55940 severely disrupted the temporal coordination of cell assemblies in short time windows (< 100 ms) yet only marginally affected population firing rates of pyramidal cells and interneurons. The decreased power of local field potential oscillations correlated with reduced temporal synchrony but not with firing rate changes. We hypothesize that reduced spike timing coordination and the associated impairment of physiological oscillations are responsible for cannabinoid-induced memory deficits.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Arizona, Div Neural Syst Mem & Aging, Tucson, AZ 85724 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Arizona	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Rueda, Pavel/GPP-1112-2022; robbe, david/O-5439-2016	robbe, david/0000-0002-9450-0553; Montgomery, Sean/0000-0001-7370-0938; Rueda-Orozco, Pavel/0000-0002-2801-803X; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS20331, NS34994, NS43157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS020331, R37NS020331, R01NS043157] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BUONAMICI M, 1982, NEUROPHARMACOLOGY, V21, P825, DOI 10.1016/0028-3908(82)90071-5; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2003, CURRENT PRACTICE CLI, P1; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CONSROE PF, 1975, PHARMACOL BIOCHEM BE, V3, P173, DOI 10.1016/0091-3057(75)90144-6; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Curran HV, 2002, PSYCHOPHARMACOLOGY, V164, P61, DOI 10.1007/s00213-002-1169-0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Egashira N, 2002, EUR J PHARMACOL, V445, P221, DOI 10.1016/S0014-2999(02)01755-7; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hampson RE, 1998, NEUROBIOL DIS, V5, P474, DOI 10.1006/nbdi.1998.0223; Hampson RE, 2000, J NEUROSCI, V20, P8932; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Ilan AB, 2004, PSYCHOPHARMACOLOGY, V176, P214, DOI 10.1007/s00213-004-1868-9; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; LICHTMAN AH, 1995, PSYCHOPHARMACOLOGY, V119, P282, DOI 10.1007/BF02246292; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MILLER LL, 1983, PSYCHOL BULL, V93, P441, DOI 10.1037/0033-2909.93.3.441; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OLPE HR, 1980, BRAIN RES BULL, V5, P507, DOI 10.1016/0361-9230(80)90082-9; Pisanu A, 2006, NEUROPHARMACOLOGY, V50, P661, DOI 10.1016/j.neuropharm.2005.11.023; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Tzavara ET, 2003, J NEUROSCI, V23, P9374; WILLINSKY MD, 1975, PSYCHOPHARMACOLOGIA, V41, P123, DOI 10.1007/BF00421068	50	241	247	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1526	1533		10.1038/nn1801	http://dx.doi.org/10.1038/nn1801			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115043				2022-12-28	WOS:000242404000017
J	Garriga-Canut, M; Schoenike, B; Qazi, R; Bergendahl, K; Daley, TJ; Pfender, RM; Morrison, JF; Ockuly, J; Stafstrom, C; Sutula, T; Roopra, A				Garriga-Canut, Mireia; Schoenike, Barry; Qazi, Romena; Bergendahl, Karen; Daley, Timothy J.; Pfender, Rebecca M.; Morrison, John F.; Ockuly, Jeffrey; Stafstrom, Carl; Sutula, Thomas; Roopra, Avtar			2-deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; ADULT-RAT; TRANSCRIPTIONAL REPRESSION; NEURONAL GENES; DENTATE GYRUS; TARGET GENES; SPONTANEOUS SEIZURES; HISTONE DEACETYLASE; MESSENGER-RNA; BDNF	Temporal lobe epilepsy is a common form of drug-resistant epilepsy that sometimes responds to dietary manipulation such as the 'ketogenic diet'. Here we have investigated the effects of the glycolytic inhibitor 2-deoxy-D-glucose ( 2DG) in the rat kindling model of temporal lobe epilepsy. We show that 2DG potently reduces the progression of kindling and blocks seizure-induced increases in the expression of brain-derived neurotrophic factor and its receptor, TrkB. This reduced expression is mediated by the transcription factor NRSF, which recruits the NADH-binding co-repressor CtBP to generate a repressive chromatin environment around the BDNF promoter. Our results show that 2DG has anticonvulsant and antiepileptic properties, suggesting that anti-glycolytic compounds may represent a new class of drugs for treating epilepsy. The metabolic regulation of neuronal genes by CtBP will open avenues of therapy for neurological disorders and cancer.	Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA; Aga Khan Univ, Dept Pathol & Microbiol, Karachi 74800, Pakistan	University of Wisconsin System; University of Wisconsin Madison; Aga Khan University	Roopra, A (corresponding author), Univ Wisconsin, Dept Neurol, Med Sci Ctr, Room 1715,1300 Univ Ave, Madison, WI 53706 USA.	roopra@neurology.wisc.edu			PHS HHS [R01 25020] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Belyaev ND, 2004, J BIOL CHEM, V279, P556, DOI 10.1074/jbc.M310353200; Binder DK, 1999, J NEUROSCI, V19, P4616; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CHANDRAMOULI V, 1977, BIOCHIM BIOPHYS ACTA, V496, P278, DOI 10.1016/0304-4165(77)90310-5; Conner JM, 1997, J NEUROSCI, V17, P2295; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Golarai G, 1996, J NEUROPHYSIOL, V75, P343, DOI 10.1152/jn.1996.75.1.343; Gowers WR, 1881, EPILEPSY OTHER CHRON; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; Murray KD, 2000, J COMP NEUROL, V418, P411, DOI 10.1002/(SICI)1096-9861(20000320)418:4<411::AID-CNE4>3.0.CO;2-F; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Peterson CL, 2000, FEBS LETT, V476, P68, DOI 10.1016/S0014-5793(00)01673-2; Roopra A, 2001, Mol Interv, V1, P219; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sayin U, 2003, J NEUROSCI, V23, P2759; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Sinha SR, 2005, NEUROLOGIST, V11, P161, DOI 10.1097/01.nrl.0000160818.58821.d2; Stafstrom Carl E, 2004, Epilepsy Curr, V4, P215, DOI 10.1111/j.1535-7597.2004.46001.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stryer L, 2002, BIOCHEMISTRY; SUTULA T, 1986, J NEUROPHYSIOL, V56, P732, DOI 10.1152/jn.1986.56.3.732; Sutula TP, 2004, EPILEPSY RES, V60, P161, DOI 10.1016/j.eplepsyres.2004.07.001; TIMMUSK T, 1994, NEUROCHEM INT, V25, P11, DOI 10.1016/0197-0186(94)90046-9; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; WICK AN, 1955, P SOC EXP BIOL MED, V89, P579; Wood IC, 2003, J MOL BIOL, V334, P863, DOI 10.1016/j.jmb.2003.10.017; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang QH, 2002, SCIENCE, V295, P1895	50	321	336	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1382	1387		10.1038/nn1791	http://dx.doi.org/10.1038/nn1791			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041593				2022-12-28	WOS:000242403800015
J	Nozaki, D; Kurtzer, I; Scott, SH				Nozaki, Daichi; Kurtzer, Isaac; Scott, Stephen H.			Limited transfer of learning between unimanual and bimanual skills within the same limb	NATURE NEUROSCIENCE			English	Article							MOTOR; REPRESENTATION; DYNAMICS	Although a limb's motion appears to be similar across unimanual and bimanual movements, here we demonstrate partial, but not complete, transfer of learning across these behavioral contexts, hidden learning that remains intact ( but invisible) until the original context is again encountered, and the ability to associate two conflicting force fields simultaneously, one with each context. These results suggest partial, but not complete, overlap in the learning processes involved in the acquisition of unimanual and bimanual skills.	Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan; Res Inst Natl Rehabil Ctr Persons Disabilities, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan; Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	University of Tokyo; Queens University - Canada	Scott, SH (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan.	steve@biomed.queensu.ca	Nozaki, Daichi/B-7909-2010	Nozaki, Daichi/0000-0002-1338-8337				Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Cunningham CL, 2002, ACTA PSYCHOL, V110, P321, DOI 10.1016/S0001-6918(02)00040-9; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; FINCH M, 2004, TRIATHLON TRAINING; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807	12	124	124	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1364	1366		10.1038/nn1785	http://dx.doi.org/10.1038/nn1785			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028583				2022-12-28	WOS:000242403800011
J	Leung, KM; van Horck, FPG; Lin, AC; Allison, R; Standart, N; Holt, CE				Leung, Kin-Mei; van Horck, Francisca P. G.; Lin, Andrew C.; Allison, Rachel; Standart, Nancy; Holt, Christine E.			Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1	NATURE NEUROSCIENCE			English	Article							LOCAL TRANSLATION; PROTEIN-SYNTHESIS; VG1 RBP; LOCALIZATION; GUIDANCE; MECHANISMS; TRANSPORT; COLLAPSE; PHOSPHORYLATION; TRANSCRIPTION	Local protein synthesis regulates the turning of growth cones to guidance cues, yet little is known about which proteins are synthesized or how they contribute to directional steering. Here we show that beta-actin mRNA resides in Xenopus laevis retinal growth cones where it binds to the RNA-binding protein Vg1RBP. Netrin-1 induces the movement of Vg1RBP granules into filopodia, suggesting that it may direct the localization and translation of mRNAs in growth cones. Indeed, a gradient of netrin-1 activates a translation initiation regulator, eIF-4E-binding protein 1 (4EBP), asymmetrically and triggers a polarized increase in beta-actin translation on the near side of the growth cone before growth cone turning. Inhibition of beta-actin translation abolishes both the asymmetric rise in beta-actin and attractive, but not repulsive, turning. Our data suggest that newly synthesized beta-actin, concentrated near sites of signal reception, provides the directional bias for polymerizing actin in the direction of an attractive stimulus.	Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Univ Cambridge, Dept Biochem, Cambridge CB2 3DY, England	University of Cambridge; University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk	Allison, Rachel J/D-1275-2013	Allison, Rachel J/0000-0002-2446-8455; Lin, Andrew/0000-0001-6310-9765; Holt, Christine Elizabeth/0000-0003-2829-121X	Biotechnology and Biological Sciences Research Council [BB/C514766/1] Funding Source: Medline; Wellcome Trust [070568] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bassell GJ, 1998, J NEUROSCI, V18, P251; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Condeelis J, 2005, BIOL CELL, V97, P97; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Eng H, 1999, J NEUROSCI, V19, P1; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 2001, GENE DEV, V15, P2852; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	348	354	0	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1247	1256		10.1038/nn1775	http://dx.doi.org/10.1038/nn1775			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980963	Green Accepted			2022-12-28	WOS:000241493900018
J	Ipata, AE; Gee, AL; Gottlieb, J; Bisley, JW; Goldberg, ME				Ipata, Anna E.; Gee, Angela L.; Gottlieb, Jacqueline; Bisley, James W.; Goldberg, Michael E.			LIP responses to a popout stimulus are reduced if it is overtly ignored	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; DRIVEN ATTENTIONAL CAPTURE; POSTERIOR PARIETAL CORTEX; VISUAL-SEARCH TASK; SALIENT DISTRACTOR; NEURONAL RESPONSES; OCULOMOTOR CAPTURE; TOP-DOWN; SACCADE	Bright objects capture our attention by virtue of 'popping out' from their surroundings. This correlates with strong responses in cortical areas thought to be important in attentional allocation. Previous studies have suggested that with the right mindset or training, humans can ignore popout stimuli. We studied the activity of neurons in monkey lateral intraparietal area while monkeys performed a visual search task. The monkeys were free to move their eyes, and a distractor, but never the search target, popped out. On trials in which the monkeys made a saccade directly to the search target, the popout distractor evoked a smaller response than the non-popout distractors. The intensity of the response to the popout correlated inversely with the monkeys' ability to ignore it. We suggest that this modulation corresponds to a top-down mechanism that the brain uses to adjust the parietal representation of salience.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Ipata, AE (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	ai2019@columbia.edu		Bisley, James/0000-0002-2841-0306	NATIONAL EYE INSTITUTE [R21EY017938, R24EY015634, R01EY014978, P30EY019007] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY015634, R24 EY015634-01, R24 EY015634-03, R01 EY014978-01, R21 EY017938-02, R21 EY017938-01, R24 EY015634-02, R01 EY014978-04, R21 EY017938, R01 EY014978, R01 EY014978-05, R24 EY015634-04, P30 EY019007] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Bichot NP, 2001, NEUROPSYCHOLOGIA, V39, P972, DOI 10.1016/S0028-3932(01)00022-7; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Irwin DE, 2000, VISION RES, V40, P1443, DOI 10.1016/S0042-6989(00)00030-4; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim MS, 1999, PERCEPT PSYCHOPHYS, V61, P1009, DOI 10.3758/BF03207609; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Lamy D, 2004, J EXP PSYCHOL HUMAN, V30, P1019, DOI 10.1037/0096-1523.30.6.1019; Lamy D, 2003, PSYCHON B REV, V10, P621, DOI 10.3758/BF03196524; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Pouget P, 2005, J NEUROPHYSIOL, V94, P2086, DOI 10.1152/jn.01097.2004; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Rauschenberger R, 2003, PSYCHON B REV, V10, P814, DOI 10.3758/BF03196545; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; Theeuwes J, 2004, PSYCHON B REV, V11, P551, DOI 10.3758/BF03196609; Theeuwes J, 1998, J EXP PSYCHOL HUMAN, V24, P1342, DOI 10.1037/0096-1523.24.5.1342; Theeuwes J, 2003, PERCEPT PSYCHOPHYS, V65, P735, DOI 10.3758/BF03194810; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wilson DR, 1997, J ARTIF INTELL RES, V6, P1, DOI 10.1613/jair.346; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95	49	112	113	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1071	1076		10.1038/nn1734	http://dx.doi.org/10.1038/nn1734			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819520	Green Accepted			2022-12-28	WOS:000240080300021
J	Yasuda, R; Harvey, CD; Zhong, HN; Sobczyk, A; van Aelst, L; Svoboda, K				Yasuda, R; Harvey, CD; Zhong, HN; Sobczyk, A; van Aelst, L; Svoboda, K			Supersensitive Ras activation in dendrites and spines revealed by two-photon fluorescence lifetime imaging	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNELS; BINDING DOMAIN; ACTION-POTENTIALS; GROWTH-FACTOR; PROTEIN; FRET; LOCALIZATION; DEPENDENCE; EXCHANGE; VARIANT	To understand the biochemical signals regulated by neural activity, it is necessary to measure protein-protein interactions and enzymatic activity in neuronal microcompartments such as axons, dendrites and their spines. We combined two-photon excitation laser scanning with fluorescence lifetime imaging to measure fluorescence resonance energy transfer at high resolutions in brain slices. We also developed sensitive fluorescent protein-based sensors for the activation of the small GTPase protein Ras with slow ( FRas) and fast ( FRas-F) kinetics. Using FRas-F, we found in CA1 hippocampal neurons that trains of back-propagating action potentials rapidly and reversibly activated Ras in dendrites and spines. The relationship between firing rate and Ras activation was highly nonlinear ( Hill coefficient similar to 5). This steep dependence was caused by a highly cooperative interaction between calcium ions ( Ca2+) and Ras activators. The Ras pathway therefore functions as a supersensitive threshold detector for neural activity and Ca2+ concentration.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Zhong, Haining/0000-0002-7109-4724; Yasuda, Ryohei/0000-0001-6263-9297				Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Davis AJ, 1996, J BIOL CHEM, V271, P24333, DOI 10.1074/jbc.271.40.24333; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MCALLISTER AK, 2000, SCI STKE, pPL1; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; PISTON DW, 1992, TIME RESOLVED LASER, V3, P379; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; SHANER NC, 2004, NAT BIOTECHNOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	196	202	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					283	291		10.1038/nn1635	http://dx.doi.org/10.1038/nn1635			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429133				2022-12-28	WOS:000234990100025
J	Konen, CS; Kastner, S				Konen, Christina S.; Kastner, Sabine			Two hierarchically organized neural systems for object information in human visual cortex	NATURE NEUROSCIENCE			English	Article							LATERAL OCCIPITAL COMPLEX; POSTERIOR PARIETAL CORTEX; TOPOGRAPHIC MAPS; AREA V4; SHAPE; REPRESENTATION; ATTENTION; NEURONS; MONKEY; SPACE	The primate visual system is broadly organized into two segregated processing pathways, a ventral stream for object vision and a dorsal stream for space vision. Here, evidence from functional brain imaging in humans demonstrates that object representations are not confined to the ventral pathway, but can also be found in several areas along the dorsal pathway. In both streams, areas at intermediate processing stages in extrastriate cortex (V4, V3A, MT and V7) showed object-selective but viewpoint- and size-specific responses. In contrast, higher-order areas in lateral occipital and posterior parietal cortex (LOC, IPS1 and IPS2) responded selectively to objects independent of image transformations. Contrary to the two-pathways hypothesis, our findings indicate that basic object information related to shape, size and viewpoint may be represented similarly in two parallel and hierarchically organized neural systems in the ventral and dorsal visual pathways.	[Konen, Christina S.; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Konen, Christina S.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA; [Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA	Princeton University; Princeton University; Princeton University	Konen, CS (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08540 USA.	ckonen@princeton.edu		Kastner, Sabine/0000-0002-9742-965X	NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH064043] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017699] Funding Source: Medline; NIMH NIH HHS [R01 MH64043, P50 MH-62196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Huk AC, 2002, J NEUROSCI, V22, P7195; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata Hideo, 2003, Adv Neurol, V93, P121; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839	50	323	327	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					224	231		10.1038/nn2036	http://dx.doi.org/10.1038/nn2036			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193041				2022-12-28	WOS:000252712100017
J	Louis, M; Huber, T; Benton, R; Sakmar, TP; Vosshall, LB				Louis, Matthieu; Huber, Thomas; Benton, Richard; Sakmar, Thomas P.; Vosshall, Leslie B.			Bilateral olfactory sensory input enhances chemotaxis behavior	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; WORKING-MEMORY; DROSOPHILA; SMELL; LATERALIZATION; MECHANISMS; RECEPTORS; TRACKING; SYSTEM; CORTEX	Neural comparisons of bilateral sensory inputs are essential for visual depth perception and accurate localization of sounds in space. All animals, from single-cell prokaryotes to humans, orient themselves in response to environmental chemical stimuli, but the contribution of spatial integration of neural activity in olfaction remains unclear. We investigated this problem in Drosophila melanogaster larvae. Using high-resolution behavioral analysis, we studied the chemotaxis behavior of larvae with a single functional olfactory neuron on either the left or right side of the head, allowing us to examine unilateral or bilateral olfactory input. We developed new spectroscopic methods to create stable odorant gradients in which odor concentrations were experimentally measured. In these controlled environments, we observed that a single functional neuron provided sufficient information to permit larval chemotaxis. We found additional evidence that the overall accuracy of navigation is enhanced by the increase in the signal-to-noise ratio conferred by bilateral sensory input.	[Louis, Matthieu; Benton, Richard; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Huber, Thomas; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10065 USA.	leslie@rockefeller.edu	Louis, Matthieu/J-5566-2015; Sakmar, Thomas P/D-1833-2015; Huber, Thomas/A-8016-2008	Louis, Matthieu/0000-0002-2267-0262; Sakmar, Thomas P/0000-0002-2836-8953; Huber, Thomas/0000-0002-1844-262X; Vosshall, Leslie/0000-0002-6060-8099				Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BENHAMOU S, 1992, ANIM BEHAV, V43, P371, DOI 10.1016/S0003-3472(05)80097-1; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BERG HC, 2004, E COIL MOTION; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; COBB M, 1992, P ROY SOC B-BIOL SCI, V248, P103, DOI 10.1098/rspb.1992.0048; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fraenkel GS, 1961, ORIENTATION ANIMALS; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Samadani A, 2006, P NATL ACAD SCI USA, V103, P11549, DOI 10.1073/pnas.0601909103; Schrick K, 1997, GENETICS, V147, P19; THESEN A, 1993, J EXP BIOL, V180, P247; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VALLORTIGARA G, 1994, NEUROPSYCHOLOGIA, V32, P417, DOI 10.1016/0028-3932(94)90087-6; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Zar J.R., 1999, BIOSTAT ANAL; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	47	123	124	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					187	199		10.1038/nn2031	http://dx.doi.org/10.1038/nn2031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18157126				2022-12-28	WOS:000252712100013
J	Sahay, A; Hen, R				Sahay, Amar; Hen, Rene			Adult hippocampal neurogenesis in depression	NATURE NEUROSCIENCE			English	Review							GENERATED GRANULE CELLS; POSITRON-EMISSION-TOMOGRAPHY; ENHANCED SYNAPTIC PLASTICITY; DORSAL-VENTRAL AXIS; LONG-TERM-MEMORY; DENTATE GYRUS; MAJOR DEPRESSION; ENTORHINAL CORTEX; NEURONAL DIFFERENTIATION; PATTERN SEPARATION	The development of new treatments for depression is predicated upon identification of neural substrates and mechanisms that underlie its etiology and pathophysiology. The heterogeneity of depression indicates that its origin may lie in dysfunction of multiple brain regions. Here we evaluate adult hippocampal neurogenesis as a candidate mechanism for the etiology of depression and as a substrate for antidepressant action. Current evidence indicates that adult hippocampal neurogenesis may not be a major contributor to the development of depression, but may be required for some of the behavioral effects of antidepressants. We next revisit the functional differentiation of the hippocampus along the septo-temporal axis within the context of adult hippocampal neurogenesis and suggest that neurogenesis in the ventral dentate gyrus may be preferentially involved in regulation of emotion. Finally, we speculate on how increased adult hippocampal neurogenesis may modulate dentate gyrus function to confer the behavioral effects of antidepressants.	Columbia Univ, Div Integrat Neurosci, Dept Neurosci, New York, NY 10032 USA; Columbia Univ, Div Integrat Neurosci, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University	Sahay, A (corresponding author), Columbia Univ, Div Integrat Neurosci, Dept Neurosci, 1051 Riverside Dr,Box 87,Pl Annex,Room 767B, New York, NY 10032 USA.	as2619@columbia.edu; rh95@columbia.edu	Yan, Shuo/B-8381-2009; Sahay, Amar/J-3696-2014					Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; AIRAN RD, 2007, SCIENCE; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bjarkam CR, 2003, HIPPOCAMPUS, V13, P21, DOI 10.1002/hipo.10042; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; CARROLL BJ, 1968, BRIT MED J, V3, P285, DOI 10.1136/bmj.3.5613.285; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; CZEH B, 2007, EUR ARCH PSYCHIAT CL; David DJ, 2007, J PHARMACOL EXP THER, V321, P237, DOI 10.1124/jpet.106.109678; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; Duman Ronald S, 2002, CNS Spectr, V7, P140; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; DUMAN RS, 2002, CNS SPECTRUMS, V7, P144, DOI DOI 10.1017/S1092852900017454; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fujise N, 1998, NEUROSCIENCE, V82, P181; GAGE FH, 1980, BRAIN RES BULL, V5, P771, DOI 10.1016/0361-9230(80)90220-8; GARCIA AD, 2007, NAT NEUROSCI, V11, P70; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould NF, 2007, AM J PSYCHIAT, V164, P516, DOI 10.1176/appi.ajp.164.3.516; HERMAN JP, 1995, J NEUROENDOCRINOL, V7, P475, DOI 10.1111/j.1365-2826.1995.tb00784.x; HOLICK KA, 2007, NEUROPSYCHOPHARMACOL; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jinno S, 2003, J COMP NEUROL, V461, P333, DOI 10.1002/cne.10700; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Leonardo ED, 2006, NEUROSCIENCE, V137, P177, DOI 10.1016/j.neuroscience.2005.08.082; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 2003, NEUROIMAG CLIN N AM, V13, P805, DOI 10.1016/S1052-5149(03)00104-7; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Ngwenya LB, 2006, J COMP NEUROL, V498, P204, DOI 10.1002/cne.21045; O'Donnell P, 1998, NEUROSCIENCE, V87, P823, DOI 10.1016/S0306-4522(98)00190-0; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE, 2007, SCIENCE, V315, P336, DOI 10.1126/science.1138711; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; WILSON MA, 1991, NEUROSCIENCE, V44, P555, DOI 10.1016/0306-4522(91)90077-2; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	101	863	891	5	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1110	1115		10.1038/nn1969	http://dx.doi.org/10.1038/nn1969			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726477				2022-12-28	WOS:000249144000009
J	Muraguchi, T; Takegami, Y; Ohtsuka, T; Kitajima, S; Chandana, EPS; Omura, A; Miki, T; Takahashi, R; Matsumoto, N; Ludwig, A; Noda, M; Takahashi, C				Muraguchi, Teruyuki; Takegami, Yujiro; Ohtsuka, Toshiyuki; Kitajima, Shunsuke; Chandana, Ediriweera P. S.; Omura, Akira; Miki, Takao; Takahashi, Rei; Matsumoto, Naoya; Ludwig, Andreas; Noda, Makoto; Takahashi, Chiaki			RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE; ALPHA-SECRETASE; DOWN-REGULATION; NERVOUS-SYSTEM; KEY REGULATOR; STEM-CELLS; CLEAVAGE; GENES	We report that during cortical development in the mouse embryo, reversion-inducing cysteine-rich protein with Kazal motifs (RECK) critically regulates Notch signaling by antagonizing the ectodomain shedding of Notch ligands, which is mediated by a disintegrin and metalloproteinase domain 10 (ADAM10). In the embryonic brain, RECK is specifically expressed in Nest-inpositive neural precursor cells (NPCs). Reck-deficient NPCs undergo precocious differentiation that is associated with downregulated Nestin expression, impaired Notch signaling and defective self-renewal. These phenotypes were substantially rescued either by enhancing Notch signaling or by suppressing endogenous ADAM10 activity. Consequently, we found that RECK regulates the ectodomain shedding of Notch ligands by directly inhibiting the proteolytic activity of ADAM10. This mechanism appeared to be essential for Notch ligands to properly induce Notch signaling in neighboring cells. These findings indicate that RECK is a physiological inhibitor of ADAM10, an upstream regulator of Notch signaling and a critical modulator of brain development.	Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Kyoto 606, Japan; Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res IMCAR, D-52074 Aachen, Germany; Kanazawa Univ, Canc Res Inst, Ctr Canc & Stem Cell Res, Div Mol Genet, Kanazawa, Ishikawa 920, Japan	Kyoto University; Kyoto University; Kyoto University; RWTH Aachen University; RWTH Aachen University Hospital; Kanazawa University	Takahashi, C (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.	chtakaha@virus.kyoto-u.ac.jp	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986				Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Chang HC, 2007, CANCER SCI, V98, P169, DOI 10.1111/j.1349-7006.2006.00367.x; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; EHEBAUER M, 2006, SCI STKE; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; NYE JS, 1994, DEVELOPMENT, V120, P2421; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	50	119	121	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					838	845		10.1038/nn1922	http://dx.doi.org/10.1038/nn1922			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558399	Green Submitted			2022-12-28	WOS:000247560200013
J	Leung, CT; Coulombe, PA; Reed, RR				Leung, Cheuk T.; Coulombe, Pierre A.; Reed, Randall R.			Contribution of olfactory neural stem cells to tissue maintenance and regeneration	NATURE NEUROSCIENCE			English	Article							GLOBOSE BASAL-CELLS; ADULT MAMMALIAN BRAIN; PROGENITOR CELLS; SUBVENTRICULAR ZONE; IN-VITRO; EPITHELIUM; LINEAGE; NEUROGENESIS; EXPRESSION; EPIDERMIS	The olfactory neuroepithelium undergoes continual neurogenesis and, after extensive lesions, fully regenerates to maintain sensory function. The stem cell population underlying this regenerative capacity remains elusive. Here we show that mouse horizontal basal cells (HBCs) function as adult olfactory neuroepithelium neural stem cells and examine their distinct dynamics in olfactory neuroepithelium maintenance and regeneration. Fate-mapping analysis after olfactory neuroepithelium lesioning shows that HBCs are competent to regenerate both neuronal and non-neuronal olfactory neuroepithelium lineages. HBCs serve as a reservoir of long-lived progenitors that remain largely quiescent during normal neuronal turnover or even after acute, selective loss of mature neurons. Under these conditions, previously identified progenitors are largely responsible for tissue maintenance. Yet after extensive injuries that deplete resident neuronal precursors, HBCs transiently proliferate and their progeny fully reconstitute the neuroepithelium. Our data support a new model of adult neurogenesis in which distinct cell populations mediate normal neuronal turnover and neuronal replacement upon traumatic injury.	Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, 725 N Wolfe St,PCTB 801, Baltimore, MD 21205 USA.	rreed@jhmi.edu		Leung, Cheuk/0000-0002-5838-5535				Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Bergman U, 2002, ARCH TOXICOL, V76, P104, DOI 10.1007/s00204-002-0321-2; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Huard JMT, 1998, J COMP NEUROL, V400, P469; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jang WC, 2003, J COMP NEUROL, V460, P123, DOI 10.1002/cne.10642; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mitchell BD, 2004, DEV NEUROSCI-BASEL, V26, P101, DOI 10.1159/000082131; Miyawaki A, 1996, EMBO J, V15, P2050, DOI 10.1002/j.1460-2075.1996.tb00558.x; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; SCHWOB JE, 1994, CHEM SENSES, V19, P671, DOI 10.1093/chemse/19.6.671; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sicard G, 1998, ANN NY ACAD SCI, V855, P223, DOI 10.1111/j.1749-6632.1998.tb10570.x; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8	38	306	320	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					720	726		10.1038/nn1882	http://dx.doi.org/10.1038/nn1882			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468753				2022-12-28	WOS:000246799800014
J	Groemer, TW; Klingauf, J				Groemer, Teja W.; Klingauf, Jurgen			Synaptic vesicles recycling spontaneously and during activity belong to the same vesicle pool	NATURE NEUROSCIENCE			English	Article							RELEASE; NEUROTRANSMISSION; NEURONS; EVENTS; CA2+	Recently, it has been claimed that vesicles recycling spontaneously and during activity belong to different pools. Here we simultaneously measured, using spectrally separable styryl dyes, the release kinetics of vesicles recycled spontaneously or upon stimulation and the effects of the v-ATPase blocker folimycin on the frequency of miniature postsynaptic currents in rat hippocampal neurons. Our results provide evidence as to the identities of the vesicle pools recycling at rest and during stimulation.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.	J.Klingauf@mpi-bpc.mpg.de		Groemer, Teja/0000-0003-3854-716X				Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Prange O, 1999, J NEUROSCI, V19, P6427; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; VANDENBERGHE P, 2006, J PHYSL; Virmani T, 2005, J NEUROSCI, V25, P10922, DOI 10.1523/JNEUROSCI.3766-05.2005; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	15	107	107	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					145	147		10.1038/nn1831	http://dx.doi.org/10.1038/nn1831			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220885	Green Published			2022-12-28	WOS:000244175200006
J	Kirby, BB; Takada, N; Latimer, AJ; Shin, J; Carney, TJ; Kelsh, RN; Appel, B				Kirby, Brandon B.; Takada, Norio; Latimer, Andrew J.; Shin, Jimann; Carney, Thomas J.; Kelsh, Robert N.; Appel, Bruce			In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS LESIONS; PRECURSOR CELL-MIGRATION; CENTRAL-NERVOUS-SYSTEM; DORSAL SPINAL-CORD; GROWTH-FACTOR; PREMYELINATING OLIGODENDROCYTES; DIFFERENTIATION; NETRIN-1; PROLIFERATION; ASTROCYTES	Myelinating oligodendrocytes arise from migratory and proliferative oligodendrocyte progenitor cells (OPCs). Complete myelination requires that oligodendrocytes be uniformly distributed and form numerous, periodically spaced membrane sheaths along the entire length of target axons. Mechanisms that determine spacing of oligodendrocytes and their myelinating processes are not known. Using in vivo time-lapse confocal microscopy, we show that zebrafish OPCs continuously extend and retract numerous filopodium-like processes as they migrate and settle into their final positions. Process remodeling and migration paths are highly variable and seem to be influenced by contact with neighboring OPCs. After laser ablation of oligodendrocyte-lineage cells, nearby OPCs divide more frequently, orient processes toward the ablated cells and migrate to fill the unoccupied space. Thus, process activity before axon wrapping might serve as a surveillance mechanism by which OPCs determine the presence or absence of nearby oligodendrocyte-lineage cells, facilitating uniform spacing of oligodendrocytes and complete myelination.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Vanderbilt University; University of Bath	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, 465 21st Ave S, Nashville, TN 37232 USA.	b.appel@vanderbilt.edu	Messier, Claude/A-2322-2008; Kelsh, Robert/B-6445-2008; Carney, Tom J/H-4389-2011; Appel, Bruce/X-6418-2019	Messier, Claude/0000-0002-4791-1763; Kelsh, Robert/0000-0002-9381-0066; Carney, Tom J/0000-0003-2371-1924; Appel, Bruce/0000-0003-4500-0672	NINDS NIH HHS [NS046668, R01 NS046668] Funding Source: Medline; CSR NIH HHS [RG 3420] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fox MA, 2006, GLIA, V53, P563, DOI 10.1002/glia.20293; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Hardy RJ, 1996, DEV NEUROSCI-BASEL, V18, P243, DOI 10.1159/000111414; Jarjour AA, 2003, J NEUROSCI, V23, P3735; KACHAR B, 1986, CELL TISSUE RES, V244, P27; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Milner R, 1997, GLIA, V21, P350; Milner R, 1996, J NEUROSCI, V16, P7240; MILNER R, 1994, DEVELOPMENT, V120, P3497; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Pfeifer T, 1997, MICROSYST TECHNOL, V3, P191, DOI 10.1007/s005420050079; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Schmidt C, 1997, GLIA, V20, P284; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Simpson PB, 1999, GLIA, V26, P22, DOI 10.1002/(SICI)1098-1136(199903)26:1<22::AID-GLIA3>3.0.CO;2-M; Sugimoto Y, 2001, DEVELOPMENT, V128, P3321; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827; Zhang H, 1996, J NEUROSCI, V16, P6886	50	285	287	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1506	1511		10.1038/nn1803	http://dx.doi.org/10.1038/nn1803			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099706				2022-12-28	WOS:000242404000014
J	Amitay, S; Irwin, A; Moore, DR				Amitay, Sygal; Irwin, Amy; Moore, David R.			Discrimination learning induced by training with identical stimuli	NATURE NEUROSCIENCE			English	Article							AUDITORY FREQUENCY DISCRIMINATION; ADAPTIVE PROCEDURES; TASK-DIFFICULTY; SPECIFICITY; CORTEX; PLASTICITY; PERCEPTION; MODULATION; CHILDREN	Sensory stimuli become easier to detect or distinguish with practice. It is generally assumed that the task-relevant stimulus dimension becomes increasingly more salient as a result of attentively performing the task at a level that is neither too easy nor too difficult. However, here we show improved auditory frequency discrimination following training with physically identical tones that were impossible to discriminate. We also show that learning transfers across tone frequencies and across modalities: training on a silent visuospatial computer game improved thresholds on the auditory discrimination task. We suggest that three processes are necessary for optimal perceptual learning: sensitization through exposure to the stimulus, modality- and dimension-specific attention, and general arousal.	UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 1EH, England; MTC Inst Hearing Res, Nottingham NG7 2RD, England	University of London; University College London	Amitay, S (corresponding author), UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, 30 Guilford St, London WC1N 1EH, England.	s.amitay@ich.ucl.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435	MRC [MC_U135079241] Funding Source: UKRI; Medical Research Council [MC_U135079241] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; [Anonymous], 1981, Br J Audiol, V15, P213; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Fahle M, 1997, VISION RES, V37, P1885, DOI 10.1016/S0042-6989(96)00308-2; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; GREEN DM, 1993, J ACOUST SOC AM, V93, P2096, DOI 10.1121/1.406696; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; TRAHIOTIS C, 1990, J ACOUST SOC AM, V87, P1359, DOI 10.1121/1.399513; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Wright BA, 1997, J NEUROSCI, V17, P3956; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498	27	126	133	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1446	1448		10.1038/nn1787	http://dx.doi.org/10.1038/nn1787			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028582				2022-12-28	WOS:000242403800024
J	Chen, YZ; Geisler, WS; Seidemann, E				Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal			Optimal decoding of correlated neural population responses in the primate visual cortex	NATURE NEUROSCIENCE			English	Article							VOLTAGE-SENSITIVE DYES; STRIATE CORTEX; CORTICAL DYNAMICS; FUNCTIONAL ARCHITECTURE; BEHAVING MONKEYS; SINGLE NEURONS; AREA MT; MACAQUE; DISCRIMINATION; ORGANIZATION	Even the simplest environmental stimuli elicit responses in large populations of neurons in early sensory cortical areas. How these distributed responses are read out by subsequent processing stages to mediate behavior remains unknown. Here we used voltage-sensitive dye imaging to measure directly population responses in the primary visual cortex ( V1) of monkeys performing a demanding visual detection task. We then evaluated the ability of different decoding rules to detect the target from the measured neural responses. We found that small visual targets elicit widespread responses in V1, and that response variability at distant sites is highly correlated. These correlations render most previously proposed decoding rules inefficient relative to one that uses spatially antagonistic center-surround summation. This optimal decoder consistently outperformed the monkey in the detection task, demonstrating the sensitivity of our techniques. Overall, our results suggest an unexpected role for inhibitory mechanisms in efficient decoding of neural population responses.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Ctr Preceptual Syst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Seidemann, E (corresponding author), Univ Texas, Dept Psychol, 1 Univ Stn,A8000, Austin, TX 78712 USA.	eyal@mail.cps.utexas.edu		Seidemann, Eyal/0000-0003-2841-5948; Geisler, Wilson/0000-0003-4630-6614	NATIONAL EYE INSTITUTE [R01EY016454, R01EY016752] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016454, R01 EY016752, R01 EY016752-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW HB, 1995, COGNITIVE NEUROSCIEN, P401; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; DeValois RL, 1988, SPATIAL VISION; Duda R. O., 2001, PATTERN CLASSIFICATI; Efron B., 1994, MONOGRAPHS STAT APPL; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GREEN DM, 1966, SIGNAL DETECTION THE; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Lee D, 1998, J NEUROSCI, V18, P1161; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; MCLLWAIN JT, 1986, TRENDS NEUROSCI, V9, P354, DOI DOI 10.1016/0166-2236(86)90113-X); MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; SNIPPE HP, 1992, BIOL CYBERN, V67, P183, DOI 10.1007/BF00201025; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; SPARKS DL, 1990, COLD SH Q B, V55, P805; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; WOOLSEY CN, 1952, BIOL MENTAL HLTH DIS; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	149	150	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1412	1420		10.1038/nn1792	http://dx.doi.org/10.1038/nn1792			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057706	Green Accepted			2022-12-28	WOS:000242403800019
J	Ozdinler, PH; Macklis, JD				Ozdinler, P. Hande; Macklis, Jeffrey D.			IGF-I specifically enhances axon outgrowth of corticospinal motor neurons	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; RETINAL GANGLION-CELLS; NEUROTROPHIC FACTOR; PROJECTION NEURONS; SURVIVAL; EXPRESSION; ALS; PROMOTE; GENES; NEUROGENESIS	Corticospinal motor neurons ( CSMN) are among the most complex CNS neurons; they control voluntary motor function and are prototypical projection neurons. In amyotrophic lateral sclerosis ( ALS), both spinal motor neurons and CSMN degenerate; their damage contributes centrally to the loss of motor function in spinal cord injury. Direct investigation of CSMN is severely limited by inaccessibility in the heterogeneous cortex. Here, using new CSMN purification and culture approaches, and in vivo analyses, we report that insulin-like growth factor-1 ( IGF-I) specifically enhances the extent and rate of murine CSMN axon outgrowth, mediated via the IGF-I receptor and downstream signaling pathways; this is distinct from IGF-I support of neuronal survival. In contrast, brain-derived neurotrophic factor ( BDNF) enhances branching and arborization, but not axon outgrowth. These experiments define specific controls over directed differentiation of CSMN, indicate a distinct role of IGF-I in CSMN axon outgrowth during development, and might enable control over CSMN derived from neural precursors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Neurosci, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	jeffrey_macklis@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045523, R01NS049553, R37NS041590, R01NS041590] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41590, NS45523, NS49553] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Catapano LA, 2004, EUR J NEUROSCI, V19, P2421, DOI 10.1111/j.0953-816X.2004.03303.x; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Giehl KM, 2001, REV NEUROSCIENCE, V12, P79; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Goldberg JL, 1998, CURR BIOL, V8, pR310, DOI 10.1016/S0960-9822(98)70195-2; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Junger H, 1997, BRAIN RES, V762, P56, DOI 10.1016/S0006-8993(97)00347-8; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; LI SL, 1993, BIOCHEM BIOPH RES CO, V196, P92, DOI 10.1006/bbrc.1993.2220; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lotz B, 1996, NEUROLOGY, V46, P1244; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Rosler KM, 2000, CLIN NEUROPHYSIOL, V111, P2208, DOI 10.1016/S1388-2457(00)00481-8; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Winhammar JMC, 2005, LANCET NEUROL, V4, P229, DOI 10.1016/S1474-4422(05)70042-9	50	237	245	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1371	1381		10.1038/nn1789	http://dx.doi.org/10.1038/nn1789			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057708				2022-12-28	WOS:000242403800014
J	Chhatwal, JP; Stanek-Rattiner, L; Davis, M; Ressler, KJ				Chhatwal, Jasmeer P.; Stanek-Rattiner, Lisa; Davis, Michael; Ressler, Kerry J.			Amygdala BDNF signaling is required for consolidation but not encoding of extinction	NATURE NEUROSCIENCE			English	Article							FEAR-POTENTIATED STARTLE; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; TYROSINE KINASE; D-CYCLOSERINE; FACILITATION; MEMORY; TRKB	Brain-derived neurotrophic factor ( BDNF) acting through the tyrosine kinase B receptor ( TrkB) is thought to be a critical mediator of learning. As there are no available selective antagonists of TrkB, we used a lentivirus encoding a dominant-negative TrkB ( TrkB.t1) to antagonize BDNF signaling during extinction of conditioned fear. Whereas TrkB. t1-infected rats showed normal within-session extinction, their retention of extinction was impaired, suggesting that amygdala TrkB activation is required for the consolidation of stable extinction memories.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Yerkes Res Ctr, Ctr Behav Neurosci, Atlanta, GA 30329 USA	Emory University	Ressler, KJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH070218, R37MH047840, R01MH047840, K01MH069884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000165-460189, P51RR000165, P51 RR000165, P51 RR000165-450216, P51 RR000165-457288] Funding Source: Medline; NIDA NIH HHS [R01 DA019624-01A2, R01 DA019624] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NIMH NIH HHS [F30 MH070218, K01 MH069884, MH070218, MH47840, MH069884, K01 MH069884-02, K01 MH069884-01, R01 MH047840, R37 MH047840, K01 MH069884-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cain CK, 2002, J NEUROSCI, V22, P9113; Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8; FALLS WA, 1992, J NEUROSCI, V12, P854; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Schroeder JP, 2004, LEARN MEMORY, V11, P641, DOI 10.1101/lm.78504; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002	15	188	193	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					870	872		10.1038/nn1718	http://dx.doi.org/10.1038/nn1718			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783370	Green Accepted			2022-12-28	WOS:000238590800009
J	Sandoval, GM; Duerr, JS; Hodgkin, J; Rand, JB; Ruvkun, G				Sandoval, GM; Duerr, JS; Hodgkin, J; Rand, JB; Ruvkun, G			A genetic interaction between the vesicular acetylcholine transporter VAChT/UNC-17 and synaptobrevin/SNB-1 in C. elegans	NATURE NEUROSCIENCE			English	Article							SYNTAXIN; MUTANTS	Acetylcholine, a major excitatory neurotransmitter in Caenorhabditis elegans, is transported into synaptic vesicles by the vesicular acetylcholine transporter encoded by unc-17. The abnormal behavior of unc-17(e245) mutants, which have a glycine-to-arginine substitution in a transmembrane domain, is markedly improved by a mutant synaptobrevin with an isoleucine-to-aspartate substitution in its transmembrane domain. These results suggest an association of vesicular soluble N-ethylmaleimide-sensitive-factor attachment protein receptor (SNARE) components with vesicular neurotransmitter transporters.	Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England; Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, Oklahoma City, OK 73104 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Biol Mol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; University System of Ohio; Ohio University; University of Oxford; Oklahoma Medical Research Foundation; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ruvkun, G (corresponding author), Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA.	ruvkun@molbio.mgh.harvard.edu			MRC [G0000114] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038679, R01GM059642] Funding Source: NIH RePORTER; Medical Research Council [G0000114] Funding Source: Medline; NIGMS NIH HHS [R01 GM059642-11, R01 GM038679-18, R01 GM038679, R01 GM059642] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Nonet ML, 1998, J NEUROSCI, V18, P70; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0	8	25	30	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					599	601		10.1038/nn1685	http://dx.doi.org/10.1038/nn1685			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16604067				2022-12-28	WOS:000237417200007
J	Xiao, T; Baier, H				Xiao, Tong; Baier, Herwig			Lamina-specific axonal projections in the zebrafish tectum require the type IV collagen dragnet	NATURE NEUROSCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; RECEPTOR TYROSINE KINASES; CELL-ADHESION MOLECULE; CHICK OPTIC TECTUM; RETINOTECTAL SYSTEM; ALPORT-SYNDROME; CADHERIN EXPRESSION; BASEMENT-MEMBRANE; NERVOUS-SYSTEM; VISUAL-SYSTEM	The mechanisms underlying the precise targeting of tectal layers by ingrowing retinal axons are largely unknown. In zebrafish, individual axons choose one of four retinorecipient layers upon entering the tectum and remain restricted to this layer, despite continual remodeling and shifting of their terminal arbors. In dragnet mutants, by contrast, a large fraction of retinal axons aberrantly trespass between layers or form terminal arbors that span two layers. The dragnet gene, drg, encodes collagen IV alpha 5 (Col4a5), a basement membrane component lining the surface of the tectum. Heparan sulfate proteoglycans (HSPGs) are normally associated with the tectal basement membrane but are dispersed in the dragnet mutant tectum. Zebrafish boxer (extl3) mutants, which are deficient in HSPG synthesis, show laminar targeting defects similar to those in dragnet. Our results show that the collagen IV sheet anchors secreted factors at the surface of the tectum, which serve as guidance cues for retinal axons.	Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Program Neurosci, 1550 Fourth St, San Francisco, CA 94158 USA.	herwig.baier@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY012406, R01-EY013855] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BARTSCH S, 1995, EUR J NEUROSCI, V7, P907, DOI 10.1111/j.1460-9568.1995.tb01078.x; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Easter SS, 2002, RES PRO CEL, V40, P346; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; FROST DO, 1986, DEV BRAIN RES, V28, P109, DOI 10.1016/0165-3806(86)90070-2; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Halfter W, 1998, J COMP NEUROL, V397, P105, DOI 10.1002/(SICI)1096-9861(19980720)397:1<105::AID-CNE8>3.0.CO;2-4; Halfter W, 2002, J NEUROSCI, V22, P6029; Halfter W, 2001, DEV BIOL, V238, P79, DOI 10.1006/dbio.2001.0396; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; KAWAKAMI H, 1990, NEPHRON, V56, P214, DOI 10.1159/000186136; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Liu Q, 1999, J COMP NEUROL, V410, P303, DOI 10.1002/(SICI)1096-9861(19990726)410:2<303::AID-CNE11>3.0.CO;2-B; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nakamura H, 2004, J NEUROBIOL, V59, P48, DOI 10.1002/neu.10339; PEREZ RG, 1993, DEV BIOL, V156, P278, DOI 10.1006/dbio.1993.1076; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Sener RN, 1998, COMPUT MED IMAG GRAP, V22, P71, DOI 10.1016/S0895-6111(97)00039-6; SHIELDS GW, 1990, SCHIZOPHR RES, V3, P235, DOI 10.1016/0920-9964(90)90003-P; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Stier H, 1998, EUR J NEUROSCI, V10, P1000, DOI 10.1046/j.1460-9568.1998.00110.x; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001	49	90	91	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1529	1537		10.1038/nn2002	http://dx.doi.org/10.1038/nn2002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982451				2022-12-28	WOS:000251172900009
J	Midorikawa, M; Tsukamoto, Y; Berglund, K; Ishii, M; Tachibana, M				Midorikawa, Mitsuharu; Tsukamoto, Yoshihiko; Berglund, Ken; Ishii, Masaaki; Tachibana, Masao			Different roles of ribbon-associated and ribbon-free active zones in retinal bipolar cells	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SYNAPTIC RIBBONS; TRANSMITTER RELEASE; CALCIUM CURRENT; VESICLE POOLS; EXOCYTOSIS; MODULATION; MEMBRANE; BASSOON; GABA	Synaptic ribbons with a halo of synaptic vesicles are seen at the active zones of sensory neurons that release transmitter tonically. Thus, ribbons are assumed to be a prerequisite for sustained exocytosis. By applying total internal reflection fluorescence microscopy to goldfish retinal bipolar cell terminals, we visualized Ca2+ entry sites, ribbons, and vesicle fusion events. Here we show that the main Ca2+ entry sites were located at ribbons, and that activation of the Ca2+ current induced immediate and delayed vesicle fusion events at ribbon- associated and ribbon-free 'hot spots', respectively. The activation of protein kinase C (PKC) specifically potentiated vesicle fusion at ribbon- free sites. Electron microscopy showed that PKC activation selectively increased the number of docked vesicles at ribbon- free sites, which faced neuronal processes with the postsynaptic density. Retinal bipolar cells have both ribbon- associated and ribbon- free active zones in their terminals and might send functionally distinct signals through ribbon-associated and ribbon-free synapses to postsynaptic neurons.	Hyogo Coll Med, Dept Biol, Nishinomiya, Hyogo 6638501, Japan; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Tokyo, Grad Sch Humanities & Sociol, Dept Psychol, Bunkyo Ku, Tokyo 1130033, Japan	Hyogo College of Medicine; Duke University; University of Tokyo	Tachibana, M (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Almers Lab, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	Itmasao@l.u-tokyo.ac.jp	Midorikawa, Mitsuharu/GSD-2712-2022	Ishii, Masaaki/0000-0002-0775-5401				ALLEN MB, 1969, ANNU REV MICROBIOL, V23, P29, DOI 10.1146/annurev.mi.23.100169.000333; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Berglund K, 2002, J NEUROSCI, V22, P4776, DOI 10.1523/JNEUROSCI.22-12-04776.2002; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Diggle P.J., 2003, STAT ANAL SPATIAL PO; Dowling J. E., 1987, RETINA APPROACHABLE; FEIGENSPAN A, 1994, J PHYSIOL-LONDON, V481, P325, DOI 10.1113/jphysiol.1994.sp020442; Gillette MA, 1996, J NEUROPHYSIOL, V76, P3070, DOI 10.1152/jn.1996.76.5.3070; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Job C, 1998, J CELL BIOL, V143, P1661, DOI 10.1083/jcb.143.6.1661; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; Llobet A, 2003, J NEUROSCI, V23, P2706; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OSBORNE NN, 1994, BRAIN RES, V637, P156, DOI 10.1016/0006-8993(94)91228-9; RAVIOLA E, 1982, J COMP NEUROL, V209, P233, DOI 10.1002/cne.902090303; ROBERTS WM, 1991, ANN NY ACAD SCI, V635, P221, DOI 10.1111/j.1749-6632.1991.tb36494.x; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; SUZUKI S, 1990, VISUAL NEUROSCI, V5, P223, DOI 10.1017/S0952523800000298; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	39	63	63	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1268	1276		10.1038/nn1963	http://dx.doi.org/10.1038/nn1963			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828257				2022-12-28	WOS:000249720800013
J	Behrens, TEJ; Woolrich, MW; Walton, ME; Rushworth, MFS				Behrens, Timothy E. J.; Woolrich, Mark W.; Walton, Mark E.; Rushworth, Matthew F. S.			Learning the value of information in an uncertain world	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINE NEURONS; REWARD; PERFORMANCE; HUMANS; NEUROMODULATION; REPRESENTATION; PREDICTION	Our decisions are guided by outcomes that are associated with decisions made in the past. However, the amount of influence each past outcome has on our next decision remains unclear. To ensure optimal decision-making, the weight given to decision outcomes should reflect their salience in predicting future outcomes, and this salience should be modulated by the volatility of the reward environment. We show that human subjects assess volatility in an optimal manner and adjust decision-making accordingly. This optimal estimate of volatility is reflected in the fMRI signal in the anterior cingulate cortex ( ACC) when each trial outcome is observed. When a new piece of information is witnessed, activity levels reflect its salience for predicting future outcomes. Furthermore, variations in this ACC signal across the population predict variations in subject learning rates. Our results provide a formal account of how we weigh our different experiences in guiding our future actions.	Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Behrens, TEJ (corresponding author), Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England.	behrens@fmrib.ox.ac.uk		Woolrich, Mark/0000-0001-8460-8854; Behrens, Timothy/0000-0003-0048-1177; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0600994, G0501316] Funding Source: UKRI; Medical Research Council [G0501316, G0600994] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Gallistel CR, 2001, J EXP PSYCHOL ANIM B, V27, P354, DOI 10.1037//0097-7403.27.4.354; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kahneman D, 2000, CHOICES VALUES FRAME; Kakade S, 2002, PSYCHOL REV, V109, P533, DOI 10.1037//0033-295X.109.3.533; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Strick PL, 1998, NOVART FDN SYMP, V218, P64; STRICK PL, 1998, NOVART FDN SYMP, V218, P75; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	51	1116	1120	9	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1214	1221		10.1038/nn1954	http://dx.doi.org/10.1038/nn1954			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676057				2022-12-28	WOS:000249144000025
J	Golarai, G; Ghahremani, DG; Whitfield-Gabrieli, S; Reiss, A; Eberhardt, JL; Gabrieli, JDE; Grill-Spector, K				Golarai, Golijeh; Ghahremani, Dara G.; Whitfield-Gabrieli, S.; Reiss, Allan; Eberhardt, Jennifer L.; Gabrieli, John D. E.; Grill-Spector, Kalanit			Differential development of high-level visual cortex correlates with category-specific recognition memory	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; OBJECT-PROCESSING STAGES; OTHER-RACE FACES; BRAIN ACTIVITY; PERCEPTION; FMRI; ACTIVATION; EXPERTISE; CHILDREN	High-level visual cortex in humans includes functionally defined regions that preferentially respond to objects, faces and places. It is unknown how these regions develop and whether their development relates to recognition memory. We used functional magnetic resonance imaging to examine the development of several functionally defined regions including object ( lateral occipital complex, LOC)-, face ('fusiform face area', FFA; superior temporal sulcus, STS)- and place ('parahippocampal place area', PPA)-selective cortices in children (ages 7 - 11), adolescents (12 - 16) and adults. Right FFA and left PPA volumes were substantially larger in adults than in children. This development occurred by expansion of FFA and PPA into surrounding cortex and was correlated with improved recognition memory for faces and places, respectively. In contrast, LOC and STS volumes and object-recognition memory remained constant across ages. Thus, the ventral stream undergoes a prolonged maturation that varies temporally across functional regions, is determined by brain region rather than stimulus category, and is correlated with the development of category-specific recognition memory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Los Angeles; Harvard University; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University	Golarai, G (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall Bldg 420, Stanford, CA 94305 USA.	ggolarai@psych.stanford.edu	Gabrieli, John/AAJ-2869-2020	Grill-Spector, Kalanit/0000-0002-5404-9606	NEI NIH HHS [R21 EY017741, 1R21EY017741] Funding Source: Medline; NIDA NIH HHS [R21 DA015893, 5R21DA15893] Funding Source: Medline; NIMH NIH HHS [T32 MH19908, 1R21MH66747, R21 MH066747, T32 MH019908] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY017741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066747, T32MH019908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015893] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Aylward EH, 2005, J COGNITIVE NEUROSCI, V17, P308, DOI 10.1162/0898929053124884; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Conner IP, 2004, J VISION, V4, P509, DOI 10.1167/4.6.10; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duvernoy HM, 1999, HUMAN BRAIN; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2006, NEUROPSYCHOLOGIA, V44, P1145, DOI 10.1016/j.neuropsychologia.2005.10.009; Gathers AD, 2004, NEUROREPORT, V15, P1549, DOI 10.1097/01.wnr.0000133299.84901.86; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; GOREN CC, 1975, PEDIATRICS, V56, P544; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P454, DOI 10.1006/nimg.2001.0979; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	50	345	350	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					512	522		10.1038/nn1865	http://dx.doi.org/10.1038/nn1865			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17351637	Green Accepted			2022-12-28	WOS:000245228600023
J	Yoo, SS; Hu, PT; Gujar, N; Jolesz, FA; Walker, MP				Yoo, Seung-Schik; Hu, Peter T.; Gujar, Ninad; Jolesz, Ferenc A.; Walker, Matthew P.			A deficit in the ability to form new human memories without sleep	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; DECLARATIVE MEMORY; EPISODIC MEMORY; WORKING-MEMORY; BRAIN ACTIVITY; DEPRIVATION; HIPPOCAMPUS; CONSOLIDATION; ORGANIZATION; RECOGNITION	Evidence indicates that sleep after learning is critical for the subsequent consolidation of human memory. Whether sleep before learning is equally essential for the initial formation of new memories, however, remains an open question. We report that a single night of sleep deprivation produces a significant deficit in hippocampal activity during episodic memory encoding, resulting in worse subsequent retention. Furthermore, these hippocampal impairments instantiate a different pattern of functional connectivity in basic alertness networks of the brainstem and thalamus. We also find that unique prefrontal regions predict the success of encoding for sleep-deprived individuals relative to those who have slept normally. These results demonstrate that an absence of prior sleep substantially compromises the neural and behavioral capacity for committing new experiences to memory. It therefore appears that sleep before learning is critical in preparing the human brain for next-day memory formation-a worrying finding considering society's increasing erosion of sleep time.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Sleep & Neuroimaging Lab,Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Walker, MP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Sleep & Neuroimaging Lab,Dept Psychiat, FD Feldberg 862, Boston, MA 02115 USA.	mwalker@hms.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH069935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048242] Funding Source: NIH RePORTER; NCRR NIH HHS [RR19703] Funding Source: Medline; NIMH NIH HHS [MH69935] Funding Source: Medline; NINDS NIH HHS [NS48242] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Davis CJ, 2003, BRAIN RES, V973, P293, DOI 10.1016/S0006-8993(03)02508-3; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2004, SLEEP MED REV, V8, P227, DOI 10.1016/j.smrv.2003.10.005; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gruart-Masso Agnes, 1995, Behavioural Brain Research, V72, P181, DOI 10.1016/0166-4328(96)00082-4; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Henson RNA, 1999, J NEUROSCI, V19, P3962; HICKS RA, 1973, PSYCHOL REP, V32, P1242, DOI 10.2466/pr0.1973.32.3c.1242; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Macmillan N. A., 1991, DETECTION THEORY USE; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDermott CM, 2003, J NEUROSCI, V23, P9687; MCGRATH MJ, 1978, PSYCHOL BULL, V85, P24, DOI 10.1037/0033-2909.85.1.24; MORUZZI G, 1995, J NEUROPSYCH CLIN N, V7, P251; Nissen C, 2006, SLEEP, V29, P1068, DOI 10.1093/sleep/29.8.1068; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; PLUMER SI, 1974, PHYSIOL BEHAV, V12, P285, DOI 10.1016/0031-9384(74)90184-X; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sei H, 2000, BRAIN RES, V877, P387, DOI 10.1016/S0006-8993(00)02708-6; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; STERN WC, 1971, PHYSIOL BEHAV, V7, P345, DOI 10.1016/0031-9384(71)90312-X; VANHULZEN ZJM, 1982, PHYSIOL BEHAV, V29, P581, DOI 10.1016/0031-9384(82)90223-2; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	49	372	382	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					385	392		10.1038/nn1851	http://dx.doi.org/10.1038/nn1851			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	140CM	17293859				2022-12-28	WOS:000244480300022
J	Futai, K; Kim, MJ; Hashikawa, T; Scheiffele, P; Sheng, M; Hayashi, Y				Futai, Kensuke; Kim, Myung Jong; Hashikawa, Tsutomu; Scheiffele, Peter; Sheng, Morgan; Hayashi, Yasunori			Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA3 PYRAMIDAL CELLS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES; ALPHA-NEUREXINS; POSTSYNAPTIC MATURATION; GLUTAMATERGIC SYNAPSES; DENDRITIC SPINES; BETA-NEUREXINS	The structure and function of presynaptic and postsynaptic components of the synapse are highly coordinated. How such coordination is achieved and the molecules involved in this process have not been clarified. Several lines of evidence suggest that presynaptic functionalities are regulated by retrograde mechanisms from the postsynaptic side. We therefore sought postsynaptic mechanisms responsible for trans- synaptic regulation of presynaptic function at excitatory synapses in rat hippocampal CA1 pyramidal neurons. We show here that the postsynaptic complex of scaffolding protein PSD- 95 and neuroligin can modulate the release probability of transmitter vesicles at synapse in a retrograde way, resulting in altered presynaptic short- term plasticity. Presynaptic beta- neurexin serves as a likely presynaptic mediator of this effect. Our results indicate that trans- synaptic proteinprotein interactions can link postsynaptic and presynaptic function.	MIT, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Lab Neural Architecture, Adv Technol Dev Grp, Wako, Saitama 3510198, Japan; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Columbia University	Hayashi, Y (corresponding author), MIT, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yhayashi@mit.edu	Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [R01 NS045014] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045014] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; deKay JGT, 2006, HIPPOCAMPUS, V16, P66, DOI 10.1002/hipo.20132; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kazama H, 2003, NEUROSCIENCE, V117, P615, DOI 10.1016/S0306-4522(02)00923-5; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schermanz K, 2002, CATALY SCI, V2, P1, DOI 10.1142/9781860949654_0001; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	213	221	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					186	195		10.1038/nn1837	http://dx.doi.org/10.1038/nn1837			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237775	Green Accepted			2022-12-28	WOS:000244175200013
J	Persaud, N; McLeod, P; Cowey, A				Persaud, Navindra; McLeod, Peter; Cowey, Alan			Post-decision wagering objectively measures awareness	NATURE NEUROSCIENCE			English	Article							UNCONSCIOUS KNOWLEDGE; VISUAL SENSITIVITY; CORTEX; DAMAGE	The lack of an accepted measure of awareness has made claims that accurate decisions can be made without awareness controversial. Here we introduce a new objective measure of awareness, post- decision wagering. We show that participants fail to maximize cash earnings by wagering high following correct decisions in blindsight, the Iowa gambling task and an artificial grammar task. This demonstrates, without the uncertainties associated with the conventional subjective measures of awareness ( verbal reports and confidence ratings), that the participants were not aware that their decisions were correct. Post- decision wagering may be used to study the neural correlates of consciousness.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Persaud, N (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	nav.persaud@utoronto.ca			Medical Research Council [G0601975] Funding Source: Medline; MRC [G0601975] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; BARBUR JL, 1994, PHILOS T R SOC B, V343, P157, DOI 10.1098/rstb.1994.0018; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BLYTHE IM, 1986, NATURE, V320, P619, DOI 10.1038/320619a0; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; King SM, 1996, VISUAL NEUROSCI, V13, P1, DOI 10.1017/S0952523800007082; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; REBER AS, 1969, J EXP PSYCHOL, V81, P115, DOI 10.1037/h0027454; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Stoerig P, 2002, CEREB CORTEX, V12, P565, DOI 10.1093/cercor/12.6.565; Tunney RJ, 2003, MEM COGNITION, V31, P1060, DOI 10.3758/BF03196127; WEISKRANTZ L, 1991, BRAIN, V114, P2269, DOI 10.1093/brain/114.5.2269	18	277	281	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					257	261		10.1038/nn1840	http://dx.doi.org/10.1038/nn1840			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	135TB	17237774				2022-12-28	WOS:000244175200021
J	Happe, F; Ronald, A; Plomin, R				Happe, Francesca; Ronald, Angelica; Plomin, Robert			Time to give up on a single explanation for autism	NATURE NEUROSCIENCE			English	Article							WEAK CENTRAL COHERENCE; GENETIC-HETEROGENEITY; SPECTRUM DISORDERS; CHILDREN; PHENOTYPE; TRAITS; DYSFUNCTION; BEHAVIORS; TWIN; MIND	We argue that there will be no single ( genetic or cognitive) cause for the diverse symptoms defining autism. We present recent evidence of behavioral fractionation of social impairment, communication difficulties and rigid and repetitive behaviors. Twin data suggest largely nonoverlapping genes acting on each of these traits. At the cognitive level, too, attempts at a single explanation for the symptoms of autism have failed. Implications for research and treatment are discussed.	Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Happe, F (corresponding author), Kings Coll London, Inst Psychiat, De Crispigny Pk, London SE5 8AF, England.	spjgarr@iop.kcl.ac.uk	Ronald, Angelica/C-7812-2009; Plomin, Robert/B-8911-2008	Ronald, Angelica/0000-0002-9576-2176; Plomin, Robert/0000-0002-0756-3629; Happe, Francesca/0000-0001-9226-4000	Medical Research Council [G0500079, G0500079(73692)] Funding Source: Medline; MRC [G0500079] Funding Source: UKRI; Medical Research Council [G9817803B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; American Psychiatric Association, 1994, DSM 4 DIAGNOSTIC STA; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S., 2000, UNDERSTANDING OTHER; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; Bishop DVM, 2003, NOVART FDN SYMP, V251, P213; BISHOP DVM, 1989, BRIT J DISORD COMMUN, V24, P107; Briskman J, 2001, J CHILD PSYCHOL PSYC, V42, P309, DOI 10.1111/1469-7610.00724; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Charman T, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P325; Charman T, 2003, INT J LANG COMM DIS, V38, P265, DOI 10.1080/136820310000104830; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GOODMAN R, 1989, J AUTISM DEV DISORD, V19, P409, DOI 10.1007/BF02212939; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HAPPE F, 2003, J AUTISM DEV DISORD, V251, P198; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Kanner L, 1943, NERV CHILD, V2, P217; KLIN A, 1992, J CHILD PSYCHOL PSYC, V33, P861, DOI 10.1111/j.1469-7610.1992.tb01961.x; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; Lord C, 1996, J AM ACAD CHILD PSY, V35, P1542, DOI 10.1097/00004583-199611000-00024; MOLIN SO, 2006, UNDERSTANDING AUTISM; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Newschaffer CJ, 2002, EPIDEMIOL REV, V24, P137, DOI 10.1093/epirev/mxf010; Pellicano E, 2006, DEV PSYCHOPATHOL, V18, P77, DOI 10.1017/S0954579406060056; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; Piven J, 1997, AM J PSYCHIAT, V154, P185; Ronald A, 2005, DEVELOPMENTAL SCI, V8, P444, DOI 10.1111/j.1467-7687.2005.00433.x; RONALD A, IN PRESS J AM ACAD C; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Turner M, 1999, J CHILD PSYCHOL PSYC, V40, P839, DOI 10.1111/1469-7610.00502; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	39	607	654	4	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1218	1220		10.1038/nn1770	http://dx.doi.org/10.1038/nn1770			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001340				2022-12-28	WOS:000241493900010
J	Armstead, WM; Nassar, T; Akkawi, S; Smith, DH; Chen, XH; Cines, DB; Higazi, AA				Armstead, William M.; Nassar, Taher; Akkawi, Saed; Smith, Douglas H.; Chen, Xiao-Han; Cines, Douglas B.; Higazi, Abd Al-Roof			Neutralizing the neurotoxic effects of exogenous and endogenous tPA	NATURE NEUROSCIENCE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CENTRAL-NERVOUS-SYSTEM; BRAIN; INHIBITOR; THERAPY; STROKE; INJURY; CEREBROVASODILATION; FIBRINOLYSIS; IMPAIRMENT	The clinical use of tissue-type plasminogen activator (tPA) in the treatment of stroke is profoundly constrained by its serious side effects. We report that the deleterious effects of tPA on cerebral edema and intracranial bleeding are separable from its fibrinolytic activity and can be neutralized. A hexapeptide (EEIIMD) corresponding to amino acids 350-355 of plasminogen activator inhibitor type 1 (PAI-1) abolished the tPA-induced increase in infarct size and intracranial bleeding in both mechanical and embolic models of stroke in rats, and reduced brain edema and neuronal loss after traumatic brain injury in pigs. These experiments suggest mechanisms to reduce the neurotoxic effects of tPA without compromising its fibrinolytic activity, through the use of selective antagonists and new tPA formulations.	Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Univ Penn, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Higazi, AA (corresponding author), Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel.	higazi@mail.med.upenn.edu	smith, douglas/A-1321-2007		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067381, P01HL076406, R01HL076206] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL67381, HL82545, HL076206, HL076406, HL06831] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; AKKAWI S, 2006, AM J PHYSIOL-HEART C, DOI DOI 10.1152/A4PHEART.01042.2005; Anderson Gregory Jon, 2009, CELL MOL LIFE SCI, V66, P3241, DOI [DOI 10.1007/s11910-002-0051-0, 10.1007/s00018-009-0051-1, DOI 10.1007/S00018-009-0051-1]; Armstead WM, 2004, J NEUROTRAUM, V21, P1204, DOI 10.1089/0897715041953849; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Atochin DN, 2004, STROKE, V35, P2177, DOI 10.1161/01.STR.0000137412.35700.0e; Bdeir K, 2000, BLOOD, V96, P1820, DOI 10.1182/blood.V96.5.1820.h8001820_1820_1826; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Ding-Zhou L, 2002, EUR J PHARMACOL, V457, P137, DOI 10.1016/S0014-2999(02)02686-9; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Higazi AA, 1998, BLOOD, V92, P2075, DOI 10.1182/blood.V92.6.2075.418k08_2075_2083; HIGAZI AAR, 1995, J BIOL CHEM, V270, P9472, DOI 10.1074/jbc.270.16.9472; Higazi AAR, 2005, BLOOD, V105, P1021, DOI 10.1182/blood-2004-03-0995; Lapchak PA, 2001, CNS DRUGS, V15, P819, DOI 10.2165/00023210-200115110-00001; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Nagai N, 2001, BLOOD, V97, P3086, DOI 10.1182/blood.V97.10.3086; Nagai N, 1999, CIRCULATION, V100, P2541, DOI 10.1161/01.CIR.100.25.2541; Nassar T, 2004, BLOOD, V103, P897, DOI 10.1182/blood-2003-05-1685; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; REBICH S, 1995, AM J PHYSIOL-HEART C, V268, pH1071, DOI 10.1152/ajpheart.1995.268.3.H1071; THOMAS JM, 1971, GROWTH, V35, P259; Tsirka SE, 1997, P NATL ACAD SCI USA, V94, P9779, DOI 10.1073/pnas.94.18.9779; WAGERLE LC, 1986, PEDIATR RES, V20, P131, DOI 10.1203/00006450-198602000-00007; Zhang LT, 1997, J BIOL CHEM, V272, P27053, DOI 10.1074/jbc.272.43.27053; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41; Zivin JA, 1999, NEUROLOGY, V53, P14, DOI 10.1212/WNL.53.1.14	32	58	61	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1150	1155		10.1038/nn1757	http://dx.doi.org/10.1038/nn1757			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16936723				2022-12-28	WOS:000240080800016
J	Singh, A; Hamedinger, D; Hoda, JC; Gebhart, M; Koschak, A; Romanin, C; Striessnig, J				Singh, Anamika; Hamedinger, Daniel; Hoda, Jean-Charles; Gebhart, Mathias; Koschak, Alexandra; Romanin, Christoph; Striessnig, Joerg			C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels	NATURE NEUROSCIENCE			English	Article							STATIONARY NIGHT BLINDNESS; CALCIUM-DEPENDENT INACTIVATION; MOUSE RETINA; CALMODULIN; CACNA1F; FORM; ROD; DETERMINANTS; LOCALIZATION; FACILITATION	Tonic neurotransmitter release at sensory cell ribbon synapses is mediated by calcium (Ca2+) influx through L-type voltage-gated Ca2+ channels. This tonic release requires the channels to inactivate slower than in other tissues. Ca(v)1.4 L-type voltage-gated Ca2+ channels (LTCCs) are found at high densities in photoreceptor terminals, and alpha 1 subunit mutations cause human congenital stationary night blindness type-2 (CSNB2). Ca(v)1.4 voltage-dependent inactivation is slow and Ca2+-dependent inactivation (CDI) is absent. We show that removal of the last 55 or 122 (C-122) C-terminal amino acid residues of the human alpha 1 subunit restores calmodulin-dependent CDI and shifts voltage of half-maximal activation to more negative potentials. The C terminus must therefore form part of a mechanism that prevents calmodulin-dependent CDI of Ca(v)1.4 and controls voltage-dependent activation. Fluorescence resonance energy transfer experiments in living cells revealed binding of C-122 to C-terminal motifs mediating CDI in other Ca2+ channels. The absence of this modulatory mechanism in the CSNB2 truncation mutant K1591X underlines its importance for normal retinal function in humans.	Univ Innsbruck, Abt Pharmakol & Toxikol, Inst Pharm, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biowissensch Innsbruck, A-6020 Innsbruck, Austria; Univ Linz, Inst Biophys, A-4040 Linz, Austria	University of Innsbruck; University of Innsbruck; Johannes Kepler University Linz	Striessnig, J (corresponding author), Univ Innsbruck, Abt Pharmakol & Toxikol, Inst Pharm, Peter Mayrstr 1-1, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Tuluc, Petronel/C-2527-2011; Romanin, Christoph/D-5399-2009; Striessnig, Joerg/S-9334-2017	Romanin, Christoph/0000-0003-3756-4136; Striessnig, Joerg/0000-0002-9406-7120; Bhargava, Anamika/0000-0002-1048-3427	Austrian Science Fund FWF [P 17109, P 17159] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Firth SI, 2001, CLIN EXP OPHTHALMOL, V29, P183, DOI 10.1046/j.1442-9071.2001.00401.x; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; HULME JT, 2006, J PHYSL, DOI DOI 10.1113/PHYSIOL.2006.111799; Kahr H, 2004, J PHYSIOL-LONDON, V557, P121, DOI 10.1113/jphysiol.2004.062653; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Morgans CW, 2000, IMMUNOL CELL BIOL, V78, P442, DOI 10.1046/j.1440-1711.2000.00923.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; vonGersdorff H, 1996, J NEUROSCI, V16, P115; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	47	101	101	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1108	1116		10.1038/nn1751	http://dx.doi.org/10.1038/nn1751			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921373				2022-12-28	WOS:000240080800011
J	Morris, G; Nevet, A; Arkadir, D; Vaadia, E; Bergman, H				Morris, Genela; Nevet, Alon; Arkadir, David; Vaadia, Eilon; Bergman, Hagai			Midbrain dopamine neurons encode decisions for future action	NATURE NEUROSCIENCE			English	Article							MATCHING BEHAVIOR; BASAL GANGLIA; REWARD; PREDICTION; REPRESENTATION; PROBABILITY; INHIBITION; MOTIVATION; SUBSTRATE; MODELS	Current models of the basal ganglia and dopamine neurons emphasize their role in reinforcement learning. However, the role of dopamine neurons in decision making is still unclear. We recorded from dopamine neurons in monkeys engaged in two types of trial: reference trials in an instructed-choice task and decision trials in a two-armed bandit decision task. We show that the activity of dopamine neurons in the decision setting is modulated according to the value of the upcoming action. Moreover, analysis of the probability matching strategy in the decision trials revealed that the dopamine population activity and not the reward during reference trials determines choice behavior. Because dopamine neurons do not have spatial or motor properties, we conclude that immediate decisions are likely to be generated elsewhere and conveyed to the dopamine neurons, which play a role in shaping long-term decision policy through dynamic modulation of the efficacy of basal ganglia synapses.	Hebrew Univ Jerusalem, ICNC, IL-91220 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Physiol, IL-91220 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morris, G (corresponding author), Hebrew Univ Jerusalem, ICNC, POB 12272, IL-91220 Jerusalem, Israel.	genela.morris@charite.de	Morris, Genela/B-7844-2008; Vaadia, Eilon/E-9347-2011; Bergman, Hagai/AAI-4683-2021	Bergman, Hagai/0000-0002-2402-6673; Morris, Genela/0000-0002-5417-8977				Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beiser, 1995, MODELS INFORM PROCES, P215; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Gurney K, 2004, TRENDS NEUROSCI, V27, P453, DOI 10.1016/j.tins.2004.06.003; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Martin RF, 2000, PRIMATE BRAIN MAPS S; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nevet A, 2004, J NEUROPHYSIOL, V92, P1973, DOI 10.1152/jn.01036.2003; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Rummery G. A, 1994, SARSA MODIFIED CONNE; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sokal R. R, 1981, BIOMETRY; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Wickens JR, 2005, HAND CHEM N, V21, P199; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolford G, 2000, J NEUROSCI, V20, part. no.	40	305	308	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1057	1063		10.1038/nn1743	http://dx.doi.org/10.1038/nn1743			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16862149				2022-12-28	WOS:000240080300019
J	Vul, E; MacLeod, DIA				Vul, Edward; MacLeod, Donald I. A.			Contingent aftereffects distinguish conscious and preconscious color processing	NATURE NEUROSCIENCE			English	Article							INVISIBLE PATTERNS; CORTICAL-NEURONS; VISUAL-CORTEX; ADAPTATION; PERCEPTION; FLICKER; MACAQUE	The brain can process input without perception, but what distinguishes conscious from preconscious processing? Using aftereffects induced by quickly alternating images, we show that cortical mechanisms track color much faster than perception, responding well to color alternations that are too rapid to be perceptible. The more restricted frequency response of the conscious perception of color suggests that extra integrative steps give conscious color perception a time course substantially slower than that of early cortical mechanisms.	Univ Calif San Diego, Dept Psychol, La Jolla, CA 92092 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Vul, E (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92092 USA.	evul@mit.edu			NEI NIH HHS [EY01711] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001711] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Grossberg S, 2002, VISION RES, V42, P1259, DOI 10.1016/S0042-6989(02)00055-X; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Humphrey GK, 1998, CONSCIOUS COGN, V7, P494, DOI 10.1006/ccog.1998.0369; KELLY DH, 1983, J OPT SOC AM, V73, P742, DOI 10.1364/JOSA.73.000742; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; Shady S, 2002, NAT NEUROSCI, V5, P729, DOI 10.1038/nn894; Solomon SG, 2005, J NEUROSCI, V25, P4779, DOI 10.1523/JNEUROSCI.5316-04.2005; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004; WISOWATY JJ, 1981, J OPT SOC AM, V71, P970, DOI 10.1364/JOSA.71.000970	14	41	42	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					873	874		10.1038/nn1723	http://dx.doi.org/10.1038/nn1723			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16767088				2022-12-28	WOS:000238590800010
J	Soler-Llavina, GJ; Sabatini, BL				Soler-Llavina, Gilberto J.; Sabatini, Bernardo L.			Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells	NATURE NEUROSCIENCE			English	Article							BOVINE CHROMAFFIN CELLS; CALCIUM-PERMEABLE AMPA; DENDRITIC SPINES; HIPPOCAMPAL INTERNEURONS; PURKINJE-CELLS; RETROGRADE INHIBITION; ENDOGENOUS CANNABINOIDS; EXCITATORY SYNAPSES; CA2+; RECEPTORS	Here we demonstrate that cerebellar stellate cells diffusionally isolate synaptically evoked signals in dendrites and are capable of input-specific synaptic plasticity. Sustained activity of parallel fibers induces a form of long-term depression that requires opening of calcium (Ca21)-permeable AMPA-type glutamate receptors (CP-AMPARs) and signaling through class 1 metabotropic glutamate receptors (mGluR1) and CB1 receptors. This depression is induced by postsynaptic increases in Ca2+ concentration ([Ca2+]) and is limited to activated synapses. To understand how synapse-specific plasticity is induced by diffusible second messengers in aspiny dendrites, we examined diffusion of Ca2+ and small molecules within stellate cell dendrites. Activation of a single parallel fiber opened CP-AMPARs, generating long-lived Ca2+ transients that were confined to submicron dendritic stretches. The diffusion of Ca2+ was severely retarded due to interactions with parvalbumin and a general restriction of small molecule mobility. Thus stellate cell dendrites spatially restrict signaling cascades that lead from CP-AMPAR activation to endocannabinoid production and trigger the selective regulation of active synapses.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049655, R01NS046579] Funding Source: NIH RePORTER; NINDS NIH HHS [1 F31 NS049655-01, R01 NS046579] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HERKENHAM M, 1992, ANN NY ACAD SCI, V654, P19, DOI 10.1111/j.1749-6632.1992.tb25953.x; HOU TT, 1991, J PHYSIOL-LONDON, V441, P285, DOI 10.1113/jphysiol.1991.sp018752; Jasuja R, 1999, BIOPHYS J, V76, P1706, DOI 10.1016/S0006-3495(99)77329-7; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Li-Smerin YY, 2001, J PHYSIOL-LONDON, V533, P729, DOI 10.1111/j.1469-7793.2001.t01-1-00729.x; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; PALAY SL, 1974, STELLATE CELL, P216; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; POPOV S, 1992, J NEUROSCI, V12, P77; Rancillac A, 2005, J NEUROSCI RES, V80, P414, DOI 10.1002/jnr.20473; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rozsa B, 2004, J NEUROSCI, V24, P661, DOI 10.1523/JNEUROSCI.3906-03.2004; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Xia P, 1998, BIOPHYS J, V74, P3302, DOI 10.1016/S0006-3495(98)78037-3; YASUDA R, 2004, SCI STKE, pP15; ZADOR A, 1994, J NEUROSCI, V14, P4705; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	50	123	127	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					798	806		10.1038/nn1698	http://dx.doi.org/10.1038/nn1698			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680164				2022-12-28	WOS:000237895200020
J	Spudich, A; Kilic, E; Xing, HY; Kilic, U; Rentsch, KM; Wunderli-Allenspach, H; Bassetti, CL; Hermann, DM				Spudich, A; Kilic, E; Xing, HY; Kilic, U; Rentsch, KM; Wunderli-Allenspach, H; Bassetti, CL; Hermann, DM			Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia	NATURE NEUROSCIENCE			English	Article							EFFLUX	The blood-brain barrier possesses active transporters carrying brain-permeable xenobiotics back into the blood against concentration gradients. We demonstrate that multidrug resistance transporter (Mdr)-1 is upregulated on capillary endothelium after focal cerebral ischemia; moreover, Mdr-1 deactivation by pharmacological inhibition or genetic knockout preferably enhances the accumulation and efficacy of two neuroprotectants known as Mdr-1 substrates in the ischemic brain. We predict that Mdr-1 inhibition may greatly facilitate neuroprotective therapies.	Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Clin Chem, CH-8091 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hermann, DM (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	dirk.hermann@usz.ch	Hermann, Dirk/GZB-9350-2022; Hermann, Dirk M/AAP-5538-2020; Kilic, Ertugrul/W-4563-2018; Hermann, Dirk M./AAT-3652-2021	Kilic, Ertugrul/0000-0001-6494-8923; Hermann, Dirk M./0000-0003-0198-3152; Bassetti, Claudio/0000-0002-4535-0245				Comerford KM, 2002, CANCER RES, V62, P3387; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Sisodiya SM, 2001, LANCET, V357, P42, DOI 10.1016/S0140-6736(00)03573-X; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Yulug B, 2004, BRAIN RES, V996, P76, DOI 10.1016/j.brainres.2003.10.012	11	126	133	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					487	488		10.1038/nn1676	http://dx.doi.org/10.1038/nn1676			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16565717				2022-12-28	WOS:000236310700014
J	Stocker, AA; Simoncelli, EP				Stocker, AA; Simoncelli, EP			Noise characteristics and prior expectations in human visual speed perception	NATURE NEUROSCIENCE			English	Article							BAYESIAN MODEL; OPTICAL-FLOW; AREA MT; MOTION; INFORMATION; CONTRAST; STATISTICS; DISCRIMINATION; COMPUTATION	Human visual speed perception is qualitatively consistent with a Bayesian observer that optimally combines noisy measurements with a prior preference for lower speeds. Quantitative validation of this model, however, is difficult because the precise noise characteristics and prior expectations are unknown. Here, we present an augmented observer model that accounts for the variability of subjective responses in a speed discrimination task. This allowed us to infer the shape of the prior probability as well as the internal noise characteristics directly from psychophysical data. For all subjects, we found that the fitted model provides an accurate description of the data across a wide range of stimulus parameters. The inferred prior distribution shows significantly heavier tails than a Gaussian, and the amplitude of the internal noise is approximately proportional to stimulus speed and depends inversely on stimulus contrast. The framework is general and should prove applicable to other experiments and perceptual modalities.	NYU, Howard Hughes Med Inst, Ctr Neural Sci, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Stocker, AA (corresponding author), NYU, Howard Hughes Med Inst, Ctr Neural Sci, 4 Washington Pl Rm 809, New York, NY 10003 USA.	alan.stocker@nyu.edu	Stocker, Alan A/A-6514-2008	Stocker, Alan A/0000-0002-2041-1515; Simoncelli, Eero/0000-0002-1206-527X				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Ascher D, 2000, VISION RES, V40, P3427, DOI 10.1016/S0042-6989(00)00176-0; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FENNEMA CL, 1979, COMPUT VISION GRAPH, V9, P301, DOI 10.1016/0146-664X(79)90097-2; Green DM, 1966, SIGNAL DETECTION THE; HEEGER D, 1994, SPATIAL VISION HUMAN; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hurlimann F, 2002, VISION RES, V42, P2253, DOI 10.1016/S0042-6989(02)00119-0; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Mamassian P, 2002, NEU INF PRO, P13; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1986, VISION RES, V26, P609, DOI 10.1016/0042-6989(86)90009-X; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; Pack CC, 2005, J NEUROPHYSIOL, V93, P1809, DOI 10.1152/jn.00629.2004; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Priebe NJ, 2004, J NEUROSCI, V24, P1907, DOI 10.1523/JNEUROSCI.4233-03.2004; Roth S, 2005, IEEE I CONF COMP VIS, P42; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli E, 1993, THESIS MIT; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; SIMONCELLI EP, 2003, VISUAL NEUROSCIENCES; STOCKER A, 2006, ADV NEURAL INFORMATI, V18; STOCKER A, 2005, ADV NEURAL INFORMATI, V17; Stocker A, 2006, ANALOG VLSI CIRCUITS; Stocker AA, 2006, ANALOG INTEGR CIRC S, V46, P121, DOI 10.1007/s10470-005-0439-2; STONE LS, 1992, VISION RES, V32, P1535, DOI 10.1016/0042-6989(92)90209-2; Thompson P, 2006, VISION RES, V46, P782, DOI 10.1016/j.visres.2005.08.005; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; WEBER J, 1995, INT J COMPUT VISION, V14, P67, DOI 10.1007/BF01421489; Weiss Y, 2002, NEU INF PRO, P77; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; Wickens T.D., 2001, ELEMENTARY SIGNAL DE; YUILLE A, 2004, ADV NEURAL INFORMATI, V16; YUILLE AL, 1988, NATURE, V333, P71, DOI 10.1038/333071a0	46	450	451	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					578	585		10.1038/nn1669	http://dx.doi.org/10.1038/nn1669			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547513	Green Submitted			2022-12-28	WOS:000236310700026
J	Chiu, PH; Lohrenz, TM; Montague, PR				Chiu, Pearl H.; Lohrenz, Terry M.; Montague, P. Read			Smokers' brains compute, but ignore, a fictive error signal in a sequential investment task	NATURE NEUROSCIENCE			English	Article							PREDICTION ERRORS; NEURAL SYSTEMS; DOPAMINE; ADDICTION; REINFORCEMENT; MECHANISMS; WITHDRAWAL; CONFLICT; CONTRAST; SMOKING	Addicted individuals pursue substances of abuse even in the clear presence of positive outcomes that may be foregone and negative outcomes that may occur. Computational models of addiction depict the addicted state as a feature of a valuation disease, where drug-induced reward prediction error signals steer decisions toward continued drug use. Related models admit the possibility that valuation and choice are also directed by 'fictive' outcomes (outcomes that have not been experienced) that possess their own detectable error signals. We hypothesize that, in addiction, anomalies in these fictive error signals contribute to the diminished influence of potential consequences. Using a simple investment game and functional magnetic resonance imaging in chronic cigarette smokers, we measured neural and behavioral responses to error signals derived from actual experience and from fictive outcomes. In nonsmokers, both fictive and experiential error signals predicted subjects' choices and possessed distinct neural correlates. In chronic smokers, choices were not guided by error signals derived from what might have happened, despite ongoing and robust neural correlates of these fictive errors. These data provide human neuroimaging support for computational models of addiction and suggest the addition of fictive learning signals to reinforcement learning accounts of drug dependence.	[Chiu, Pearl H.; Lohrenz, Terry M.; Montague, P. Read] Baylor Coll Med, Comptat Psychiat Unit, Houston, TX 77030 USA; [Chiu, Pearl H.; Lohrenz, Terry M.; Montague, P. Read] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chiu, Pearl H.; Montague, P. Read] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Montague, PR (corresponding author), Baylor Coll Med, Comptat Psychiat Unit, 1 Baylor Pl, Houston, TX 77030 USA.	rmontague@cpu.bcm.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH078485, T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA011723, R01 DA11723] Funding Source: Medline; NIMH NIH HHS [F32 MH078485, T32 MH18882] Funding Source: Medline; NINDS NIH HHS [R01 NS045790] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brody AL, 2006, J PSYCHIATR RES, V40, P404, DOI 10.1016/j.jpsychires.2005.04.012; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hope BT, 2007, J NEUROSCI, V27, P1964, DOI 10.1523/JNEUROSCI.3661-06.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jarvik ME, 2000, PHARMACOL BIOCHEM BE, V66, P553, DOI 10.1016/S0091-3057(00)00261-6; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Li J, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000103; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Martiila K, 2006, NEUROPHARMACOLOGY, V51, P44, DOI 10.1016/j.neuropharm.2006.02.014; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Odum Amy L, 2002, Nicotine Tob Res, V4, P295, DOI 10.1080/14622200210141257; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Ohmura Y, 2005, PSYCHOPHARMACOLOGY, V182, P508, DOI 10.1007/s00213-005-0110-8; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rosenstein M.T., 2004, LEARNING APPROXIMATE, P359; Schepis TS, 2008, AM J ADDICTION, V17, P6, DOI 10.1080/10550490701756146; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SHIFFMAN SM, 1976, PSYCHOPHARMACOLOGY, V50, P35, DOI 10.1007/BF00634151; Talairach J., 1988, COPLANAR STEREOTAXIC; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; WALD NJ, 1981, THORAX, V36, P366, DOI 10.1136/thx.36.5.366; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	50	107	108	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					514	520		10.1038/nn2067	http://dx.doi.org/10.1038/nn2067			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311134				2022-12-28	WOS:000254359300024
J	O'Neill, J; Senior, TJ; Allen, K; Huxter, JR; Csicsvari, J				O'Neill, Joseph; Senior, Timothy J.; Allen, Kevin; Huxter, John R.; Csicsvari, Jozsef			Reactivation of experience-dependent cell assembly patterns in the hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSEQUENT SLEEP EPISODES; CA1 PYRAMIDAL CELLS; SHARP WAVES; SYNAPTIC PLASTICITY; BEHAVING RAT; SEQUENTIAL EXPERIENCE; AWAKE STATE; MEMORY; NEURONS	The hippocampus is thought to be involved in episodic memory formation by reactivating traces of waking experience during sleep. Indeed, the joint firing of spatially tuned pyramidal cells encoding nearby places recur during sleep. We found that the sleep cofiring of rat CA1 pyramidal cells encoding similar places increased relative to the sleep session before exploration. This cofiring increase depended on the number of times that cells fired together with short latencies ( < 50 ms) during exploration, and was strongest between cells representing the most visited places. This is indicative of a Hebbian learning rule in which changes in firing associations between cells are determined by the number of waking coincident firing events. In contrast, cells encoding different locations reduced their cofiring in proportion to the number of times that they fired independently. Together these data indicate that reactivated patterns are shaped by both positive and negative changes in cofiring, which are determined by recent behavior.	[O'Neill, Joseph; Senior, Timothy J.; Allen, Kevin; Huxter, John R.; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	jozsef.csicsvari@pharm.ox.ac.uk		Allen, Kevin/0000-0001-5319-3721	Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U138169944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Battaglia FP, 2005, NEURAL NETWORKS, V18, P1280, DOI 10.1016/j.neunet.2005.08.011; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Shen B, 1996, HIPPOCAMPUS, V6, P685; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	46	182	182	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					209	215		10.1038/nn2037	http://dx.doi.org/10.1038/nn2037			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193040				2022-12-28	WOS:000252712100015
J	Corneil, BD; Munoz, DP; Chapman, BB; Admans, T; Cushing, SL				Corneil, Brian D.; Munoz, Douglas P.; Chapman, Brendan B.; Admans, Tania; Cushing, Sharon L.			Neuromuscular consequences of reflexive covert orienting	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS; VISUAL RESPONSES; EYE-MOVEMENTS; MONKEY; INHIBITION; ATTENTION; NEURONS; REWARD; RETURN	Visual stimulus presentation activates the oculomotor network without requiring a gaze shift. Here, we demonstrate that primate neck muscles are recruited during such reflexive covert orienting in a manner that parallels activity recorded from the superior colliculus (SC). Our results indicate the presence of a brainstem circuit whereby reflexive covert orienting is prevented from shifting gaze, but recruits neck muscles, predicting that similarities between SC and neck muscle activity should extend to other cognitive processes that are known to influence SC activity.	[Corneil, Brian D.; Admans, Tania] Univ Western Ontario, Dept Physiol, CIHR, Grp Act & Percep, London, ON N6A 5C1, Canada; [Corneil, Brian D.; Admans, Tania] Univ Western Ontario, Dept Psychol, CIHR, Grp Act & Percep, London, ON N6A 5C1, Canada; [Corneil, Brian D.; Admans, Tania] Univ Western Ontario, Dept Pharmacol, CIHR, Grp Act & Percep, London, ON, Canada; [Corneil, Brian D.; Chapman, Brendan B.] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Munoz, Douglas P.] Queens Univ, Dept Med, CIHR Grp Sensory Motor Sysyt, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Munoz, Douglas P.] Queens Univ, Dept Physiol, CIHR Grp Sensory Motor Sysyt, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Munoz, Douglas P.] Queens Univ, Dept Psychol, CIHR Grp Sensory Motor Sysyt, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Cushing, Sharon L.] Univ Toronto, Dept Otorhinolaryngol Head & Neck Surg, Toronto, ON M5G 2N2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto	Corneil, BD (corresponding author), Univ Western Ontario, Dept Physiol, CIHR, Grp Act & Percep, London, ON N6A 5C1, Canada.	bcorneil@uwo.ca	Corneil, Brian D/K-6401-2013	Corneil, Brian D/0000-0002-4702-7089				Corneil BD, 2004, NEURON, V42, P831, DOI 10.1016/S0896-6273(04)00267-3; Corneil BD, 2007, J NEUROPHYSIOL, V97, P701, DOI 10.1152/jn.00670.2006; Dorris MC, 1998, J NEUROSCI, V18, P7015; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; GRANTYN A, 1989, PROG BRAIN RES, V80, P159; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Rodgers CK, 2006, J NEUROPHYSIOL, V95, P3502, DOI 10.1152/jn.00908.2005; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575	15	56	56	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					13	15		10.1038/nn2023	http://dx.doi.org/10.1038/nn2023			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18059264				2022-12-28	WOS:000252117900006
J	Falsig, J; Julius, C; Margalith, I; Schwarz, P; Heppner, FL; Aguzzi, A				Falsig, Jeppe; Julius, Christian; Margalith, Ilan; Schwarz, Petra; Heppner, Frank L.; Aguzzi, Adriano			A versatile prion replication assay in organotypic brain slices	NATURE NEUROSCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; ADULT TRANSGENIC MICE; SCRAPIE PRION; PROTEIN; PRP; MICROGLIA; AGENT; CELLS; IDENTIFICATION; INFECTIVITY	Methods enabling prion replication ex vivo are important for advancing prion studies. However, few such technologies exist, and many prion strains are not amenable to them. Here we describe a prion organotypic slice culture assay (POSCA) that allows prion amplification and titration ex vivo under conditions that closely resemble intracerebral infection. Thirty-five days after contact with prions, mouse cerebellar slices had amplified the abnormal isoform of prion protein, PrPSc, > 10(5)-fold. This is quantitatively similar to amplification in vivo, but fivefold faster. PrPSc accumulated predominantly in the molecular layer, as in infected mice. The POSCA detected replication of prion strains from disparate sources, including bovines and ovines, with variable detection efficiency. Pharmacogenetic ablation of microglia from POSCA slices led to a 15-fold increase in prion titers and PrPSc concentrations over those in microglia-containing slices, as well as an increase in susceptibility to infection. This suggests that the extensive microglial activation accompanying prion diseases represents an efficacious defensive reaction.	[Falsig, Jeppe; Julius, Christian; Margalith, Ilan; Schwarz, Petra; Heppner, Frank L.; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008; Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917; Aguzzi, Adriano/0000-0002-0344-6708	NINDS NIH HHS [R01 NS 046006, R01 NS046006-05, R01 NS046006] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Andreoletti O, 2002, J HISTOCHEM CYTOCHEM, V50, P1357, DOI 10.1177/002215540205001009; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; CARP RI, 1982, INTERVIROLOGY, V17, P201, DOI 10.1159/000149289; Dandoy-Dron F, 1998, J BIOL CHEM, V273, P7691, DOI 10.1074/jbc.273.13.7691; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; MANUELIDIS L, 1987, EMBO J, V6, P341, DOI 10.1002/j.1460-2075.1987.tb04760.x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MICHEL B, 1987, REV NEUROL, V143, P526; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Rubsam LZ, 1998, CANCER RES, V58, P3873; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; [No title captured], DOI DOI 10.1007/BF01863914	34	112	114	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					109	117		10.1038/nn2028	http://dx.doi.org/10.1038/nn2028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066056	Green Accepted			2022-12-28	WOS:000252117900019
J	Li, XL; Gao, X; Liu, GF; Xiong, WC; Wu, J; Rao, Y				Li, Xiaoling; Gao, Xue; Liu, Guofa; Xiong, Wencheng; Wu, Jane; Rao, Yi			Netrin signal transduction and the guanine nucleotide exchange factor DOCK180 in attractive signaling	NATURE NEUROSCIENCE			English	Article							COMMISSURAL AXON GUIDANCE; FOCAL ADHESION KINASE; C-ELEGANS; COLORECTAL-CANCER; CELL-MIGRATION; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; NERVOUS-SYSTEM; MYOBLAST CITY; GUIDES CELL	Netrins are prototypical axon guidance cues whose attractive signaling requires the small GTPase Rac1. It remains unclear how Rac1 is regulated in the netrin pathway. DOCK180 is a member of a new family of guanine nucleotide exchange factors for Rho GTPases. Here we provide evidence implicating DOCK180 in netrin signal transduction. Netrin promoted the formation of a protein-protein interaction complex that included DOCK180 and the netrin receptor deleted in colorectal carcinoma (DCC). Inhibition of DOCK180 reduced activation of Rac1 by netrin. Both axon outgrowth and axon attraction induced by netrin were inhibited after DOCK180 knockdown in vertebrate neurons. The in vivo functional role of DOCK180 was demonstrated by its requirement for projection of commissural axons in the neural tube. These findings indicate that netrin stimulation recruits DOCK180 through DCC, which then activates small GTPases, suggesting an essential role for DOCK180 in mediating attractive responses by neurons to netrin-1.	[Li, Xiaoling; Gao, Xue; Liu, Guofa; Wu, Jane; Rao, Yi] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Xiong, Wencheng] Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; [Wu, Jane] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Wu, Jane] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Rao, Yi] Beijing Univ, Sch Life Sci, Beijing 100871, Peoples R China	Northwestern University; Feinberg School of Medicine; University System of Georgia; Augusta University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Peking University	Wu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, 303 E Superior Ave, Chicago, IL 60611 USA.	jane-wu@northwestern.edu; y-rao@northwestern.edu		Li, Xiaoling/0000-0002-3408-7066	NATIONAL CANCER INSTITUTE [R01CA107193, R01CA114197] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107193, R01 CA107193-03, R01 CA114197, R01 CA114197-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DeFelipe J., 1991, CAJALS DEGENERATION; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Merz DC, 2001, GENETICS, V158, P1071; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zhou WS, 2001, J VIS COMMUN IMAGE R, V12, P1, DOI 10.1006/jvci.2000.0459	50	83	85	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					28	35		10.1038/nn2022	http://dx.doi.org/10.1038/nn2022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066058	Green Accepted			2022-12-28	WOS:000252117900009
J	Gu, Y; DeAngelis, GC; Angelaki, DE				Gu, Yong; DeAngelis, Gregory C.; Angelaki, Dora E.			A functional link between area MSTd and heading perception based on vestibular signals	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; STEREOSCOPIC DEPTH-PERCEPTION; INNERVATING OTOLITH ORGANS; SELF-MOTION; OPTIC FLOW; SQUIRREL-MONKEY; EYE-MOVEMENTS; PSYCHOPHYSICAL SENSITIVITY; VESTIBULOOCULAR REFLEX; NEURON RESPONSES	Recent findings of vestibular responses in part of the visual cortex - the dorsal medial superior temporal area (MSTd) - indicate that vestibular signals might contribute to cortical processes that mediate the perception of self-motion. We tested this hypothesis in monkeys trained to perform a fine heading discrimination task solely on the basis of inertial motion cues. The sensitivity of the neuronal responses was typically lower than that of psychophysical performance, and only the most sensitive neurons rivaled behavioral performance. Responses recorded in MSTd were significantly correlated with perceptual decisions, and the correlations were strongest for the most sensitive neurons. These results support a functional link between MSTd and heading perception based on inertial motion cues. These cues seem mainly to be of vestibular origin, as labyrinthectomy produced a marked elevation of psychophysical thresholds and abolished MSTd responses. This study provides evidence that links single-unit activity to spatial perception mediated by vestibular signals, and supports the idea that the role of MSTd in self-motion perception extends beyond optic flow processing.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273	NEI NIH HHS [R01 EY017866, R01 EY016178, EY016178, EY017866, R01 EY016178-03] Funding Source: Medline; NIDCD NIH HHS [DC04260, R01 DC004260] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016178, R01EY017866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Angelaki DE, 2005, NAT REV NEUROSCI, V6, P966, DOI 10.1038/nrn1804; Angelaki DE, 2004, J NEUROPHYSIOL, V92, P20, DOI 10.1152/jn.00047.2004; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; Ben Hamed S, 2003, J NEUROPHYSIOL, V90, P549, DOI 10.1152/jn.00639.2002; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Chen-Huang C, 2006, EXP BRAIN RES, V168, P410, DOI 10.1007/s00221-005-0098-7; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P985, DOI 10.1152/jn.1976.39.5.985; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; GU Y, 2006, J VIS, V6, pA409; GUEDRY FE, 1974, HDB SENSORY PHYSL, P1; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; Heuer HW, 2004, J NEUROPHYSIOL, V91, P1314, DOI 10.1152/jn.00637.2003; KARUNARATNE AD, 2006, SOC NEUR ABSTR; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Lappe M, 1996, J NEUROSCI, V16, P6265; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Newlands SD, 2001, EXP BRAIN RES, V140, P25, DOI 10.1007/s002210100810; Ohmi M, 1996, COGNITIVE BRAIN RES, V5, P87, DOI 10.1016/S0926-6410(96)00044-4; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; SMITH ST, 2002, SOC NEUR ABSTR; TAKAHASHI K, 2006, SOC NEUR ABSTR; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TELFORD L, 1995, EXP BRAIN RES, V104, P502; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; XU HPW, 2006, SOC NEUR ASTR	50	218	222	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1038	1047		10.1038/nn1935	http://dx.doi.org/10.1038/nn1935			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618278	Green Accepted			2022-12-28	WOS:000248357500018
J	Jia, YC; Zhou, J; Tai, YL; Wang, YZ				Jia, Yichang; Zhou, Jian; Tai, Yilin; Wang, Yizheng			TRPC channels promote cerebellar granule neuron survival	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH CONES; SIGNALING PATHWAY; CELL-DEATH; CREB PHOSPHORYLATION; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; CALCIUM-CHANNEL; GENE-EXPRESSION; CATION CHANNELS; KINASE PATHWAY	Channels formed by the transient receptor potential (TRP) family of proteins have a variety of physiological functions. Here we report that two members of the TRP cation channel (TRPC) subfamily, TRPC3 and 6, protected cerebellar granule neurons ( CGNs) against serum deprivation - induced cell death in cultures and promoted CGN survival in rat brain. In CGN cultures, blocking TRPC channels or downregulating TRPC3 or 6 suppressed brain- derived neurotrophic factor ( BDNF) - mediated protection, BDNF-triggered intracellular Ca2+ elevation and BDNF-induced CREB activation. By contrast, overexpressing TRPC3 or 6 increased CREB-dependent reporter gene transcription and prevented apoptosis in the neurons deprived of serum, and this protection was blocked by the dominant negative form of CREB. Furthermore, downregulating TRPC3 or 6 induced CGN apoptosis in neonatal rat cerebellum, and this effect was rescued by overexpressing either TRPC3 or 6. Thus, our findings provide in vitro and in vivo evidence that TRPC channels are important in promoting neuronal survival.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Key Lab Neurobiol,Lab Neural Signal Transduct, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, YZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Key Lab Neurobiol,Lab Neural Signal Transduct, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Atabay C, 1996, J NEUROSCI RES, V43, P465; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; Fahlman CS, 2002, BRAIN RES, V958, P43, DOI 10.1016/S0006-8993(02)03433-9; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MINKE B, 1977, BIOPHYS STRUCT MECH, V3, P59, DOI 10.1007/BF00536455; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	49	194	205	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					559	567		10.1038/nn1870	http://dx.doi.org/10.1038/nn1870			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396124				2022-12-28	WOS:000245948000012
J	Hall, J; Whalley, HC; Job, DE; Baig, BJ; McIntosh, AM; Evans, KL; Thomson, PA; Porteous, DJ; Cunningham-Owens, DG; Johnstone, EC; Lawrie, SM				Hall, Jeremy; Whalley, Heather C.; Job, Dominic E.; Baig, Ben J.; McIntosh, Andrew M.; Evans, Kathryn L.; Thomson, Pippa A.; Porteous, David J.; Cunningham-Owens, David G.; Johnstone, Eve C.; Lawrie, Stephen M.			A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms	NATURE NEUROSCIENCE			English	Article							BIPOLAR DISORDER; ENHANCED RISK; SCHIZOPHRENIA; SUSCEPTIBILITY; METAANALYSIS; POPULATION; GENE	NRG1, encoding neuregulin 1, is a susceptibility gene for schizophrenia, but no functional mutation causally related to the disorder has yet been identified. Here we investigate the effects of a variant in the human NRG1 promoter region in subjects at high risk of schizophrenia. We show that this variant is associated with (i) decreased activation of frontal and temporal lobe regions, (ii) increased development of psychotic symptoms and (iii) decreased premorbid IQ.	Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Hall, J (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Morningside Pk, Edinburgh EH10 5HF, Midlothian, Scotland.	jhall5@staffmail.ed.ac.uk	McIntosh, Andrew M/B-9379-2008; Evans, Kathryn KL/I-5910-2012; Lawrie, Stephen MacGregor/AAD-1607-2021; Baig, Benjamin J/C-6714-2009; Porteous, David/AAA-3446-2021; Whalley, Heather C/N-1886-2019; Porteous, David J/C-7289-2013	McIntosh, Andrew M/0000-0002-0198-4588; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Porteous, David/0000-0003-1249-6106; Whalley, Heather C/0000-0002-4505-8869; Porteous, David J/0000-0003-1249-6106; Evans, Kathryn/0000-0002-7884-5877; Hall, Jeremy/0000-0002-0403-3278; Baig, Benjamin/0000-0003-2766-9014; Job, Dominic/0000-0002-7829-7217	Medical Research Council [G0100266, G0600429] Funding Source: Medline; MRC [G0100266] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Honey GD, 2003, PSYCHOL MED, V33, P1007, DOI 10.1017/S0033291703007864; Johnstone EC, 2000, SCHIZOPHR RES, V46, P1, DOI 10.1016/S0920-9964(99)00225-X; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; LAWRIE SM, 2004, SCHIZOPHRENIA IMAGIN; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Marjoram D, 2006, NEUROIMAGE, V31, P1850, DOI 10.1016/j.neuroimage.2006.02.011; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Whalley HC, 2004, BRAIN, V127, P478, DOI 10.1093/brain/awh070; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480	15	202	204	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1477	1478		10.1038/nn1795	http://dx.doi.org/10.1038/nn1795			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TP	17072305				2022-12-28	WOS:000242404000010
J	Ling, S; Carrasco, M				Ling, Sam; Carrasco, Marisa			When sustained attention impairs perception	NATURE NEUROSCIENCE			English	Article							VISUAL-ATTENTION; CONTRAST; ADAPTATION; SENSITIVITY; STRENGTH; NEURONS; CORTEX	Virtually all behavioral and neurophysiological studies have shown that sustained (endogenous, conceptually driven) attention enhances perception. But can this enhancement be held indefinitely? We assessed the time course of attention's effects on contrast sensitivity, reasoning that if attention does indeed boost stimulus strength, the strengthened representation could result in stronger adaptation over time. We found that attention initially enhances contrast sensitivity, but that over time sustained attention can actually impair sensitivity to an attended stimulus.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Ling, S (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	ling@nyu.edu		Ling, Sam/0000-0002-6735-2508	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS051111] Funding Source: NIH RePORTER; NINDS NIH HHS [F31 NS051111-02, F31 NS051111] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alais D, 1999, NAT NEUROSCI, V2, P1015, DOI 10.1038/14814; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Dosher BA, 2000, VISION RES, V40, P1269, DOI 10.1016/S0042-6989(00)00019-5; FOLEY JM, 1993, VISION RES, V33, P959, DOI 10.1016/0042-6989(93)90079-C; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Langley K, 2002, SPATIAL VISION, V16, P77, DOI 10.1163/15685680260433922; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Lou LG, 1999, PERCEPTION, V28, P519, DOI 10.1068/p2816; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4	15	98	99	4	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1243	1245		10.1038/nn1761	http://dx.doi.org/10.1038/nn1761			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964254	Green Accepted			2022-12-28	WOS:000241493900017
J	Cardona, AE; Pioro, EP; Sasse, ME; Kostenko, V; Cardona, SM; Dijkstra, IM; Huang, DR; Kidd, G; Dombrowski, S; Dutta, R; Lee, JC; Cook, DN; Jung, S; Lira, SA; Littman, DR; Ransohoff, RM				Cardona, Astrid E.; Pioro, Erik P.; Sasse, Margaret E.; Kostenko, Volodymyr; Cardona, Sandra M.; Dijkstra, Ineke M.; Huang, DeRen; Kidd, Grahame; Dombrowski, Stephen; Dutta, RanJan; Lee, Jar-Chi; Cook, Donald N.; Jung, Steffen; Lira, Sergio A.; Littman, Dan R.; Ransohoff, Richard M.			Control of microglial neurotoxicity by the fractalkine receptor	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; CHEMOKINE FRACTALKINE; TARGETED DELETION; IN-VIVO; BRAIN; MICE; MECHANISMS; EXPRESSION; NEURONS	Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor ( CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1(-/-) mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1(-/-) mice showed more extensive neuronal cell loss than Cx3cr(+) littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.	Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA; Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin, Dept Neurosurg, Cleveland, OH 44195 USA; Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; NIEHS, Res Triangle Pk, NC 27709 USA; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Weizmann Institute of Science; Howard Hughes Medical Institute; New York University; New York University; Icahn School of Medicine at Mount Sinai	Ransohoff, RM (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA.	ransohr@ccf.org	Jung, Steffen/K-1409-2012; Cardona, Astrid E/K-4749-2013; Cook, Donald/E-5079-2019; Pioro, Erik P/AAZ-5318-2020	Jung, Steffen/0000-0003-4290-5716; Cardona, Astrid E/0000-0002-5093-8078; Cook, Donald/0000-0002-0052-3755; Pioro, Erik P/0000-0002-0737-6065; Kidd, Grahame/0000-0003-3956-2206	NINDS NIH HHS [NS32151] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Carson MJ, 1999, AM J PATHOL, V154, P481, DOI 10.1016/S0002-9440(10)65294-7; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Cybulsky MI, 2003, J CLIN INVEST, V111, P1118, DOI 10.1172/JCI200318237; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Hulshof S, 2003, J NEUROPATH EXP NEUR, V62, P899, DOI 10.1093/jnen/62.9.899; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kust BM, 2003, AMYOTROPH LATERAL SC, V4, P100, DOI 10.1080/14660820301185; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 2001, P NATL ACAD SCI USA, V98, P15393; Milligan E, 2005, EUR J NEUROSCI, V22, P2775, DOI 10.1111/j.1460-9568.2005.04470.x; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Mitsumoto H, 2001, MUSCLE NERVE, V24, P769, DOI 10.1002/mus.1068; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Soriano SG, 2002, J NEUROIMMUNOL, V125, P59, DOI 10.1016/S0165-5728(02)00033-4; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; WEST RW, 1993, CARCINOGENESIS, V14, P285, DOI 10.1093/carcin/14.2.285; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	38	1083	1112	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					917	924		10.1038/nn1715	http://dx.doi.org/10.1038/nn1715			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732273				2022-12-28	WOS:000238590800018
J	Kennerley, SW; Walton, ME; Behrens, TEJ; Buckley, MJ; Rushworth, MFS				Kennerley, Steven W.; Walton, Mark E.; Behrens, Timothy E. J.; Buckley, Mark J.; Rushworth, Matthew F. S.			Optimal decision making and the anterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; FRONTAL-CORTEX; NEURONAL-ACTIVITY; DOPAMINE NEURONS; RHESUS-MONKEY; MATCHING BEHAVIOR; PREDICTION ERROR; PARIETAL CORTEX; MOTOR AREAS; REWARD	Learning the value of options in an uncertain environment is central to optimal decision making. The anterior cingulate cortex ( ACC) has been implicated in using reinforcement information to control behavior. Here we demonstrate that the ACC's critical role in reinforcement-guided behavior is neither in detecting nor in correcting errors, but in guiding voluntary choices based on the history of actions and outcomes. ACC lesions did not impair the performance of monkeys ( Macaca mulatta) immediately after errors, but made them unable to sustain rewarded responses in a reinforcement-guided choice task and to integrate risk and payoff in a dynamic foraging task. These data suggest that the ACC is essential for learning the value of actions.	Dept Expt Psychol, Oxford OX1 3UD, England; John Radcliffe Hosp, Oxford Ctr FMRIB, Oxford OX3 9DU, England	University of Oxford	Kennerley, SW (corresponding author), Dept Expt Psychol, S Pk Rd, Oxford OX1 3UD, England.	skennerley@berkeley.edu	Kennerley, Steven W/E-3330-2018	Kennerley, Steven W/0000-0002-5696-7507; Rushworth, Matthew/0000-0002-5578-9884; Behrens, Timothy/0000-0003-0048-1177	Medical Research Council [G0501316, G0300665] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0300665, G0501316] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; AMIEZ C, 2005, CEREB CORTEX; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; HE SQ, 1995, J NEUROSCI, V15, P3284; Herrnstein R. J., 1997, MATCHING LAW PAPERS; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Morecraft RJ, 1998, BRAIN RES BULL, V45, P209, DOI 10.1016/S0361-9230(97)00344-4; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; MURRAY EA, 1989, EXP BRAIN RES, V74, P173; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paxinos G., 1999, RHESUS MONKEY BRAIN, DOI DOI 10.1016/J.CEJA.2021.100223; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	631	639	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					940	947		10.1038/nn1724	http://dx.doi.org/10.1038/nn1724			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783368				2022-12-28	WOS:000238590800021
J	Li, Y; Fitzpatrick, D; White, LE				Li, Y; Fitzpatrick, D; White, LE			The development of direction selectivity in ferret visual cortex requires early visual experience	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; CATS STRIATE CORTEX; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; SIMPLE CELLS; AREA 17; CRITICAL PERIOD; CORTICAL-CELLS; KITTENS	Development of the selective response properties that define columns in sensory cortex is thought to begin early in cortical maturation, without the need for experience. We investigated the development of direction selectivity in ferret visual cortex using optical imaging and electrophysiological techniques and found an exception to this view. Unlike orientation selectivity and ocular dominance, direction selectivity was not detected at eye opening. Direction selectivity emerged several days later and strengthened to adult levels over the following 2 weeks. Visual experience was essential for this process, as shown by the absence of direction selectivity in dark-reared ferrets. The impairment persisted in dark-reared ferrets that were given experience after this period, despite the recovery of response amplitude, preference and bandwidth for stimulus orientation, spatial and temporal frequency, and contrast. Visual experience in early postnatal life plays a necessary and unique role in the development of cortical direction selectivity.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Div Phys Therapy, Durham, NC 27710 USA	Duke University; Duke University	White, LE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	len.white@duke.edu			NATIONAL EYE INSTITUTE [P30EY005722] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY005722, P30 EY005722-21] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Bonhoeffer Tobias, 1996, P55; Braddick O, 2005, VISION RES, V45, P3169, DOI 10.1016/j.visres.2005.07.021; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; CYNADER M, 1976, SCIENCE, V193, P504, DOI 10.1126/science.941025; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DAW NW, 1978, SCIENCE, V199, P565, DOI 10.1126/science.622560; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Hatta S, 1998, INVEST OPHTH VIS SCI, V39, P2259; Horton JC, 1996, J NEUROSCI, V16, P1791; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Humphrey AL, 1998, J NEUROPHYSIOL, V80, P3005, DOI 10.1152/jn.1998.80.6.3005; Humphrey AL, 1998, J NEUROPHYSIOL, V80, P2991, DOI 10.1152/jn.1998.80.6.2991; IMBERT M, 1975, EXP BRAIN RES, V22, P25; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kisvarday ZF, 2001, CEREB CORTEX, V11, P636, DOI 10.1093/cercor/11.7.636; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; Moore BD, 2005, J NEUROPHYSIOL, V94, P1336, DOI 10.1152/jn.01224.2004; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 2005, J NEUROSCI, V25, P2712, DOI 10.1523/JNEUROSCI.2356-04.2005; MOWER GD, 1981, DEV BRAIN RES, V1, P418, DOI 10.1016/0165-3806(81)90079-1; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; OLSON CR, 1974, BRAIN RES, V70, P189, DOI 10.1016/0006-8993(74)90312-6; PETERSON M, 2005, J NEUROPHYSIOL; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; Ruthazer ES, 2005, NEURON, V45, P825, DOI 10.1016/j.neuron.2005.03.008; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Saul AB, 2002, J NEUROSCI, V22, P2945, DOI 10.1523/JNEUROSCI.22-07-02945.2002; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Shmuel A, 1996, J NEUROSCI, V16, P6945; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Tanaka S, 2004, NEURAL NETWORKS, V17, P1363, DOI 10.1016/j.neunet.2004.06.014; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Wenisch OG, 2005, BIOL CYBERN, V93, P239, DOI 10.1007/s00422-005-0006-z; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; ZHOU YF, 1995, J NEUROSCI, V15, P689	50	131	132	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					676	681		10.1038/nn1684	http://dx.doi.org/10.1038/nn1684			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16604068				2022-12-28	WOS:000237417200019
J	Zheng, JJ; Lee, S; Zhou, ZJ				Zheng, JJ; Lee, S; Zhou, ZJ			A transient network of intrinsically bursting starburst cells underlies the generation of retinal waves	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; RETINOTOPIC MAP REFINEMENT; RAT HIPPOCAMPAL-NEURONS; AMACRINE CELLS; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; RABBIT RETINA; MICE LACKING; AFTER-HYPERPOLARIZATIONS; SUPERIOR COLLICULUS	Pharmacologically isolated starburst amacrine cells (SACs) in perinatal rabbit retinas spontaneously generated semiperiodic calcium spikes and long-lasting after-hyperpolarizations (AHPs), mediated by calcium-activated, cyclic AMP-sensitive potassium currents. These AHPs, rather than a depletion of neurotransmitters (as was previously believed), produced the refractory period of spontaneous retinal waves and set the upper limit of the wave frequency. Each SAC received inputs from roughly 10-30 neighboring SACs during a wave. These inputs synchronized and reshaped the intrinsic bursts to produce network oscillations at a rhythm different from that of individual SACs. With maturation, the semiperiodic bursts in SACs disappeared, owing to reduced intrinsic excitability and increased network inhibition. Thus, retinal waves are generated by a transient and specific network of cell-autonomous oscillators synchronized by reciprocally excitatory connections.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NATIONAL EYE INSTITUTE [R01EY010894] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY10894] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Bansal A, 2000, J NEUROSCI, V20, P7672; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 1999, J NEUROSCI, V19, P3657; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; SCHWINDT PC, 1992, NEUROSCIENCE, V47, P571, DOI 10.1016/0306-4522(92)90166-Y; Shah MM, 2001, BRIT J PHARMACOL, V132, P889, DOI 10.1038/sj.bjp.0703895; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Velumian AA, 1999, J PHYSIOL-LONDON, V517, P201, DOI 10.1111/j.1469-7793.1999.0201z.x; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou Z J, 2001, Prog Brain Res, V131, P599; Zhou ZJ, 2000, J NEUROSCI, V20, P6570, DOI 10.1523/JNEUROSCI.20-17-06570.2000; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	44	94	94	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					363	371		10.1038/nn1644	http://dx.doi.org/10.1038/nn1644			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462736				2022-12-28	WOS:000235645600016
J	Chen, G; Sima, J; Jin, M; Wang, KY; Xue, XJ; Zheng, W; Ding, YQ; Yuan, XB				Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing			Semaphorin-3A guides radial migration of cortical neurons during development	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; GROWTH CONES; RECEPTOR; NEUROPILIN; PROTEIN; REELIN; BRAIN; NEOCORTEX	Postmitotic neurons in the developing cortex migrate along radial glial fibers to their proper location in the cortical plate and form the layered structure. Here we report that the radial migration of rat layer II/III cortical neurons requires guidance by the extracellular diffusible factor Semaphorin-3A (Sema3A). This factor is expressed in a descending gradient across the cortical layers, whereas its receptor neuropilin-1 (NP1) is highly expressed in migrating neurons. Downregulation or conditional knockout of NP1 in newborn cortical neurons impedes their radial migration by disrupting their radial orientation during migration without altering their cell fate. Studies in cultured cortical slices further show that the endogenous gradient of Sema3A is required for the proper migration of newborn neurons. In addition, transwell chemotaxis assays show that isolated newborn neurons are attracted by Sema3A. Thus, Sema3A may function as a chemoattractive guidance signal for the radial migration of newborn cortical neurons toward upper layers.	[Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key State Lab Neurobiol, Shanghai 200031, Peoples R China; [Chen, Gang; Sima, Jian; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Yuan, XB (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yuanxb@ion.ac.cn		Ding, Yu-Qiang/0000-0003-1202-4635; Yuan, Xiaobing/0000-0002-1632-8460; Zheng, Wang/0000-0002-7050-6133; Sima, Jian/0000-0002-4127-1638				Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Behar TN, 2001, CEREB CORTEX, V11, P744, DOI 10.1093/cercor/11.8.744; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; FISHELL G, 1991, DEVELOPMENT, V113, P755; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; GUIARRO P, 2006, MOL CELL NEUROSCI, V33, P389; Gupta A, 2003, NEUROSIGNALS, V12, P173, DOI 10.1159/000074618; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Jossin Y, 2003, J NEUROSCI, V23, P9953; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Petreanu L, 2002, J NEUROSCI, V22, P6106; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rakic P, 1998, J AM ACAD CHILD PSY, V37, P116, DOI 10.1097/00004583-199801000-00026; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	50	188	192	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					36	44		10.1038/nn2018	http://dx.doi.org/10.1038/nn2018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18059265				2022-12-28	WOS:000252117900010
J	Klein, ME; Lioy, DT; Ma, L; Impey, S; Mandel, G; Goodman, RH				Klein, Matthew E.; Lioy, Daniel T.; Ma, Lin; Impey, Soren; Mandel, Gail; Goodman, Richard H.			Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA	NATURE NEUROSCIENCE			English	Article							RETT-SYNDROME; MICE; DUPLICATION; MATURATION; DROSOPHILA; MALES	Both increases and decreases in methyl CpG-binding protein 2 (MeCP2) levels cause neurodevelopmental defects. We found that MeCP2 translation is regulated by microRNA 132 (miR132). Block of miR132- mediated repression increased MeCP2 and brain- derived neurotrophic factor (BDNF) levels in cultured rat neurons and the loss of MeCP2 reduced BDNF and miR132 levels in vivo. This feedback loop may provide a mechanism for homeostatic control of MeCP2 expression.	Oregon Hlth & Sci Univ, Vollurn Inst, Portland, OR 97239 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth & Sci Univ, Vollurn Inst, L-474,3181 SW Sam Jackson Rd, Portland, OR 97239 USA.	goodmanr@ohsu.edu	klein, matthew/GPS-5798-2022					Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006	15	355	386	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1513	1514		10.1038/nn2010	http://dx.doi.org/10.1038/nn2010			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994015				2022-12-28	WOS:000251172900006
J	Bhandawat, V; Olsen, SR; Gouwens, NW; Schlief, ML; Wilson, RI				Bhandawat, Vikas; Olsen, Shawn R.; Gouwens, Nathan W.; Schlief, Michelle L.; Wilson, Rachel I.			Sensory processing in the Drosophila antennal lobe increases reliability and separability of ensemble odor representations	NATURE NEUROSCIENCE			English	Article							OLFACTORY NETWORK DYNAMICS; PRIMARY VISUAL-CORTEX; RESPONSE VARIABILITY; CORTICAL-NEURONS; SYSTEM; MELANOGASTER; ORGANIZATION; INFORMATION; BULB; FLY	Here we describe several fundamental principles of olfactory processing in the Drosophila melanogaster antennal lobe (the analog of the vertebrate olfactory bulb), through the systematic analysis of input and output spike trains of seven identified glomeruli. Repeated presentations of the same odor elicit more reproducible responses in second-order projection neurons (PNs) than in their presynaptic olfactory receptor neurons (ORNs). PN responses rise and accommodate rapidly, emphasizing odor onset. Furthermore, weak ORN inputs are amplified in the PN layer but strong inputs are not. This nonlinear transformation broadens PN tuning and produces more uniform distances between odor representations in PN coding space. In addition, portions of the odor response profile of a PN are not systematically related to their direct ORN inputs, which probably indicates the presence of lateral connections between glomeruli. Finally, we show that a linear discriminator classifies odors more accurately using PN spike trains than using an equivalent number of ORN spike trains.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266; Olsen, Shawn/0000-0002-9568-7057	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174, F32DC008741] Funding Source: NIH RePORTER; NIDCD NIH HHS [1F32DC008471-01A1, F32 DC008741, R01 DC008174, R01 DC008174-02] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Berry MJ, 1998, J NEUROSCI, V18, P2200; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DERBY CD, 1984, J NEUROPHYSIOL, V51, P906, DOI 10.1152/jn.1984.51.5.906; DUCHAMP A, 1982, CHEM SENSES, V7, P191, DOI 10.1093/chemse/7.2.191; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Laissue PP, 1999, J COMP NEUROL, V405, P543; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MATHEWS DF, 1972, J GEN PHYSIOL, V60, P166; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogel A, 2005, J NEUROPHYSIOL, V93, P3548, DOI 10.1152/jn.01288.2004; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	48	223	225	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1474	1482		10.1038/nn1976	http://dx.doi.org/10.1038/nn1976			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17922008	Green Accepted			2022-12-28	WOS:000250508400026
J	Iadecola, C; Nedergaard, M				Iadecola, Costantino; Nedergaard, Maiken			Glial regulation of the cerebral microvasculature	NATURE NEUROSCIENCE			English	Review							NITRIC-OXIDE SYNTHASE; BLOOD-FLOW; NEURONAL-ACTIVITY; IN-VIVO; ASTROCYTE ENDFEET; SOMATOSENSORY STIMULATION; BRAIN MICROCIRCULATION; FUNCTIONAL HYPEREMIA; OXIDATIVE-METABOLISM; ALZHEIMERS-DISEASE	The brain is a heterogeneous organ with regionally varied and constantly changing energetic needs. Blood vessels in the brain are equipped with control mechanisms that match oxygen and glucose delivery through blood flow with the local metabolic demands that are imposed by neural activity. However, the cellular bases of this mechanism have remained elusive. A major advance has been the demonstration that astrocytes, cells with extensive contacts with both synapses and cerebral blood vessels, participate in the increases in flow evoked by synaptic activity. Their organization in nonoverlapping spatial domains indicates that they are uniquely positioned to shape the spatial distribution of the vascular responses that are evoked by neural activity. Astrocytic calcium is an important determinant of microvascular function and may regulate flow independently of synaptic activity. The involvement of astrocytes in neurovascular coupling has broad implications for the interpretation of functional imaging signals and for the understanding of brain diseases that are associated with neurovascular dysfunction.	Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY 10021 USA; Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Dept Neurosurg, Rochester, NY 14642 USA	Cornell University; University of Rochester	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, 411 E 69th St, New York, NY 10021 USA.	coi2001@med.cornell.edu; nedergaard@urmc.rochester.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037853, R01NS056188, P01NS050315] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL18974] Funding Source: Medline; NINDS NIH HHS [NS37853, NS56188, NS50315] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ances BM, 2004, J CEREBR BLOOD F MET, V24, P1, DOI 10.1097/01.WCB.0000103920.96801.12; Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; ARMSTEAD WM, 1989, CIRC RES, V64, P136, DOI 10.1161/01.RES.64.1.136; ASTRUP J, 1978, CIBA F S, V56, P313; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Valle-Rodriguez A, 2006, P NATL ACAD SCI USA, V103, P4316, DOI 10.1073/pnas.0508781103; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; GARCIAROLDAN JL, 1990, CIRC RES, V66, P1445, DOI 10.1161/01.RES.66.5.1445; GOLGI C, 1886, SULLA FINA ANATOMIA; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HARDER DR, 1988, PFLUG ARCH EUR J PHY, V411, P698, DOI 10.1007/BF00580870; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hill MA, 2007, TRENDS PHARMACOL SCI, V28, P308, DOI 10.1016/j.tips.2007.05.006; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; IADECOLA C, 2002, CEREBRAL BLOOD FLOW, P295; Iadecola C, 2007, NEURON, V54, P3, DOI 10.1016/j.neuron.2007.03.013; JONES EG, 1970, J ANAT, V106, P507; Kacem K, 1998, GLIA, V23, P1; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Leffler CW, 2006, AM J PHYSIOL-HEART C, V291, pH2897, DOI 10.1152/ajpheart.00722.2006; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LOVATT D, 2007, IN PRESS J NEUROSCI; Marrelli SP, 2001, AM J PHYSIOL-HEART C, V281, pH1759, DOI 10.1152/ajpheart.2001.281.4.H1759; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; MathieuCostello O, 1996, J APPL PHYSIOL, V80, P904, DOI 10.1152/jappl.1996.80.3.904; Metea MR, 2007, J NEUROSCI, V27, P2468, DOI 10.1523/JNEUROSCI.3204-06.2007; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; NGAI AC, 1988, AM J PHYSIOL, V254, P133; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Oz G, 2004, J NEUROSCI, V24, P11273, DOI 10.1523/JNEUROSCI.3564-04.2004; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Peters A., 1991, FINE STRUCTURE NERVO, P494; Phillis John W., 2004, Critical Reviews in Neurobiology, V16, P237, DOI 10.1615/CritRevNeurobiol.v16.i4.20; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; REIS DJ, 1991, ADV NEUROSC, V1, P523; ROGGENDORF W, 1976, P23; RUBIO R, 1975, AM J PHYSIOL, V228, P1896, DOI 10.1152/ajplegacy.1975.228.6.1896; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Simard M, 2003, J NEUROSCI, V23, P9254; Sloan Tod B, 2002, Anesthesiol Clin North Am, V20, P265, DOI 10.1016/S0889-8537(01)00002-5; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; TAMAKI K, 1986, AM J PHYSIOL, V251, pH1176, DOI 10.1152/ajpheart.1986.251.6.H1176; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang H, 2005, CEREB CORTEX, V15, P1250, DOI 10.1093/cercor/bhi008; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; WILLIAMS LR, 1989, CLIN PHYS PHYSIOL M, V10, P187, DOI 10.1088/0143-0815/10/3/001; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Xu HL, 2007, EXP PHYSIOL, V92, P647, DOI 10.1113/expphysiol.2006.036863; Yang G, 2003, AM J PHYSIOL-HEART C, V285, pH298, DOI 10.1152/ajpheart.00043.2003; Yang G, 2000, J NEUROSCI, V20, P6968, DOI 10.1523/JNEUROSCI.20-18-06968.2000; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	96	784	812	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1369	1376		10.1038/nn2003	http://dx.doi.org/10.1038/nn2003			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965657				2022-12-28	WOS:000250508400011
J	Soto, D; Coombs, ID; Kelly, L; Farrant, M; Cull-Candy, SG				Soto, David; Coombs, Ian D.; Kelly, Leah; Farrant, Mark; Cull-Candy, Stuart G.			Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors	NATURE NEUROSCIENCE			English	Article							FIBER-INTERNEURON SYNAPSES; LONG-TERM POTENTIATION; 2 DISTINCT MECHANISMS; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; CA2+ PERMEABILITY; SUBUNIT; NEURONS; CHANNELS; TRAFFICKING	Endogenous polyamines profoundly affect the activity of various ion channels, including that of calcium-permeable AMPA-type glutamate receptors (CP-AMPARs). Here we show that stargazin, a transmembrane AMPAR regulatory protein ( TARP) known to influence transport, gating and desensitization of AMPARs, greatly reduces block of CP-AMPARs by intracellular polyamines. By decreasing CP-AMPAR affinity for cytoplasmic polyamines, stargazin enhances the charge transfer following single glutamate applications and eliminates the frequency-dependent facilitation seen with repeated applications. In cerebellar stellate cells, which express both synaptic CP-AMPARs and stargazin, we found that the rectification and unitary conductance of channels underlying excitatory postsynaptic currents were matched by those of recombinant AMPARs only when the latter were associated with stargazin. Taken together, our observations establish modulatory actions of stargazin that are specific to CP-AMPARs, and suggest that during synaptic transmission the activity of such receptors, and thus calcium influx, is fundamentally changed by TARPs.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	m.farrant@ucl.ac.uk	Soto, David/L-4403-2014	Soto, David/0000-0001-7995-3805; Coombs, Ian/0000-0003-1006-7471; Cull-Candy, Stuart G/0000-0002-0831-8326; Farrant, Mark/0000-0002-9918-0376	Wellcome Trust [074340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Cu CH, 1998, NEUROPHARMACOLOGY, V37, P1381, DOI 10.1016/S0028-3908(98)00112-9; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Moss FJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-23; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Shin J, 2005, J NEUROPHYSIOL, V93, P2634, DOI 10.1152/jn.01054.2004; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	50	149	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1260	1267		10.1038/nn1966	http://dx.doi.org/10.1038/nn1966			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873873	Green Accepted			2022-12-28	WOS:000249720800012
J	Hojjati, MR; van Woerden, GM; Tyler, WJ; Giese, KP; Silva, AJ; Pozzo-Miller, L; Elgersma, Y				Hojjati, Mohammad Reza; van Woerden, Geeske M.; Tyler, William J.; Giese, Karl Peter; Silva, Alcino J.; Pozzo-Miller, Lucas; Elgersma, Ype			Kinase activity is not required for alpha CaMKII-dependent presynaptic plasticity at CA3-CA1 synapses	NATURE NEUROSCIENCE			English	Review							PROTEIN-KINASE; NEUROTRANSMITTER RELEASE; INHIBITOR	Using targeted mouse mutants and pharmacologic inhibition of alpha CaMKII, we demonstrate that the aCaMKII protein, but not its activation, autophosphorylation or its ability to phosphorylate synapsin I, is required for normal short-term presynaptic plasticity. Furthermore, aCaMKII regulates the number of docked vesicles independent of its ability to be activated. These results indicate that aCaMKII has a nonenzymatic role in short-term presynaptic plasticity at hippocampal CA3-CA1 synapses.	Erasmus Univ, Med Ctr, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; Shahrekord Univ Med Sci, Dept Physiol, Shahrekord 88155, Iran; Univ Alabama Birmingham, Civitan Int Res Ctr, Mcknight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA; Kings Coll London, Inst Psychiat, London SE5 9NU, England; Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat & Psychol, Los Angeles, CA 90095 USA	Erasmus University Rotterdam; Erasmus MC; Shahrekord University Medical Sciences; University of Alabama System; University of Alabama Birmingham; University of London; King's College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Elgersma, Y (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Giese, Karl P/A-3112-2011; Hojjati, Mohammad reza/B-9941-2013; Tyler, William/J-1818-2012; Silva, Alcino/ABD-7684-2021; Elgersma, Ype/F-5164-2013	Giese, Karl P/0000-0003-4503-7344; Hojjati, Mohammad reza/0000-0001-7889-2545; Silva, Alcino/0000-0002-1587-4558; Elgersma, Ype/0000-0002-3758-1297; Tyler, William/0000-0002-7758-5022; Pozzo-Miller, Lucas/0000-0001-6085-5527; Silva, Alcino/0000-0001-5525-0494	MRC [G0400983] Funding Source: UKRI; Medical Research Council [G0400983] Funding Source: Medline; NICHD NIH HHS [P30-HD38985, P30 HD038985] Funding Source: Medline; NINDS NIH HHS [P30 NS047466, R01 NS040593-09, P30-NS57098, P30 NS057098, R01 NS040593, P30-NS47466] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS040593, P30NS057098] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	15	34	35	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1125	1127		10.1038/nn1946	http://dx.doi.org/10.1038/nn1946			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660813	Green Accepted			2022-12-28	WOS:000249144000011
J	Agarwal, N; Pacher, P; Tegeder, I; Amaya, F; Constantin, CE; Brenner, GJ; Rubino, T; Michalski, CW; Marsicano, G; Monory, K; Mackie, K; Marian, C; Batkai, S; Parolaro, D; Fischer, MJ; Reeh, P; Kunos, G; Kress, M; Lutz, B; Woolf, CJ; Kuner, R				Agarwal, Nitin; Pacher, Pal; Tegeder, Irmgard; Amaya, Fumimasa; Constantin, Cristina E.; Brenner, Gary J.; Rubino, Tiziana; Michalski, Christoph W.; Marsicano, Giovanni; Monory, Krisztina; Mackie, Ken; Marian, Claudiu; Batkai, Sandor; Parolaro, Daniela; Fischer, Michael J.; Reeh, Peter; Kunos, George; Kress, Michaela; Lutz, Beat; Woolf, Clifford J.; Kuner, Rohini			Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; DORSAL-ROOT GANGLIA; NEUROPATHIC PAIN; ENDOGENOUS CANNABINOIDS; SPINAL NEURONS; KNOCKOUT MICE; WIN 55,212-2; RATS; CB1; HYPERALGESIA	Although endocannabinoids constitute one of the first lines of defense against pain, the anatomical locus and the precise receptor mechanisms underlying cannabinergic modulation of pain are uncertain. Clinical exploitation of the system is severely hindered by the cognitive deficits, memory impairment, motor disturbances and psychotropic effects resulting from the central actions of cannabinoids. We deleted the type 1 cannabinoid receptor (CB1) specifically in nociceptive neurons localized in the peripheral nervous system of mice, preserving its expression in the CNS, and analyzed these genetically modified mice in preclinical models of inflammatory and neuropathic pain. The nociceptor-specific loss of CB1 substantially reduced the analgesia produced by local and systemic, but not intrathecal, delivery of cannabinoids. We conclude that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects.	Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; NIH, NIAAA, Lab Physiol Studies, Bethesda, MD 20892 USA; Univ Frankfurt Klinikum, D-60590 Frankfurt, Germany; Massachusetts Gen Hosp, Harvard Med Sch, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Med Univ Innsbruck, Dept Physiol & Med Phys, Div Physiol, A-6020 Innsbruck, Austria; Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Harvard University; Massachusetts General Hospital; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Erlangen Nuremberg	Kuner, R (corresponding author), Univ Heidelberg, Inst Pharmacol, Im Neuenheimer Feld, D-69120 Heidelberg, Germany.	rohini.kuner@pharma.uni-heidelberg.de	amaya, fumimasa/AAD-7176-2020; Lutz, Beat/AAG-4538-2022; Fischer, Michael/F-7976-2010; Tegeder, Irmgard/AAM-2266-2020; Brenner, Gary/AAI-1293-2019; Rubino, Tiziana/AAC-8210-2020; Batkai, Sandor/H-7983-2014; Reeh, Peter W./J-8981-2012; Lutz, Beat/AFK-6229-2022; Kuner, Rohini/AGU-0204-2022; Mackie, Kenneth P/B-7358-2011; Pacher, Pal/B-6378-2008; Batkai, Sandor/G-3889-2010; Marsicano, Giovanni/I-9603-2016; Michalski, Christoph/U-9167-2019; Tegeder, Irmgard/AAM-2246-2020; Woolf, Clifford/A-9784-2010; Mackie, Ken/E-3715-2013; Fischer, Michael J.M./P-8715-2014	Tegeder, Irmgard/0000-0001-7524-8025; Brenner, Gary/0000-0002-4586-1723; Reeh, Peter W./0000-0002-4367-094X; Pacher, Pal/0000-0001-7036-8108; Tegeder, Irmgard/0000-0001-7524-8025; Mackie, Ken/0000-0001-8501-6199; Fischer, Michael J.M./0000-0002-3811-7066; RUBINO, Tiziana/0000-0002-3128-6377; amaya, fumimasa/0000-0003-2934-0845; Kress, Michaela/0000-0002-8921-7470; Marsicano, Giovanni/0000-0003-3804-1951	Intramural NIH HHS [Z01 AA000375-02] Funding Source: Medline; NIDA NIH HHS [DA00286, K02 DA000286-04, R01 DA011322-02, DA11322, R01 DA011322, K02 DA000286] Funding Source: Medline; NINDS NIH HHS [R37 NS039518, R01 NS038253-01S1, NS 038253, R01 NS039518, R01 NS039518-01A2, R01 NS038253, NS039518] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R01NS039518, R37NS039518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000350, Z01AA000375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000286, R01DA011322] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Binzen U, 2006, NEUROSCIENCE, V142, P527, DOI 10.1016/j.neuroscience.2006.06.020; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dogrul A, 2003, PAIN, V105, P11, DOI 10.1016/S0304-3959(03)00068-X; Finn DP, 2003, NEUROPHARMACOLOGY, V45, P594, DOI 10.1016/S0028-3908(03)00235-1; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Ibrahim MM, 2006, PAIN, V122, P36, DOI 10.1016/j.pain.2005.12.018; Janson W., 2003, Current Pharmaceutical Biotechnology, V4, P270, DOI 10.2174/1389201033489766; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Johanek LM, 2001, PAIN, V93, P303, DOI 10.1016/S0304-3959(01)00336-0; Kolesnikov YA, 1996, J PHARMACOL EXP THER, V279, P502; Kress M, 1999, J NEUROPHYSIOL, V81, P2612, DOI 10.1152/jn.1999.81.6.2612; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MARTIN WJ, 1993, BRAIN RES, V629, P300, DOI 10.1016/0006-8993(93)91334-O; Martin WJ, 1999, PAIN, V82, P199, DOI 10.1016/S0304-3959(99)00045-7; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pascual D, 2005, PAIN, V118, P23, DOI 10.1016/j.pain.2005.07.008; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; PERTWEE RG, 1972, BRIT J PHARMACOL, V46, P753, DOI 10.1111/j.1476-5381.1972.tb06900.x; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Quartilho A, 2003, ANESTHESIOLOGY, V99, P955, DOI 10.1097/00000542-200310000-00031; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Rubino T, 2000, J NEUROCHEM, V75, P2080, DOI 10.1046/j.1471-4159.2000.0752080.x; SHIRE D, 1995, J BIOL CHEM, V270, P3726, DOI 10.1074/jbc.270.8.3726; Sokal DM, 2003, NEUROPHARMACOLOGY, V45, P404, DOI 10.1016/S0028-3908(03)00195-3; TSAY DG, 1987, INVEST RADIOL, V22, P556, DOI 10.1097/00004424-198707000-00005; Ulugol A, 2004, NEUROSCI LETT, V371, P167, DOI 10.1016/j.neulet.2004.08.061; Valiveti S, 2004, PHARM RES-DORDR, V21, P1137, DOI 10.1023/B:PHAM.0000032999.31948.2e; Walker JM, 2005, HANDB EXP PHARMACOL, V168, P509; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	46	422	441	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					870	879		10.1038/nn1916	http://dx.doi.org/10.1038/nn1916			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558404	Green Accepted			2022-12-28	WOS:000247560200017
J	Newman-Norlund, RD; van Schie, HT; van Zuijlen, AMJ; Bekkering, H				Newman-Norlund, Roger D.; van Schie, Hein T.; van Zuijlen, Alexander M. J.; Bekkering, Harold			The mirror neuron system is more active during complementary compared with imitative action	NATURE NEUROSCIENCE			English	Editorial Material							MOTOR	We assessed the role of the human mirror neuron system (MNS) in complementary actions using functional magnetic resonance imaging while participants prepared to execute imitative or complementary actions. The BOLD signal in the right inferior frontal gyrus and bilateral inferior parietal lobes was greater during preparation of complementary than during imitative actions, suggesting that the MNS may be essential in dynamically coupling action observation to action execution.	Radboud Univ Nijmegen, Nijmegen Inst Cognit Res & Informat, NL-6500 HE Nijmegen, Netherlands; Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Newman-Norlund, RD (corresponding author), Radboud Univ Nijmegen, Nijmegen Inst Cognit Res & Informat, PO Box 9104, NL-6500 HE Nijmegen, Netherlands.	rogern@nici.ru.nl	Bekkering, Harold/A-6357-2009; van Schie, Hein T/D-2281-2010; Galantucci, Bruno/E-5770-2010					Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048	13	251	254	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					817	818		10.1038/nn1911	http://dx.doi.org/10.1038/nn1911			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529986				2022-12-28	WOS:000247560200010
J	Semenova, MM; Maki-Hokkonen, AMJ; Cao, J; Komarovski, V; Forsberg, KM; Koistinaho, M; Coffey, ET; Courtney, MJ				Semenova, Maria M.; Maki-Hokkonen, Anu M. J.; Cao, Jiong; Komarovski, Vladislav; Forsberg, K. Marjut; Koistinaho, Milla; Coffey, Eleanor T.; Courtney, Michael J.			Rho mediates calcium-dependent activation of p38 alpha and subsequent excitotoxic cell death	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE NEURONS; N-TERMINAL KINASE; BOTULINUM C3 EXOENZYME; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; SERINE/THREONINE KINASE; CORTICAL CULTURES; CEREBRAL-ISCHEMIA; AXON REGENERATION; FAMILY GTPASES	Excitotoxic neuronal death contributes to many neurological disorders, and involves calcium influx and stress-activated protein kinases (SAPKs) such as p38 alpha. There is indirect evidence that the small Rho-family GTPases Rac and cdc42 are involved in neuronal death subsequent to the withdrawal of nerve growth factor (NGF), whereas Rho is involved in the inhibition of neurite regeneration and the release of the amyloidogenic A beta(42) peptide. Here we show that Rho is activated in rat neurons by conditions that elevate intracellular calcium and in the mouse cerebral cortex during ischemia. Rho is required for the rapid glutamate-induced activation of p38a and ensuing neuronal death. The ability of RhoA to activate p38 alpha was not expected, and it was specific to primary neuronal cultures. The expression of active RhoA alone not only activated p38 alpha but also induced neuronal death that was sensitive to the anti-apoptotic protein Bcl-2, showing that RhoA was sufficient to induce the excitotoxic pathway. Therefore, Rho is an essential component of the excitotoxic cell death pathway.	Univ Kuopio, AI Virtanen Inst, Dept Neurobiol, FIN-70211 Kuopio, Finland; Medeia Therapeut Ltd, FI-40211 Kuopio, Finland; Abo Akad Univ, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; Univ Turku, FIN-20521 Turku, Finland	University of Eastern Finland; Abo Akademi University; University of Turku	Courtney, MJ (corresponding author), Univ Kuopio, AI Virtanen Inst, Dept Neurobiol, FIN-70211 Kuopio, Finland.	courtney@messi.uku.fi	Courtney, Michael J/D-6648-2016	Courtney, Michael J/0000-0001-8693-3933; Coffey, Eleanor/0000-0002-9717-5610				Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bazenet CE, 1998, P NATL ACAD SCI USA, V95, P3984, DOI 10.1073/pnas.95.7.3984; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; COURTNEY MJ, 1990, J NEUROSCI, V10, P3873, DOI 10.1523/JNEUROSCI.10-12-03873.1990; Courtney MJ, 1997, J NEUROSCI, V17, P4201; CSERNANSKY CA, 1994, J NEUROSCI RES, V38, P101, DOI 10.1002/jnr.490380113; Dawson VL, 1996, J NEUROSCI, V16, P2479; Didenko VV, 2002, MOL MED, V8, P347, DOI 10.1007/BF03402015; Fukuda T, 1999, NEUROSCI RES, V33, P49, DOI 10.1016/S0168-0102(98)00111-4; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jeon S, 2002, J BIOL CHEM, V277, P16576, DOI 10.1074/jbc.M110380200; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Legos JJ, 2001, BRAIN RES, V892, P70, DOI 10.1016/S0006-8993(00)03228-5; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Lobner D, 1996, NEUROSCIENCE, V72, P335, DOI 10.1016/0306-4522(95)00561-7; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Palmer GC, 2000, AMINO ACIDS, V19, P151, DOI 10.1007/s007260070043; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sohn S, 1998, NEUROSCI LETT, V240, P147, DOI 10.1016/S0304-3940(97)00936-1; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Wilde C, 2000, J BIOL CHEM, V275, P16478, DOI 10.1074/jbc.M910362199; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Zong H, 1999, J BIOL CHEM, V274, P4551, DOI 10.1074/jbc.274.8.4551	50	100	104	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					436	443		10.1038/nn1869	http://dx.doi.org/10.1038/nn1869			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369826				2022-12-28	WOS:000245228600014
J	Lai, J; Luo, MC; Chen, QM; Ma, SW; Gardell, LR; Ossipov, MH; Porreca, F				Lai, Josephine; Luo, Miaw-Chyi; Chen, Qingmin; Ma, Shouwu; Gardell, Luis R.; Ossipov, Michael H.; Porreca, Frank			Dynorphin A activates bradykinin receptors to maintain neuropathic pain	NATURE NEUROSCIENCE			English	Article							RAT SENSORY NEURONS; DEPENDENT PROTEIN-KINASE; DORSAL-ROOT-GANGLIA; CALCIUM-CHANNELS; SPINAL-CORD; OPIOID RECEPTOR; PROSTAGLANDIN E-2; ENDOGENOUS LIGAND; CELLS; RELEASE	Dynorphin A is an endogenous opioid peptide that produces non-opioid receptor-mediated neural excitation. Here we demonstrate that dynorphin induces calcium influx via voltage-sensitive calcium channels in sensory neurons by activating bradykinin receptors. This action of dynorphin at bradykinin receptors is distinct from the primary signaling pathway activated by bradykinin and underlies the hyperalgesia produced by pharmacological administration of dynorphin by the spinal route in rats and mice. Blockade of spinal B1 or B2 receptor also reverses persistent neuropathic pain but only when there is sustained elevation of endogenous spinal dynorphin, which is required for maintenance of neuropathic pain. These data reveal a mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention.	Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona Health Sciences	Lai, J (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	lai@u.arizona.edu						Austin CE, 1997, J BIOL CHEM, V272, P11420; Banik RK, 2001, J NEUROPHYSIOL, V86, P2727, DOI 10.1152/jn.2001.86.6.2727; BEAUMONT A, 1979, ANNU REV PHARMACOL, V19, P245, DOI 10.1146/annurev.pa.19.040179.001333; BOTTICELLI LJ, 1981, P NATL ACAD SCI-BIOL, V78, P7783, DOI 10.1073/pnas.78.12.7783; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Cloutier F, 2002, BRIT J PHARMACOL, V135, P1641, DOI 10.1038/sj.bjp.0704632; CORBETT AD, 1982, NATURE, V299, P79, DOI 10.1038/299079a0; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Evans AR, 1996, BRAIN RES, V712, P265, DOI 10.1016/0006-8993(95)01447-0; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FALCONE RC, 1993, J PHARMACOL EXP THER, V266, P1291; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Fox A, 2003, PAIN, V104, P683, DOI 10.1016/S0304-3959(03)00141-6; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Gardell LR, 2002, J NEUROSCI, V22, P6747; GOLDSTEIN A, 1979, P NATL ACAD SCI USA, V76, P6666, DOI 10.1073/pnas.76.12.6666; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; HERMAN BH, 1985, J PHARMACOL EXP THER, V232, P27; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Koetzner L, 2004, J NEUROSCI, V24, P1451, DOI 10.1523/JNEUROSCI.1517-03.2004; LAI J, 1988, LIFE SCI, V42, P2489, DOI 10.1016/0024-3205(88)90348-7; Liebmann C, 1996, BIOCHEM J, V313, P109, DOI 10.1042/bj3130109; Linhart O, 2003, NEUROSCIENCE, V118, P69, DOI 10.1016/S0306-4522(02)00960-0; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; Marceau F, 1998, PHARMACOL REV, V50, P357; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; QUIRION R, 1984, EUR J PHARMACOL, V99, P361, DOI 10.1016/0014-2999(84)90148-1; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Simasko SM, 1999, BRAIN RES, V824, P89, DOI 10.1016/S0006-8993(99)01188-9; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; STEVENS CW, 1987, EUR J PHARMACOL, V138, P299, DOI 10.1016/0014-2999(87)90449-3; Tang QB, 2000, J NEUROPHYSIOL, V83, P2610, DOI 10.1152/jn.2000.83.5.2610; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Vanderah TW, 2000, J NEUROSCI, V20, P7074, DOI 10.1523/JNEUROSCI.20-18-07074.2000; VASKO MR, 1994, J NEUROSCI, V14, P4987; WALKER JM, 1982, SCIENCE, V218, P1136, DOI 10.1126/science.6128791; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Wetzel CH, 2001, EUR J NEUROSCI, V14, P1056, DOI 10.1046/j.0953-816x.2001.01722.x; Wotherspoon G, 2000, NEUROSCI LETT, V294, P175, DOI 10.1016/S0304-3940(00)01561-5; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Zanner R, 2002, AM J PHYSIOL-CELL PH, V282, pC374, DOI 10.1152/ajpcell.00366.2001; Zhang SW, 1998, J PHARMACOL EXP THER, V286, P136	50	118	125	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1534	1540		10.1038/nn1804	http://dx.doi.org/10.1038/nn1804			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115041				2022-12-28	WOS:000242404000018
J	Rubino, D; Robbins, KA; Hatsopoulos, NG				Rubino, Doug; Robbins, Kay A.; Hatsopoulos, Nicholas G.			Propagating waves mediate information transfer in the motor cortex	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; FRONTAL-LOBE INPUTS; SENSORIMOTOR CORTEX; CORTICAL PROJECTIONS; OSCILLATIONS; SYNCHRONIZATION; ACTIVATION; DYNAMICS; REPRESENTATIONS; RESPONSES	High-frequency oscillations in the beta range (10-45 Hz) are most active in motor cortex during motor preparation and are postulated to reflect the steady postural state or global attentive state of the animal. By simultaneously recording multiple local field potential signals across the primary motor and dorsal premotor cortices of monkeys (Macaca mulatta) trained to perform an instructed-delay reaching task, we found that these oscillations propagated as waves across the surface of the motor cortex along dominant spatial axes characteristic of the local circuitry of the motor cortex. Moreover, we found that information about the visual target to be reached was encoded in terms of both latency and amplitude of evoked waves at a time when the field phase-locked with respect to the target onset. These findings suggest that high-frequency oscillations may subserve intra- and intercortical information transfer during movement preparation and execution.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Texas, Dept Comp Sci, San Antonio, TX 78249 USA	University of Chicago; University of Texas System	Hatsopoulos, NG (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	nicho@uchicago.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045853] Funding Source: NIH RePORTER; NCRR NIH HHS [2G12RR1364-06A1] Funding Source: Medline; NINDS NIH HHS [R01 NS045853, R01 NS45853-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Cauller LJ, 1998, J COMP NEUROL, V390, P297; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Cover TM, 1991, ELEMENTS INFORM THEO; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Du XX, 2006, IEEE T BIO-MED ENG, V53, P1688, DOI 10.1109/TBME.2006.877796; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLEET DJ, 1990, INT J COMPUT VISION, V5, P77, DOI 10.1007/BF00056772; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Ghosh S, 1995, SOMATOSENS MOT RES, V12, P359, DOI 10.3109/08990229509093668; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2001, J CLIN NEUROPHYSIOL, V18, P559, DOI 10.1097/00004691-200111000-00006; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Robbins KA, 2004, J COMPUT NEUROSCI, V16, P267, DOI 10.1023/B:JCNS.0000025689.01581.26; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Senseman D M, 1999, J Neurosci, V19, pRC3; Senseman DM, 2002, J NEUROPHYSIOL, V87, P1499, DOI 10.1152/jn.00475.2001; Wang WX, 2005, J COMPUT NEUROSCI, V19, P263, DOI 10.1007/s10827-005-2288-5; Wu JY, 1999, J NEUROSCI, V19, P5005	38	302	304	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1549	1557		10.1038/nn1802	http://dx.doi.org/10.1038/nn1802			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115042				2022-12-28	WOS:000242404000020
J	Custer, SK; Garden, GA; Gill, N; Rueb, U; Libby, RT; Schultz, C; Guyenet, SJ; Deller, T; Westrum, LE; Sopher, BL; La Spada, AR				Custer, Sara K.; Garden, Gwenn A.; Gill, Nishi; Rueb, Udo; Libby, Randell T.; Schultz, Christian; Guyenet, Stephan J.; Deller, Thomas; Westrum, Lesnick E.; Sopher, Bryce L.; La Spada, Albert R.			Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; ASTROCYTE-SPECIFIC EXPRESSION; TRANSGENIC MICE; MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; NERVOUS-SYSTEM; DEGENERATION; SUBTYPES; NEURONS	Non-neuronal cells may be pivotal in neurodegenerative disease, but the mechanistic basis of this effect remains ill-defined. In the polyglutamine disease spinocerebellar ataxia type 7 (SCA7), Purkinje cells undergo non-cell-autonomous degeneration in transgenic mice. We considered the possibility that glial dysfunction leads to Purkinje cell degeneration, and generated mice that express ataxin-7 in Bergmann glia of the cerebellum with the Gfa2 promoter. Bergmann glia-specific expression of mutant ataxin-7 was sufficient to produce ataxia and neurodegeneration. Expression of the Bergmann glia-specific glutamate transporter GLAST was reduced in Gfa2-SCA7 mice and was associated with impaired glutamate transport in cultured Bergmann glia, cerebellar slices and cerebellar synaptosomes. Ultrastructural analysis of Purkinje cells revealed findings of dark cell degeneration consistent with excitotoxic injury. Our studies indicate that impairment of glutamate transport secondary to glial dysfunction contributes to SCA7 neurodegeneration, and suggest a similar role for glial dysfunction in other polyglutamine diseases and SCAs.	Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Neurol Neurogenet, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA; Goethe Univ Frankfurt, Dept Clin Neuroanat, D-60590 Frankfurt, Germany; Univ Washington, Med Ctr, Dept Neurosurg, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Med Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Goethe University Frankfurt; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020; Garden, Gwenn/CAF-9344-2022	Garden, Gwenn/0000-0002-8753-6515	NATIONAL EYE INSTITUTE [R01EY014061] Funding Source: NIH RePORTER; NEI NIH HHS [EY14061] Funding Source: Medline; NICHD NIH HHS [P30 HD02774] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brenner Michael, 1996, Methods (Orlando), V10, P351, DOI 10.1006/meth.1996.0113; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Duan SM, 1999, J NEUROSCI, V19, P10193; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Furuta A, 1997, J NEUROSCI, V17, P8363; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LERANTH C, 1970, ACTA BIOL ACAD SCI H, V21, P405; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; ORTEGA A, 1991, NEUROSCIENCE, V41, P335, DOI 10.1016/0306-4522(91)90331-H; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Probst-Cousin S, 2004, J NEUROL NEUROSUR PS, V75, P503, DOI 10.1136/jnnp.2003.011825; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Robinson M B, 1997, Adv Pharmacol, V37, P69; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Shimada F, 1999, EUR J PHARMACOL, V386, P263, DOI 10.1016/S0014-2999(99)00735-9; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Strahlendorf JC, 1998, NEUROCHEM RES, V23, P1355, DOI 10.1023/A:1020742404945; Strahlendorf JC, 1999, NEUROSCI RES, V33, P155, DOI 10.1016/S0168-0102(98)00126-6; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Yamada K, 2000, J COMP NEUROL, V418, P106; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	49	178	179	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1302	1311		10.1038/nn1750	http://dx.doi.org/10.1038/nn1750			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16936724				2022-12-28	WOS:000241493900024
J	Sosa, L; Dupraz, S; Laurino, L; Bollati, F; Bisbal, M; Caceres, A; Pfenninger, KH; Quiroga, S				Sosa, Lucas; Dupraz, Sebastian; Laurino, Lisandro; Bollati, Flavia; Bisbal, Mariano; Caceres, Alfredo; Pfenninger, Karl H.; Quiroga, Santiago			IGF-1 receptor is essential for the establishment of hippocampal neuronal polarity	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; BETA-SUBUNIT VARIANT; MEMBRANE EXPANSION; ACTIVATION; BRAIN; CONE; GENE	How a neuron becomes polarized remains largely unknown. Results obtained with a function-blocking antibody and an siRNA targeting the insulin-like growth factor-1 (IGF-1) receptor suggest that an essential step in the establishment of hippocampal neuronal polarity and the initiation of axonal outgrowth is the activation of the phosphatidylinositol 3-kinase (PI3k)-Cdc42 pathway by the IGF-1 receptor, but not by the TrkA or TrkB receptors.	Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina; Consejo Nacl Invest Cient & Tecn, CIQUIBIC, Cordoba, Argentina; Consejo Nacl Invest Cient & Tecn, INIMEC, Cordoba, Argentina; Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; Univ Colorado, Ctr Canc, Aurora, CO 80045 USA	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Quiroga, S (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina.	squiroga@dqbfcq.uncor.edu	Bisbal, Mariano/AAE-9308-2021	Bisbal, Mariano/0000-0002-3870-6151; Sosa, Lucas/0000-0002-9153-7537	FIC NIH HHS [1R03 TW05763] Funding Source: Medline; NINDS NIH HHS [R01 NS41029] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW005763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041029] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Mascotti F, 1997, J NEUROSCI, V17, P1447; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; QUIROGA S, 1995, P NATL ACAD SCI USA, V92, P4309, DOI 10.1073/pnas.92.10.4309; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	15	106	106	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					993	995		10.1038/nn1742	http://dx.doi.org/10.1038/nn1742			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845384				2022-12-28	WOS:000240080300007
J	Vandenbulcke, M; Peeters, R; Fannes, K; Vandenberghe, R				Vandenbulcke, Mathieu; Peeters, Ronald; Fannes, Katrien; Vandenberghe, Rik			Knowledge of visual attributes in the right hemisphere	NATURE NEUROSCIENCE			English	Article							MEANING SYSTEMS; CATEGORIES; MODALITY; COLOR; NEUROPSYCHOLOGY; IMPAIRMENTS; GENERATION; RETRIEVAL; APHASIA; PATIENT	Neurobiological theories of knowledge processing are biased toward the language-dominant ( usually the left) hemisphere. Does the right hemisphere critically contribute to knowledge processing? J.A. is a left-hemisphere language-dominant individual who suffered a lesion confined to the right mid- and anterior fusiform gyrus. Although her language abilities are intact, she showed a partial loss of knowledge of the visual attributes of biological and nonbiological entities. This was observed regardless of the task performed: object discrimination, oral feature generation, forced-choice naming-to-definition or free-hand drawing. Functional-associative and nonvisual sensory attributes were spared. The same region that was lesioned in J.A. was activated in a functional magnetic resonance imaging study in 27 volunteers who retrieved semantic associations between concepts, but only if the concepts were represented as pictures and not as words. Therefore, right fusiform gyrus critically contributes to the conscious recollection of visual attributes of familiar entities.	Katholieke Univ Leuven, Cognit Neurol Lab, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Psychiat, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Radiol, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Neurol, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Vandenberghe, R (corresponding author), Katholieke Univ Leuven, Cognit Neurol Lab, Herestr 49, B-3000 Louvain, Belgium.	rik.vandenberghe@uz.kuleuven.ac.be	Vandenberghe, Rik/AAR-7485-2020; Vandenberghe, Rik/K-2145-2014	Vandenberghe, Rik/0000-0001-6237-2502; Vandenberghe, Rik/0000-0001-6237-2502				Allport D.A., 1985, CURRENT PERSPECTIVES, P32; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; BREEDIN SD, 1994, COGNITIVE NEUROPSYCH, V11, P617, DOI 10.1080/02643299408251987; Caramazza A., 2000, NEW COGNITIVE NEUROS, P1037; Carbonnel S, 1997, CORTEX, V33, P391, DOI 10.1016/S0010-9452(08)70227-2; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; FAGLIONI P, 1993, CORTEX, V29, P501, DOI 10.1016/S0010-9452(13)80256-0; Farah M., 2004, VISUAL AGNOSIA, V2nd; FARAH MJ, 1984, COGNITION, V18, P245, DOI 10.1016/0010-0277(84)90026-X; Forde EME, 1997, COGNITIVE NEUROPSYCH, V14, P403, DOI 10.1080/026432997381538; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HART J, 1992, NATURE, V359, P60, DOI 10.1038/359060a0; HILLIS AE, 1991, BRAIN, V114, P2081, DOI 10.1093/brain/114.5.2081; Howard D., 1992, PYRAMID PALM TREES T; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; JACKENDOFF R, 1987, COGNITION, V26, P89, DOI 10.1016/0010-0277(87)90026-6; KOSSLYN SM, 1977, COGNITIVE PSYCHOL, V9, P52, DOI 10.1016/0010-0285(77)90004-4; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Laiacona M, 2001, COGNITIVE NEUROPSYCH, V18, P39, DOI 10.1080/02643290042000035; Lauro-Grotto R, 1997, CORTEX, V33, P593, DOI 10.1016/S0010-9452(08)70720-2; LUZZATTI C, 1994, NEUROPSYCHOLOGIA, V32, P933, DOI 10.1016/0028-3932(94)90044-2; Marr D., 1982, VISION; MCCARTHY RA, 1988, NATURE, V334, P428, DOI 10.1038/334428a0; MCKENNA P, 2000, HDB NEUROPSYCHOLOGY, V2, P355; Miceli G, 2001, NAT NEUROSCI, V4, P662, DOI 10.1038/88497; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; POWELL J, 1995, MEMORY, V3, P435, DOI 10.1080/09658219508253160; Pylyshyn Z.W., 2003, SEEING VISUALIZING I; RIDDOCH MJ, 1987, COGN NEUROPSYCHOL, V4, P131, DOI 10.1080/02643298708252038; Riddoch MJ., 1993, BORB BIRMINGHAM OBJE; Ruts W, 2004, BEHAV RES METH INS C, V36, P506, DOI 10.3758/BF03195597; Saffran E. M., 1999, NEUROCOGNITION LANGU, P241; SARTORI G, 1988, COGNITIVE NEUROPSYCH, V5, P105, DOI 10.1080/02643298808252928; SERGENT J, 1990, BRAIN COGNITION, V13, P98, DOI 10.1016/0278-2626(90)90043-N; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Vandenbulcke M, 2005, ANN NEUROL, V58, P362, DOI 10.1002/ana.20588; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; WARRINGTON EK, 1994, NEUROPSYCHOLOGIA, V32, P1465, DOI 10.1016/0028-3932(94)90118-X; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Warrington EK., 1991, VISUAL OBJECT SPACE	49	53	53	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					964	970		10.1038/nn1721	http://dx.doi.org/10.1038/nn1721			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	057IZ	16767090	Green Published			2022-12-28	WOS:000238590800024
J	Smith, KM; Ohkubo, Y; Maragnoli, ME; Rasin, MR; Schwartz, ML; Sestan, N; Vaccarino, FM				Smith, Karen Mueller; Ohkubo, Yasushi; Maragnoli, Maria Elisabetta; Rasin, Mladen-Roko; Schwartz, Michael L.; Sestan, Nenad; Vaccarino, Flora M.			Midline radial glia translocation and corpus callosum formation require FGF signaling	NATURE NEUROSCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; ABNORMAL-DEVELOPMENT; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; CELLS; GENERATION; EXPRESSION; NEOCORTEX; AXONS; CRE	Midline astroglia in the cerebral cortex develop earlier than other astrocytes through mechanisms that are still unknown. We show that radial glia in dorsomedial cortex retract their apical endfeet at midneurogenesis and translocate to the overlaying pia, forming the indusium griseum. These cells require the fibroblast growth factor receptor 1 (Fgfr1) gene for their precocious somal translocation to the dorsal midline, as demonstrated by inactivating the Fgfr1 gene in radial glial cells and by RNAi knockdown of Fgfr1 in vivo. Dysfunctional astroglial migration underlies the callosal dysgenesis in conditional Fgfr1 knockout mice, suggesting that precise targeting of astroglia to the cortex has unexpected roles in axon guidance. FGF signaling is sufficient to induce somal translocation of radial glial cells throughout the cortex; furthermore, the targeting of astroglia to dorsolateral cortex requires FGFr2 signaling after neurogenesis. Hence, FGFs have an important role in the transition from radial glia to astrocytes by stimulating somal translocation of radial glial cells.	Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Vaccarino, FM (corresponding author), Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA.	flora.vaccarino@yale.edu		Vaccarino, Flora/0000-0003-2167-981X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067715, T32MH018268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035476, R01NS054273] Funding Source: NIH RePORTER; NICHD NIH HHS [HD045481] Funding Source: Medline; NIMH NIH HHS [MH067715, 5T32-MH18268] Funding Source: Medline; NINDS NIH HHS [NS054273, NS35476] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cheng YH, 2002, EUR J NEUROSCI, V15, P3, DOI 10.1046/j.0953-816x.2001.01832.x; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gregg C, 2003, J NEUROSCI, V23, P11587; Hasegawa H, 2004, J NEUROSCI, V24, P8711, DOI 10.1523/JNEUROSCI.3070-04.2004; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; Huffman KJ, 2004, J NEUROSCI, V24, P8917, DOI 10.1523/JNEUROSCI.2086-04.2004; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Minowada G, 1999, DEVELOPMENT, V126, P4465; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Morrow T, 2001, DEVELOPMENT, V128, P3585; Ohkubo Y, 2004, J NEUROSCI, V24, P6057, DOI 10.1523/JNEUROSCI.1140-04.2004; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Ornitz DM, 2001, GENOME BIOL, V2; OZAKI HS, 1992, J COMP NEUROL, V323, P81, DOI 10.1002/cne.903230107; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Raballo R, 2000, J NEUROSCI, V20, P5012; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schmid RS, 2006, GLIA, V53, P345, DOI 10.1002/glia.20274; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shin DM, 2004, J NEUROSCI, V24, P2247, DOI 10.1523/JNEUROSCI.5285-03.2004; Shu TZ, 2003, J NEUROBIOL, V57, P81, DOI 10.1002/neu.10252; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2003, J NEUROSCI, V23, P203; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; SILVER J, 1983, SCIENCE, V220, P1067, DOI 10.1126/science.6844928; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Webber CA, 2003, DEV BIOL, V263, P24, DOI 10.1016/S0012-1606(03)00435-4; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	50	106	107	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					787	797		10.1038/nn1705	http://dx.doi.org/10.1038/nn1705			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715082				2022-12-28	WOS:000237895200019
J	Xu, HX; Delling, M; Jun, JC; Clapham, DE				Xu, HX; Delling, M; Jun, JC; Clapham, DE			Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels	NATURE NEUROSCIENCE			English	Article							GATED ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; CELLS; RECEPTOR; KERATINOCYTES; HEAT; CURRENTS; THERMOSENSATION; MECHANISMS; STIMULI	Carvacrol, eugenol and thymol are major components of plants such as oregano, savory, clove and thyme. When applied to the tongue, these flavors elicit a warm sensation. They are also known to be skin sensitizers and allergens. The transient receptor potential channel (TRPV3) is a warm-sensitive Ca2+-permeable cation channel highly expressed in the skin, tongue and nose. Here we show that TRPV3 is strongly activated and sensitized by carvacrol, thymol and eugenol. Tongue and skin epithelial cells respond to carvacrol and eugenol with an increase in intracellular Ca2+ levels. We also show that this TRPV3 activity is strongly potentiated by phospholipase C-linked, G protein-coupled receptor stimulation. In addition, carvacrol activates and rapidly desensitizes TRPA1, which may explain the pungency of oregano. Our results support a role for temperature-sensitive TRP channels in chemesthesis in oral and nasal epithelium and suggest that TRPV3 may be a molecular target of plant-derived skin sensitizers.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Belitz H. D., 2004, FOOD CHEM, V3rd, DOI [DOI 10.1007/978-3-540-69934-7, 10.1007/978-3-540-69934-7]; Berova N, 1990, Dermatol Monatsschr, V176, P15; BRYANT B, 2000, NEUROBIOLOGY TASTE S; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Corsini E, 1998, TOXICOLOGY, V129, P193, DOI 10.1016/S0300-483X(98)00088-2; CORSINI E, 1998, TOXICOL LETT, V102, P277; Effendy I, 2000, J APPL TOXICOL, V20, P335, DOI 10.1002/1099-1263(200007/08)20:4<335::AID-JAT698>3.0.CO;2-L; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; FINGER TE, 2000, NEUROBIOLOGY TASTE S; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang YJ, 2005, CHEM SENSES, V30, pI39, DOI 10.1093/chemse/bjh102; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Scholl I, 2004, INT ARCH ALLERGY IMM, V135, P247, DOI 10.1159/000081950; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; YUSPA SH, 1983, J INVEST DERMATOL, V81, pS162, DOI 10.1111/1523-1747.ep12540999; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	39	456	474	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					628	635		10.1038/nn1692	http://dx.doi.org/10.1038/nn1692			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617338				2022-12-28	WOS:000237417200013
J	Yudowski, GA; Puthenveedu, MA; von Zastrow, M				Yudowski, GA; Puthenveedu, MA; von Zastrow, M			Distinct modes of regulated receptor insertion to the somatodendritic plasma membrane	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; SYNAPTIC PLASTICITY; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; OPIOID RECEPTORS; AMPA RECEPTORS; SECRETORY GRANULES; ENDOCYTOSIS; RESENSITIZATION; MECHANISM	Many neural signaling receptors are regulated by endocytosis, but little is known about receptor insertion into the plasma membrane. Time-lapse imaging of the beta 2 adrenergic receptor expressed in cultured rat hippocampal neurons, using pH-sensitive green fluorescent protein tagging and total internal reflection fluorescence microscopy, resolved distinct vesicular fusion events mediating receptor insertion into the somatodendritic plasma membrane. A 'transient' insertion mode resulted in rapid lateral dispersion of receptors immediately after insertion. A 'persistent' insertion mode resulted in the retention of inserted receptors in surface-accessible domains, which were relatively immobile for a prolonged 'wait' period before dispersing laterally. Distinct insertion modes were oppositely regulated by receptor activation and by mechanisms differing in their dependence on the signaling effector cyclic AMP-dependent protein kinase. These results reveal a new mechanism for homeostatic regulation of postsynaptic signaling and a 'kiss-and-wait' mode of regulated membrane protein insertion in neurons.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, 600 16th St, San Francisco, CA 94143 USA.	zastrow@itsa.ucsf.edu	; Puthenveedu, Manojkumar/A-3795-2016	Yudowski, Guillermo/0000-0001-5989-4131; Puthenveedu, Manojkumar/0000-0002-3177-4231				Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hegener O, 2004, BIOCHEMISTRY-US, V43, P6190, DOI 10.1021/bi035928t; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kim KA, 2003, J NEUROSCI, V23, P2075; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; VON ZM, 1992, J BIOL CHEM, V267, P3530; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; YU SS, 1993, J BIOL CHEM, V268, P337	45	63	63	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					622	627		10.1038/nn1679	http://dx.doi.org/10.1038/nn1679			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16604070				2022-12-28	WOS:000237417200012
J	Adler, CE; Fetter, RD; Bargmann, CI				Adler, CE; Fetter, RD; Bargmann, CI			UNC-6/Netrin induces neuronal asymmetry and defines the site of axon formation	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; NETRIN RECEPTOR; EXPRESSION PATTERNS; HIPPOCAMPAL-NEURONS; ACTIN CYTOSKELETON; ENA/VASP PROTEINS; COLORECTAL-CANCER; CELL-MIGRATION; PI 3-KINASE	UNC-6/Netrin and its receptor UNC-40/DCC are conserved regulators of growth cone guidance. By directly observing developing neurons in vivo, we show that UNC-6 and UNC-40 also function during axon formation to initiate, maintain and orient asymmetric neuronal growth. The immature HSN neuron of Caenorhabditis elegans breaks spherical symmetry to extend a leading edge toward ventral UNC-6. In unc-6 and unc-40 mutants, leading edge formation fails, the cell remains symmetrical until late in development and the axon that eventually forms is misguided. Thus netrin has two activities: one that breaks neuronal symmetry and one that guides the future axon. As the axon forms, UNC-6, UNC-40 and the lipid modulators AGE-1/phosphoinositide 3-kinase (PI3K) and DAF-18/PTEN drive the actin-regulatory pleckstrin homology (PH) domain protein MIG-10/lamellipodin ventrally in HSN to promote asymmetric growth. The coupling of a directional netrin cue to sustained asymmetric growth via PI3K signaling is reminiscent of polarization in chemotaxing cells.	Rockefeller Univ, Howard Hughes Med Inst, Lab Naeural Circuits & Behav, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Naeural Circuits & Behav, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618	NIGMS NIH HHS [F32 GM084661, F32 GM084661-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084661] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; BRENNER S, 1974, GENETICS, V77, P71; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Manser J, 1997, DEV BIOL, V184, P150, DOI 10.1006/dbio.1997.8516; Mello C, 1995, METHOD CELL BIOL, V48, P451; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321	47	205	217	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					511	518		10.1038/nn1666	http://dx.doi.org/10.1038/nn1666			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520734	Green Accepted			2022-12-28	WOS:000236310700018
J	Shmuel, A; Augath, M; Oeltermann, A; Logothetis, NK				Shmuel, A; Augath, M; Oeltermann, A; Logothetis, NK			Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; RESONANCE-IMAGING SIGNAL; RAT SOMATOSENSORY CORTEX; HUMAN-BRAIN; SENSORY STIMULATION; OXYGEN-CONSUMPTION; HEMODYNAMIC-RESPONSE; INTRINSIC SIGNALS; ACTIVATION; FMRI	Most functional brain imaging studies use task-induced hemodynamic responses to infer underlying changes in neuronal activity. In addition to increases in cerebral blood flow and blood oxygenation level-dependent (BOLD) signals, sustained negative responses are pervasive in functional imaging. The origin of negative responses and their relationship to neural activity remain poorly understood. Through simultaneous functional magnetic resonance imaging and electrophysiological recording, we demonstrate a negative BOLD response (NBR) beyond the stimulated regions of visual cortex, associated with local decreases in neuronal activity below spontaneous activity, detected 7.15 +/- 3.14 mm away from the closest positively responding region in V1. Trial-by-trial amplitude fluctuations revealed tight coupling between the NBR and neuronal activity decreases. The NBR was associated with comparable decreases in local field potentials and multiunit activity. Our findings indicate that a significant component of the NBR originates in neuronal activity decreases.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Nikos.Logothetis@tuebingen.mpg.de	Shmuel, Amir/G-8690-2013; Logothetis, Nikos/U-9282-2019					Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer AA, 2002, J NEUROSCI, V22, P10416; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pfeuffer J, 2004, MAGN RESON IMAGING, V22, P1343, DOI 10.1016/j.mri.2004.10.004; RAICHLE ME, 1983, J NUCL MED, V24, P790; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013	50	679	686	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					569	577		10.1038/nn1675	http://dx.doi.org/10.1038/nn1675			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547508				2022-12-28	WOS:000236310700025
J	Law, CT; Gold, JI				Law, Chi-Tat; Gold, Joshua I.			Neural correlates of perceptual learning in a sensory-motor, but not a sensory, cortical area	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PRIMARY VISUAL-CORTEX; PARIETAL CORTEX; RESPONSES; DECISION; MOTION; DISCRIMINATION; REPRESENTATION; NEURONS; PLASTICITY	This study aimed to identify neural mechanisms that underlie perceptual learning in a visual-discrimination task. We trained two monkeys (Macaca mulatta) to determine the direction of visual motion while we recorded from their middle temporal area (MT), which in trained monkeys represents motion information that is used to solve the task, and lateral intraparietal area (LIP), which represents the transformation of motion information into a saccadic choice. During training, improved behavioral sensitivity to weak motion signals was accompanied by changes in motion-driven responses of neurons in LIP, but not in MT. The time course and magnitude of the changes in LIP correlated with the changes in behavioral sensitivity throughout training. Thus, for this task, perceptual learning does not appear to involve improvements in how sensory information is represented in the brain, but rather how the sensory representation is interpreted to form the decision that guides behavior.	[Law, Chi-Tat; Gold, Joshua I.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Gold, JI (corresponding author), Univ Penn, 116 Johnson Pavilion,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jigold@mail.med.upenn.edu			NEI NIH HHS [R01 EY015260-01A1, R01 EY015260-03, R01 EY015260-04, R01 EY015260, R01 EY015260-02, R01-EY015260, T32-EY007035, T32 EY007035] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007035, R01EY015260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Eckhoff P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015006; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; HALL G, 1991, PERCEPTUAL ASSOCIATI; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liu ZL, 2000, VISION RES, V40, P97, DOI 10.1016/S0042-6989(99)00140-6; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mollon JD, 1996, SPATIAL VISION, V10, P51, DOI 10.1163/156856896X00051; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; VANESSEN DC, 2004, VISUAL NEUROSCIENCES, P507; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	50	343	349	4	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					505	513		10.1038/nn2070	http://dx.doi.org/10.1038/nn2070			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18327253	Green Accepted			2022-12-28	WOS:000254359300023
J	Papadia, S; Soriano, FX; Leveille, F; Martel, MA; Dakin, KA; Hansen, HH; Kaindl, A; Sifringer, M; Fowler, J; Stefovska, V; Mckenzie, G; Craigon, M; Corriveau, R; Ghazal, P; Horsburgh, K; Yankner, BA; Wyllie, DJA; Ikonomidou, C; Hardingham, GE				Papadia, Sofia; Soriano, Francesc X.; Leveille, Frederic; Martel, Marc-Andre; Dakin, Kelly A.; Hansen, Henrik H.; Kaindl, Angela; Sifringer, Marco; Fowler, Jill; Stefovska, Vanya; Mckenzie, Grahame; Craigon, Marie; Corriveau, Roderick; Ghazal, Peter; Horsburgh, Karen; Yankner, Bruce A.; Wyllie, David J. A.; Ikonomidou, Chrysanthy; Hardingham, Giles E.			Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses	NATURE NEUROSCIENCE			English	Article							CYSTEINE-SULFINIC ACID; PROMOTES OXIDATIVE STRESS; CELL-DEATH; APOPTOTIC NEURODEGENERATION; ALZHEIMERS-DISEASE; RESPONSE ELEMENT; GENE-EXPRESSION; NEURONAL DEATH; THIOREDOXIN; PROTEIN	Intrinsic antioxidant defenses are important for neuronal longevity. We found that in rat neurons, synaptic activity, acting via NMDA receptor (NMDAR) signaling, boosted antioxidant defenses by making changes to the thioredoxin-peroxiredoxin (Prx) system. Synaptic activity enhanced thioredoxin activity, facilitated the reduction of overoxidized Prxs and promoted resistance to oxidative stress. Resistance was mediated by coordinated transcriptional changes; synaptic NMDAR activity inactivated a previously unknown Forkhead box O target gene, the thioredoxin inhibitor Txnip. Conversely, NMDAR blockade upregulated Txnip in vivo and in vitro, where it bound thioredoxin and promoted vulnerability to oxidative damage. Synaptic activity also upregulated the Prx reactivating genes Sesn2 (sestrin 2) and Srxn1 (sulfiredoxin), via C/EBP beta and AP-1, respectively. Mimicking these expression changes was sufficient to strengthen antioxidant defenses. Trans-synaptic stimulation of synaptic NMDARs was crucial for boosting antioxidant defenses; chronic bath activation of all (synaptic and extrasynaptic) NMDARs induced no antioxidative effects. Thus, synaptic NMDAR activity may influence the progression of pathological processes associated with oxidative damage.	[Papadia, Sofia; Soriano, Francesc X.; Leveille, Frederic; Martel, Marc-Andre; Fowler, Jill; Horsburgh, Karen; Wyllie, David J. A.; Hardingham, Giles E.] Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Dakin, Kelly A.; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hansen, Henrik H.; Sifringer, Marco; Stefovska, Vanya; Ikonomidou, Chrysanthy] Tech Univ Dresden, Dept Pediat Neurol, D-01307 Dresden, Germany; [Kaindl, Angela] Charite, Dept Pediat Neurol, D-13353 Berlin, Germany; [Kaindl, Angela] Hop Robert Debre, Lab Neurol Dev, INSERM, U676, F-75019 Paris, France; [Mckenzie, Grahame] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England; [Craigon, Marie; Ghazal, Peter] Univ Edinburgh, Div Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Corriveau, Roderick] Coriell Inst Med Res, Camden, NJ 08103 USA; [Hardingham, Giles E.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; Harvard University; Harvard Medical School; Technische Universitat Dresden; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; Coriell Institute for Medical Research; University of Edinburgh	Hardingham, GE (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Hugh Robson Bldg George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	giles.hardingham@ed.ac.uk	Wyllie, David J A/AAK-4678-2021; Soriano, Francesc X/U-7552-2017	Wyllie, David J A/0000-0002-4957-6049; Soriano, Francesc X/0000-0003-1678-7162; Hardingham, Giles/0000-0002-7629-5314; Horsburgh, Karen/0000-0002-9620-3691; Kaindl, Angela/0000-0001-9454-206X; Ghazal, Peter/0000-0003-0035-2228	Biotechnology and Biological Sciences Research Council [BB/D011388/1] Funding Source: Medline; NIA NIH HHS [P30 AG010161, P30AG10161] Funding Source: Medline; Wellcome Trust [078178] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010161] Funding Source: NIH RePORTER; BBSRC [BB/D011388/1] Funding Source: UKRI; Medical Research Council [G0700704B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kapinya K, 2000, BRAIN RES, V872, P282, DOI 10.1016/S0006-8993(00)02503-8; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Osada S, 1996, J BIOL CHEM, V271, P3891; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Sanchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Spires TL, 2005, FEBS J, V272, P2347, DOI 10.1111/j.1742-4658.2005.04677.x; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tovar KR, 1999, J NEUROSCI, V19, P4180; WESEMANN W, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1243; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	50	398	411	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					476	487		10.1038/nn2071	http://dx.doi.org/10.1038/nn2071			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344994	Green Accepted			2022-12-28	WOS:000254359300020
J	Vizard, TN; O'Keeffe, GW; Gutierrez, H; Kos, CH; Riccardi, D; Davies, AM				Vizard, Thomas N.; O'Keeffe, Gerard W.; Gutierrez, Humberto; Kos, Claudine H.; Riccardi, Daniela; Davies, Alun M.			Regulation of axonal and dendritic growth by the extracellular calcium-sensing receptor	NATURE NEUROSCIENCE			English	Article							NEONATAL HYPERPARATHYROIDISM; CA2+-SENSING RECEPTOR; IN-VIVO; NEURONS; RAT; HYPERCALCEMIA; SIGNALS; CA2+; NGF; HOMEOSTASIS	The extracellular calcium-sensing receptor (CaSR) monitors the systemic, extracellular, free ionized-calcium level ([Ca2(+)](0)) in organs involved in systemic [Ca2+](0) homeostasis. However, CaSR is also expressed in the nervous system, where its role is unknown. We found large amounts of CaSR in perinatal mouse sympathetic neurons when their axons were innervating and branching extensively in their targets. Manipulating CaSR function in these neurons by varying [Ca2+](0), using CaSR agonists and antagonists, or expressing a dominant-negative CaSR markedly affected neurite growth in vitro. Sympathetic neurons lacking CaSR had smaller neurite arbors in vitro, and sympathetic innervation density was reduced in CaSR-deficient mice in vivo. Hippocampal pyramidal neurons, which also express CaSR, had smaller dendrites when transfected with dominant-negative CaSR in postnatal organotypic cultures. Our findings reveal a crucial role for CaSR in regulating the growth of neural processes in the peripheral and central nervous systems.	[Vizard, Thomas N.; O'Keeffe, Gerard W.; Gutierrez, Humberto; Riccardi, Daniela; Davies, Alun M.] Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Kos, Claudine H.] Tufts Univ, Vitamins & Carcenogenesis Lab, HNRCA, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA)	Riccardi, D (corresponding author), Sch Biosci, Biomed Bldg,Museum Ave, Cardiff CF10 3US, S Glam, Wales.	riccardi@cf.ac.uk; daviesalun@cf.ac.uk	Riccardi, Daniela/A-4674-2010; Davies, Alun M/A-4334-2010	Riccardi, Daniela/0000-0002-7322-3163; Davies, Alun M/0000-0001-5841-8176; Gutierrez, Humberto/0000-0002-5021-8636; O'Keeffe, Gerard/0000-0001-5149-0933	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust [071251] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bai M, 1997, J CLIN INVEST, V99, P88, DOI 10.1172/JCI119137; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chang WH, 1998, J BONE MINER RES, V13, P570, DOI 10.1359/jbmr.1998.13.4.570; Chattopadhyay N, 1997, DEV BRAIN RES, V100, P13, DOI 10.1016/S0165-3806(97)00009-6; Chikatsu N, 1999, CLIN ENDOCRINOL, V50, P537, DOI 10.1046/j.1365-2265.1999.00729.x; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; COLE DEC, 1990, J CRAN GENET DEV BIO, V10, P205; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Gutierrez H, 2007, J NEUROSCI METH, V163, P24, DOI 10.1016/j.jneumeth.2007.02.002; HAMON B, 1986, EXP BRAIN RES, V64, P27; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; JONES HC, 1988, J PHYSIOL-LONDON, V402, P579, DOI 10.1113/jphysiol.1988.sp017223; Kos CH, 2003, J CLIN INVEST, V111, P1021, DOI 10.1172/JCI200317416; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Oda Y, 2000, J BIOL CHEM, V275, P1183, DOI 10.1074/jbc.275.2.1183; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; SHOLL DA, 1953, J ANAT, V87, P387; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	33	89	93	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					285	291		10.1038/nn2044	http://dx.doi.org/10.1038/nn2044			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223649	Green Accepted			2022-12-28	WOS:000253548300011
J	Morin, X; Jaouen, F; Durbec, P				Morin, Xavier; Jaouen, Florence; Durbec, Pascale			Control of planar divisions by the G-protein regulator LGN maintains progenitors in the chick neuroepithelium	NATURE NEUROSCIENCE			English	Article							HETEROTRIMERIC G-PROTEINS; ASYMMETRIC CELL DIVISIONS; DROSOPHILA NEUROBLAST; SPINDLE ORIENTATION; PLASMA-MEMBRANE; SIGNALING PATHWAYS; MAMMALIAN-CELLS; CEREBRAL-CORTEX; SIZE ASYMMETRY; GOLOCO MOTIF	The spatio-temporal regulation of symmetrical as opposed to asymmetric cell divisions directs the fate and location of cells in the developing CNS. In invertebrates, G-protein regulators control spindle orientation in asymmetric divisions, which generate progeny with different identities. We investigated the role of the G-protein regulator LGN (also called Gpsm2) in spindle orientation and cell-fate determination in the spinal cord neuroepithelium of the developing chick embryo. We show that LGN is located at the cell cortex and spindle poles of neural progenitors, and that it regulates spindle movements and orientation. LGN promotes planar divisions in the early spinal cord. Interfering with LGN function randomizes the plane of division. Notably, this does not affect cell fate, but frequently leads one daughter of proliferative symmetric divisions to exit the neuroepithelium prematurely and to proliferate aberrantly in the mantle zone. Hence, tight control of planar spindle orientation maintains neural progenitors in the neuroepithelium, and regulates the proper development of the nervous system.	Univ Aix Marseille 2, Marseille, France; CNRS, Inst Dev Biol, UMR6216, F-13288 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Morin, X (corresponding author), Univ Aix Marseille 2, Marseille, France.	morin@ibdml.univ-mrs.fr	morin, xavier/AAI-3306-2020	Morin, Xavier/0000-0001-9999-0355				Adams RJ, 1996, J NEUROSCI, V16, P7610; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hilgers V, 2005, DEV BIOL, V284, P292, DOI 10.1016/j.ydbio.2005.05.021; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Roszko I, 2006, DEV BIOL, V298, P212, DOI 10.1016/j.ydbio.2006.06.031; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Voronina E, 2006, DEV GROWTH DIFFER, V48, P549, DOI 10.1111/j.1440-169x.2006.00895.x; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	50	186	188	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1440	1448		10.1038/nn1984	http://dx.doi.org/10.1038/nn1984			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934458				2022-12-28	WOS:000250508400022
J	Putzar, L; Goerendt, I; Lange, K; Rosler, F; Roder, B				Putzar, Lisa; Goerendt, Ines; Lange, Kathrin; Roesler, Frank; Roeder, Brigitte			Early visual deprivation impairs multisensory interactions in humans	NATURE NEUROSCIENCE			English	Article							INTEGRATION; EXPERIENCE; VISION; DETERMINES; BLIND	Animal studies have shown that visual deprivation during the first months of life permanently impairs the interactions between sensory systems. Here we report an analogous effect for humans who had been deprived of pattern vision for at least the first five months of their life as a result of congenital binocular cataracts. These patients showed reduced audiovisual interactions in later life, although their visual performance in control tasks was unimpaired. Thus, adequate ( multisensory) input during the first months of life seems to be a prerequisite in humans, as well as in animals, for the full development of cross-modal interactions.	Univ Hamburg, D-20146 Hamburg, Germany; Univ Dusseldorf, Dept Expt Psychol, D-40225 Dusseldorf, Germany; Univ Marburg, D-35032 Marburg, Germany	University of Hamburg; Heinrich Heine University Dusseldorf; Philipps University Marburg	Putzar, L (corresponding author), Univ Hamburg, Von Melle Pk 11, D-20146 Hamburg, Germany.	lisa.putzar@uni-hamburg.de		Lange, Kathrin/0000-0001-8230-5120				[Anonymous], 1994, DEV INTERSENSORY PER; CARLSON S, 1987, DEV BRAIN RES, V33, P101, DOI 10.1016/0165-3806(87)90180-5; Ellemberg D, 1999, VISION RES, V39, P3480, DOI 10.1016/S0042-6989(99)00078-4; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Hotting K, 2004, EXP BRAIN RES, V159, P370, DOI 10.1007/s00221-004-1965-3; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Wallace M.T., 2004, COGNIT PROCESS, V5, P69, DOI [10.1007/s10339-004-0017-z, DOI 10.1007/S10339-004-0017-Z]; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 1997, J NEUROSCI, V17, P2429; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004	14	115	118	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1243	1245		10.1038/nn1978	http://dx.doi.org/10.1038/nn1978			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873871				2022-12-28	WOS:000249720800009
J	Pack-Chung, E; Kurshan, PT; Dickman, DK; Schwarz, TL				Pack-Chung, Eunju; Kurshan, Peri T.; Dickman, Dion K.; Schwarz, Thomas L.			A Drosophila kinesin required for synaptic bouton formation and synaptic vesicle transport	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC ACTIVE ZONES; AXONAL-TRANSPORT; NEUROMUSCULAR-JUNCTION; MOLECULAR-MECHANISMS; TRANSMITTER RELEASE; GROWTH CONE; MOTOR; PROTEIN; RECEPTOR; NEURONS	The morphological transition of growth cones to synaptic boutons characterizes synaptogenesis. Here we have isolated mutations in immaculate connections (imac; CG8566), a previously uncharacterized Drosophila gene encoding a member of the Kinesin-3 family. Whereas earlier studies in Drosophila implicated Kinesin-1 in transporting synaptic vesicle precursors, we find that imac is essential for this transport. An unexpected feature of imac mutants is the failure of synaptic boutons to form. Motor neurons lacking imac properly target to muscles but remain within target fields as thin processes, a structure that is distinct from either growth cones or mature terminals. Few active zones form at these endings. We show that the arrest of synaptogenesis is not a secondary consequence of the absence of transmission. Our data thus indicate that Imac transports components required for synaptic maturation and provide insight into presynaptic maturation as a process that can be differentiated from axon outgrowth and targeting.	Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Schwarz, TL (corresponding author), Childrens Hosp, Program Neurobiol, 300 Longwood Ave, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH075058] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE KS, 1993, J NEUROSCI, V13, P144; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Chang TN, 1996, J NEUROSCI, V16, P5715; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hurd DD, 1996, GENETICS, V144, P1075; Jacob TC, 2003, J NEUROSCI, V23, P2122; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lee H, 2003, CURR BIOL, V13, pR152, DOI 10.1016/S0960-9822(03)00080-0; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Ma DL, 2000, J NEUROSCI, V20, P2112; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prokop Andreas, 1993, P33; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rheuben MB, 1999, INT REV NEUROBIOL, V43, P69, DOI 10.1016/S0074-7742(08)60541-3; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Schwarz TL, 2006, INT REV NEUROBIOL, V75, P105, DOI 10.1016/S0074-7742(06)75006-1; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Stowers RS, 1999, GENETICS, V152, P1631; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	50	112	113	3	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					980	989		10.1038/nn1936	http://dx.doi.org/10.1038/nn1936			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17643120				2022-12-28	WOS:000248357500012
J	Tsetsenis, T; Ma, XH; Lo Iacono, L; Beck, SG; Gross, C				Tsetsenis, Theodoros; Ma, Xiao-Hong; Lo Iacono, Luisa; Beck, Sheryl G.; Gross, Cornelius			Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus	NATURE NEUROSCIENCE			English	Article							5-HT1A RECEPTOR; SEROTONIN(1A) RECEPTOR; CENTRAL NUCLEUS; PYRAMIDAL NEURONS; ANXIETY DISORDER; MICE LACKING; AMYGDALA; RAT; FEAR; HIPPOCAMPUS	Serotonin receptor 1A knockout (Htr1a(KO)) mice show increased anxiety-related behavior in tests measuring innate avoidance. Here we demonstrate that Htr1a(KO) mice show enhanced fear conditioning to ambiguous conditioned stimuli, a hallmark of human anxiety. To examine the involvement of specific forebrain circuits in this phenotype, we developed a pharmacogenetic technique for the rapid tissue- and cell type-specific silencing of neural activity in vivo. Inhibition of neurons in the central nucleus of the amygdala suppressed conditioned responses to both ambiguous and nonambiguous cues. In contrast, inhibition of hippocampal dentate gyrus granule cells selectively suppressed conditioned responses to ambiguous cues and reversed the knockout phenotype. These data demonstrate that Htr1a(KO) mice have a bias in the processing of threatening cues that is moderated by hippocampal mossy-fiber circuits, and suggest that the hippocampus is important in the response to ambiguous aversive stimuli.	European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	European Molecular Biology Laboratory (EMBL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gross, C (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	Iacono, Luisa Lo/G-8480-2016; MA, XIAO/HHN-5611-2022	Iacono, Luisa Lo/0000-0003-2979-6957; Tsetsenis, Theodoros/0000-0002-4642-6539	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH048125, RC1MH089800, R01MH075047, R21MH099488] Funding Source: NIH RePORTER; NIMH NIH HHS [RC1 MH089800, MH07540407, R21 MH099488, MH048125, R01 MH075047, R01 MH075047-01A1, P01 MH048125] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Beck A.T., 1988, ANXIETY RES, V1, P23, DOI [DOI 10.1080/10615808808248218, 10.1080/10615808808248218]; Beck SG, 2004, J NEUROPHYSIOL, V91, P994, DOI 10.1152/jn.00744.2003; BEST MR, 1976, EXP NEUROL, V51, P564, DOI 10.1016/0014-4886(76)90180-1; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; CHALMERS DT, 1991, BRAIN RES, V561, P51, DOI 10.1016/0006-8993(91)90748-K; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; Delgado-Garcia JM, 2006, TRENDS NEUROSCI, V29, P330, DOI 10.1016/j.tins.2006.05.003; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Greiner EF, 2000, P NATL ACAD SCI USA, V97, P7160, DOI 10.1073/pnas.97.13.7160; Groenink L, 2003, EUR J PHARMACOL, V463, P185, DOI 10.1016/S0014-2999(03)01281-0; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Haddjeri N, 1998, J NEUROSCI, V18, P10150; HAN JS, 1995, J NEUROSCI, V15, P7323; Hazlett-Stevens H, 2004, BEHAV RES THER, V42, P881, DOI 10.1016/S0005-7967(03)00204-3; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kia HK, 1996, J COMP NEUROL, V365, P289; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MARTIN KF, 1992, BRIT J PHARMACOL, V107, P15, DOI 10.1111/j.1476-5381.1992.tb14457.x; MATHEWS A, 1989, J ABNORM PSYCHOL, V98, P236, DOI 10.1037/0021-843X.98.3.236; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Munera A, 2001, J NEUROPHYSIOL, V86, P2571, DOI 10.1152/jn.2001.86.5.2571; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; OKUHARA DY, 1994, J NEUROPHYSIOL, V71, P2161, DOI 10.1152/jn.1994.71.6.2161; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Quinn JJ, 2002, HIPPOCAMPUS, V12, P495, DOI 10.1002/hipo.10029; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Schiess MC, 1999, J NEUROSCI RES, V58, P663, DOI 10.1002/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.3.CO;2-1; Sibille E, 2000, J NEUROSCI, V20, P2758; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Veinante P, 1997, NEUROREPORT, V8, P2985, DOI 10.1097/00001756-199709080-00035; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	45	115	116	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					896	902		10.1038/nn1919	http://dx.doi.org/10.1038/nn1919			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558402	Green Accepted			2022-12-28	WOS:000247560200020
J	Kapfer, C; Glickfeld, LL; Atallah, BV; Scanziani, M				Kapfer, Christoph; Glickfeld, Lindsey L.; Atallah, Bassam V.; Scanziani, Massimo			Supralinear increase of recurrent inhibition during sparse activity in the somatosensory cortex	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; INTRACELLULAR-RECORDINGS; GABAERGIC INTERNEURONS; SYNAPTIC-INTERACTIONS; PYRAMIDAL NEURONS; CORTICAL-NEURONS; NEOCORTEX	The balance between excitation and inhibition in the cortex is crucial in determining sensory processing. Because the amount of excitation varies, maintaining this balance is a dynamic process; yet the underlying mechanisms are poorly understood. We show here that the activity of even a single layer 2/3 pyramidal cell in the somatosensory cortex of the rat generates widespread inhibition that increases disproportionately with the number of active pyramidal neurons. This supralinear increase of inhibition results from the incremental recruitment of somatostatin-expressing inhibitory interneurons located in layers 2/3 and 5. The recruitment of these interneurons increases tenfold when they are excited by two pyramidal cells. A simple model demonstrates that the distribution of excitatory input amplitudes onto inhibitory neurons influences the sensitivity and dynamic range of the recurrent circuit. These data show that through a highly sensitive recurrent inhibitory circuit, cortical excitability can be modulated by one pyramidal cell.	Univ Calif San Diego, Grad Program Neurosci, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Grad Program Neurosci, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	massimo@ucsd.edu		Atallah, Bassam/0000-0003-2315-7126	NIMH NIH HHS [R01 MH071401, MH71401, MH70058, R01 MH070058] Funding Source: Medline; NINDS NIH HHS [1-F31NS056529-01, F31 NS056529] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058, R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056529] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Carandini M, 1997, J NEUROSCI, V17, P8621; Chu ZG, 2003, J NEUROSCI, V23, P96; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; Fairen A., 1984, CEREB CORTEX, V1, P201; FERSTER D, 1992, J NEUROSCI, V12, P1262; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	41	295	297	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					743	753		10.1038/nn1909	http://dx.doi.org/10.1038/nn1909			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515899	Green Accepted			2022-12-28	WOS:000246799800017
J	Takano, T; Tian, GF; Peng, WG; Lou, NH; Lovatt, D; Hansen, AJ; Kasischke, KA; Nedergaard, M				Takano, Takahiro; Tian, Guo-Feng; Peng, Weiguo; Lou, Nanhong; Lovatt, Ditte; Hansen, Anker J.; Kasischke, Karl A.; Nedergaard, Maiken			Cortical spreading depression causes and coincides with tissue hypoxia	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSGENIC MICE; VISUAL-CORTEX; MIGRAINE; BRAIN; ISCHEMIA; DEPOLARIZATION; MECHANISMS; HYPEREMIA; HEADACHE	Cortical spreading depression (CSD) is a self-propagating wave of cellular depolarization that has been implicated in migraine and in progressive neuronal injury after stroke and head trauma. Using two-photon microscopic NADH imaging and oxygen sensor microelectrodes in live mouse cortex, we find that CSD is linked to severe hypoxia and marked neuronal swelling that can last up to several minutes. Changes in dendritic structures and loss of spines during CSD are comparable to those during anoxic depolarization. Increasing O-2 availability shortens the duration of CSD and improves local redox state. Our results indicate that tissue hypoxia associated with CSD is caused by a transient increase in O-2 demand exceeding vascular O-2 supply.	Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; Novo Nordisk AS, Discovery, DK-2760 Malov, Denmark	University of Rochester; Novo Nordisk	Takano, T (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	takahiro_takano@urmc.rochester.edu		Kasischke, Karl/0000-0003-0582-4319; Takano, Takahiro/0000-0002-6235-6673	NINDS NIH HHS [NS38073, NS30007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038073, R29NS030007, R01NS030007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akin R, 2005, TURKISH J PEDIATR, V47, P150; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; Capobianco DJ, 2006, SEMIN NEUROL, V26, P242, DOI 10.1055/s-2006-939925; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; FABRICIUS M, 1993, BRAIN RES, V602, P350, DOI 10.1016/0006-8993(93)90701-N; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1988, NEUROCHEM PATHOL, V9, P195; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Mayevsky A, 1998, ACT NEUR S, V71, P78; MAYEVSKY A, 1983, ADV EXP MED BIOL, V159, P129; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1982, BRAIN RES, V236, P93, DOI 10.1016/0006-8993(82)90037-3; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MAYEVSKY A, 1980, J NEUROSCI RES, V5, P173, DOI 10.1002/jnr.490050302; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1061, DOI 10.1167/iovs.03-0936; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; NICHOLSON C, 1978, ARZNEIMITTEL-FORSCH, V28-1, P874; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Riva D, 2006, CEPHALALGIA, V26, P596, DOI 10.1111/j.1468-2982.2006.01072.x; Schulte ML, 2006, NEUROSCI LETT, V394, P63, DOI 10.1016/j.neulet.2005.10.008; Shepherd AJ, 2005, CEPHALALGIA, V25, P412, DOI 10.1111/j.1468-2982.2004.00831.x; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tomita M, 2005, J CEREBR BLOOD F MET, V25, P742, DOI 10.1038/sj.jcbfm.9600074; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; Van Harreveld A, 1970, J Neurobiol, V2, P13, DOI 10.1002/neu.480020103; VANHARREVELD A, 1957, AM J PHYSIOL, V101, P233; Waldie KE, 2002, NEUROLOGY, V59, P904, DOI 10.1212/WNL.59.6.904; Yenice O, 2007, EYE, V21, P218, DOI 10.1038/sj.eye.6702251	50	324	331	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					754	762		10.1038/nn1902	http://dx.doi.org/10.1038/nn1902			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468748				2022-12-28	WOS:000246799800018
J	Yamazaki, D; Horiuchi, J; Nakagami, Y; Nagano, S; Tamura, T; Saitoe, M				Yamazaki, Daisuke; Horiuchi, Junjiro; Nakagami, Yasuko; Nagano, Shintaro; Tamura, Takuya; Saitoe, Minoru			The Drosophila DC0 mutation suppresses age-related memory impairment without affecting lifespan	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-A; SUPEROXIDE DISMUTASE/CATALASE MIMETICS; LONG-TERM POTENTIATION; PREFERENTIAL EXPRESSION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; GENETIC DISSECTION; LEARNING-DEFICITS; CALCIUM-CHANNELS; OXIDATIVE STRESS	The study of age-related memory impairment (AMI) has been hindered by a lack of AMI-specific mutants. In a screen for such mutants in Drosophila melanogaster, we found that heterozygous mutations of DC0 (DC0/+), which encodes the major catalytic subunit of cAMP-dependent protein kinase (PKA), delay AMI more than twofold without affecting lifespan or memory at early ages. AMI is restored when a DC0 transgene is expressed in mushroom bodies, structures important for olfactory memory formation. Furthermore, increasing cAMP and PKA activity in mushroom bodies causes premature AMI, whereas reducing activity suppresses AMI. In Drosophila AMI consists of a specific reduction in memory dependent on the amnesiac (amn) gene. amn encodes putative neuropeptides that have been proposed to regulate cAMP levels in mushroom bodies. Notably, both the memory and AMI defects of amn mutants are restored in amn; DC0/+ double mutants, suggesting that AMI is caused by an age-related disruption of amn-dependent memory via PKA activity in mushroom bodies.	Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba 2788510, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University; Tokyo University of Science; Tokyo Medical & Dental University (TMDU)	Saitoe, M (corresponding author), Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan.	saitoe@tmin.ac.jp		Saitoe, Minoru/0000-0001-9731-4214				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Foster TC, 2002, PROG BRAIN RES, V138, P283, DOI 10.1016/S0079-6123(02)38083-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Horiuchi J, 2005, AGEING RES REV, V4, P83, DOI 10.1016/j.arr.2004.10.001; Kiger JA, 2001, GENETICS, V158, P1157; Kiger JA, 1999, GENETICS, V152, P281; Kim D W, 2000, J Nutr Health Aging, V4, P233; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; Markowska AL, 1999, NEUROBIOL AGING, V20, P177, DOI 10.1016/S0197-4580(99)00031-7; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Rosay P, 2001, NEURON, V30, P759, DOI 10.1016/S0896-6273(01)00323-3; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Saitoe M, 2005, REV NEUROSCIENCE, V16, P137; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; STRAUBE KT, 1990, NEUROBIOL AGING, V11, P659, DOI 10.1016/0197-4580(90)90033-V; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Tully T, 1996, COLD SPRING HARB SYM, V61, P207; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Yanai S, 2004, NEUROBIOL AGING, V25, P325, DOI 10.1016/S0197-4580(03)00115-5; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	49	59	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					478	484		10.1038/nn1863	http://dx.doi.org/10.1038/nn1863			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322874				2022-12-28	WOS:000245228600019
J	Tojima, T; Akiyama, H; Itofusa, R; Li, Y; Katayama, H; Miyawaki, A; Kamiguchi, H				Tojima, Takuro; Akiyama, Hiroki; Itofusa, Rurika; Li, Yan; Katayama, Hiroyuki; Miyawaki, Atsushi; Kamiguchi, Hiroyuki			Attractive axon guidance involves asymmetric membrane transport and exocytosis in the growth cone	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; FLUORESCENT PROTEIN; SIGNAL-TRANSDUCTION; TRPC CHANNELS; RHO-GTPASES; DYNAMICS; FILOPODIA; ADHESION; NEURONS; SNARE	Asymmetric elevation of the Ca2+ concentration in the growth cone can mediate both attractive and repulsive axon guidance. Ca2+ signals that are accompanied by Ca2+-induced Ca2+ release (CICR) trigger attraction, whereas Ca2+ signals that are not accompanied by CICR trigger repulsion. The molecular machinery downstream of Ca2+ signals, however, remains largely unknown. Here we report that asymmetric membrane trafficking mediates growth cone attraction. Local photolysis of caged Ca2+, together with CICR, on one side of the growth cone of a chick dorsal root ganglion neuron facilitated the microtubule-dependent centrifugal transport of vesicles towards the leading edge and their subsequent vesicle-associated membrane-protein 2 (VAMP2)-mediated exocytosis on the side with an elevated Ca2+ concentration. In contrast, Ca2+ signals without CICR had no effect on the vesicle transport. Furthermore, pharmacological inhibition of VAMP2-mediated exocytosis prevented growth cone attraction, but not repulsion. These results strongly suggest that growth cone attraction and repulsion are driven by distinct mechanisms, rather than using the same molecular machinery with opposing polarities.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan	RIKEN; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; RIKEN	Kamiguchi, H (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014; Kamiguchi, Hiroyuki/N-5409-2015; Tojima, Takuro/C-3667-2017	Miyawaki, Atsushi/0000-0002-2329-3235; Kamiguchi, Hiroyuki/0000-0003-1802-6324; Tojima, Takuro/0000-0002-9140-3205				Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Buck KB, 2002, J NEUROSCI, V22, P9358; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Igarashi M, 1997, J NEUROSCI, V17, P1460; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; LOCKERBIE RO, 1991, J CELL BIOL, V112, P1215, DOI 10.1083/jcb.112.6.1215; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140	49	124	124	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					58	66		10.1038/nn1814	http://dx.doi.org/10.1038/nn1814			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159991				2022-12-28	WOS:000243096100016
J	Altier, C; Zamponi, GW				Altier, Christophe; Zamponi, Gerald W.			Opioid, cheating on its receptors, exacerbates pain	NATURE NEUROSCIENCE			English	Editorial Material							CALCIUM CHANNELS; BRADYKININ; DYNORPHIN; NEUROPATHY; RELEASE		Univ Calgary, Dept Physiol & Biophys, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	University of Calgary	Altier, C (corresponding author), Univ Calgary, Dept Physiol & Biophys, Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066				Altier C, 2004, TRENDS PHARMACOL SCI, V25, P465, DOI 10.1016/j.tips.2004.07.004; Beedle AM, 2001, DRUG DEVELOP RES, V54, P118, DOI 10.1002/ddr.10026; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Gardell LR, 2003, J NEUROSCI, V23, P8370; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Koetzner L, 2004, J NEUROSCI, V24, P1451, DOI 10.1523/JNEUROSCI.1517-03.2004; Krarup C, 2003, CURR OPIN NEUROL, V16, P603, DOI 10.1097/00019052-200310000-00007; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sugiura T, 2002, J NEUROPHYSIOL, V88, P544, DOI 10.1152/jn.2002.88.1.544; Wang HB, 2005, J NEUROSCI, V25, P7986, DOI 10.1523/JNEUROSCI.2393-05.2005; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Zhang SW, 1998, J PHARMACOL EXP THER, V286, P136	15	22	22	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1465	1467		10.1038/nn1206-1465b	http://dx.doi.org/10.1038/nn1206-1465b			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17128281				2022-12-28	WOS:000242404000005
J	Fisher, PM; Meltzer, CC; Ziolko, SK; Price, JC; Hariri, AR				Fisher, P. M.; Meltzer, C. C.; Ziolko, S. K.; Price, J. C.; Hariri, A. R.			Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity	NATURE NEUROSCIENCE			English	Article							GENETIC-VARIATION; MAJOR DEPRESSION; MICE LACKING; POLYMORPHISM; BINDING	We examined the contribution of 5-HT1A autoreceptors ( with [ C-11] WAY100635 positron emission tomography) to amygdala reactivity ( with blood oxygenation level - dependent functional magnetic resonance imaging) in 20 healthy adult volunteers. We found a significant inverse relationship wherein 5-HT1A autoreceptor density predicted a notable 30 - 44% of the variability in amygdala reactivity. Our data suggest a potential molecular mechanism by which a reduced capacity for negative feedback regulation of 5-HT release is associated with increased amygdala reactivity.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hariri, AR (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA.	haririar@upmc.edu	Fisher, Patrick MacDonald/V-8158-2017; Hariri, Ahmad/D-5761-2011	Fisher, Patrick MacDonald/0000-0002-8115-0611; 	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH072837, K24MH064625, R01MH079164, R01MH067602] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64625, R01 MH067602, K24 MH064625, MH072837, R01 MH079164, MH067602] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arborelius L, 1999, IDrugs, V2, P121; Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699; Lemonde S, 2003, J NEUROSCI, V23, P8788; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Parsey RV, 2006, BIOL PSYCHIAT, V59, P106, DOI 10.1016/j.biopsych.2005.06.016	12	129	130	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1362	1363		10.1038/nn1780	http://dx.doi.org/10.1038/nn1780			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013380				2022-12-28	WOS:000242403800010
J	Hansen, T; Olkkonen, M; Walter, S; Gegenfurtner, KR				Hansen, Thorsten; Olkkonen, Maria; Walter, Sebastian; Gegenfurtner, Karl R.			Memory modulates color appearance	NATURE NEUROSCIENCE			English	Article							PAST EXPERIENCE; CONSTANCY; PERCEPTION	We asked human observers to adjust the color of natural fruit objects until they appeared achromatic. The objects were generally perceived to be gray when their color was shifted away from the observers' gray point in a direction opposite to the typical color of the fruit. These results show that color sensations are not determined by the incoming sensory data alone, but are significantly modulated by high-level visual memory.	Univ Giessen, D-35394 Giessen, Germany	Justus Liebig University Giessen	Gegenfurtner, KR (corresponding author), Univ Giessen, Otto Behaghel Str 10F, D-35394 Giessen, Germany.	gegenfurtner@uni-giessen.de	Olkkonen, Maria/AAW-6469-2020	Olkkonen, Maria/0000-0001-7962-2256; Sanchez-Fernandez, Gregorio Esteban/0000-0002-6059-7182; Gegenfurtner, Karl/0000-0001-5390-0684				BARTLESON CJ, 1960, J OPT SOC AM, V50, P73, DOI 10.1364/JOSA.50.000073; BOLLES RC, 1959, CAN J PSYCHOLOGY, V13, P175, DOI 10.1037/h0083774; BRUNER JS, 1951, AM J PSYCHOL, V64, P216, DOI 10.2307/1418668; DELK JL, 1965, AM J PSYCHOL, V78, P290, DOI 10.2307/1420503; Duncker K, 1939, AM J PSYCHOL, V52, P255, DOI 10.2307/1416111; FISHER SC, 1956, AM J PSYCHOL, V69, P546, DOI 10.2307/1419079; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Jin EW, 1996, J OPT SOC AM A, V13, P1981, DOI 10.1364/JOSAA.13.001981; Knill DC, 1996, PERCEPTION BAYESIAN; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; Taylor AH, 1941, J OPT SOC AM, V31, P3, DOI 10.1364/JOSA.31.000003	14	283	285	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1367	1368		10.1038/nn1794	http://dx.doi.org/10.1038/nn1794			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041591				2022-12-28	WOS:000242403800012
J	Heurteaux, C; Lucas, G; Guy, N; El Yacoubi, M; Thummler, S; Peng, XD; Noble, F; Blondeau, N; Widmann, C; Borsotto, M; Gobbi, G; Vaugeois, JM; Debonnel, G; Lazdunski, M				Heurteaux, Catherine; Lucas, Guillaume; Guy, Nicolas; El Yacoubi, Malika; Thummler, Susanne; Peng, Xiao-Dong; Noble, Florence; Blondeau, Nicolas; Widmann, Catherine; Borsotto, Marc; Gobbi, Gabriella; Vaugeois, Jean-Marie; Debonnel, Guy; Lazdunski, Michel			Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype	NATURE NEUROSCIENCE			English	Article							DOMAIN K+ CHANNELS; TAIL SUSPENSION TEST; FORCED SWIM TEST; IN-VIVO; ANTIDEPRESSANT TREATMENTS; METABOLITE NORFLUOXETINE; HIPPOCAMPAL NEUROGENESIS; LEARNED HELPLESSNESS; ARACHIDONIC-ACID; NERVOUS-SYSTEM	Depression is a devastating illness with a lifetime prevalence of up to 20%. The neurotransmitter serotonin or 5-hydroxytryptamine (5-HT) is involved in the pathophysiology of depression and in the effects of antidepressant treatments. However, molecular alterations that underlie the pathology or treatment of depression are still poorly understood. The TREK-1 protein is a background K+ channel regulated by various neurotransmitters including 5-HT. In mice, the deletion of its gene (Kcnk2, also called TREK-1) led to animals with an increased efficacy of 5-HT neurotransmission and a resistance to depression in five different models and a substantially reduced elevation of corticosterone levels under stress. TREK-1-deficient (Kcnk2(-/-)) mice showed behavior similar to that of naive animals treated with classical antidepressants such as fluoxetine. Our results indicate that alterations in the functioning, regulation or both of the TREK-1 channel may alter mood, and that this particular K+ channel may be a potential target for new antidepressants.	Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel, F-06560 Valbonne, France; McGill Univ, Dept Psychiat, Montreal, PQ, Canada; CNRS, Fac Med & Pharm, Unite Neuropsychopharmacol Expt, FRE 2735,IFRMP 23, F-76183 Rouen, France; CNRS, Dept Pharmacochim Mol & Struct, INSERM U266, FRE 2463,Unite Format & Rech Sci Pharmaceut & Bio, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; McGill University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lazdunski, M (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	Blondeau, Nicolas P/M-5002-2016; BORSOTTO, Marc/M-5096-2016; Lucas, Guillaume/N-6993-2017; Blondeau, Nicolas/T-1136-2019; Yan, Shuo/B-8381-2009; HEURTEAUX, Catherine/M-4947-2016; Gobbi, Gabriella/I-2786-2013	Blondeau, Nicolas P/0000-0001-5954-4094; BORSOTTO, Marc/0000-0002-1302-7419; Lucas, Guillaume/0000-0003-0647-9756; HEURTEAUX, Catherine/0000-0002-9741-9777; Gobbi, Gabriella/0000-0003-4124-9825; THUMMLER, Susanne/0000-0001-9993-6981; Vaugeois, Jean-Marie/0000-0001-8296-672X; Noble, Florence/0000-0003-4497-0212; EL YACOUBI, Malika/0000-0002-1010-9179				Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Caldarone BJ, 2000, PHARMACOL BIOCHEM BE, V66, P811, DOI 10.1016/S0091-3057(00)00271-9; Caldarone BJ, 2003, PSYCHOPHARMACOLOGY, V170, P94, DOI 10.1007/s00213-003-1518-7; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2002, EUR J PHARMACOL, V436, P197, DOI 10.1016/S0014-2999(01)01628-4; Delgado PL, 1999, BIOL PSYCHIAT, V46, P212, DOI 10.1016/S0006-3223(99)00014-1; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Haddjeri N, 1998, J NEUROSCI, V18, P10150; HERMANN G, 1994, J NEUROIMMUNOL, V53, P173, DOI 10.1016/0165-5728(94)90027-2; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; KAMEYAMA T, 1985, NEUROPHARMACOLOGY, V24, P285, DOI 10.1016/0028-3908(85)90133-9; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; KOMOROSKI RA, 1994, MAGNET RESON MED, V31, P204, DOI 10.1002/mrm.1910310214; LAPIN IP, 1969, LANCET, V1, P132; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Maes Michael, 1995, P933; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/0278-5846(84)90120-9; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Owens M J, 1996, Depress Anxiety, V4, P153, DOI 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Redrobe JP, 2005, PEPTIDES, V26, P1394, DOI 10.1016/j.peptides.2005.03.029; Reyes R, 2000, NEUROSCIENCE, V95, P893; Ripoll N, 2003, BEHAV BRAIN RES, V143, P193, DOI 10.1016/S0166-4328(03)00034-2; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Xu XG, 2002, J NEUROGENET, V16, P263, DOI 10.1080/01677060216294	49	290	314	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1134	1141		10.1038/nn1749	http://dx.doi.org/10.1038/nn1749			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16906152				2022-12-28	WOS:000240080800014
J	Moriceau, S; Sullivan, RM				Moriceau, Stephanie; Sullivan, Regina M.			Maternal presence serves as a switch between learning fear and attraction in infancy	NATURE NEUROSCIENCE			English	Article							MALTREATMENT; NEUROBIOLOGY; BEHAVIOR; AMYGDALA; EVENTS; STRESS	Odor-shock conditioning produces either olfactory preference or aversion in preweanling (12-15 days old) rats, depending on the context. In the mother's absence, odor-shock conditioning produces amygdala activation and learned odor avoidance. With maternal presence, this same conditioning yields an odor preference without amygdala activation. Maternal presence acts through modulation of pup corticosterone and corticosterone's regulation of amygdala activity. Over-riding maternal suppression of corticosterone through intra-amygdala corticosterone infusions permits fear conditioning and amygdala activation.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Sullivan, RM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	rsullivan@ou.edu		Moriceau, Stephanie/0000-0002-1413-9359; Sullivan, Regina Marie/0000-0002-2406-8857	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033402] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33402, R01 HD033402] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barr G A, 1995, NIDA Res Monogr, V158, P172; CAMP LL, 1988, DEV PSYCHOBIOL, V21, P25, DOI 10.1002/dev.420210103; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; HAROUTUNIAN V, 1979, SCIENCE, V205, P927, DOI 10.1126/science.472715; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Levine S, 2000, EUR J PHARMACOL, V405, P149, DOI 10.1016/S0014-2999(00)00548-3; Maestripieri D, 2005, NEUROSCI BIOBEHAV R, V29, P51, DOI 10.1016/j.neubiorev.2004.05.004; Moriceau S, 2004, BEHAV NEUROSCI, V118, P274, DOI 10.1037/0735-7044.118.2.274; MORICEAU S, J NEUROSCI, V26, P6737; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; STANTON ME, 1990, DEV PSYCHOBIOL, V23, P411, DOI 10.1002/dev.420230504; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1	15	259	263	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1004	1006		10.1038/nn1733	http://dx.doi.org/10.1038/nn1733			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829957	Green Accepted			2022-12-28	WOS:000240080300011
J	Maimon, G; Assad, JA				Maimon, Gaby; Assad, John A.			A cognitive signal for the proactive timing of action in macaque LIP	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SACCADE-RELATED ACTIVITY; NEURONAL-ACTIVITY; EYE-MOVEMENTS; TIME; MONKEY; CONNECTIONS; RESPONSES; VISION; CORTEX	Natural movements often occur without any immediate external event to cause them. In contrast to reactive movements, which are directly triggered by external cues, it is less clear how these proactive actions are initiated or when they will be made. We found that single neurons in the macaque's lateral intraparietal area ( LIP) exhibit gradual firing rate elevations that reach a consistent value - which may correspond to a threshold - at the time of proactive, but not reactive, arm movements. This activity differs from sensory- and motor-related activity recorded in nearby cortical areas and could provide an internal trigger for action when abrupt external triggers in the visual input are unavailable.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu			NEI NIH HHS [EY12106] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012106] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Deecke L, 1996, COGNITIVE BRAIN RES, V3, P59, DOI 10.1016/0926-6410(95)00046-1; DiCarlo JJ, 2005, J NEUROPHYSIOL, V93, P2974, DOI 10.1152/jn.00508.2004; Eskandar EN, 2002, J NEUROPHYSIOL, V88, P1777, DOI 10.1152/jn.2002.88.4.1777; Gallistel C. R., 1990, ORG LEARNING; Gibson J.J., 1986, ECOLOGICAL APPROACH; Glimcher PW, 2003, BRADFORD BOOKS, P1; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Lee DN, 2001, EXP BRAIN RES, V139, P151, DOI 10.1007/s002210100725; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Matelli M, 1998, J COMP NEUROL, V402, P327; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Riehle A, 2005, FRON NEUROS, P213; Roitman JD, 2002, J NEUROSCI, V22, P9475; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Scherberger H, 2003, J NEUROSCI METH, V130, P1, DOI 10.1016/S0165-0270(03)00190-0; SEAL J, 1985, EXP BRAIN RES, V58, P144; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0	36	131	131	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					948	955		10.1038/nn1716	http://dx.doi.org/10.1038/nn1716			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16751764				2022-12-28	WOS:000238590800022
J	Doi, M; Yujnovsky, I; Hirayama, J; Malerba, M; Tirotta, E; Sassone-Corsi, P; Borrelli, E				Doi, Masao; Yujnovsky, Irene; Hirayama, Jun; Malerba, Monica; Tirotta, Emanuele; Sassone-Corsi, Paolo; Borrelli, Emiliana			Impaired light masking in dopamine D2 receptor-null mice	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK	Disruption of overt circadian rhythms can occur without influencing the endogenous pacemaker, the so-called 'masking' effect classically elicited by light. As the physiological pathways involved in light masking remain elusive, we analyzed mice lacking the dopamine D2 receptor. Although circadian rhythmicity was normal, D2R-null mice showed a markedly deficient light masking response, indicating that D2R-mediated signaling is an essential component of the neuronal pathways leading to light masking of circadian rhythms.	Kobe Univ, Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA	Kobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Irvine; University of California System; University of California Irvine	Borrelli, E (corresponding author), Kobe Univ, Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, 7-5-1 Kusonoki Cho, Kobe, Hyogo 6500017, Japan.	paolosc@igbmc.u-strasbg.fr; eb@igbmc.u-strasbg.fr	Doi, Masao/J-9267-2019; Jansen, Heiko T./A-5770-2008; Sassone-Corsi, Paolo/H-6182-2011; Borrelli, Emiliana/M-8994-2018	Doi, Masao/0000-0001-6264-9217; Jansen, Heiko T./0000-0003-0178-396X; Hirayama, Jun/0000-0002-8485-3320				BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; CAHILL GM, 1991, J NEUROSCI, V11, P2959; Cermakian N, 2002, CURR OPIN NEUROBIOL, V12, P359, DOI 10.1016/S0959-4388(02)00347-1; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; IUVONE PM, 1978, SCIENCE, V202, P901, DOI 10.1126/science.30997; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nir I, 2000, BRAIN RES, V870, P118, DOI 10.1016/S0006-8993(00)02409-4; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Steenhard BM, 2000, J NEUROSCI, V20, P8572; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	15	60	62	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					732	734		10.1038/nn1711	http://dx.doi.org/10.1038/nn1711			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715079				2022-12-28	WOS:000237895200010
J	Yamanaka, K; Chun, SJ; Boillee, S; Fujimori-Tonou, N; Yamashita, H; Gutmann, DH; Takahashi, R; Misawa, H; Cleveland, DW				Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Fujimori-Tonou, Noriko; Yamashita, Hirofumi; Gutmann, David H.; Takahashi, Ryosuke; Misawa, Hidemi; Cleveland, Don W.			Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURONS; EXTEND SURVIVAL; RAT MODEL; ALS; MICE; MICROGLIA	Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), an adult-onset neurodegenerative disease that is characterized by the loss of motor neurons. Using mice carrying a deletable mutant gene, diminished mutant expression in astrocytes did not affect onset, but delayed microglial activation and sharply slowed later disease progression. These findings demonstrate that mutant astrocytes are viable targets for therapies for slowing the progression of non-cell autonomous killing of motor neurons in ALS.	[Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Med & Neurosci, La Jolla, CA 92093 USA; [Yamanaka, Koji; Fujimori-Tonou, Noriko; Yamashita, Hirofumi] RIKEN, Brain Sci Inst, Yamanaka Res Unit, Wako, Saitama 3510198, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Misawa, Hidemi] Kyoritsu Univ Pharm, Dept Pharmacol, Minato Ku, Tokyo 1058512, Japan	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN; Washington University (WUSTL); Kyoto University	Yamanaka, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kyamanaka@brain.riken.jp; dcleveland@ucsd.edu	Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; Boillee, Severine/J-4027-2017; Cleveland, Don/AAN-9783-2021	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Cleveland, Don/0000-0002-1934-3682; BOILLEE, Severine/0000-0001-5518-9005; Gutmann, David/0000-0002-3127-5045	NINDS NIH HHS [R01 NS027036, NS 27036, R37 NS027036-23, R37 NS027036, R37 NS027036-22] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Son M, 2001, ANN NEUROL, V50, P273, DOI 10.1002/ana.1104; Vermeiren C, 2006, J NEUROCHEM, V96, P719, DOI 10.1111/j.1471-4159.2005.03577.x	15	804	843	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					251	253		10.1038/nn2047	http://dx.doi.org/10.1038/nn2047			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18246065	Green Accepted			2022-12-28	WOS:000253548300006
J	Lim, BK; Matsuda, N; Poo, MM				Lim, Byung Kook; Matsuda, Naoto; Poo, Mu-Ming			Ephrin-B reverse signaling promotes structural and functional synaptic maturation in vivo	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RECEPTOR TYROSINE KINASES; AXON BRANCH DYNAMICS; EPHB RECEPTORS; GLUTAMATERGIC SYNAPSE; SPINE MORPHOGENESIS; NEURAL DEVELOPMENT; NMDA RECEPTORS; GROWTH CONES; PLASTICITY	Ephrin-Eph signaling is involved in axon guidance during development, but it may also regulate synapse development after the axon has contacted the target cell. Here we report that the activation of ephrin-B reverse signaling in the developing Xenopus laevis optic tectum promotes morphological and functional maturation of retinotectal synapses. Elevation of ephrin-B signaling increased the number of retinotectal synapses and stabilized the axon arbors of retinal ganglion cells. It also enhanced basal synaptic transmission and activity-induced long-term potentiation (LTP) of retinotectal synapses. The functional effects were caused by a rapid enhancement of presynaptic glutamate release and a delayed increase in the postsynaptic glutamate responsiveness. The facilitated LTP induction occurred during the early phase of enhanced transmitter release and appeared to be causally related to the late-phase postsynaptic maturation via an NMDA receptor-dependent mechanism. This ephrin-B-dependent synapse maturation supports the notion that the ephrin/Eph protein families have multiple functions in neural development.	[Lim, Byung Kook; Matsuda, Naoto; Poo, Mu-Ming] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu		Lim, Byungkook/0000-0002-3766-5415	NEI NIH HHS [EY014979] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014979] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dingwell KS, 2000, J NEUROBIOL, V44, P246; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	50	93	96	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					160	169		10.1038/nn2033	http://dx.doi.org/10.1038/nn2033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193042				2022-12-28	WOS:000252712100010
J	Jansen, P; Giehl, K; Nyengaard, JR; Teng, K; Lioubinski, O; Sjoegaard, SS; Breiderhoff, T; Gotthardt, M; Lin, F; Eilers, A; Petersen, CM; Lewin, GR; Hempstead, BL; Willnow, TE; Nykjaer, A				Jansen, Pernille; Giehl, Klaus; Nyengaard, Jens R.; Teng, Kenneth; Lioubinski, Oleg; Sjoegaard, Susanne S.; Breiderhoff, Tilman; Gotthardt, Michael; Lin, Fuyu; Eilers, Andreas; Petersen, Claus M.; Lewin, Gary R.; Hempstead, Barbara L.; Willnow, Thomas E.; Nykjaer, Anders			Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; GANGLION-CELL NUMBER; SYMPATHETIC NEURONS; IN-VIVO; SPINAL-CORD; DEATH; P75; APOPTOSIS; SURVIVAL	Neurotrophins are essential for development and maintenance of the vertebrate nervous system. Paradoxically, although mature neurotrophins promote neuronal survival by binding to tropomyosin receptor kinases and p75 neurotrophin receptor (p75(NTR)), pro-neurotrophins induce apoptosis in cultured neurons by engaging sortilin and p75(NTR) in a death-signaling receptor complex. Substantial amounts of neurotrophins are secreted in pro-form in vivo, yet their physiological significance remains unclear. We generated a sortilin-deficient mouse to examine the contribution of the p75(NTR)/sortilin receptor complex to neuronal viability. In the developing retina, Sortilin 1 (Sort1)(-/-) mice showed reduced neuronal apoptosis that was indistinguishable from that observed in p75(NTR)-deficient (Ngfr(-/-)) mice. To our surprise, although sortilin deficiency did not affect developmentally regulated apoptosis of sympathetic neurons, it did prevent their age-dependent degeneration. Furthermore, in an injury protocol, lesioned corticospinal neurons in Sort1(-/-) mice were protected from death. Thus, the sortilin pathway has distinct roles in pro-neurotrophin-induced apoptotic signaling in pathological conditions, but also in specific stages of neuronal development and aging.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Aarhus Univ, MIND Ctr, Dept Med Biochem, DK-8000 Aarhus, Denmark; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Cell Biol, Dallas, TX 75390 USA; Aarhus Univ, MIND Ctr, Stereol & Elect Microscopy Res Lab, DK-8000 Aarhus, Denmark; Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Aarhus University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Aarhus University; Cornell University	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	willnow@mdc-berlin.de; an@biokemi.au.dk	Breiderhoff, Tilman/X-9364-2019; Lewin, Gary R/B-8028-2011; Gotthardt, Michael/ABE-8274-2021	Breiderhoff, Tilman/0000-0002-1676-7498; Gotthardt, Michael/0000-0003-1788-3172; Teng, Kenneth/0000-0002-9392-2172; Willnow, Thomas/0000-0001-9515-7921; Nykjaer, Anders/0000-0001-6422-6736; Lewin, Gary/0000-0002-2890-6352	NINDS NIH HHS [NS30687] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREWS TJ, 1994, J NEUROCYTOL, V23, P234, DOI 10.1007/BF01275527; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bierl MA, 2007, NEUROBIOL AGING, V28, P122, DOI 10.1016/j.neurobiolaging.2005.11.008; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gatzinsky KP, 2004, EUR J NEUROSCI, V20, P2848, DOI 10.1111/j.1460-9568.2004.03780.x; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Gonzalez-Hoyuela M, 2001, DEVELOPMENT, V128, P117; Harada C, 2006, DEV BIOL, V290, P57, DOI 10.1016/j.ydbio.2005.08.051; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hasan W, 2003, J NEUROBIOL, V57, P38, DOI 10.1002/neu.10250; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JENSEN EBV, 1993, J MICROSC-OXFORD, V170, P35, DOI 10.1111/j.1365-2818.1993.tb03321.x; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Majdan M, 1997, J NEUROSCI, V17, P6988; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Peng SY, 2004, J NEUROPATH EXP NEUR, V63, P641, DOI 10.1093/jnen/63.6.641; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; SCHMIDT RE, 1995, J NEUROCYTOL, V24, P189, DOI 10.1007/BF01181534; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Yoon SO, 1998, J NEUROSCI, V18, P3273	50	211	244	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1449	1457		10.1038/nn2000	http://dx.doi.org/10.1038/nn2000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934455				2022-12-28	WOS:000250508400023
J	Hung, CP; Ramsden, BM; Roe, AW				Hung, Chou P.; Ramsden, Benjamin M.; Roe, Anna Wang			A functional circuitry for edge-induced brightness perception	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; FILLING-IN; MACAQUE V1; SPATIAL SUMMATION; STRIATE CORTEX; SIMPLE CELLS; SURFACE; REPRESENTATION; SYNCHRONIZATION; LUMINANCE	The identification of visual contours and surfaces is central to visual scene segmentation. One view of image construction argues that object contours are first identified and then surfaces are filled in. Although there are psychophysical and single-unit data to suggest that the filling-in view is correct, the underlying circuitry is unknown. Here we examine specific spike-timing relationships between border and surface responses in cat visual cortical areas 17 and 18. With both real and illusory ( Cornsweet) brightness contrast stimuli, we found a border-to- surface shift in the relative timing of spike activity. This shift was absent when borders were absent and could be reversed with relocation of the stimulus border, indicating that the direction of information flow is highly dependent on stimulus conditions. Furthermore, this effect was seen predominantly in 17-18,and not 17-17, interactions. These results demonstrate a border-to- surface mechanism at early stages of visual processing and emphasize the importance of interareal circuitry in vision.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; Natl Yang Ming Univ, Inst Neurosci & Brain Res Ctr, Taipei 112, Taiwan; W Virginia Sch Med, Sensory Neurosci Res Ctr, Dept Neurobiol & Anat, Morgantown, WV 26506 USA	Vanderbilt University; National Yang Ming Chiao Tung University	Roe, AW (corresponding author), Vanderbilt Univ, Dept Psychol, 301 Wilson Hall, Nashville, TN 37203 USA.	anna.roe@vanderbilt.edu		Roe, Anna Wang/0000-0003-4146-9705	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011744, T32EY007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-15574] Funding Source: Medline; NEI NIH HHS [EY-11744, 5T32 EY-07115] Funding Source: Medline; NIDA NIH HHS [5T32 DA-07290] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Blakeslee B, 2005, VISION RES, V45, P607, DOI 10.1016/j.visres.2004.09.027; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; BRAVO M, 1988, VISION RES, V28, P861, DOI 10.1016/0042-6989(88)90095-8; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1264, DOI 10.1152/jn.1979.42.5.1264; BURR DC, 1987, VISION RES, V27, P1903, DOI 10.1016/0042-6989(87)90056-3; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cornsweet T., 1970, VISUAL PERCEPTION; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Davey MP, 1998, VISION RES, V38, P2037, DOI 10.1016/S0042-6989(97)00329-5; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; DEWEERD P, 1993, EUR J NEUROSCI, V5, P1695; Elder JH, 1998, VISION RES, V38, P143, DOI 10.1016/S0042-6989(97)00138-7; FERSTER D, 1991, J NEUROPHYSIOL, V66, P1667, DOI 10.1152/jn.1991.66.5.1667; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; Grossberg S, 2006, SPATIAL VISION, V19, P263, DOI 10.1163/156856806776923399; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Hung CP, 2002, J NEUROPHYSIOL, V87, P2542, DOI 10.1152/jn.00420.2001; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Komatsu H, 1998, BEHAV BRAIN SCI, V21, P761, DOI 10.1017/S0140525X98371757; Komatsu H, 2000, J NEUROSCI, V20, P9310; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; MUMFORD D, 1987, P NATL ACAD SCI USA, V84, P7354, DOI 10.1073/pnas.84.20.7354; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Paradiso MA, 1996, VISION RES, V36, P2657, DOI 10.1016/0042-6989(96)00033-8; Paradiso MA, 2000, CURR BIOL, V10, pR15, DOI 10.1016/S0960-9822(99)00249-3; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Purves D, 1999, J NEUROSCI, V19, P8542; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Siegel M, 2003, J NEUROSCI, V23, P4251; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; TSO DY, 1986, J NEUROSCI, V6, P1160; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; [No title captured]	48	46	46	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1185	1190		10.1038/nn1948	http://dx.doi.org/10.1038/nn1948			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17704775				2022-12-28	WOS:000249144000021
J	Day, JJ; Roitman, MF; Wightman, RM; Carelli, RM				Day, Jeremy J.; Roitman, Mitchell F.; Wightman, R. Mark; Carelli, Regina M.			Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; VENTRAL TEGMENTAL AREA; NEURONS ENCODE; REWARD; RECEPTORS; RESPONSES; RELEASE; CORE; PERFORMANCE; STIMULI	The ability to predict favorable outcomes using environmental cues is an essential part of learned behavior. Dopamine neurons in the midbrain encode such stimulus-reward relationships in a manner consistent with contemporary learning models, but it is unclear how encoding this translates into actual dopamine release in target regions. Here, we sampled dopamine levels in the rat nucleus accumbens on a rapid (100 ms) timescale using electrochemical technology during a classical conditioning procedure. Early in conditioning, transient dopamine-release events signaled a primary reward, but not predictive cues. After repeated cue-reward pairings, dopamine signals shifted in time to predictive cue onset and were no longer observed at reward delivery. In the absence of stimulus-reward conditioning, there was no shift in the dopamine signal. Consistent with proposed roles in reward prediction and incentive salience, these results indicate that rapid dopamine release provides a reward signal that is dynamically modified by associative learning.	Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Dept Psychol, CB 3270, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399	NIDA NIH HHS [F31 DA021979-01, DA 018298, DA 10900, DA 021979, F31 DA021979, DA 017318] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA021979, R01DA017318, R01DA010900, K01DA018298] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bassareo V, 1997, J NEUROSCI, V17, P851; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Cardinal RN, 2002, BEHAV NEUROSCI, V116, P553, DOI 10.1037/0735-7044.116.4.553; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Day JJ, 2006, EUR J NEUROSCI, V23, P1341, DOI 10.1111/j.1460-9568.2006.04654.x; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Eyny YS, 2003, J NEUROSCI, V23, P1584; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; MARGOLIS EB, 2006, J PHYSL, V15, P907; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Phillips PEM, 2003, METH MOLEC MED, V79, P443; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	50	443	446	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1020	1028		10.1038/nn1923	http://dx.doi.org/10.1038/nn1923			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603481				2022-12-28	WOS:000248357500016
J	Liu, Q; Vrontou, S; Rice, FL; Zylka, MJ; Dong, XZ; Anderson, DJ				Liu, Qin; Vrontou, Sophia; Rice, Frank L.; Zylka, Mark J.; Dong, Xinzhong; Anderson, David J.			Molecular genetic visualization of a rare subset of unmyelinated sensory neurons that may detect gentle touch	NATURE NEUROSCIENCE			English	Article							TACTILE AFFERENTS; HUMAN SKIN; FAMILY; RECEPTORS; FIBERS; HAIRY; GPCRS	C-fiber tactile afferents are a subpopulation of unmyelinated cutaneous sensory neurons activated by gentle stroking. Using a genetically encoded tracer, we found that Mas-related G protein-coupled receptor B4 marks a rare subpopulation of unmyelinated, nonpeptidergic sensory fibers that exclusively innervate hairy skin. These fibers terminate in large arborizations similar in size and distribution to C-fiber tactile afferent receptive fields, suggesting that MrgprB4 may provide genetic access to these elusive neurons in mice.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Howard Hughes Med Inst, Pasadena, CA 91125 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Univ N Carolina, Ctr Neurosci, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Johns Hopkins University; California Institute of Technology; Howard Hughes Medical Institute; Albany Medical College; University of North Carolina; University of North Carolina Chapel Hill	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	xdong2@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS048499] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Habler HJ, 1999, NEUROSCIENCE, V89, P1259, DOI 10.1016/S0306-4522(98)00322-4; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; KUMAZAWA T, 1977, J PHYSIOLOGY PARIS, V73, P287; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Schmidt R, 2002, J NEUROPHYSIOL, V88, P1859, DOI 10.1152/jn.2002.88.4.1859; SENO N, 1993, NEUROSCIENCE, V55, P563, DOI 10.1016/0306-4522(93)90524-J; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	15	140	141	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					946	948		10.1038/nn1937	http://dx.doi.org/10.1038/nn1937			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618277				2022-12-28	WOS:000248357500007
J	Tsai, JW; Bremner, KH; Vallee, RB				Tsai, Jin-Wu; Bremner, K. Helen; Vallee, Richard B.			Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue	NATURE NEUROSCIENCE			English	Article							CYTOPLASMIC DYNEIN; BINDING PROTEIN; CENTROSOME; MYOSIN; ORGANIZATION; CDC42; MOVEMENT; DYNACTIN; DIVISION; MOTILITY	During brain development, neural precursor cells migrate along radial glial fibers to populate the neocortex. RNA interference (RNAi) of the lissencephaly gene LIS1 (also known as PAFAH1b1) inhibits somal movement but not process extension of neural precursors in live brain slices. Here we report imaging of the subcellular events accompanying neural precursor migration and the effects of LIS1, cytoplasmic dynein and myosin II inhibition. Centrosomes move continuously and often far in advance of nuclei, which show extreme saltatory behavior. LIS1 and dynein RNAi inhibit centrosomal and nuclear movement independently, whereas myosin II inhibition blocks only nuclear translocation. Imaging of the microtubule end-binding protein 3 (EB3) reveals a centrosome-centered array of microtubules in live neural precursors under all conditions examined. Dynein is concentrated both at a swelling in the leading process reported to initiate each migratory cycle and in the soma. Thus, dynein pulls on the microtubule network from the swelling. The nucleus is transported along the trailing microtubules by dynein assisted by myosin II.	Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Vallee, RB (corresponding author), Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, 630 W 168th St, New York, NY 10032 USA.	rv2025@columbia.edu	Tsai, Jin W/A-6428-2009	Tsai, Jin-Wu/0000-0003-0135-759X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047434, R37GM047434] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40182] Funding Source: Medline; NIGMS NIH HHS [GM47434] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; JACOBS JR, 1986, J CELL BIOL, V103, P895, DOI 10.1083/jcb.103.3.895; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Morris R, 2000, NAT CELL BIOL, V2, pE201, DOI 10.1038/35041123; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Xie ZG, 2004, CELL CYCLE, V3, P108	38	326	329	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					970	979		10.1038/nn1934	http://dx.doi.org/10.1038/nn1934			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618279				2022-12-28	WOS:000248357500011
J	Smith, WLW; Pei, Z; Jiang, HB; Dawson, VL; Dawson, TM; Ross, CA				Smith, Wanli W.; Pei, Zhong; Jiang, Haibing; Dawson, Valina L.; Dawson, Ted M.; Ross, Christopher A.			Kinase activity of mutant LRRK2 mediates neuronal toxicity	NATURE NEUROSCIENCE			English	Article							PARKINSONS-DISEASE; MUTATIONS; GENETICS; BINDING; DOMAIN; GTP; ROC	Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal- dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity. These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Smith, WLW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	wsmith60@jhmi.edu; caross@jhu.edu	Dawson, Valina/Y-9757-2019; Ross, Christopher A/H-8395-2013	Dawson, Valina/0000-0002-2915-3970	NINDS NIH HHS [NS38377, R21NS055684-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R21NS055684] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht M, 2005, LANCET, V365, P1230, DOI 10.1016/S0140-6736(05)74810-8; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Di Fonzo A, 2005, LANCET, V365, P412; Farrer M, 2005, NEUROLOGY, V65, P738, DOI 10.1212/01.WNL.0000169023.51764.b0; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	15	515	521	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1231	1233		10.1038/nn1776	http://dx.doi.org/10.1038/nn1776			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980962				2022-12-28	WOS:000241493900013
J	Knott, GW; Holtmaat, A; Wilbrecht, L; Welker, E; Svoboda, K				Knott, Graham W.; Holtmaat, Anthony; Wilbrecht, Linda; Welker, Egbert; Svoboda, Karel			Spine growth precedes synapse formation in the adult neocortex in vivo	NATURE NEUROSCIENCE			English	Article							RAT VISUAL-CORTEX; DENDRITIC SPINES; CELL-TYPE; 3-DIMENSIONAL STRUCTURE; STRUCTURAL PLASTICITY; NMDA RECEPTORS; AMPA; CA1; SYNAPTOGENESIS; EXPERIENCE	Dendritic spines appear and disappear in an experience-dependent manner. Although some new spines have been shown to contain synapses, little is known about the relationship between spine addition and synapse formation, the relative time course of these events, or whether they are coupled to de novo growth of axonal boutons. We imaged dendrites in barrel cortex of adult mice over 1 month, tracking gains and losses of spines. Using serial section electron microscopy, we analyzed the ultrastructure of spines and associated boutons. Spines reconstructed shortly after they appeared often lacked synapses, whereas spines that persisted for 4 d or more always had synapses. New spines had a large surface-to-volume ratio and preferentially contacted boutons with other synapses. In some instances, two new spines contacted the same axon. Our data show that spine growth precedes synapse formation and that new synapses form preferentially onto existing boutons.	Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	University of Lausanne; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Knott, GW (corresponding author), Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland.	Graham.Knott@unil.ch	Wilbrecht, Linda/J-7988-2013	Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; Braitenberg V, 1991, ANATOMY CORTEX; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A., 1991, FINE STRUCTURE NERVO; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	48	417	423	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1117	1124		10.1038/nn1747	http://dx.doi.org/10.1038/nn1747			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892056				2022-12-28	WOS:000240080800012
J	Mattson, MP				Mattson, Mark P.			Nitro-PDI incites toxic waste accumulation	NATURE NEUROSCIENCE			English	Editorial Material							PROTEIN-DISULFIDE-ISOMERASE; PARKINSONS-DISEASE; S-NITROSYLATION; MITOCHONDRIAL DYSFUNCTION; NEURODEGENERATION; OXIDE; ALZHEIMERS; MODULATION; EXPRESSION	In Parkinson disease and related disorders, nitric oxide may disable PDI, an enzyme critical for proper protein folding in the endoplasmic reticulum, resulting in the accumulation of damaged proteins and eventually neuronal death.	NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012					Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Dawson VL, 1998, PROG BRAIN RES, V118, P215; Downen M, 1999, J NEUROPATH EXP NEUR, V58, P12, DOI 10.1097/00005072-199901000-00002; Forloni G, 2002, NEUROBIOL AGING, V23, P957, DOI 10.1016/S0197-4580(02)00076-3; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782	15	12	12	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					865	867		10.1038/nn0706-865	http://dx.doi.org/10.1038/nn0706-865			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16801918				2022-12-28	WOS:000238590800006
J	Kaneko, M; Hanover, JL; England, PM; Stryker, MP				Kaneko, Megumi; Hanover, Jessica L.; England, Pamela M.; Stryker, Michael P.			TrkB kinase is required for recovery, but not loss, of cortical responses following monocular deprivation	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; CAT VISUAL-CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; CRITICAL PERIOD; MESSENGER-RNA; EXCITATORY SYNAPSES; PROTEIN-SYNTHESIS; INTRINSIC SIGNAL	Changes in visual cortical responses that are induced by monocular visual deprivation are a widely studied example of competitive, experience-dependent neural plasticity. It has been thought that the deprived-eye pathway will fail to compete against the open-eye pathway for limited amounts of brain-derived neurotrophic factor, which acts on TrkB and is needed to sustain effective synaptic connections. We tested this model by using a chemical-genetic approach in mice to inhibit TrkB kinase activity rapidly and specifically during the induction of cortical plasticity in vivo. Contrary to the model, TrkB kinase activity was not required for any of the effects of monocular deprivation. When the deprived eye was re-opened during the critical period, cortical responses to it recovered. This recovery was blocked by TrkB inhibition. These findings suggest a more conventional trophic role for TrkB signaling in the enhancement of responses or growth of new connections, rather than a role in competition.	[Kaneko, Megumi; Hanover, Jessica L.; Stryker, Michael P.] Univ Calif San Francisco, Wm Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Kaneko, Megumi; Hanover, Jessica L.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [England, Pamela M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [England, Pamela M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, Wm Keck Fdn Ctr Integrat Neurosci, 513 Parnassus Ave,Room HSE-801,Box 0444, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [T32EY007120, R37EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY002874-24S2, R37 EY002874, T32 EY007120, R37-EY02874, T32-EY07120] Funding Source: Medline; NIMH NIH HHS [P50-MH077972, P50 MH077972] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aloyz R, 1999, LEARN MEMORY, V6, P216; BEAR MF, 1990, J NEUROSCI, V10, P909; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Galuske RAW, 2000, EUR J NEUROSCI, V12, P3315, DOI 10.1046/j.1460-9568.2000.00213.x; Gillespie DC, 2000, J NEUROSCI, V20, P9174; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kang HJ, 2000, NEUROSCI LETT, V282, P141, DOI 10.1016/S0304-3940(00)00893-4; Korte M, 2000, NEUROPHARMACOLOGY, V39, P717, DOI 10.1016/S0028-3908(99)00273-7; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lessmann V, 1998, NEUROSCIENCE, V86, P399; Li YX, 1998, J NEUROSCI, V18, P10231; Liao DS, 2002, J NEUROSCI, V22, P9015; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHATZ CJ, 1997, MOL CELLULAR APPROAC, P509; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tyler WJ, 2006, J PHYSIOL-LONDON, V574, P787, DOI 10.1113/jphysiol.2006.111310; Ugolini G, 1995, BRAIN RES, V704, P121, DOI 10.1016/0006-8993(95)01191-9; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	50	63	63	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					497	504		10.1038/nn2068	http://dx.doi.org/10.1038/nn2068			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311133	Green Accepted			2022-12-28	WOS:000254359300022
J	Li, XM; Dong, XP; Luo, SW; Zhang, B; Lee, DH; Ting, AKL; Neiswender, H; Kim, CH; Carpenter-Hyland, E; Gao, TM; Xiong, WC; Mei, L				Li, Xiao-Ming; Dong, Xian-Ping; Luo, Shi-Wen; Zhang, Bin; Lee, Dae-Hoon; Ting, Annie K. L.; Neiswender, Hannah; Kim, Chang-Hoon; Carpenter-Hyland, Ezekiel; Gao, Tian-Ming; Xiong, Wen-Cheng; Mei, Lin			Retrograde regulation of motoneuron differentiation by muscle beta-catenin	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTIONS; SYNAPTIC DIFFERENTIATION; N-CADHERIN; SYNAPSES; NEUROTROPHINS; ROLES; GENE; NEUROTRANSMISSION; TRAFFICKING; WINGLESS	Synapse formation requires proper interaction between pre- and postsynaptic cells. In anterograde signaling, neurons release factors to guide postsynaptic differentiation. However, less is known about how postsynaptic targets retrogradely regulate presynaptic differentiation or function. We found that muscle-specific conditional knockout of beta-catenin (Ctnnb1, also known as beta-cat) in mice caused both morphologic and functional defects in motoneuron terminals of neuromuscular junctions (NMJs). In the absence of muscle beta-catenin, acetylcholine receptor clusters were increased in size and distributed throughout a wider region. Primary nerve branches were mislocated, whereas secondary or intramuscular nerve branches were elongated and reduced in number. Both spontaneous and evoked neurotransmitter release was reduced at the mutant NMJs. Furthermore, short-term plasticity and calcium sensitivity of neurotransmitter release were compromised in beta-catenin-deficient muscle. In contrast, the NMJ was normal in morphology and function in motoneuron-specific beta-catenin-deficient mice. Taken together, these observations indicate a role for muscle beta-catenin in presynaptic differentiation and function, identifying a previously unknown retrograde signaling in the synapse formation and synaptic plasticity.	[Li, Xiao-Ming; Dong, Xian-Ping; Luo, Shi-Wen; Zhang, Bin; Lee, Dae-Hoon; Ting, Annie K. L.; Neiswender, Hannah; Kim, Chang-Hoon; Carpenter-Hyland, Ezekiel; Xiong, Wen-Cheng; Mei, Lin] Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; [Gao, Tian-Ming; Mei, Lin] So Med Univ, Dept Anat & Neurobiol, Guangzhou 510515, Peoples R China	University System of Georgia; Augusta University; Southern Medical University - China	Mei, L (corresponding author), Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, 1120 15th St, Augusta, GA 30912 USA.	lmei@mcg.edu	Mei, Lin/G-8755-2012	Xiong, Wen-Cheng/0000-0001-9071-7598; Zhang, Bin/0000-0003-1323-8678; Kim, Changhoon/0000-0001-5971-863X; Dong, Xianping/0000-0002-4496-7104				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Brault V, 2001, DEVELOPMENT, V128, P1253; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dong XP, 2006, NEUROSIGNALS, V15, P53, DOI 10.1159/000094484; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HAMBURGER V, 1980, ANNU REV NEUROSCI, V3, P269, DOI 10.1146/annurev.ne.03.030180.001413; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin YR, 2005, CRYST GROWTH DES, V5, P579, DOI 10.1021/cg049747h; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; WANG T, 1995, J NEUROSCI, V15, P4796; Wang ZZ, 2003, J NEUROSCI, V23, P5161; Xiong WC, 2005, NEURON, V46, P521, DOI 10.1016/j.neuron.2005.05.008; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007	50	98	102	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					262	268		10.1038/nn2053	http://dx.doi.org/10.1038/nn2053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278041				2022-12-28	WOS:000253548300008
J	Bangasser, DA; Shors, TJ				Bangasser, Debra A.; Shors, Tracey J.			The hippocampus is necessary for enhancements and impairments of learning following stress	NATURE NEUROSCIENCE			English	Article							EXPERIENCE; AMYGDALA; FEMALES; NUCLEUS; NEURONS; MALES	The hippocampus is often considered to be an important site for stress and learning interactions; however, it has never been demonstrated whether these effects require the hippocampus. In the current study, hippocampal lesions prevented both enhancements of learning after stress in male rats and impairments of learning after stress in female rats without disrupting learning itself in either sex. Thus, the hippocampus is necessary for modifying learning in males and females after acute stressful experience.	Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, 152 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	shors@rutgers.edu	Bangasser, Debra A/F-9036-2012	Bangasser, Debra A/0000-0003-2951-4921	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG019957] Funding Source: NIH RePORTER; NIA NIH HHS [AG19957-06] Funding Source: Medline; NIMH NIH HHS [R01 MH059970-07, R01 MH059970-05, R01 MH059970-06] Funding Source: Medline; PHS HHS [59970] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bangasser DA, 2005, BEHAV NEUROSCI, V119, P1459, DOI 10.1037/0735-7044.119.6.1459; Beylin AV, 2003, HORM BEHAV, V43, P124, DOI 10.1016/S0018-506X(02)00025-9; Leuner B, 2004, BIOL PSYCHIAT, V56, P964, DOI 10.1016/j.biopsych.2004.09.018; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Shors TJ, 2001, NEUROBIOL LEARN MEM, V75, P10, DOI 10.1006/nlme.1999.3956; Shors TJ, 1998, LEARN MEMORY, V5, P220; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Tuvnes FA, 2003, J NEUROSCI, V23, P4345; Weiss C, 2005, LEARN MEMORY, V12, P138, DOI 10.1101/lm.89005; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066	15	80	85	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1401	1403		10.1038/nn1973	http://dx.doi.org/10.1038/nn1973			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	225HT	17906620	Green Accepted			2022-12-28	WOS:000250508400016
J	Read, JCA; Cumming, BG				Read, Jenny C. A.; Cumming, Bruce G.			Sensors for impossible stimuli may solve the stereo correspondence problem	NATURE NEUROSCIENCE			English	Article							BINOCULAR DISPARITY; VISUAL-CORTEX; SURFACE ORIENTATION; NEURAL MECHANISMS; ENERGY-MODEL; DEPTH; MACAQUE; NEURONS; POSITION; SELECTIVITY	One of the fundamental challenges of binocular vision is that objects project to different positions on the two retinas ( binocular disparity). Neurons in visual cortex show two distinct types of tuning to disparity, position and phase disparity, which are the results of differences in receptive field location and profile, respectively. Here, we point out that phase disparity does not occur in natural images. Why, then, should the brain encode it? We propose that phase-disparity detectors help to work out which feature in the left eye corresponds to a given feature in the right. This correspondence problem is plagued by false matches: regions of the image that look similar, but do not correspond to the same object. We show that phase-disparity neurons tend to be more strongly activated by false matches. Thus, they may act as 'lie detectors', enabling the true correspondence to be deduced by a process of elimination.	Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Read, JCA (corresponding author), Univ Newcastle, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.c.a.read@ncl.ac.uk	Read, Jenny/A-7493-2013	Read, Jenny/0000-0002-9029-5185	NATIONAL EYE INSTITUTE [Z01EY000404] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 EY000404-06, NIH0013247660] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; Chen YH, 2004, NEURAL COMPUT, V16, P1545, DOI 10.1162/089976604774201596; COGAN AI, 1993, VISION RES, V33, P1959, DOI 10.1016/0042-6989(93)90021-N; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; FLEET DJ, 1994, 1994 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN, AND CYBERNETICS - HUMANS, INFORMATION AND TECHNOLOGY, VOLS 1-3, P48, DOI 10.1109/ICSMC.1994.399810; FREEMAN RD, 1990, VISION RES, V30, P1661, DOI 10.1016/0042-6989(90)90151-A; HAEFNER R, 2005, SOC NEUROSCI ABSTR, V583; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; JEPSON AD, 1989, P CVPR 89 IEEE COMP, P389; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Nienborg H, 2004, J NEUROSCI, V24, P2065, DOI 10.1523/JNEUROSCI.3887-03.2004; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; PARKER AJ, 1991, NATURE, V352, P109, DOI 10.1038/352109a0; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Prince SJD, 1999, P ROY SOC B-BIOL SCI, V266, P1361, DOI 10.1098/rspb.1999.0788; Prince SJD, 1998, PERCEPTION, V27, P1345, DOI 10.1068/p271345; Prince SJD, 2000, VISION RES, V40, P1143, DOI 10.1016/S0042-6989(99)00241-2; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; QIAN N, 1994, NEURAL COMPUT, V6, P390, DOI 10.1162/neco.1994.6.3.390; Qian N, 1997, VISION RES, V37, P1811, DOI 10.1016/S0042-6989(96)00331-8; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Read JCA, 2003, J NEUROPHYSIOL, V90, P2795, DOI 10.1152/jn.01110.2002; Read JCA, 2002, NEURAL COMPUT, V14, P1371, DOI 10.1162/089976602753712981; Read JCA, 2002, BIOL CYBERN, V86, P117, DOI 10.1007/s004220100280; ROGERS BJ, 1975, PERCEPTION, V4, P193, DOI 10.1068/p040193; ROHALY AM, 1993, J OPT SOC AM A, V10, P2433, DOI 10.1364/JOSAA.10.002433; SANGER TD, 1988, BIOL CYBERN, V59, P405, DOI 10.1007/BF00336114; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Smallman HS, 1997, PERCEPTION, V26, P977, DOI 10.1068/p260977; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tsai JJ, 2003, VISION RES, V43, P445, DOI 10.1016/S0042-6989(02)00510-2; TYLER CW, 1974, NATURE, V251, P140, DOI 10.1038/251140a0; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4	46	64	69	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1322	1328		10.1038/nn1951	http://dx.doi.org/10.1038/nn1951			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828262	Green Accepted			2022-12-28	WOS:000249720800020
J	Young, JM; Waleszczyk, WJ; Wang, C; Calford, MB; Dreher, B; Obermayer, K				Young, Joshua M.; Waleszczyk, Wioletta J.; Wang, Chun; Calford, Michael B.; Dreher, Bogdan; Obermayer, Klaus			Cortical reorganization consistent with spike timing but not correlation-dependent plasticity	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; ADULT CAT; RETINAL LESIONS; STRIATE CORTEX; SYNAPTIC PLASTICITY; TOPOGRAPHIC REORGANIZATION; HORIZONTAL CONNECTIONS; QUANTAL AMPLITUDE; MONOCULAR LESIONS; SPECIFICITY	The receptive fields of neurons in primary visual cortex that are inactivated by retinal damage are known to 'shift' to nondamaged retinal locations, seemingly due to the plasticity of intracortical connections. We have observed in cats that these shifts occur in a pattern that is highly convergent, even among receptive fields that are separated by large distances before inactivation. Here we show, using a computational model of primary visual cortex, that the observed convergent shifts are inconsistent with the common assumption that the underlying intracortical connection plasticity is dependent on the temporal correlation of pre- and postsynaptic action potentials. The shifts are, however, consistent with the hypothesis that this plasticity is dependent on the temporal order of pre- and postsynaptic action potentials. This convergent reorganization seems to require increased neuronal gain, revealing a mechanism that networks may use to selectively facilitate the didactic transfer of neuronal response properties.	Berlin Univ Technol, Dept Elect & Comp Sci, Neural Informat Proc Grp, D-10587 Berlin, Germany; Humboldt Univ, Bernstein Ctr Comp Neurosci, D-10115 Berlin, Germany; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; Univ Newcastle, Sch Biomed Sci, Hunter Med Res Inst, Newcastle, NSW 2308, Australia	Technical University of Berlin; Humboldt University of Berlin; University of Sydney; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Hunter Medical Research Institute; University of Newcastle	Young, JM (corresponding author), Berlin Univ Technol, Dept Elect & Comp Sci, Neural Informat Proc Grp, Franklinstr 28-29, D-10587 Berlin, Germany.	joshua.young@bccn-berlin.de; oby@cs.tu-berlin.de	Waleszczyk, Wioletta/F-6027-2010; Calford, Mike/B-4637-2009	Calford, Mike/0000-0002-5727-0234; Waleszczyk, Wioletta/0000-0002-7300-6193				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Arckens L, 2000, EUR J NEUROSCI, V12, P4222, DOI 10.1046/j.0953-816X.2000.01328.x; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Calford MB, 1999, P ROY SOC B-BIOL SCI, V266, P499, DOI 10.1098/rspb.1999.0665; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Calford MB, 2003, J NEUROSCI, V23, P6434; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chino Y, 2001, NAT NEUROSCI, V4, P689, DOI 10.1038/89469; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Eyding D, 2002, NEUROSCIENCE, V112, P195, DOI 10.1016/S0306-4522(02)00039-8; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FITZGIBBON T, 1991, VISUAL NEUROSCI, V6, P159, DOI 10.1017/S0952523800010543; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERTSMITH C, 1992, J NEUROSCI, V356, P150; Hebb Donald O., 1949, ORG BEHAV; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MIIKULAINEN R, 1997, PSYCHOL LEARN MOTIV, P257; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OLSON CR, 1980, EXP BRAIN RES, V39, P17; PEARSON JC, 1987, J NEUROSCI, V7, P4209; PETTIGREW JD, 1974, J PHYSIOL-LONDON, V237, P49, DOI 10.1113/jphysiol.1974.sp010469; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Waleszczyk WJ, 2003, EUR J NEUROSCI, V17, P2351, DOI 10.1046/j.1460-9568.2003.02674.x; Xing J, 1996, J NEUROPHYSIOL, V75, P217, DOI 10.1152/jn.1996.75.1.217; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Young JM, 2002, J PHYSIOL-LONDON, V541, P601, DOI 10.1113/jphysiol.2001.016212	50	65	67	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					887	895		10.1038/nn1913	http://dx.doi.org/10.1038/nn1913			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529985				2022-12-28	WOS:000247560200019
J	Plachta, N; Annaheim, C; Bissiere, S; Lin, S; Ruegg, M; Hoving, S; Muller, D; Poirier, F; Bibel, M; Barde, YA				Plachta, Nicolas; Annaheim, Christine; Bissiere, Stephanie; Lin, Shuo; Ruegg, Markus; Hoving, Sjouke; Muller, Dieter; Poirier, Francoise; Bibel, Miriam; Barde, Yves-Alain			Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; WALLERIAN DEGENERATION; BASAL FOREBRAIN; NERVE GROWTH; PERIPHERAL-NERVES; SCHWANN-CELLS; GALECTIN-1; MOUSE; AXOTOMY; MICE	Unlike the mechanisms involved in the death of neuronal cell bodies, those causing the elimination of processes are not well understood owing to the lack of suitable experimental systems. As the neurotrophin receptor p75(NTR) is known to restrict the growth of neuronal processes, we engineered mouse embryonic stem (ES) cells to express an Ngfr (p75(NTR)) cDNA under the control of the Mapt locus (the gene encoding tau), which begins to be active when ES cell - derived progenitors start elongating processes. This caused a progressive, synchronous degeneration of all processes, and a prospective proteomic analysis showed increased levels of the sugar-binding protein galectin-1 in the p75(NTR)-engineered cells. Function-blocking galectin-1 antibodies prevented the degeneration of processes, and recombinant galectin-1 caused the processes of wild-type neurons to degenerate first, followed by the cell bodies. In vivo, the application of a glutamate receptor agonist, a maneuver known to upregulate p75(NTR), led to an increase in the amount of galectin-1 and to the degeneration of neurons and their processes in a galectin-1-dependent fashion. Section of the sciatic nerve also rapidly upregulated levels of p75(NTR) and galectin-1 in terminal Schwann cells, and the elimination of nerve endings was delayed at the neuromuscular junction of mice lacking Lgals1 (the gene encoding galectin- 1). These results indicate that galectin-1 actively participates in the elimination of neuronal processes after lesion, and that engineered ES cells are a useful tool for studying relevant aspects of neuronal degeneration that have been hitherto difficult to analyze.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland; Novartis Inst Biomed Res, Genome & Proteome Sci Dept, CH-4002 Basel, Switzerland; Univ Paris 06, Inst Jacques Monod, CNRS, Unite Mixte Rech 7592, Paris, France; Univ Paris 07, Inst Jacques Monod, CNRS, Unite Mixte Rech 7592, Paris, France	University of Basel; Novartis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Barde, YA (corresponding author), Univ Basel, Bioctr, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011; Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Barde, Yves/0000-0002-7627-461X; Lin, Shuo/0000-0003-2317-0339				Aggarwal P, 2000, BRAIN RES, V882, P75, DOI 10.1016/S0006-8993(00)02832-8; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; BROWN MC, 1991, NEUROSCIENCE, V43, P279, DOI 10.1016/0306-4522(91)90435-Q; CHEN S, 1993, J COMP NEUROL, V333, P449, DOI 10.1002/cne.903330310; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Finn JT, 2000, J NEUROSCI, V20, P1333; Hahn HP, 2004, CELL DEATH DIFFER, V11, P1277, DOI 10.1038/sj.cdd.4401485; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Horie H, 1999, J NEUROSCI, V19, P9964; Horie H, 2004, J NEUROSCI, V24, P1873, DOI 10.1523/JNEUROSCI.4483-03.2004; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P166, DOI 10.1006/bbrc.2001.4556; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Majdan M, 1997, J NEUROSCI, V17, P6988; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; McGraw J, 2005, EXP NEUROL, V195, P103, DOI 10.1016/j.expneurol.2005.04.004; McGraw J, 2004, EUR J NEUROSCI, V20, P2872, DOI 10.1111/j.1460-9568.2004.03802.x; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Parson SH, 1997, EUR J NEUROSCI, V9, P1586, DOI 10.1111/j.1460-9568.1997.tb01516.x; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; REICHERT F, 1994, J NEUROSCI, V14, P3231; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saporito MS, 1998, NEUROSCIENCE, V86, P461, DOI 10.1016/S0306-4522(98)00059-1; SPRINGER JE, 1987, J NEUROSCI RES, V17, P111, DOI 10.1002/jnr.490170204; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN Q, 1988, J NEUROSCI, V8, P3481; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	45	50	52	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					712	719		10.1038/nn1897	http://dx.doi.org/10.1038/nn1897			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486104				2022-12-28	WOS:000246799800013
J	Yoshii, A; Constantine-Paton, M				Yoshii, Akira; Constantine-Paton, Martha			BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; CALCIUM CHANNELS; LIPID RAFTS; SYNAPSES; PROTEINS; NEUROTROPHINS; TRANSMISSION	The N-methyl-D-aspartate receptor (NMDAR), brain-derived neurotrophic factor (BDNF), postsynaptic density protein 95 (PSD-95) and phosphatidylinositol 3-kinase (PI3K) have all been implicated in long-term potentiation. Here we show that these molecules are involved in a single pathway for synaptic potentiation. In visual cortical neurons in young rodents, the neurotrophin receptor TrkB is associated with PSD-95. When BDNF is applied to cultured visual cortical neurons, PSD-95-labeled synaptic puncta enlarge, and fluorescent recovery after photobleaching (FRAP) reveals increased delivery of green fluorescent protein-tagged PSD-95 to the dendrites. The recovery of fluorescence requires TrkB, signaling through PI3K and the serine-threonine kinase Akt, and an intact Golgi apparatus. Stimulation of NMDARs mimics the PSD-95 trafficking that is induced by BDNF but requires active BDNF and PI3K. Furthermore, local dendritic contact with a BDNF-coated microsphere induces PSD-95 FRAP throughout the dendrites of the stimulated neuron, suggesting that this mechanism induces rapid neuron-wide synaptic increases in PSD-95 and refinement whenever a few robust inputs activate the NMDAR-BDNF-PI3K pathway.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Yoshii, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ayoshii@mit.edu			NATIONAL EYE INSTITUTE [R01EY014074, R01EY006039] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY006039, R01EY014074] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AELD EH, 2002, CELL, V108, P849; Alarcon JM, 2006, J NEUROSCI, V26, P256, DOI 10.1523/JNEUROSCI.3196-05.2006; BANKERG, 1991, CULTURING NERVE CELL; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hering H, 2003, J NEUROSCI, V23, P3262; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Stein V, 2003, J NEUROSCI, V23, P5503; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100	50	222	229	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					702	711		10.1038/nn1903	http://dx.doi.org/10.1038/nn1903			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515902				2022-12-28	WOS:000246799800012
J	Schwartz, G; Harris, R; Shrom, D; Berry, MJ				Schwartz, Greg; Harris, Rob; Shrom, David; Berry, Michael J., II			Detection and prediction of periodic patterns by the retina	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; RESPONSES; NOVELTY	A fundamental task of the brain is detecting patterns in the environment that enable predictions about the future. Here, we show that the salamander and mouse retinas can recognize a wide class of periodic temporal patterns, such that a subset of ganglion cells fire strongly and specifically in response to a violation of the periodicity. This sophisticated retinal processing may provide a substrate for hierarchical pattern detection in subsequent circuits.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Sussex, Sch Life Sci, Sussex Ctr Neurosci, Brighton BN1 9Q6, E Sussex, England	Princeton University; University of Sussex	Berry, MJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	berry@princeton.edu		Schwartz, Greg/0000-0001-8909-4397	NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY14196, R01 EY014196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BULLOCK TH, 1994, ELECTROEN CLIN NEURO, V91, P42, DOI 10.1016/0013-4694(94)90017-5; BULLOCK TH, 1990, J NEUROPHYSIOL, V64, P903, DOI 10.1152/jn.1990.64.3.903; Busse L, 2003, NEUROIMAGE, V18, P856, DOI 10.1016/S1053-8119(03)00012-0; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; KARAMURSEL S, 1994, ELECTROEN CLIN NEURO, V90, P461, DOI 10.1016/0013-4694(94)90138-4; Karamursel S, 2000, INT J NEUROSCI, V100, P1, DOI 10.3109/00207450008999674; KLINKE R, 1968, ELECTROEN CLIN NEURO, V25, P119, DOI 10.1016/0013-4694(68)90135-1; Mecklinger A, 1997, NEUROSCI LETT, V235, P65, DOI 10.1016/S0304-3940(97)00712-X; ROGERS RL, 1992, ELECTROEN CLIN NEURO, V83, P146, DOI 10.1016/0013-4694(92)90028-G; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; TIITINEN H, 1994, NEUROREPORT, V6, P190, DOI 10.1097/00001756-199412300-00048	13	54	54	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					552	554		10.1038/nn1887	http://dx.doi.org/10.1038/nn1887			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450138	Green Accepted			2022-12-28	WOS:000245948000010
J	Raingo, J; Castiglioni, AJ; Lipscombe, D				Raingo, Jesica; Castiglioni, Andrew J.; Lipscombe, Diane			Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors	NATURE NEUROSCIENCE			English	Article							GAMMA-BINDING DOMAIN; G-BETA-GAMMA; CA2+ CHANNELS; SENSORY NEURONS; CA(V)2.2 CHANNELS; KINASE-C; MODULATION; CURRENTS; PATHWAYS; SUBUNITS	Neurotransmitter release from mammalian sensory neurons is controlled by Ca(V)2.2 N-type calcium channels. N-type channels are a major target of neurotransmitters and drugs that inhibit calcium entry, transmitter release and nociception through their specific G protein-coupled receptors. G protein-coupled receptor inhibition of these channels is typically voltage-dependent and mediated by G beta gamma, whereas N-type channels in sensory neurons are sensitive to a second G protein - coupled receptor pathway that inhibits the channel independent of voltage. Here we show that preferential inclusion in nociceptors of exon 37a in rat Cacna1b ( encoding CaV2.2) creates, de novo, a C-terminal module that mediates voltage-independent inhibition. This inhibitory pathway requires tyrosine kinase activation but not G beta gamma. A tyrosine encoded within exon 37a constitutes a critical part of a molecular switch controlling N-type current density and G protein-mediated voltage-independent inhibition. Our data define the molecular origins of voltage-independent inhibition of N-type channels in the pain pathway.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Sidney E Frank Hall Life Sci,185 Meeting St, Providence, RI 02912 USA.	Diane_Lipscombe@brown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055251, R29NS029967, R01NS029967] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007601] Funding Source: Medline; NINDS NIH HHS [NS55251, R01 NS055251, NS29967, R01 NS055251-04, R01 NS029967] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bourinet E, 2005, CURR TOP MED CHEM, V5, P539, DOI 10.2174/1568026054367610; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; Castiglioni AJ, 2006, J PHYSIOL-LONDON, V576, P119, DOI 10.1113/jphysiol.2006.115030; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Elmslie KS, 2003, J BIOENERG BIOMEMBR, V35, P477, DOI 10.1023/B:JOBB.0000008021.55853.18; Fujikawa S, 1997, PFLUG ARCH EUR J PHY, V434, P84, DOI 10.1007/s004240050366; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1995, LIFE SCI, V56, P989, DOI 10.1016/0024-3205(95)00038-8; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; IKEDA SR, 1996, NATURE, V380, P258; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Li B, 2004, MOL PHARMACOL, V66, P761; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2006, NAT NEUROSCI, V9, P8, DOI 10.1038/nn0106-8; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Ossipov MH, 2000, ANN NY ACAD SCI, V909, P12; Park D, 1998, J NEUROSCI, V18, P6757; Polo-Parada L, 1999, J NEUROSCI, V19, P5213; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; Richman RW, 2004, J BIOL CHEM, V279, P24649, DOI 10.1074/jbc.M312182200; Richman RW, 2004, METHOD ENZYMOL, V390, P224; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Strock J, 2004, MOL PHARMACOL, V66, P1071, DOI 10.1124/mol.104.002261; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200	43	124	132	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					285	292		10.1038/nn1848	http://dx.doi.org/10.1038/nn1848			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293861	Green Accepted			2022-12-28	WOS:000244480300010
J	Lavenex, P; Lavenex, PB; Amaral, DG				Lavenex, Pierre; Lavenex, Pamela Banta; Amaral, David G.			Spatial relational learning persists following neonatal hippocampal lesions in macaque monkeys	NATURE NEUROSCIENCE			English	Article							ENDURING MEMORY IMPAIRMENT; MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; COGNITIVE NEUROSCIENCE; DEVELOPMENTAL AMNESIA; PRENATAL REMOVAL; EPISODIC MEMORY; SEMANTIC MEMORY; FIMBRIA-FORNIX; DAMAGE	The hippocampus is important for the acquisition of spatial representations of the environment and consequently in contextual memory. This suggests that the neural substrates underlying spatial cognition might be essential for remembering specific life episodes. Indeed, hippocampal lesions prevent spatial relational learning in adult rodents and monkeys, and result in profound amnesia in adult humans. In contrast, we show here that monkeys with neonatal hippocampal lesions learned new spatial relational information. Our experiments suggest that early hippocampal damage leads to functional brain reorganization that enables spatial information to be acquired through the use of brain regions that normally do not subserve this function.	Univ Calif Davis, Dept Psychiat & Behav Sci, Calif Natl Primate Res Ctr, MIND Inst,Ctr Neurosci, Sacramento, CA 95817 USA; Univ Fribourg, Dept Med, Unit Physiol, CH-1700 Fribourg, Switzerland	University of California System; University of California Davis; University of Fribourg	Lavenex, P (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Calif Natl Primate Res Ctr, MIND Inst,Ctr Neurosci, 2805 50th St, Sacramento, CA 95817 USA.	pierre.lavenex@unifr.ch		Lavenex, Pierre/0000-0002-9278-1312; Banta Lavenex, Pamela/0000-0001-8868-2912	NCRR NIH HHS [RR00169] Funding Source: Medline; NIMH NIH HHS [R01-MH57502] Funding Source: Medline; NINDS NIH HHS [R01-NS16980] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016980] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amaral D., 2006, HIPPOCAMPUS BOOK, VVolume 1, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001; Astur RS, 2002, BEHAV BRAIN RES, V132, P77, DOI 10.1016/S0166-4328(01)00399-0; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Bauman MD, 2004, J NEUROSCI, V24, P711, DOI 10.1523/JNEUROSCI.3263-03.2004; Bohbot VD, 2004, NEUROPSYCHOLOGY, V18, P418, DOI 10.1037/0894-4105.18.3.418; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Coutureau E, 2000, EXP BRAIN RES, V131, P381, DOI 10.1007/s002219900301; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; GOLDMAN PS, 1978, BRAIN RES, V152, P451, DOI 10.1016/0006-8993(78)91103-4; GOLDMAN PS, 1978, SCIENCE, V202, P768, DOI 10.1126/science.102031; King JA, 2004, NEUROPSYCHOLOGY, V18, P405, DOI 10.1037/0894-4105.18.3.405; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lavenex P, 2006, LEARN MEMORY, V13, P84, DOI 10.1101/lm.97606; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadel L, 2004, NEUROPSYCHOLOGY, V18, P473, DOI 10.1037/0894-4105.18.3.473; Nadel L., 1991, Hippocampus, V1, P221, DOI 10.1002/hipo.450010302; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Parslow DM, 2004, NEUROPSYCHOLOGY, V18, P450, DOI 10.1037/0894-4105.18.3.450; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schenk F., 1995, V82, P277; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shelton AL, 2004, NEUROPSYCHOLOGY, V18, P442, DOI 10.1037/0894-4105.18.3.442; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STEWARD O, 1992, HIPPOCAMPUS, V2, P247, DOI 10.1002/hipo.450020305; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Villablanca JR, 2000, NEUROSCIENCE, V95, P625; Whishaw IQ, 1995, HIPPOCAMPUS, V5, P595, DOI 10.1002/hipo.450050610; Winocur G, 2005, NEUROPSYCHOLOGIA, V43, P1580, DOI 10.1016/j.neuropsychologia.2005.01.013; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	44	39	39	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					234	239		10.1038/nn1820	http://dx.doi.org/10.1038/nn1820			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17195843	Green Submitted			2022-12-28	WOS:000244175200018
J	Kozlov, AS; Risler, T; Hudspeth, AJ				Kozlov, Andrei S.; Risler, Thomas; Hudspeth, A. J.			Coherent motion of stereocilia assures the concerted gating of hair-cell transduction channels	NATURE NEUROSCIENCE			English	Article							MECHANOELECTRICAL TRANSDUCTION; MECHANICAL-PROPERTIES; BUNDLE STIFFNESS; AMPLIFICATION; SENSITIVITY; ADAPTATION; INTEGRITY	The hair cell's mechanoreceptive organelle, the hair bundle, is highly sensitive because its transduction channels open over a very narrow range of displacements. The synchronous gating of transduction channels also underlies the active hair-bundle motility that amplifies and tunes responsiveness. The extent to which the gating of independent transduction channels is coordinated depends on how tightly individual stereocilia are constrained to move as a unit. Using dual-beam interferometry in the bullfrog's sacculus, we found that thermal movements of stereocilia located as far apart as a hair bundle's opposite edges showed high coherence and negligible phase lag. Because the mechanical degrees of freedom of stereocilia are strongly constrained, a force applied anywhere in the hair bundle deflects the structure as a unit. This feature assures the concerted gating of transduction channels that maximizes the sensitivity of mechanoelectrical transduction and enhances the hair bundle's capacity to amplify its inputs.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	hudspaj@rockefeller.edu	Risler, Thomas/E-6943-2011	Risler, Thomas/0000-0003-1677-4636	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC000241-26, R01 DC000241] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bashtanov ME, 2004, J PHYSIOL-LONDON, V559, P287, DOI 10.1113/jphysiol.2004.065565; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DENK W, 1992, J NEUROPHYSIOL, V68, P927, DOI 10.1152/jn.1992.68.3.927; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; DENK W, 1990, APPL OPTICS, V29, P2382, DOI 10.1364/AO.29.002382; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; Henderson S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.088302; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1983, ANNU REV NEUROSCI, V6, P187, DOI 10.1146/annurev.ne.06.030183.001155; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; Iwasa KH, 2002, J ACOUST SOC AM, V111, P2208, DOI 10.1121/1.1466864; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Karavitaki KD, 2006, Auditory Mechanisms: Processes and Models, P286, DOI 10.1142/9789812773456_0048; Marquis RE, 1997, P NATL ACAD SCI USA, V94, P11923, DOI 10.1073/pnas.94.22.11923; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 2003, J NEUROSCI, V23, P4533; Nam JH, 2006, BIOPHYS J, V90, P2786, DOI 10.1529/biophysj.105.066027; Nowak MA, 1999, ASTROPHYS J, V510, P874, DOI 10.1086/306610; Silber J, 2004, HEARING RES, V197, P112, DOI 10.1016/j.heares.2004.06.006	22	75	78	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					87	92		10.1038/nn1818	http://dx.doi.org/10.1038/nn1818			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173047	Green Accepted, Green Submitted			2022-12-28	WOS:000243096100019
J	Wang, HY; Yan, Y; Liu, Q; Huang, YH; Shen, Y; Chen, LJ; Chen, Y; Yang, QY; Hao, Q; Wang, KW; Chai, JJ				Wang, Huayi; Yan, Yan; Liu, Qun; Huang, Yanhua; Shen, Yue; Chen, Linjie; Chen, Yi; Yang, Qiuyue; Hao, Quan; Wang, KeWei; Chai, Jijie			Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP subunits	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS; I-TO; INACTIVATION; EXPRESSION; TRANSIENT; BINDING; ELIMINATION; COMPONENT; FAMILY; DOMAIN	KChIPs coassemble with pore-forming Kv4 alpha subunits to form a native complex in the brain and heart and regulate the expression and gating properties of Kv4 K+ channels, but the mechanisms underlying these processes are unknown. Here we report a co-crystal structure of the complex of human Kv4.3 N-terminus and KChIP1 at a 3.2-angstrom resolution. The structure reveals a unique clamping action of the complex, in which a single KChIP1 molecule, as a monomer, laterally clamps two neighboring Kv4.3 N-termini in a 4: 4 manner, forming an octamer. The proximal N-terminal peptide of Kv4.3 is sequestered by its binding to an elongated groove on the surface of KChIP1, which is indispensable for the modulation of Kv4.3 by KChIP1, and the same KChIP1 molecule binds to an adjacent T1 domain to stabilize the tetrameric Kv4.3 channels. Taken together with biochemical and functional data, our findings provide a structural basis for the modulation of Kv4 by KChIPs.	Peking Univ, Hlth Sci Ctr, Ctr Prot Sci, Minist Educ,Key Lab Neurosci,Dept Neurobiol,Neuro, Beijing 100083, Peoples R China; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA	Peking University; National Institute of Biological Sciences, Beijing; Cornell University	Wang, KW (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Prot Sci, Minist Educ,Key Lab Neurosci,Dept Neurobiol,Neuro, Beijing 100083, Peoples R China.	wangkw@bjmu.edu.cn; chaijijie@nibs.ac.cn	Hao, Quan/C-4304-2009; huang, yao/GWR-5388-2022; Huang, Yunhui/C-3752-2014; Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514; Chai, Jijie/0000-0001-7591-3873	NCRR NIH HHS [RR01646] Funding Source: Medline; PHS HHS [DMR-0225180] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Jahng AW, 2002, J BIOL CHEM, V277, P47885, DOI 10.1074/jbc.M208416200; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Orlova EV, 2003, J MOL BIOL, V326, P1005, DOI 10.1016/S0022-2836(02)00708-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shibata R, 2000, J NEUROSCI, V20, P4145; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	36	107	113	5	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					32	39		10.1038/nn1822	http://dx.doi.org/10.1038/nn1822			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17187064				2022-12-28	WOS:000243096100013
J	Patel, MR; Lehrman, EK; Poon, VY; Crump, JG; Zhen, M; Bargmann, CI; Shen, K				Patel, Maulik R.; Lehrman, Emily K.; Poon, Vivian Y.; Crump, Justin G.; Zhen, Mei; Bargmann, Cornelia I.; Shen, Kang			Hierarchical assembly of presynaptic components in defined C. elegans synapses	NATURE NEUROSCIENCE			English	Article							ACTIVE ZONE; LIPRIN-ALPHA; NEUROTRANSMITTER RELEASE; CAENORHABDITIS-ELEGANS; SYNAPTIC VESICLES; TYROSINE-PHOSPHATASE; NERVOUS-SYSTEM; PROTEIN; RECEPTOR; COMPLEX	The presynaptic regions of axons accumulate synaptic vesicles, active zone proteins and periactive zone proteins. However, the rules for orderly recruitment of presynaptic components are not well understood. We systematically examined molecular mechanisms of presynaptic development in egg-laying synapses of Caenorhabditis elegans, demonstrating that two scaffolding molecules, SYD-1 and SYD-2, have key roles in presynaptic assembly. SYD-2 (liprin-alpha) was previously shown to regulate the size and the shape of active zones. We now show that in syd-1 and syd-2 mutants, synaptic vesicles and numerous other presynaptic proteins fail to accumulate at presynaptic sites. SYD-1 and SYD-2 function cell-autonomously at presynaptic terminals, downstream of synaptic specificity molecule SYG-1. SYD-1 is likely to act upstream of SYD-2 to positively regulate its synaptic assembly activity. These data imply a hierarchical organization of presynaptic assembly, in which transmembrane specificity molecules initiate synaptogenesis by recruiting a few key scaffolding proteins, which in turn assemble other presynaptic components.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ So Calif, Zilkha Neurogent Inst, Los Angeles, CA 90089 USA; Univ Toronto, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Stanford University; Stanford University; University of Southern California; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Howard Hughes Medical Institute; Rockefeller University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Bargmann, Cornelia/0000-0002-8484-0618	NINDS NIH HHS [1R01NS048392, R01 NS048392] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRENNER S, 1974, GENETICS, V77, P71; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; FISCHER V, 1990, P NATL ACAD SCI USA, V87, P1988; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hata Y, 1996, J NEUROSCI, V16, P2488; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2003, J NEUROSCI, V23, P1667; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	50	134	164	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1488	1498		10.1038/nn1806	http://dx.doi.org/10.1038/nn1806			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115039	Green Accepted			2022-12-28	WOS:000242404000012
J	Nader, MA; Morgan, D; Gage, HD; Nader, SH; Calhoun, TL; Buchheimer, N; Ehrenkaufer, R; Mach, RH				Nader, Michael A.; Morgan, Drake; Gage, H. Donald; Nader, Susan H.; Calhoun, Tonya L.; Buchheimer, Nancy; Ehrenkaufer, Richard; Mach, Robert H.			PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENDOGENOUS DOPAMINE; NONHUMAN-PRIMATES; VERTICAL SHIFTS; BINDING-SITES; IN-VIVO; DRUG; ADDICTION; MODEL; STRESS	Dopamine neurotransmission is associated with high susceptibility to cocaine abuse. Positron emission tomography was used in 12 rhesus macaques to determine if dopamine D2 receptor availability was associated with the rate of cocaine reinforcement, and to study changes in brain dopaminergic function during maintenance of and abstinence from cocaine. Baseline D2 receptor availability was negatively correlated with rates of cocaine self-administration. D2 receptor availability decreased by 15-20% within 1 week of initiating self-administration and remained reduced by similar to 20% during 1 year of exposure. Long-term reductions in D2 receptor availability were observed, with decreases persisting for up to 1 year of abstinence in some monkeys. These data provide evidence for a predisposition to self-administer cocaine based on D2 receptor availability, and demonstrate that the brain dopamine system responds rapidly following cocaine exposure. Individual differences in the rate of recovery of D2 receptor function during abstinence were noted.	Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Nader, MA (corresponding author), Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	mnader@wfubmc.edu	Morgan, Drake/A-6373-2008; Morgan, Drake/F-6664-2012		NIDA NIH HHS [DA 14637, DA 08468] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008468, R01DA014637] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Blum K, 1996, AM SCI, V84, P132; Bradberry CW, 2000, J NEUROSCI, V20, P7109, DOI 10.1523/JNEUROSCI.20-18-07109.2000; Calabresi P, 1997, NEUROSCIENCE, V78, P39; Czoty PW, 2005, SYNAPSE, V58, P215, DOI 10.1002/syn.20200; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; DEWEY SL, 1995, J NEUROSCI, V15, P821; DEWEY SL, 1992, J NEUROSCI, V12, P3773; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Griffiths R.R., 1980, ADV SUBSTANC ABUSE, P1; Grigson PS, 2002, BEHAV NEUROSCI, V116, P321, DOI 10.1037/0735-7044.116.2.321; Hietala J, 1997, PSYCHOPHARMACOLOGY, V132, P361, DOI 10.1007/s002130050356; KALIVAS PW, 1989, BIOL PSYCHIAT, V25, P913, DOI 10.1016/0006-3223(89)90271-0; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Mach RH, 1996, SYNAPSE, V24, P322, DOI 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; MACH RH, 1993, NUCL MED BIOL, V20, P777, DOI 10.1016/0969-8051(93)90165-Q; MACH RH, 1993, J MED CHEM, V36, P3707, DOI 10.1021/jm00075a028; MADRAS BK, 1989, J PHARMACOL EXP THER, V251, P131; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Mello NK, 1996, NEUROPSYCHOPHARMACOL, V14, P375, DOI 10.1016/0893-133X(95)00274-H; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moore RJ, 1998, SYNAPSE, V30, P88, DOI 10.1002/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L; Morgan Myfanwy., 2002, QUAL RES, V2, P5, DOI [10.1177/1468794102002001636, DOI 10.1177/1468794102002001636]; Nader MA, 2005, AM J PSYCHIAT, V162, P1473, DOI 10.1176/appi.ajp.162.8.1473; Nader MA, 1999, NEUROPSYCHOPHARMACOL, V21, P589, DOI 10.1016/S0893-133X(98)00101-8; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; REITH MEA, 1980, LIFE SCI, V27, P1055, DOI 10.1016/0024-3205(80)90029-6; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SPEALMAN RD, 1978, ANNU REV PHARMACOL, V18, P313, DOI 10.1146/annurev.pa.18.040178.001525; *US DEP HHS, 2004, 2003 NAT SURV DRUG U; *US DEP HHS, 2002, EM DEP TRENDS DRUG A; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; WOOLVERTON WL, 1990, MODERN METHODS PHARM, V6, P165; World Health Organization, 2004, NEUR PSYCH SUBST US; Zernig G, 2004, PSYCHOPHARMACOLOGY, V171, P349, DOI 10.1007/s00213-003-1601-0	47	331	336	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1050	1056		10.1038/nn1737	http://dx.doi.org/10.1038/nn1737			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829955				2022-12-28	WOS:000240080300018
J	Falck-Ytter, T; Gredeback, G; von Hofsten, C				Falck-Ytter, Terje; Gredeback, Gustaf; von Hofsten, Claes			Infants predict other people's action goals	NATURE NEUROSCIENCE			English	Article							SOCIAL COGNITION; SYSTEM	Do infants come to understand other people's actions through a mirror neuron system that maps an observed action onto motor representations of that action? We demonstrate that a specialized system for action perception guides proactive goal-directed eye movements in 12-month-old but not in 6-month-old infants, providing direct support for this view. The activation of this system requires observing an interaction between the hand of the agent and an object.	Uppsala Univ, Dept Psychol, S-75142 Uppsala, Sweden	Uppsala University	Falck-Ytter, T (corresponding author), Uppsala Univ, Dept Psychol, Box 1225, S-75142 Uppsala, Sweden.	terje.falck-ytter@psyk.uu.se	Gredebäck, Gustaf/C-1676-2009	Gredebäck, Gustaf/0000-0003-3046-0043; Falck-Ytter, Terje/0000-0001-9714-0197				BRUNER JS, 1970, MECHANISMS MOTOR SKI, P63; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; ROSSANDER K, 2000, COGNITION, V91, P1; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; Tomasello Michael, 1999, CULTURAL ORIGINS HUM	15	361	368	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					878	879		10.1038/nn1729	http://dx.doi.org/10.1038/nn1729			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783366				2022-12-28	WOS:000238590800012
J	Martin, M; T Chen, B; Hopf, FW; Bowers, MS; Bonci, A				Martin, Miquel; T Chen, Billy; Hopf, F. Woodward; Bowers, M. Scott; Bonci, Antonello			Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; BEHAVIORAL SENSITIZATION; SEEKING BEHAVIOR; MOTIVATION; EXPRESSION; ADDICTION; CIRCUITRY; STRIATUM; AMYGDALA; DRUGS	The core and shell of the nucleus accumbens have critical, differential roles in drug-dependent behaviors. Here we show that operant cocaine self-administration inhibits long-term depression ( LTD) in both structures after 1 d of abstinence. However, after 21 d of abstinence, LTD was abolished exclusively in the nucleus accumbens core of cocaine self-administering rats, suggesting that voluntary cocaine self-administration induced long- lasting neuroadaptations in the core that could underlie drug-seeking behavior and relapse.	Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94608 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonci, A (corresponding author), Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	bonci@itsa.ucsf.edu		Bowers, M Scott/0000-0003-0047-6765	NIDA NIH HHS [1R01DA15096-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Udo T, 2004, PSYCHOPHARMACOLOGY, V174, P237, DOI 10.1007/s00213-003-1734-1; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	15	156	159	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					868	869		10.1038/nn1713	http://dx.doi.org/10.1038/nn1713			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732275				2022-12-28	WOS:000238590800008
J	Shakiryanova, D; Tully, A; Levitan, ES				Shakiryanova, Dinara; Tully, Arvonn; Levitan, Edwin S.			Activity-dependent synaptic capture of transiting peptidergic vesicles	NATURE NEUROSCIENCE			English	Article							AXONAL-TRANSPORT; DROSOPHILA; RELEASE; NEUROPEPTIDE; TERMINALS; ULTRASTRUCTURE; INCREASES; SYSTEM	Synapses require resources synthesized in the neuronal soma, but there are no known mechanisms to overcome delays associated with the synthesis and axonal transport of new proteins generated in response to activity, or to direct resources specifically to active synapses. Here, in vivo imaging of the Drosophila melanogaster neuromuscular junction reveals a cell-biological strategy that addresses these constraints. Peptidergic vesicles continually transit through resting terminals, but retrograde peptidergic vesicle flux is accessed following activity to rapidly boost neuropeptide content in synaptic boutons. The presence of excess transiting vesicles implies that synaptic neuropeptide stores are limited by the capture of peptidergic vesicles at the terminal, rather than by synthesis in the soma or delivery via the axon. Furthermore, activity-dependent capture from a pool of transiting vesicles provides a nerve terminal-based mechanism for directing distally and slowly generated resources quickly to active synapses. Finally, retrograde transport in the nerve terminal is regulated by activity.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levitan, ES (corresponding author), Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA.	levitan@server.pharm.pitt.edu		Bulgari, Dinara/0000-0001-5352-6207	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32385] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; Husain QM, 2004, J NEUROBIOL, V59, P181, DOI 10.1002/neu.10309; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Levitan ES, 1998, METHODS, V16, P182, DOI 10.1006/meth.1998.0665; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; NEUBIG R, 1990, PRINCIPLES DRUG ACTI, P311; Pierce JP, 2001, SYNAPSE, V39, P249, DOI 10.1002/1098-2396(20010301)39:3<249::AID-SYN1006>3.0.CO;2-5; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Shakiryanova D, 2005, NAT NEUROSCI, V8, P173, DOI 10.1038/nn1377; Sturman DA, 2006, BIOPHYS J, V90, pL45, DOI 10.1529/biophysj.106.080978; Taghert PH, 2003, ADV GENET, V49, P1, DOI 10.1016/S0065-2660(03)01001-0; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zupanc GKH, 1996, MICRON, V27, P35, DOI 10.1016/0968-4328(95)00028-3	22	76	76	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					896	900		10.1038/nn1719	http://dx.doi.org/10.1038/nn1719			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16767091				2022-12-28	WOS:000238590800015
J	Anggono, V; Smillie, KJ; Graham, ME; Valova, VA; Cousin, MA; Robinson, PJ				Anggono, Victor; Smillie, Karen J.; Graham, Mark E.; Valova, Valentina A.; Cousin, Michael A.; Robinson, Phillip J.			Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis	NATURE NEUROSCIENCE			English	Article							ACTIN-BINDING PROTEIN; PROLINE-RICH DOMAIN; NERVE-TERMINALS; MEDIATED ENDOCYTOSIS; GTPASE DYNAMIN; SH3 DOMAIN; CYTOSKELETON; AMPHIPHYSIN-1; ENDOPHILIN; CELLS	Dynamin I is dephosphorylated at Ser-774 and Ser-778 during synaptic vesicle endocytosis (SVE) in nerve terminals. Phosphorylation was proposed to regulate the assembly of an endocytic protein complex with amphiphysin or endophilin. Instead, we found it recruits syndapin I for SVE and does not control amphiphysin or endophilin binding in rat synaptosomes. After depolarization, syndapin showed a calcineurin-mediated interaction with dynamin. A peptide mimicking the phosphorylation sites disrupted the dynamin-syndapin complex, not the dynamin-endophilin complex, arrested SVE and produced glutamate release fatigue after repetitive stimulation. Pseudophosphorylation of Ser-774 or Ser-778 inhibited syndapin binding without affecting amphiphysin recruitment. Site mutagenesis to alanine arrested SVE in cultured neurons. The effects of the sites were additive for syndapin I binding and SVE. Thus syndapin I is a central component of the endocytic protein complex for SVE via stimulus-dependent recruitment to dynamin I and has a key role in synaptic transmission.	Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia; Univ Edinburgh, Membrane Biol Grp, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	Children's Medical Research Institute - Australia; University of Edinburgh	Robinson, PJ (corresponding author), Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.	phrobins@mail.usyd.edu.au	Anggono, Victor/J-2750-2013; Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011	Anggono, Victor/0000-0002-4062-4884; Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313; Cousin, Michael/0000-0002-1762-160X; Smillie, Karen/0000-0003-4369-0470	Wellcome Trust [070569, GR070569] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tibbs GR, 1996, J NEUROCHEM, V67, P389; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455	40	165	174	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					752	760		10.1038/nn1695	http://dx.doi.org/10.1038/nn1695			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648848	Green Accepted			2022-12-28	WOS:000237895200015
J	Weiler, N; Wood, L; Yu, JI; Solla, SA; Shepherd, GMG				Weiler, Nicholas; Wood, Lydia; Yu, Jianing; Solla, Sara A.; Shepherd, Gordon M. G.			Top-down laminar organization of the excitatory network in motor cortex	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL-ORGANIZATION; PYRAMIDAL NEURONS; CORTICAL COLUMN; LAYER-IV; RAT; CONNECTIVITY; CIRCUITS; PROJECTIONS; INPUT; CELLS	Cortical layering is a hallmark of the mammalian neocortex and a major determinant of local synaptic circuit organization in sensory systems. In motor cortex, the laminar organization of cortical circuits has not been resolved, although their input-output operations are crucial for motor control. Here, we developed a general approach for estimating layer-specific connectivity in cortical circuits and applied it to mouse motor cortex. From these data we computed a laminar presynaptic -> postsynaptic connectivity matrix, W-post,W-pre, revealing a complement of stereotypic pathways dominated by layer 2 outflow to deeper layers. Network modeling predicted, and experiments with disinhibited slices confirmed, that stimuli targeting upper, but not lower, cortical layers effectively evoked network-wide events. Thus, in motor cortex, descending excitation from a preamplifier-like network of upper-layer neurons drives output neurons in lower layers. Our analysis provides a quantitative wiring-diagram framework for further investigation of the excitatory networks mediating cortical mechanisms of motor control.	[Weiler, Nicholas; Yu, Jianing; Solla, Sara A.; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Solla, Sara A.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Shepherd, GMG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Morton 5-660,303E Chicago Ave, Chicago, IL 60611 USA.	g-shepherd@northwestern.edu	Shepherd, Gordon/F-2679-2010; Weiler, Norbert/E-5356-2010	Weiler, Nicholas/0000-0001-6750-9248	NINDS NIH HHS [R01 NS061963-01, R01 NS061963] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Briggs F, 2005, CEREB CORTEX, V15, P479, DOI 10.1093/cercor/bhh154; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149, DOI 10.1152/jn.1989.62.5.1149; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Donoghue JP, 1986, SENSORY MOTOR AREAS, P243; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fregnac Y., 2006, MICROCIRCUITS INTERF, P393; Helmstaedter M, 2007, BRAIN RES REV, V55, P193, DOI 10.1016/j.brainresrev.2007.07.011; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; JONES EG, 1975, J COMP NEUROL, V160, P167, DOI 10.1002/cne.901600203; Kaneko T, 1995, J NEUROSCI, V15, P8362; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; Llinas R., 2002, I VORTEX NEURONS SEL; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shipp S, 2005, PHILOS T R SOC B, V360, P797, DOI 10.1098/rstb.2005.1630; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; STRICK PL, 1974, J COMP NEUROL, V153, P77, DOI 10.1002/cne.901530107; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	213	215	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					360	366		10.1038/nn2049	http://dx.doi.org/10.1038/nn2049			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18246064	Green Accepted			2022-12-28	WOS:000253548300020
J	Kramer, H; Kavalali, ET				Kraemer, Helmut; Kavalali, Ege T.			Dynamin-independent synaptic vesicle retrieval?	NATURE NEUROSCIENCE			English	Editorial Material							ENDOCYTOSIS; MEMBRANE; FISSION; BODY; HYDROLYSIS; REQUIRES	A new study proposes that synaptic vesicle endocytosis at a large synaptic terminal is partly independent of dynamin and GTP hydrolysis, suggesting a new mechanism leading to vesicle fission and maintenance of neurotransmission.	[Kraemer, Helmut; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kramer, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kavalali@utsouthwestern.edu	Gimenez, Luis E Diaz/D-9291-2011	Kramer, Helmut/0000-0002-1167-2676	NEI NIH HHS [R01 EY010199-13, R01 EY010199] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010199] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Sun JY, 2004, J NEUROSCI METH, V134, P121, DOI 10.1016/j.jneumeth.2003.11.018; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Wu W, 2007, P NATL ACAD SCI USA, V104, P10234, DOI 10.1073/pnas.0611512104; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	15	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					6	8		10.1038/nn0108-6	http://dx.doi.org/10.1038/nn0108-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160955	Green Accepted, Green Submitted			2022-12-28	WOS:000252117900003
J	Liu, BH; Wu, GK; Arbuckle, R; Tao, HW; Zhang, LI				Liu, Bao-hua; Wu, Guangying K.; Arbuckle, Robert; Tao, Huizhong W.; Zhang, Li I.			Defining cortical frequency tuning with recurrent excitatory circuitry	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PRIMARY AUDITORY-CORTEX; RECEPTIVE-FIELDS; SIMPLE CELLS; BARREL CORTEX; ORIENTATION SELECTIVITY; THALAMOCORTICAL SYSTEM/; DIRECTION SELECTIVITY; SYNAPTIC INTEGRATION; GABA(B) RECEPTORS	Neurons in the recipient layers of sensory cortices receive excitatory input from two major sources: the feedforward thalamocortical and recurrent intracortical inputs. To address their respective functional roles, we developed a new method for silencing cortex by competitively activating GABA(A) while blocking GABA(B) receptors. In the rat primary auditory cortex, in vivo whole-cell recording from the same neuron before and after local cortical silencing revealed that thalamic input occupied the same area of frequency-intensity tonal receptive field as the total excitatory input, but showed a flattened tuning curve. In contrast, excitatory intracortical input was sharply tuned with a tuning curve that closely matched that of suprathreshold responses. This can be attributed to a selective amplification of cortical cells' responses at preferred frequencies by intracortical inputs from similarly tuned neurons. Thus, weakly tuned thalamocortical inputs determine the subthreshold responding range, whereas intracortical inputs largely define the tuning. Such circuits may ensure a faithful conveyance of sensory information.	Univ So Calif, Zilka Neurogenet Inst, Los Angeles, CA 90033 USA; Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Zilka Neurogenet Inst, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Wu, Guangying/E-8117-2010; Tao, Huizhong W/HDM-9767-2022	Wu, Guangying/0000-0002-7243-5412	NATIONAL EYE INSTITUTE [R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006814, R01DC008983] Funding Source: NIH RePORTER; NEI NIH HHS [R21 EY018718, R21 EY018718-01] Funding Source: Medline; NIDCD NIH HHS [R01 DC008983-01, R01 DC008983, R03 DC006814-03, R03 DC006814] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fox K, 2003, J NEUROSCI, V23, P8380; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MILLER W, 1988, CABIOS, V4, P11; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Roerig B, 2002, CEREB CORTEX, V12, P187, DOI 10.1093/cercor/12.2.187; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	41	135	136	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1594	1600		10.1038/nn2012	http://dx.doi.org/10.1038/nn2012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994013	Green Accepted			2022-12-28	WOS:000251172900017
J	Scholz, J; Woolf, CJ				Scholz, Joachim; Woolf, Clifford J.			The neuropathic pain triad: Neurons, immune cells and glia	NATURE NEUROSCIENCE			English	Review							PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; CHRONIC CONSTRICTION INJURY; RAT SCIATIC-NERVE; RANDOMIZED CONTROLLED-TRIAL; PRIMARY SENSORY NEURONS; SPINAL-CORD MICROGLIA; WALLERIAN DEGENERATION	Nociceptive pain results from the detection of intense or noxious stimuli by specialized high-threshold sensory neurons (nociceptors), a transfer of action potentials to the spinal cord, and onward transmission of the warning signal to the brain. In contrast, clinical pain such as pain after nerve injury (neuropathic pain) is characterized by pain in the absence of a stimulus and reduced nociceptive thresholds so that normally innocuous stimuli produce pain. The development of neuropathic pain involves not only neuronal pathways, but also Schwann cells, satellite cells in the dorsal root ganglia, components of the peripheral immune system, spinal microglia and astrocytes. As we increasingly appreciate that neuropathic pain has many features of a neuroimmune disorder, immunosuppression and blockade of the reciprocal signaling pathways between neuronal and non-neuronal cells offer new opportunities for disease modification and more successful management of pain.	Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Nueral Plast Res Grp, Charlestown, MA 02129 USA	Harvard University; Harvard University; Massachusetts General Hospital	Scholz, J (corresponding author), Harvard Univ, Sch Med, 149 13th St,Room 4309, Charlestown, MA 02129 USA.	scholz.joachim@mgh.harvard.edu	Woolf, Clifford/A-9784-2010					Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Arruda JL, 2000, BRAIN RES, V879, P216, DOI 10.1016/S0006-8993(00)02807-9; Beggs S, 2007, BRAIN BEHAV IMMUN, V21, P624, DOI 10.1016/j.bbi.2006.10.017; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen Y, 2005, PAIN, V119, P38, DOI 10.1016/j.pain.2005.09.007; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Dorf ME, 2000, J NEUROIMMUNOL, V111, P109, DOI 10.1016/S0165-5728(00)00371-4; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; ECHEVERRY S, 2007, PAIN            0608; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; George A, 2000, PAIN, V88, P267, DOI 10.1016/S0304-3959(00)00333-X; Goncharov NV, 2006, J APPL TOXICOL, V26, P148, DOI 10.1002/jat.1118; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hu P, 2003, EXP NEUROL, V184, P590, DOI 10.1016/S0014-4886(03)00307-8; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jin SX, 2003, J NEUROSCI, V23, P4017; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; Kobayashi K, 2006, J COMP NEUROL, V498, P443, DOI 10.1002/cne.21066; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Li HY, 2007, STEM CELLS, V25, P2053, DOI 10.1634/stemcells.2007-0080; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; Ma W, 2003, NEUROSCIENCE, V121, P691, DOI 10.1016/S0306-4522(03)00495-0; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; McGaraughty S, 2005, DRUG NEWS PERSPECT, V18, P501, DOI 10.1358/dnp.2005.18.8.942082; Melli G, 2006, BRAIN, V129, P1330, DOI 10.1093/brain/awl058; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Morin N, 2007, J NEUROIMMUNOL, V184, P164, DOI 10.1016/j.jneuroim.2006.12.009; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ramer MS, 1998, PAIN, V78, P115, DOI 10.1016/S0304-3959(98)00121-3; Schafers M, 2003, J NEUROSCI, V23, P2517; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Sharp CJ, 2006, BRIT J PHARMACOL, V148, P845, DOI 10.1038/sj.bjp.0706790; Shi TJS, 2001, NEUROSCIENCE, V105, P249, DOI 10.1016/S0306-4522(01)00148-8; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Si QS, 1998, BRAIN RES, V812, P97, DOI 10.1016/S0006-8993(98)00954-8; Sommer C, 1998, PAIN, V74, P83, DOI 10.1016/S0304-3959(97)00154-1; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Svensson CI, 2005, J NEUROCHEM, V92, P1508, DOI 10.1111/j.1471-4159.2004.02996.x; Sweitzer SM, 2002, J PAIN, V3, P360, DOI 10.1054/jpai.2002.125181; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Umapathi T, 2005, CURR OPIN NEUROL, V18, P574, DOI 10.1097/01.wco.0000180158.34713.aa; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; van Wijck AJM, 2006, LANCET, V367, P219, DOI 10.1016/S0140-6736(06)68032-X; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; White FA, 2005, NAT REV DRUG DISCOV, V4, P834, DOI 10.1038/nrd1852; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Winkelstein BA, 2001, J COMP NEUROL, V439, P127; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zochodne DW, 1999, NEUROSCIENCE, V91, P1515, DOI 10.1016/S0306-4522(98)00729-5	100	1240	1305	10	257	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1361	1368		10.1038/nn1992	http://dx.doi.org/10.1038/nn1992			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965656				2022-12-28	WOS:000250508400010
J	Schuske, K; Palfreyman, MT; Watanabe, S; Jorgensen, EM				Schuske, Kim; Palfreyman, Mark T.; Watanabe, Shigeki; Jorgensen, Erik M.			UNC-46 is required for trafficking of the vesicular GABA transporter	NATURE NEUROSCIENCE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; C-ELEGANS; ACETYLCHOLINE TRANSPORTER; LYSOSOME BIOGENESIS; SYNAPTIC VESICLES; PROTEIN; IDENTIFICATION; LOCALIZATION; ENDOPHILIN; LAMP-2	Mutations in unc-46 in Caenorhabditis elegans cause defects in all behaviors that are mediated by GABA. Here we show that UNC-46 is a sorting factor that localizes the vesicular GABA transporter to synaptic vesicles. The UNC-46 protein is related to the LAMP ( lysosomal associated membrane protein) family of proteins and is localized at synapses. In unc-46 mutants, the vesicular transporter is not found specifically in synaptic vesicles but rather is diffusely spread along the axon. Mislocalization of the transporter severely reduces the frequency of miniature currents, but the remaining currents are normal in amplitude. Because the number of synaptic vesicles is not depleted, it is likely that only a fraction of vesicles harbor the transporter in unc-46 mutants. Our data indicate that the transporter and UNC-46 have mutual roles in sorting. The vesicular GABA transporter recruits UNC-46 to synaptic vesicle precursors in the cell body, and UNC-46 sorts the transporter at the cell body and during endocytosis at the synapse.	Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu		Watanabe, Shigeki/0000-0001-7580-8141				Bamber BA, 1999, J NEUROSCI, V19, P5348; Barbosa J, 2002, J NEUROCHEM, V82, P1221, DOI 10.1046/j.1471-4159.2002.01068.x; CLARK SG, 1994, GENETICS, V137, P987; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; David A, 2007, J CELL SCI, V120, P353, DOI 10.1242/jcs.03316; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Eastman C, 1999, J NEUROSCI, V19, P6225; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Jin YS, 1999, J NEUROSCI, V19, P539; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kostich M, 2000, J CELL SCI, V113, P2595; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shan G, 2005, DEV BIOL, V280, P494, DOI 10.1016/j.ydbio.2005.01.032; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006	36	33	41	1	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					846	853		10.1038/nn1920	http://dx.doi.org/10.1038/nn1920			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558401				2022-12-28	WOS:000247560200014
J	Ledda, F; Paratcha, G; Sandoval-Guzman, T; Ibanez, CF				Ledda, Fernanda; Paratcha, Gustavo; Sandoval-Guzman, Tatiana; Ibanez, Carlos F.			GDNF and GFR alpha 1 promote formation of neuronal synapses by ligand-induced cell adhesion	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; RECEPTOR TYROSINE KINASE; NEUROTROPHIC FACTOR; C-RET; MOLECULE NCAM; IN-VIVO; BINDING; ACTIVATION; FAMILY; BRAIN	The establishment of synaptic connections requires precise alignment of pre- and postsynaptic terminals. The glial cell line derived neurotrophic factor (GDNF) receptor GFR alpha 1 is enriched at pre- and postsynaptic compartments in hippocampal neurons, suggesting that it has a function in synapse formation. GDNF triggered trans-homophilic binding between GFR alpha 1 molecules and cell adhesion between GFR alpha 1-expressing cells. This represents the first example of a cell-cell interaction being mediated by a ligand-induced cell adhesion molecule (LICAM). In the presence of GDNF, ectopic GFR alpha 1 induced localized presynaptic differentiation in hippocampal neurons, as visualized by clustering of vesicular proteins and neurotransmitter transporters, and by activity-dependent vesicle recycling. Presynaptic differentiation induced by GDNF was markedly reduced in neurons lacking GFR alpha 1. Gdnf mutant mice showed reduced synaptic localization of presynaptic proteins and a marked decrease in the density of presynaptic puncta, indicating a role for GDNF signaling in hippocampal synaptogenesis in vivo. We propose that GFR alpha 1 functions as a LICAM to establish precise synaptic contacts and induce presynaptic differentiation.	Karolinska Inst, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Karolinska Inst, Mol & Cellular Neurosci Lab, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ledda, F (corresponding author), Karolinska Inst, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	fernanda.ledda@ki.se; carlos.ibanez@ki.se	Sandoval-Guzman, Tatiana/P-3795-2018; Sandoval-Guzmán, Tatiana/P-2473-2019; Sandoval-Guzmán, Tatiana/B-8172-2017	Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Sandoval-Guzmán, Tatiana/0000-0003-1802-5145				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Maximov A, 2002, J NEUROSCI, V22, P6939; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Serra MP, 2002, BRAIN RES, V928, P138, DOI 10.1016/S0006-8993(01)03377-7; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; TRUPP M, 1996, NATURE, V381, P789; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Voikar V, 2004, EUR J NEUROSCI, V20, P308, DOI 10.1111/j.1460-9568.2004.03475.x; Wang CY, 2002, J BIOL CHEM, V277, P10614, DOI 10.1074/jbc.M106116200; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yamada MK, 2002, J NEUROSCI, V22, P7580; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	45	123	130	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					293	300		10.1038/nn1855	http://dx.doi.org/10.1038/nn1855			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310246				2022-12-28	WOS:000244480300011
J	van Woerden, GM; Harris, KD; Hojjati, MR; Gustin, RM; Qiu, SF; Freire, RDA; Jiang, YH; Elgersma, Y; Weeber, EJ				van Woerden, Geeske M.; Harris, Karen D.; Hojjati, Mohammad Reza; Gustin, Richard M.; Qiu, Shenfeng; Freire, Rogerio de Avila; Jiang, Yong-hui; Elgersma, Ype; Weeber, Edwin J.			Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alpha CaMKII inhibitory phosphorylation	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; UBE3A; HIPPOCAMPAL; MUTATIONS; LIGASE; GENE; AUTOPHOSPHORYLATION; PLASTICITY; DELETION	Angelman syndrome ( AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of alpha CaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of aCaMKII.	Univ Med Ctr, Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Erasmus University Rotterdam; Erasmus MC; Vanderbilt University; Vanderbilt University; Baylor College of Medicine	Elgersma, Y (corresponding author), Univ Med Ctr, Erasmus MC, Dept Neurosci, Dr Molewaterplein 50,POB 2040, NL-3000 CA Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Elgersma, Ype/F-5164-2013; Hojjati, Mohammad reza/B-9941-2013; Weeber, Edwin J/A-5396-2012	Elgersma, Ype/0000-0002-3758-1297; Hojjati, Mohammad reza/0000-0001-7889-2545; 				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; CLAYTONSMITH J, 1993, AM J MED GENET, V46, P12, DOI 10.1002/ajmg.1320460105; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Moncla A, 1999, J MED GENET, V36, P554; Smith A, 1996, J MED GENET, V33, P107, DOI 10.1136/jmg.33.2.107; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Zhang L, 2005, J NEUROSCI, V25, P7697, DOI 10.1523/JNEUROSCI.2086-05.2005	15	208	215	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					280	282		10.1038/nn1845	http://dx.doi.org/10.1038/nn1845			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259980	Green Submitted			2022-12-28	WOS:000244480300008
J	Atallah, HE; Lopez-Paniagua, D; Rudy, JW; O'Reilly, RC				Atallah, Hisham E.; Lopez-Paniagua, Dan; Rudy, Jerry W.; O'Reilly, Randall C.			Separate neural substrates for skill learning and performance in the ventral and dorsal striatum	NATURE NEUROSCIENCE			English	Article							CAUDATE-NUCLEUS LESIONS; BASAL GANGLIA; DORSOCENTRAL STRIATUM; DOUBLE DISSOCIATION; PREDICTION ERRORS; PREFRONTAL CORTEX; MAZE TASKS; REWARD; DOPAMINE; ORGANIZATION	It is widely accepted that the striatum of the basal ganglia is a primary substrate for the learning and performance of skills. We provide evidence that two regions of the rat striatum, ventral and dorsal, play distinct roles in instrumental conditioning ( skill learning), with the ventral striatum being critical for learning and the dorsal striatum being important for performance but, notably, not for learning. This implies an actor ( dorsal) versus director ( ventral) division of labor, which is a new variant of the widely discussed actor-critic architecture. Our results also imply that the successful performance of a skill can ultimately result in its establishment as a habit outside the basal ganglia.	Univ Colorado, Dept Psychiat, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Atallah, HE (corresponding author), Univ Colorado, Dept Psychiat, 345 UCB, Boulder, CO 80309 USA.	hisham.atallah@colorado.edu; randy.oreilly@colorado.edu	O'Reilly, Randall/A-5819-2008	O'Reilly, Randall/0000-0003-0322-4600	NIMH NIH HHS [MH069597-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069597] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Andrzejewski ME, 2004, BEHAV NEUROSCI, V118, P715, DOI 10.1037/0735-7044.118.4.715; Atallah HE, 2004, NEUROBIOL LEARN MEM, V82, P253, DOI 10.1016/j.nlm.2004.06.004; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Cheatwood JL, 2005, BRAIN RES, V1036, P90, DOI 10.1016/j.brainres.2004.12.049; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; DICKINSON A, 1995, ANIM LEARN BEHAV, V23, P197, DOI 10.3758/BF03199935; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Featherstone RE, 2004, BEHAV BRAIN RES, V150, P15, DOI 10.1016/S0166-4328(03)00218-3; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Han JS, 1997, J NEUROSCI, V17, P3913; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; JOEL D, 2000, CONC ADV BRAIN RES, V1, P209; Kantak KM, 2001, BEHAV NEUROSCI, V115, P589, DOI 10.1037//0735-7044.115.3.589; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Reep RL, 2003, J COMP NEUROL, V467, P271, DOI 10.1002/cne.10868; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	47	193	195	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					126	131		10.1038/nn1817	http://dx.doi.org/10.1038/nn1817			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17187065				2022-12-28	WOS:000243096100024
J	Kim, MS; Pak, YK; Jang, PG; Namkoong, C; Choi, YS; Won, JC; Kim, KS; Kim, SW; Kim, HS; Park, JY; Kim, YB; Lee, KU				Kim, Min-Seon; Pak, Youngmi K.; Jang, Pil-Geum; Namkoong, Cherl; Choi, Yon-Sik; Won, Jong-Chul; Kim, Kyung-Sup; Kim, Seung-Whan; Kim, Hyo-Soo; Park, Joong-Yeol; Kim, Young-Bum; Lee, Ki-Up			Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis	NATURE NEUROSCIENCE			English	Article						t	GENE-EXPRESSION; PROTEASOMAL DEGRADATION; RAT HYPOTHALAMUS; INDUCED ANOREXIA; ARCUATE NUCLEUS; BODY-WEIGHT; FAT-BODY; INSULIN; LEPTIN; BRAIN	Insulin signaling in the hypothalamus plays a role in maintaining body weight. Studies suggest that the forkhead transcription factor Foxo1 is an important mediator of insulin signaling in peripheral tissues. Here we demonstrate that in normal mice, hypothalamic Foxo1 expression is reduced by the anorexigenic hormones insulin and leptin. These hormones' effects on feeding are inhibited when hypothalamic Foxo1 is activated, establishing a new signaling pathway through which insulin and leptin regulate food intake in hypothalamic neurons. Moreover, activation of Foxo1 in the hypothalamus increases food intake and body weight, whereas inhibition of Foxo1 decreases both. Foxo1 stimulates the transcription of the orexigenic neuropeptide Y and Agouti-related protein through the phosphatidylinositol-3-kinase ( PI3K)/Akt signaling pathway, but suppresses the transcription of anorexigenic proopiomelanocortin by antagonizing the activity of signal transducer-activated transcript-3 ( STAT3). Our data suggest that hypothalamic Foxo1 is an important regulator of food intake and energy balance.	Univ Ulsan, Coll Med, Dept Internal Med, Seoul 138736, South Korea; Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea; Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	University of Ulsan; University of Ulsan; Yonsei University; Seoul National University (SNU); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lee, KU (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, 138-736 Pungnapdong, Seoul 138736, South Korea.	kulee@amc.seoul.kr	Pak, Youngmi Kim/AAI-1091-2020; Kim, Hyo Soo/J-2753-2012; Choi, Hyung Jin/AAU-9629-2020	Pak, Youngmi Kim/0000-0001-7424-3484; Kim, Seung-Whan/0000-0001-6983-0481; Kim, Kyung-sup/0000-0001-8483-8537; Won, Jong Chul/0000-0002-2219-4083; NamKoong, Cherl/0000-0002-1869-4405				Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; CANICK JA, 1986, BRAIN RES, V372, P277, DOI 10.1016/0006-8993(86)91135-2; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spiegel A, 2005, NAT NEUROSCI, V8, P552, DOI 10.1038/nn0505-552; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	240	251	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					901	906		10.1038/nn1731	http://dx.doi.org/10.1038/nn1731			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783365				2022-12-28	WOS:000238590800016
J	Fonseca, R; Nagerl, UV; Bonhoeffer, T				Fonseca, R; Nagerl, UV; Bonhoeffer, T			Neuronal activity determines the protein synthesis dependence of long-term potentiation	NATURE NEUROSCIENCE			English	Article							MEMORY; RECONSOLIDATION; PHOSPHORYLATION; REACTIVATION; HIPPOCAMPUS; RETRIEVAL; REGION; FORMS; SHOCK; LTP	Long-term potentiation (LTP) is generally divided into two phases, early (E-) and late (L-) LTP, of which only L-LTP is thought to depend on protein synthesis. Here we report that E-LTP can also be dependent on protein synthesis at higher levels of synaptic activation. Moreover, we show that the requirement for protein synthesis during L-LTP extends beyond the early induction phase and that it depends on synaptic stimulation. This suggests that the level of neuronal activity is a crucial determinant for the role of protein synthesis in E- and L-LTP.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Fonseca, Rosalina/I-1715-2012; Fonseca, Rosalina/AAS-1117-2020; Nägerl, Valentin/AAD-2575-2022; Bonhoeffer, Tobias/B-9481-2009	Fonseca, Rosalina/0000-0003-0884-6441; Nägerl, Valentin/0000-0001-6831-9008; Bonhoeffer, Tobias/0000-0001-7897-6634				Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; SPRINGER AD, 1972, SCIENCE, V177, P628, DOI 10.1126/science.177.4049.628; STANTON PK, 1984, J NEUROSCI, V4, P3080; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214	15	105	110	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					478	480		10.1038/nn1667	http://dx.doi.org/10.1038/nn1667			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531998				2022-12-28	WOS:000236310700011
J	Lamprecht, R; Farb, CR; Rodrigues, SM; LeDoux, JE				Lamprecht, R; Farb, CR; Rodrigues, SM; LeDoux, JE			Fear conditioning drives profilin into amygdala dendritic spines	NATURE NEUROSCIENCE			English	Article							MEMORY; SYNAPSES	Changes in spine morphology may underlie memory formation, but the molecular mechanisms that subserve such alterations are poorly understood. Here we show that fear conditioning in rats leads to the movement of profilin, an actin polymerization-regulatory protein, into dendritic spines in the lateral amygdala and that these spines undergo enlargements in their postsynaptic densities (PSDs). A greater proportion of profilin-containing spines with enlarged PSDs could contribute to the enhancement of associatively induced synaptic responses in the lateral amygdala following fear learning.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	Lamprecht, R (corresponding author), Univ Haifa, Fac Sci & Sci Educ, Dept Neurobiol & Ethol, IL-31905 Haifa, Israel.	rlamp@research.haifa.ac.il			NIMH NIH HHS [MH58911, MH067048, MH38774, MH46516] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038774, K05MH067048, R01MH046516, R37MH038774, P50MH058911] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; MILLHOUSE OE, 1983, NEUROSCIENCE, V10, P1269, DOI 10.1016/0306-4522(83)90112-4; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003	13	81	82	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					481	483		10.1038/nn1672	http://dx.doi.org/10.1038/nn1672			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547510				2022-12-28	WOS:000236310700012
J	Murray, SO; Boyaci, H; Kersten, D				Murray, SO; Boyaci, H; Kersten, D			The representation of perceived angular size in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							MOON ILLUSION; SPATIAL SUMMATION; RECEPTIVE-FIELDS; FUNCTIONAL MRI; DISTANCE; MODULATION; RETINOTOPY; PERCEPTION; VISION; SYSTEM	Two objects that project the same visual angle on the retina can appear to occupy very different proportions of the visual field if they are perceived to be at different distances. What happens to the retinotopic map in primary visual cortex (V1) during the perception of these size illusions? Here we show, using functional magnetic resonance imaging (fMRI), that the retinotopic representation of an object changes in accordance with its perceived angular size. A distant object that appears to occupy a larger portion of the visual field activates a larger area in V1 than an object of equal angular size that is perceived to be closer and smaller. These results demonstrate that the retinal size of an object and the depth information in a scene are combined early in the human visual system.	Univ Washington, Dept Psychol, Seattle, WA 98195 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Murray, SO (corresponding author), Univ Washington, Dept Psychol, Box 351525, Seattle, WA 98195 USA.	somurray@u.washington.edu	Boyaci, Huseyin/ABI-5769-2020	Boyaci, Huseyin/0000-0003-3168-0654	NEI NIH HHS [R01 EY-015261, F32 EY015342] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015261, F32EY015342] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FOLEY JM, 1972, VISION RES, V12, P323, DOI 10.1016/0042-6989(72)90121-6; GILINSKY A S, 1955, Am J Psychol, V68, P173; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; JENKIN N, 1959, AM J PSYCHOL, V72, P68, DOI 10.2307/1420212; Joynson RB, 1949, Q J EXP PSYCHOL, V1, P119; KAUFMAN L, 1962, SCIENCE, V136, P953, DOI 10.1126/science.136.3520.953; Kaufman L, 2000, P NATL ACAD SCI USA, V97, P500, DOI 10.1073/pnas.97.1.500; KERSTEN D, 1984, VISION RES, V24, P1977, DOI 10.1016/0042-6989(84)90033-6; KING WL, 1962, SCIENCE, V135, P1125, DOI 10.1126/science.135.3509.1125; LARSON GW, 1996, RENDERING RADIANCE A; LEIBOWITZ H, 1969, SCIENCE, V166, P1174, DOI 10.1126/science.166.3909.1174; MARG E, 1970, EXPERIENTIA, V26, P270, DOI 10.1007/BF01900088; MCCREADY D, 1985, PERCEPT PSYCHOPHYS, V37, P323, DOI 10.3758/BF03211355; ONO H, 1966, AM J PSYCHOL, V79, P234, DOI 10.2307/1421129; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; RICHARDS W, 1968, KYBERNETIK, V4, P146, DOI 10.1007/BF00288548; RICHARDS W, 1967, NEUROPSYCHOLOGIA, V5, P63, DOI 10.1016/0028-3932(67)90051-6; ROCK I, 1962, SCIENCE, V136, P1023, DOI 10.1126/science.136.3521.1023; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839	27	277	282	7	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					429	434		10.1038/nn1641	http://dx.doi.org/10.1038/nn1641			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462737				2022-12-28	WOS:000235645600023
J	Walter, JT; Alvina, K; Womack, MD; Chevez, C; Khodakhah, K				Walter, JT; Alvina, K; Womack, MD; Chevez, C; Khodakhah, K			Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; CALCIUM-CHANNEL; MUTANT MICE; SYNAPTIC-TRANSMISSION; ELECTRICAL-ACTIVITY; CENTRAL NEURONS; CURRENTS; PATTERNS; OUTPUT	Episodic ataxia type-2 (EA2) is caused by mutations in P/Q-type voltage-gated calcium channels that are expressed at high densities in cerebellar Purkinje cells. Because P/Q channels support neurotransmitter release at many synapses, it is believed that ataxia is caused by impaired synaptic transmission. Here we show that in ataxic P/Q channel mutant mice, the precision of Purkinje cell pacemaking is lost such that there is a significant degradation of the synaptic information encoded in their activity. The irregular pacemaking is caused by reduced activation of calcium-activated potassium (K-Ca) channels and was reversed by pharmacologically increasing their activity with 1-ethyl-2-benzimidazolinone (EBIO). Moreover, chronic in vivo perfusion of EBIO into the cerebellum of ataxic mice significantly improved motor performance. Our data support the hypothesis that the precision of intrinsic pacemaking in Purkinje cells is essential for motor coordination and suggest that K-Ca channels may constitute a potential therapeutic target in EA2.	Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 506 Kennedy Ctr,1410 Pelham Pkwy S, Bronx, NY 10461 USA.	Kkhodakh@aecom.yu.edu		Alvina, Karina/0000-0002-8369-0953	NINDS NIH HHS [R01 NS050808] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; Dove LS, 1998, J NEUROSCI, V18, P7687; Doyle JL, 1998, TRENDS GENET, V14, P92, DOI 10.1016/S0168-9525(97)01370-X; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1967, EXP BRAIN RES, V3, P81; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; GRIGGS RC, 1995, ANN NEUROL, V37, P285, DOI 10.1002/ana.410370302; Harno H, 2004, J NEUROL, V251, P232, DOI 10.1007/s00415-004-0299-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Ito M, 1984, CEREBELLUM NEURAL CO; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaunisto MA, 2004, NEUROGENETICS, V5, P69, DOI 10.1007/s10048-003-0161-0; Khavandgar S, 2005, J PHYSIOL-LONDON, V569, P545, DOI 10.1113/jphysiol.2005.098053; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nam SC, 1997, J NEUROBIOL, V33, P18, DOI 10.1002/(SICI)1097-4695(199707)33:1<18::AID-NEU3>3.0.CO;2-G; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 1999, J NEUROSCI, V19, P1663; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; STONE TW, 1993, PHARMACOL REV, V45, P309; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Swensen AM, 2003, J NEUROSCI, V23, P9650; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Tricarico D, 2000, ANN NEUROL, V48, P304, DOI 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Weisz CJC, 2005, J NEUROSCI, V25, P4141, DOI 10.1523/JNEUROSCI.0098-05.2005; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643	50	301	309	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					389	397		10.1038/nn1648	http://dx.doi.org/10.1038/nn1648			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474392				2022-12-28	WOS:000235645600019
J	Zhong, ZH; Deane, R; Ali, Z; Parisi, M; Shapovalov, Y; O'Banion, MK; Stojanovic, K; Sagare, A; Boillee, S; Cleveland, DW; Zlokovic, BV				Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Shapovalov, Yuriy; O'Banion, M. Kerry; Stojanovic, Konstantin; Sagare, Abhay; Boillee, Severine; Cleveland, Don W.; Zlokovic, Berislav V.			ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; DISEASE; MICE; PROGRESSION; MICROGLIA; ONSET	We report here that amyotrophic lateral sclerosis-linked superoxide dismutase 1 (SOD1) mutants with different biochemical characteristics disrupted the blood-spinal cord barrier in mice by reducing the levels of the tight junction proteins ZO-1, occludin and claudin-5 between endothelial cells. This resulted in microhemorrhages with release of neurotoxic hemoglobin-derived products, reductions in microcirculation and hypoperfusion. SOD1 mutant-mediated endothelial damage accumulated before motor neuron degeneration and the neurovascular inflammatory response occurred, indicating that it was a central contributor to disease initiation.	[Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Stojanovic, Konstantin; Sagare, Abhay; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Stojanovic, Konstantin; Sagare, Abhay; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Stojanovic, Konstantin; Sagare, Abhay; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Shapovalov, Yuriy; O'Banion, M. Kerry] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; [Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Kornberg Med Res Bldg,601 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu	Boillee, Severine/J-4027-2017; Sagare, Abhay/Y-3273-2019; Cleveland, Don/AAN-9783-2021	Sagare, Abhay/0000-0002-8178-3785; BOILLEE, Severine/0000-0001-5518-9005; Cleveland, Don/0000-0002-1934-3682; O'Banion, M. Kerry/0000-0003-1246-3363	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063290-01, R01 HL063290, HL63290] Funding Source: Medline; NIA NIH HHS [R37 AG023084, R37 AG023084-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS034467, R37 NS34467, R37 NS034467-10, R37 NS027036, R37 NS27036, R37 NS034467] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	15	338	356	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					420	422		10.1038/nn2073	http://dx.doi.org/10.1038/nn2073			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344992	Green Accepted			2022-12-28	WOS:000254359300012
J	Anderson, SM; Famous, KR; Sadri-Vakili, G; Kumaresan, V; Schmidt, HD; Bass, CE; Terwilliger, EF; Cha, JHJ; Pierce, RC				Anderson, Sharon M.; Famous, Katie R.; Sadri-Vakili, Ghazaleh; Kumaresan, Vidhya; Schmidt, Heath D.; Bass, Caroline E.; Terwilliger, Ernest F.; Cha, Jang-Ho J.; Pierce, R. Christopher			CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; VENTRAL TEGMENTAL AREA; RECEPTOR STIMULATION INCREASES; INDUCED BEHAVIORAL SENSITIZATION; PRIMING-INDUCED REINSTATEMENT; NUCLEUS-ACCUMBENS; AMPA RECEPTOR; SYNAPTIC PLASTICITY; DRUG-SEEKING; SURFACE EXPRESSION	Increases in dopamine and glutamate transmission in the nucleus accumbens independently promote the reinstatement of cocaine seeking, an animal model of relapse. Here we have tested whether cocaine reinstatement in rats depends on interactions between accumbal dopamine and glutamate systems that are mediated by Ca2+/calmodulin-mediated kinase II (CaMKII). We show that stimulation of D1-like dopamine receptors in the nucleus accumbens shell reinstates cocaine seeking by activating L-type Ca2+ channels and CaMKII. Cocaine reinstatement is associated with D1-like dopamine receptor-dependent increases in accumbens shell CaMKII phosphorylated on Thr286 and glutamate receptor 1 (GluR1) phosphorylated on Ser831 (a known CaMKII phosphorylation site), in addition to increases in cell-surface expression of GluR1-containing AMPA receptors in the shell. Consistent with these findings, cocaine reinstatement is attenuated by intra-shell administration of AAV10-GluR1-C99, a vector that impairs the transport of GluR1-containing AMPA receptors. Thus, CaMKII may be an essential link between accumbens shell dopamine and glutamate systems involved in the neuronal plasticity underlying cocaine craving and relapse.	[Anderson, Sharon M.; Famous, Katie R.; Kumaresan, Vidhya; Schmidt, Heath D.; Pierce, R. Christopher] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Pierce, R. Christopher] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Bass, Caroline E.; Terwilliger, Ernest F.] Beth Israel Deaconess Med Ctr, Harvard Inst Med, Div Expt Med, Boston, MA 02115 USA; [Terwilliger, Ernest F.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Pierce, RC (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, 715 Albany St, Boston, MA 02118 USA.	rcpierce@bu.edu	Kumaresan, Vidhya/ABD-6847-2020	Kumaresan, Vidhya/0000-0002-3374-5741; Bass, Caroline/0000-0002-5856-6387	NIDA NIH HHS [DA16824, R21 DA18333, K02 DA18678, F30 DA19304, F32 DA017543, R01 DA15214] Funding Source: Medline; NIGMS NIH HHS [T32 GM008541-7] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA019304, F31DA016824, R01DA015214, R21DA018333, K02DA018678, F32DA017543] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson SM, 2003, PSYCHOPHARMACOLOGY, V168, P132, DOI 10.1007/s00213-002-1298-5; Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Beurrier C, 2002, J NEUROSCI, V22, P5817; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; Chartoff EH, 2006, BIOL PSYCHIAT, V59, P1236, DOI 10.1016/j.biopsych.2005.09.024; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cooper DC, 2000, BRAIN RES, V880, P212, DOI 10.1016/S0006-8993(00)02868-7; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Edwards S, 2007, EUR J NEUROSCI, V25, P2201, DOI 10.1111/j.1460-9568.2007.05473.x; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Galarraga E, 1997, NEUROREPORT, V8, P2183, DOI 10.1097/00001756-199707070-00019; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; Licata SC, 2004, EUR J NEUROSCI, V19, P405, DOI 10.1111/j.0953-816X.2003.03110.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; Lynch WJ, 2005, EUR J NEUROSCI, V22, P1214, DOI 10.1111/j.1460-9568.2005.04305.x; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McFarland K, 2003, J NEUROSCI, V23, P3531; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pierce RC, 1998, J PHARMACOL EXP THER, V286, P1171; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Scheggi S, 2002, NEUROSCIENCE, V109, P267, DOI 10.1016/S0306-4522(01)00483-3; Schmidt HD, 2006, NEUROSCIENCE, V142, P451, DOI 10.1016/j.neuroscience.2006.06.004; Schmidt HD, 2006, EUR J NEUROSCI, V23, P219, DOI 10.1111/j.1460-9568.2005.04524.x; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; Self DW, 1998, J NEUROSCI, V18, P1848; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Suemaru J, 2000, SYNAPSE, V36, P155, DOI 10.1002/(SICI)1098-2396(20000601)36:3<155::AID-SYN1>3.0.CO;2-N; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Suto N, 2004, NEUROPSYCHOPHARMACOL, V29, P2149, DOI 10.1038/sj.npp.1300533; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	50	238	245	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					344	353		10.1038/nn2054	http://dx.doi.org/10.1038/nn2054			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278040				2022-12-28	WOS:000253548300018
J	Stranahan, AM; Arumugam, TV; Cutler, RG; Lee, K; Egan, JM; Mattson, MP				Stranahan, Alexis M.; Arumugam, Thiruma V.; Cutler, Roy G.; Lee, Kim; Egan, Josephine M.; Mattson, Mark P.			Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; STRESS-INDUCED IMPAIRMENTS; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; GRANULE CELLS; CORTISOL-LEVELS; SPATIAL MEMORY; DENTATE GYRUS; RAT; HYPERGLYCEMIA	Many organ systems are adversely affected by diabetes, including the brain, which undergoes changes that may increase the risk of cognitive decline. Although diabetes influences the hypothalamic-pituitary-adrenal axis, the role of this neuroendocrine system in diabetes-induced cognitive dysfunction remains unexplored. Here we demonstrate that, in both insulin-deficient rats and insulin-resistant mice, diabetes impairs hippocampus-dependent memory, perforant path synaptic plasticity and adult neurogenesis, and the adrenal steroid corticosterone contributes to these adverse effects. Rats treated with streptozocin have reduced insulin and show hyperglycemia, increased corticosterone, and impairments in hippocampal neurogenesis, synaptic plasticity and learning. Similar deficits are observed in db/db mice, which are characterized by insulin resistance, elevated corticosterone and obesity. Changes in hippocampal plasticity and function in both models are reversed when normal physiological levels of corticosterone are maintained, suggesting that cognitive impairment in diabetes may result from glucocorticoid-mediated deficits in neurogenesis and synaptic plasticity.	[Stranahan, Alexis M.; Arumugam, Thiruma V.; Cutler, Roy G.; Lee, Kim; Mattson, Mark P.] NIA, Intramural Res Program, Neurosci Lab, Cellular & Mol Neurosci Sect, Baltimore, MD 21224 USA; [Egan, Josephine M.] NIA, Intramural Res Program, Diabet Sect, Lab Child Invest, Baltimore, MD 21224 USA; [Stranahan, Alexis M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Princeton University	Mattson, MP (corresponding author), NIA, Intramural Res Program, Neurosci Lab, Cellular & Mol Neurosci Sect, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Arumugam, Thiruma Valavan/B-4898-2011; Arumugam, Thiruma/AAG-6958-2019; Arumugam, Thiruma/C-7969-2009; Cutler, Roy G./L-5572-2013; Mattson, Mark P/F-6038-2012; Stranahan, Alexis/AAF-3559-2020	Lee, Kim/0000-0002-5675-1896; Arumugam, Thiruma/0000-0002-3377-0939	NATIONAL INSTITUTE ON AGING [F31AG024690, ZIAAG000312, ZIAAG000315, ZIAAG000330, Z01AG000314, ZIAAG000317, Z01AG000313] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000312-07, Z01 AG000314-07, Z01 AG000313-07] Funding Source: Medline; NIA NIH HHS [F31 AG024690-01, F31 AG024690-03, F31AG024690-03, F31 AG024690-04, F31 AG024690, F31 AG024690-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chan O, 2005, AM J PHYSIOL-REG I, V289, pR235, DOI 10.1152/ajpregu.00674.2004; Desrocher M, 2004, CHILD NEUROPSYCHOL, V10, P36, DOI 10.1076/chin.10.1.36.26241; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; GOULD E, 1992, J NEUROSCI, V12, P3642; Green MC, 2005, POLIT PSYCHOL, V26, P1, DOI 10.1111/j.1467-9221.2005.00407.x; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; Korz V, 2003, J NEUROSCI, V23, P7281; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; LANGLEY SC, 1990, AM J PHYSIOL, V259, pR539, DOI 10.1152/ajpregu.1990.259.3.R539; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; MacLullich AMJ, 2005, PSYCHONEUROENDOCRINO, V30, P505, DOI 10.1016/j.psyneuen.2004.12.005; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; MESSIER C, 2005, AGING S1, V26, pS26; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; Moosavi M, 2007, BEHAV BRAIN RES, V176, P230, DOI 10.1016/j.bbr.2006.10.011; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oitzl MS, 1998, EUR J NEUROSCI, V10, P3759, DOI 10.1046/j.1460-9568.1998.00381.x; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Reagan LP, 2001, P NATL ACAD SCI USA, V98, P2820, DOI 10.1073/pnas.051629798; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; TOKUYAMA K, 1987, AM J PHYSIOL, V252, pE202, DOI 10.1152/ajpendo.1987.252.2.E202; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; Wright RL, 2006, EUR J NEUROSCI, V24, P595, DOI 10.1111/j.1460-9568.2006.04948.x; Zhang WJ, 2008, ACTA NEUROL SCAND, V117, P205, DOI 10.1111/j.1600-0404.2007.00928.x	48	461	480	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					309	317		10.1038/nn2055	http://dx.doi.org/10.1038/nn2055			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278039	Green Accepted			2022-12-28	WOS:000253548300014
J	Mcnab, F; Klingberg, T				McNab, Fiona; Klingberg, Torkel			Prefrontal cortex and basal ganglia control access to working memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; CAPACITY; ATTENTION; PERFORMANCE; SET	Our capacity to store information in working memory might be determined by the degree to which only relevant information is remembered. The question remains as to how this selection of relevant items to be remembered is accomplished. Here we show that activity in the prefrontal cortex and basal ganglia preceded the filtering of irrelevant information and that activity, particularly in the globus pallidus, predicted the extent to which only relevant information is stored. The preceding frontal and basal ganglia activity were also associated with inter-individual differences in working memory capacity. These findings reveal a mechanism by which frontal and basal ganglia activity exerts attentional control over access to working memory storage in the parietal cortex in humans, and makes an important contribution to inter-individual differences in working memory capacity.	[McNab, Fiona; Klingberg, Torkel] Karolinska Inst, Stockholm Brain Inst, MR Centrum, S-17176 Stockholm, Sweden	Karolinska Institutet	Klingberg, T (corresponding author), Karolinska Inst, Stockholm Brain Inst, MR Centrum, N8 00, S-17176 Stockholm, Sweden.	Torkel.Klingberg@ki.se		Klingberg, Torkel/0000-0002-3175-2171				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bleckley MK, 2003, PSYCHON B REV, V10, P884, DOI 10.3758/BF03196548; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 1996, MEMORY, V4, P577, DOI 10.1080/741940997; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Grabli D, 2004, BRAIN, V127, P2039, DOI 10.1093/brain/awh220; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Menon V, 2000, NEUROREPORT, V11, P3641, DOI 10.1097/00001756-200011090-00048; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Mushiake H, 1995, J NEUROPHYSIOL, V74, P2754, DOI 10.1152/jn.1995.74.6.2754; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; SCHNEIDER JS, 1984, BIOL PSYCHIAT, V19, P1693; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Taylor PE, 1996, TRANSPLANT P, V28, P281; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447	29	705	727	3	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					103	107		10.1038/nn2024	http://dx.doi.org/10.1038/nn2024			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066057				2022-12-28	WOS:000252117900018
J	Roesch, MR; Calu, DJ; Schoenbaum, G				Roesch, Matthew R.; Calu, Donna J.; Schoenbaum, Geoffrey			Dopamine neurons encode the better option in rats deciding between differently delayed or sized rewards	NATURE NEUROSCIENCE			English	Article							ORBITAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; IMPULSIVE CHOICE; DORSOLATERAL STRIATUM; QUANTITATIVE-ANALYSIS; NUCLEUS-ACCUMBENS; PREDICTION ERROR; REINFORCEMENT; AMYGDALA; LESIONS	The dopamine system is thought to be involved in making decisions about reward. Here we recorded from the ventral tegmental area in rats learning to choose between differently delayed and sized rewards. As expected, the activity of many putative dopamine neurons reflected reward prediction errors, changing when the value of the reward increased or decreased unexpectedly. During learning, neural responses to reward in these neurons waned and responses to cues that predicted reward emerged. Notably, this cue-evoked activity varied with size and delay. Moreover, when rats were given a choice between two differently valued outcomes, the activity of the neurons initially reflected the more valuable option, even when it was not subsequently selected.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Roesch, MR (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St HSF-2 S251, Baltimore, MD 21201 USA.	mroes001@umaryland.edu		Calu, Donna/0000-0003-2377-9494	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH080514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718, K01DA021609] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG027097, R01 AG027097-01A2, R01-AG027097] Funding Source: Medline; NIDA NIH HHS [R01-DA015718, R01 DA015718-05, K01-DA021609, K01 DA021609, R01 DA015718] Funding Source: Medline; NIMH NIH HHS [F31-MH085014, F31 MH080514] Funding Source: Medline; NINDS NIH HHS [T32-NS07375, T32 NS007375] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baxter MG, 2000, J NEUROSCI, V20, P4311; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BUNNEY BS, 1973, NATURE-NEW BIOL, V245, P123, DOI 10.1038/newbio245123a0; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2000, J NEUROSCI, V20, P2369; Hatfield T, 1996, J NEUROSCI, V16, P5256; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LOWENSTEIN G, 1992, CHOICE OVER TIME; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SKIRBOLL LR, 1979, SCIENCE, V206, P80, DOI 10.1126/science.482929; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	47	420	421	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1615	1624		10.1038/nn2013	http://dx.doi.org/10.1038/nn2013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026098	Green Accepted			2022-12-28	WOS:000251172900020
J	He, HY; Ray, B; Dennis, K; Quinlan, EM				He, Hai-Yan; Ray, Baisali; Dennis, Katie; Quinlan, Elizabeth M.			Experience-dependent recovery of vision following chronic deprivation amblyopia	NATURE NEUROSCIENCE			English	Review							OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; MONOCULAR DEPRIVATION; SELECTIVITY; RATS	The shift in ocular dominance induced by brief monocular deprivation is greatest during a postnatal critical period and is thought to decline irreversibly thereafter. However, here we demonstrate that complete visual deprivation through dark exposure restores rapid ocular dominance plasticity in adult rats. In addition, the loss of visual acuity resulting from chronic monocular deprivation is reversed if dark exposure precedes removal of the occlusion in adulthood, suggesting a potential use for dark exposure in the treatment of adult amblyopia.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Quinlan, EM (corresponding author), Univ Maryland, Dept Biol, 1210 Biol Psychol Bldg 144, College Pk, MD 20742 USA.	equinlan@umd.edu		He, Haiyan/0000-0002-6692-6012	NATIONAL EYE INSTITUTE [R03EY013818] Funding Source: NIH RePORTER; NEI NIH HHS [EY13818] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; MERABET LB, 1909, J NEUROPHYSIOL, V97, P1633; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005	16	166	172	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1134	1136		10.1038/nn1965	http://dx.doi.org/10.1038/nn1965			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694050				2022-12-28	WOS:000249144000014
J	Zalfa, F; Eleuteri, B; Dickson, KS; Mercaldo, V; De Rubeis, S; di Penta, A; Tabolacci, E; Chiurazzi, P; Neri, G; Grant, SGN; Bagni, C				Zalfa, Francesca; Eleuteri, Boris; Dickson, Kirsten S.; Mercaldo, Valentina; De Rubeis, Silvia; di Penta, Alessandra; Tabolacci, Elisabetta; Chiurazzi, Pietro; Neri, Giovanni; Grant, Seth G. N.; Bagni, Claudia			A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; NMDA RECEPTOR; ALZHEIMERS-DISEASE; BINDING PROTEINS; FMRP; TRANSLATION; MECHANISMS; SYNAPSES; MICE; IDENTIFICATION	Fragile X syndrome ( FXS) results from the loss of the fragile X mental retardation protein ( FMRP), an RNA- binding protein that regulates a variety of cytoplasmic mRNAs. FMRP regulates mRNA translation and may be important in mRNA localization to dendrites. We report a third cytoplasmic regulatory function for FMRP: control of mRNA stability. In mice, we found that FMRP binds, in vivo, the mRNA encoding PSD- 95, a key molecule that regulates neuronal synaptic signaling and learning. This interaction occurs through the 3' untranslated region of the PSD- 95 ( also known as Dlg4) mRNA, increasing message stability. Moreover, stabilization is further increased by mGluR activation. Although we also found that the PSD- 95 mRNA is synaptically localized in vivo, localization occurs independently of FMRP. Through our functional analysis of this FMRP target we provide evidence that dysregulation of mRNA stability may contribute to the cognitive impairments in individuals with FXS.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Fdn Santa Lucia, Ist Neurosci Sperimentali, I-00143 Rome, Italy; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Cattolica, Ist Genet Med, I-00168 Rome, Italy; Wellcome Trust Res Labs, Sanger Inst, Hinxton CB10 1SA, Cambs, England	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Edinburgh; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Wellcome Trust Sanger Institute	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci 1, I-00133 Rome, Italy.	dickson.kris@gmail.com; claudia.bagni@uniroma2.it	Mercaldo, Valentina/AAA-6000-2019; TABOLACCI, Elisabetta/AAR-6538-2020; De Rubeis, Silvia/E-9852-2013; Zalfa, Francesca/J-7759-2018; Chiurazzi, Pietro/J-3169-2012	TABOLACCI, Elisabetta/0000-0002-4707-2242; De Rubeis, Silvia/0000-0001-9383-6883; Zalfa, Francesca/0000-0002-1922-9468; Grant, Seth/0000-0001-8732-8735; Bagni, Claudia/0000-0002-4419-210X	Telethon [GGP05269] Funding Source: Medline; Wellcome Trust [077155, 056523] Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bencini G, 2005, BRAIN LANG, V95, P133, DOI 10.1016/j.bandl.2005.07.075; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; REISS AL, 1994, NEUROLOGY, V44, P1317, DOI 10.1212/WNL.44.7.1317; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Smith CL, 2004, J NEUROBIOL, V61, P222, DOI 10.1002/neu.20038; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; VICKERS CA, 2006, BRAIN RES; Wang HP, 2004, HUM MOL GENET, V13, P79, DOI 10.1093/hmg/ddh009; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	50	275	284	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					578	587		10.1038/nn1893	http://dx.doi.org/10.1038/nn1893			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417632	Green Accepted, Green Published			2022-12-28	WOS:000245948000014
J	Smith, SL; Trachtenberg, JT				Smith, Spencer L.; Trachtenberg, Joshua T.			Experience-dependent binocular competition in the visual cortex begins at eye opening	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; CRITICAL-PERIOD; ORIENTATION SELECTIVITY; FERRET; MOUSE; COLUMNS; KITTEN; DEPRIVATION; MATURATION; AMBLYOPIA	Visual experience begins at eye opening, but current models consider cortical circuitry to be resistant to experience-dependent competitive modification until the activation of a later critical period. Here we examine this idea using optical imaging to map the time course of receptive field refinement in normal mice, mice in which the contralateral eye never opens and mice in which the contralateral eye is silenced. We found that the refinement of ipsilateral eye retinotopy is retarded by contralateral deprivation, but accelerated by silencing of the contralateral eye. Patterned visual experience through the ipsilateral eye is required for this acceleration. These differences are most obvious at postnatal day 15, long before the start of the critical period, indicating that experience-dependent binocular plasticity occurs much earlier than was previously thought. Furthermore, these results suggest that the quality of activity, in terms of signal to noise, and not the quantity, determines robust receptive field development.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Trachtenberg, JT (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	jtrachtenberg@mednet.ucla.edu						Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Isenberg SJ, 2006, OPHTHALMOLOGY, V113, P893, DOI 10.1016/j.ophtha.2006.04.010; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; OLSON CR, 1980, EXP BRAIN RES, V39, P17; PETTIGREW JD, 1974, J PHYSIOL-LONDON, V237, P49, DOI 10.1113/jphysiol.1974.sp010469; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	34	103	105	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					370	375		10.1038/nn1844	http://dx.doi.org/10.1038/nn1844			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293862				2022-12-28	WOS:000244480300020
J	Kim, JH; Sizov, I; Dobretsov, M; von Gersdorff, H				Kim, Jun Hee; Sizov, Igor; Dobretsov, Maxim; von Gersdorff, Henrique			Presynaptic Ca2+ buffers control the strength of a fast post-tetanic hyperpolarization mediated by the alpha 3 Na+/K+-ATPase	NATURE NEUROSCIENCE			English	Article							AUDITORY BRAIN-STEM; TRAPEZOID BODY; NA+/CA2+ EXCHANGE; COCHLEAR NUCLEUS; NERVE-FIBERS; I-H; RAT; CALYX; PUMP; CHANNELS	The excitability of CNS presynaptic terminals after a tetanic burst of action potentials is important for synaptic plasticity. The mechanisms that regulate excitability, however, are not well understood. Using direct recordings from the rat calyx of Held terminal, we found that a fast Na+/K+-ATPase (NKA)-mediated post-tetanic hyperpolarization ( PTH) controls the probability and precision of subsequent firing. Notably, increasing the concentration of internal Ca2+ buffers or decreasing Ca2+ influx led to larger PTH amplitudes, indicating that an increase in [Ca2+](i) regulates PTH via inhibition of NKAs. The characterization for the first time of a presynaptic NKA pump current, combined with immunofluorescence staining, identified the alpha 3-NKA isoform on calyx terminals. Accordingly, the increased ability of the calyx to faithfully fire during a high-frequency train as it matures is paralleled by a larger expression of alpha 3-NKA during development. We propose that this newly discovered Ca2+ dependence of PTH is important in the post-burst excitability of nerve terminals.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Arkansas Med Sci, Dept Anesthesiol, Little Rock, AR 72205 USA	Oregon Health & Science University; University of Arkansas System; University of Arkansas Medical Sciences	von Gersdorff, H (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	vongersd@ohsu.edu	Dobretsov, Maxim/U-9770-2018; Sizov, Igor/A-1814-2014	Sizov, Igor/0000-0003-0726-2006; Dobretsov, Maxim/0000-0001-6007-9775	NIDCD NIH HHS [DC04274] Funding Source: Medline; NIDDK NIH HHS [DK067248] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004274] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Carr CE, 2001, CURR OPIN NEUROBIOL, V11, P727, DOI 10.1016/S0959-4388(01)00276-8; Clapham DE, 1998, NEURON, V21, P5, DOI 10.1016/S0896-6273(00)80508-5; Clarke Donald D., 1994, P645; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dobretsov M, 1999, NEUROSCIENCE, V93, P723, DOI 10.1016/S0306-4522(99)00122-0; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GOLDING NL, 1995, J NEUROSCI, V15, P3138; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; ISHII T, 1995, EMBO J, V14, P58, DOI 10.1002/j.1460-2075.1995.tb06975.x; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; Kadner A, 2006, J NEUROPHYSIOL, V95, P1499, DOI 10.1152/jn.00902.2005; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Leao RM, 2005, J NEUROSCI, V25, P3724, DOI 10.1523/JNEUROSCI.3983-04.2005; Leao RN, 2005, EUR J NEUROSCI, V22, P147, DOI 10.1111/j.1460-9568.2005.04185.x; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; MORITA K, 1993, J NEUROPHYSIOL, V70, P1874, DOI 10.1152/jn.1993.70.5.1874; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Parker D, 1996, J NEUROPHYSIOL, V76, P540, DOI 10.1152/jn.1996.76.1.540; RANG HP, 1968, J PHYSIOL-LONDON, V196, P183, DOI 10.1113/jphysiol.1968.sp008502; SCHNEIDER JW, 1988, P NATL ACAD SCI USA, V85, P284, DOI 10.1073/pnas.85.1.284; Senatorov VV, 1997, J PHYSIOL-LONDON, V502, P387, DOI 10.1111/j.1469-7793.1997.387bk.x; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; SOMMER I, 1993, EXP BRAIN RES, V95, P223; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Verdru P, 1997, J NEUROPHYSIOL, V77, P484, DOI 10.1152/jn.1997.77.1.484; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; Zhong N, 2001, J NEUROSCI, V21, P9598, DOI 10.1523/JNEUROSCI.21-24-09598.2001	50	86	89	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					196	205		10.1038/nn1839	http://dx.doi.org/10.1038/nn1839			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220883				2022-12-28	WOS:000244175200014
J	Tankersley, D; Stowe, CJ; Huettel, SA				Tankersley, Dharol; Stowe, C. Jill; Huettel, Scott A.			Altruism is associated with an increased neural response to agency	NATURE NEUROSCIENCE			English	Article							EMPATHY; MIND; PSYCHOLOGY; OTHERS; PEOPLE	Although the neural mechanisms underlying altruism remain unknown, empathy and its component abilities, such as the perception of the actions and intentions of others, have been proposed as key contributors. Tasks requiring the perception of agency activate the posterior superior temporal cortex ( pSTC), particularly in the right hemisphere. Here, we demonstrate that differential activation of the human pSTC during action perception versus action performance predicts self-reported altruism.	Duke Univ, Fuqua Sch Business, Durham, NC 27708 USA; Duke Univ, Med Ctr, Ctr Neuroecon Studies, Durham, NC 27710 USA; Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Fuqua Sch Business, 1 Towerview Dr, Durham, NC 27708 USA.	scott.huettel@duke.edu			PHS HHS [70685, 41328] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Post SG, 2005, INT J BEHAV MED, V12, P66, DOI 10.1207/s15327558ijbm1202_4; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022	14	132	139	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					150	151		10.1038/nn1833	http://dx.doi.org/10.1038/nn1833			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237779				2022-12-28	WOS:000244175200008
J	Filosa, JA; Bonev, AD; Straub, SV; Meredith, AL; Wilkerson, MK; Aldrich, RW; Nelson, MT				Filosa, Jessica A.; Bonev, Adrian D.; Straub, Stephen V.; Meredith, Andrea L.; Wilkerson, M. Keith; Aldrich, Richard W.; Nelson, Mark T.			Local potassium signaling couples neuronal activity to vasodilation in the brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; ARTERIAL SMOOTH-MUSCLE; K+ CHANNELS; ASTROCYTE ENDFEET; NEURAL ACTIVITY; GLIAL-CELLS; RAT; STIMULATION; MEMBRANE; OPENER	The mechanisms by which active neurons, via astrocytes, rapidly signal intracerebral arterioles to dilate remain obscure. Here we show that modest elevation of extracellular potassium ( K+) activated inward rectifier K+ ( Kir) channels and caused membrane potential hyperpolarization in smooth muscle cells ( SMCs) of intracerebral arterioles and, in cortical brain slices, induced Kir-dependent vasodilation and suppression of SMC intracellular calcium ( Ca2+) oscillations. Neuronal activation induced a rapid ( < 2 s latency) vasodilation that was greatly reduced by Kir channel blockade and completely abrogated by concurrent cyclooxygenase inhibition. Astrocytic endfeet exhibited large-conductance, Ca2+-sensitive K+ ( BK) channel currents that could be activated by neuronal stimulation. Blocking BK channels or ablating the gene encoding these channels prevented neuronally induced vasodilation and suppression of arteriolar SMC Ca2+, without affecting the astrocytic Ca2+ elevation. These results support the concept of intercellular K+ channel-to-K+ channel signaling, through which neuronal activity in the form of an astrocytic Ca2+ signal is decoded by astrocytic BK channels, which locally release K+ into the perivascular space to activate SMC Kir channels and cause vasodilation.	Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Vermont; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; Stanford University; Stanford University	Nelson, MT (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA.	Mark.Nelson@uvm.edu	Filosa, Jessica Andrea/ABG-4524-2020	Filosa, Jessica Andrea/0000-0001-7536-2039; Meredith, Andrea/0000-0003-1061-2302; Nelson, Mark/0000-0002-6608-8784	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044455, R01HL063722] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07944, HL63722, HL44455] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; Brown LA, 2002, AUTON NEUROSCI-BASIC, V95, P137, DOI 10.1016/S1566-0702(01)00395-2; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cheney JA, 2001, J CEREBR BLOOD F MET, V21, P396, DOI 10.1097/00004647-200104000-00008; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Horiuchi T, 2001, STROKE, V32, P218, DOI 10.1161/01.STR.32.1.218; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jensen BS, 2002, CNS DRUG REV, V8, P353; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LANGTON PD, 1991, AM J PHYSIOL, V260, P927; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NELSON MT, 1995, AM J PHYSIOL, V268, P799; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rossi DJ, 2006, NAT NEUROSCI, V9, P159, DOI 10.1038/nn0206-159; Roy C S, 1890, J Physiol, V11, P85; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Silva AC, 1999, J CEREBR BLOOD F MET, V19, P871, DOI 10.1097/00004647-199908000-00006; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	44	383	391	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1397	1403		10.1038/nn1779	http://dx.doi.org/10.1038/nn1779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013381				2022-12-28	WOS:000242403800017
J	Goel, A; Jiang, B; Xu, LW; Song, LH; Kirkwood, A; Lee, HK				Goel, Anubhuthi; Jiang, Bin; Xu, Linda W.; Song, Lihua; Kirkwood, Alfredo; Lee, Hey-Kyoung			Cross-modal regulation of synaptic AMPA receptors in primary sensory cortices by visual experience	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; PLASTICITY; EXPRESSION; NEURONS	Lack of a sensory input not only alters the cortical circuitry subserving the deprived sense, but also produces compensatory changes in the functionality of other sensory modalities. Here we report that visual deprivation produces opposite changes in synaptic function in primary visual and somatosensory cortices in rats, which are rapidly reversed by visual experience. This type of bidirectional cross-modal plasticity is associated with changes in synaptic AMPA receptor subunit composition.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, NACS Program, College Pk, MD 20742 USA; Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Lee, HK (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	hlee21@umd.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	NATIONAL EYE INSTITUTE [R01EY014882, R01EY012124] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014882-02, R01 EY014882, R01-EY012124, R01 EY014882-03, R01 EY012124, R01-EY014882, R01 EY014882-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Goldreich D, 2003, J NEUROSCI, V23, P3439; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393	13	150	153	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1001	1003		10.1038/nn1725	http://dx.doi.org/10.1038/nn1725			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819524	Green Accepted			2022-12-28	WOS:000240080300010
J	Pun, S; Santos, AF; Saxena, S; Xu, L; Caroni, P				Pun, S; Santos, AF; Saxena, S; Xu, L; Caroni, P			Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; MOTOR-NEURON DISEASE; MUTANT SUPEROXIDE-DISMUTASE; UBIQUITIN-PROTEASOME SYSTEM; TRANSGENIC MOUSE MODEL; LINKED SOD1 MUTANTS; ALZHEIMERS-DISEASE; MUSCLE-FIBERS; ALS MICE	Neurodegenerative diseases can have long preclinical phases and insidious progression patterns, but the mechanisms of disease progression are poorly understood. Because quantitative accounts of neuronal circuitry affected by disease have been lacking, it has remained unclear whether disease progression reflects processes of stochastic loss or temporally defined selective vulnerabilities of distinct synapses or axons. Here we derive a quantitative topographic map of muscle innervation in the hindlimb. We show that in two mouse models of motoneuron disease (G93A SOD1 and G85R SOD1), axons of fast-fatiguable motoneurons are affected synchronously, long before symptoms appear. Fast-fatigue-resistant motoneuron axons are affected at symptom-onset, whereas axons of slow motoneurons are resistant. Axonal vulnerability leads to synaptic vesicle stalling and accumulation of BC12a1-a, an anti-apoptotic protein. It is alleviated by ciliary neurotrophic factor and triggers proteasome-dependent pruning of peripheral axon branches. Thus, motoneuron disease involves predictable, selective vulnerability patterns by physiological subtypes of axons, episodes of abrupt pruning in the target region and compensation by resistant axons.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	Santos, Alexsandro/HCI-9028-2022	Saxena, Smita/0000-0003-4574-4591				Al-Chalabi A, 2003, ANN NEUROL, V54, P130, DOI 10.1002/ana.10638; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Burke RE, 1994, MYOLOGY, P464; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; DELIO DA, 1992, J NEUROL SCI, V109, P30, DOI 10.1016/0022-510X(92)90090-8; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LARSSON L, 1995, J NEUROL SCI, V132, P182, DOI 10.1016/0022-510X(95)00138-R; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Peterson WM, 2000, J NEUROSCI, V20, P4081; PINTER MJ, 1995, J NEUROSCI, V15, P3447; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Sagot Y, 1998, J NEUROSCI, V18, P1132; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Shaw PJ, 2000, J NEUROL, V247, P17; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	50	455	468	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					408	419		10.1038/nn1653	http://dx.doi.org/10.1038/nn1653			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474388				2022-12-28	WOS:000235645600021
J	Kole, MHP; Ilschner, SU; Kampa, BM; Williams, SR; Ruben, PC; Stuart, GJ				Kole, Maarten H. P.; Ilschner, Susanne U.; Kampa, Bjoern M.; Williams, Stephen R.; Ruben, Peter C.; Stuart, Greg J.			Action potential generation requires a high sodium channel density in the axon initial segment	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE-CELLS; GATED ION CHANNELS; SPIKE INITIATION; DENDRITES; VOLTAGE; SITE; PROPAGATION; RANVIER; CHANDELIER	The axon initial segment ( AIS) is a specialized region in neurons where action potentials are initiated. It is commonly assumed that this process requires a high density of voltage-gated sodium ( Na(+)) channels. Paradoxically, the results of patch-clamp studies suggest that the Na(+) channel density at the AIS is similar to that at the soma and proximal dendrites. Here we provide data obtained by antibody staining, whole-cell voltage-clamp and Na(+) imaging, together with modeling, which indicate that the Na(+) channel density at the AIS of cortical pyramidal neurons is similar to 50 times that in the proximal dendrites. Anchoring of Na(+) channels to the cytoskeleton can explain this discrepancy, as disruption of the actin cytoskeleton increased the Na(+) current measured in patches from the AIS. Computational models required a high Na(+) channel density (similar to 2,500 pS mu m(-2)) at the AIS to account for observations on action potential generation and backpropagation. In conclusion, action potential generation requires a high Na(+) channel density at the AIS, which is maintained by tight anchoring to the actin cytoskeleton.	[Kole, Maarten H. P.; Ilschner, Susanne U.; Kampa, Bjoern M.; Williams, Stephen R.; Ruben, Peter C.; Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia; [Williams, Stephen R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Ruben, Peter C.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada	Australian National University; John Curtin School of Medical Research; MRC Laboratory Molecular Biology; Simon Fraser University	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Garran Rd, Canberra, ACT 0200, Australia.	greg.stuart@anu.edu.au	stuart, greg j/F-7328-2011; Kampa, Bjoern M/D-6213-2015; Kampa, Bjoern/A-1612-2008; Kampa, Bjoern/GWC-5714-2022	Kampa, Bjoern M/0000-0002-4343-2634; Kampa, Bjoern/0000-0002-4343-2634; stuart, greg/0000-0001-9395-2219; Williams, Stephen/0000-0001-5352-7947; Kole, Maarten/0000-0002-3883-5682	MRC [MC_U105170644] Funding Source: UKRI; Medical Research Council [MC_U105170644] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Carnevale NT, 2006, NEURON BOOK; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; Eccles, 2013, PHYSL SYNAPSES; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MILTON RL, 1990, J NEUROSCI, V10, P885; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; NEUMCKE B, 1982, J PHYSIOL-LONDON, V329, P163, DOI 10.1113/jphysiol.1982.sp014296; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PETERS A, 1968, J CELL BIOL, V39, P604, DOI 10.1083/jcb.39.3.604; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	50	429	440	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					178	186		10.1038/nn2040	http://dx.doi.org/10.1038/nn2040			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204443				2022-12-28	WOS:000252712100012
J	Sauvage, MM; Fortin, NJ; Owens, CB; Yonelinas, AP; Eichenbaum, H				Sauvage, Magdalena M.; Fortin, Norbert J.; Owens, Cullen B.; Yonelinas, Andrew P.; Eichenbaum, Howard			Recognition memory: opposite effects of hippocampal damage on recollection and familiarity	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; FACILITATION; COMPONENTS; AMNESIA; CORTEX	A major controversy in memory research concerns whether recognition is subdivided into distinct cognitive mechanisms of recollection and familiarity that are supported by different neural substrates. Here we developed a new associative recognition protocol for rats that enabled us to show that recollection is reduced, whereas familiarity is increased following hippocampal damage. These results provide strong evidence that these processes are qualitatively different and that the hippocampus supports recollection and not familiarity.	[Sauvage, Magdalena M.; Fortin, Norbert J.; Owens, Cullen B.; Yonelinas, Andrew P.; Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Sauvage, Magdalena/0000-0002-7586-6410; Fortin, Norbert/0000-0002-6793-6984; Yonelinas, Andrew/0000-0002-9580-4997	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH052090] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 71702, P50 MH071702-01A2, MH 52090, R01 MH052090, P50 MH071702, R01 MH052090-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggleton JP, 2005, NEUROPSYCHOLOGIA, V43, P1810, DOI 10.1016/j.neuropsychologia.2005.01.019; Birrell JM, 2000, J NEUROSCI, V20, P4320; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum Howard, 1994, P147; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Giovanello KS, 2006, NEUROPSYCHOLOGIA, V44, P1859, DOI 10.1016/j.neuropsychologia.2006.03.004; Parks CM, 2007, PSYCHOL REV, V114, P188, DOI 10.1037/0033-295X.114.1.188; Quamme JR, 2007, HIPPOCAMPUS, V17, P192, DOI 10.1002/hipo.20257; Reinitz MT, 1996, MEM COGNITION, V24, P129, DOI 10.3758/BF03200875; Saksida LM, 2007, CEREB CORTEX, V17, P108, DOI 10.1093/cercor/bhj128; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939	15	131	131	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					16	18		10.1038/nn2016	http://dx.doi.org/10.1038/nn2016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18037884	Green Accepted			2022-12-28	WOS:000252117900007
J	Dellisanti, CD; Yao, Y; Stroud, JC; Wang, ZZ; Chen, L				Dellisanti, Cosma D.; Yao, Yun; Stroud, James C.; Wang, Zuo-Zhong; Chen, Lin			Crystal structure of the extracellular domain of nAChR alpha 1 bound to alpha-bungarotoxin at 1.94 A resolution	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; CYS-LOOP RECEPTORS; ESCHERICHIA-COLI; GATING MECHANISM; AGONIST BINDING; PICHIA-PASTORIS; PROTEIN; SUBUNIT; CHANNEL	We determined the crystal structure of the extracellular domain of the mouse nicotinic acetylcholine receptor (nAChR) alpha 1 subunit bound to alpha-bungarotoxin at 1.94 angstrom resolution. This structure is the first atomic-resolution view of a nAChR subunit extracellular domain, revealing receptor-specific features such as the main immunogenic region (MIR), the signature Cys-loop and the N-linked carbohydrate chain. The toxin binds to the receptor through extensive protein-protein and protein-sugar interactions. To our surprise, the structure showed a well-ordered water molecule and two hydrophilic residues deep in the core of the a1 subunit. The two hydrophilic core residues are highly conserved in nAChRs, but correspond to hydrophobic residues in the nonchannel homolog acetylcholine-binding proteins. We carried out site-directed mutagenesis and electrophysiology analyses to assess the functional role of the glycosylation and the hydrophilic core residues. Our structural and functional studies show essential features of the nAChR and provide new insights into the gating mechanism.	Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Univ So Calif, Norris Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ Calif Los Angeles, Inst Genom & Proteom, Dept Energy, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles	Chen, L (corresponding author), Univ So Calif, 1050 Childs Way,RIH201, Los Angeles, CA 90089 USA.	zzwang@usc.edu; linchen@usc.edu	Stroud, James C/B-3230-2012; chen, Lin/A-3392-2008	Stroud, James C/0000-0003-0850-4812; chen, Lin/0000-0003-4798-6199	NHLBI NIH HHS [R01 HL076334] Funding Source: Medline; NIGMS NIH HHS [R01 GM077320, R01 GM064642] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077320, R01GM064642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexeev T, 1999, EUR J BIOCHEM, V259, P310, DOI 10.1046/j.1432-1327.1999.00041.x; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chen DN, 1998, J NEUROCHEM, V70, P349; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gehle VM, 1997, MOL BRAIN RES, V45, P219, DOI 10.1016/S0169-328X(96)00256-2; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A, 2004, NEURON, V41, P841, DOI 10.1016/S0896-6273(04)00151-5; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Konstantakaki M, 2007, BIOCHEM BIOPH RES CO, V359, P413, DOI 10.1016/j.bbrc.2007.05.126; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Qasba PK, 2000, CARBOHYD POLYM, V41, P293, DOI 10.1016/S0144-8617(99)00148-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tsouloufis T, 2000, INT IMMUNOL, V12, P1255, DOI 10.1093/intimm/12.9.1255; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Wang T, 2003, PROTEIN EXPRES PURIF, V30, P140, DOI 10.1016/S1046-5928(03)00098-6; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YAO J, 1994, J MOL BIOL, V243, P736, DOI 10.1016/0022-2836(94)90044-2; Yao Y, 2002, J BIOL CHEM, V277, P12613, DOI 10.1074/jbc.M108845200	50	348	355	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					953	962		10.1038/nn1942	http://dx.doi.org/10.1038/nn1942			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17643119				2022-12-28	WOS:000248357500009
J	Qiu, FTT; von der Heydt, D				Qiu, Fangtu T.; von der Heydt, Diger			Neural representation of transparent overlay	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; PERCEPTION; DEPTH	Perceptual transparency is a surprising phenomenon in which a number of regions of different shades organize into overlaying transparent objects. We recorded single neuron responses from Macaca mulatta area V2 to a display of two bright and two dark squares that appeared as two overlaying bars. We found that neurons assign border ownership according to the transparent interpretation, representing the shapes of the bars rather than the squares.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	von der Heydt, D (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY002966, R01EY016281] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016281, R01 EY02966, R01 EY016281-03, R01 EY002966] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; ADELSON EH, P AM ASS ART INT WOR, P77; BECK J, 1984, PERCEPT PSYCHOPHYS, V35, P407, DOI 10.3758/BF03203917; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	9	37	38	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					283	284		10.1038/nn1853	http://dx.doi.org/10.1038/nn1853			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310247	Green Accepted			2022-12-28	WOS:000244480300009
J	Ulanovsky, N; Moss, CF				Ulanovsky, Nachum; Moss, Cynthia F.			Hippocampal cellular and network activity in freely moving echolocating bats	NATURE NEUROSCIENCE			English	Article							THETA-RHYTHM; EPTESICUS-FUSCUS; PHASE PRECESSION; PYRAMIDAL CELLS; OSCILLATIONS; PLACE; SLEEP; DYNAMICS; MEMORY; RAT	The hippocampus is crucial for episodic and spatial memory. In freely moving rodents, hippocampal pyramidal neurons show spatially selective firing when the animal passes through a neuron's 'place- field', and theta-band oscillation is continuously present during locomotion. Here we report the first hippocampal recordings from echolocating bats, mammals phylogenetically distant from rodents, which showed place cells very similar to those of rodents. High- frequency 'ripple' oscillations were also rodent- like. Theta oscillation, however, differed from rodents in two important ways: ( i) theta occurred when bats explored the environment without locomoting, using distal sensing through echolocation, and ( ii) theta was not continuous, but occurred in short intermittent bouts. The intermittence of theta suggests that models of hippocampal function that rely on continuous theta may not apply to bats. Our data support the hypothesis that theta oscillation in the mammalian hippocampus is involved in sequence learning and hence, theta power should increase with sensory- input rate-which explains why theta power correlates with running speed in rodents and with echolocation call rate in bats.	Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ulanovsky, N (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	nulanovsky@psyc.umd.edu	; Moss, Cynthia/J-5208-2017	Ulanovsky, Nachum/0000-0001-8598-4667; Moss, Cynthia/0000-0001-6916-0000	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056366] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH56366] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cantero JL, 2003, J NEUROSCI, V23, P10897; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; ELLINS SR, 1974, BRAIN BEHAV EVOLUT, V9, P248, DOI 10.1159/000123669; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Georges-Francois P, 1999, CEREB CORTEX, V9, P197, DOI 10.1093/cercor/9.3.197; Griffin D. R., 1970, P233; Griffin DR, 1958, LISTENING DARK; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lengyel M, 2005, BIOL CYBERN, V92, P393, DOI 10.1007/s00422-005-0567-x; Ludvig N, 2004, BRAIN RES, V1014, P97, DOI 10.1016/j.brainres.2004.03.071; MACRIDES F, 1982, J NEUROSCI, V2, P1705; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCCRACKEN GF, 1993, ANIM BEHAV, V45, P811, DOI 10.1006/anbe.1993.1094; MULLER HC, 1979, J MAMMAL, V60, P198; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OKEEFE J, 1978, HIPPOCAMPU COGNITIVE; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siegel JJ, 2000, HIPPOCAMPUS, V10, P627, DOI 10.1002/1098-1063(2000)10:6<627::AID-HIPO1000>3.0.CO;2-W; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Suzuki WA, 2000, CURR OPIN NEUROBIOL, V10, P768, DOI 10.1016/S0959-4388(00)00148-3; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WILLIAMS TC, 1970, ANIM BEHAV, V18, P302, DOI 10.1016/S0003-3472(70)80042-2; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4	50	161	163	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					224	233		10.1038/nn1829	http://dx.doi.org/10.1038/nn1829			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220886				2022-12-28	WOS:000244175200017
J	Fu, WY; Chen, Y; Sahin, M; Zhao, XS; Shi, L; Bikoff, JB; Lai, KO; Yung, WH; Fu, AKY; Greenberg, ME; Ip, NY				Fu, Wing-Yu; Chen, Yu; Sahin, Mustafa; Zhao, Xiao-Su; Shi, Lei; Bikoff, Jay B.; Lai, Kwok-On; Yung, Wing-Ho; Fu, Amy K. Y.; Greenberg, Michael E.; Ip, Nancy Y.			Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GROWTH CONE DYNAMICS; LONG-TERM DEPRESSION; EPH RECEPTORS; NEURAL DEVELOPMENT; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH	The development of dendritic spines is thought to be crucial for synaptic plasticity. Dendritic spines are retracted upon Eph receptor A4 ( EphA4) activation, but the mechanisms that control this process are not well understood. Here we report an important function of cyclin-dependent kinase 5 (Cdk5) in EphA4-dependent spine retraction in mice. We found that blocking Cdk5 activity inhibits ephrin-A1- triggered spine retraction and reduction of mEPSC frequency at hippocampal synapses. The activation of EphA4 resulted in the recruitment of Cdk5 to EphA4, leading to the tyrosine phosphorylation and activation of Cdk5. EphA4 and Cdk5 then enhanced the activation of ephexin1, a guanine-nucleotide exchange factor that regulates activation of the small Rho GTPase RhoA. The association between EphA4 and ephexin1 was significantly reduced in Cdk5(-/-) brains and Cdk5-dependent phosphorylation of ephexin1 was required for the ephrin-A1- mediated regulation of spine density. These findings suggest that ephrin-A1 promotes EphA4-dependent spine retraction through the activation of Cdk5 and ephexin1, which in turn modulates actin cytoskeletal dynamics.	Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Chinese University of Hong Kong	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	SAHIN, MUSTAFA/I-8653-2019; Yung, Ho/R-6161-2018; Lai, Kwok-On/E-5182-2011; Bikoff, Jay/N-8107-2018; Lai, Kwok-On/L-7468-2019; Lai, Kwok On/ABC-8046-2021	SAHIN, MUSTAFA/0000-0001-7044-2953; Yung, Ho/0000-0002-5542-8173; Lai, Kwok-On/0000-0002-4069-054X; Fu, Kit Yu/0000-0003-4085-6201; Shi, Lei/0000-0001-8695-3432; Ip, Nancy Yuk-Yu/0000-0002-2763-8907	NICHD NIH HHS [K08 HD01384, HD18655] Funding Source: Medline; NINDS NIH HHS [NS045500, R01 NS045500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Chen JX, 2003, COMPUT SCI ENG, V5, P12, DOI 10.1109/MCISE.2003.1182957; Cheng Q, 2003, MOL CELL NEUROSCI, V24, P632, DOI 10.1016/S1044-7431(03)00220-3; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu WY, 2002, NEUROREPORT, V13, P243, DOI 10.1097/00001756-200202110-00014; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; IP NY, 1993, J NEUROSCI, V13, P3394; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Lai KO, 2001, MOL CELL NEUROSCI, V17, P1034, DOI 10.1006/mcne.2001.0997; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	50	243	262	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					67	76		10.1038/nn1811	http://dx.doi.org/10.1038/nn1811			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17143272	Green Submitted			2022-12-28	WOS:000243096100017
J	Kim, S; Burette, A; Chung, HS; Kwon, SK; Woo, J; Lee, HW; Kim, K; Kim, H; Weinberg, RJ; Kim, E				Kim, Seho; Burette, Alain; Chung, Hye Sun; Kwon, Seok-Kyu; Woo, Jooyeon; Lee, Hyun Woo; Kim, Karam; Kim, Hyun; Weinberg, Richard J.; Kim, Eunjoon			NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION; INHIBITORY SYNAPSES; NEUROLIGIN; BINDING; GENES; NEUREXINS; NETRIN-G1; PSD-95; MUTATION; LIGAND	Synaptic cell adhesion molecules (CAMs) regulate synapse formation through their trans-synaptic and heterophilic adhesion. Here we show that postsynaptic netrin-G ligand (NGL)CAMs associate with netrin-G CAMs in an isoform-specific manner and, through their cytosolic tail, with the abundant postsynaptic scaffold postsynaptic density-95 (PSD-95). Overexpression of NGL-2 in cultured rat neurons increased the number of PSD-95-positive dendritic protrusions. NGL-2 located on heterologous cells or beads induced functional presynaptic differentiation in contacting neurites. Direct aggregation of NGL-2 on the surface membrane of dendrites induced the clustering of excitatory postsynaptic proteins. Competitive inhibition by soluble NGL-2 reduced the number of excitatory synapses. NGL-2 knockdown reduced excitatory, but not inhibitory, synapse numbers and currents. These results suggest that NGL regulates the formation of excitatory synapses.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea; Korea Univ, Div Brain Korea 21, Coll Med, Seoul 136705, South Korea; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of North Carolina; University of North Carolina Chapel Hill; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of North Carolina; University of North Carolina Chapel Hill	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea.	kime@kaist.ac.kr	Weinberg, Richard/AAC-1898-2020; Kim, Karam/K-1412-2018; Kim, Eunjoon/C-1566-2011	Kim, Karam/0000-0002-1886-5163; Weinberg, Richard/0000-0001-9689-7278; Kim, Hyun/0000-0002-7210-5798; Kwon, Seok-Kyu/0000-0002-7280-9867	NINDS NIH HHS [NS-39444] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039444] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Hata Y, 1996, J NEUROSCI, V16, P2488; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Meerabux JMA, 2005, GENOMICS, V86, P112, DOI 10.1016/j.ygeno.2005.04.004; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089	50	177	190	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1294	1301		10.1038/nn1763	http://dx.doi.org/10.1038/nn1763			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980967				2022-12-28	WOS:000241493900023
J	Komai, S; Licznerski, P; Cetin, A; Waters, J; Denk, W; Brecht, M; Osten, P				Komai, Shoji; Licznerski, Pawel; Cetin, Ali; Waters, Jack; Denk, Winfried; Brecht, Michael; Osten, Pavel			Postsynaptic excitability is necessary for strengthening of cortical sensory responses during experience-dependent development	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; NEOCORTICAL PYRAMIDAL NEURONS; PRIMARY SOMATOSENSORY CORTEX; IN-VIVO; ACTION-POTENTIALS; RECEPTIVE-FIELDS; DENDRITIC SPINES; STRIATE CORTEX; MAP PLASTICITY; CEREBRAL-CORTEX	Sensory experience is necessary for normal cortical development. This has been shown by sensory deprivation and pharmacological perturbation of the cortex. Because these manipulations affect the cortical network as a whole, the role of postsynaptic cellular properties during experience-dependent development is unclear. Here we addressed the developmental role of somatodendritic excitability, which enables postsynaptic spike timing-dependent forms of plasticity, in rat somatosensory cortex. We used short interfering RNA (siRNA)-based knockdown of Na+ channels to suppress the somatodendritic excitability of small numbers of layer 2/3 pyramidal neurons in the barrel cortex, without altering the ascending sensory pathway. In vivo recordings from siRNA-expressing cells revealed that this manipulation interfered with the normal developmental strengthening of sensory responses. The sensory responsiveness of neighboring cortical neurons was unchanged, indicating that the cortical network was unchanged. We conclude that somatodendritic excitability of the postsynaptic neuron is needed for the regulation of synaptic strength in the developing sensory cortex.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Univ Rotterdam, Med Ctr, Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	Max Planck Society; Northwestern University; Feinberg School of Medicine; Erasmus University Rotterdam; Erasmus MC	Osten, P (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	p-osten@northwestern.edu	denk, winfried/I-6627-2012; Komai, Shoji/L-9273-2018	Komai, Shoji/0000-0002-8474-7800; Brecht, Michael/0000-0002-5387-0953; Licznerski, Pawel/0000-0003-2761-8428				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; [Anonymous], [No title captured]; BEAR MF, 1990, J NEUROSCI, V10, P909; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; FOX K, 1992, J NEUROSCI, V12, P1826; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Ruthazer ES, 2005, NEURON, V45, P825, DOI 10.1016/j.neuron.2005.03.008; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Waters J, 2003, J NEUROSCI, V23, P8558; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	50	24	29	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1125	1133		10.1038/nn1752	http://dx.doi.org/10.1038/nn1752			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921372				2022-12-28	WOS:000240080800013
J	Ferris, J; Ge, H; Liu, LZ; Roman, G				Ferris, Jacob; Ge, Hong; Liu, Lingzhi; Roman, Gregg			G(o) signaling is required for Drosophila associative learning	NATURE NEUROSCIENCE			English	Article							PERTUSSIS TOXIN; MUSHROOM BODIES; PROTEIN; MEMORY; EXPRESSION; GENE; MELANOGASTER; DEFICIENT; SUBUNIT; RESCUE	Heterotrimeric G(o) is one of the most abundant proteins in the brain, yet relatively little is known of its neural functions in vivo. Here we demonstrate that G(o) signaling is required for the formation of associative memory. In Drosophila melanogaster, pertussis toxin (PTX) is a selective inhibitor of G(o) signaling. The postdevelopmental expression of PTX within mushroom body neurons robustly and reversibly inhibits associative learning. The effect of G(o) inhibition is distributed in both gamma- and alpha/beta-lobe mushroom body neurons. However, the expression of PTX in neurons adjacent to the mushroom bodies does not affect memory. PTX expression also does not interact genetically with a rutabaga adenylyl cyclase loss-of-function mutation. Thus, G(o) defines a new signaling pathway required in mushroom body neurons for the formation of associative memory.	Baylor Univ, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor University	Roman, G (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	gwroman@UH.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042185] Funding Source: NIH RePORTER; NINDS NIH HHS [NS042185-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; FITCH CL, 1993, CELL SIGNAL, V5, P187, DOI 10.1016/0898-6568(93)90070-3; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Goodwin SF, 1997, J NEUROSCI, V17, P8817; GUILLEN A, 1990, EMBO J, V9, P1449, DOI 10.1002/j.1460-2075.1990.tb08261.x; HOPKINS RS, 1988, BIOCHIM BIOPHYS ACTA, V970, P355, DOI 10.1016/0167-4889(88)90135-8; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; THAMBI NC, 1989, J BIOL CHEM, V264, P18552; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	49	52	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1036	1040		10.1038/nn1738	http://dx.doi.org/10.1038/nn1738			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845387				2022-12-28	WOS:000240080300016
J	Rao, VR; Pintchovski, SA; Chin, J; Peebles, CL; Mitra, S; Finkbeiner, S				Rao, Vikram R.; Pintchovski, Sean A.; Chin, Jeannie; Peebles, Carol L.; Mitra, Siddhartha; Finkbeiner, Steven			AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; MESSENGER-RNA; SYNAPTIC PLASTICITY; EXPRESSION; ACTIVATION; BRAIN; KINASE; MEMORY; HIPPOCAMPUS	Learning and memory depend critically on long-term synaptic plasticity, which requires neuronal gene expression. In the prevailing view, AMPA receptors mediate fast excitatory synaptic transmission and effect short-term plasticity, but they do not directly regulate neuronal gene expression. By studying regulation of Arc, a gene required for long-term plasticity, we uncovered a new role for AMPA receptors in neuronal gene expression. Spontaneous synaptic activity or activity induced by brain-derived neurotrophic factor ( BDNF) elicited Arc expression in cultures of rat cortical neurons and in organotypic brain slices. Notably, inhibiting AMPA receptors strongly potentiated activity-dependent Arc expression. We found that AMPA receptors negatively regulate Arc transcription, but not translation or stability, through a mechanism involving a pertussis toxin-sensitive G protein. These results provide insights into the activity-dependent mechanisms of Arc expression and suggest that, in addition to effecting short-term plasticity, AMPA receptors regulate genes involved in long-term plasticity.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	sfinkbeiner@gladstone.ucsf.edu		Chin, Jeannie/0000-0001-9902-3744				Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kawai F, 1999, J NEUROSCI, V19, P2954; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Mokin M, 2006, J NEUROPHYSIOL, V95, P215, DOI 10.1152/jn.00737.2005; Montag-Sallaz M, 2003, LEARN MEMORY, V10, P99, DOI 10.1101/lm.53403; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; WANG YZ, 1995, J BIOL CHEM, V270, P22783, DOI 10.1074/jbc.270.39.22783; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wheeler DG, 2004, MOL CELL NEUROSCI, V26, P50, DOI 10.1016/j.mcn.2003.12.016; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; YU WF, 1995, BRAIN RES, V692, P190, DOI 10.1016/0006-8993(95)00665-D; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	50	137	139	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					887	895		10.1038/nn1708	http://dx.doi.org/10.1038/nn1708			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732277				2022-12-28	WOS:000238590800014
J	Bellone, C; Luscher, C				Bellone, C; Luscher, C			Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; MESOLIMBIC DOPAMINE SYSTEM; DOMAIN-CONTAINING PROTEIN; KINASE-C-ALPHA; SYNAPTIC PLASTICITY; INDUCED POTENTIATION; SUBUNIT COMPOSITION; LTP INDUCTION; NEURONS; SENSITIZATION	Drugs of abuse induce long-lasting changes in neural circuits that may underlie core components of addiction. Here we focus on glutamatergic synapses onto dopamine (DA) neurons of the ventral tegmental area (VTA). Using an 'ex vivo' approach in mice, we show that a single injection of cocaine caused strong rectification and conferred sensitivity to the polyamine Joro spider toxin (JST) of AMPAR-mediated excitatory postsynaptic currents (AMPAR EPSCs), indicating the recruitment of receptors that lack GluR2. This qualitative change in transmission was paralleled by an increase in the AMPAR: NMDAR ratio and was prevented by interfering with the protein interacting with C kinase-1 (PICK1) in vivo. Activation of metabotropic glutamate receptors (mGluR1s) by intraperitoneal injection of a positive modulator depotentiated synapses and abolished rectification in slices of cocaine-treated mice, revealing a mechanism to reverse cocaine-induced synaptic plasticity in vivo.	Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; Univ Geneva, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, 1 Michel Servet, CH-1211 Geneva, Switzerland.	Christian.Luscher@medecine.unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; bellone, camilla/0000-0002-6774-6275				Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; NISHIOKA N S, 1987, Lasers in Medical Science, V2, P21, DOI 10.1007/BF02594126; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SCHENK S, 1994, BRAIN RES, V659, P17, DOI 10.1016/0006-8993(94)90858-3; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Szumlinski KK, 2003, ANN NY ACAD SCI, V1003, P468, DOI 10.1196/annals.1300.055; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Washburn MS, 1997, J NEUROSCI, V17, P9393; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	50	327	337	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					636	641		10.1038/nn1682	http://dx.doi.org/10.1038/nn1682			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582902				2022-12-28	WOS:000237417200014
J	Ramirez-Castillejo, C; Sanchez-Sanchez, F; Andreu-Agullo, C; Ferron, SR; Aroca-Aguilar, JD; Sanchez, P; Mira, H; Escribano, J; Farinas, I				Ramirez-Castillejo, C; Sanchez-Sanchez, F; Andreu-Agullo, C; Ferron, SR; Aroca-Aguilar, JD; Sanchez, P; Mira, H; Escribano, J; Farinas, I			Pigment epithelium-derived factor is a niche signal for neural stem cell renewal	NATURE NEUROSCIENCE			English	Article							ADULT MAMMALIAN BRAIN; IN-VIVO; GROWTH-FACTOR; FACTOR PEDF; STIMULATES NEUROGENESIS; NEUROTROPHIC ACTIVITY; ENDOTHELIAL-CELLS; SELF-RENEWAL; MOUSE BRAIN; NEURONS	Adult stem cells are characterized by self-renewal and multilineage differentiation, and these properties seem to be regulated by signals from adjacent differentiated cell types and by extracellular matrix molecules, which collectively define the stem cell "niche.'' Self-renewal is essential for the lifelong persistence of stem cells, but its regulation is poorly understood. In the mammalian brain, neurogenesis persists in two germinal areas, the subventricular zone (SVZ) and the hippocampus, where continuous postnatal neuronal production seems to be supported by neural stem cells (NSCs). Here we show that pigment epithelium-derived factor (PEDF) is secreted by components of the murine SVZ and promotes self-renewal of adult NSCs in vitro. In addition, intraventricular PEDF infusion activated slowly dividing stem cells, whereas a blockade of endogenous PEDF decreased their cycling. These data demonstrate that PEDF is a niche-derived regulator of adult NSCs and provide evidence for a role for PEDF protein in NSC maintenance.	Univ Castilla La Mancha, Fac Med, Area Genet, Albacete 02006, Spain; Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete 02006, Spain; Univ Valencia, Dept Cellular Biol, E-46100 Burjassot, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Valencia	Farinas, I (corresponding author), Univ Valencia, Fac Med, Oncol Mol Lab, E-46100 Burjassot, Spain.	isabel.farinas@uv.es	Ferrón, Sacri R./I-2958-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Escribano, Julio/D-9742-2015; Aroca-Aguilar, J.Daniel/B-7842-2008; Ramirez-Castillejo, Carmen/S-7276-2019; Sánchez-Gómez, Pilar/K-8256-2014; Farinas, Isabel/L-7118-2014	Ferrón, Sacri R./0000-0003-0854-8575; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Ramirez-Castillejo, Carmen/0000-0002-1877-3381; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Mira, Helena/0000-0001-8574-9544; Farinas, Isabel/0000-0003-2903-4960				Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Aparicio S, 2005, BIOCHEM BIOPH RES CO, V326, P387, DOI 10.1016/j.bbrc.2004.11.041; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Craig CG, 1996, J NEUROSCI, V16, P2649; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pignolo RJ, 2003, J CELL PHYSIOL, V195, P12, DOI 10.1002/jcp.10212; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	46	350	382	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					331	339		10.1038/nn1657	http://dx.doi.org/10.1038/nn1657			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491078				2022-12-28	WOS:000235645600012
J	Schulz, DJ; Goaillard, JM; Marder, E				Schulz, DJ; Goaillard, JM; Marder, E			Variable channel expression in identified single and electrically coupled neurons in different animals	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; GENE-EXPRESSION; STOMATOGASTRIC GANGLION; POTASSIUM CURRENTS; SHAL GENE; I-A; NETWORK; CRAB; CONDUCTANCES; MODULATION	It is often assumed that all neurons of the same cell type have identical intrinsic properties, both within an animal and between animals. We exploited the large size and small number of unambiguously identifiable neurons in the crab stomatogastric ganglion to test this assumption at the level of channel mRNA expression and membrane currents (measured in voltage-clamp experiments). In lateral pyloric (LP) neurons, we saw strong correlations between measured current and the abundance of Shal and BK-KCa mRNAs (encoding the Shal-family voltage-gated potassium channel and large-conductance calcium-activated potassium channel, respectively). We also saw two- to fourfold interanimal variability for three potassium currents and their mRNA expression. Measurements of channel expression in the two electrically coupled pyloric dilator (PD) neurons showed significant interanimal variability, but copy numbers for IH (encoding the hyperpolarization-activated, inward-current channel) and Shal mRNA in the two PD neurons from the same crab were similar, suggesting that the regulation of some currents may be shared in electrically coupled neurons.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Schulz, DJ (corresponding author), Univ Missouri, Columbia, MO 65211 USA.	SchulzD@missouri.edu		Schulz, David/0000-0003-4532-5362	NIMH NIH HHS [MH46742, MH70292, F32 MH070292] Funding Source: Medline; NINDS NIH HHS [NS17813, R01 NS017813] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, F32MH070292, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017813, R37NS017813] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Baro DJ, 1998, ANN NY ACAD SCI, V860, P281, DOI 10.1111/j.1749-6632.1998.tb09056.x; Baro DJ, 1997, J NEUROSCI, V17, P6597; Baro DJ, 2001, NEUROSCIENCE, V106, P419, DOI 10.1016/S0306-4522(01)00261-5; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P193; Baro DJ, 1996, J NEUROSCI, V16, P1689; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P350; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Cristobal R, 2005, MOL BRAIN RES, V133, P19, DOI 10.1016/j.molbrainres.2004.10.001; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; French LB, 2004, NEUROSCIENCE, V123, P919, DOI 10.1016/j.neuroscience.2003.08.036; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HOOPER SL, 1986, J COMP PHYSIOL A, V159, P227, DOI 10.1007/BF00612305; Kamme F, 2003, J NEUROSCI, V23, P3607; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu Z, 1998, J NEUROSCI, V18, P2309; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Luther JA, 2003, J NEUROPHYSIOL, V90, P2720, DOI 10.1152/jn.00370.2003; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; MARDER E, 1976, J PHYSIOL-LONDON, V257, P63, DOI 10.1113/jphysiol.1976.sp011356; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rozen S, 2000, Methods Mol Biol, V132, P365; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Tietjen I, 2005, INT J DEV BIOL, V49, P201, DOI 10.1387/ijdb.041939it; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	44	300	303	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					356	362		10.1038/nn1639	http://dx.doi.org/10.1038/nn1639			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16444270				2022-12-28	WOS:000235645600015
J	Zhu, HT; Hummel, T; Clemens, JC; Berdnik, D; Zipursky, SL; Luo, LQ				Zhu, HT; Hummel, T; Clemens, JC; Berdnik, D; Zipursky, SL; Luo, LQ			Dendritic patterning by Dscam and synaptic partner matching in the Drosophila antennal lobe	NATURE NEUROSCIENCE			English	Article							OLFACTORY PROJECTION NEURONS; ODORANT RECEPTORS; AXON GUIDANCE; WIRING SPECIFICITY; SENSORY MAP; FLY BRAIN; REPRESENTATION; CONNECTIONS; EXPRESSION; GLOMERULI	In the olfactory system of Drosophila melanogaster, axons of olfactory receptor neurons (ORNs) and dendrites of second-order projection neurons typically target 1 of similar to 50 glomeruli. Dscam, an immunoglobulin superfamily protein, acts in ORNs to regulate axon targeting. Here we show that Dscam acts in projection neurons and local interneurons to control the elaboration of dendritic fields. The removal of Dscam selectively from projection neurons or local interneurons led to clumped dendrites and marked reduction in their dendritic field size. Overexpression of Dscam in projection neurons caused dendrites to be more diffuse during development and shifted their relative position in adulthood. Notably, the positional shift of projection neuron dendrites caused a corresponding shift of its partner ORN axons, thus maintaining the connection specificity. This observation provides evidence for a pre- and postsynaptic matching mechanism independent of precise glomerular positioning.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lzipursky@mednet.ucla.edu; lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Zipursky, Stephen/0000-0001-5630-7181	NIDCD NIH HHS [R01-DC005982, R01-DC006485] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485, R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; COUTO A, 2005, CURR BIOL; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	34	124	127	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					349	355		10.1038/nn1652	http://dx.doi.org/10.1038/nn1652			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474389				2022-12-28	WOS:000235645600014
J	Pratt, KG; Dong, W; Aizenman, CD				Pratt, Kara G.; Dong, Wei; Aizenman, Carlos D.			Development and spike timing-dependent plasticity of recurrent excitation in the Xenopus optic tectum	NATURE NEUROSCIENCE			English	Article							ACTIVITY IN-VIVO; NICOTINIC ACETYLCHOLINE-RECEPTOR; DEVELOPING RETINOTECTAL SYSTEM; LASER-PULSE PHOTOLYSIS; SYNAPTIC-TRANSMISSION; SUPERIOR COLLICULUS; CORTICAL SIMPLE; VISUAL-CORTEX; TIME REGION; INHIBITION	Much of the information processing in the brain occurs at the level of local circuits; however, the mechanisms underlying their initial development are poorly understood. We sought to examine the early development and plasticity of local excitatory circuits in the optic tectum of Xenopus laevis tadpoles. We found that retinal input recruits persistent, recurrent intratectal synaptic excitation that becomes more temporally compact and less variable over development, thus increasing the temporal coherence and precision of tectal cell spiking. We also saw that patterned retinal input can sculpt recurrent activity according to a spike timing-dependent plasticity rule, and that impairing this plasticity during development results in abnormal refinement of the temporal characteristics of recurrent circuits. This plasticity is a previously unknown mechanism by which patterned retinal activity allows intratectal circuitry to self-organize, optimizing the temporal response properties of the tectal network, and provides a substrate for rapid modulation of tectal neuron receptive-field properties.	[Pratt, Kara G.; Dong, Wei; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Aizenman, CD (corresponding author), Brown Univ, Dept Neurosci, Box G-LN, Providence, RI 02912 USA.	carlos_aizenman@brown.edu		Dong, Wei/0000-0002-8151-9407				Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Grewer C, 1999, BIOCHEMISTRY-US, V38, P7837, DOI 10.1021/bi9827767; Grusser O.-J, 1976, P297; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jayaraman V, 1999, BIOCHEMISTRY-US, V38, P11406, DOI 10.1021/bi991219x; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; LAZAR G, 1973, J ANAT, V116, P347; Lazar Gy., 1967, Journal fuer Hirnforschung, V9, P329; Lee PH, 1997, P NATL ACAD SCI USA, V94, P13299, DOI 10.1073/pnas.94.24.13299; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lopez JM, 2002, J COMP NEUROL, V453, P418, DOI 10.1002/cne.10419; MCCORMICK DA, 1995, J NEUROSCI, V15, P5739; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Nakagawa H, 1997, VISUAL NEUROSCI, V14, P263, DOI 10.1017/S0952523800011408; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rajan I, 1998, J NEUROSCI, V18, P7836; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Saito Y, 2003, J NEUROSCI, V23, P5854; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; UDIN SB, 1985, J COMP NEUROL, V232, P25, DOI 10.1002/cne.902320103; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	49	56	56	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					467	475		10.1038/nn2076	http://dx.doi.org/10.1038/nn2076			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344990				2022-12-28	WOS:000254359300019
J	Vasudevan, A; Long, JE; Crandall, JE; Rubenstein, JLR; Bhide, PG				Vasudevan, Anju; Long, Jason E.; Crandall, James E.; Rubenstein, John L. R.; Bhide, Pradeep G.			Compartment-specific transcription factors orchestrate angiogenesis gradients in the embryonic brain	NATURE NEUROSCIENCE			English	Article							MOUSE CORPUS STRIATUM; NEURAL-TUBE; VENTRAL FOREBRAIN; BASAL FOREBRAIN; GENE-EXPRESSION; CELL-CYCLE; DLX GENES; TELENCEPHALON; DIFFERENTIATION; MECHANISMS	Prevailing notions of cerebral vascularization imply that blood vessels sprout passively into the brain parenchyma from pial vascular plexuses to meet metabolic needs of growing neuronal populations. Endothelial cells, building blocks of blood vessels, are thought to be homogeneous in the brain with respect to their origins, gene expression patterns and developmental mechanisms. These current notions that cerebral angiogenesis is regulated by local environmental signals contrast with current models of cell-autonomous regulation of neuronal development. Here we demonstrate that telencephalic angiogenesis in mice progresses in an orderly, ventral-to-dorsal gradient regulated by compartment-specific homeobox transcription factors. Our data offer new perspectives on intrinsic regulation of angiogenesis in the embryonic telencephalon, call for a revision of the current models of telencephalic angiogenesis and support novel roles for endothelial cells in brain development.	[Vasudevan, Anju; Bhide, Pradeep G.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Vasudevan, Anju; Bhide, Pradeep G.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Long, Jason E.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Crandall, James E.] Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr Mental Retardat Inc, Waltham, MA 02452 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California San Francisco; University of Massachusetts System	Bhide, PG (corresponding author), Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	anju.vasudevan@mgh.harvard.edu; bhide@helix.mgh.harvard.edu		Bhide, Pradeep/0000-0003-4236-9415; VASUDEVAN, ANJU/0000-0001-9814-2389	NIDA NIH HHS [R01 DA020796-03, R01 DA020796, R01DA020796] Funding Source: Medline; NINDS NIH HHS [P30 NS045776, R01 NS043426, R01 NS043246, R01NS43246,, P30 NS045776-05, P30NS045776, R01 NS043426-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043246, R01NS043426, P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020796] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bayer S. A., 1991, J NEOCORTICAL DEV; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Bhide PG, 1996, J COMP NEUROL, V374, P506; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Cohen MM, 2003, ANN ACAD MED SINGAP, V32, P244; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; KEYNES R, 1990, NEURON, V4, P1, DOI 10.1016/0896-6273(90)90438-L; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kurz H, 2000, J NEURO-ONCOL, V50, P17, DOI 10.1023/A:1006485716743; Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327; Marin O, 2000, J NEUROSCI, V20, P6063; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nery S, 2003, CEREB CORTEX, V13, P895, DOI 10.1093/cercor/13.9.895; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Sheth AN, 1997, J COMP NEUROL, V383, P220; Shimamura K, 1997, DEV NEUROSCI-BASEL, V19, P88, DOI 10.1159/000111190; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STRONG LH, 1964, J COMP NEUROL, V123, P151, DOI 10.1002/cne.901230111; Super H, 1997, DEV BRAIN RES, V98, P15, DOI 10.1016/S0165-3806(96)00155-1; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi T, 1999, J NEUROSCI, V19, P10357; Takahashi T, 1996, J NEUROSCI, V16, P6183; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Yun K, 2002, DEVELOPMENT, V129, P5029	49	143	145	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					429	439		10.1038/nn2074	http://dx.doi.org/10.1038/nn2074			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344991	Green Accepted			2022-12-28	WOS:000254359300015
J	Gallardo, G; Schlueter, OM; Suedhof, TC				Gallardo, Gilbert; Schlueter, Oliver M.; Suedhof, Thomas C.			A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and A beta peptides	NATURE NEUROSCIENCE			English	Article							FAMILIAL PARKINSONS-DISEASE; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LEWY BODIES; MOUSE MODEL; PLAQUE-FORMATION; GENE; DEGENERATION; PROTEIN	Pathogenic aggregates of alpha-synuclein are thought to contribute to the development of Parkinson's disease. Inclusion bodies containing alpha-synuclein are present in Parkinson's disease and other neurodegenerative diseases, including Alzheimer's disease. Moreover, alpha-synuclein mutations are found in cases of familial Parkinson's disease, and transgenic overexpression of alpha-synuclein causes neurodegeneration in mice. The molecular mechanisms involved, however, remain incompletely understood. Here we show that, in transgenic mice, alpha-synuclein induced neurodegeneration involves activation of the ubiquitin/proteasome system, a massive increase in apolipoprotein E ( ApoE) levels and accumulation of insoluble mouse Ab. ApoE was not protective, but was injurious, as deletion of ApoE delayed the neurodegeneration caused by alpha-synuclein and suppressed the accumulation of Ab. Our data reveal a molecular link between central pathogenic mechanisms implicated in Parkinson's disease and Alzheimer's disease and suggest that intracellular alpha-synuclein is pathogenic, at least in part, by activation of extracellular signaling pathways involving ApoE.	[Gallardo, Gilbert; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Schlueter, Oliver M.] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Schlueter, Oliver M.] European Neurosci Inst, D-37075 Gottingen, Germany; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gallardo, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	gilbert.gallardo@utsouthwestern.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069585] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH069585] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; HALL SM, 1993, J NEUROCYTOL, V22, P480, DOI 10.1007/BF01181567; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuo YM, 2000, MOL MED, V6, P430, DOI 10.1007/BF03401785; Lee MK, 2002, ANTIVIR RES, V53, P99, DOI 10.1016/S0166-3542(01)00196-6; Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2004, J MOL NEUROSCI, V24, P425, DOI 10.1385/JMN:24:3:425; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Springer W, 2006, CURR NEUROL NEUROSCI, V6, P432, DOI 10.1007/s11910-996-0025-8; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Tandon Anurag, 2000, Current Opinion in Neurology, V13, P377, DOI 10.1097/00019052-200008000-00003; Tsuang DW, 2002, ARCH NEUROL-CHICAGO, V59, P1622, DOI 10.1001/archneur.59.10.1622	47	110	117	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					301	308		10.1038/nn2058	http://dx.doi.org/10.1038/nn2058			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297066				2022-12-28	WOS:000253548300013
J	Jin, JZ; Weng, C; Yeh, CI; Gordon, JA; Ruthazer, ES; Stryker, MP; Swadlow, HA; Alonso, JM				Jin, Jianzhong Z.; Weng, Chong; Yeh, Chun-I; Gordon, Joshua A.; Ruthazer, Edward S.; Stryker, Michael P.; Swadlow, Harvey A.; Alonso, Jose-Manuel			On and off domains of geniculate afferents in cat primary visual cortex	NATURE NEUROSCIENCE			English	Article							REVERSED-CONTRAST CHARTS; OFF-CENTER INPUTS; GANGLION-CELLS; RECEPTIVE-FIELDS; ON-CENTER; LAMINAR ORGANIZATION; ORIENTATION COLUMNS; STRIATE CORTEX; GENICULOCORTICAL AFFERENTS; ALPHA-GANGLION	On- and off-center geniculate afferents form two major channels of visual processing that are thought to converge in the primary visual cortex. However, humans with severely reduced on responses can have normal visual acuity when tested in a white background, which indicates that off channels can function relatively independently from on channels under certain conditions. Consistent with this functional independence of channels, we demonstrate here that on- and off-center geniculate afferents segregate in different domains of the cat primary visual cortex and that off responses dominate the cortical representation of the area centralis. On average, 70% of the geniculate afferents converging at the same cortical domain had receptive fields of the same contrast polarity. Moreover, off-center afferents dominated the representation of the area centralis in the cortex, but not in the thalamus, indicating that on- and off-center afferents are balanced in number, but not in the amount of cortical territory that they cover.	[Jin, Jianzhong Z.; Weng, Chong; Yeh, Chun-I; Swadlow, Harvey A.; Alonso, Jose-Manuel] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Yeh, Chun-I; Swadlow, Harvey A.; Alonso, Jose-Manuel] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gordon, Joshua A.; Ruthazer, Edward S.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut; Columbia University; University of California System; University of California San Francisco; McGill University	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, 33 W 42 St, New York, NY 10036 USA.	jalonso@sunyopt.edu	Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014; Gordon, Joshua A/E-6778-2012	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151; Gordon, Joshua A/0000-0002-5488-8266; YEH, CHUN-I/0000-0002-2375-0723; Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R37 EY002874-24S2, EY 02874, R01 EY005253-22, R01 EY002874, EY 05253, R01 EY005253, R37 EY002874] Funding Source: Medline; NIMH NIH HHS [R01 MH064024, MH 64024] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005253, R37EY002874, R37EY005253, R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Aronov D, 2003, J NEUROPHYSIOL, V89, P3304, DOI 10.1152/jn.00826.2002; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BERMAN NEJ, 1989, NEUROSCIENCE, V32, P721, DOI 10.1016/0306-4522(89)90293-5; BOWLING DB, 1986, J PHYSIOL-LONDON, V375, P561, DOI 10.1113/jphysiol.1986.sp016133; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CONLEY M, 1984, J NEUROSCI, V4, P171; CONWAY JL, 1983, J NEUROPHYSIOL, V50, P1330, DOI 10.1152/jn.1983.50.6.1330; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; FAMIGLIETTI EV, 1977, SCIENCE, V198, P1267, DOI 10.1126/science.73223; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; Gheorghita F, 2006, J NEUROSCI, V26, P10057, DOI 10.1523/JNEUROSCI.1263-06.2006; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; KRETZ R, 1986, J COMP NEUROL, V251, P135, DOI 10.1002/cne.902510110; LEVAY S, 1982, NATURE, V300, P350, DOI 10.1038/300350a0; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, J NEUROSCI, V14, P409; Nakagama H, 2000, BIOL CYBERN, V83, P85, DOI 10.1007/s004220000148; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; RACZKOWSKI D, 1990, J COMP NEUROL, V302, P500, DOI 10.1002/cne.903020307; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; WEHRHAHN C, 1992, J NEUROSCI, V12, P2247; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P749, DOI 10.1097/00006324-200311000-00011; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P745, DOI 10.1097/00006324-200311000-00010; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410; ZEMON V, 1988, VISUAL NEUROSCI, V1, P145, DOI 10.1017/S0952523800001085	50	121	121	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					88	94		10.1038/nn2029	http://dx.doi.org/10.1038/nn2029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084287	Green Accepted			2022-12-28	WOS:000252117900016
J	Kim, N; Burden, SJ				Kim, Natalie; Burden, Steven J.			MuSK controls where motor axons grow and form synapses	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; ACETYLCHOLINE-RECEPTOR CLUSTERS; NERVE MUSCLE JUNCTIONS; TYROSINE KINASE MUSK; SKELETAL-MUSCLE; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; STRIATED-MUSCLE; MESSENGER-RNA; MUTANT MICE	Motor axons approach muscles that are regionally prespecialized, as acetylcholine receptors are clustered in the central region of muscle before and independently of innervation. This muscle prepattern requires MuSK, a receptor tyrosine kinase that is essential for synapse formation. It is not known how muscle prepatterning is established, and whether motor axons recognize this prepattern. Here we show that expression of Musk is prepatterned in muscle and that early Musk expression in developing myotubes is sufficient to establish muscle prepatterning. We further show that ectopic Musk expression promotes ectopic synapse formation, indicating that muscle prepatterning normally has an instructive role in directing where synapses will form. In addition, ectopic Musk expression stimulates synapse formation in the absence of Agrin and rescues the lethality of Agrn mutant mice, demonstrating that the postsynaptic cell, and MuSK in particular, has a potent role in regulating the formation of synapses.	[Kim, Natalie; Burden, Steven J.] NYU, Helen L & Martin S Kimmel Ctr, Mol Neurobiol Program, Sch Med,Biol & Med Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Burden, SJ (corresponding author), NYU, Helen L & Martin S Kimmel Ctr, Mol Neurobiol Program, Sch Med,Biol & Med Skirball Inst Biomol Med, 540 First Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu	Tuluc, Petronel/C-2527-2011	Burden, Steven/0000-0002-3550-6891	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS027963, R01NS036193] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36193, R01 NS027963-10, R01 NS027963] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dimitropoulou A, 2005, MOL CELL NEUROSCI, V28, P292, DOI 10.1016/j.mcn.2004.09.013; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; Fu AKY, 2001, MOL BRAIN RES, V96, P21, DOI 10.1016/S0169-328X(01)00253-4; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hesser BA, 1999, FEBS LETT, V442, P133, DOI 10.1016/S0014-5793(98)01641-X; Jaworski A, 2006, J NEUROSCI, V26, P655, DOI 10.1523/JNEUROSCI.4506-05.2006; Jones G, 1999, J NEUROSCI, V19, P3376; Kandel E., 2000, PRINCIPLES NEURAL SC; Lacazette E, 2003, J CELL BIOL, V161, P727, DOI 10.1083/jcb.200210156; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin YR, 2005, CRYST GROWTH DES, V5, P579, DOI 10.1021/cg049747h; MINTY AJ, 1982, CELL, V30, P185, DOI 10.1016/0092-8674(82)90024-1; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SLATER CR, 1982, DEV BIOL, V94, P11, DOI 10.1016/0012-1606(82)90063-X; SLATER CR, 1982, DEV BIOL, V94, P23, DOI 10.1016/0012-1606(82)90064-1; Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; WILLIAMS PE, 1971, J CELL SCI, V9, P751; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	44	155	160	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					19	27		10.1038/nn2026	http://dx.doi.org/10.1038/nn2026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084289	Green Accepted			2022-12-28	WOS:000252117900008
J	Yao, Y; Wu, Y; Yin, C; Ozawa, R; Aigaki, T; Wouda, RR; Noordermeer, JN; Fradkin, LG; Hing, H				Yao, Ying; Wu, Yuping; Yin, Chong; Ozawa, Rie; Aigaki, Toshiro; Wouda, Rene R.; Noordermeer, Jasprina N.; Fradkin, Lee G.; Hing, Huey			Antagonistic roles of Wnt5 and the Drl receptor in patterning the Drosophila antennal lobe	NATURE NEUROSCIENCE			English	Article							OLFACTORY GLOMERULI; TYROSINE KINASE; NEURONS; AXONS; RYK; MAP; CONNECTIONS; GENES; BRAIN	Numerous studies have shown that ingrowing olfactory axons exert powerful inductive influences on olfactory map development. From an overexpression screen, we have identified wnt5 as a potent organizer of the olfactory map in Drosophila melanogaster. Loss of wnt5 resulted in severe derangement of the glomerular pattern, whereas overexpression of wnt5 resulted in the formation of ectopic midline glomeruli. Cell type-specific cDNA rescue and mosaic experiments showed that wnt5 functions in olfactory neurons. Mutation of the derailed (drl) gene, encoding a receptor for Wnt5, resulted in derangement of the glomerular map, ectopic midline glomeruli and the accumulation of Wnt5 at the midline. We show here that drl functions in glial cells, where it acts upstream of wnt5 to modulate its function in glomerular patterning. Our findings establish wnt5 as an anterograde signal that is expressed by olfactory axons and demonstrate a previously unappreciated, yet powerful, role for glia in patterning the Drosophila olfactory map.	Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Tokyo Metropolitan Univ, Tokyo 1920397, Japan; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, Dev Neurobiol Lab, NL-2300 RC Leiden, Netherlands	University of Illinois System; University of Illinois Urbana-Champaign; Tokyo Metropolitan University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hing, H (corresponding author), Univ Illinois, Neurosci Program, 601 S Goodwin Ave, Urbana, IL 61801 USA.	hing@life.uiuc.edu	wu, Yuping/B-5104-2012		NIDCD NIH HHS [DC5408-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005408] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Ang LH, 2006, DEV BIOL, V293, P178, DOI 10.1016/j.ydbio.2006.01.030; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; GRAZIADEI PPC, 1980, BRAIN RES, V201, P39, DOI 10.1016/0006-8993(80)90773-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hassan B, 2006, PLOS BIOL, V4, P2411, DOI 10.1371/journal.pbio.0040432; HOFBAUER A, 1991, EINE BIBLIOTHEK MONO; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Key B, 2002, CHEM SENSES, V27, P245, DOI 10.1093/chemse/27.3.245; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 1999, CURR OPIN NEUROBIOL, V9, P74, DOI 10.1016/S0959-4388(99)80009-9; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Miyasaka N, 2005, DEVELOPMENT, V132, P1283, DOI 10.1242/dev.01698; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; OLAND LA, 1990, J NEUROSCI, V10, P2096; Oland LA, 1996, J NEUROBIOL, V30, P92; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHNEIDERMAN AM, 1982, NATURE, V298, P844, DOI 10.1038/298844a0; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Taillebourg E, 2005, DEV GENES EVOL, V215, P158, DOI 10.1007/s00427-004-0457-6; Toba G, 1999, GENETICS, V151, P725; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zhang DS, 2006, GENESIS, V44, P189, DOI 10.1002/dvg.20202	37	31	32	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1423	1432		10.1038/nn1993	http://dx.doi.org/10.1038/nn1993			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934456				2022-12-28	WOS:000250508400020
J	Sale, A; Maya-Vetencourt, JF; Medinin, P; Cenni, MC; Baroncelli, L; De Pasquale, R; Maffei, L				Sale, Alessandro; Maya-Vetencourt, Jose Fernando; Medinin, Paolo; Cenni, Maria Cristina; Baroncelli, Laura; De Pasquale, Roberto; Maffei, Lamberto			Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; VISUAL-CORTEX; CRITICAL-PERIOD; DEPRIVATION	Loss of visual acuity caused by abnormal visual experience during development (amblyopia) is an untreatable pathology in adults. We report that environmental enrichment in adult amblyopic rats restored normal visual acuity and ocular dominance. These effects were due to reduced GABAergic inhibition in the visual cortex, accompanied by increased expression of BDNF and reduced density of extra-cellular-matrix perineuronal nets, and were prevented by enhancement of inhibition through benzodiazepine cortical infusion.	Scuola Normale Super Pisa, I-56100 Pisa, Italy; CNR, Inst Neurosci, I-56100 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Sale, A (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56100 Pisa, Italy.	a.sale@sns.it	Maya-Vetencourt, Jose Fernando/F-3566-2011; Medini, Paolo/GWC-1936-2022; Maya-Vetencourt, Jose Fernando/Q-6539-2019; Baroncelli, Laura/K-5823-2016; DE PASQUALE, ROBERTO/AAE-2941-2019; Sale, Alessandro/K-7760-2016	Maya-Vetencourt, Jose Fernando/0000-0003-3808-8944; Baroncelli, Laura/0000-0001-6739-2860; Sale, Alessandro/0000-0001-7608-4456; De Pasquale, Roberto/0000-0003-3383-7715				ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Erisir A, 2003, J NEUROSCI, V23, P5208; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	15	352	362	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					679	681		10.1038/nn1899	http://dx.doi.org/10.1038/nn1899			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468749				2022-12-28	WOS:000246799800007
J	Xu, HT; Pan, F; Yang, G; Gan, WB				Xu, Hua-Tai; Pan, Feng; Yang, Guang; Gan, Wen-Biao			Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; ADULT CORTEX; BRAIN; STABILITY; NEOCORTEX		NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Yang, Guang/0000-0002-5739-9126				Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Meyer MP, 2003, CURR BIOL, V13, pR180, DOI 10.1016/S0960-9822(03)00118-0; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; Ottersen OP, 2002, NATURE, V420, P751, DOI 10.1038/420751a; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	15	293	301	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					549	551		10.1038/nn1883	http://dx.doi.org/10.1038/nn1883			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417634				2022-12-28	WOS:000245948000009
J	Jourdain, P; Bergersen, LH; Bhaukaurally, K; Bezzi, P; Santello, M; Domercq, M; Matute, C; Tonello, F; Gundersen, V; Volterra, A				Jourdain, Pascal; Bergersen, Linda H.; Bhaukaurally, Khaleel; Bezzi, Paola; Santello, Mirko; Domercq, Maria; Matute, Carlos; Tonello, Fiorella; Gundersen, Vidar; Volterra, Andrea			Glutamate exocytosis from astrocytes controls synaptic strength	NATURE NEUROSCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; GYRUS GRANULE CELLS; RAT HIPPOCAMPUS; NMDA RECEPTORS; DENTATE GYRUS; CALCIUM OSCILLATIONS; ENTORHINAL CORTEX; GLIAL-CELLS; IN-SITU; RELEASE	The release of transmitters from glia influences synaptic functions. The modalities and physiological functions of glial release are poorly understood. Here we show that glutamate exocytosis from astrocytes of the rat hippocampal dentate molecular layer enhances synaptic strength at excitatory synapses between perforant path afferents and granule cells. The effect is mediated by ifenprodil-sensitive NMDA ionotropic glutamate receptors and involves an increase of transmitter release at the synapse. Correspondingly, we identify NMDA receptor 2B subunits on the extrasynaptic portion of excitatory nerve terminals. The receptor distribution is spatially related to glutamate-containing synaptic-like microvesicles in the apposed astrocytic processes. This glial regulatory pathway is endogenously activated by neuronal activity-dependent stimulation of purinergic P2Y1 receptors on the astrocytes. Thus, we provide the first combined functional and ultrastructural evidence for a physiological control of synaptic activity via exocytosis of glutamate from astrocytes.	Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland; Univ Oslo, Dept Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Basque Country, Dept Neurosci, Vizcaya 48640, Spain; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Hosp, Dept Neurol, Rikshosp, N-0023 Oslo, Norway	University of Lausanne; University of Oslo; University of Oslo; University of Basque Country; University of Padua; University of Oslo; National Hospital Norway	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	andrea.volterra@unil.ch	Domercq, Maria/Z-2274-2019; Tonello, Fiorella/G-8957-2013; Matute, Carlos/N-5559-2014; Tonello, Fiorella/AAM-6737-2021; Bezzi, Paola/AAP-2440-2020; Santello, Mirko/F-9007-2014	Domercq, Maria/0000-0002-4918-9276; Tonello, Fiorella/0000-0001-8935-8938; Matute, Carlos/0000-0001-8672-711X; Tonello, Fiorella/0000-0001-8935-8938; Santello, Mirko/0000-0002-7709-4127; Volterra, Andrea/0000-0003-1069-1602; Bergersen, Linda Hildegard/0000-0002-9964-9744				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Bushong EA, 2003, J COMP NEUROL, V462, P241, DOI 10.1002/cne.10728; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dalby NO, 2003, J NEUROPHYSIOL, V90, P786, DOI 10.1152/jn.00118.2003; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gundersen V, 1998, J NEUROSCI, V18, P6059; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Rossetto O, 2001, TOXICON, V39, P1151, DOI 10.1016/S0041-0101(00)00252-X; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rusakov DA, 2002, TRENDS NEUROSCI, V25, P492, DOI 10.1016/S0166-2236(02)02230-0; RUTECKI PA, 1989, J NEUROSURG, V70, P667, DOI 10.3171/jns.1989.70.5.0667; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STALEY KJ, 1991, SYNAPSE, V9, P219, DOI 10.1002/syn.890090308; STEINHAUSER C, 1992, EUR J NEUROSCI, V4, P472, DOI 10.1111/j.1460-9568.1992.tb00897.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; VONKUGELGEN I, 2000, N-S ARCH PHARMACOL, V352, P310; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101	50	574	593	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					331	339		10.1038/nn1849	http://dx.doi.org/10.1038/nn1849			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310248				2022-12-28	WOS:000244480300015
J	Kettenmann, H				Kettenmann, Helmut			Triggering the brain's pathology sensor	NATURE NEUROSCIENCE			English	Editorial Material							MICROGLIAL CELLS; ACTIVATION; ATP		Max Delbruck Ctr Mol Med, D-13082 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13082 Berlin, Germany.	kettenmann@mdc-berlin.de	Kettenmann, Helmut/AAJ-5142-2021	Kettenmann, Helmut/0000-0001-8208-0291				Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deitmer JW, 2006, GLIA, V54, P639, DOI 10.1002/glia.20428; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Moller T, 2000, BRAIN RES, V853, P49, DOI 10.1016/S0006-8993(99)02244-1; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	12	20	20	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1463	1464		10.1038/nn1206-1463	http://dx.doi.org/10.1038/nn1206-1463			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17128280				2022-12-28	WOS:000242404000003
J	Neri, P; Luu, JY; Levi, DM				Neri, Peter; Luu, Jennifer Y.; Levi, Dennis M.			Meaningful interactions can enhance visual discrimination of human agents	NATURE NEUROSCIENCE			English	Article							BIOLOGICAL MOTION; ACTION REPRESENTATION; MIRROR NEURONS; BRAIN-AREAS; PERCEPTION; MECHANISMS; RECOGNITION; IMITATION; CHILDREN; OTHERS	The ability to interpret and predict other people's actions is highly evolved in humans and is believed to play a central role in their cognitive behavior. However, there is no direct evidence that this ability confers a tangible benefit to sensory processing. Our quantitative behavioral experiments show that visual discrimination of a human agent is influenced by the presence of a second agent. This effect depended on whether the two agents interacted ( by fighting or dancing) in a meaningful synchronized fashion that allowed the actions of one agent to serve as predictors for the expected actions of the other agent, even though synchronization was irrelevant to the visual discrimination task. Our results demonstrate that action understanding has a pervasive impact on the human ability to extract visual information from the actions of other humans, providing quantitative evidence of its significance in performance.	Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Neri, P (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	pn@white.stanford.edu	Neri, Peter/G-1066-2012; Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Neri, Peter/0000-0003-1981-5309	Medical Research Council [G0800396] Funding Source: Medline; NEI NIH HHS [R01EY01728] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001728] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Barlow H. B., 1985, Models of the visual cortex, P37; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; BASSILI JN, 1978, J EXP PSYCHOL HUMAN, V4, P373, DOI 10.1037/0096-1523.4.3.373; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Bonda E, 1996, J NEUROSCI, V16, P3737; Brown WM, 2005, NATURE, V438, P1148, DOI 10.1038/nature04344; Bulthoff I, 1998, NAT NEUROSCI, V1, P254, DOI 10.1038/699; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lange J, 2006, J NEUROSCI, V26, P2894, DOI 10.1523/JNEUROSCI.4915-05.2006; Martin A, 2003, COGN NEUROPSYCHOL, V20, P575, DOI 10.1080/02643290342000005; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schultz J, 2005, NEURON, V45, P625, DOI 10.1016/j.neuron.2004.12.052; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	44	90	93	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1186	1192		10.1038/nn1759	http://dx.doi.org/10.1038/nn1759			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16936721				2022-12-28	WOS:000240080800021
J	Williams, ME; Lu, XW; McKenna, WL; Washington, R; Boyette, A; Strickland, P; Dillon, A; Kaprielian, Z; Tessier-Lavigne, M; Hinck, L				Williams, Megan E.; Lu, Xiaowei; McKenna, William L.; Washington, Raesha; Boyette, Adam; Strickland, Phyllis; Dillon, Allison; Kaprielian, Zaven; Tessier-Lavigne, Marc; Hinck, Lindsay			UNC5A promotes neuronal apoptosis during spinal cord development independent of netrin-1	NATURE NEUROSCIENCE			English	Article							CELL-DEATH; INTERACTING PROTEIN; RECEPTORS; EXPRESSION; MECHANISM; HOMOLOG; NRAGE; DCC	In addition to their role as chemorepellent netrin-1 receptors, UNC5 proteins may mediate cell death because they induce apoptosis in cultured cells. To test this in vivo, we generated Unc5a (formerly Unc5h1) knockout mice and found that this deletion decreased apoptosis and increased the number of neurons in the spinal cord. In contrast, loss of netrin-1 (Ntn1) did not affect the amount of apoptosis, suggesting that NTN1 is not required for neuronal apoptosis in vivo.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Genentech	Hinck, L (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	hinck@biology.ucsc.edu		Hinck, Lindsay/0000-0002-4009-3913; Kaprielian, Zaven/0000-0003-3364-3806; Williams, Megan/0000-0002-5461-4126	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039572] Funding Source: NIH RePORTER; NIMH NIH HHS [MH12813] Funding Source: Medline; NINDS NIH HHS [NS39572, R01 NS039572] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang H, 1999, J NEUROSCI, V19, P4938; Williams ME, 2003, J NEUROSCI, V23, P11279; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200	14	45	47	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					996	998		10.1038/nn1736	http://dx.doi.org/10.1038/nn1736			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829956				2022-12-28	WOS:000240080300008
J	Yano, H; Ninan, I; Zhang, H; Milner, TA; Arancio, O; Chao, MV				Yano, Hiroko; Ninan, Ipe; Zhang, Hong; Milner, Teresa A.; Arancio, Ottavio; Chao, Moses V.			BDNF-mediated neurotransmission relies upon a myosin VI motor complex	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; TRKB RECEPTORS; KNOCKOUT MICE; PROTEIN; TRANSPORT; RELEASE; ROLES	Brain-derived neurotrophic factor (BDNF) has been implicated in higher-order cognitive functions and in psychiatric disorders such as depression and schizophrenia. BDNF modulates synaptic transmission and plasticity primarily through the TrkB receptor, but the molecules involved in BDNF-mediated synaptic modulation are largely unknown. Myosin VI (Myo6) is a minus end directed actin-based motor found in neurons that express Trk receptors. Here we report that Myo6 and a Myo6-binding protein, GIPC1, form a complex that can engage TrkB. Myo6 and GIPC1 were necessary for BDNF-TrkB-mediated facilitation of long-term potentiation in postnatal day 12-13 (P12-13) hippocampus. Moreover, BDNF-mediated enhancement of glutamate release from presynaptic terminals depended not only upon TrkB but also upon Myo6 and GIPC1. Similar defects in basal synaptic transmission as well as presynaptic properties were observed in Myo6 and GIPC1 mutant mice. Together, these results define an important role for the Myo6-GIPC1 motor complex in presynaptic function and in BDNF-TrkB-mediated synaptic plasticity.	NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Neurosci, New York, NY 10016 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	New York University; New York University; New York University; Columbia University; Columbia University; Cornell University	Chao, MV (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Cell Biol, 540 1St Ave, New York, NY 10016 USA.	chao@saturn.med.nyu.edu	arancio, ottavio/AAB-7959-2019	Ninan, Ipe/0000-0001-9774-6455; Chao, Moses/0000-0002-6969-3744; arancio, ottavio/0000-0001-6335-164X	NHLBI NIH HHS [HL-18974] Funding Source: Medline; NICHD NIH HHS [HD23315] Funding Source: Medline; NIDA NIH HHS [DA08259] Funding Source: Medline; NINDS NIH HHS [NS21072, NS40045] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040045, R01NS021072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Drake CT, 1999, J NEUROSCI, V19, P8009; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Evans LL, 1998, J CELL SCI, V111, P2055; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Roberts R, 2004, PHILOS T R SOC B, V359, P1931, DOI 10.1098/rstb.2004.1563; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	48	106	109	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1009	1018		10.1038/nn1730	http://dx.doi.org/10.1038/nn1730			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819522				2022-12-28	WOS:000240080300013
J	Kleim, JA; Chan, S; Pringle, E; Schallert, K; Procaccio, V; Jimenez, R; Cramer, SC				Kleim, Jeffrey A.; Chan, Sheila; Pringle, Erin; Schallert, Kellan; Procaccio, Vincent; Jimenez, Richard; Cramer, Steven C.			BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN-MEMORY	Motor training can induce profound physiological plasticity within primary motor cortex, including changes in corticospinal output and motor map topography. Using transcranial magnetic stimulation, we show that training-dependent increases in the amplitude of motor-evoked potentials and motor map reorganization are reduced in healthy subjects with a val66met polymorphism in the brain-derived neurotrophic factor gene ( BDNF), as compared to subjects without the polymorphism. The results suggest that BDNF is involved in mediating experience-dependent plasticity of human motor cortex.	Malcorn Randall VA Hosp, Brain Res Rehabil Ctr, Gainesville, FL 32608 USA; Univ Florida, Dept Neurosci, Mcknight Brain Inst, Gainesville, FL 32610 USA; Univ Calif Irvine, Ctr Med, Dept Neurol, Orange, CA 92868 USA; Univ Calif Irvine, Ctr Med, Dept Anat & Neurobiol, Orange, CA 92868 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	State University System of Florida; University of Florida; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kleim, JA (corresponding author), Malcorn Randall VA Hosp, Brain Res Rehabil Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	jkleim@ufl.edu		procaccio, Vincent/0000-0002-1537-4684	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T35NS045563] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01RR 00827-29] Funding Source: Medline; NINDS NIH HHS [NS-45563] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; OEFNER PJ, 1998, CURRENT PROTOCOLS HU; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Wolf SL, 2004, CLIN NEUROPHYSIOL, V115, P1740, DOI 10.1016/j.clinph.2004.02.027; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	14	398	402	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					735	737		10.1038/nn1699	http://dx.doi.org/10.1038/nn1699			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680163	Green Published			2022-12-28	WOS:000237895200011
J	Gooley, JJ; Schomer, A; Saper, CB				Gooley, JJ; Schomer, A; Saper, CB			The dorsomedial hypothalamic nucleus is critical for the expression of food- entrainable circadian rhythms	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; ANTICIPATORY ACTIVITY; EFFERENT PROJECTIONS; PREOPTIC NUCLEUS; LESIONS; RATS; ENTRAINMENT; ORGANIZATION; TEMPERATURE	Circadian rhythms of behavior and physiology can be entrained by daily cycles of restricted food availability, but the pathways that mediate food entrainment are unknown. The dorsomedial hypothalamic nucleus (DMH) is critical for the expression of circadian rhythms and receives input from systems that monitor food availability. Here we report that restricted feeding synchronized the daily rhythm of DMH activity in rats such that c-Fos expression in the DMH was highest at scheduled mealtime. During food restriction, unlesioned rats showed a marked preprandial rise in locomotor activity, body temperature and wakefulness, and these responses were blocked by cell-specific lesions in the DMH. Furthermore, the degree of food entrainment correlated with the number of remaining DMH neurons, and lesions in cell groups surrounding the DMH did not block entrainment by food. These results establish that the neurons of the DMH have a critical role in the expression of food-entrainable circadian rhythms.	Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saper, CB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	csaper@caregroup.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067413] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60292] Funding Source: Medline; NIMH NIH HHS [MH67413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Choi SJ, 1998, J NEUROSCI, V18, P3843; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Chou WB, 2002, ACTA PHARMACOL SIN, V23, P691; COMPERATORE CA, 1990, PHYSIOL BEHAV, V47, P671, DOI 10.1016/0031-9384(90)90076-G; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; INOUYE SIT, 1982, BRAIN RES, V250, P183, DOI 10.1016/0006-8993(82)90967-2; INOUYE SIT, 1982, BRAIN RES, V232, P194, DOI 10.1016/0006-8993(82)90625-4; KRIEGER DT, 1980, ENDOCRINOLOGY, V106, P649, DOI 10.1210/endo-106-3-649; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamont EW, 2005, NEUROSCIENCE, V132, P245, DOI 10.1016/j.neuroscience.2005.01.029; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; MOREIRA AC, 1982, PHYSIOL BEHAV, V28, P787, DOI 10.1016/0031-9384(82)90194-9; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1981, J COMP PHYSIOL, V143, P401, DOI 10.1007/BF00609906; STEPHAN FK, 1992, PHYSIOL BEHAV, V52, P985, DOI 10.1016/0031-9384(92)90381-B; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	50	316	324	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					398	407		10.1038/nn1651	http://dx.doi.org/10.1038/nn1651			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491082				2022-12-28	WOS:000235645600020
J	Karadottir, R; Hamilton, NB; Bakiri, Y; Attwell, D				Karadottir, Ragnhildur; Hamilton, Nicola B.; Bakiri, Yamina; Attwell, David			Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; PROGENITOR CELLS; NG2 PROTEOGLYCAN; PHYSIOLOGICAL-PROPERTIES; NG2-POSITIVE CELLS; ALPHA-RECEPTOR; ADULT CNS; AREA CA1; BRAIN; GLUTAMATE	A defining feature of glial cells has been their inability to generate action potentials. We show here that there are two distinct types of morphologically identical oligodendrocyte precursor glial cells (OPCs) in situ in rat CNS white matter. One type expresses voltage-gated sodium and potassium channels, generates action potentials when depolarized and senses its environment by receiving excitatory and inhibitory synaptic input from axons. The other type lacks action potentials and synaptic input. We found that when OPCs suffered glutamate-mediated damage, as occurs in cerebral palsy, stroke and spinal cord injury, the action potential-generating OPCs were preferentially damaged, as they expressed more glutamate receptors, and received increased spontaneous glutamatergic synaptic input in ischemia. These data challenge the idea that only neurons generate action potentials in the CNS and imply that the development of therapies for demyelinating disorders will require defining which OPC type can carry out remyelination.	[Karadottir, Ragnhildur; Hamilton, Nicola B.; Bakiri, Yamina; Attwell, David] UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Karadottir, R (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	rk385@cam.ac.uk	Hamilton, Nicola/C-2108-2008; Messier, Claude/A-2322-2008; Attwell, David/ABE-6750-2020; Hamilton-Whitaker, Nicola/H-8867-2012	Messier, Claude/0000-0002-4791-1763; Hamilton-Whitaker, Nicola/0000-0002-0168-8068; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	MRC [G0300723] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; Medical Research Council [G0800784, G0300723] Funding Source: Medline; Wellcome Trust [075232, 065424] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Back SA, 2001, J NEUROSCI, V21, P1302; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Chittajallu R, 2005, J NEUROSCI, V25, P8601, DOI 10.1523/JNEUROSCI.2122-05.2005; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukuda A, 1998, J NEUROPHYSIOL, V79, P430, DOI 10.1152/jn.1998.79.1.430; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Horner PJ, 2000, J NEUROSCI, V20, P2218; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karadottir R, 2006, NAT PROTOC, V1, P1977, DOI 10.1038/nprot.2006.261; KAWASAKI K, 1990, J NEUROPHYSIOL, V63, P385, DOI 10.1152/jn.1990.63.3.385; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Li S, 1999, J Neurosci, V19, pRC16; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Newell EW, 2005, J PHYSIOL-LONDON, V567, P869, DOI 10.1113/jphysiol.2005.092056; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Patt S, 1996, NEUROSCIENCE, V71, P601, DOI 10.1016/0306-4522(95)00468-8; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	40	251	254	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					450	456		10.1038/nn2060	http://dx.doi.org/10.1038/nn2060			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311136	Green Accepted			2022-12-28	WOS:000254359300017
J	Murphy, GJ; Rieke, F				Murphy, Gabe J.; Rieke, Fred			Signals and noise in an inhibitory interneuron diverge to control activity in nearby retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							INNER PLEXIFORM LAYER; AII AMACRINE CELLS; MAMMALIAN RETINA; VISUAL-CORTEX; RABBIT RETINA; ROD PATHWAYS; LIGHT RESPONSES; PRIMATE RETINA; MOUSE RETINA; CAT RETINA	Information about sensory stimuli is represented by spatiotemporal patterns of neural activity. The complexity of the central nervous system, however, frequently obscures the origin and properties of signals and noise that underlie these activity patterns. We minimized this constraint by examining mechanisms governing correlated activity in mouse retinal ganglion cells (RGCs) under conditions in which light-evoked responses traverse a specific circuit, the rod bipolar pathway. Signals and noise in this circuit produced correlated synaptic input to neighboring On and Off RGCs. Temporal modulation of light intensity did not alter the degree to which noise in the input to nearby RGCs was correlated, and action potential generation in individual RGCs was largely insensitive to differences in network noise generated by dynamic and static light stimuli. Together, these features enable noise in shared circuitry to diminish simultaneous action potential generation in neighboring On and Off RGCs under a variety of conditions.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Phys & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murphy, GJ (corresponding author), Univ Washington, Howard Hughes Med Inst, 1705 NE Pacific St,HSB J187,Box 357290, Seattle, WA 98195 USA.	gjmurphy@u.washington.edu		Murphy, Gabe/0000-0002-9321-8556	NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY011850-10, EY-11850, R01 EY011850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARNETT D, 1981, J PHYSIOL-LONDON, V317, P29, DOI 10.1113/jphysiol.1981.sp013812; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Cohen ED, 1998, J NEUROPHYSIOL, V80, P2975, DOI 10.1152/jn.1998.80.6.2975; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACHEUX RF, 1986, J NEUROSCI, V6, P331; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; GINSBURG KS, 1984, J PHYSIOL-LONDON, V351, P433, DOI 10.1113/jphysiol.1984.sp015254; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pang JJ, 2007, J PHYSIOL-LONDON, V580, P397, DOI 10.1113/jphysiol.2006.120790; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; PRESS WH, 1992, NUMERICAL RECIPES; Protti DA, 1997, J NEUROSCI, V17, P6075; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Shu YS, 2003, J NEUROSCI, V23, P10388; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	48	69	69	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					318	326		10.1038/nn2045	http://dx.doi.org/10.1038/nn2045			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223648	Green Accepted			2022-12-28	WOS:000253548300015
J	Vyazovskiy, VV; Cirelli, C; Pfister-Genskow, M; Faraguna, U; Tononi, G				Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Pfister-Genskow, Martha; Faraguna, Ugo; Tononi, Giulio			Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPUS IN-VIVO; CORTICAL SYNCHRONIZATION; RECEPTOR TRAFFICKING; SLOW WAVES; BRAIN TEMPERATURE; AMPA RECEPTORS; PLASTICITY; RAT; HOMEOSTASIS	Plastic changes occurring during wakefulness aid in the acquisition and consolidation of memories. For some memories, further consolidation requires sleep, but whether plastic processes during wakefulness and sleep differ is unclear. We show that, in rat cortex and hippocampus, GluR1-containing AMPA receptor ( AMPAR) levels are high during wakefulness and low during sleep, and changes in the phosphorylation states of AMPARs, CamKII and GSK3 beta are consistent with synaptic potentiation during wakefulness and depression during sleep. Furthermore, slope and amplitude of cortical evoked responses increase after wakefulness, decrease after sleep and correlate with changes in slow-wave activity, a marker of sleep pressure. Changes in molecular and electrophysiological indicators of synaptic strength are largely independent of the time of day. Finally, cortical long-term potentiation can be easily induced after sleep, but not after wakefulness. Thus, wakefulness appears to be associated with net synaptic potentiation, whereas sleep may favor global synaptic depression, thereby preserving an overall balance of synaptic strength.	[Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Pfister-Genskow, Martha; Faraguna, Ugo; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Faraguna, Ugo] Scuola Normale S Anna, I-56127 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	ccirelli@wisc.edu; gtononi@wisc.edu	Tononi, Giulio/B-8387-2009; Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218; Vyazovskiy, Vladyslav/0000-0002-4336-6681	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000579] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Borbely A.A., 2005, PRINCIPLES PRACTICE; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; CAIN DP, 1994, BRAIN RES, V658, P135, DOI 10.1016/S0006-8993(09)90019-1; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Cirelli C, 2000, J NEUROSCI, V20, P9187; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CZAMECKI A, 2007, J PHYSIOL-LONDON, V578, P471; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; GEOL A, 2006, NAT NEUROSCI, V9, P1001; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Glazewski S, 1998, NEUROPHARMACOLOGY, V37, P581, DOI 10.1016/S0028-3908(98)00039-2; HALL RD, 1970, EXP BRAIN RES, V11, P93; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McDermott CM, 2003, J NEUROSCI, V23, P9687; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2005, BRAINSTEM CONTROL WA, P728; Tartar JL, 2006, EUR J NEUROSCI, V23, P2739, DOI 10.1111/j.1460-9568.2006.04808.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	50	534	545	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					200	208		10.1038/nn2035	http://dx.doi.org/10.1038/nn2035			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204445				2022-12-28	WOS:000252712100014
J	Sun, P; Ueno, K; Waggoner, RA; Gardner, JL; Tanaka, K; Cheng, K				Sun, Pei; Ueno, Kenichi; Waggoner, R. Allen; Gardner, Justin L.; Tanaka, Keiji; Cheng, Kang			A temporal frequency-dependent functional architecture in human V1 revealed by high-resolution fMRI	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; PRIMARY VISUAL-CORTEX; MONKEY; CAT; SELECTIVITY; CONTRAST; NEURONS; MAPS	Although cortical neurons with similar functional properties often cluster together in a columnar organization, only ocular dominance columns, the columnar structure representing segregated anatomical input (from one of the two eyes), have been found in human primary visual cortex (V1). It has yet to be shown whether other columnar organizations that arise only from differential responses to stimulus properties also exist in human V1. Using high-resolution functional magnetic resonance imaging, we have found such a functional architecture containing domains that respond preferentially to either low or high temporal frequency.	RIKEN, Brain Sci Inst, Lab Cognit Braion Mapping, Wako, Saitama 3510198, Japan; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Dept Psychol, New York, NY 10003 USA	RIKEN; New York University; New York University	Sun, P (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Braion Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	psun@brain.riken.jp	Waggoner, Allen/F-2654-2010; Cheng, Kang/A-6448-2016; Sun, Pei/B-5191-2013; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015	Waggoner, Allen/0000-0002-4921-7521; Sun, Pei/0000-0003-4184-1079; Tanaka, Keiji/0000-0002-1910-3427; Gardner, Justin/0000-0003-2220-5050				Baker TI, 2005, J NEUROPHYSIOL, V94, P775, DOI 10.1152/jn.01093.2004; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; HAMMETT ST, 1992, VISION RES, V32, P285, DOI 10.1016/0042-6989(92)90139-A; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HORTON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1025, DOI 10.1001/archopht.1990.01070090127054; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; Shmuel A, 2007, NEUROIMAGE, V35, P539, DOI 10.1016/j.neuroimage.2006.12.030; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3	15	41	41	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1404	1406		10.1038/nn1983	http://dx.doi.org/10.1038/nn1983			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934459				2022-12-28	WOS:000250508400017
J	Mazzuca, M; Heurteaux, C; Alloui, A; Diochot, S; Baron, A; Voilley, N; Blondeau, N; Escoubas, P; Gelot, A; Cupo, A; Zimmer, A; Zimmer, AM; Eschalier, A; Lazdunski, M				Mazzuca, Michel; Heurteaux, Catherine; Alloui, Abdelkrim; Diochot, Sylvie; Baron, Anne; Voilley, Nicolas; Blondeau, Nicolas; Escoubas, Pierre; Gelot, Agnes; Cupo, Anny; Zimmer, Andreas; Zimmer, Anne M.; Eschalier, Alain; Lazdunski, Michel			A tarantula peptide against pain via ASIC1a channels and opioid mechanisms	NATURE NEUROSCIENCE			English	Article								Psalmotoxin 1, a peptide extracted from the South American tarantula Psalmopoeus cambridgei, has very potent analgesic properties against thermal, mechanical, chemical, inflammatory and neuropathic pain in rodents. It exerts its action by blocking acid-sensing ion channel 1a, and this blockade results in an activation of the endogenous enkephalin pathway. The analgesic properties of the peptide are suppressed by antagonists of the mu and delta-opioid receptors and are lost in Penk1(-/-) mice.	Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, Inst Paul Hamel, F-06560 Valbonne, France; CHU, Fac Med, INSERM, Unite Mixte Rech 766, Clermont Ferrand, France; Univ Bonn, Dept Mol Psychiat, D-53105 Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn	Lazdunski, M (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, Inst Paul Hamel, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	Blondeau, Nicolas/T-1136-2019; Blondeau, Nicolas P/M-5002-2016; ESCHALIER, Alain/L-9957-2015; Zimmer, Andreas/B-8357-2009; BARON, Anne/N-5691-2016; HEURTEAUX, Catherine/M-4947-2016; Diochot, Sylvie/ABG-5495-2020	Blondeau, Nicolas P/0000-0001-5954-4094; BARON, Anne/0000-0002-8026-6380; HEURTEAUX, Catherine/0000-0002-9741-9777; 				Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Ettaiche M, 2006, J NEUROSCI, V26, P5800, DOI 10.1523/JNEUROSCI.0344-06.2006; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mamet J, 2002, J NEUROSCI, V22, P10662; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wood J N, 2007, Handb Exp Pharmacol, P329	15	195	204	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					943	945		10.1038/nn1940	http://dx.doi.org/10.1038/nn1940			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632507				2022-12-28	WOS:000248357500006
J	Chihara, T; Luginbuhl, D; Luo, L				Chihara, Takahiro; Luginbuhl, David; Luo, Liqun			Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization	NATURE NEUROSCIENCE			English	Article							TRANSFER-RNA SYNTHETASE; MARIE-TOOTH-DISEASE; SACCHAROMYCES-CEREVISIAE; OLFACTORY MAP; GENE MUTATION; DROSOPHILA; MORPHOGENESIS; NEURONS; REPRESENTATION; NEUROPATHY	We identified a mutation in Aats-gly (also known as gars or glycyl-tRNA synthetase), the Drosophila melanogaster ortholog of the human GARS gene that is associated with Charcot-Marie-Tooth neuropathy type 2D (CMT2D), from a mosaic genetic screen. Loss of gars in Drosophila neurons preferentially affects the elaboration and stability of terminal arborization of axons and dendrites. The human and Drosophila genes each encode both a cytoplasmic and a mitochondrial isoform. Using additional mutants that selectively disrupt cytoplasmic or mitochondrial protein translation, we found that cytoplasmic protein translation is required for terminal arborization of both dendrites and axons during development. In contrast, disruption of mitochondrial protein translation preferentially affects the maintenance of dendritic arborization in adults. We also provide evidence that human GARS shows equivalent functions in Drosophila, and that CMT2D causal mutations show loss-of-function properties. Our study highlights different demands of protein translation for the development and maintenance of axons and dendrites.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo 1130033, Japan	Howard Hughes Medical Institute; Stanford University; University of Tokyo	Luo, L (corresponding author), Stanford Univ, Howard Hughes Med Inst, 385 Serra Mall, Stanford, CA 94305 USA.	lluo@stanford.edu	Chihara, Takahiro/G-7639-2019	Chihara, Takahiro/0000-0001-9989-3619; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982, R01 DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Overly CC, 1996, J CELL SCI, V109, P971; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Seshaiah P, 1999, MOL BIOL CELL, V10, P1595, DOI 10.1091/mbc.10.5.1595; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Shy ME, 2004, CURR OPIN NEUROL, V17, P579, DOI 10.1097/00019052-200410000-00008; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Toivonen JM, 2001, GENETICS, V159, P241; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100	48	83	85	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					828	837		10.1038/nn1910	http://dx.doi.org/10.1038/nn1910			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529987				2022-12-28	WOS:000247560200012
J	Wong, PCM; Skoe, E; Russo, NM; Dees, T; Kraus, N				Wong, Patrick C. M.; Skoe, Erika; Russo, Nicole M.; Dees, Tasha; Kraus, Nina			Musical experience shapes human brainstem encoding of linguistic pitch patterns	NATURE NEUROSCIENCE			English	Article							LANGUAGE; SPEECH; CORTEX	Music and speech are very cognitively demanding auditory phenomena generally attributed to cortical rather than subcortical circuitry. We examined brainstem encoding of linguistic pitch and found that musicians show more robust and faithful encoding compared with nonmusicians. These results not only implicate a common subcortical manifestation for two presumed cortical functions, but also a possible reciprocity of corticofugal speech and music tuning, providing neurophysiological explanations for musicians' higher language-learning ability.	Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; Northwestern Univ, Interdepartmental Neurosci Program, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Dept Otolaryngol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, 2240 Campus Dr, Evanston, IL 60208 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012	Wong, Patrick/0000-0002-6105-5027; Russo-Ponsaran, Nicole/0000-0002-9430-152X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD051827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC007468, R01DC001510] Funding Source: NIH RePORTER; NICHD NIH HHS [R03HD051827, R03 HD051827] Funding Source: Medline; NIDCD NIH HHS [R01 DC001510, R01DC001510, R21DC007468, R21 DC007468] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Gordon M, 2000, J COMP NEUROL, V426, P165, DOI 10.1002/1096-9861(20001016)426:2<165::AID-CNE1>3.0.CO;2-I; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; WONG PCM, IN PRESS HUM BRAIN M	15	607	625	1	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					420	422		10.1038/nn1872	http://dx.doi.org/10.1038/nn1872			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	150PL	17351633	Green Accepted			2022-12-28	WOS:000245228600011
J	Sieburth, D; Madison, JM; Kaplan, JM				Sieburth, Derek; Madison, Jon M.; Kaplan, Joshua M.			PKC-1 regulates secretion of neuropeptides	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; READILY RELEASABLE POOL; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; PHORBOL ESTERS; DEPENDENT PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; FLUORESCENT PROTEIN; CYTOSOLIC PROTEIN	The secretion of neurotransmitters and neuropeptides is mediated by distinct organelles-synaptic vesicles (SVs) and dense-core vesicles (DCVs), respectively. Relatively little is known about the factors that differentially regulate SV and DCV secretion. Here we show that protein kinase C-1 (PKC-1), which is most similar to the vertebrate PKC eta and epsilon isoforms, regulates exocytosis of DCVs in Caenorhabditis elegans motor neurons. Mutants lacking PCK-1 activity had delayed paralysis induced by the acetylcholinesterase inhibitor aldicarb, whereas mutants with increased PKC-1 activity had more rapid aldicarb-induced paralysis. Imaging and electrophysiological assays indicated that SV release occurred normally in pkc-1 mutants. By contrast, genetic analysis of aldicarb responses and imaging of fluorescently tagged neuropeptides indicated that mutants lacking PKC-1 had reduced neuropeptide secretion. Similar neuropeptide secretion defects were found in mutants lacking unc-31 ( encoding the protein CAPS) or unc-13 (encoding Munc13). These results suggest that PKC-1 selectively regulates DCV release from neurons.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Simches 7,185 Cambridge St, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu			NINDS NIH HHS [1F32NS10310] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010310] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Craig TJ, 2003, J NEUROCHEM, V86, P1450, DOI 10.1046/j.1471-4159.2003.01955.x; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gonelle-Gispert C, 2002, BIOCHEM J, V368, P223, DOI 10.1042/BJ20020896; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LAND M, 1994, J BIOL CHEM, V269, P9234; LAND M, 1994, J BIOL CHEM, V269, P14820; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lonart G, 2000, J BIOL CHEM, V275, P27703; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Misonou H, 1998, CELL MOL NEUROBIOL, V18, P379, DOI 10.1023/A:1022593330685; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy G, 2002, J NEUROSCI, V22, P9278; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; NGUYEN M, 1995, GENETICS, V140, P527; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Smith C, 1999, J NEUROSCI, V19, P589; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Waters J, 2000, J NEUROSCI, V20, P7863; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	65	169	187	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					49	57		10.1038/nn1810	http://dx.doi.org/10.1038/nn1810			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17128266				2022-12-28	WOS:000243096100015
J	Zhang, JS; Pho, V; Bonasera, SJ; Holtzman, J; Tang, AT; Hellmuth, J; Tang, SW; Janak, PH; Tecott, LH; Huang, EJ				Zhang, Jiasheng; Pho, Vanee; Bonasera, Stephen J.; Holtzman, Jed; Tang, Amy T.; Hellmuth, Joanna; Tang, Siuwah; Janak, Patricia H.; Tecott, Laurence H.; Huang, Eric J.			Essential function of HIPK2 in TGF beta-dependent survival of midbrain dopamine neurons	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-BETA; INTERACTING PROTEIN KINASE-2; NERVOUS-SYSTEM; SUBSTANTIA-NIGRA; CELL-DEATH; NEUROTROPHIC FACTOR; IN-VIVO; TRANSCRIPTION FACTORS; PARKINSONS-DISEASE; SYNAPTIC GROWTH	Transforming growth factor beta (TGF beta) is a potent trophic factor for midbrain dopamine (DA) neurons, but its in vivo function and signaling mechanisms are not entirely understood. We show that the transcriptional cofactor homeodomain interacting protein kinase 2 (HIPK2) is required for the TGF beta-mediated survival of mouse DA neurons. The targeted deletion of Hipk2 has no deleterious effect on the neurogenesis of DA neurons, but leads to a selective loss of these neurons that is due to increased apoptosis during programmed cell death. As a consequence, Hipk2(-/-) mutants show an array of psychomotor abnormalities. The function of HIPK2 depends on its interaction with receptor-regulated Smads to activate TGFb target genes. In support of this notion, DA neurons from Hipk2(-/-) mutants fail to survive in the presence of TGF beta 3 and Tgf beta 3(-/-) mutants show DA neuron abnormalities similar to those seen in Hipk2(-/-) mutants. These data underscore the importance of the TGF beta-smad-HIPK2 pathway in the survival of DA neurons and its potential as a therapeutic target for promoting DA neuron survival during neurodegeneration.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; VA Med Ctr, Pathol Serv 113B, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, EJ (corresponding author), Univ Calif San Francisco, Dept Pathol, 505 Parnassus Ave, San Francisco, CA 94143 USA.	eric.huang2@ucsf.edu	Huang, Eric J./AAH-7997-2019	Huang, Eric J./0000-0002-5381-3801; Bonasera, Stephen/0000-0001-6808-2821; Janak, Patricia/0000-0002-3333-9049	NIA NIH HHS [AG23501, P50 AG023501] Funding Source: Medline; NINDS NIH HHS [NS48393, K02 NS044223, NS44223, R01 NS048393] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048393, K02NS044223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chin J, 2002, J NEUROSCI, V22; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Farkas LM, 2003, J NEUROSCI, V23, P5178; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HYMAN C, 1994, J NEUROSCI, V14, P335; HYNES MA, 1994, J NEUROSCI RES, V37, P144, DOI 10.1002/jnr.490370118; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kholodilov N, 2004, J NEUROSCI, V24, P3136, DOI 10.1523/JNEUROSCI.4506-03.2004; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Lie DC, 2002, J NEUROSCI, V22, P6639; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Oo TF, 2003, J NEUROSCI, V23, P5141; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	49	100	100	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					77	86		10.1038/nn1816	http://dx.doi.org/10.1038/nn1816			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159989	Green Accepted			2022-12-28	WOS:000243096100018
J	Thompson, SK; von Kriegstein, K; Deane-Pratt, A; Marquardt, T; Deichmann, R; Griffiths, TD; McAlpine, D				Thompson, Sarah K.; von Kriegstein, Katharina; Deane-Pratt, Adenike; Marquardt, Torsten; Deichmann, Ralf; Griffiths, Timothy D.; McAlpine, David			Representation of interaural time delay in the human auditory midbrain	NATURE NEUROSCIENCE			English	Article							INFERIOR COLLICULUS; LATERALIZATION; SENSITIVITY; NOISE; BANDS; DISCRIMINATION; DIFFERENCE; BANDWIDTH; STIMULI; TONES	Interaural time difference (ITD) is a critical cue to sound-source localization. Traditional models assume that sounds leading at one ear, and perceived on that side, are processed in the opposite midbrain. Using functional magnetic resonance imaging we demonstrate that as the ITDs of sounds increase, midbrain activity can switch sides, even though perceived location remains on the same side. The data require a new model for human ITD processing.	UCL, Dept Physiol, London WC1X 8EE, England; UCL, Ear Inst, London WC1X 8EE, England; UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Newcastle Upon Tyne, Auditory Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of London; University College London; University of London; University College London; University of London; University College London; Newcastle University - UK	McAlpine, D (corresponding author), UCL, Dept Physiol, 332 Grays Inn Rd, London WC1X 8EE, England.	d.mcalpine@ucl.ac.uk	von Kriegstein, Katharina/C-3135-2008	von Kriegstein, Katharina/0000-0001-7989-5860; Deane-Pratt, Ade/0000-0001-9940-9233; McAlpine, David/0000-0001-5467-6725; Griffiths, Timothy/0000-0001-8066-4381	MRC [G0300417] Funding Source: UKRI; Medical Research Council [G0300417] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bernstein LR, 2003, J ACOUST SOC AM, V113, P3335, DOI 10.1121/1.1570431; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; SCHIANO JL, 1986, J ACOUST SOC AM, V79, P1563, DOI 10.1121/1.393683; STERN RM, 1985, J ACOUST SOC AM, V77, P753, DOI 10.1121/1.392345; STERN RM, 1997, P 11 INT S HEAR; TRAHIOTIS C, 1986, J ACOUST SOC AM, V79, P1950, DOI 10.1121/1.393202; Trahiotis C, 2001, J ACOUST SOC AM, V109, P321, DOI 10.1121/1.1327579; TRAHIOTIS C, 1994, J ACOUST SOC AM, V96, P3804, DOI 10.1121/1.410570; TRAHIOTIS C, 1989, J ACOUST SOC AM, V86, P1285, DOI 10.1121/1.398743; WAGNER H, 1987, J NEUROSCI, V7, P3105; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	15	53	54	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1096	1098		10.1038/nn1755	http://dx.doi.org/10.1038/nn1755			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921369				2022-12-28	WOS:000240080800009
J	Weissman, DH; Roberts, KC; Visscher, KM; Woldorff, MG				Weissman, D. H.; Roberts, K. C.; Visscher, K. M.; Woldorff, M. G.			The neural bases of momentary lapses in attention	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; SUSTAINED ATTENTION; FUNCTIONAL MRI; DEFICIT/HYPERACTIVITY DISORDER; SELECTIVE ATTENTION; FRONTAL LESIONS; BRAIN ACTIVITY; VISUAL-CORTEX; DEFAULT-MODE; TASK	Momentary lapses in attention frequently impair goal-directed behavior, sometimes with serious consequences. Nevertheless, we lack an integrated view of the brain mechanisms underlying such lapses. By investigating trial-by-trial relationships between brain activity and response time in humans, we determined that attentional lapses begin with reduced prestimulus activity in anterior cingulate and right prefrontal regions involved in controlling attention. Less efficient stimulus processing during attentional lapses was also characterized by less deactivation of a 'default-mode' network, reduced stimulus-evoked sensory activity, and increased activity in widespread regions of frontal and parietal cortex. Finally, consistent with a mechanism for recovering from attentional lapses, increased stimulus-evoked activity in the right inferior frontal gyrus and the right temporal-parietal junction predicted better performance on the next trial. Our findings provide a new, system-wide understanding of the patterns of brain activity that are associated with brief attentional lapses, which informs both theoretical and clinical models of goal-directed behavior.	Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; Duke Univ, Dept Psychiat, Durham, NC 27708 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Duke University; Duke University; Brandeis University	Weissman, DH (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	weissman@duke.edu		Woldorff, Marty/0000-0002-2683-4551; Roberts, Kenneth/0000-0002-8033-0864; Visscher, Kristina/0000-0003-0737-4024	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS041867, P01NS041328] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60415] Funding Source: Medline; NINDS NIH HHS [1 F32 NS41867-01, P01 NS41328] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Drummond SPA, 2005, SLEEP, V28, P1059; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P141; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Indovina I, 2004, MAGN RESON IMAGING, V22, P1477, DOI 10.1016/j.mri.2004.10.016; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Lavie N, 2003, PERCEPT PSYCHOPHYS, V65, P202, DOI 10.3758/BF03194795; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Petrides M, 1995, ANN NY ACAD SCI, V769, P85, DOI 10.1111/j.1749-6632.1995.tb38133.x; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reimer B, 2005, ACCIDENT ANAL PREV, V37, P996, DOI 10.1016/j.aap.2005.05.002; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Schacter D. L., 2001, 7 SINS MEMORY MIND F; TALAIRCH J, 1988, CO PLANAR STEREOTACT; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Weissman DH, 1999, J EXP PSYCHOL GEN, V128, P283, DOI 10.1037/0096-3445.128.3.283; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	50	1137	1154	0	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					971	978		10.1038/nn1727	http://dx.doi.org/10.1038/nn1727			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16767087				2022-12-28	WOS:000238590800025
J	Hanks, TD; Ditterich, J; Shadlen, MN				Hanks, TD; Ditterich, J; Shadlen, MN			Microstimulation of macaque area LIP affects decision-making in a motion discrimination task	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; PERCEPTION FOLLOWING LESIONS; SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; ELECTRICAL-STIMULATION; TARGET SELECTION; RESPONSE-TIMES; VISUAL-MOTION; MONKEY	A central goal of cognitive neuroscience is to elucidate the neural mechanisms underlying decision-making. Recent physiological studies suggest that neurons in association areas may be involved in this process. To test this, we measured the effects of electrical microstimulation in the lateral intraparietal area ( LIP) while monkeys performed a reaction-time motion discrimination task with a saccadic response. In each experiment, we identified a cluster of LIP cells with overlapping response fields (RFs) and sustained activity during memory-guided saccades. Microstimulation of this cluster caused an increase in the proportion of choices toward the RF of the stimulated neurons. Choices toward the stimulated RF were faster with microstimulation, while choices in the opposite direction were slower. Microstimulation never directly evoked saccades, nor did it change reaction times in a simple saccade task. These results demonstrate that the discharge of LIP neurons is causally related to decision formation in the discrimination task.	Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Davis	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P51 RR000166, P51 RR000166-390015] Funding Source: Medline; NEI NIH HHS [R01 EY011378-11A1, R01 EY011378] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Holmes P, 2005, IEICE T FUND ELECTR, VE88A, P2496, DOI [10.1093/ietfec/e88-a.10.2496, 10.1093/ietfec/e88.a.10.2496]; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Link SW, 1992, WAVE THEORY DIFFEREN; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Opris I, 2005, VISION RES, V45, P3414, DOI 10.1016/j.visres.2005.03.014; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; PASTERNAK T, 1994, CEREB CORTEX, V4, P247, DOI 10.1093/cercor/4.3.247; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Press W. H., 1988, NUMERICAL RECIPES C, P735; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SMITH PL, 1990, J MATH PSYCHOL, V34, P445, DOI 10.1016/0022-2496(90)90023-3; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0	50	233	235	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					682	689		10.1038/nn1683	http://dx.doi.org/10.1038/nn1683			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	040YI	16604069	Green Accepted			2022-12-28	WOS:000237417200020
J	Skeberdis, VA; Chevaleyre, V; Lau, CG; Goldberg, JH; Pettit, DL; Suadicani, SO; Lin, Y; Bennett, MVL; Yuste, R; Castillo, PE; Zukin, RS				Skeberdis, VA; Chevaleyre, V; Lau, CG; Goldberg, JH; Pettit, DL; Suadicani, SO; Lin, Y; Bennett, MVL; Yuste, R; Castillo, PE; Zukin, RS			Protein kinase A regulates calcium permeability of NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTOR; DENDRITIC SPINES; VISUAL-CORTEX; CA1 REGION; LATE-PHASE; CHANNELS; LTP; EXPRESSION	Calcium (Ca2+) influx through NMDA receptors (NMDARs) is essential for synaptogenesis, experience-dependent synaptic remodeling and plasticity. The NMDAR-mediated rise in postsynaptic Ca2+ activates a network of kinases and phosphatases that promote persistent changes in synaptic strength, such as long-term potentiation (LTP). Here we show that the Ca2+ permeability of neuronal NMDARs is under the control of the cyclic AMP-protein kinase A (cAMP-PKA) signaling cascade. PKA blockers reduced the relative fractional Ca2+ influx through NMDARs as determined by reversal potential shift analysis and by a combination of electrical recording and Ca2+ influx measurements in rat hippocampal neurons in culture and hippocampal slices from mice. In slices, PKA blockers markedly inhibited NMDAR-mediated Ca21 rises in activated dendritic spines, with no significant effect on synaptic current. Consistent with this, PKA blockers depressed the early phase of NMDAR-dependent LTP at hippocampal Schaffer collateral-CA1 (Sch-CA1) synapses. Our data link PKA-dependent synaptic plasticity to Ca2+ signaling in spines and thus provide a new mechanism whereby PKA regulates the induction of LTP.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Dev Disa, Bronx, NY 10461 USA; Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Howard Hughes Medical Institute	Zukin, RS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Dev Disa, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zukin@aecom.yu.edu	Lau, C. Geoffrey/G-4036-2014; Bennett, Michael/A-6958-2009	Lau, C. Geoffrey/0000-0001-9750-2514; Castillo, Pablo/0000-0002-9834-1801; Chevaleyre, Vivien/0000-0002-3679-4856; Goldberg, Jesse/0000-0003-0422-8902; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187	NIDA NIH HHS [DA17392] Funding Source: Medline; NIMH NIH HHS [MH65495] Funding Source: Medline; NINDS NIH HHS [NS20752, NS45287] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752, R01NS045287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Huang Y Y, 1994, Learn Mem, V1, P74; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; ROGERS M, 1995, BIOPHYS J, V68, P501, DOI 10.1016/S0006-3495(95)80211-0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scemes E, 2000, J NEUROSCI, V20, P1435; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schneider MC, 1996, MOL MED TODAY, V2, P70, DOI 10.1016/1357-4310(96)88741-7; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Snyder GL, 1998, J NEUROSCI, V18, P10297; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; ZHONG J, 1994, MOL PHARMACOL, V45, P846; ZORUMSKI CF, 1989, CELL MOL NEUROBIOL, V9, P95, DOI 10.1007/BF00711446	50	232	239	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					501	510		10.1038/nn1664	http://dx.doi.org/10.1038/nn1664			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531999				2022-12-28	WOS:000236310700017
J	Huang, ZJ				Huang, ZJ			Subcellular organization of GABAergic synapses: role of ankyrins and L1 cell adhesion molecules	NATURE NEUROSCIENCE			English	Article							AXON GUIDANCE; MOSSY FIBERS; INTERNEURONS; NEUROFASCIN; INPUTS; INNERVATION; HIPPOCAMPUS; MECHANISMS; SEGMENTS; NEURONS	In vertebrate nervous systems, different classes of synaptic inputs are often segregated into restricted compartments of target neurons. For example, distinct types of GABAergic interneurons preferentially innervate subcellular domains and have been implicated in the precise temporal regulation of integration within neurons and activity within networks. Recent studies suggest that the subcellular segregation of different classes of GABAergic synapses is largely genetically determined. The localization and signaling of L1 family immunoglobulin proteins recruited by ankyrin-based membrane adaptors might serve as compartmental labels, which contribute to subcellular synapse organization in cerebellar Purkinje neurons.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X				AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; CAJAL S, 1995, HISTOLOGY NERVOUS MA; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KING JS, 1993, ANAT EMBRYOL, V188, P299; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Mohler PJ, 2002, J CELL SCI, V115, P1565; Palay S.L., 1974, CEREBELLAR CORTEX; RAISMAN G, 1983, NEUROSCIENCE, V9, P783, DOI 10.1016/0306-4522(83)90267-1; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Shen K, 2004, CURR OPIN NEUROBIOL, V14, P83, DOI 10.1016/j.conb.2004.01.007; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; ZIMMER J, 1987, J COMP NEUROL, V264, P1, DOI 10.1002/cne.902640102	35	30	30	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					163	166		10.1038/nn1638	http://dx.doi.org/10.1038/nn1638			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16439983				2022-12-28	WOS:000234990100008
J	Bayer, H				Bayer, Hannah			Focus on decision making	NATURE NEUROSCIENCE			English	Editorial Material														Bayer, Hannah/0000-0002-5644-4124				Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593	1	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					387	387		10.1038/nn0408-387	http://dx.doi.org/10.1038/nn0408-387			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18368044				2022-12-28	WOS:000254359300006
J	Liu, F; Day, M; Muniz, LC; Bitran, D; Arias, R; Revilla-Sanchez, R; Grauer, S; Zhang, G; Kelley, C; Pulito, V; Sung, A; Mervis, RF; Navarra, R; Hirst, WD; Reinhart, PH; Marquis, KL; Moss, SJ; Pangalos, MN; Brandon, NJ				Liu, Feng; Day, Mark; Muniz, Luis C.; Bitran, Daniel; Arias, Robert; Revilla-Sanchez, Raquel; Grauer, Steve; Zhang, Guoming; Kelley, Cody; Pulito, Virginia; Sung, Amy; Mervis, Ronald F.; Navarra, Rachel; Hirst, Warren D.; Reinhart, Peter H.; Marquis, Karen L.; Moss, Stephen J.; Pangalos, Menelas N.; Brandon, Nicholas J.			Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL CELLS; DENDRITIC SPINE DENSITY; ELEMENT-BINDING PROTEIN; SPATIAL MEMORY; INHIBITORY AVOIDANCE; MESSENGER-RNA; FEMALE MICE; RAT-BRAIN; ADULT-RAT	Estrogens have long been implicated in influencing cognitive processes, yet the molecular mechanisms underlying these effects and the roles of the estrogen receptors alpha (ER alpha) and beta (ER beta) remain unclear. Using pharmacological, biochemical and behavioral techniques, we demonstrate that the effects of estrogen on hippocampal synaptic plasticity and memory are mediated through ER beta. Selective ER beta agonists increased key synaptic proteins in vivo, including PSD-95, synaptophysin and the AMPA-receptor subunit GluR1. These effects were absent in ER beta knockout mice. In hippocampal slices, ER beta activation enhanced long-term potentiation, an effect that was absent in slices from ER beta knockout mice. ER beta activation induced morphological changes in hippocampal neurons in vivo, including increased dendritic branching and increased density of mushroom-type spines. An ER beta agonist, but not an ER alpha agonist, also improved performance in hippocampus-dependent memory tasks. Our data suggest that activation of ER beta can regulate hippocampal synaptic plasticity and improve hippocampus-dependent cognition.	[Bitran, Daniel] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA; [Revilla-Sanchez, Raquel; Moss, Stephen J.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Mervis, Ronald F.] Univ S Florida, Ctr Excellence Aging & Brain Repair, Neurostruct Res Labs Inc, Tampa, FL 33637 USA	College of the Holy Cross; University of Pennsylvania; State University System of Florida; University of South Florida		daym1@wyeth.com; liuf2@wyeth.com		Brandon, Nicholas/0000-0002-3917-0096; Hirst, Warren/0000-0003-0389-8891	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478, P01NS054900, R01NS056359, R01NS051195, R01NS048045] Funding Source: NIH RePORTER; Medical Research Council Funding Source: Medline; NINDS NIH HHS [NS056359, P01NS054900, NS051195, NS046478, NS048045] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MM, 2004, J COMP NEUROL, V474, P419, DOI 10.1002/cne.20148; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Cyr M, 2001, NEUROPSYCHOPHARMACOL, V25, P242, DOI 10.1016/S0893-133X(01)00233-0; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Frye CA, 2002, BRAIN RES, V956, P285, DOI 10.1016/S0006-8993(02)03559-X; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lee SJ, 2004, NEUROSCIENCE, V124, P549, DOI 10.1016/j.neuroscience.2003.11.035; Lein PJ, 2007, ENVIRON HEALTH PERSP, V115, P556, DOI 10.1289/ehp.9773; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; MacLennan AH, 2006, MENOPAUSE, V13, P28, DOI 10.1097/01.gme.0000191204.38664.61; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Ostlund H, 2003, ANN NY ACAD SCI, V1007, P54, DOI 10.1196/annals.1286.006; Pfaff DW, 2000, J STEROID BIOCHEM, V74, P365, DOI 10.1016/S0960-0760(00)00114-X; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rhodes ME, 2006, NEUROBIOL LEARN MEM, V85, P183, DOI 10.1016/j.nlm.2005.10.003; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; ROY EJ, 1977, STEROIDS, V30, P657, DOI 10.1016/0039-128X(77)90055-1; Rudick CN, 2003, ENDOCRINOLOGY, V144, P179, DOI 10.1210/en.2002-220581; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Savonenko AV, 2003, NEUROSCIENCE, V119, P821, DOI 10.1016/S0306-4522(03)00213-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Wang SX, 2003, J BIOL CHEM, V278, P2713, DOI 10.1074/jbc.M208411200; Woolley CS, 1997, J NEUROSCI, V17, P1848; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Y, 1996, ENDOCRINOLOGY, V137, P2163, DOI 10.1210/en.137.5.2163	50	380	393	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					334	343		10.1038/nn2057	http://dx.doi.org/10.1038/nn2057			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297067				2022-12-28	WOS:000253548300017
J	Salazar, H; Llorente, I; Jara-Oseguera, A; Garcia-Villegas, R; Munari, M; Gordon, SE; Islas, LD; Rosenbaum, T				Salazar, Hector; Llorente, Itzel; Jara-Oseguera, Andres; Garcia-Villegas, Refugio; Munari, Mika; Gordon, Sharona E.; Islas, Leon D.; Rosenbaum, Tamara			A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic	NATURE NEUROSCIENCE			English	Article							ION-CHANNEL; COVALENT MODIFICATION; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; ANKYRIN REPEATS; S-NITROSYLATION; TRPA1; CHEMISTRY; ALLIUM; PAIN	Some members of the transient receptor potential (TRP) family of cation channels mediate sensory responses to irritant substances. Although it is well known that TRPA1 channels are activated by pungent compounds found in garlic, onion, mustard and cinnamon extracts, activation of TRPV1 by these extracts remains controversial. Here we establish that TRPV1 is activated by pungent extracts from onion and garlic, as well as by allicin, the active compound in these preparations, and participates together with TRPA1 in the pain-related behavior induced by this compound. We found that in TRPV1 these agents act by covalent modification of cysteine residues. In contrast to TRPA1 channels, modification of a single cysteine located in the N-terminal region of TRPV1 was necessary and sufficient for all the effects we observed. Our findings point to a conserved mechanism of activation in TRP channels, which provides new insights into the molecular basis of noxious stimuli detection.	[Salazar, Hector; Llorente, Itzel; Jara-Oseguera, Andres; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Dept Biofis, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Islas, Leon D.] Univ Nacl Autonoma Mexico, Dept Fisiol, Fac Med, Mexico City 04510, DF, Mexico; [Garcia-Villegas, Refugio] Estudios Avanzados Inst Politecn Nacl, Ctr Invest, Dept Fisiol Biofis & Neurosci, Mexico City 07360, DF, Mexico; [Munari, Mika; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIO - Centro de Investigaciones en Optica A.C.; University of Washington; University of Washington Seattle	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Dept Biofis, Inst Fisiol Celular, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Islas, Leon D/AAW-9845-2020	Islas, Leon D/0000-0002-7461-5214; Garcia-Villegas, Refugio/0000-0001-8468-6676; Jara Oseguera, Andres/0000-0001-5921-9320; Rosenbaum, Tamara/0000-0002-4791-3195	NATIONAL EYE INSTITUTE [R01EY017564] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017564, R01 EY017564-04] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLOCK E, 1985, SCI AM, V252, P114, DOI 10.1038/scientificamerican0385-114; Block E, 1996, ADV EXP MED BIOL, V401, P155; CALVEY EM, 1994, J CHROMATOGR SCI, V32, P93, DOI 10.1093/chromsci/32.3.93; Calvey EM, 1998, PHYTOCHEMISTRY, V49, P359, DOI 10.1016/S0031-9422(98)00191-5; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; JARA A, 2007, BIOPHYS J, V92, P3901; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Matalon S, 2003, AM J PHYSIOL-LUNG C, V285, pL1184, DOI 10.1152/ajplung.00281.2003; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Szallasi A, 1999, PHARMACOL REV, V51, P159; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vyklicky L, 2002, NEUROSCIENCE, V111, P435, DOI 10.1016/S0306-4522(02)00051-9; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	35	158	164	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					255	261		10.1038/nn2056	http://dx.doi.org/10.1038/nn2056			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297068	Green Accepted			2022-12-28	WOS:000253548300007
J	Arevian, AC; Kapoor, V; Urban, NN				Arevian, Armen C.; Kapoor, Vikrant; Urban, Nathaniel N.			Activity-dependent gating of lateral inhibition in the mouse olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT MOLECULAR-FEATURES; GRANULE CELLS; DENDRODENDRITIC INHIBITION; HORIZONTAL CONNECTIONS; RESPONSE PROPERTIES; REPRESENTATIONS; ORGANIZATION; MAPS; DISCRIMINATION; COMBINATORIAL	Lateral inhibition is a circuit motif found throughout the nervous system that often generates contrast enhancement and center-surround receptive fields. We investigated the functional properties of the circuits mediating lateral inhibition between olfactory bulb principal neurons (mitral cells) in vitro. We found that the lateral inhibition received by mitral cells is gated by postsynaptic firing, such that a minimum threshold of postsynaptic activity is required before effective lateral inhibition is recruited. This dynamic regulation allows the strength of lateral inhibition to be enhanced between cells with correlated activity. Simulations show that this regulation of lateral inhibition causes decorrelation of mitral cell activity that is evoked by similar stimuli, even when stimuli have no clear spatial structure. These results show that this previously unknown mechanism for specifying lateral inhibitory connections allows functional inhibitory connectivity to be dynamically remapped to relevant populations of neurons.	[Arevian, Armen C.; Urban, Nathaniel N.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Arevian, Armen C.; Kapoor, Vikrant; Urban, Nathaniel N.] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kapoor, Vikrant; Urban, Nathaniel N.] Carnegie Mellon Univ, Dept Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Urban, NN (corresponding author), Univ Pittsburgh, Ctr Neurosci, A210 Langley Hall, Pittsburgh, PA 15260 USA.	nurban@cmu.edu	Urban, Nathaniel/A-4974-2008	Urban, Nathaniel/0000-0002-0365-9068	NIDCD NIH HHS [F30 DC 008274, R01 DC 005798, F30 DC008274-02, R01 DC005798, F30 DC008274-03, F30 DC008274-01A2, F30 DC008274] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC008274, R01DC005798] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carlson GC, 2000, J NEUROSCI, V20, P2011; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnson BA, 2004, J COMP NEUROL, V480, P234, DOI 10.1002/cne.20335; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Linster C, 2005, J NEUROPHYSIOL, V93, P3410, DOI 10.1152/jn.01285.2004; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Meister M, 2001, J NEUROSCI, V21, P1351; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PRICE JL, 1970, J CELL SCI, V7, P125; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	42	128	130	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					80	87		10.1038/nn2030	http://dx.doi.org/10.1038/nn2030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084286	Green Accepted			2022-12-28	WOS:000252117900015
J	Colonnese, MT; Phillips, MA; Constantine-Paton, M; Kaila, K; Jasanoff, A				Colonnese, Matthew T.; Phillips, Marnie A.; Constantine-Paton, Martha; Kaila, Kai; Jasanoff, Alan			Development of hemodynamic responses and functional connectivity in rat somatosensory cortex	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; FETAL-BRAIN ACTIVITY; VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; OXYGEN-CONSUMPTION; BOLD; FMRI; INFANTS; STIMULATION; ACTIVATION	Functional magnetic resonance imaging (fMRI) is a valuable method for probing postnatal circuit refinement and plasticity. However, its use during early development has been hindered by uncertainty as to the nature of neurovascular coupling in young individuals. Here we used somatosensory stimulation in rats to determine age-related parameters of the blood oxygenation level-dependent (BOLD) signal from its apparent inception on postnatal day 13 to adulthood. By comparing fMRI measurements with electrophysiological recordings, we determined that the regional BOLD response in these animals undergoes a systematic decline in latency and growth in amplitude over this period. We found no evidence of negative BOLD at any age. Maturation of hemodynamic responses correlated with age-dependent increases in susceptibility to inhibition of carbonic anhydrase. With knowledge of the infant BOLD response characteristics, we showed that interhemispheric and higher-order cortical stimulus responses are enhanced during the first several weeks after birth.	[Colonnese, Matthew T.; Constantine-Paton, Martha] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Phillips, Marnie A.; Constantine-Paton, Martha; Jasanoff, Alan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Constantine-Paton, Martha] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kaila, Kai] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Jasanoff, Alan] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Helsinki; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Colonnese, MT (corresponding author), MIT, McGovern Inst Brain Res, 150 Albany St,NW14-2213, Cambridge, MA 02139 USA.	colonnese@inmed.univ-mrs.fr	Kaila, Kai K/R-8528-2016	Kaila, Kai K/0000-0003-0668-5955; Colonnese, Matthew/0000-0002-2480-1270				Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; APKON M, 1995, J PHYSIOL-LONDON, V484, P743, DOI 10.1113/jphysiol.1995.sp020700; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; BINMOLLER FJ, 1992, GLIA, V6, P127, DOI 10.1002/glia.440060207; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; BRION LP, 1988, ANAL BIOCHEM, V175, P289, DOI 10.1016/0003-2697(88)90391-0; Brown GG, 2003, J CEREBR BLOOD F MET, V23, P829, DOI 10.1097/01.WCB.0000071887.63724.B2; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Buxton R., 2002, INTRO FUNCTIONAL MAG; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAHLGREN N, 1981, ACTA PHYSIOL SCAND, V111, P475, DOI 10.1111/j.1748-1716.1981.tb06766.x; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Erberich SG, 2003, NEUROIMAGE, V20, P683, DOI 10.1016/S1053-8119(03)00370-7; Fulford J, 2004, HUM BRAIN MAPP, V22, P116, DOI 10.1002/hbm.20019; GRAMSBERGEN A, 1976, DEV PSYCHOBIOL, V9, P501, DOI 10.1002/dev.420090604; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HIMWICH WA, 1970, DEV NEUROBIOLOGY; Hykin J, 1999, LANCET, V354, P645, DOI 10.1016/S0140-6736(99)02901-3; KAUR C, 1989, ACTA ANAT, V136, P204; KELLY PAT, 1995, J CEREBR BLOOD F MET, V15, P766, DOI 10.1038/jcbfm.1995.96; Kourtzi Z, 2006, MAGN RESON IMAGING, V24, P359, DOI 10.1016/j.mri.2005.12.025; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mueggler T, 2001, MAGNET RESON MED, V46, P292, DOI 10.1002/mrm.1190; Muramoto S, 2002, J COMPUT ASSIST TOMO, V26, P894, DOI 10.1097/00004728-200211000-00007; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; Olavarria JF, 2006, J COMP NEUROL, V496, P495, DOI 10.1002/cne.20938; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Ramos-Cabrer P, 2005, NMR BIOMED, V18, P440, DOI 10.1002/nbm.978; Richter W, 2003, NEUROIMAGE, V20, P1122, DOI 10.1016/S1053-8119(03)00347-1; RODMAN HR, 1993, J NEUROPHYSIOL, V70, P1115, DOI 10.1152/jn.1993.70.3.1115; ROWAN RA, 1981, AM J ANAT, V160, P247, DOI 10.1002/aja.1001600303; Ruusuvuori E, 2004, J NEUROSCI, V24, P2699, DOI 10.1523/JNEUROSCI.5176-03.2004; Sanders RD, 2005, BRIT J ANAESTH, V95, P393, DOI 10.1093/bja/aei182; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Stout RW, 2001, COMPARATIVE MED, V51, P524; SWENSON ER, 1978, RESP PHYSIOL, V35, P129, DOI 10.1016/0034-5687(78)90018-X; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; WISTRAND PJ, 1981, ACTA PHYSIOL SCAND, V113, P417, DOI 10.1111/j.1748-1716.1981.tb06918.x; Wu CC, 1997, J COMP NEUROL, V384, P323, DOI 10.1002/(SICI)1096-9861(19970804)384:3<323::AID-CNE1>3.0.CO;2-5; Yamada H, 1997, NEUROREPORT, V8, P3775, DOI 10.1097/00001756-199712010-00024	49	92	92	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					72	79		10.1038/nn2017	http://dx.doi.org/10.1038/nn2017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18037883				2022-12-28	WOS:000252117900014
J	Amodio, DM; Jost, JT; Master, SL; Yee, CM				Amodio, David M.; Jost, John T.; Master, Sarah L.; Yee, Cindy M.			Neurocognitive correlates of liberalism and conservatism	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE; ERROR-DETECTION; CONFLICT	Political scientists and psychologists have noted that, on average, conservatives show more structured and persistent cognitive styles, whereas liberals are more responsive to informational complexity, ambiguity and novelty. We tested the hypothesis that these profiles relate to differences in general neurocognitive functioning using event-related potentials, and found that greater liberalism was associated with stronger conflict-related anterior cingulate activity, suggesting greater neurocognitive sensitivity to cues for altering a habitual response pattern.	NYU, Dept Psychol, New York, NY 10003 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	New York University; University of California System; University of California Los Angeles	Amodio, DM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	david.amodio@nyu.edu	sarinopoulos, isidoros/B-5453-2010	Jost, John/0000-0002-2844-4645				Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Block J, 2006, J RES PERS, V40, P734, DOI 10.1016/j.jrp.2005.09.005; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; DeHaven RN, 2005, CURR TOP MED CHEM, V5, P303, DOI 10.2174/1568026053544542; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kaplan JT, 2007, NEUROPSYCHOLOGIA, V45, P55, DOI 10.1016/j.neuropsychologia.2006.04.024; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Knutson KM, 2006, SOC NEUROSCI-UK, V1, P25, DOI 10.1080/17470910600670603; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	14	316	320	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1246	1247		10.1038/nn1979	http://dx.doi.org/10.1038/nn1979			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	214FG	17828253				2022-12-28	WOS:000249720800010
J	Assisi, C; Stopfer, M; Laurent, G; Bazhenov, M				Assisi, Collins; Stopfer, Mark; Laurent, Gilles; Bazhenov, Maxim			Adaptive regulation of sparseness by feedforward inhibition	NATURE NEUROSCIENCE			English	Article							LOCUST ANTENNAL LOBE; OSCILLATING NEURAL ASSEMBLIES; OLFACTORY NETWORK DYNAMICS; ODOR REPRESENTATIONS; SYSTEM; CELLS; MODEL; SYNCHRONIZATION; INFORMATION; MECHANISMS	In the mushroom body of insects, odors are represented by very few spikes in a small number of neurons, a highly efficient strategy known as sparse coding. Physiological studies of these neurons have shown that sparseness is maintained across thousand-fold changes in odor concentration. Using a realistic computational model, we propose that sparseness in the olfactory system is regulated by adaptive feedforward inhibition. When odor concentration changes, feedforward inhibition modulates the duration of the temporal window over which the mushroom body neurons may integrate excitatory presynaptic input. This simple adaptive mechanism could maintain the sparseness of sensory representations across wide ranges of stimulus conditions.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; NICHHD, US NIH, Bethesda, MD 20892 USA; CALTECH, Pasadena, CA 91125 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); California Institute of Technology	Bazhenov, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bazhenov@salk.edu	Laurent, Gilles/A-4583-2012; Assisi, Collins/R-7467-2016	Laurent, Gilles/0000-0002-2296-114X; Assisi, Collins/0000-0003-0108-582X; Stopfer, Mark/0000-0001-9200-1884	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006306] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCD NIH HHS [R01 DC006306-01A1, R01 DC006306] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Anton S., 1999, INSECT OLFACTION; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; ERNST KD, 1977, CELL TISSUE RES, V176, P285, DOI 10.1007/BF00221789; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kanerva P., 1988, SPARSE DISTRIBUTED M; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005	43	80	80	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1176	1184		10.1038/nn1947	http://dx.doi.org/10.1038/nn1947			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660812	Green Accepted			2022-12-28	WOS:000249144000020
J	Shima, Y; Kawaguchi, S; Kosaka, K; Nakayama, M; Hoshino, M; Nabeshima, Y; Hirano, T; Uemura, T				Shima, Yasuyuki; Kawaguchi, Shin-ya; Kosaka, Kazuyoshi; Nakayama, Manabu; Hoshino, Mikio; Nabeshima, Yoichi; Hirano, Tomoo; Uemura, Tadashi			Opposing roles in neurite growth control by two seven-pass transmembrane cadherins	NATURE NEUROSCIENCE			English	Article							CELL POLARIZATION; IN-VIVO; DROSOPHILA; FLAMINGO; GENES; AXON; SUPERFAMILY; RECEPTOR; POLARITY; CALCIUM	The growth of neurites (axon and dendrite) should be appropriately regulated by their interactions in the development of nervous systems where a myriad of neurons and their neurites are tightly packed. We show here that mammalian seven-pass transmembrane cadherins Celsr2 and Celsr3 are activated by their homophilic interactions and regulate neurite growth in an opposing manner. Both gene-silencing and coculture assay with rat neuron cultures showed that Celsr2 enhanced neurite growth, whereas Celsr3 suppressed it, and that their opposite functions were most likely the result of a difference of a single amino acid residue in the transmembrane domain. Together with calcium imaging and pharmacological analyses, our results suggest that Celsr2 and Celsr3 fulfill their functions through second messengers, and that differences in the activities of the homologs results in opposite effects in neurite growth regulation.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068501, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan; Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Brandeis University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kazusa DNA Research Institute; Kyoto University	Uemura, T (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 S St, Waltham, MA 02454 USA.	tauemura@lif.kyoto-u.ac.jp	Kawaguchi, Shin-ya/X-4166-2018	Kawaguchi, Shin-ya/0000-0002-8386-1185; UEMURA, Tadashi/0000-0001-7204-3606				Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Harmar AJ, 2001, GENOME BIOL, V2; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tanabe K, 2004, DEV DYNAM, V229, P899, DOI 10.1002/dvdy.10493; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang YS, 2002, J NEUROSCI, V22, P8563; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yagi T, 2000, GENE DEV, V14, P1169; Ye B, 2005, TRENDS CELL BIOL, V15, P64, DOI 10.1016/j.tcb.2004.12.003	46	115	116	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					963	969		10.1038/nn1933	http://dx.doi.org/10.1038/nn1933			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618280				2022-12-28	WOS:000248357500010
J	Di Giorgio, FP; Carrasco, MA; Siao, MC; Maniatis, T; Eggan, K				Di Giorgio, Francesco Paolo; Carrasco, Monica A.; Siao, Michelle C.; Maniatis, Tom; Eggan, Kevin			Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; EXTEND SURVIVAL; MOUSE EMBRYOS; DISEASE; DEGENERATION; MUTATIONS; GENE; DIFFERENTIATION	Here we report an in vitro model system for studying the molecular and cellular mechanisms that underlie the neurodegenerative disease amyotrophic lateral sclerosis ( ALS). Embryonic stem cells ( ESCs) derived from mice carrying normal or mutant transgenic alleles of the human SOD1 gene were used to generate motor neurons by in vitro differentiation. These motor neurons could be maintained in long-term coculture either with additional cells that arose during differentiation or with primary glial cells. Motor neurons carrying either the nonpathological human SOD1 transgene or the mutant SOD1G93A allele showed neurodegenerative properties when cocultured with SOD1G93A glial cells. Thus, our studies demonstrate that glial cells carrying a human SOD1G93A mutation have a direct, non - cell autonomous effect on motor neuron survival. More generally, our results show that ESC- based models of disease provide a powerful tool for studying the mechanisms of neural degeneration. These phenotypes displayed in culture could provide cell- based assays for the identification of new ALS drugs.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Stem Cell Inst, Stowers Med Inst, Cambridge, MA 02138 USA; Univ Perugia, I-06100 Perugia, Italy	Harvard University; Harvard University; Stowers Institute for Medical Research; University of Perugia	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	maniatis@mcb.harvard.edu; eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018	Siao, Michelle/0000-0002-3600-9483	NICHD NIH HHS [R01 HD046732, R01 HD046732-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS043915-27, R01 NS043915] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BANKER G, 1998, CULTURING NERVE CELL; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Ben-Nun IF, 2006, MOL CELL ENDOCRINOL, V252, P154, DOI 10.1016/j.mce.2006.03.034; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cole N, 1999, SEMIN NEUROL, V19, P407, DOI 10.1055/s-2008-1040855; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hogan B, 1994, MANIPULATING MOUSE E; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	32	613	647	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					608	614		10.1038/nn1885	http://dx.doi.org/10.1038/nn1885			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435754	Green Accepted			2022-12-28	WOS:000245948000017
J	Jiang, Y; Zhou, K; He, S				Jiang, Yi; Zhou, Ke; He, Sheng			Human visual cortex responds to invisible chromatic flicker	NATURE NEUROSCIENCE			English	Article							OCCIPITAL CORTEX; COLOR; AWARENESS; ADAPTATION; ACHROMATOPSIA; FEEDFORWARD; PERCEPTION; SIGNAL; AREA	When two isoluminant colors alternate at frequencies of 25 Hz or higher, observers perceive only one fused color. Chromatic flicker beyond the fusion frequency induces flicker adaptation in human observers and stimulates monkey V1 neurons. Here we use functional magnetic resonance imaging ( fMRI) to show that many human visual cortical areas, with the exception of VO, can distinguish between fused chromatic flicker and its matched nonflickering control. This result supports the existence of significant intracortical temporal filtering of high-frequency chromatic information. The result also suggests that a considerable difference in cortical activation in many visual cortical areas does not necessarily lead to different conscious experiences.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Chinese Acad Sci, Grad Sch, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	sheng@umn.edu	Jiang, Yi/I-1688-2018; Zhou, Ke/B-6745-2014	Jiang, Yi/0000-0002-5746-7301; 	NATIONAL EYE INSTITUTE [R01EY015261] Funding Source: NIH RePORTER; NEI NIH HHS [EY-015261-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLAKE R, 2005, FITTING MIND WORLD A; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Brown JL, 1965, VISION VISUAL PERCEP; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; Davison AC, 1997, BOOTSTRAP METHODS TH; DELANGEDZN H, 1958, J OPT SOC AM, V48, P784, DOI 10.1364/JOSA.48.000784; Efron B., 1994, MONOGRAPHS STAT APPL; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Juan CH, 2003, PROG BRAIN RES, V144, P117, DOI 10.1016/S0079-6123(03)14400-8; KELLY DH, 1971, J OPT SOC AM, V61, P537, DOI 10.1364/JOSA.61.000537; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2001, ACTA PSYCHOL, V107, P209, DOI 10.1016/S0001-6918(01)00020-8; Liu JJ, 2005, J NEUROSCI, V25, P3459, DOI 10.1523/JNEUROSCI.4206-04.2005; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MATIN L, 1968, J OPT SOC AM, V58, P404, DOI 10.1364/JOSA.58.000404; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PEARLMAN AL, 1979, ANN NEUROL, V5, P253, DOI 10.1002/ana.410050307; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; Steven MS, 2006, CORTEX, V42, P304, DOI 10.1016/S0010-9452(08)70356-3; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721	32	78	78	5	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					657	662		10.1038/nn1879	http://dx.doi.org/10.1038/nn1879			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396122				2022-12-28	WOS:000245948000023
J	Brown, RM; Robertson, EM				Brown, Rachel M.; Robertson, Edwin M.			Inducing motor skill improvements with a declarative task	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; MEMORY; SLEEP; CONSOLIDATION; SYSTEMS	During sequence learning, individuals show motor- skill acquisition and an ability to verbally describe items within the sequence. We disrupted this latter, declarative component by having participants learn a word list immediately after sequence learning. This induced off- line skill improvements. We conclude that off- line memory processing relies not only on the engagement of neuroplastic mechanisms but also on the disengagement of an interaction between declarative and procedural memory systems.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Robertson, EM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, 330 Brookline Ave,Kirstein Bldg KS 446, Boston, MA 02215 USA.	emrobert@bidmc.harvard.edu		Brown, Rachel M./0000-0002-4851-8429	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051446] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051446] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Willingham DB, 1997, NEURON, V18, P5, DOI 10.1016/S0896-6273(01)80040-4; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047	12	93	93	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					148	149		10.1038/nn1836	http://dx.doi.org/10.1038/nn1836			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237776	Green Accepted			2022-12-28	WOS:000244175200007
J	Kim, YJ; Grabowecky, M; Paller, KA; Muthu, K; Suzuki, S				Kim, Yee Joon; Grabowecky, Marcia; Paller, Ken A.; Muthu, Krishnakumar; Suzuki, Satoru			Attention induces synchronization-based response gain in steady-state visual evoked potentials	NATURE NEUROSCIENCE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; FREQUENCY SELECTIVITY; CORTICAL-NEURONS; MODULATION; CORTEX; DISCRIMINATION; SENSITIVITY; COMPETITION; MECHANISMS; DYNAMICS	When attention is voluntarily directed to a spatial location, visual sensitivity increases at that location. What causes this improved sensitivity? Studies of single neuron spike rates in monkeys have provided mixed results in regard to whether attending to a stimulus increases its effective contrast ( contrast gain) or multiplicatively boosts stimulus-driven neural responses ( response or activity gain). We monitored frequency-tagged steady-state visual evoked potentials (SSVEPs) in humans and found that voluntary sustained attention multiplicatively increased stimulus-driven population electrophysiological activity. Analyses of intertrial phase coherence showed that this attentional response gain was at least partially due to the increased synchronization of SSVEPs to stimulus flicker. These results suggest that attention operates in a complementary manner at different levels; attention seems to increase single-neuron spike rates in a variety of ways, including contrast, response and activity gains, while also inducing a multiplicative boost on neural population activity via enhanced response synchronization.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd, Evanston, IL 60208 USA.	satoru@northwestern.edu	Paller, Ken/M-2676-2019	Paller, Ken/0000-0003-4415-4143	NEI NIH HHS [EY14110] Funding Source: Medline; NINDS NIH HHS [NS34639] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034639, R29NS034639] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hou C, 2003, J NEUROSCI, V23, P8630; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Regan D., 1989, HUMAN BRAIN ELECTROP; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; SCHILLER PH, 1990, VISUAL NEUROSCI, V5, P321, DOI 10.1017/S0952523800000420; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	50	168	170	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					117	125		10.1038/nn1821	http://dx.doi.org/10.1038/nn1821			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173045				2022-12-28	WOS:000243096100023
J	Koida, K; Komatsu, H				Koida, Kowa; Komatsu, Hidehiko			Effects of task demands on the responses of color-selective neurons in the inferior temporal cortex	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; MACAQUE VISUAL-CORTEX; AREA V4; INFEROTEMPORAL CORTEX; SINGLE NEURONS; RECOGNITION MEMORY; ATTENTION; DISCRIMINATION; MONKEYS; SEARCH	Categorization and fine discrimination are two different functions in visual perception, and we can switch between these two functions depending on the situation or task demands. To explore how visual cortical neurons behave in such situations, we recorded the activities of color-selective neurons in the inferior temporal ( IT) cortex of two monkeys trained to perform a color categorization task, a color discrimination task and a simple fixation task. Many IT neurons changed their activity depending upon the task, although color selectivity was well conserved. A majority of neurons showed stronger responses during the categorization task. Moreover, for the population of IT neurons as a whole, signals contributing to performing the categorization task were enhanced. These results imply that judgment of color category by color-selective IT neurons is facilitated during the categorization task and suppressed during the discrimination task as a consequence of task-dependent modulation of their activities.	Natl Inst Physiol Sci, Div Sensory & Cognit Informat, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Komatsu, H (corresponding author), Natl Inst Physiol Sci, Div Sensory & Cognit Informat, Okazaki, Aichi 4448585, Japan.	komatsu@nips.ac.jp	Koida, Kowa/F-5712-2010	Koida, Kowa/0000-0003-0156-3406				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bornstein MH., 1987, CATEGORICAL PERCEPTI, P287; Buckley MJ, 1997, J NEUROPHYSIOL, V77, P587, DOI 10.1152/jn.1997.77.2.587; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Conner CE, 1997, J NEUROSCI, V17, P3201; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; ESKANDAR EN, 1992, J NEUROPHYSIOL, V68, P1277, DOI 10.1152/jn.1992.68.4.1277; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; HEYWOOD CA, 1995, EUR J NEUROSCI, V7, P1064, DOI 10.1111/j.1460-9568.1995.tb01093.x; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Huxlin KR, 2000, CEREB CORTEX, V10, P671, DOI 10.1093/cercor/10.7.671; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kaiser P.K, 1996, HUMAN COLOR VISION; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOMATSU H, 1992, J NEUROSCI, V12, P408; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MIKAMI A, 1980, BRAIN RES, V182, P65, DOI 10.1016/0006-8993(80)90830-6; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; RICHMOND BJ, 1987, J NEUROPHYSIOL, V58, P1292, DOI 10.1152/jn.1987.58.6.1292; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Suzuki W, 2006, J NEUROSCI, V26, P10524, DOI 10.1523/JNEUROSCI.1532-06.2006; Takechi H, 1997, NEUROSCI LETT, V230, P17, DOI 10.1016/S0304-3940(97)00461-8; Takeda M, 2005, NEURON, V48, P839, DOI 10.1016/j.neuron.2005.09.028; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	47	88	89	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					108	116		10.1038/nn1823	http://dx.doi.org/10.1038/nn1823			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173044				2022-12-28	WOS:000243096100022
J	Ding, J; Guzman, JN; Tkatch, T; Chen, SH; Goldberg, JA; Ebert, PJ; Levitt, P; Wilson, CJ; Hamm, HE; Surmeier, DJ				Ding, Jun; Guzman, Jaime N.; Tkatch, Tatiana; Chen, Songhai; Goldberg, Joshua A.; Ebert, Philip J.; Levitt, Pat; Wilson, Charles J.; Hamm, Heidi E.; Surmeier, D. James			RGS4-dependent attenuation of M-4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion	NATURE NEUROSCIENCE			English	Article							RGS MESSENGER-RNAS; REDUCE N-TYPE; BASAL GANGLIA; RECEPTOR SUPERSENSITIVITY; ACETYLCHOLINE-RELEASE; PARKINSONS-DISEASE; SYNTHETIC PEPTIDES; ALPHA-SUBUNITS; CA2+ CURRENTS; RAT STRIATUM	Parkinson disease is a neurodegenerative disorder whose symptoms are caused by the loss of dopaminergic neurons innervating the striatum. As striatal dopamine levels fall, striatal acetylcholine release rises, exacerbating motor symptoms. This adaptation is commonly attributed to the loss of interneuronal regulation by inhibitory D-2 dopamine receptors. Our results point to a completely different, new mechanism. After striatal dopamine depletion, D2 dopamine receptor modulation of calcium (Ca2+) channels controlling vesicular acetylcholine release in interneurons was unchanged, but M-4 muscarinic autoreceptor coupling to these same channels was markedly attenuated. This adaptation was attributable to the upregulation of RGS4-an autoreceptor-associated, GTPase-accelerating protein. This specific signaling adaptation extended to a broader loss of autoreceptor control of interneuron spiking. These observations suggest that RGS4-dependent attenuation of interneuronal autoreceptor signaling is a major factor in the elevation of striatal acetylcholine release in Parkinson disease.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Texas, Dept Biol, San Antonio, TX 78249 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; Vanderbilt University; Vanderbilt University	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Wilson, Charles/D-2529-2011; Hamm, Heidi E/G-2374-2014; Ding, Jun/B-2513-2009; Goldberg, Joshua/B-3398-2009	Wilson, Charles/0000-0002-9004-2145; Ding, Jun/0000-0003-0690-1312; Ebert, Philip/0000-0002-8945-2948; Goldberg, Joshua/0000-0002-5740-4087; Tkatch, Tatiana/0000-0001-6626-7435; chen, songhai/0000-0001-7316-7125	NICHD NIH HHS [HD15052] Funding Source: Medline; NIMH NIH HHS [T32 MH065215, MH45156, MH065215] Funding Source: Medline; NINDS NIH HHS [32 NS 050900, NS 34696, NS 37760] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R01NS037760, F32NS050900, R37NS034696, R37NS037760] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Calabresi P, 1998, J PHYSIOL-LONDON, V510, P421, DOI 10.1111/j.1469-7793.1998.421bk.x; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; DOLEZAL V, 1990, J PHARMACOL EXP THER, V252, P739; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; FREUND TF, 1985, J NEUROSCI, V5, P603; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Geurts M, 2002, NEUROSCI LETT, V333, P146, DOI 10.1016/S0304-3940(02)01004-2; GOLARD A, 1993, J NEUROSCI, V13, P3884; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HU XT, 1990, J NEUROSCI, V10, P2318; Inanobe A, 2001, J PHYSIOL-LONDON, V535, P133, DOI 10.1111/j.1469-7793.2001.t01-1-00133.x; JOYCE JN, 1991, EXP NEUROL, V113, P277, DOI 10.1016/0014-4886(91)90017-7; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; MACKENZIE RG, 1989, EUR J PHARMACOL, V168, P43, DOI 10.1016/0014-2999(89)90631-6; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; MILESON BE, 1991, BRAIN RES, V561, P1, DOI 10.1016/0006-8993(91)90742-E; NASTUK MA, 1985, J COMP NEUROL, V237, P176, DOI 10.1002/cne.902370204; Ni YG, 1999, J NEUROSCI, V19, P3674; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; UEDA H, 1995, BIOMED PHARMACOTHER, V49, P169, DOI 10.1016/0753-3322(96)82617-5; WICHMANN T, 1988, N-S ARCH PHARMACOL, V338, P623, DOI 10.1007/BF00165626; WOOTEN GF, 1990, NEUROBIOL DIS, P454; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yan Z, 1996, J NEUROSCI, V16, P2592; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; ZHANG W, 2000, J NEUROSCI, V22, P1709	49	181	184	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					832	842		10.1038/nn1700	http://dx.doi.org/10.1038/nn1700			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699510				2022-12-28	WOS:000237895200024
J	Koizumi, H; Higginbotham, H; Poon, T; Tanaka, T; Brinkman, BC; Gleeson, JG				Koizumi, Hiroyuki; Higginbotham, Holden; Poon, Tiffany; Tanaka, Teruyuki; Brinkman, Brendan C.; Gleeson, Joseph G.			Doublecortin maintains bipolar shape and nuclear translocation during migration in the adult forebrain	NATURE NEUROSCIENCE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; RAT OLFACTORY-BULB; NEURONAL MIGRATION; DIRECTIONAL GUIDANCE; CELL-MIGRATION; SUBVENTRICULAR ZONE; RADIAL MIGRATION; GRANULE NEURONS; CHAIN-MIGRATION; MAMMALIAN BRAIN	The ability of the mature mammalian nervous system to continually produce neuronal precursors is of considerable importance, as manipulation of this process might one day permit the replacement of cells lost as a result of injury or disease. In mammals, the anterior subventricular zone (SVZa) region is one of the primary sites of adult neurogenesis. Here we show that doublecortin (DCX), a widely used marker for newly generated neurons, when deleted in mice results in a severe morphological defect in the rostral migratory stream and delayed neuronal migration that is independent of direction or responsiveness to Slit chemorepulsion. DCX is required for nuclear translocation and maintenance of bipolar morphology during migration of these cells. Our data identifies a critical function for DCX in the movement of newly generated neurons in the adult brain.	Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [R01 NS04387, NS02331, R01 NS041537, R01 NS47101] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BRINON JG, 1992, CELL TISSUE RES, V269, P289, DOI 10.1007/BF00319620; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chazal G, 2000, J NEUROSCI, V20, P1446; Corbo JC, 2002, J NEUROSCI, V22, P7548; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Liu GF, 2003, J NEUROSCI, V23, P6651; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Murase S, 2002, J NEUROSCI, V22, P3568; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Petreanu L, 2002, J NEUROSCI, V22, P6106; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Ward M, 2003, J NEUROSCI, V23, P5170; Ward ME, 2005, MOL CELL NEUROSCI, V30, P378, DOI 10.1016/j.mcn.2005.08.002; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619	49	179	185	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					779	786		10.1038/nn1704	http://dx.doi.org/10.1038/nn1704			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699506	Green Submitted			2022-12-28	WOS:000237895200018
J	Meshi, D; Drew, MR; Saxe, M; Ansorge, MS; David, D; Santarelli, L; Malapani, C; Moore, H; Hen, R				Meshi, Dar; Drew, Michael R.; Saxe, Michael; Ansorge, Mark S.; David, Denis; Santarelli, Luca; Malapani, Chariklia; Moore, Holly; Hen, Rene			Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; DENTATE GYRUS; EXPRESSION; NEURONS; MICE	Environmental enrichment increases adult hippocampal neurogenesis and alters hippocampal-dependent behavior in rodents. To investigate a causal link between these two observations, we analyzed the effect of enrichment on spatial learning and anxiety-like behavior while blocking adult hippocampal neurogenesis. We report that environmental enrichment alters behavior in mice regardless of their hippocampal neurogenic capability, providing evidence that the newborn cells do not mediate these effects of enrichment.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, Biopsychol Unit, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Univ Paris Sud, Fac Pharm, F-92296 Chatenay Malabry, France	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; UDICE-French Research Universities; Universite Paris Saclay	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	rh95@columbia.edu	DAVID, Denis/K-1173-2014; Drew, Michael R/M-4787-2016; ansorge, mark s/L-1360-2014	DAVID, Denis/0000-0002-0506-6688; Drew, Michael R/0000-0002-3883-1542; Meshi, Dar/0000-0003-0772-037X	NIMH NIH HHS [5T32MH018264-22, 5R01MH068542-03, 5F31MH069089-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018264, R01MH068542, F31MH069089] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	15	353	367	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					729	731		10.1038/nn1696	http://dx.doi.org/10.1038/nn1696			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648847				2022-12-28	WOS:000237895200009
J	Narain, C				Narain, C			Going down BOLDly	NATURE NEUROSCIENCE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					474	474		10.1038/nn0406-474	http://dx.doi.org/10.1038/nn0406-474			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16568106	Bronze			2022-12-28	WOS:000236310700009
J	Levitan, IB				Levitan, IB			Signaling protein complexes associated with neuronal ion channels	NATURE NEUROSCIENCE			English	Review							CA2+-ACTIVATED K+ CHANNELS; CGMP-GATED CHANNEL; POTASSIUM CHANNEL; BETA-SUBUNIT; SKELETAL-MUSCLE; GENE-EXPRESSION; SODIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; SLOWPOKE CHANNEL; TYROSINE KINASE	The pore-forming subunits of many ion channels exist in the membrane as one component of a regulatory protein complex, which may also contain one or more signaling proteins that contribute to the modulation of channel properties. Here I review this field, with emphasis on several different kinds of neuronal potassium channels for which the evidence for ion channel signaling complexes is most compelling. A key challenge for the future is to determine the roles of such signaling protein complexes in neuronal physiology and behavior.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Levitan, IB (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	levitani@mail.med.upenn.edu						An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BARCHI RL, 1983, J NEUROCHEM, V40, P1377, DOI 10.1111/j.1471-4159.1983.tb13580.x; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Bonigk W, 1996, J NEUROSCI, V16, P7458; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cloues RK, 2003, J NEUROSCI, V23, P1593; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; DOLLY JO, 1994, BIOCHEM SOC T, V22, P473, DOI 10.1042/bst0220473; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; FERRIS CD, 1992, J BIOL CHEM, V267, P7036; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; HUCHO F, 1973, FEBS LETT, V38, P11, DOI 10.1016/0014-5793(73)80500-9; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NAKAJO S, 1988, J BIOCHEM-TOKYO, V104, P946, DOI 10.1093/oxfordjournals.jbchem.a122588; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; PICTON C, 1980, EUR J BIOCHEM, V111, P553, DOI 10.1111/j.1432-1033.1980.tb04971.x; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; REINHART PH, 1995, J NEUROSCI, V15, P4572; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Selyanko AA, 1999, J NEUROSCI, V19, P7742; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; SIGEL E, 1983, J BIOL CHEM, V258, P6965; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; VALDERRAMA R, 1976, ANN NY ACAD SCI, V274, P108, DOI 10.1111/j.1749-6632.1976.tb47679.x; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WANG J, 1999, J NEUROSCI, V19, P1; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia XM, 1998, J NEUROSCI, V18, P2360; Xia XM, 2000, J NEUROSCI, V20, P4890; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422; YU FH, 2004, SCI STKE; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zeng HY, 2005, J GEN PHYSIOL, V125, P631, DOI 10.1085/jgp.200509252; Zeng HY, 2004, NEUROSCI LETT, V365, P33, DOI 10.1016/j.neulet.2004.04.043; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	100	91	93	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					305	310		10.1038/nn1647	http://dx.doi.org/10.1038/nn1647			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16498425				2022-12-28	WOS:000235645600008
